PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Becker, V; Schilling, M; Bachmann, J; Baumann, U; Raue, A; Maiwald, T; Timmer, J; Klingmuller, U				Becker, Verena; Schilling, Marcel; Bachmann, Julie; Baumann, Ute; Raue, Andreas; Maiwald, Thomas; Timmer, Jens; Klingmueller, Ursula			Covering a Broad Dynamic Range: Information Processing at the Erythropoietin Receptor	SCIENCE			English	Article							EPIDERMAL-GROWTH-FACTOR; SIGNAL-TRANSDUCTION; SURFACE; INTERNALIZATION; ENDOCYTOSIS; GENERATION; ACTIVATION; EXPRESSION; CELLS	Cell surface receptors convert extracellular cues into receptor activation, thereby triggering intracellular signaling networks and controlling cellular decisions. A major unresolved issue is the identification of receptor properties that critically determine processing of ligand-encoded information. We show by mathematical modeling of quantitative data and experimental validation that rapid ligand depletion and replenishment of the cell surface receptor are characteristic features of the erythropoietin (Epo) receptor (EpoR). The amount of Epo-EpoR complexes and EpoR activation integrated over time corresponds linearly to ligand input; this process is carried out over a broad range of ligand concentrations. This relation depends solely on EpoR turnover independent of ligand binding, which suggests an essential role of large intracellular receptor pools. These receptor properties enable the system to cope with basal and acute demand in the hematopoietic system.	[Becker, Verena; Schilling, Marcel; Bachmann, Julie; Baumann, Ute; Klingmueller, Ursula] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Syst Biol Signal Transduct, D-69120 Heidelberg, Germany; [Becker, Verena; Klingmueller, Ursula] Univ Heidelberg, D-69120 Heidelberg, Germany; [Raue, Andreas; Maiwald, Thomas; Timmer, Jens] Univ Freiburg, Inst Phys, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Freiburg Inst Adv Studies, D-79104 Freiburg, Germany; [Timmer, Jens] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79104 Freiburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Freiburg; University of Freiburg; University of Freiburg	Klingmuller, U (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, Div Syst Biol Signal Transduct, D-69120 Heidelberg, Germany.	u.klingmueller@dkfz-heidelberg.de	Schilling, Marcel/A-4426-2008; Klingmüller, Ursula/G-8477-2013	Schilling, Marcel/0000-0002-9517-5166; Klingmüller, Ursula/0000-0001-9845-3099	Helmholtz Alliance on Systems Biology (SBCancer); German Federal Ministry of Education and Research (BMBF); Excellence Initiative of the German Federal and State Governments [EXC 294]	Helmholtz Alliance on Systems Biology (SBCancer); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal and State Governments	We thank R. Eils, U. Kummer, R. Meyer, A. C. Pfeifer, J. P. Schloder, C. Schultz, and V. Starkuviene for critically reading the manuscript; S. N. Constantinescu for HA-EpoR constructs; and S. Manthey and S. Lattermann for technical assistance. This work was supported by the Helmholtz Alliance on Systems Biology (SBCancer) (V.B., M.S., J.T., and U.K.), the German Federal Ministry of Education and Research (BMBF)-funded MedSys-Network LungSys (J.B., A.R., and U.K.), and the Excellence Initiative of the German Federal and State Governments (EXC 294) (J.T.).	BAJZER Z, 1989, J BIOL CHEM, V264, P13623; Beckman DL, 1999, BLOOD, V94, P2667, DOI 10.1182/blood.V94.8.2667.420k27_2667_2675; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Jelkmann W, 2004, INTERNAL MED, V43, P649, DOI 10.2169/internalmedicine.43.649; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Macdougall IC, 2006, LANCET, V368, P947, DOI 10.1016/S0140-6736(06)69120-4; Price KS, 2003, AM J RESP CELL MOL, V28, P420, DOI 10.1165/rcmb.2002-0155OC; RAUE A, 1923, BIOINFORMATICS, V25, P2009; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; WILEY HS, 1991, J BIOL CHEM, V266, P11083; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; YOSHIMURA A, 1990, P NATL ACAD SCI USA, V87, P4139, DOI 10.1073/pnas.87.11.4139; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223	17	113	114	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1404	1408		10.1126/science.1184913	http://dx.doi.org/10.1126/science.1184913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20488988				2022-12-28	WOS:000278598400041
J	Beyea, J				Beyea, Jan			The Smart Electricity Grid and Scientific Research	SCIENCE			English	Editorial Material							SCIENCE; CANCER		Consulting Publ Interest, Lambertville, NJ 08530 USA		Beyea, J (corresponding author), Consulting Publ Interest, Lambertville, NJ 08530 USA.	jbeyea@cipi.com	Beyea, Jan/E-6505-2016	Beyea, Jan/0000-0002-0547-880X				*CEN, WORKSH DAT PROT PRIV; CERN, WORLDW LHC COMP GRID; Drenker S, 1999, IEEE COMPUT APPL POW, V12, P47, DOI 10.1109/67.795138; ELMAHRSI MK, 2009, P 3 INT C RES CHALL; Enfield KB, 2008, RESP CARE, V53, P1330; Faruqui A, 2009, ELECT J, V22, P55, DOI [10.1016/j.tej.2009.06.012, DOI 10.1016/J.TEJ.2009.06.012]; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Hey AJG, 2003, GRID COMPUTING MAKIN, P809, DOI DOI 10.1002/0470867167.CH36; Jones Douglas N., 2001, ENERGY L J, V22, P41; KING M, 2007, ELECT J, V20, P38; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LERNER JI, 2008, STANFORD TECHNOL LAW, P3; Lisovich M.A., 2008, CLEMS POW SYST C 200, V1, P1; Meyers RJ, 2010, ENERG BUILDINGS, V42, P563, DOI 10.1016/j.enbuild.2009.10.026; Mezei G, 2008, EPIDEMIOLOGY, V19, P424, DOI 10.1097/EDE.0b013e3181690715; Newborough M, 1999, IEE P-GENER TRANSM D, V146, P283, DOI 10.1049/ip-gtd:19990318; *OFF SCI TECHN POL, CONS INT SMART GRID; Pringle H, 2010, SCIENCE, V327, P1322, DOI 10.1126/science.327.5971.1322; Prudenzi A, 2002, 2002 IEEE POWER ENGINEERING SOCIETY WINTER MEETING, VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P941, DOI 10.1109/PESW.2002.985144; Rice TW, 2008, RESP CARE, V53, P1325; Roberts S, 2008, ENERG POLICY, V36, P4552, DOI 10.1016/j.enpol.2008.09.012; Strbac G, 2008, ENERG POLICY, V36, P4419, DOI 10.1016/j.enpol.2008.09.030; SULTANEM F, 1991, IEEE T POWER DELIVER, V6, P1380, DOI 10.1109/61.97667; *US NIST, 2009, 7628 US NIST NISTIR; Venables Mark, 2009, Engineering & Technology, V4, P10, DOI 10.1049/et.2009.1800	25	21	21	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2010	328	5981					979	980		10.1126/science.1189229	http://dx.doi.org/10.1126/science.1189229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	598YW	20489008				2022-12-28	WOS:000277877100023
J	Krauss, LM; Dodelson, S; Meyer, S				Krauss, Lawrence M.; Dodelson, Scott; Meyer, Stephan			Primordial Gravitational Waves and Cosmology	SCIENCE			English	Review							INFLATIONARY UNIVERSE; GRAND UNIFICATION; POLARIZATION; FLATNESS; HORIZON; CMB	The observation of primordial gravitational waves could provide a new and unique window on the earliest moments in the history of the universe and on possible new physics at energies many orders of magnitude beyond those accessible at particle accelerators. Such waves might be detectable soon, in current or planned satellite experiments that will probe for characteristic imprints in the polarization of the cosmic microwave background, or later with direct space-based interferometers. A positive detection could provide definitive evidence for inflation in the early universe and would constrain new physics from the grand unification scale to the Planck scale.	[Krauss, Lawrence M.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Krauss, Lawrence M.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Dodelson, Scott] Ctr Particle Astrophys, Fermi Natl Lab, Batavia, IL 60510 USA; [Dodelson, Scott; Meyer, Stephan] Univ Chicago, Dept Astron & Astrophys, Chicago, IL 60637 USA; [Dodelson, Scott; Meyer, Stephan] Univ Chicago, Kavli Inst Cosmol Phys, Chicago, IL 60637 USA; [Meyer, Stephan] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Meyer, Stephan] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Krauss, LM (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, POB 871404, Tempe, AZ 85287 USA.	krauss@asu.edu	Dodelson, Scott/O-4043-2017	Dodelson, Scott/0000-0002-8446-3859	U.S. Department of Energy's Office of Science (Arizona); NASA; NSF, Chicago; Division Of Astronomical Sciences [0908072] Funding Source: National Science Foundation	U.S. Department of Energy's Office of Science (Arizona)(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); NSF, Chicago; Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge a host of theoretical and experimental collaborators who have helped focus their energy and interest on new ideas that will play a crucial role in the detection of gravitational waves and whose work we have tried to outline here. Our own research is supported by the U.S. Department of Energy's Office of Science (Arizona), NASA, and the NSF for research at Chicago.	ALBRECHT A, 1982, PHYS REV LETT, V48, P1220, DOI 10.1103/PhysRevLett.48.1220; Dodelson S, 2003, AIP CONF PROC, V689, P184, DOI 10.1063/1.1627736; Fenu E, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/10/005; GUTH AH, 1981, PHYS REV D, V23, P347, DOI 10.1103/PhysRevD.23.347; Hu W, 1997, NEW ASTRON, V2, P323, DOI 10.1016/S1384-1076(97)00022-5; Jones-Smith K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.131302; Kamionkowski M, 1997, PHYS REV D, V55, P7368, DOI 10.1103/PhysRevD.55.7368; KRAUSS LM, 1992, PHYS LETT B, V284, P229, DOI 10.1016/0370-2693(92)90425-4; KRAUSS LM, 1992, PHYS REV LETT, V69, P869, DOI 10.1103/PhysRevLett.69.869; LINDE AD, 1982, PHYS LETT B, V108, P389, DOI 10.1016/0370-2693(82)91219-9; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; Silverstein E, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.106003; STAROBINSKII AA, 1979, JETP LETT+, V30, P682; Zaldarriaga M, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.023003; Zaldarriaga M, 1997, PHYS REV D, V55, P1830, DOI 10.1103/PhysRevD.55.1830	17	31	31	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					989	992		10.1126/science.1179541	http://dx.doi.org/10.1126/science.1179541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489015	Green Submitted			2022-12-28	WOS:000277877100030
J	D'Andrea, AD				D'Andrea, Alan D.			MECHANISMS OF DISEASE Susceptibility Pathways in Fanconi's Anemia and Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SHARED GENETIC SUSCEPTIBILITY; DNA-DAMAGE; HOMOLOGOUS RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; CORE COMPLEX; GERMLINE MUTATIONS; PROTEIN COMPLEX; BRCA PATHWAY; FA PATHWAY; FANCD2		[D'Andrea, Alan D.] Childrens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [D'Andrea, Alan D.] Childrens Hosp, Dept Pediat, Dana Farber Canc Inst, Boston, MA 02115 USA; [D'Andrea, Alan D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), Childrens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [RO1DK43889, R01HL52725, PO1CA092584, U19A1067751]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL052725, R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (RO1DK43889, R01HL52725, PO1CA092584, and U19A1067751) from the National Institutes of Health.	Alter Blanche P, 2007, Hematology Am Soc Hematol Educ Program, P29, DOI 10.1182/asheducation-2007.1.29; Alter BP, 2003, BLOOD, V101, P2072, DOI 10.1182/blood-2002-11-3597; Ameziane N, 2009, CELL ONCOL, V31, P53, DOI 10.3233/CLO-2009-0462; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; AUERBACH AD, 2003, CURR PROTOC HUM GENE, pCH8; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bagby GC, 2006, SEMIN HEMATOL, V43, P147, DOI 10.1053/j.seminhematol.2006.04.005; Berwick M, 2007, CANCER RES, V67, P9591, DOI 10.1158/0008-5472.CAN-07-1501; Bryant HE, 2006, NUCLEIC ACIDS RES, V34, P1685, DOI 10.1093/nar/gkl108; Bryant HE, 2004, BIOCHEM SOC T, V32, P959, DOI 10.1042/BST0320959; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Chen CC, 2007, J MOL MED, V85, P497, DOI 10.1007/s00109-006-0153-2; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Couch FJ, 2005, CANCER RES, V65, P383; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Dhillon VS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-33; Dorsman JC, 2007, CELL ONCOL, V29, P211; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Elledge SJ, 2002, CANCER CELL, V1, P129, DOI 10.1016/S1535-6108(02)00041-7; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Gallmeier E, 2007, CANCER RES, V67, P2169, DOI 10.1158/0008-5472.CAN-06-2711; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Grompe M, 2007, DEV CELL, V12, P661, DOI 10.1016/j.devcel.2007.04.008; Hahn SA, 2003, JNCI-J NATL CANCER I, V95, P214, DOI 10.1093/jnci/95.3.214; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hess CJ, 2008, CELL ONCOL, V30, P299, DOI 10.3233/CLO-2008-0426; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hruban Ralph H, 2007, Expert Rev Gastroenterol Hepatol, V1, P81, DOI 10.1586/17474124.1.1.81; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Hussain S, 2003, HUM MOL GENET, V12, P2503, DOI 10.1093/hmg/ddg266; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Kim JM, 2008, BLOOD, V111, P5215, DOI 10.1182/blood-2007-09-113092; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lancaster JM, 1996, NAT GENET, V13, P238, DOI 10.1038/ng0696-238; Landais I, 2009, INT J CANCER, V124, P783, DOI 10.1002/ijc.24039; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Litman R, 2008, ANTI-CANCER AGENT ME, V8, P426, DOI 10.2174/187152008784220285; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Marsit CJ, 2004, ONCOGENE, V23, P1000, DOI 10.1038/sj.onc.1207256; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nakanishi K, 2002, NAT CELL BIOL, V4, P913, DOI 10.1038/ncb879; Narayan G, 2004, CANCER RES, V64, P2994, DOI 10.1158/0008-5472.CAN-04-0245; Niedernhofer LJ, 2007, MOL CELL, V25, P487, DOI 10.1016/j.molcel.2007.02.002; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Oliver AW, 2009, EMBO REP, V10, P990, DOI 10.1038/embor.2009.126; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Pulsipher M, 1998, MOL MED, V4, P468, DOI 10.1007/BF03401752; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Rebbeck TR, 2002, EUR J CANCER, V38, pS15; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Rosado IV, 2009, NUCLEIC ACIDS RES, V37, P4360, DOI 10.1093/nar/gkp365; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Shimamura A, 2003, BLOOD, V102, P3459, DOI 10.1182/blood-2003-04-1297; Shimamura A, 2002, BLOOD, V100, P4649, DOI 10.1182/blood-2002-05-1399; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stewart G, 2002, MOL CELL, V10, P2, DOI 10.1016/S1097-2765(02)00580-4; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Swisher EM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-48; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Teodoridis JM, 2005, CANCER RES, V65, P8961, DOI 10.1158/0008-5472.CAN-05-1187; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tischkowitz M, 2003, BRIT J HAEMATOL, V123, P469, DOI 10.1046/j.1365-2141.2003.04640.x; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Tischkowitz MD, 2004, LEUKEMIA, V18, P420, DOI 10.1038/sj.leu.2403280; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Van der Heijden MS, 2004, CANCER BIOL THER, V3, P534, DOI 10.4161/cbt.3.6.844; Van der Heijden MS, 2004, AM J PATHOL, V165, P651, DOI 10.1016/S0002-9440(10)63329-9; van der Heijden MS, 2003, CANCER RES, V63, P2585; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Venkitaraman AR, 2003, NEW ENGL J MED, V348, P1917, DOI 10.1056/NEJMcibr023150; Verlinsky Y, 2001, JAMA-J AM MED ASSOC, V285, P3130, DOI 10.1001/jama.285.24.3130; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wei MJ, 2008, BREAST CANCER RES TR, V111, P113, DOI 10.1007/s10549-007-9766-6; Williams DA, 2005, CURR OPIN MOL THER, V7, P461; Wilson JB, 2008, ONCOGENE, V27, P3641, DOI 10.1038/sj.onc.1211034; Wolpin BM, 2006, NEW ENGL J MED, V354, P1828; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xie Y, 2000, BRIT J HAEMATOL, V111, P1057, DOI 10.1111/j.1365-2141.2000.02450.x; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Zhang QS, 2008, CANCER RES, V68, P1601, DOI 10.1158/0008-5472.CAN-07-5186; Zhi G, 2009, CANCER RES, V69, P8775, DOI 10.1158/0008-5472.CAN-09-2312	117	243	254	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1909	1919		10.1056/NEJMra0809889	http://dx.doi.org/10.1056/NEJMra0809889			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484397	Green Accepted			2022-12-28	WOS:000277815600009
J	Yoon, J; Jo, S; Chun, IS; Jung, I; Kim, HS; Meitl, M; Menard, E; Li, XL; Coleman, JJ; Paik, U; Rogers, JA				Yoon, Jongseung; Jo, Sungjin; Chun, Ik Su; Jung, Inhwa; Kim, Hoon-Sik; Meitl, Matthew; Menard, Etienne; Li, Xiuling; Coleman, James J.; Paik, Ungyu; Rogers, John A.			GaAs photovoltaics and optoelectronics using releasable multilayer epitaxial assemblies	NATURE			English	Article							THIN-FILM GAAS; LIFT-OFF; SOLAR-CELLS; EFFICIENCY; ELECTRONICS; INTEGRATION; DEVICES; SI	Compound semiconductors like gallium arsenide (GaAs) provide advantages over silicon for many applications, owing to their direct bandgaps and high electron mobilities. Examples range from efficient photovoltaic devices(1,2) to radio-frequency electronics(3,4) and most forms of optoelectronics(5,6). However, growing large, high quality wafers of these materials, and intimately integrating them on silicon or amorphous substrates (such as glass or plastic) is expensive, which restricts their use. Here we describe materials and fabrication concepts that address many of these challenges, through the use of films of GaAs or AlGaAs grown in thick, multilayer epitaxial assemblies, then separated from each other and distributed on foreign substrates by printing. This method yields large quantities of high quality semiconductor material capable of device integration in large area formats, in a manner that also allows the wafer to be reused for additional growths. We demonstrate some capabilities of this approach with three different applications: GaAs-based metal semiconductor field effect transistors and logic gates on plates of glass, near-infrared imaging devices on wafers of silicon, and photovoltaic modules on sheets of plastic. These results illustrate the implementation of compound semiconductors such as GaAs in applications whose cost structures, formats, area coverages or modes of use are incompatible with conventional growth or integration strategies.	[Yoon, Jongseung; Jo, Sungjin; Jung, Inhwa; Kim, Hoon-Sik; Rogers, John A.] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Yoon, Jongseung; Jo, Sungjin; Jung, Inhwa; Kim, Hoon-Sik; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Chun, Ik Su; Li, Xiuling; Coleman, James J.; Rogers, John A.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Meitl, Matthew; Menard, Etienne] Semprius Inc, Durham, NC 27713 USA; [Jo, Sungjin; Paik, Ungyu] Hanyang Univ, WCU Dept Energy Engn, Div Mat Sci Engn, Seoul 133791, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Hanyang University	Rogers, JA (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Mat Sci & Engn, Urbana, IL 61801 USA.	matt.meitl@semprius.com; upaik@hanyang.ac.kr; jrogers@uiuc.edu	Li, Xiuling/A-2240-2010; Rogers, John/L-2798-2016; Coleman, James J/C-9703-2011; huang, yonggang/O-6236-2019; Jung, Inhwa/AAI-8615-2020	Coleman, James J/0000-0001-6217-0812; Jung, Inhwa/0000-0002-0235-7383	National Security Science and Engineering Faculty; US Department of Energy, Division of Materials Sciences through the Frederick Seitz MRL and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign [DEFG02-91ER45439]; Division of Energy Efficiency and Renewable Energy [DE-FG36-08GO18021]; National Science Foundation [DMI-0328162]; Korean Ministry of Education, Science and Technology [K2070400000307A050000310]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001013]; Beckman Institute; Korea Research Foundation [KRF-2008-357-D00134]	National Security Science and Engineering Faculty; US Department of Energy, Division of Materials Sciences through the Frederick Seitz MRL and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); Division of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Beckman Institute; Korea Research Foundation(National Research Foundation of Korea)	We thank T. Banks, J. Soares and T. Spila for help using facilities at the Frederick Seitz MRL; D. Stevenson, S. Robinson and D. Sievers for help with photography, SEM and four point probe measurements, respectively; and A. Gray for guidance in calculating the cell conversion efficiency and the calibration of the solar simulator. J.Y. thanks D. Shir for help with optics simulation. This paper is based partly on work supported by a National Security Science and Engineering Faculty Fellowship (NIR cameras and MESFETs) and by the US Department of Energy, Division of Materials Sciences (DEFG02-91ER45439), through the Frederick Seitz MRL and Center for Microanalysis of Materials at the University of Illinois at Urbana-Champaign (materials, growth aspects) and the Division of Energy Efficiency and Renewable Energy (DE-FG36-08GO18021) (solar cells). We also acknowledge the Center for Nanoscale Chemical Electrical Mechanical Manufacturing Systems in the University of Illinois, which is funded by the National Science Foundation (DMI-0328162) (printing-based manufacturing) and separate funding from the National Research Foundation of Korea through a grant (K2070400000307A050000310, Global Research Laboratory Program) provided by the Korean Ministry of Education, Science and Technology. J. J. C. acknowledges support by the Center for Energy Nanoscience, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Office of Basic Energy Sciences (DE-SC0001013). J.Y. acknowledges support from a Beckman Institute postdoctoral fellowship. S. J. thanks the Korea Research Foundation for a postdoctoral fellowship (KRF-2008-357-D00134).	Algora C, 2001, IEEE T ELECTRON DEV, V48, P840, DOI 10.1109/16.918225; Baca AJ, 2008, ANGEW CHEM INT EDIT, V47, P5524, DOI 10.1002/anie.200703238; Bett AW, 1999, APPL PHYS A-MATER, V69, P119, DOI 10.1007/s003390050983; Bolkhovityanov YB, 2008, PHYS-USP+, V51, P437, DOI 10.1070/PU2008v051n05ABEH006529; Bosi M, 2007, PROG PHOTOVOLTAICS, V15, P51, DOI 10.1002/pip.715; Chang K. Y., 1994, GAAS HIGH SPEED DEVI; Cotal H, 2009, ENERG ENVIRON SCI, V2, P174, DOI 10.1039/b809257e; DEMEESTER P, 1993, SEMICOND SCI TECH, V8, P1124, DOI 10.1088/0268-1242/8/6/021; Fan ZY, 2008, NANO LETT, V8, P20, DOI 10.1021/nl071626r; Garrou P, 2000, IEEE T ADV PACKAGING, V23, P198, DOI 10.1109/6040.846634; HAYASHI T, 1992, IEEE T COMPON HYBR, V15, P225, DOI 10.1109/33.142898; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; KONAGAI M, 1978, J CRYST GROWTH, V45, P277, DOI 10.1016/0022-0248(78)90449-9; Laskar J, 1997, P SOC PHOTO-OPT INS, V3212, P97, DOI 10.1117/12.284581; Meitl MA, 2006, NAT MATER, V5, P33, DOI 10.1038/nmat1532; Mokkapati S, 2009, MATER TODAY, V12, P22, DOI 10.1016/S1369-7021(09)70110-5; Roelkens G, 2007, MATER TODAY, V10, P36, DOI 10.1016/S1369-7021(07)70178-5; Rogalski A, 2002, INFRARED PHYS TECHN, V43, P187, DOI 10.1016/S1350-4495(02)00140-8; Schermer JJ, 2005, PROG PHOTOVOLTAICS, V13, P587, DOI 10.1002/pip.616; Schwierz F, 2007, SOLID STATE ELECTRON, V51, P1079, DOI 10.1016/j.sse.2007.05.020; Sun YG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2198832; TONG QY, 1994, MATER CHEM PHYS, V37, P101, DOI 10.1016/0254-0584(94)90080-9; van Deelen J, 2007, J CRYST GROWTH, V298, P772, DOI 10.1016/j.jcrysgro.2006.10.094; vanGeelen A, 1997, MAT SCI ENG B-SOLID, V45, P162, DOI 10.1016/S0921-5107(96)02029-6; Voncken MMAJ, 2004, APPL PHYS A-MATER, V79, P1801, DOI 10.1007/s00339-003-2100-1; WADA O, 1988, OPT QUANT ELECTRON, V20, P441, DOI 10.1007/BF00635747; YABLONOVITCH E, 1987, APPL PHYS LETT, V51, P2222, DOI 10.1063/1.98946; Yamaguchi M, 2005, SOL ENERGY, V79, P78, DOI 10.1016/j.solener.2004.09.018; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287; Yu GH, 2007, NAT NANOTECHNOL, V2, P372, DOI 10.1038/nnano.2007.150	30	437	568	10	339	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					329	U80		10.1038/nature09054	http://dx.doi.org/10.1038/nature09054			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485431				2022-12-28	WOS:000277829200036
J	Taylor, AL; Gostin, LO				Taylor, Allyn L.; Gostin, Lawrence O.			International recruitment of health personnel	LANCET			English	Editorial Material									[Taylor, Allyn L.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Taylor, AL (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	alt28@law.georgetown.edu							0	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 15	2010	375	9727					1673	1675		10.1016/S0140-6736(10)60596-X	http://dx.doi.org/10.1016/S0140-6736(10)60596-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	599DK	20472155				2022-12-28	WOS:000277890200008
J	Fryxell, JM; Packer, C; McCann, K; Solberg, EJ; Saether, BE				Fryxell, John M.; Packer, Craig; McCann, Kevin; Solberg, Erling J.; Saether, Bernt-Erik			Resource Management Cycles and the Sustainability of Harvested Wildlife Populations	SCIENCE			English	Article							DENSITY-DEPENDENCE; MARINE RESERVES; CONSEQUENCES; FLUCTUATIONS; CONSERVATION	Constant harvest policies for fish and wildlife populations can lead to population collapse in the face of stochastic variation in population growth rates. Here, we show that weak compensatory response by resource users or managers to changing levels of resource abundance can readily induce harvest cycles that accentuate the risk of catastrophic population collapse. Dynamic system models incorporating this mix of feedback predict that cycles or quasi-cycles with decadal periodicity should commonly occur in harvested wildlife populations, with effort and quotas lagging far behind resources, whereas harvests should exhibit lags of intermediate length. Empirical data gathered from three hunted populations of white-tailed deer and moose were consistent with these predictions of both underlying behavioral causes and dynamical consequences.	[Fryxell, John M.; McCann, Kevin] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Packer, Craig] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Solberg, Erling J.] Norwegian Inst Nat Res, N-7485 Trondheim, Norway; [Saether, Bernt-Erik] NTNU, Dept Biol, Ctr Conservat Biol, N-7491 Trondheim, Norway	University of Guelph; University of Minnesota System; University of Minnesota Twin Cities; Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU)	Fryxell, JM (corresponding author), Univ Guelph, Dept Integrat Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	jfryxell@uoguelph.ca			Natural Sciences and Engineering Research Council of Canada; NSF; Directorate for Nature Management; Norwegian Research Council [196304/V40]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSF(National Science Foundation (NSF)); Directorate for Nature Management; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Discovery Grants to J.M.F. and K.M. from the Natural Sciences and Engineering Research Council of Canada, and NSF Grants for Long-Term Research in Environmental Biology and Biocomplexity to C.P. The contributions by B.E.S. and E.J.S. were funded by the Directorate for Nature Management and the Norwegian Research Council (Changing Landscapes, Lanskap i Endring, and project 196304/V40). We thank A. Fryxell, T. Avgar, M. Anderson, T. Nudds, and two anonymous reviewers for helpful suggestions. Details of the dynamical stability analysis are available on request from the senior author.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Beckerman AP, 2002, TRENDS ECOL EVOL, V17, P263, DOI 10.1016/S0169-5347(02)02469-2; BEDDINGTON JR, 1977, SCIENCE, V197, P463, DOI 10.1126/science.197.4302.463; BELL G, 1977, J FISH RES BOARD CAN, V34, P942, DOI 10.1139/f77-147; BERRYMAN AA, 1991, OIKOS, V62, P106, DOI 10.2307/3545457; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Clark C.W., 1990, MATH BIOECONOMICS OP, V2nd; Coulson T, 2008, ECOLOGY, V89, P1661, DOI 10.1890/07-1099.1; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; FRYXELL JM, 1991, J WILDLIFE MANAGE, V55, P377, DOI 10.2307/3808963; Hastings A, 1999, SCIENCE, V284, P1537, DOI 10.1126/science.284.5419.1537; Hastings A., 1997, POPULATION BIOL CONC; Lande R, 1997, ECOLOGY, V78, P1341; Lande R., 2003, OXFORD SERIES ECOLOG; Mangel M, 1998, ECOL LETT, V1, P87; MCGARVEY R, 1994, CAN J FISH AQUAT SCI, V51, P900, DOI 10.1139/f94-089; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Neubert MG, 2003, ECOL LETT, V6, P843, DOI 10.1046/j.1461-0248.2003.00493.x; Nisbet RM, 1982, MODELLING FLUCTUATIN; Otto SP, 2007, BIOL GUIDE MATH MODE; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; Schaefer MB., 1954, INT AM TROPICAL TUNA, V1, P23; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	29	83	87	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					903	906		10.1126/science.1185802	http://dx.doi.org/10.1126/science.1185802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466934				2022-12-28	WOS:000277618800052
J	Nudds, RL; Dyke, GJ				Nudds, Robert L.; Dyke, Gareth J.			Narrow Primary Feather Rachises in Confuciusornis and Archaeopteryx Suggest Poor Flight Ability	SCIENCE			English	Article							EVOLUTION; FOSSIL; ORIGIN	The fossil birds Archaeopteryx and Confuciusornis had feathered wings resembling those of living birds, but their flight capabilities remain uncertain. Analysis of the rachises of their primary feathers shows that the rachises were much thinner and weaker than those of modern birds, and thus the birds were not capable of flight. Only if the primary feather rachises were solid in cross-section (the strongest structural configuration), and not hollow as in living birds, would flight have been possible. Hence, if Archaeopteryx and Confuciusornis were flapping flyers, they must have had a feather structure that was fundamentally different from that of living birds. Alternatively, if they were only gliders, then the flapping wing stroke must have appeared after the divergence of Confuciusornis, likely within the enantiornithine or ornithurine radiations.	[Nudds, Robert L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Dyke, Gareth J.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 4, Ireland	University of Manchester; University College Dublin	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	robert.nudds@manchester.ac.uk	Dyke, Gareth/AAJ-9320-2020	Dyke, Gareth/0000-0002-8390-7817				Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Corning WR, 1998, J EXP BIOL, V201, P3057; Elzanowski Andrzej, 2002, P129; Fountaine TMR, 2005, P ROY SOC B-BIOL SCI, V272, P289, DOI 10.1098/rspb.2004.2923; Hou LH, 2004, NATURWISSENSCHAFTEN, V91, P22, DOI 10.1007/s00114-003-0489-1; Norberg R.A., 1985, P303; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Nudds RL, 2007, J AVIAN BIOL, V38, P515, DOI 10.1111/j.0908-8857.2007.03913.x; Nudds RL, 2009, EVOLUTION, V63, P994, DOI 10.1111/j.1558-5646.2009.00613.x; OLSON SL, 1979, NATURE, V278, P247, DOI 10.1038/278247a0; OSTROM JH, 1974, Q REV BIOL, V49, P27, DOI 10.1086/407902; Rietschel S., 1985, P251; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; SPEAKMAN JR, 1994, NATURE, V370, P514, DOI 10.1038/370514a0; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; Wellnhofer P, 2004, LIFE O PAST, P282; Worcester SE, 1996, J ZOOL, V239, P609, DOI 10.1111/j.1469-7998.1996.tb05947.x; YALDEN DW, 1971, IBIS, V113, P349, DOI 10.1111/j.1474-919X.1971.tb05165.x; Zhou Zhong-He, 2004, Acta Zoologica Sinica, V50, P913	22	73	76	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					887	889		10.1126/science.1188895	http://dx.doi.org/10.1126/science.1188895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466930				2022-12-28	WOS:000277618800047
J	Sweatt, JD				Sweatt, J. David			Epigenetics and Cognitive Aging	SCIENCE			English	Editorial Material							PLASTICITY; BRAIN		[Sweatt, J. David] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; [Sweatt, J. David] Univ Alabama, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@uab.edu		Sweatt, J. David/0000-0003-3567-485X				[Anonymous], GERIATRIC NEUROPSYCH; Bandyopadhyay D, 2003, EXP GERONTOL, V38, P1299, DOI 10.1016/j.exger.2003.09.009; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Penner MR, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00009; Ramirez CL, 2007, CELL MOL LIFE SCI, V64, P155, DOI 10.1007/s00018-006-6349-3; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044	15	32	36	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					701	702		10.1126/science.1189968	http://dx.doi.org/10.1126/science.1189968			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448174				2022-12-28	WOS:000277357100026
J	Widder, EA				Widder, E. A.			Bioluminescence in the Ocean: Origins of Biological, Chemical, and Ecological Diversity	SCIENCE			English	Review							DEEP-SEA; MARINE BIOLUMINESCENCE; MOLECULAR EVOLUTION; LUCIFERASE GENE; COELENTERAZINE; PERCEPTION; ORGANISMS; SPECTRA; DOMAINS; FISHES	From bacteria to fish, a remarkable variety of marine life depends on bioluminescence ( the chemical generation of light) for finding food, attracting mates, and evading predators. Disparate biochemical systems and diverse phylogenetic distribution patterns of light-emitting organisms highlight the ecological benefits of bioluminescence, with biochemical and genetic analyses providing new insights into the mechanisms of its evolution. The origins and functions of some bioluminescent systems, however, remain obscure. Here, I review recent advances in understanding bioluminescence in the ocean and highlight future research efforts that will unite molecular details with ecological and evolutionary relationships.	Ocean Res & Conservat Assoc, Ft Pierce, FL 34949 USA		Widder, EA (corresponding author), Ocean Res & Conservat Assoc, Ft Pierce, FL 34949 USA.	ewidder@teamorca.org			Office of Naval Research	Office of Naval Research(Office of Naval Research)	I am grateful to P. Herring for helpful comments and the Office of Naval Research for its long-standing support of bioluminescence research.	Baker A, 2008, J PHYCOL, V44, P419, DOI 10.1111/j.1529-8817.2008.00474.x; Czyz A, 2003, LUMINESCENCE, V18, P140, DOI 10.1002/bio.715; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Dunlap PV., 2009, ENCY MICROBIOLOGY, P45, DOI [10.1016/B978-012373944-5.00066-3, DOI 10.1016/B978-012373944-5.00066-3]; Guerrero-Ferreira RC, 2007, CLADISTICS, V23, P497, DOI 10.1111/j.1096-0031.2007.00155.x; Haddock SHD, 2001, P NATL ACAD SCI USA, V98, P11148, DOI 10.1073/pnas.201329798; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; HERRING PJ, 1983, PROC R SOC SER B-BIO, V220, P183, DOI 10.1098/rspb.1983.0095; HERRING PJ, 2001, ENCY OCEAN SCI, V1, P308; Johnsen S, 2004, BIOL BULL-US, V207, P1, DOI 10.2307/1543624; Johnsen S, 1999, NATURE, V398, P113, DOI 10.1038/18131; LATZ MI, 1988, MAR BIOL, V98, P441, DOI 10.1007/BF00391120; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; Liu LY, 2004, P NATL ACAD SCI USA, V101, P16555, DOI 10.1073/pnas.0407597101; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; McFall-Ngai M, 2008, ADV EXP MED BIOL, V635, P102, DOI 10.1007/978-0-387-09550-9_9; Mensinger AF, 1997, J EXP MAR BIOL ECOL, V210, P75, DOI 10.1016/S0022-0981(96)02719-0; Miller SD, 2005, P NATL ACAD SCI USA, V102, P14181, DOI 10.1073/pnas.0507253102; Nyholm SV, 2004, NAT REV MICROBIOL, V2, P632, DOI 10.1038/nrmicro957; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Osborn KJ, 2009, SCIENCE, V325, P964, DOI 10.1126/science.1172488; Priede IG, 2006, DEEP-SEA RES PT I, V53, P1272, DOI 10.1016/j.dsr.2006.05.004; Rees JF, 1998, J EXP BIOL, V201, P1211; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; SELIGER HH, 1993, NAV RES REV, V45, P5; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; THOMSON CM, 1995, J MAR BIOL ASSOC UK, V75, P165, DOI 10.1017/S0025315400015277; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Widder E.A., 1999, P555; Widder EA, 2002, MAR FRESHW BEHAV PHY, V35, P1, DOI 10.1080/10236240290025581; WIDDER EA, 1984, SCIENCE, V225, P512, DOI 10.1126/science.225.4661.512; WIDDER EA, 1983, BIOL BULL, V165, P791, DOI 10.2307/1541479; Widder EA, 2007, OCEANOGRAPHY, V20, P46, DOI 10.5670/oceanog.2007.04	38	306	314	33	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					704	708		10.1126/science.1174269	http://dx.doi.org/10.1126/science.1174269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448176				2022-12-28	WOS:000277357100028
J	Jones, DA				Jones, Diane Auer			Financial pain should focus universities	NATURE			English	Editorial Material									[Jones, Diane Auer] Washington Campus, Washington, DC 20005 USA		Jones, DA (corresponding author), Washington Campus, Washington, DC 20005 USA.	djones@washcampus.edu						[Anonymous], 2010, SCI ENG IND 2010; BERDAHL RM, 2009, CHRONICLE HIGHE 0629; Capaldi Elizabeth D., 2008, TOP AM RES U 2008 AN; LOMBARDI J, 2000, TOP AM RES U OCCASIO; LOMBARDI JV, 2007, TOP AM RES U 2007 AN; National Science Foundation, 2008, SCI ENG IND 2008; *OFF SCI TECHN POL, 2009, REN COMM SCI TECHN	7	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					32	33		10.1038/465032a	http://dx.doi.org/10.1038/465032a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	591OW	20445610				2022-12-28	WOS:000277311900017
J	Jun, M; Foote, C; Lv, JC; Neal, B; Patel, A; Nicholls, SJ; Grobbee, DE; Cass, A; Chalmers, J; Perkovic, V				Jun, Min; Foote, Celine; Lv, Jicheng; Neal, Bruce; Patel, Anushka; Nicholls, Stephen J.; Grobbee, Diederick E.; Cass, Alan; Chalmers, John; Perkovic, Vlado			Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis	LANCET			English	Review							EXTREMITY ARTERIAL-DISEASE; CORONARY-HEART-DISEASE; RISK; MEN; PREVENTION; TRIAL; ATHEROSCLEROSIS; INTERVENTION; GEMFIBROZIL; CHOLESTEROL	Background Several clinical trials have reported inconsistent findings for the effect of fibrates on cardiovascular risk. We undertook a systematic review and meta-analysis to investigate the effects of fibrates on major clinical outcomes. Methods We systematically searched Medline, Embase, and the Cochrane Library for trials published between 1950 and March, 2010. We included prospective randomised controlled trials assessing the effects of fibrates on cardiovascular outcomes compared with placebo. Summary estimates of relative risk (RR) reductions were calculated with a random effects model. Outcomes analysed were major cardiovascular events, coronary events, stroke, heart failure, coronary revascularisation, all-cause mortality, cardiovascular death, non-vascular death, sudden death, new onset albuminuria, and drug-related adverse events. Findings We identified 18 trials providing data for 45058 participants, including 2870 major cardiovascular events, 4552 coronary events, and 3880 deaths. Fibrate therapy produced a 10% RR reduction (95% CI 0-18) for major cardiovascular events (p=0.048) and a 13% RR reduction (7-19) for coronary events (p<0.0001), but had no benefit on stroke (-3%, -16 to 9; p=0.69). We noted no effect of fibrate therapy on the risk of all-cause mortality (0%, 8 to 7; p=0.92), cardiovascular mortality (3%, 7 to 12; p=0.59), sudden death (11%, 6 to 26; p=0.19), or non-vascular mortality (-10%, -21 to 0.5; p=0.063). Fibrates reduced the risk of albuminuria progression by 14% (2-25; p=0.028). Serious drug-related adverse events were not significantly increased by fibrates (17413 participants, 225 events; RR 1.21,0.91-1.61; p=0.19), although increases in serum creatinine concentrations were common (1.99, 1.46-2.70; p<0.0001). Interpretation Fibrates can reduce the risk of major cardiovascular events predominantly by prevention of coronary events, and might have a role in individuals at high risk of cardiovascular events and in those with combined dyslipidaemia.	[Jun, Min; Foote, Celine; Lv, Jicheng; Neal, Bruce; Patel, Anushka; Cass, Alan; Chalmers, John; Perkovic, Vlado] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2050, Australia; [Lv, Jicheng] Peking Univ First Hosp, Beijing, Peoples R China; [Nicholls, Stephen J.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Nicholls, Stephen J.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44106 USA; [Grobbee, Diederick E.] Univ Med Ctr, Julius Ctr, Utrecht, Netherlands	University of Sydney; Peking University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Utrecht University; Utrecht University Medical Center	Perkovic, V (corresponding author), Univ Sydney, George Inst Int Hlth, POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	vperkovic@george.org.au	Grobbee, Diederick/C-7651-2014; Perkovic, Vlado/AAY-1933-2021	Grobbee, Diederick/0000-0003-4472-4468; Chalmers, John/0000-0002-9931-0580; Jun, Min/0000-0003-1460-7535; Patel, Anushka/0000-0003-3825-4092; Perkovic, Vlado/0000-0002-4257-7620; Cass, Alan/0000-0002-3923-3173; Nicholls, Stephen/0000-0002-9668-4368; Neal, Bruce/0000-0002-0490-7465	Australian Postgraduate Award; Australasian Kidney Trials Network (AKTN); Amgen; NHMRC; Heart Foundation/Office of Science and Medical Research (NSW); National Health and Medical Research Council of Australia [571281]; Pfizer; Roche; Takeda; Johnson and Johnson; Merck Schering Plough; Servier; United Healthcare Group; AstraZeneca; GlaxoSmithKline; Sanofi-Aventis; Tanabe; Abbott; Novartis; Eli Lilly; Anthera; Resverlogix; Organon/Merck Schering Plough; Wyeth; Unilever; Solvay; Baxter; Gambro; Servier Daiichi	Australian Postgraduate Award(Australian Government); Australasian Kidney Trials Network (AKTN); Amgen(Amgen); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Heart Foundation/Office of Science and Medical Research (NSW); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Merck Schering Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); United Healthcare Group; AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Tanabe; Abbott(Abbott Laboratories); Novartis(Novartis); Eli Lilly(Eli Lilly); Anthera; Resverlogix; Organon/Merck Schering Plough(Merck & CompanySchering Plough Corporation); Wyeth(Wyeth); Unilever(Unilever); Solvay(Solvay SA); Baxter; Gambro; Servier Daiichi	MJ was supported by an Australian Postgraduate Award and the Australasian Kidney Trials Network (AKTN). CF and JL were supported by an Amgen Renal Research Fellowship. AC and AP were supported by NHMRC Senior Research Fellowships. VP was supported by the Heart Foundation/Office of Science and Medical Research (NSW) Career Development Award. This study was supported by a programme grant from the National Health and Medical Research Council of Australia (grant number 571281).; CF and JL are recipients of a Research Fellowship supported by Amgen. BN reports receiving consulting fees from Pfizer, Roche, and Takeda; grant support from Johnson and Johnson, Merck Schering Plough, Servier, and United Healthcare Group; lecture fees and travel reimbursements from Amgen, AstraZeneca, GlaxoSmithKline, Pfizer, Roche, Sanofi-Aventis, Servier, and Tanabe; and being a member of advisory boards for Pfizer and Roche. AP reports receiving grant support from Servier, Pfizer, and Sanofi-Aventis; and lecture fees from Pfizer, Sanofi-Aventis, AstraZeneca, Servier, and Abbott. SJN reports being on advisory boards for Merck, AstraZeneca, Pfizer, Roche, Takeda, Anthera, and Novo-Nordisk; receiving lecture fees from Pfizer, Merck, AstraZeneca, Roche, and Takeda; and receiving research support from AstraZeneca, Novartis, Eli Lilly, Anthera, and Resverlogix. DEG reports being on an advisory boards for Organon, Pfizer, Roche, and Takeda; receiving consulting, lecture fees, and travel reimbursements from Roche, Takeda, Organon/Merck Schering Plough, AstraZeneca, and Servier, and research grants from Pfizer, AstraZeneca, Novartis, Organon/Merck Schering Plough, Wyeth, Unilever, GlaxoSmithKline, and Solvay. AC reports being on a grant advisory panel for Roche; receiving grant support from Baxter, Servier, and Gambro; and receiving lecture fees and travel reimbursements from Servier and Amgen. JC reports being on the Servier Diabetes Advisory Board, and receiving grant support from Servier and lecture fees and travel reimbursements from Servier Daiichi and Pfizer. VP reports receiving grants for clinical trials from Baxter, Johnson and Johnson, Novartis, Roche, and Servier; and lecture fees from Abbott, AstraZeneca, Roche, and Servier. MJ declares that he has no conflicts of interest.	ACHESON J, 1972, ATHEROSCLEROSIS, V15, P177, DOI 10.1016/0021-9150(72)90067-6; Alsheikh-Ali AA, 2004, AM J CARDIOL, V94, P935, DOI 10.1016/j.amjcard.2004.06.033; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; [Anonymous], 1973, Stroke, V4, P684; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; ARTHUR JB, 1971, BRIT MED J, V4, P767; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Drury P, 2008, CIRCULATION, V118, pS1088; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elkeles RS, 1998, DIABETES CARE, V21, P641, DOI 10.2337/diacare.21.4.641; Emmerich KH, 2009, KLIN MONATSBL AUGENH, V226, P561, DOI 10.1055/s-0028-1109516; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; FREYBERGER H, 1994, MED KLIN, V89, P594; Frick MH, 1997, CIRCULATION, V96, P2137; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; GORDON T, 1981, ARCH INTERN MED, V141, P1128, DOI 10.1001/archinte.141.9.1128; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; HANEFELD M, 1991, DIABETES CARE, V14, P308, DOI 10.2337/diacare.14.4.308; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Jadad AR, 1996, PAIN, V66, P239, DOI 10.1016/0304-3959(96)03033-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37; Marx N, 2002, CIRC RES, V90, P703, DOI 10.1161/01.RES.0000014225.20727.8F; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; Meade TW, 2001, CURR CONTR TRIALS C, V2, P195, DOI 10.1186/CVM-2-4-195; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nicholls SJ, 2005, CURR OPIN LIPIDOL, V16, P345, DOI 10.1097/01.mol.0000169356.58513.25; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; OLIVER M F, 1978, British Heart Journal, V40, P1069, DOI 10.1136/hrt.40.10.1069; Packard C, 2004, EUR HEART J SUPPL, V6, pA28, DOI 10.1016/j.ehjsup.2004.01.007; Research Committee of the Scottish Society of Physicians, 1971, BMJ-BRIT MED J, V4, P775; Ruan XZ, 2003, J AM SOC NEPHROL, V14, P593, DOI 10.1097/01.ASN.0000050414.52908.DA; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Steiner G, 2001, LANCET, V357, P905; The Coronary Drug Project, 1972, JAMA-J AM MED ASSOC, V220, P996, DOI [10.1001/jama.1972.03200070084015, DOI 10.1001/JAMA.1972.03200070084015]; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Woodward M., 2005, EPIDEMIOLOGY DESIGN	46	625	681	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1875	1884		10.1016/S0140-6736(10)60656-3	http://dx.doi.org/10.1016/S0140-6736(10)60656-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20462635				2022-12-28	WOS:000278628800029
J	Jia, HB; Rochefort, NL; Chen, XW; Konnerth, A				Jia, Hongbo; Rochefort, Nathalie L.; Chen, Xiaowei; Konnerth, Arthur			Dendritic organization of sensory input to cortical neurons in vivo	NATURE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; MOUSE VISUAL-CORTEX; RECEPTIVE-FIELDS; CALCIUM DYNAMICS; FUNCTIONAL ARCHITECTURE; SYNAPTIC INTEGRATION; BASAL DENDRITES; CELLS; POTENTIALS; SPINES	In sensory cortex regions, neurons are tuned to specific stimulus features. For example, in the visual cortex, many neurons fire predominantly in response to moving objects of a preferred orientation. However, the characteristics of the synaptic input that cortical neurons receive to generate their output firing pattern remain unclear. Here we report a novel approach for the visualization and functional mapping of sensory inputs to the dendrites of cortical neurons in vivo. By combining high-speed two-photon imaging with electrophysiological recordings, we identify local subthreshold calcium signals that correspond to orientation-specific synaptic inputs. We find that even inputs that share the same orientation preference are widely distributed throughout the dendritic tree. At the same time, inputs of different orientation preference are interspersed, so that adjacent dendritic segments are tuned to distinct orientations. Thus, orientation-tuned neurons can compute their characteristic firing pattern by integrating spatially distributed synaptic inputs coding for multiple stimulus orientations.	[Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, D-80802 Munich, Germany; Tech Univ Munich, Ctr Integrated Prot Sci, D-80802 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurosci, Biedersteinerstr 29, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Jia, Hongbo/H-2476-2017	Jia, Hongbo/0000-0003-1585-2161; Rochefort, Nathalie/0000-0002-3498-6221	DFG [IRTG 1373]; Friedrich Schiedel Foundation	DFG(German Research Foundation (DFG)); Friedrich Schiedel Foundation	We are grateful to B. Sakmann for discussions and to Y. Kovalchuk for help in the initial experiments. This work was supported by grants from the DFG (to A. K.) and the Friedrich Schiedel Foundation. A. K. is a Carl von Linde Senior Fellow of the Institute for Advanced Study of the TUM. H.J., N.L.R. and X. C. were supported by the DFG (IRTG 1373).	Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Bannister AP, 2005, NEUROSCI RES, V53, P95, DOI 10.1016/j.neures.2005.06.019; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hirsch JA, 2006, CURR OPIN NEUROBIOL, V16, P377, DOI 10.1016/j.conb.2006.06.014; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; METIN C, 1988, EXP BRAIN RES, V69, P594; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Ohki K, 2007, CURR OPIN NEUROBIOL, V17, P401, DOI 10.1016/j.conb.2007.07.007; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	39	342	348	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1307	1312		10.1038/nature08947	http://dx.doi.org/10.1038/nature08947			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428163				2022-12-28	WOS:000277149000037
J	Nakamura, S; Kobayashi, K; Nishimura, T; Higashijima, S; Tanaka, M				Nakamura, Shuhei; Kobayashi, Kayo; Nishimura, Toshiya; Higashijima, Shin-ichi; Tanaka, Minoru			Identification of Germline Stem Cells in the Ovary of the Teleost Medaka	SCIENCE			English	Article							ORYZIAS-LATIPES; HEMATOPOIETIC STEM; EXPRESSION; SOX9; OOGENESIS; REVEALS; FISH; MICE	Germline stem cells continually produce sperm in vertebrate testes, whereas there is no direct evidence showing that germline stem cells are present in adult vertebrate ovaries. By using transgenic methods and clonal analysis, we identified germline stem cells that supported oogenesis and the production of offspring in the ovaries of adult medaka fish. Early-stage germ cells were localized in clusters along interwoven threadlike cords of sox9b-expressing somatic cells (termed germinal cradles) where the germ cells developed. Germline stem cells gave rise to germ cells that divided to produce cysts, which then underwent cell death or separated to form follicles. Our results provide insight into the germline stem cell biology of medaka and provide a model system for studying vertebrate stem cell niches.	[Nakamura, Shuhei; Kobayashi, Kayo; Nishimura, Toshiya; Tanaka, Minoru] Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan; [Nishimura, Toshiya; Tanaka, Minoru] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Higashijima, Shin-ichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Higashijima, Shin-ichi] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan	Tanaka, M (corresponding author), Natl Inst Basic Biol, Lab Mol Genet Reprod, Okazaki, Aichi 4448787, Japan.	mtanaka@nibb.ac.jp	Shuhei, Nakamura/AGZ-2173-2022; Nakamura, Shuhei/G-8571-2011	Shuhei, Nakamura/0000-0002-1488-8317; Higashijima, Shin-ichi/0000-0001-6350-4992; TANAKA, MINORU/0000-0001-9100-1487	National BioResource Project Medaka; Daiko Foundation; Center for the Promotion of Integrated Science (CPIS) of SOKENDAI;  [21116509];  [21770072];  [21370101]	National BioResource Project Medaka(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Daiko Foundation(Daiko Foundation); Center for the Promotion of Integrated Science (CPIS) of SOKENDAI; ; ; 	We thank M. Yamashita and T. Iwai for anti-medaka SYCP antibodies, T. Czerny for plasmids containing the hs promoter region, and S. Yoshida for helpful discussions. We are grateful to Y. Ichikawa and C. Kinoshita for maintaining the fish colony. This work was supported in part by Grants-in-Aid for Scientific Research on Innovative Areas, "Gamete Stem Cells" (grant 21116509) and for Young Scientists (B) (21770072) (to S.N.), and for Scientific Research on Priority Areas (B) (21370101); the National BioResource Project Medaka; and the Daiko Foundation and the Center for the Promotion of Integrated Science (CPIS) of SOKENDAI (to M. T.).	Aoki Y, 2008, DEV DYNAM, V237, P800, DOI 10.1002/dvdy.21448; Aoki Y, 2009, ZOOL SCI, V26, P112, DOI 10.2108/zsj.26.112; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Iwai T, 2006, EXP CELL RES, V312, P2528, DOI 10.1016/j.yexcr.2006.04.015; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kluver N, 2005, DEV GENES EVOL, V215, P297, DOI 10.1007/s00427-005-0477-x; KUMAR TCA, 1968, PROC R SOC SER B-BIO, V169, P167, DOI 10.1098/rspb.1968.0004; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Morinaga C, 2007, P NATL ACAD SCI USA, V104, P9691, DOI 10.1073/pnas.0611379104; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Pacchiarotti J, 2010, DIFFERENTIATION, V79, P159, DOI 10.1016/j.diff.2010.01.001; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Stahl Y, 2005, INT J DEV BIOL, V49, P479, DOI 10.1387/ijdb.041929ys; Tanaka M, 2001, P NATL ACAD SCI USA, V98, P2544, DOI 10.1073/pnas.041315498; Tokarz R.R., 1978, P145; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WALLACE RA, 1990, J ELECTRON MICR TECH, V16, P175, DOI 10.1002/jemt.1060160302; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	21	165	174	2	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1561	1563		10.1126/science.1185473	http://dx.doi.org/10.1126/science.1185473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20488987				2022-12-28	WOS:000278859200047
J	Rohlsberger, R; Schlage, K; Sahoo, B; Couet, S; Ruffer, R				Roehlsberger, Ralf; Schlage, Kai; Sahoo, Balaram; Couet, Sebastien; Rueffer, Rudolf			Collective Lamb Shift in Single-Photon Superradiance	SCIENCE			English	Article							SPONTANEOUS-EMISSION; 2-LEVEL ATOMS; SUPER-RADIANCE; RESONANCE; SCATTERING; SYSTEM	Superradiance, the cooperative spontaneous emission of photons from an ensemble of identical atoms, provides valuable insights into the many-body physics of photons and atoms. We show that an ensemble of resonant atoms embedded in the center of a planar cavity can be collectively excited by synchrotron radiation into a purely superradiant state. The collective coupling of the atoms via the radiation field leads to a substantial radiative shift of the transition energy, the collective Lamb shift. We simultaneously measured the temporal evolution of the superradiant decay and the collective Lamb shift of resonant (57)Fe nuclei excited with 14.4-kilo-electron volt synchrotron radiation. Our experimental technique provides a simple method for spectroscopic analysis of the superradiant emission.	[Roehlsberger, Ralf; Schlage, Kai; Sahoo, Balaram] Deutsch Elektronen Synchrotron DESY, D-22607 Hamburg, Germany; [Couet, Sebastien] Katholieke Univ Leuven, Inst Kern Stralingsfys, B-3001 Leuven, Belgium; [Couet, Sebastien] Katholieke Univ Leuven, INPAC, B-3001 Leuven, Belgium; [Rueffer, Rudolf] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); KU Leuven; KU Leuven; European Synchrotron Radiation Facility (ESRF)	Rohlsberger, R (corresponding author), Deutsch Elektronen Synchrotron DESY, Notkestr 85, D-22607 Hamburg, Germany.	ralf.roehlsberger@desy.de	Sahoo, Balaram/E-4828-2011; Röhlsberger, Ralf/J-4173-2013	Sahoo, Balaram/0000-0002-2050-4746; Röhlsberger, Ralf/0000-0001-6005-5183	Geconcerteerde Onderzoeksacties; Fonds Wetenschappelijk Onderzoek Flanders	Geconcerteerde Onderzoeksacties; Fonds Wetenschappelijk Onderzoek Flanders(FWO)	We thank A. N. Poddubny for valuable discussions and for helpful comments on the manuscript; H. Lipkin, J. T. Manassah, B. W. Adams, and K. Temst for fruitful discussions on this and related topics; and W. Pfutzner for assistance during sample preparation. Supported by the Geconcerteerde Onderzoeksacties and Fonds Wetenschappelijk Onderzoek Flanders programs (S.C.).	ADAMS BW, 1974, J MOD OPTIC, V56, P2009; BETHE HA, 1947, PHYS REV, V72, P339, DOI 10.1103/PhysRev.72.339; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Friedberg R., 1973, Physics Reports. Physics Letters Section C, V7c, P101, DOI 10.1016/0370-1573(73)90001-X; FRIEDBERG R, 1989, PHYS REV A, V39, P93, DOI 10.1103/PhysRevA.39.93; Friedberg R, 2010, PHYS LETT A, V374, P1648, DOI 10.1016/j.physleta.2010.02.012; Friedberg R, 2009, PHYS LETT A, V373, P3423, DOI 10.1016/j.physleta.2009.07.061; GARRETT WR, 1990, PHYS REV LETT, V64, P1717, DOI 10.1103/PhysRevLett.64.1717; GROSS M, 1982, PHYS REP, V93, P301, DOI 10.1016/0370-1573(82)90102-8; Hannon JP, 1999, HYPERFINE INTERACT, V123, P127, DOI 10.1023/A:1017011621007; HEINZEN DJ, 1987, PHYS REV LETT, V59, P2623, DOI 10.1103/PhysRevLett.59.2623; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; LEONARDI C, 1982, NUOVO CIMENTO B, V67, P256, DOI 10.1007/BF02721166; Manassah JT, 2010, LASER PHYS, V20, P259, DOI 10.1134/S1054660X10010159; Mazets IE, 2007, J PHYS B-AT MOL OPT, V40, pF105, DOI 10.1088/0953-4075/40/6/F01; Rohlsberger R, 1999, HYPERFINE INTERACT, V123, P301, DOI 10.1023/A:1017063605078; Scully MO, 2007, LASER PHYS, V17, P635, DOI 10.1134/S1054660X07050064; Scully MO, 2009, SCIENCE, V325, P1510, DOI 10.1126/science.1176695; Scully MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.143601; Scully MO, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010501; SKRIBANO.N, 1973, PHYS REV LETT, V30, P309, DOI 10.1103/PhysRevLett.30.309; STURHAHN W, 1994, PHYS REV B, V49, P9285, DOI 10.1103/PhysRevB.49.9285; Sturhahn W, 2000, HYPERFINE INTERACT, V125, P149, DOI 10.1023/A:1012681503686; Svidzinsky A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.043833; Temnov VV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.243602; van Burck U, 1999, HYPERFINE INTERACT, V123, P483, DOI 10.1023/A:1017080008712	26	298	299	5	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1248	1251		10.1126/science.1187770	http://dx.doi.org/10.1126/science.1187770			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20466883	Green Published			2022-12-28	WOS:000278318600026
J	Banci, L; Bertini, I; Ciofi-Baffoni, S; Kozyreva, T; Zovo, K; Palumaa, P				Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana; Zovo, Kairit; Palumaa, Peep			Affinity gradients drive copper to cellular destinations	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MENKES-DISEASE PROTEIN; SUPEROXIDE-DISMUTASE; ZINC-BINDING; CHAPERONE; DOMAIN; COX17; MECHANISM; ATP7A; METALLOTHIONEIN	Copper is an essential trace element for eukaryotes and most prokaryotes(1). However, intracellular free copper must be strictly limited because of its toxic side effects. Complex systems for copper trafficking evolved to satisfy cellular requirements while minimizing toxicity(2). The factors driving the copper transfer between protein partners along cellular copper routes are, however, not fully rationalized. Until now, inconsistent, scattered and incomparable data on the copper-binding affinities of copper proteins have been reported. Here we determine, through a unified electrospray ionization mass spectrometry (ESI-MS)-based strategy, in an environment that mimics the cellular redox milieu, the apparent Cu(I)-binding affinities for a representative set of intracellular copper proteins involved in enzymatic redox catalysis, in copper trafficking to and within various cellular compartments, and in copper storage. The resulting thermodynamic data show that copper is drawn to the enzymes that require it by passing from one copper protein site to another, exploiting gradients of increasing copper-binding affinity. This result complements the finding that fast copper-transfer pathways require metal-mediated protein-protein interactions and therefore protein-protein specific recognition(3). Together with Cu, Zn-SOD1, metallothioneins have the highest affinity for copper(I), and may play special roles in the regulation of cellular copper distribution; however, for kinetic reasons they cannot demetallate copper enzymes. Our study provides the thermodynamic basis for the kinetic processes that lead to the distribution of cellular copper.	[Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy; [Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Kozyreva, Tatiana] Univ Florence, Dept Chem, I-50019 Florence, Italy; [Zovo, Kairit; Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	University of Florence; University of Florence; Tallinn University of Technology	Bertini, I (corresponding author), Univ Florence, Magnet Resonance Ctr CERM, Via Luigi Sacconi 6, I-50019 Florence, Italy.	ivanobertini@cerm.unifi.it; peepp@staff.ttu.ee	Palumaa, Peep/AAF-7617-2020; Ciofi-Baffoni, Simone/AAH-9778-2021; Palumaa, Peep/B-4668-2019	Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; BANCI, LUCIA/0000-0003-0562-5774; Zovo, Kairit/0000-0001-5834-5157; Ciofi Baffoni, Simone/0000-0002-2376-3321; Kozyreva, Tatiana/0000-0003-3104-0489	Estonian Science Foundation [7191]; Estonian Ministry of Education and Research [SF0140055s08]; SPINE-II-COMPLEXES [LSHG-CT-2006-031220]; FIRB PROTEOMICA MIUR [RBRN07BMCT]; World Federation of Scientists	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); SPINE-II-COMPLEXES; FIRB PROTEOMICA MIUR(Ministry of Education, Universities and Research (MIUR)); World Federation of Scientists	This work was supported by grants from the Estonian Science Foundation project 7191, the Estonian Ministry of Education and Research (grant SF0140055s08), by the SPINE-II-COMPLEXES contract LSHG-CT-2006-031220, by the FIRB PROTEOMICA MIUR contract RBRN07BMCT and by a World Federation of Scientists scholarship to K.Z. We thank K. Saar for preparative work with rat mitochondrial fractions and for measuring the enzymatic activity of CcO, and C. Massagni for preparing the CCS expression plasmid.	Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2008, P NATL ACAD SCI USA, V105, P6803, DOI 10.1073/pnas.0800019105; Banci L, 2008, J BIOL CHEM, V283, P7912, DOI 10.1074/jbc.M708016200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, J BIOL CHEM, V281, P29141, DOI 10.1074/jbc.M603176200; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Eriste E, 2003, PROTEIN EXPRES PURIF, V31, P161, DOI 10.1016/S1046-5928(03)00144-X; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; HALLEWELL RA, 1989, J BIOL CHEM, V264, P5260; Hitomi Y, 2001, J AM CHEM SOC, V123, P8614, DOI 10.1021/ja016146v; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Jensen PY, 1999, BBA-PROTEIN STRUCT M, V1434, P103, DOI 10.1016/S0167-4838(99)00161-2; KAGI JHR, 1993, METALLOTHIONEIN; Kim BE, 2008, NAT CHEM BIOL, V4, P176, DOI 10.1038/nchembio.72; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; LAPPALAINEN P, 1993, J BIOL CHEM, V268, P26416; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; Linz R, 2007, J BIOENERG BIOMEMBR, V39, P403, DOI 10.1007/s10863-007-9101-2; NIELSON KB, 1984, J BIOL CHEM, V259, P4941; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PRESTA A, 1995, EUR J BIOCHEM, V227, P226, DOI 10.1111/j.1432-1033.1995.tb20380.x; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Rae TD, 2001, J BIOL CHEM, V276, P5166, DOI 10.1074/jbc.M008005200; SAKS VA, 1980, J BIOL CHEM, V255, P755; Slutter CE, 1996, BIOCHEMISTRY-US, V35, P3387, DOI 10.1021/bi9525839; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; VONWACHENFELDT C, 1994, FEBS LETT, V340, P109, DOI 10.1016/0014-5793(94)80182-7; Voronova A, 2007, PROTEIN EXPRES PURIF, V53, P138, DOI 10.1016/j.pep.2006.11.014; Voskoboinik I, 2002, J BIOENERG BIOMEMBR, V34, P363, DOI 10.1023/A:1021250003104; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200; YONETANI T, 1965, J BIOL CHEM, V240, P3392	37	331	335	4	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					645	U145		10.1038/nature09018	http://dx.doi.org/10.1038/nature09018			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20463663				2022-12-28	WOS:000278249000048
J	Cheloufi, S; Dos Santos, CO; Chong, MMW; Hannon, GJ				Cheloufi, Sihem; Dos Santos, Camila O.; Chong, Mark M. W.; Hannon, Gregory J.			A Dicer-independent miRNA biogenesis pathway that requires Ago catalysis	NATURE			English	Article							CRYSTAL-STRUCTURE; ARGONAUTE FAMILY; SMALL RNAS; SLICER; RISC; IDENTIFICATION; MICRORNAS; SIRNAS; GENE; RECRUITS	The nucleolytic activity of animal Argonaute proteins is deeply conserved, despite its having no obvious role in microRNA-directed gene regulation. In mice, Ago2 (also known as Eif2c2) is uniquely required for viability, and only this family member retains catalytic competence. To investigate the evolutionary pressure to conserve Argonaute enzymatic activity, we engineered a mouse with catalytically inactive Ago2 alleles. Homozygous mutants died shortly after birth with an obvious anaemia. Examination of microRNAs and their potential targets revealed a loss of miR-451, a small RNA important for erythropoiesis. Though this microRNA is processed by Drosha (also known as Rnasen), its maturation does not require Dicer. Instead, the pre-miRNA becomes loaded into Ago and is cleaved by the Ago catalytic centre to generate an intermediate 39 end, which is then further trimmed. Our findings link the conservation of Argonaute catalysis to a conserved mechanism of microRNA biogenesis that is important for vertebrate development.	[Cheloufi, Sihem; Dos Santos, Camila O.; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Cheloufi, Sihem] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; [Chong, Mark M. W.] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Chong, Mark M. W.] Walter & Eliza Hall Inst Med Res Parkville, Parkville, Vic 3052, Australia	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; New York University; Walter & Eliza Hall Institute	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Chong, Mark/H-6684-2016; Hannon, Gregory/AAB-3568-2019	Chong, Mark/0000-0002-3701-7397; Cheloufi, Sihem/0000-0002-1726-4796	NIH; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Mosquera, S. Y. Kim, D. Frendewey and A. Economides for help with generating mutants and caring for animals. A. Nagy, M. Shen, J. Murn, V. Vagin and A. Aravin provided discussion. N. Kim, D. Littman, I. Ibarra and E. Wagenblast provided critical reagents, and O. Tam, R. Sachidanandam, Z. Xuan, D. McCombie and M. Rooks provided support for generation and analysis of deep sequencing data. This work was supported by grants from the NIH and by a gift from K. W. Davis.	Alisch RS, 2007, PLOS GENET, V3, P2565, DOI 10.1371/journal.pgen.0030227; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Joshua-Tor L, 2006, COLD SPRING HARB SYM, V71, P67, DOI 10.1101/sqb.2006.71.048; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Morita S, 2007, GENOMICS, V89, P687, DOI 10.1016/j.ygeno.2007.01.004; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Nagy A., 2003, MANIPULATING MOUSE E; NAGY A, 2000, GENE TARGETING PRACT, P189; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Papapetrou EP, 2010, STEM CELLS, V28, P287, DOI 10.1002/stem.257; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Rossant J., 2002, MOUSE DEV PATTERNING, P155; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wang HW, 2009, NAT STRUCT MOL BIOL, V16, P1148, DOI 10.1038/nsmb.1673; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	55	750	811	0	130	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					584	U76		10.1038/nature09092	http://dx.doi.org/10.1038/nature09092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20424607	Green Accepted			2022-12-28	WOS:000278249000034
J	Gamo, FJ; Sanz, LM; Vidal, J; de Cozar, C; Alvarez, E; Lavandera, JL; Vanderwall, DE; Green, DVS; Kumar, V; Hasan, S; Brown, JR; Peishoff, CE; Cardon, LR; Garcia-Bustos, JF				Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Vanderwall, Dana E.; Green, Darren V. S.; Kumar, Vinod; Hasan, Samiul; Brown, James R.; Peishoff, Catherine E.; Cardon, Lon R.; Garcia-Bustos, Jose F.			Thousands of chemical starting points for antimalarial lead identification	NATURE			English	Article							PLASMODIUM-FALCIPARUM; MALARIA; DRUGS; SENSITIVITY; DISCOVERY; EFFICACY; KINOME; GENOME	Malaria is a devastating infection caused by protozoa of the genus Plasmodium. Drug resistance is widespread, no new chemical class of antimalarials has been introduced into clinical practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs. We screened nearly 2 million compounds in GlaxoSmithKline's chemical library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 mu M concentration. More than 8,000 also showed potent activity against the multidrug resistant strain Dd2. Most (82%) compounds originate from internal company projects and are new to the malaria community. Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host-pathogen interaction related targets. Chemical structures and associated data are hereby made public to encourage additional drug lead identification efforts and further research into this disease.	[Gamo, Francisco-Javier; Sanz, Laura M.; Vidal, Jaume; de Cozar, Cristina; Alvarez, Emilio; Lavandera, Jose-Luis; Garcia-Bustos, Jose F.] GlaxoSmithKline, Tres Cantos 28760, Spain; [Vanderwall, Dana E.] GlaxoSmithKline, Computat & Struct Chem, Res Triangle Pk, NC 27709 USA; [Green, Darren V. S.] GlaxoSmithKline, Computat & Struct Chem, Med Res Ctr, Stevenage SG1 2NY, Herts, England; [Kumar, Vinod; Hasan, Samiul; Brown, James R.] GlaxoSmithKline, Quantitat Sci, Computat Biol, Collegeville, PA 19426 USA; [Peishoff, Catherine E.] GlaxoSmithKline, Computat & Struct Chem, Collegeville, PA 19426 USA; [Cardon, Lon R.] GlaxoSmithKline, Quantitat Sci, King Of Prussia, PA 19406 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Garcia-Bustos, JF (corresponding author), GlaxoSmithKline, Cantos Med Dev Campus,Severo Ochoa 2, Tres Cantos 28760, Spain.	jose.f.garcia-bustos@gsk.com	Lavandera, José Luis/J-6913-2019; Lavandera, Jose Luis L/K-3690-2014; Green, Darren/AAG-5754-2019	Lavandera, José Luis/0000-0003-0730-6865; Lavandera, Jose Luis L/0000-0003-0730-6865; Green, Darren/0000-0001-9063-2754; Garcia-Bustos, Jose/0000-0002-6310-796X; Vanderwall, Dana/0000-0003-1076-8788; Brown, James/0000-0002-9368-627X	Medicines for Malaria Venture	Medicines for Malaria Venture	We thank S. Peregrina and S. Prats for technical assistance, and D. Jimenez-Alfaro for supplying compounds pre-dispensed in microtitre plates. We thank P. Vallance and R. Keenan for organising support for this work, R. Macarron and J. Luengo for developing the IFI index and getting the chemistry data ready for publication, together with J. M. Fiandor, S. Chakravorty and members of GSK's Chemistry Council. J. Lewis, A. Clow, J. Overington and M. Davies were instrumental in the uploading and formatting of the data. We also thank N. Cammack, P. Sanseau and J. Burrows for critically commenting on the manuscript. The support and funding of Medicines for Malaria Venture is gratefully acknowledged.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Andriantsoanirina V, 2009, ANTIMICROB AGENTS CH, V53, P4588, DOI 10.1128/AAC.00610-09; Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; *AUR PHARM, 2004, AUR PHARM AURSCOPE D; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bonnet M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-192; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Davis AM, 2005, CURR TOP MED CHEM, V5, P421, DOI 10.2174/1568026053828411; Daylight Chemical Information Systems Inc., 2008, DAYL THEOR MAN; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Ekland EH, 2008, INT J PARASITOL, V38, P743, DOI 10.1016/j.ijpara.2008.03.004; FELSENTEIN J, PHYLIP PHYLOGENETIC; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; JOHNSON M, 1989, QSAR QUANTITATIVE ST, P167; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Leroy D, 2008, TRENDS PHARMACOL SCI, V29, P241, DOI 10.1016/j.tips.2008.02.005; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; O'Brien PJ, 2006, ARCH TOXICOL, V80, P580, DOI 10.1007/s00204-006-0091-3; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Ramya TNC, 2007, ANTIMICROB AGENTS CH, V51, P307, DOI 10.1128/AAC.00808-06; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; *WHO, 2009, WORLD MAL REP; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Yuan J, 2009, NAT CHEM BIOL, V5, P765, DOI 10.1038/nchembio.215; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	723	747	3	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					305	U56		10.1038/nature09107	http://dx.doi.org/10.1038/nature09107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	598IO	20485427				2022-12-28	WOS:000277829200031
J	Jones, C; Hill, J; Chapple, C				Jones, Clare; Hill, Jennifer; Chapple, Christopher		Guideline Dev Grp	Management of lower urinary tract symptoms in men: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chapple, Christopher] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, Guideline Dev Grp, London NW1 4LE, England; [Chapple, Christopher] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Urol, Guideline Dev Grp, Sheffield S10 2JF, S Yorkshire, England	Royal College of Physicians; University of Sheffield	Chapple, C (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, Guideline Dev Grp, London NW1 4LE, England.	c.r.chapple@sheffield.ac.uk		Chapple, Christopher/0000-0002-2960-9931	Nation Clinical Excellence	Nation Clinical Excellence	The National Clinical Guideline Centre for Acute and Chronic Conditions was commissioned and funded by the Nation Clinical Excellence to write this summary.	Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Chapple CR, 2009, URODYNAMICS MADE EAS; CHAPPLE CR, 1999, EUR UROL, V36; MEBUST WK, 1991, INT CONS BEN PROST H, P51; *NAT I HLTH CLIN E, 2010, MAN LOW UR TRACT SYM, V97; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V40	7	56	57	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2010	340								c2354	10.1136/bmj.c2354	http://dx.doi.org/10.1136/bmj.c2354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484350	Green Submitted			2022-12-28	WOS:000278061800002
J	Paulson, JF; Bazemore, SD				Paulson, James F.; Bazemore, Sharnail D.			Prenatal and Postpartum Depression in Fathers and Its Association With Maternal Depression A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSTNATAL DEPRESSION; PSYCHOLOGICAL DISTRESS; PATERNAL DEPRESSION; EXPECTANT FATHERS; CHILD-DEVELOPMENT; 1ST-TIME FATHERS; SOCIAL SUPPORT; MENTAL-HEALTH; MOTHERS; PREGNANCY	Context It is well established that maternal prenatal and postpartum depression is prevalent and has negative personal, family, and child developmental outcomes. Paternal depression during this period may have similar characteristics, but data are based on an emerging and currently inconsistent literature. Objective To describe point estimates and variability in rates of paternal prenatal and postpartum depression over time and its association with maternal depression. Data Sources Studies that documented depression in fathers between the first trimester and the first postpartum year were identified through MEDLINE, PsycINFO, EMBASE, Google Scholar, dissertation abstracts, and reference lists for the period between January 1980 and October 2009. Study Selection Studies that reported identified cases within the selected time frame were included, yielding a total of 43 studies involving 28 004 participants after duplicate reports and data were excluded. Data Extraction Information on rates of paternal and maternal depression, as well as reported paternal-maternal depressive correlations, was extracted independently by 2 raters. Effect sizes were calculated using logits, which were back-transformed and reported as proportions. Random-effects models of event rates were used because of significant heterogeneity. Moderator analyses included timing, measurement method, and study location. Study quality ratings were calculated and used for sensitivity analysis. Publication bias was evaluated with funnel plots and the Egger method. Data Synthesis Substantial heterogeneity was observed among rates of paternal depression, with a meta-estimate of 10.4% (95% confidence interval [CI], 8.5%-12.7%). Higher rates of depression were reported during the 3- to 6-month postpartum period (25.6%; 95% CI, 17.3%-36.1%). The correlation between paternal and maternal depression was positive and moderate in size (r=0.308; 95% CI, 0.228-0.384). No evidence of significant publication bias was detected. Conclusions Prenatal and postpartum depression was evident in about 10% of men in the reviewed studies and was relatively higher in the 3- to 6-month postpartum period. Paternal depression also showed a moderate positive correlation with maternal depression. JAMA. 2010; 303(19): 1961-1969	[Paulson, James F.; Bazemore, Sharnail D.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23510 USA	Eastern Virginia Medical School	Paulson, JF (corresponding author), Eastern Virginia Med Sch, Dept Pediat, EV Williams Hall,855 W Brambleton Ave, Norfolk, VA 23510 USA.	paulsojf@evms.edu						Affonso DD, 2000, J PSYCHOSOM RES, V49, P207, DOI 10.1016/S0022-3999(00)00176-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2009, COMPR MET COMP PROGR; Areias MEG, 1996, BRIT J PSYCHIAT, V169, P30, DOI 10.1192/bjp.169.1.30; ATKINSON AK, 1984, J ABNORM PSYCHOL, V93, P115, DOI 10.1037/0021-843X.93.1.115; BALLARD CG, 1993, EUR J PSYCHIAT, V7, P117; BALLARD CG, 1994, BRIT J PSYCHIAT, V164, P782, DOI 10.1192/bjp.164.6.782; Beardslee WR, 1998, J AM ACAD CHILD PSY, V37, P1134, DOI 10.1097/00004583-199811000-00012; Beck A, 1993, MANUAL BECK DEPRESSI; Beck CT, 1996, NURS RES, V45, P297, DOI 10.1097/00006199-199609000-00008; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; Bielawska-Batorowicz E, 2006, J REPROD INFANT PSYC, V24, P21, DOI 10.1080/02646830500475179; BOURNE H, 2006, THESIS U MASSACHUSET; Boyce P, 2007, AUST NZ J PSYCHIAT, V41, P718, DOI 10.1080/00048670701517959; Bronte-Tinkew J, 2007, J FAM ISSUES, V28, P61, DOI 10.1177/0192513X06293609; Buist A, 2003, JOGNN-J OBST GYN NEO, V32, P172, DOI 10.1177/0884217503252127; CARRO MG, 1993, DEV PSYCHOPATHOL, V5, P567, DOI 10.1017/S0954579400006167; Condon JT, 2004, AUST NZ J PSYCHIAT, V38, P56, DOI 10.1177/000486740403800102; Cooper H, 2009, HDB RES SYNTHESIS ME; Cooper H. M., 1998, SYNTHESIZING RES GUI, V2; Cox J, 2005, LANCET, V366, P982, DOI 10.1016/S0140-6736(05)67372-2; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dave S, 2005, BRIT J DEV PSYCHOL, V23, P609, DOI 10.1348/026151004X22962; Dudley M, 2001, J REPROD INFANT PSYC, V19, P187; Edhborg M, 2005, ARCH WOMEN MENT HLTH, V8, P221, DOI 10.1007/s00737-005-0097-5; Edhborg M, 2008, SCAND J CARING SCI, V22, P186, DOI 10.1111/j.1471-6712.2007.00512.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Escriba-Agueir V, 2008, J EPIDEMIOL COMMUN H, V62, P410, DOI 10.1136/jech.2007.063016; FAWCETT J, 1986, NURS RES, V35, P144; FERKETICH SL, 1995, NURS RES, V44, P89; Field T, 2006, INFANT BEHAV DEV, V29, P579, DOI 10.1016/j.infbeh.2006.07.010; Fletcher R, 2008, ARCH WOMEN MENT HLTH, V11, P27, DOI 10.1007/s00737-008-0211-6; Freeman MP, 2005, J WOMENS HEALTH, V14, P929, DOI 10.1089/jwh.2005.14.929; FROST LA, 1996, THESIS U WISCONSIN M; Gao LL, 2009, RES NURS HEALTH, V32, P50, DOI 10.1002/nur.20306; Goodman JH, 2008, INFANT MENT HEALTH J, V29, P624, DOI 10.1002/imhj.20199; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; GOTLIB IH, 1989, J CONSULT CLIN PSYCH, V57, P269, DOI 10.1037/0022-006X.57.2.269; Greenhalgh R, 2000, BIRTH-ISS PERINAT C, V27, P177, DOI 10.1046/j.1523-536x.2000.00177.x; Hall W.A., 2007, J PRENATAL PERINATAL, V21, P231; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hjelmstedt A, 2003, ACTA OBSTET GYN SCAN, V82, P152, DOI 10.1080/j.1600-0412.2003.00040.x; Hjelmstedt A, 2008, SCAND J CARING SCI, V22, P72, DOI 10.1111/j.1471-6712.2007.00537.x; Keeton CP, 2008, J FAM PSYCHOL, V22, P212, DOI 10.1037/0893-3200.22.2.212; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lane A, 1997, BRIT J PSYCHIAT, V171, P550, DOI 10.1192/bjp.171.6.550; Leathers SJ, 1997, J NERV MENT DIS, V185, P129, DOI 10.1097/00005053-199703000-00001; Leathers SJ, 2000, AM J ORTHOPSYCHIAT, V70, P523, DOI 10.1037/h0087671; Lipsey M. W., 2000, PRACTICAL METAANALAY; Madsen S.A., 2007, J MENS HLTH GEND, V4, P26, DOI [10.1016/j.jmhg.2006.10.017, DOI 10.1016/J.JMHG.2006.10.017]; Marchesi C, 2009, OBSTET GYNECOL, V113, P1292, DOI 10.1097/AOG.0b013e3181a45e90; Matthey S, 2003, J AFFECT DISORDERS, V74, P139, DOI 10.1016/S0165-0327(02)00012-5; Matthey S, 2000, J AFFECT DISORDERS, V60, P75, DOI 10.1016/S0165-0327(99)00159-7; Matthey S, 2001, J AFFECT DISORDERS, V64, P175, DOI 10.1016/S0165-0327(00)00236-6; Mezulis AH, 2004, J FAM PSYCHOL, V18, P575, DOI 10.1037/0893-3200.18.4.575; Morse CA, 2000, J PSYCHOSOM OBST GYN, V21, P109, DOI 10.3109/01674820009075616; Orwin RG, 1983, J ED STAT, V8, P157, DOI [DOI 10.2307/1164923, 10.3102/10769986008002157]; Paulson JF, 2006, PEDIATRICS, V118, P659, DOI 10.1542/peds.2005-2948; Paulson JF, 2009, J CHILD PSYCHOL PSYC, V50, P254, DOI 10.1111/j.1469-7610.2008.01973.x; Pinheiro RT, 2006, ACTA PSYCHIAT SCAND, V113, P230, DOI 10.1111/j.1600-0447.2005.00708.x; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Ramchandani PG, 2008, J AM ACAD CHILD PSY, V47, P390, DOI 10.1097/CHI.0b013e31816429c2; RASKIN VD, 1990, AM J PSYCHIAT, V147, P658; SANDBERG J, 1986, THESIS B YOUNG U PRO; Schumacher Marina, 2008, Women Birth, V21, P65, DOI 10.1016/j.wombi.2008.03.008; Skari H, 2002, BJOG-INT J OBSTET GY, V109, P1154, DOI 10.1111/j.1471-0528.2002.00468.x; Smart J, 2007, J PAEDIATR CHILD H, V43, P293, DOI 10.1111/j.1440-1754.2007.01060.x; Soliday E, 1999, AM J ORTHOPSYCHIAT, V69, P30, DOI 10.1037/h0080379; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Thorpe K.J., 1992, J REPROD INFANT PSYC, V10, P205, DOI DOI 10.1080/; van den Berg MP, 2009, PEDIATRICS, V124, pE96, DOI 10.1542/peds.2008-3100; Wang SY, 2006, J PSYCHOSOM RES, V60, P303, DOI 10.1016/j.jpsychores.2005.08.012	73	759	773	2	149	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1961	1969		10.1001/jama.2010.605	http://dx.doi.org/10.1001/jama.2010.605			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597NJ	20483973				2022-12-28	WOS:000277764500023
J	Cohen, D; Berger, SP; Steup-Beekman, GM; Bloemenkamp, KWM; Bajema, IM				Cohen, Danielle; Berger, Stefan P.; Steup-Beekman, Gerda M.; Bloemenkamp, Kitty W. M.; Bajema, Ingeborg M.			Diagnosis and management of the antiphospholipid syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTERNATIONAL CONSENSUS STATEMENT; ANTICARDIOLIPIN ANTIBODIES; CLASSIFICATION CRITERIA; ANTITHROMBOTIC THERAPY; RECURRENT THROMBOSIS; RISK-FACTORS; DISEASE; ASSOCIATION; PREVENTION; GUIDELINES		[Cohen, Danielle; Bajema, Ingeborg M.] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands; [Berger, Stefan P.] Haga Teaching Hosp, Dept Internal Med, NL-2504 LN The Hague, Netherlands; [Berger, Stefan P.] Leiden Univ, Med Ctr, Dept Nephrol, NL-2504 LN The Hague, Netherlands; [Steup-Beekman, Gerda M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2509 JH The Hague, Netherlands; [Steup-Beekman, Gerda M.] Bronovo Hosp, NL-2509 JH The Hague, Netherlands; [Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, Dept Obstet, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haaglanden Medical Center; Bronovo Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Cohen, D (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, POB 9600, NL-2300 RC Leiden, Netherlands.	d.cohen@lumc.nl						Asherson RA, 2003, LUPUS, V12, P530, DOI 10.1191/0961203303lu394oa; Avcin T, 2008, PEDIATRICS, V122, pE1100, DOI 10.1542/peds.2008-1209; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bertsias G, 2008, ANN RHEUM DIS, V67, P195, DOI 10.1136/ard.2007.070367; Cervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; de Laat B, 2008, NAT CLIN PRACT RHEUM, V4, P192, DOI 10.1038/ncprheum0740; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Empson M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002859.pub2; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Galli M, 2003, BLOOD, V101, P1827, DOI 10.1182/blood-2002-02-0441; Giannakopoulos B, 2009, BLOOD, V114, P2020, DOI 10.1182/blood-2009-05-220756; Giannakopoulos B, 2009, BLOOD, V113, P985, DOI 10.1182/blood-2007-12-129627; Hirsh J, 2008, CHEST, V133, p110S, DOI 10.1378/chest.08-0652; HUGHES GRV, 1983, BRIT MED J, V287, P1088, DOI 10.1136/bmj.287.6399.1088; Jauniaux E, 2006, HUM REPROD, V21, P2216, DOI 10.1093/humrep/del150; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Levine SR, 2004, JAMA-J AM MED ASSOC, V291, P576, DOI 10.1001/jama.291.5.576; Lim W, 2006, JAMA-J AM MED ASSOC, V295, P1050, DOI 10.1001/jama.295.9.1050; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; MOSCA M, 2010, ANN RHEUM DIS; Opatrny L, 2006, J RHEUMATOL, V33, P2214; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Pierangeli SS, 2008, SEMIN THROMB HEMOST, V34, P236, DOI 10.1055/s-0028-1082267; Pierangeli SS, 2008, NAT PROTOC, V3, P840, DOI 10.1038/nprot.2008.48; *ROYAL COLL GYN, 2009, RED RISK THROMB EMB; Ruiz-Irastorza G, 2007, ARTHRIT RHEUM-ARTHR, V57, P1487, DOI 10.1002/art.23109	28	38	41	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2010	340								c2541	10.1136/bmj.c2541	http://dx.doi.org/10.1136/bmj.c2541			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HS	20472677				2022-12-28	WOS:000277826600003
J	Huey, RB; Losos, JB; Moritz, C				Huey, Raymond B.; Losos, Jonathan B.; Moritz, Craig			Are Lizards Toast?	SCIENCE			English	Editorial Material							CLIMATE-CHANGE		[Huey, Raymond B.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; Harvard University; University of California System; University of California Berkeley	Huey, RB (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	hueyrb@uw.edu	Huey, Raymond/F-1597-2010	Huey, Raymond/0000-0002-4962-8670				ADOLPH SC, 1993, AM NAT, V142, P273, DOI 10.1086/285538; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Buckley LB, 2008, AM NAT, V171, pE1, DOI 10.1086/523949; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; DUNHAM AE, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P95; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104	15	103	104	4	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					832	833		10.1126/science.1190374	http://dx.doi.org/10.1126/science.1190374			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466909	Green Published			2022-12-28	WOS:000277618800025
J	Seshadri, S; Fitzpatrick, AL; Ikram, MA; DeStefano, AL; Gudnason, V; Boada, M; Bis, JC; Smith, AV; Carassquillo, MM; Lambert, JC; Harold, D; Schrijvers, EMC; Ramirez-Lorca, R; Debette, S; Longstreth, WT; Janssens, ACJW; Pankratz, VS; Dartigues, JF; Hollingworth, P; Aspelund, T; Hernandez, I; Beiser, A; Kuller, LH; Koudstaal, PJ; Dickson, DW; Tzourio, C; Abraham, R; Antunez, C; Du, YC; Rotter, JI; Aulchenko, YS; Harris, TB; Petersen, RC; Berr, C; Owen, MJ; Lopez-Arrieta, J; Varadarajan, BN; Becker, JT; Rivadeneira, F; Nalls, MA; Graff-Radford, NR; Campion, D; Auerbach, S; Rice, K; Hofman, A; Jonsson, PV; Schmidt, H; Lathrop, M; Mosley, TH; Au, R; Psaty, BM; Uitterlinden, AG; Farrer, LA; Lumley, T; Ruiz, A; Williams, J; Amouyel, P; Younkin, SG; Wolf, PA; Launer, LJ; Lopez, OL; van Duijn, CM; Breteler, MMB				Seshadri, Sudha; Fitzpatrick, Annette L.; Ikram, M. Arfan; DeStefano, Anita L.; Gudnason, Vilmundur; Boada, Merce; Bis, Joshua C.; Smith, Albert V.; Carassquillo, Minerva M.; Lambert, Jean Charles; Harold, Denise; Schrijvers, Elisabeth M. C.; Ramirez-Lorca, Reposo; Debette, Stephanie; Longstreth, W. T., Jr.; Janssens, A. Cecile J. W.; Pankratz, V. Shane; Dartigues, Jean Francois; Hollingworth, Paul; Aspelund, Thor; Hernandez, Isabel; Beiser, Alexa; Kuller, Lewis H.; Koudstaal, Peter J.; Dickson, Dennis W.; Tzourio, Christophe; Abraham, Richard; Antunez, Carmen; Du, Yangchun; Rotter, Jerome I.; Aulchenko, Yurii S.; Harris, Tamara B.; Petersen, Ronald C.; Berr, Claudine; Owen, Michael J.; Lopez-Arrieta, Jesus; Varadarajan, Badri N.; Becker, James T.; Rivadeneira, Fernando; Nalls, Michael A.; Graff-Radford, Neill R.; Campion, Dominique; Auerbach, Sanford; Rice, Kenneth; Hofman, Albert; Jonsson, Palmi V.; Schmidt, Helena; Lathrop, Mark; Mosley, Thomas H.; Au, Rhoda; Psaty, Bruce M.; Uitterlinden, Andre G.; Farrer, Lindsay A.; Lumley, Thomas; Ruiz, Agustin; Williams, Julie; Amouyel, Philippe; Younkin, Steve G.; Wolf, Philip A.; Launer, Lenore J.; Lopez, Oscar L.; van Duijn, Cornelia M.; Breteler, Monique M. B.		CHARGE GERAD1 EADI1 Consortia	Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORGANELLES COMPLEX-1 BLOC-1; IDENTIFIES VARIANTS; SUSCEPTIBILITY; RISK; APOE; METAANALYSES; ENDOCYTOSIS; BIOGENESIS; CARRIERS; REVEALS	Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM, and CR1 as novel genes for late-onset Alzheimer disease (AD). Objectives To identify and strengthen additional loci associated with AD and confirm these in an independent sample and to examine the contribution of recently identified genes to AD risk prediction in a 3-stage analysis of new and previously published GWAS on more than 35 000 persons (8371 AD cases). Design, Setting, and Participants In stage 1, we identified strong genetic associations (P < 10(-3)) in a sample of 3006 AD cases and 14 642 controls by combining new data from the population-based Cohorts for Heart and Aging Research in Genomic Epidemiology consortium (1367 AD cases [973 incident]) with previously reported results from the Translational Genomics Research Institute and the Mayo AD GWAS. We identified 2708 single-nucleotide polymorphisms (SNPs) with P < 10(-3). In stage 2, we pooled results for these SNPs with the European AD Initiative (2032 cases and 5328 controls) to identify 38 SNPs (10 loci) with P < 10(-5). In stage 3, we combined data for these 10 loci with data from the Genetic and Environmental Risk in AD consortium (3333 cases and 6995 controls) to identify 4 SNPs with P < 1.7 x 10(-8). These 4 SNPs were replicated in an independent Spanish sample (1140 AD cases and 1209 controls). Genome-wide association analyses were completed in 2007-2008 and the meta-analyses and replication in 2009. Main Outcome Measure Presence of Alzheimer disease. Results Two loci were identified to have genome-wide significance for the first time: rs744373 near BIN1 (odds ratio [OR], 1.13; 95% confidence interval [CI], 1.06-1.21 per copy of the minor allele; P=1.59 x 10(-11)) and rs597668 near EXOC3L2/BLOC1S3/MARK4 (OR, 1.18; 95% CI, 1.07-1.29; P=6.45 x 10(-9)). Associations of these 2 loci plus the previously identified loci CLU and PICALM with AD were confirmed in the Spanish sample (P<.05). However, although CLU and PICALM were confirmed to be associated with AD in this independent sample, they did not improve the ability of a model that included age, sex, and APOE to predict incident AD (improvement in area under the receiver operating characteristic curve from 0.847 to 0.849 in the Rotterdam Study and 0.702 to 0.705 in the Cardiovascular Health Study). Conclusions Two genetic loci for AD were found for the first time to reach genome-wide statistical significance. These findings were replicated in an independent population. Two recently reported associations were also confirmed. These loci did not improve AD risk prediction. While not clinically useful, they may implicate biological pathways useful for future research. JAMA. 2010;303(18):1832-1840 www.jama.com	[Breteler, Monique M. B.] Univ Med Ctr Rotterdam, Dept Epidemiol Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Breteler, MMB (corresponding author), Univ Med Ctr Rotterdam, Dept Epidemiol Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Tzourio, christophe/L-6344-2019; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Lambert, jean-charles/A-9553-2014; Aulchenko, Yurii/M-8270-2013; Farrer, Lindsay/AAS-1035-2020; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/K-6885-2015; Ramirez-Lorca, Reposo/A-5807-2012; Ruiz, Agustin/G-5677-2012; DARTIGUES, Jean François/T-4513-2019; Reposo, Ramirez-Lorca/D-7907-2014; LICEND, CEMND/F-1296-2015; Ikram, M. Arfan/AAM-5225-2021; Tzourio, christophe/B-4015-2009; Aspelund, Thor/C-5983-2008; Debette, Stephanie/T-4946-2019; Breteler, Monique M.B./J-5058-2014; berr, Claudine/D-5238-2014; Ruiz, Agustín/L-4469-2019; Smith, Albert Vernon/K-5150-2015; Rivadeneira, Fernando/O-5385-2015; lambert, jean-charles/F-8787-2013; Aspelund, Thor/F-4826-2011	Tzourio, christophe/0000-0002-6517-2984; Gudnason, Vilmundur/0000-0001-5696-0084; Lambert, jean-charles/0000-0003-0829-7817; Aulchenko, Yurii/0000-0002-7899-1575; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Tzourio, christophe/0000-0002-6517-2984; Aspelund, Thor/0000-0002-7998-5433; Debette, Stephanie/0000-0001-8675-7968; Breteler, Monique M.B./0000-0002-0626-9305; berr, Claudine/0000-0001-5254-7655; Ruiz, Agustín/0000-0003-2633-2495; Smith, Albert Vernon/0000-0003-1942-5845; Rivadeneira, Fernando/0000-0001-9435-9441; lambert, jean-charles/0000-0003-0829-7817; Becker, James/0000-0003-4425-4726; Ikram, Mohammad Arfan/0000-0003-0372-8585; Janssens, A Cecile/0000-0002-6153-4976; Van Duijn, Cornelia/0000-0002-2374-9204; Auerbach, Sanford/0000-0003-2962-6405; Amouyel, Philippe/0000-0001-9088-234X; Harold, Denise/0000-0001-5195-0143; DeStefano, Anita/0000-0002-9335-2819; Williams, Julie/0000-0002-4069-0259; Seshadri, Sudha/0000-0001-6135-2622; Au, Rhoda/0000-0001-7742-4491; Farrer, Lindsay/0000-0001-5533-4225; Beiser, Alexa/0000-0001-8551-7778; Ramirez Lorca, Reposo/0000-0002-1594-0404; Klein, Ronald/0000-0002-4428-6237; Wolf, Philip/0000-0002-3628-301X; Dickson, Dennis W/0000-0001-7189-7917	Intramural NIH HHS [Z01 AG000950-06] Funding Source: Medline; Medical Research Council [G0300429] Funding Source: Medline; NCRR NIH HHS [M01 RR000425-39, M01RR00425] Funding Source: Medline; NHLBI NIH HHS [N01 HC085081, U01 HL080295-04, R01 HL087652-03, U01 HL080295, N01 HC075150, N01 HC015103, N01 HC085083, N01 HC085085, R01 HL087652, N01 HC035129, N01-HC-85086, N01 HC045133, N01 HC085079, R01 HL064278, N01 HC085082, N01-HC-85082, N01 HC085080, N01 HC-55222, N01-HC-85079, N01 HC055222, N01-HC-85083, N01-HC-75150, N01-HC-85080, R01 HL064278-04, N01 HC085084, N01-HC-85081, N01 HC025195, N02-HL-6-4278, N01-HC-25195, N01 HC085086] Funding Source: Medline; NIA NIH HHS [P50 AG005133, R01 AG033193-02, AG15928, R01 AG018023-07, P50 AG05681, P01 AG003991, P01 AG017216-099001, P01 AG003949-25, P01 AG017216, U01 AG006786, P01 AG003949, AG16495, AG17216, AG03949, P30AG013846, R01 AG031287, R01 AG033193, P30 AG013846-13, U24 AG021886-07, N01 AG012100, AG05133, P01 AG003949-259002, R01 AG020098-05, R01 AG016495-10, U01 AG006786-17, R01 AG008122, R01 AG016495, P50 AG016574-11, AG033193, P30 AG013846, P50 AG005133-25, U24 AG21886, P50 AG005681, AG20098, U24 AG021886, AG025259, R01 AG015928-02, AG031287, U01 AG06576, P01 AG003991-26, R01 AG025259, R01 AG008122-20, R01 AG018023, R01 AG020098, N01-AG-12100, P50 AG005681-25, R01 AG025259-04, AG25711, R01 AG18023, P50 AG016574, R01 AG031287-01A2, P01 AG03991, AG08122, P50 AG16574] Funding Source: Medline; NIDDK NIH HHS [P30 DK063491, R01 DK033651, P30 DK063491-07, DK063491] Funding Source: Medline; NINDS NIH HHS [NS17950, R01 NS017950, R01 NS017950-28] Funding Source: Medline; Wellcome Trust Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC035129, N01HC025195, N01HC085083, N01HC085080, N01HC085086, N01HC055222, N01HC085081, N01HC045133, N01HC085084, N01HC085079, N01HC085085, N01HC075150, N01HC085082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, U01HL080295, R01HL087652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK033651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928, R01AG016495, P01AG003991, R01AG033193, P50AG016574, P30AG013846, R01AG018023, ZIAAG007380, P50AG025711, N01AG012100, ZIAAG006000, P50AG005133, R01AG020098, R01AG008122, R01AG025259, U01AG006786, P50AG005681, P01AG017216, ZIAAG007270, ZIAAG000950, R56AG020098, U24AG021886, R01AG031287, P01AG003949] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish; MRC [G0300429] Funding Source: UKRI	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antunez C, 2009, J ALZHEIMERS DIS, V18, P751, DOI 10.3233/JAD-2009-1200; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Beecham GW, 2009, AM J HUM GENET, V84, P35, DOI 10.1016/j.ajhg.2008.12.008; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; English JA, 2009, PROTEOMICS, V9, P3368, DOI 10.1002/pmic.200900015; Ertekin-Taner N, 2007, NEUROL CLIN, V25, P611, DOI 10.1016/j.ncl.2007.03.009; Feulner TM, 2009, MOL PSYCHIAT; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Moroni RF, 2006, NEUROSCIENCE, V143, P83, DOI 10.1016/j.neuroscience.2006.07.052; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Poduslo SE, 2009, AM J MED GENET B, V150B, P50, DOI 10.1002/ajmg.b.30767; Poduslo SE, 2001, NEUROREPORT, V12, P3759, DOI 10.1097/00001756-200112040-00031; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ramirez-Lorca R, 2009, J NUTR HEALTH AGING, V13, P214, DOI 10.1007/s12603-009-0061-6; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Trinczek B, 2004, J BIOL CHEM, V279, P5915, DOI 10.1074/jbc.M304528200; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012	35	885	913	1	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1832	1840		10.1001/jama.2010.574	http://dx.doi.org/10.1001/jama.2010.574			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460622	Green Accepted			2022-12-28	WOS:000277513900024
J	Zakamska, NL				Zakamska, Nadia L.			H-2 emission arises outside photodissociation regions in ultraluminous infrared galaxies	NATURE			English	Article							SHOCKED MOLECULAR-HYDROGEN; EXCITATION; FEATURES; SINGS; DUST; AGNS; IRS	Ultraluminous infrared galaxies are among the most luminous objects in the local Universe and are thought to be powered by intense star formation(1,2). It has been shown that in these objects the rotational spectral lines of molecular hydrogen observed at mid-infrared wavelengths are not affected by dust obscuration(3), but left unresolved was the source of excitation for this emission. Here I report an analysis of archival Spitzer Space Telescope data on ultraluminous infrared galaxies and demonstrate that dust obscuration affects star formation indicators but not molecular hydrogen. I thereby establish that the emission of H-2 is not co-spatial with the buried starburst activity and originates outside the obscured regions. This is unexpected in light of the standard view that H-2 emission is directly associated with star-formation activity(3-5). I propose the alternative view that H-2 emission in these objects traces shocks in the surrounding material that are excited by interactions with nearby galaxies. Large-scale shocks cooling by means of H-2 emission may accordingly be more common than previously thought. In the early Universe, a boost in H-2 emission by this process may have accelerated the cooling of matter as it collapsed to form the first stars and galaxies, and would make these first structures more readily observable(6).	Inst Adv Study, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Zakamska, NL (corresponding author), Inst Adv Study, Einstein Dr, Princeton, NJ 08540 USA.	zakamska@ias.edu		Zakamska, Nadia/0000-0001-6100-6869	NASA; John N. Bahcall Fellowship at the Institute for Advanced Study; NSF [AST-0807444]	NASA(National Aeronautics & Space Administration (NASA)); John N. Bahcall Fellowship at the Institute for Advanced Study; NSF(National Science Foundation (NSF))	This work was supported by the Spitzer Space Telescope Fellowship provided by NASA through a contract issued by the Jet Propulsion Laboratory, California Institute of Technology, by the John N. Bahcall Fellowship at the Institute for Advanced Study and by the NSF grant AST-0807444. I would like to thank M. Imanishi for providing reduced, flux-calibrated ULIRG data in electronic form and for his permission to use these data for a study of H<INF>2</INF> emission. I would like to thank P. Goldreich, J. Krolik and S. Davis for discussions, and H. Spoon and L. Hao for providing electronic data.	ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; Appleton PN, 2006, ASTROPHYS J, V639, pL51, DOI 10.1086/502646; APPLETON PN, 2009, 2 US NAT AC SCI ASTR; Chiar JE, 2006, ASTROPHYS J, V637, P774, DOI 10.1086/498406; Egami E, 2006, ASTROPHYS J, V652, pL21, DOI 10.1086/509886; FORBES DA, 1993, ASTROPHYS J, V406, pL11, DOI 10.1086/186774; Genzel R, 1998, ASTROPHYS J, V498, P579, DOI 10.1086/305576; GERAKINES PA, 1995, ASTRON ASTROPHYS, V296, P810; Greif TH, 2008, MON NOT R ASTRON SOC, V387, P1021, DOI 10.1111/j.1365-2966.2008.13326.x; Guillard P, 2009, ASTRON ASTROPHYS, V502, P515, DOI 10.1051/0004-6361/200811263; Hao L., 2007, APJ, V655, P77; Higdon SJU, 2006, ASTROPHYS J, V648, P323, DOI 10.1086/505701; Hollenbach DJ, 1997, ANNU REV ASTRON ASTR, V35, P179, DOI 10.1146/annurev.astro.35.1.179; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; Imanishi M, 2007, ASTROPHYS J SUPPL S, V171, P72, DOI 10.1086/513715; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kennicutt RC, 2003, PUBL ASTRON SOC PAC, V115, P928, DOI 10.1086/376941; Kim DC, 2002, ASTROPHYS J SUPPL S, V143, P277, DOI 10.1086/343843; Monreal-Ibero A, 2006, ASTROPHYS J, V637, P138, DOI 10.1086/498257; Ogle P, 2007, ASTROPHYS J, V668, P699, DOI 10.1086/521334; RIEKE GH, 1985, ASTROPHYS J, V290, P116, DOI 10.1086/162965; Roussel H, 2007, ASTROPHYS J, V669, P959, DOI 10.1086/521667; Sanders DB, 1996, ANNU REV ASTRON ASTR, V34, P749, DOI 10.1146/annurev.astro.34.1.749; Shi Y, 2007, ASTROPHYS J, V669, P841, DOI 10.1086/521594; Smith JDT, 2007, ASTROPHYS J, V656, P770, DOI 10.1086/510549; Spoon HWW, 2007, ASTROPHYS J, V654, pL49, DOI 10.1086/511268; Van der Werf PP, 1999, IAU SYMP, P303; VANDERWERF PP, 1993, ASTROPHYS J, V405, P522, DOI 10.1086/172384; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Zakamska NL, 2008, ASTRON J, V136, P1607, DOI 10.1088/0004-6256/136/4/1607	30	26	27	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					60	63		10.1038/nature09037	http://dx.doi.org/10.1038/nature09037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445624	Green Submitted			2022-12-28	WOS:000277311900030
J	Sussman, JB; Hayward, RA				Sussman, Jeremy B.; Hayward, Rodney A.			An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHRONIC HEART-FAILURE; INTENT-TO-TREAT; CLINICAL-TRIALS; BREAST-CANCER; NONCOMPLIANCE; MORTALITY; OUTCOMES; RISK; ADHERENCE; SURVIVAL	Although the randomised controlled trial is the "gold standard" for studying the efficacy and safety of medical treatments, it is not necessarily free from bias. When patients do not follow the protocol for their assigned treatment, the resultant "treatment contamination" can produce misleading findings. The methods used historically to deal with this problem, the "as treated" and "per protocol" analysis techniques, are flawed and inaccurate. Intention to treat analysis is the solution most often used to analyse randomised controlled trials, but this approach ignores this issue of treatment contamination. Intention to treat analysis estimates the effect of recommending a treatment to study participants, not the effect of the treatment on those study participants who actually received it. In this article, we describe a simple yet rarely used analytical technique, the "contamination adjusted intention to treat analysis," which complements the intention to treat approach by producing a better estimate of the benefits and harms of receiving a treatment. This method uses the statistical technique of instrumental variable analysis to address contamination. We discuss the strengths and limitations of the current methods of addressing treatment contamination and the contamination adjusted intention to treat technique, provide examples of effective uses, and discuss how using estimates generated by contamination adjusted intention to treat analysis can improve clinical decision making and patient care.	[Sussman, Jeremy B.; Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Sussman, Jeremy B.; Hayward, Rodney A.] Vet Affairs Ann Arbor Healthcare Syst, Dept Vet Affairs, Vet Affairs Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Sussman, JB (corresponding author), Univ Michigan, Dept Internal Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA.	jeremysu@med.umich.edu	Sussman, Jeremy/W-3394-2019	Sussman, Jeremy/0000-0002-2158-3618	Robert Wood Johnson Clinical Scholars Program; Department of Veteran Affairs [465 FS]; Measurement Core of the Michigan Diabetes Research & Training Center (NIDDK of The National Institutes of Health) [P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Robert Wood Johnson Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); Department of Veteran Affairs(US Department of Veterans Affairs); Measurement Core of the Michigan Diabetes Research & Training Center (NIDDK of The National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Robert Wood Johnson Clinical Scholars Program, the Department of Veteran Affairs Cooperative Studies Program (CSP #465 FS), and the Measurement Core of the Michigan Diabetes Research & Training Center (NIDDK of The National Institutes of Health [P60 DK-20572]). None of the funders had any role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Altman DG, 1996, BRIT MED J, V313, P570; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Bang H, 2007, STAT MED, V26, P954, DOI 10.1002/sim.2663; Basu A, 2007, HEALTH ECON, V16, P1133, DOI 10.1002/hec.1291; Bond SJ, 2007, STAT MED, V26, P1473, DOI 10.1002/sim.2644; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cole JA, 2006, PHARMACOTHERAPY, V26, P1157, DOI 10.1592/phco.26.8.1157; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Dunn G, 2005, STAT METHODS MED RES, V14, P369, DOI 10.1191/0962280205sm403oa; Dunn Graham, 2002, Epidemiol Psichiatr Soc, V11, P206; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; Evans WN, 1999, J PUBLIC ECON, V72, P135, DOI 10.1016/S0047-2727(98)00090-5; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Greenland S, 2008, CLIN TRIALS, V5, P5, DOI 10.1177/1740774507087703; HEARST N, 1986, NEW ENGL J MED, V314, P620, DOI 10.1056/NEJM198603063141005; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Mealli F, 2004, BIOSTATISTICS, V5, P207, DOI 10.1093/biostatistics/5.2.207; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; PEDERSEN TR, 1994, LANCET, V344, P1383; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Sato T, 2001, STAT MED, V20, P2761, DOI 10.1002/sim.741; Schiffner R, 2001, BRIT J DERMATOL, V144, P1154, DOI 10.1046/j.1365-2133.2001.04234.x; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Schneeweiss S, 2007, CAN MED ASSOC J, V176, P627, DOI 10.1503/cmaj.061250; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; SOMMER A, 1991, STAT MED, V10, P45, DOI 10.1002/sim.4780100110; Straus SE, 2005, EVIDENCE BASED MED P; Walter SD, 2006, J CLIN EPIDEMIOL, V59, P685, DOI 10.1016/j.jclinepi.2005.11.016; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	37	110	110	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2010	340								c2073	10.1136/bmj.c2073	http://dx.doi.org/10.1136/bmj.c2073			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XB	20442226	Green Published			2022-12-28	WOS:000277572400001
J	Horton, R				Horton, Richard			Offline: The Old School House	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1510	1510		10.1016/S0140-6736(10)60627-7	http://dx.doi.org/10.1016/S0140-6736(10)60627-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435218				2022-12-28	WOS:000277655100012
J	Baranzini, SE; Mudge, J; van Velkinburgh, JC; Khankhanian, P; Khrebtukova, I; Miller, NA; Zhang, L; Farmer, AD; Bell, CJ; Kim, RW; May, GD; Woodward, JE; Caillier, SJ; McElroy, JP; Gomez, R; Pando, MJ; Clendenen, LE; Ganusova, EE; Schilkey, FD; Ramaraj, T; Khan, OA; Huntley, JJ; Luo, SJ; Kwok, P; Wu, TD; Schroth, GP; Oksenberg, JR; Hauser, SL; Kingsmore, SF				Baranzini, Sergio E.; Mudge, Joann; van Velkinburgh, Jennifer C.; Khankhanian, Pouya; Khrebtukova, Irina; Miller, Neil A.; Zhang, Lu; Farmer, Andrew D.; Bell, Callum J.; Kim, Ryan W.; May, Gregory D.; Woodward, Jimmy E.; Caillier, Stacy J.; McElroy, Joseph P.; Gomez, Refujia; Pando, Marcelo J.; Clendenen, Leonda E.; Ganusova, Elena E.; Schilkey, Faye D.; Ramaraj, Thiruvarangan; Khan, Omar A.; Huntley, Jim J.; Luo, Shujun; Kwok, Pui-yan; Wu, Thomas D.; Schroth, Gary P.; Oksenberg, Jorge R.; Hauser, Stephen L.; Kingsmore, Stephen F.			Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis	NATURE			English	Article							DNA METHYLATION; CONCORDANCE; CELLS; PATHOGENESIS; PROFILES; RATES; RISK; MAPS	Monozygotic or 'identical' twins have been widely studied to dissect the relative contributions of genetics and environment in human diseases. In multiple sclerosis (MS), an autoimmune demyelinating disease and common cause of neurodegeneration and disability in young adults, disease discordance in monozygotic twins has been interpreted to indicate environmental importance in its pathogenesis(1-8). However, genetic and epigenetic differences between monozygotic twins have been described, challenging the accepted experimental model in disambiguating the effects of nature and nurture(9-12). Here we report the genome sequences of one MS-discordant monozygotic twin pair, and messenger RNA transcriptome and epigenome sequences of CD4(+) lymphocytes from three MS-discordant, monozygotic twin pairs. No reproducible differences were detected between co-twins among similar to 3.6 million single nucleotide polymorphisms (SNPs) or similar to 0.2 million insertion-deletion polymorphisms. Nor were any reproducible differences observed between siblings of the three twin pairs in HLA haplotypes, confirmed MS-susceptibility SNPs, copy number variations, mRNA and genomic SNP and insertion-deletion genotypes, or the expression of similar to 19,000 genes in CD4(+) T cells. Only 2 to 176 differences in the methylation of similar to 2 million CpG dinucleotides were detected between siblings of the three twin pairs, in contrast to similar to 800 methylation differences between T cells of unrelated individuals and several thousand differences between tissues or between normal and cancerous tissues. In the first systematic effort to estimate sequence variation among monozygotic co-twins, we did not find evidence for genetic, epigenetic or transcriptome differences that explained disease discordance. These are the first, to our knowledge, female, twin and autoimmune disease individual genome sequences reported.	[Baranzini, Sergio E.; Khankhanian, Pouya; Caillier, Stacy J.; McElroy, Joseph P.; Gomez, Refujia; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Mudge, Joann; van Velkinburgh, Jennifer C.; Miller, Neil A.; Farmer, Andrew D.; Bell, Callum J.; Kim, Ryan W.; May, Gregory D.; Woodward, Jimmy E.; Clendenen, Leonda E.; Ganusova, Elena E.; Schilkey, Faye D.; Ramaraj, Thiruvarangan; Kingsmore, Stephen F.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Khrebtukova, Irina; Zhang, Lu; Huntley, Jim J.; Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA; [Pando, Marcelo J.] Stanford Med Sch, Ctr Blood, Palo Alto, CA 94303 USA; [Khan, Omar A.] Wayne State Med Sch, Dept Neurol, Detroit, MI 48201 USA; [Kwok, Pui-yan] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Kwok, Pui-yan; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Wu, Thomas D.] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA	University of California System; University of California San Francisco; National Center for Genome Resources (NCGR); Illumina; Stanford University; Wayne State University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech	Baranzini, SE (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	sebaran@cgl.ucsf.edu; sfk@ncgr.org	Baranzini, Sergio/A-9422-2013; Kwok, Pui-Yan/F-7725-2014; Hauser, Stephen L/J-2978-2016; van Velkinburgh, Jennifer/D-7205-2015	Baranzini, Sergio/0000-0003-0067-194X; Kwok, Pui-Yan/0000-0002-5087-3059; Pando, Marcelo Jorge/0000-0003-0866-0583; Kingsmore, Stephen/0000-0001-7180-2527; Gomez, Refujia/0000-0003-0730-8019; van Velkinburgh, Jennifer/0000-0002-4592-2397; kingsmore, stephen/0000-0002-3758-4631; Mudge, Joann/0000-0002-2972-1640	Small Ventures USA Inc.; A. J. Brass Foundation; Nancy Davis Foundation; NIH [RR016480, RO1NS26799, RO1NS46297]; National MS Society (NMSS) [RG3060C8, RG2901D9]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077693] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI066569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS046297] Funding Source: NIH RePORTER	Small Ventures USA Inc.; A. J. Brass Foundation; Nancy Davis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society (NMSS)(National Multiple Sclerosis Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the study subjects. This work was supported by grants from Small Ventures USA Inc., A. J. Brass Foundation, Nancy Davis Foundation, NIH grants RR016480 to F. D. S., RO1NS26799 to S. L. H., RO1NS46297 to J.R.O. and National MS Society (NMSS) grants RG3060C8 and RG2901D9 to J.R.O. S.E.B is a Harry Weaver Neuroscience Scholar of NMSS.	ALPEROVITCH A, 1992, ANN NEUROL, V32, P724; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chitnis T, 2007, INT REV NEUROBIOL, V79, P43, DOI 10.1016/S0074-7742(07)79003-7; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gringras P, 2001, EARLY HUM DEV, V64, P105, DOI 10.1016/S0378-3782(01)00171-2; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Islam T, 2006, ANN NEUROL, V60, P56, DOI 10.1002/ana.20871; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; Mane SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-264; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; MUMFORD CJ, 1994, NEUROLOGY, V44, P11, DOI 10.1212/WNL.44.1.11; Nielsen NM, 2005, AM J EPIDEMIOL, V162, P774, DOI 10.1093/aje/kwi280; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Pop M, 2004, BRIEF BIOINFORM, V5, P237, DOI 10.1093/bib/5.3.237; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sawkins MC, 2004, PLANT MOL BIOL, V56, P465, DOI 10.1007/s11103-004-4950-0; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sugarbaker DJ, 2008, P NATL ACAD SCI USA, V105, P3521, DOI 10.1073/pnas.0712399105; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; WU TD, 2010, BIOINFORMATICS  0210, DOI DOI 10.1093/BIOINFORMATICS/BTQ057	33	350	365	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1351	U6		10.1038/nature08990	http://dx.doi.org/10.1038/nature08990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428171	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000277149000047
J	Hidalgo, M				Hidalgo, Manuel			Pancreatic Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PHASE-III TRIAL; RANDOMIZED CONTROLLED-TRIAL; DUCTAL ADENOCARCINOMA; CURATIVE-INTENT; TUMOR-GROWTH; RISK-FACTORS; ADJUVANT CHEMOTHERAPY; PLUS CAPECITABINE; CLINICAL BENEFIT; STELLATE CELLS		[Hidalgo, Manuel] Ctr Nacl Invest Oncol, Madrid, Spain; [Hidalgo, Manuel] Hosp Madrid, Madrid, Spain; [Hidalgo, Manuel] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Johns Hopkins University	Hidalgo, M (corresponding author), 1650 Orleans St,Rm 489, Baltimore, MD 21230 USA.	mhidalgo@cnio.es	Giuseppe, Zamboni/A-5991-2016; HIDALGO, MANUEL/I-4995-2015; Lo, Chung Mau/C-4352-2009	HIDALGO, MANUEL/0000-0002-3765-3318; 	Roche; Daichi; American Biosciences; Agensys [AGS-1C4D4]; Eisai [MORAb-009]; OSI-Genentech; Merck; Agensys	Roche(Roche Holding); Daichi; American Biosciences; Agensys; Eisai(Eisai Co Ltd); OSI-Genentech; Merck(Merck & Company); Agensys	Dr. Hidalgo reports receiving grant support from Roche and Daichi; being the principal investigator and receiving grant support for clinical studies of nanoparticle albumin-bound paclitaxel from American Biosciences, of erlotinib from Roche, of AGS-1C4D4 from Agensys, and of MORAb-009 from Eisai; and receiving consulting fees from American Biosciences, OSI-Genentech, Merck, and Agensys. No other potential conflict of interest relevant to this article was reported.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Batty GD, 2009, CANCER EPIDEM BIOMAR, V18, P673, DOI 10.1158/1055-9965.EPI-08-1032; Berger AC, 2008, J CLIN ONCOL, V26, P5918, DOI 10.1200/JCO.2008.18.6288; Bernhard J, 2008, J CLIN ONCOL, V26, P3695, DOI 10.1200/JCO.2007.15.6240; Bilimoria KY, 2007, CANCER-AM CANCER SOC, V110, P738, DOI 10.1002/cncr.22852; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chauffert B, 2008, ANN ONCOL, V19, P1592, DOI 10.1093/annonc/mdn281; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Chung EJ, 2009, CLIN CANCER RES, V15, P3050, DOI 10.1158/1078-0432.CCR-08-2954; Couch FJ, 2007, CANCER EPIDEM BIOMAR, V16, P342, DOI 10.1158/1055-9965.EPI-06-0783; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; DeRosier LC, 2007, MOL CANCER THER, V6, P3198, DOI 10.1158/1535-7163.MCT-07-0299; Dumonceau JM, 2007, ENDOSCOPY, V39, P124, DOI 10.1055/s-2006-945096; Edge SB, 2010, AJCC CANC STAGING MA; Erkan MM, 2009, NEOPLASIA, V11, P497, DOI 10.1593/neo.81618; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Farrell JJ, 2009, GASTROENTEROLOGY, V136, P187, DOI 10.1053/j.gastro.2008.09.067; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Ferrone CR, 2006, J CLIN ONCOL, V24, P2897, DOI 10.1200/JCO.2005.05.3934; Genkinger JM, 2009, CANCER EPIDEM BIOMAR, V18, P765, DOI 10.1158/1055-9965.EPI-08-0880; Gold DV, 2003, CLIN CANCER RES, V9, p3929S; Greenhalf W, 2009, PANCREATOLOGY, V9, P215, DOI 10.1159/000210262; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Haklai R, 2008, CANCER CHEMOTH PHARM, V61, P89, DOI 10.1007/s00280-007-0451-6; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; Hassan Raffit, 2007, Cancer Immun, V7, P20; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Heinemann V, 2006, J CLIN ONCOL, V24, P3946, DOI 10.1200/JCO.2005.05.1490; Herman JM, 2008, J CLIN ONCOL, V26, P3503, DOI 10.1200/JCO.2007.15.8469; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hernandez JM, 2009, J GASTROINTEST SURG, V13, P349, DOI 10.1007/s11605-008-0696-3; Hess V, 2008, LANCET ONCOL, V9, P132, DOI 10.1016/S1470-2045(08)70001-9; Hewish M, 2009, RECENT PAT ANTI-CANC, V4, P54, DOI 10.2174/157489209787002515; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2008, INT J CLIN EXP PATHO, V1, P306; Huguet F, 2007, J CLIN ONCOL, V25, P326, DOI 10.1200/JCO.2006.07.5663; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Karmazanovsky G, 2005, ABDOM IMAGING, V30, P488, DOI 10.1007/s00261-004-0279-z; Katz MHG, 2008, J AM COLL SURGEONS, V206, P833, DOI 10.1016/j.jamcollsurg.2007.12.020; Katz MHG, 2009, ANN SURG ONCOL, V16, P836, DOI 10.1245/s10434-008-0295-2; Ko AH, 2005, BRIT J CANCER, V93, P195, DOI 10.1038/sj.bjc.6602687; Kulke MH, 2007, J CLIN ONCOL, V25, P4787, DOI 10.1200/JCO.2007.11.8521; Landi S, 2009, MUTAT RES-REV MUTAT, V681, P299, DOI 10.1016/j.mrrev.2008.12.001; Larghi A, 2009, CLIN CANCER RES, V15, P1907, DOI 10.1158/1078-0432.CCR-08-1966; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li J, 2009, J PANCREAS, V10, P361; Loehrer PJ, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4506; Louvet C, 2005, J CLIN ONCOL, V23, P3509, DOI 10.1200/JCO.2005.06.023; Lowenfels AB, 2006, BEST PRACT RES CL GA, V20, P197, DOI 10.1016/j.bpg.2005.10.001; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Masamune A, 2009, J GASTROENTEROL, V44, P249, DOI 10.1007/s00535-009-0013-2; Mayo SC, 2009, J AM COLL SURGEONS, V208, P87, DOI 10.1016/j.jamcollsurg.2008.10.014; Miura Fumihiko, 2006, HPB (Oxford), V8, P337, DOI 10.1080/13651820500540949; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mukherjee P, 2009, J IMMUNOL, V182, P216, DOI 10.4049/jimmunol.182.1.216; Murugesan SR, 2009, CANCER GENE THER, V16, P841, DOI 10.1038/cgt.2009.32; Neoptolemos JP, 2004, NEW ENGL J MED, V351, P726; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pausawasdi N, 2007, CURR OPIN GASTROEN, V23, P515, DOI 10.1097/MOG.0b013e3282ba5713; Pawlik TM, 2008, ANN SURG ONCOL, V15, P2081, DOI 10.1245/s10434-008-9929-7; Rajeshkumar NV, 2009, CLIN CANCER RES, V15, P4138, DOI 10.1158/1078-0432.CCR-08-3021; Raut CP, 2007, ANN SURG, V246, P52, DOI 10.1097/01.sla.0000259391.84304.2b; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1902; Regine WF, 2008, JAMA-J AM MED ASSOC, V299, P1019, DOI 10.1001/jama.299.9.1019; Rubio-Viqueira B, 2009, CLIN PHARMACOL THER, V85, P217, DOI 10.1038/clpt.2008.200; Shaib Y, 2007, AM J GASTROENTEROL, V102, P1377, DOI 10.1111/j.1572-0241.2007.01202.x; Shi C, 2009, ARCH PATHOL LAB MED, V133, P365, DOI 10.1043/1543-2165-133.3.365; Slidell MB, 2008, ANN SURG ONCOL, V15, P165, DOI 10.1245/s10434-007-9587-1; Sultana A, 2007, BRIT J CANCER, V96, P1183, DOI 10.1038/sj.bjc.6603719; Sultana A, 2007, J CLIN ONCOL, V25, P2607, DOI 10.1200/JCO.2006.09.2551; Takaori K, 2007, J HEPATO-BILIARY-PAN, V14, P217, DOI 10.1007/s00534-006-1165-6; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Tersmette AC, 2001, CLIN CANCER RES, V7, P738; Tseng JF, 2006, BEST PRACT RES CL GA, V20, P349, DOI 10.1016/j.bpg.2005.11.003; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wente MN, 2005, PANCREAS, V31, P119, DOI 10.1097/01.mpa.0000173459.81193.4d; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; Xiong HQ, 2008, CANCER-AM CANCER SOC, V113, P2046, DOI 10.1002/cncr.23810; Zhang WW, 2007, CANCER BIOL THER, V6, P218, DOI 10.4161/cbt.6.2.3623	89	2114	2247	5	465	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1605	1617		10.1056/NEJMra0901557	http://dx.doi.org/10.1056/NEJMra0901557			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20427809				2022-12-28	WOS:000277117400009
J	Ni, KK; Ospelkaus, S; Wang, D; Quemener, G; Neyenhuis, B; de Miranda, MHG; Bohn, JL; Ye, J; Jin, DS				Ni, K. -K.; Ospelkaus, S.; Wang, D.; Quemener, G.; Neyenhuis, B.; de Miranda, M. H. G.; Bohn, J. L.; Ye, J.; Jin, D. S.			Dipolar collisions of polar molecules in the quantum regime	NATURE			English	Article								Ultracold polar molecules offer the possibility of exploring quantum gases with interparticle interactions that are strong, long-range and spatially anisotropic. This is in stark contrast to the much studied dilute gases of ultracold atoms, which have isotropic and extremely short-range (or 'contact') interactions. Furthermore, the large electric dipole moment of polar molecules can be tuned using an external electric field; this has a range of applications such as the control of ultracold chemical reactions(1), the design of a platform for quantum information processing(2-4) and the realization of novel quantum many-body systems(5-8). Despite intense experimental efforts aimed at observing the influence of dipoles on ultracold molecules(9), only recently have sufficiently high densities been achieved(10). Here we report the experimental observation of dipolar collisions in an ultracold molecular gas prepared close to quantum degeneracy. For modest values of an applied electric field, we observe a pronounced increase in the loss rate of fermionic potassium-rubidium molecules due to ultracold chemical reactions. We find that the loss rate has a steep power-law dependence on the induced electric dipole moment, and we show that this dependence can be understood in a relatively simple model based on quantum threshold laws for the scattering of fermionic polar molecules. In addition, we directly observe the spatial anisotropy of the dipolar interaction through measurements of the thermodynamics of the dipolar gas. These results demonstrate how the long-range dipolar interaction can be used for electric-field control of chemical reaction rates in an ultracold gas of polar molecules. Furthermore, the large loss rates in an applied electric field suggest that creating a long-lived ensemble of ultracold polar molecules may require confinement in a two-dimensional trap geometry to suppress the influence of the attractive, 'head-to-tail', dipolar interactions(11-14).	[Ni, K. -K.; Ospelkaus, S.; Wang, D.; Quemener, G.; Neyenhuis, B.; de Miranda, M. H. G.; Bohn, J. L.; Ye, J.; Jin, D. S.] Univ Colorado, NIST, JILA, Boulder, CO 80309 USA; [Ni, K. -K.; Ospelkaus, S.; Wang, D.; Quemener, G.; Neyenhuis, B.; de Miranda, M. H. G.; Bohn, J. L.; Ye, J.; Jin, D. S.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), Univ Colorado, NIST, JILA, Boulder, CO 80309 USA.	ye@jila.colorado.edu; jin@jilau1.colorado.edu	de Miranda, Marcio H. G./J-8293-2016; Wang, Dajun/F-7026-2012; Ye, Jun/C-3312-2011	de Miranda, Marcio H. G./0000-0002-4502-3623; Ye, Jun/0000-0003-0076-2112; Quemener, Goulven/0000-0001-9396-7701	US National Institute of Standards and Technology; US National Science Foundation (NSF) Physics Frontier Center at JILA; US Department of Energy, Air Force Office of Scientific Research Multidisciplinary Research Initiative on Ultracold Molecules	US National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); US National Science Foundation (NSF) Physics Frontier Center at JILA(National Science Foundation (NSF)); US Department of Energy, Air Force Office of Scientific Research Multidisciplinary Research Initiative on Ultracold Molecules(United States Department of Energy (DOE))	This work was supported by the US National Institute of Standards and Technology programme Innovations in Measurement Science-Ultracold Stable Molecules, the US National Science Foundation (NSF) Physics Frontier Center at JILA, the US Department of Energy, Air Force Office of Scientific Research Multidisciplinary Research Initiative on Ultracold Molecules, and a NSF graduate fellowship (B.N.).	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Bohn JL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055039; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; CAPOGROSSOSANSO.B, 2009, PHYS REV LE IN PRESS; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Cooper NR, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.155302; DeMarco B, 1999, PHYS REV LETT, V82, P4208, DOI 10.1103/PhysRevLett.82.4208; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Goral K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.170406; Gorshkov AV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.073201; Klawunn M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013604; KOTOCHIGOVA S, 2010, DISPERSION INTERACTI; Krems RV, 2008, PHYS CHEM CHEM PHYS, V10, P4079, DOI 10.1039/b802322k; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Li Z, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.050701; MASUHARA N, 1988, PHYS REV LETT, V61, P935, DOI 10.1103/PhysRevLett.61.935; Micheli A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043604; Micheli A, 2006, NAT PHYS, V2, P341, DOI 10.1038/nphys287; MONROE CR, 1993, PHYS REV LETT, V70, P414, DOI 10.1103/PhysRevLett.70.414; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Ospelkaus S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.030402; POLLET L, 2009, SUPERSOLID PHASE COL; Pupillo G., 2009, COLD MOL THEORY EXPT, P421; Quemener G, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.022702; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; Vengalattore M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170403; Wang DW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180413; Yelin SF, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.050301	30	439	442	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1324	1328		10.1038/nature08953	http://dx.doi.org/10.1038/nature08953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428166	Green Submitted			2022-12-28	WOS:000277149000041
J	Sweeney, HL; Houdusse, A				Sweeney, H. Lee; Houdusse, Anne			Myosin VI Rewrites the Rules for Myosin Motors	CELL			English	Review							COCHLEAR HAIR-CELLS; LARGE STEP-SIZE; HAND-OVER-HAND; UNCONVENTIONAL MYOSIN; PROCESSIVE MOTOR; ACTIN-FILAMENTS; CARGO-BINDING; UNIQUE INSERT; MECHANISM; ORGANIZATION	Myosin VI is the only type of myosin motor known to move toward the minus ends of actin filaments. This reversal in the direction of its movement is in part a consequence of the repositioning of its lever arm. In addition, myosin VI has a number of other specialized structural and functional adaptations that optimize performance of its unique cellular roles. Given that other classes of myosins may share some of these features, understanding the design principles of myosin VI will help guide the study of the functions of myosins that adopt similar strategies.	[Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Houdusse, Anne] CNRS, Inst Curie, UMR144, F-75248 Paris 05, France	University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Sweeney, HL (corresponding author), Univ Penn, Sch Med, Dept Physiol, B700 Richards Bldg,3700 Hamilton Walk, Philadelphia, PA 19104 USA.	lsweeney@mail.med.upenn.edu; anne.houdusse@curie.fr	Sweeney, H Lee/F-1862-2010	houdusse, anne/0000-0002-8566-0336	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Deafness and Other Communication Disorders (NIDCD); CNRS; HFSPO; ANR blanche [BLAN07-3_ 193368]; ACI BCMS	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); CNRS(Centre National de la Recherche Scientifique (CNRS)); HFSPO(Human Frontier Science Program); ANR blanche(French National Research Agency (ANR)); ACI BCMS	H.L.S. is supported by grants from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the National Institute on Deafness and Other Communication Disorders (NIDCD). A.H. is supported by grants from the CNRS, the HFSPO, the ANR blanche BLAN07-3_ 193368, and the ACI BCMS.	Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Aschenbrenner L, 2004, MOL BIOL CELL, V15, P2253, DOI 10.1091/mbc.E04-01-0002; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Frank DJ, 2004, CURR OPIN CELL BIOL, V16, P189, DOI 10.1016/j.ceb.2004.02.001; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hertzano R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000207; Iwaki M, 2006, BIOPHYS J, V90, P3643, DOI 10.1529/biophysj.105.075721; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Liao JC, 2009, J MOL BIOL, V392, P862, DOI 10.1016/j.jmb.2009.07.046; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2007, CELL, V131, P300, DOI 10.1016/j.cell.2007.08.027; Millo H, 2004, MECH DEVELOP, V121, P1335, DOI 10.1016/j.mod.2004.06.007; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Noguchi T, 2009, MOL BIOL CELL, V20, P358, DOI 10.1091/mbc.E08-07-0776; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; ONISHI H, 1982, J BIOCHEM-TOKYO, V92, P871, DOI 10.1093/oxfordjournals.jbchem.a134001; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; REIFENBERGER JG, 2009, P NATL ACAD IN PRESS; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; SMALL JV, 1995, J CELL BIOL, V129, P1275, DOI 10.1083/jcb.129.5.1275; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Suter DM, 2000, J NEUROBIOL, V42, P370, DOI 10.1002/(SICI)1097-4695(20000215)42:3<370::AID-NEU8>3.3.CO;2-M; Sweeney HL, 2007, EMBO J, V26, P2682, DOI 10.1038/sj.emboj.7601720; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; TILNEY LG, 1980, J CELL BIOL, V86, P244, DOI 10.1083/jcb.86.1.244; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Toprak E, 2006, P NATL ACAD SCI USA, V103, P6495, DOI 10.1073/pnas.0507134103; Tsiavaliaris G, 2004, NATURE, V427, P558, DOI 10.1038/nature02303; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	68	96	97	1	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					573	582		10.1016/j.cell.2010.04.028	http://dx.doi.org/10.1016/j.cell.2010.04.028			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478251	Bronze			2022-12-28	WOS:000277623600011
J	Sokol, DK				Sokol, Daniel K.			Ethics Man What to tell junior doctors about ethics	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com							0	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 12	2010	340								c2489	10.1136/bmj.c2489	http://dx.doi.org/10.1136/bmj.c2489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598HQ	20462929				2022-12-28	WOS:000277826400007
J	Gorelov, V				Gorelov, Vladimir			UK licence to practise comes short of a "UKMLE"	LANCET			English	Editorial Material									Calderdale Royal Hosp, Halifax HX3 0PW, England		Gorelov, V (corresponding author), Calderdale Royal Hosp, Halifax HX3 0PW, England.	vgorelov01@googlemail.com						*ASS AM MED COLL N, CHART OUTC MATCH; Association of American Medical Colleges, EL RES APPL SERV ERA; *GEN MED COUNC, 2009, MOR 218000 DOCT NOW; Green M, 2009, ACAD MED, V84, P362, DOI 10.1097/ACM.0b013e3181970c6b; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; *NAT RES MATCH PRO, AB NRMP; Scoles PV, 2008, ADV PHYSIOL EDUC, V32, P109, DOI 10.1152/advan.90140.2008; *UK FDN PROGR OFF, 2010 FDN APPL HDB; *USMLE, 2010 STEP 1 CONT DES	9	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1591	1592		10.1016/S0140-6736(10)60002-5	http://dx.doi.org/10.1016/S0140-6736(10)60002-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452508				2022-12-28	WOS:000277734700010
J	Nittler, LR				Nittler, Larry R.			Cometary Dust in the Laboratory	SCIENCE			English	Editorial Material							INTERPLANETARY DUST; 81P/WILD-2; METEORITES; STARDUST; MATTER; CLOUD		Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	Carnegie Institution for Science	Nittler, LR (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	lnittler@ciw.edu		Gatrell, Peter/0000-0002-5945-6868				BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Busemann H, 2009, EARTH PLANET SC LETT, V288, P44, DOI 10.1016/j.epsl.2009.09.007; Duprat J, 2010, SCIENCE, V328, P742, DOI 10.1126/science.1184832; Genge MJ, 1997, GEOCHIM COSMOCHIM AC, V61, P5149, DOI 10.1016/S0016-7037(97)00308-6; Ishii HA, 2008, SCIENCE, V319, P447, DOI 10.1126/science.1150683; LAWLER ME, 1992, NATURE, V359, P810, DOI 10.1038/359810a0; Matzel JEP, 2010, SCIENCE, V328, P483, DOI 10.1126/science.1184741; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Villeneuve J, 2009, SCIENCE, V325, P985, DOI 10.1126/science.1173907; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	15	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					698	699		10.1126/science.1187725	http://dx.doi.org/10.1126/science.1187725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448172				2022-12-28	WOS:000277357100024
J	Larson, EB; Reid, R				Larson, Eric B.; Reid, Robert			The Patient-Centered Medical Home Movement Why Now?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; SYSTEMS; HEALTH		[Larson, Eric B.; Reid, Robert] Grp Hlth Res Inst, Seattle, WA 98101 USA		Larson, EB (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	larson.e@ghc.org						Institute of Medicine, 2001, CROSSING QUALITY CHA; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Sandy LG, 2009, HEALTH AFFAIR, V28, P1136, DOI 10.1377/hlthaff.28.4.1136; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Sia C, 2004, PEDIATRICS, V113, P1473; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Tufano JT, 2008, J GEN INTERN MED, V23, P1778, DOI 10.1007/s11606-008-0761-3; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Whitcomb ME, 2004, NEW ENGL J MED, V351, P710, DOI 10.1056/NEJMsb045003	9	35	35	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1644	1645		10.1001/jama.2010.524	http://dx.doi.org/10.1001/jama.2010.524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424256				2022-12-28	WOS:000277085200029
J	Palmer, SC; Navaneethan, SD; Craig, JC; Johnson, DW; Tonelli, M; GargMd, AX; Pellegrini, F; Ravani, P; Jardine, M; Perkovic, V; Graziano, G; McGee, R; Nicolucci, A; Tognoni, G; Strippoli, GFM				Palmer, Suetonia C.; Navaneethan, Sankar D.; Craig, Jonathan C.; Johnson, David W.; Tonelli, Marcello; GargMd, Amit X.; Pellegrini, Fabio; Ravani, Pietro; Jardine, Meg; Perkovic, Vlado; Graziano, Giusi; McGee, Richard; Nicolucci, Antonio; Tognoni, Gianni; Strippoli, Giovanni F. M.			Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease	ANNALS OF INTERNAL MEDICINE			English	Review							RECOMBINANT-HUMAN-ERYTHROPOIETIN; LEFT-VENTRICULAR MASS; CHRONIC-RENAL-FAILURE; HEMODIALYSIS-PATIENTS; EPOETIN-ALPHA; ANEMIA CORRECTION; HEMOGLOBIN MAINTENANCE; CONSORT STATEMENT; DARBEPOETIN ALPHA; RANDOMIZED-TRIAL	Background: Previous meta-analyses suggest that treatment with erythropoiesis-stimulating agents (ESAs) in chronic kidney disease (CKD) increases the risk for death. Additional randomized trials have been recently completed. Purpose: To summarize the effects of ESA treatment on clinical outcomes in patients with anemia and CKD. Data Sources: MEDLINE (January 1966 to November 2009), EMBASE (January 1980 to November 2009), and the Cochrane database (to March 2010) were searched without language restriction. Study Selection: Two authors independently screened reports to identify randomized trials evaluating ESA treatment in people with CKD. Hemoglobin target trials or trials of ESA versus no treatment or placebo were included. Data Extraction: Two authors independently extracted data on patient characteristics, study risks for bias, and the effects of ESA therapy. Data Synthesis: 27 trials (10 452 patients) were identified. A higher hemoglobin target was associated with increased risks for stroke (relative risk [RR], 1.51 [95% CI, 1.03 to 2.21]), hypertension (RR, 1.67 [CI, 1.31 to 2.12]), and vascular access thrombosis RR, 1.33 [CI, 1.16 to 1.53]) compared with a lower hemoglobin target. No statistically significant differences in the risks for mortality (RR, 1.09 [CI, 0.99 to 1.20]), serious cardiovascular events (RR, 1.15 [CI, 0.98 to 1.33]), or end-stage kidney disease (RR, 1.08 [CI, 0.97 to 1.20]) were observed, although point estimates favored a lower hemoglobin target. Treatment effects were consistent across subgroups, including all stages of CKD. Limitations: The evidence for effects on quality of life was limited by selective reporting. Trials also reported insufficient information to allow analysis of the independent effects of ESA dose on clinical outcomes. Conclusion: Targeting higher hemoglobin levels in CKD increases risks for stroke, hypertension, and vascular access thrombosis and probably increases risks for death, serious cardiovascular events, and end-stage renal disease. The mechanisms for harm remain unclear, and meta-analysis of individual-patient data and trials on fixed ESA doses are recommended to elucidate these mechanisms.	[Strippoli, Giovanni F. M.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; Univ Otago, Christchurch, New Zealand; Cleveland Clin, Cleveland, OH 44106 USA; Univ Sydney, Sydney, NSW 2006, Australia; George Inst Int Hlth, Sydney, NSW, Australia; Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia; Univ Alberta, Edmonton, AB, Canada; Univ Calgary, Calgary, AB, Canada; Univ Western Ontario, London, ON, Canada; IRCCS Casa Sollievo Sofferenza, Foggia, Italy; Diaverum, Lund, Sweden	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Otago; Cleveland Clinic Foundation; University of Sydney; University of Sydney; University of Queensland; University of Alberta; University of Calgary; Western University (University of Western Ontario); IRCCS Casa Sollievo Della Sofferenza; Diaverum	Strippoli, GFM (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	strippoli@negrisud.it	Jardine, Meg/AFR-1699-2022; Craig, Jonathan/E-2813-2013; Tonelli, Marcello/B-3028-2009; Mc Gee, Richard G/C-6117-2009; Jardine, Meg/AAS-1864-2020; Ravani, Pietro/J-3050-2015; Perkovic, Vlado/AAY-1933-2021; Graziano, Giusi/J-9083-2016; Garg, Amit X/G-3295-2011; Johnson, David/F-2897-2011	Jardine, Meg/0000-0002-0160-2375; Craig, Jonathan/0000-0002-2548-4035; Tonelli, Marcello/0000-0002-0846-3187; Mc Gee, Richard G/0000-0002-3125-8253; Jardine, Meg/0000-0002-0160-2375; Ravani, Pietro/0000-0001-6973-8570; Graziano, Giusi/0000-0002-3347-8049; Johnson, David/0000-0001-5491-3460; Perkovic, Vlado/0000-0002-4257-7620	Ortho Biotech at the University of Western Ontario; Royal Australasian College of Physicians Servier; Australian National Health and Medical Research Council; Italian Agency for Drugs	Ortho Biotech at the University of Western Ontario; Royal Australasian College of Physicians Servier; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Italian Agency for Drugs	Dr. Johnson: Consultancies: Amgen, Roche, Janssen-Cilag, Sandoz; Grants/grants pending, honoraria, and travel/accommodations expenses covered or reimbursed: Amgen, Roche, Janssen-Cilag; Payment for development of educational presentations including service on speakers' bureaus: Amgen, Janssen-Cilag. Dr. Tonelli: Grants/grants pending (money to institution): Amgen. Dr. Garg: Other: Ortho Biotech funds a research scholarship (unrestricted educational grant) at the University of Western Ontario that provides partial salary support to physicians pursuing additional years of research training; Dr. Tonelli has supervised some of these research projects. Dr. Jardine: Grants received (money to institution): Royal Australasian College of Physicians Servier Staff Postdoctoral Fellowship. Dr. Perkovic: Grants/grants pending (money to institution): Australian National Health and Medical Research Council Project Grants, Baxter, Johnson & Johnson, Novartis, Roche, Servier, Amgen; Honoraria: Abbott, AstraZeneca, Roche, Servier. Dr. Strippoli: Grants/grants pending (money to institution): Italian Agency for Drugs (independent research funding body for CEDOSE [Clinical Evaluation of the Dose of Erythropoietins], independently funded by Agenzia Italiana del Farmaco). Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-0120.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BAHLMANN J, 1991, CONTRIB NEPHROL, V88, P90; Berns JS, 1999, KIDNEY INT, V56, P253, DOI 10.1046/j.1523-1755.1999.00531.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BodeBoger SM, 1996, KIDNEY INT, V50, P1255, DOI 10.1038/ki.1996.435; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; BOMMER J, 1987, Nephrology Dialysis Transplantation, V2, P238; Brandt JR, 1999, PEDIATR NEPHROL, V13, P143, DOI 10.1007/s004670050583; Cianciaruso B, 2008, J NEPHROL, V21, P861; CLYNE N, 1992, NEPHRON, V60, P390, DOI 10.1159/000186797; Conlon PJ, 2000, RENAL FAILURE, V22, P435, DOI 10.1081/JDI-100100885; Cotter DJ, 2004, J CLIN EPIDEMIOL, V57, P1086, DOI 10.1016/j.jclinepi.2004.05.002; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Foley RN, 2000, KIDNEY INT, V58, P1325, DOI 10.1046/j.1523-1755.2000.00289.x; Furuland H, 2003, NEPHROL DIAL TRANSPL, V18, P353, DOI 10.1093/ndt/18.2.353; Gouva C, 2004, KIDNEY INT, V66, P753, DOI 10.1111/j.1523-1755.2004.00797.x; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; KLEINMAN KS, 1989, AM J KIDNEY DIS, V14, P486, DOI 10.1016/S0272-6386(89)80149-0; Kuriyama S, 1997, NEPHRON, V77, P176, DOI 10.1159/000190270; LAUPACIS A, 1990, BMJ-BRIT MED J, V300, P573; Levin A, 2005, AM J KIDNEY DIS, V46, P799, DOI 10.1053/j.ajkd.2005.08.007; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P784, DOI 10.1093/ndt/gfl483; MCGONIGLE RJS, 1984, KIDNEY INT, V25, P437, DOI 10.1038/ki.1984.36; MCMAHON L, 2008, HAEMOGLOBIN NEPHR S2, V13, pS44; McMurray JJV, 2009, EUR J HEART FAIL, V11, P795, DOI 10.1093/eurjhf/hfp098; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; MORRIS KP, 1993, ARCH DIS CHILD, V68, P644, DOI 10.1136/adc.68.5.644; *NAT KIDN FDN, 2007, KDOQI CLIN PRACT GUI; NISSENSON AR, 1995, J AM SOC NEPHROL, V5, P1517; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pfeffer MA, 2008, AM J KIDNEY DIS, V51, P366, DOI 10.1053/j.ajkd.2008.01.003; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phrommintikul A, 2007, LANCET, V369, P381, DOI 10.1016/S0140-6736(07)60194-9; REVICKI DA, 1995, AM J KIDNEY DIS, V25, P548, DOI 10.1016/0272-6386(95)90122-1; Ritz E, 2007, AM J KIDNEY DIS, V49, P194, DOI 10.1053/j.ajkd.2006.11.032; Roger SD, 2004, J AM SOC NEPHROL, V15, P148, DOI 10.1097/01.ASN.0000102471.89084.8B; Rossert J, 2006, AM J KIDNEY DIS, V47, P738, DOI 10.1053/j.ajkd.2006.02.170; SIKOLE A, 1993, ARTIF ORGANS, V17, P977, DOI 10.1111/j.1525-1594.1993.tb03179.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh AK, 2009, J AM SOC NEPHROL, V20, P1436, DOI 10.1681/ASN.2009040444; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; van der Meer P, 2009, HEART, V95, P1309, DOI 10.1136/hrt.2008.161091; WATSON AJ, 1990, AM J MED, V89, P432, DOI 10.1016/0002-9343(90)90371-J; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; ZINS B, 1986, LANCET, V2, P1329	50	234	255	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					23	W23		10.7326/0003-4819-153-1-201007060-00252	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00252			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20439566				2022-12-28	WOS:000279487700004
J	Joshi, PA; Jackson, HW; Beristain, AG; Di Grappa, MA; Mote, PA; Clarke, CL; Stingl, J; Waterhouse, PD; Khokha, R				Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Mote, Patricia A.; Clarke, Christine L.; Stingl, John; Waterhouse, Paul D.; Khokha, Rama			Progesterone induces adult mammary stem cell expansion	NATURE			English	Article							BREAST-CANCER; GLAND DEVELOPMENT; EPITHELIAL-CELLS; ESTROUS-CYCLE; RECEPTOR-B; DIFFERENTIATION; RISK; 17-BETA-ESTRADIOL; PROLIFERATION; MORPHOGENESIS	Reproductive history is the strongest risk factor for breast cancer after age, genetics and breast density(1,2). Increased breast cancer risk is entwined with a greater number of ovarian hormone-dependent reproductive cycles, yet the basis for this predisposition is unknown(3-5). Mammary stem cells (MaSCs) are located within a specialized niche in the basal epithelial compartment that is under local and systemic regulation(6). The emerging role of MaSCs in cancer initiation warrants the study of ovarian hormones in MaSC homeostasis. Here we show that the MaSC pool increases 14-fold during maximal progesterone levels at the luteal dioestrus phase of the mouse. Stem-cell-enriched CD49f(hi) cells amplify at dioestrus, or with exogenous progesterone, demonstrating a key role for progesterone in propelling this expansion. In aged mice, CD49f(hi) cells display stasis upon cessation of the reproductive cycle. Progesterone drives a series of events where luminal cells probably provide Wnt4 and RANKL signals to basal cells which in turn respond by upregulating their cognate receptors, transcriptional targets and cell cycle markers. Our findings uncover a dynamic role for progesterone in activating adult MaSCs within the mammary stem cell niche during the reproductive cycle, where MaSCs are putative targets for cell transformation events leading to breast cancer.	[Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Waterhouse, Paul D.; Khokha, Rama] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Joshi, Purna A.; Jackson, Hartland W.; Beristain, Alexander G.; Di Grappa, Marco A.; Waterhouse, Paul D.; Khokha, Rama] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; [Mote, Patricia A.; Clarke, Christine L.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Stingl, John] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Sydney; Westmead Institute for Medical Research; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Khokha, R (corresponding author), Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca	Jackson, Hartland/AAL-7751-2020	Jackson, Hartland/0000-0001-6423-2415; Waterhouse, Paul/0000-0001-8745-5224; Joshi, Purna/0000-0002-1628-9940; Beristain, Alexander/0000-0002-1117-6242; Clarke, Christine/0000-0001-7568-111X	Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada; Canadian Breast Cancer Foundation, Ontario; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0300723B, G0800784B, G0800784] Funding Source: researchfish	Canadian Breast Cancer Research Alliance; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Breast Cancer Foundation, Ontario; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Canadian Breast Cancer Research Alliance. P.A.J. holds a Terry Fox Foundation studentship through an award from the National Cancer Institute of Canada; H.W.J. holds a studentship and A. G. B. a fellowship from the Canadian Breast Cancer Foundation, Ontario. The authors thank F. Tong and R. Nayyar of the OCI FACS facility for cell sorting, and M. Monroy and S. Yousef of the UHN Animal Resources Center for performing ovariectomies.	APTER D, 1989, INT J CANCER, V44, P783, DOI 10.1002/ijc.2910440506; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2006, J NATL CANCER I, V98, P1011, DOI 10.1093/jnci/djj267; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Bernstein L, 2002, J MAMMARY GLAND BIOL, V7, P3, DOI 10.1023/A:1015714305420; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Chepko G, 1999, J MAMMARY GLAND BIOL, V4, P35, DOI 10.1023/A:1018752519356; DANIEL CW, 1987, CANCER RES, V47, P6052; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Graham JD, 2009, ENDOCRINOLOGY, V150, P3318, DOI 10.1210/en.2008-1630; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Harmes DC, 2009, J MAMMARY GLAND BIOL, V14, P19, DOI 10.1007/s10911-009-9111-2; HASLAM SZ, 1979, BIOCHEM J, V182, P127, DOI 10.1042/bj1820127; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Lydon JP, 1999, CANCER RES, V59, P4276; Mote PA, 2006, ENDOCRINOLOGY, V147, P5503, DOI 10.1210/en.2006-0040; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; TRICHOPOULOS D, 1972, JNCI-J NATL CANCER I, V48, P605; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4	30	499	510	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					803	807		10.1038/nature09091	http://dx.doi.org/10.1038/nature09091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20445538				2022-12-28	WOS:000278551800050
J	Wang, YD; Nakayama, M; Pitulescu, ME; Schmidt, TS; Bochenek, ML; Sakakibara, A; Adams, S; Davy, A; Deutsch, U; Luthi, U; Barberis, A; Benjamin, LE; Makinen, T; Nobes, CD; Adams, RH				Wang, Yingdi; Nakayama, Masanori; Pitulescu, Mara E.; Schmidt, Tim S.; Bochenek, Magdalena L.; Sakakibara, Akira; Adams, Susanne; Davy, Alice; Deutsch, Urban; Luethi, Urs; Barberis, Alcide; Benjamin, Laura E.; Maekinen, Taija; Nobes, Catherine D.; Adams, Ralf H.			Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis	NATURE			English	Article							CARDIOVASCULAR DEVELOPMENT; MOLECULAR REGULATION; ENDOTHELIAL-CELLS; TRANSGENIC MOUSE; SMOOTH-MUSCLE; AXON GUIDANCE; EXPRESSION; ADULT; RECEPTORS; ARTERIAL	In development, tissue regeneration or certain diseases, angiogenic growth leads to the expansion of blood vessels and the lymphatic vasculature. This involves endothelial cell proliferation as well as angiogenic sprouting, in which a subset of cells, termed tip cells, acquires motile, invasive behaviour and extends filopodial protrusions(1-3). Although it is already appreciated that angiogenesis is triggered by tissue-derived signals, such as vascular endothelial growth factor (VEGF) family growth factors, the resulting signalling processes in endothelial cells are only partly understood. Here we show with genetic experiments in mouse and zebrafish that ephrin-B2, a transmembrane ligand for Eph receptor tyrosine kinases, promotes sprouting behaviour and motility in the angiogenic endothelium. We link this pro-angiogenic function to a crucial role of ephrin-B2 in the VEGF signalling pathway, which we have studied in detail for VEGFR3, the receptor for VEGF-C. In the absence of ephrin-B2, the internalization of VEGFR3 in cultured cells and mutant mice is defective, which compromises downstream signal transduction by the small GTPase Rac1, Akt and the mitogen-activated protein kinase Erk. Our results show that full VEGFR3 signalling is coupled to receptor internalization. Ephrin-B2 is a key regulator of this process and thereby controls angiogenic and lymphangiogenic growth.	[Wang, Yingdi; Schmidt, Tim S.; Sakakibara, Akira; Adams, Susanne; Adams, Ralf H.] Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; [Nakayama, Masanori; Pitulescu, Mara E.; Bochenek, Magdalena L.; Adams, Susanne; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Nakayama, Masanori; Pitulescu, Mara E.; Bochenek, Magdalena L.; Adams, Susanne; Adams, Ralf H.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; [Bochenek, Magdalena L.; Nobes, Catherine D.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS6 6BS, Avon, England; [Bochenek, Magdalena L.; Nobes, Catherine D.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS6 6BS, Avon, England; [Davy, Alice] Univ Toulouse, CNRS, CBD UMR 5547, Ctr Dev Biol, F-31062 Toulouse 9, France; [Deutsch, Urban] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland; [Luethi, Urs; Barberis, Alcide] Oncalis AG, Schlieren, Switzerland; [Benjamin, Laura E.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Maekinen, Taija] Canc Res UK London Res Inst, Lymphat Dev Lab, London WC2A 3PX, England	Cancer Research UK; University of Munster; Max Planck Society; University of Bristol; University of Bristol; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Bern; Harvard University; Beth Israel Deaconess Medical Center; Cancer Research UK	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@mpi-muenster.mpg.de	Makinen, Taija/C-5765-2014; Wang, Yingdi/O-1807-2013; Makinen, Taija/CAI-2233-2022; Adams, Ralf H/AAE-9274-2019	Makinen, Taija/0000-0002-9338-1257; Makinen, Taija/0000-0002-9338-1257; Pitulescu, Mara E/0000-0001-5322-8146; Deutsch, Urban/0000-0003-4265-6262	Cancer Research UK; Max-Planck-Society; German Research Foundation [SFB 629, SPP 1190]; EMBO LTF	Cancer Research UK(Cancer Research UK); Max-Planck-Society(Max Planck Society); German Research Foundation(German Research Foundation (DFG)); EMBO LTF(European Molecular Biology Organization (EMBO))	We thank R. Benedito, I. Schmidt, S. Hoffmann, I. Rosewell, S. M. Kuijper, F. Gisler and N. Hostettler for their help, N. Copeland and A. Eichmann for information and reagents, P. Chambon for the CreERT2 cDNA, A. L. Bermange, J.D. Leslie and J. Lewis for help with zebrafish experiments, and A. Acker-Palmer for discussions and for reading the manuscript. Cancer Research UK, the Max-Planck-Society, the German Research Foundation (programmes SFB 629 and SPP 1190) and the EMBO LTF programme provided funding.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Davy A, 2007, DEV BIOL, V304, P182, DOI 10.1016/j.ydbio.2006.12.028; Deutsch U, 2008, EXP CELL RES, V314, P1202, DOI 10.1016/j.yexcr.2007.12.026; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Gerhardt H, 2005, EXP SUPPL, V94, P3; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Lamont RE, 2006, SCI STKE, DOI [10.1126/stke.3552006pe39, DOI 10.1126/STKE.3552006PE39]; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; McColl BK, 2004, APMIS, V112, P463, DOI 10.1111/j.1600-0463.2004.apm11207-0807.x; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osoegawa K, 2000, GENOME RES, V10, P116; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Taylor AC, 2007, MICROCIRCULATION, V14, P253, DOI 10.1080/10739680601141829; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6	37	782	805	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					483	U108		10.1038/nature09002	http://dx.doi.org/10.1038/nature09002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20445537				2022-12-28	WOS:000278043700036
J	Delamothe, T				Delamothe, Tony			On the Contrary Don't take me to your leader	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England		Delamothe, T (corresponding author), BMJ, London, England.	tdelamothe@bmj.com							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 19	2010	340								c2675	10.1136/bmj.c2675	http://dx.doi.org/10.1136/bmj.c2675			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601LU	20484357				2022-12-28	WOS:000278061800009
J	Roy-Byrne, P; Craske, MG; Sullivan, G; Rose, RD; Edlund, MJ; Lang, AJ; Bystritsky, A; Welch, SS; Chavira, DA; Golinelli, D; Campbell-Sills, L; Sherbourne, CD; Stein, MB				Roy-Byrne, Peter; Craske, Michelle G.; Sullivan, Greer; Rose, Raphael D.; Edlund, Mark J.; Lang, Ariel J.; Bystritsky, Alexander; Welch, Stacy Shaw; Chavira, Denise A.; Golinelli, Daniela; Campbell-Sills, Laura; Sherbourne, Cathy D.; Stein, Murray B.			Delivery of Evidence-Based Treatment for Multiple Anxiety Disorders in Primary Care A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COGNITIVE-BEHAVIORAL THERAPY; COLLABORATIVE CARE; COST-EFFECTIVENESS; IMPROVE TREATMENT; PANIC DISORDER; DSM-IV; DEPRESSION; MANAGEMENT; SEVERITY; QUALITY	Context Improving the quality of mental health care requires moving clinical interventions from controlled research settings into real-world practice settings. Although such advances have been made for depression, little work has been performed for anxiety disorders. Objective To determine whether a flexible treatment-delivery model for multiple primary care anxiety disorders (panic, generalized anxiety, social anxiety, and post-traumatic stress disorders) would be better than usual care (UC). Design, Setting, and Patients A randomized controlled effectiveness trial of Coordinated Anxiety Learning and Management(CALM) compared with UC in 17 primary care clinics in 4 US cities. Between June 2006 and April 2008, 1004 patients with anxiety disorders (with or with out major depression), aged 18 to 75 years, English-or Spanish-speaking, were enrolled and subsequently received treatment for 3 to 12 months. Blinded follow-up assessments at 6, 12, and 18 months after baseline were completed in October 2009. Intervention CALM allowed choice of cognitive behavioral therapy (CBT), medication, or both; included real-time Web-based outcomes monitoring to optimize treatment decisions; and a computer-assisted program to optimize delivery of CBT by nonexpert care managers who also assisted primary care clinicians in promoting adherence and optimizing medications. Main Outcome Measures Twelve-item Brief Symptom Inventory (BSI-12) anxiety and somatic symptoms score. Secondary outcomes included proportion of responders(>= 50% reduction from pretreatment BSI-12 score) and remitters (total BSI-12 score <6). Results A significantly greater improvement for CALM vs UC in global anxiety symptoms was found (BSI-12 group mean differences of -2.49 [95% confidence interval {CI}, -3.59 to -1.40], -2.63 [95% CI, -3.73 to -1.54], and -1.63 [95% CI, -2.73 to -0.53] at 6, 12, and 18 months, respectively). At 12 months, response and remission rates (CALM vs UC) were 63.66% (95% CI, 58.95%-68.37%) vs 44.68% (95% CI, 39.76%-49.59%), and 51.49% (95% CI, 46.60%-56.38%) vs 33.28% (95% CI, 28.62%-37.93%), with a number needed to treat of 5.27 (95% CI, 4.18-7.13) for response and 5.50 (95% CI, 4.32-7.55) for remission. Conclusion For patients with anxiety disorders treated in primary care clinics, CALM compared with UC resulted in greater improvement in anxiety symptoms, depression symptoms, functional disability, and quality of care during 18 months of follow-up.	[Roy-Byrne, Peter] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Harborview Med Ctr, Seattle, WA 98104 USA; [Roy-Byrne, Peter; Welch, Stacy Shaw] Harborview Ctr Healthcare Improvement Addict Ment, Seattle, WA USA; [Craske, Michelle G.; Rose, Raphael D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; [Bystritsky, Alexander] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Sullivan, Greer; Edlund, Mark J.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Sullivan, Greer] Univ Arkansas Med Sci, VA S Cent Mental Illness Res Educ & Clin Ctr, Little Rock, AR 72205 USA; [Lang, Ariel J.; Chavira, Denise A.; Campbell-Sills, Laura; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Lang, Ariel J.] VA San Diego Hlth Care Syst Ctr Excellence Stress, San Diego, CA USA; [Sullivan, Greer; Golinelli, Daniela; Sherbourne, Cathy D.] RAND Corp, Santa Monica, CA USA	Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; RAND Corporation	Roy-Byrne, P (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Harborview Med Ctr, 325 Ninth Ave,POB 359911, Seattle, WA 98104 USA.	roybyrne@u.washington.edu	Roy-Byrne, Peter/AAV-2991-2020; roy-byrne, peter/AAC-9130-2019; Golinelli, Daniela/H-2287-2015	Golinelli, Daniela/0000-0002-6433-1752	National Institute of Mental Health [U01 MH057858, K24 MH065324, U01 MH058915, U01 MH070022, U01 MH070018, U01MH057835, K24 MH64122]; National Institutes of Health; US Department of Defense; Eli Lilly; GlaxoSmithKline; Hoffmann-La Roche; US Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH065324, U01MH058915, K24MH064122, U01MH057858, U01MH070018, U01MH057835, U01MH070022] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Hoffmann-La Roche(Hoffmann-La Roche); US Veterans Affairs; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants U01 MH057858 and K24 MH065324 (Dr Roy-Byrne), U01 MH058915 (Dr Craske), U01 MH070022 (Dr Sullivan), U01 MH070018 (Dr Sherbourne), and U01MH057835 and K24 MH64122 (Dr Stein) from the National Institute of Mental Health.; Financial Disclosures: Dr Roy-Byrne reported receiving research grant support from the National Institutes of Health; having served as a paid member of advisory boards for Jazz Pharmaceuticals and Solvay Pharmaceuticals (1 meeting for each); having received honoraria for CME-sponsored speaking from the American Psychiatric Association, Anxiety Disorders Association of America, CME LLC, CMP Media, Current Medical Directions, Imedex, Massachusetts General Hospital Academy, and PRIMEDIA Healthcare; and serving as editor in chief for Journal Watch Psychiatry (Massachusetts Medical Society) and Depression and Anxiety (Wiley-Liss Inc). Dr Roy-Byrne reported also serving as an expert witness on multiple legal cases related to anxiety; none involving pharmaceutical companies or specific psychopharmacology issues. Dr Bystritsky reported serving as a paid consultant for Jazz Pharmaceuticals. Dr Stein reported receiving or having received research support from the US Department of Defense, Eli Lilly, GlaxoSmithKline, Hoffmann-La Roche, National Institutes of Health, and the US Veterans Affairs Research Program; and is currently or has been a paid consultant for AstraZeneca, Avera Pharmaceuticals, BrainCells Inc, Bristol-Myers Squibb, Comprehensive NeuroScience; Eli Lilly, Forest Laboratories, GlaxoSmithKline, Hoffmann-La Roche, Jazz Pharmaceuticals, Johnson & Johnson, Mindsite, Pfizer, Sepracor, and Transcept Pharmaceuticals. No other authors reported any financial disclosures.	[Anonymous], 2000, MEAS HLTH DAYS; Brick J M, 1996, Stat Methods Med Res, V5, P215, DOI 10.1177/096228029600500302; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Chilvers C, 2001, BMJ-BRIT MED J, V322, P772, DOI 10.1136/bmj.322.7289.772; Craske MG, 2009, DEPRESS ANXIETY, V26, P235, DOI 10.1002/da.20542; Feeny NC, 2009, DEPRESS ANXIETY, V26, P724, DOI 10.1002/da.20588; Grilo CM, 1998, COMPR PSYCHIAT, V39, P323, DOI 10.1016/S0010-440X(98)90043-8; Hazlett-Stevens H, 2002, GEN HOSP PSYCHIAT, V24, P316, DOI 10.1016/S0163-8343(02)00204-9; Heuzenroeder L, 2004, AUST NZ J PSYCHIAT, V38, P602, DOI 10.1080/j.1440-1614.2004.01423.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Katon W, 1996, ARCH GEN PSYCHIAT, V53, P924; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Little R. J. A., 1987, STAT ANAL MISSING DA; Means-Christensen AJ, 2006, GEN HOSP PSYCHIAT, V28, P108, DOI 10.1016/j.genhosppsych.2005.08.010; Mojtabai R, 2002, ARCH GEN PSYCHIAT, V59, P77, DOI 10.1001/archpsyc.59.1.77; MOORE A, WHAT IS NUMBER NEEDE; Nadiga DN, 2003, DEPRESS ANXIETY, V17, P58, DOI 10.1002/da.10084; Nuovo J, 2002, JAMA-J AM MED ASSOC, V287, P2813, DOI 10.1001/jama.287.21.2813; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Rollman BL, 2005, ARCH GEN PSYCHIAT, V62, P1332, DOI 10.1001/archpsyc.62.12.1332; Roy-Byrne P, 2009, J AM BOARD FAM MED, V22, P175, DOI 10.3122/jabfm.2009.02.080078; Roy-Byrne PP, 2005, ARCH GEN PSYCHIAT, V62, P290, DOI 10.1001/archpsyc.62.3.290; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simon GE, 2001, AM J PSYCHIAT, V158, P1638, DOI 10.1176/appi.ajp.158.10.1638; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Stein MB, 2004, AM J PSYCHIAT, V161, P2230, DOI 10.1176/appi.ajp.161.12.2230; Steketee G, 1997, J Psychother Pract Res, V6, P194; Sullivan G, 2007, GEN HOSP PSYCHIAT, V29, P379, DOI 10.1016/j.genhosppsych.2007.04.005; Tsao JCI, 2005, BEHAV RES THER, V43, P959, DOI 10.1016/j.brat.2004.11.013; Unutzer J, 2002, PSYCHIATR SERV, V53, P671, DOI 10.1176/appi.ps.53.6.671; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ware J. E. J., 2002, SCORE VERSION 2 SF 1; Weissman MM, 2006, ARCH GEN PSYCHIAT, V63, P925, DOI 10.1001/archpsyc.63.8.925; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403	39	304	308	0	98	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1921	1928		10.1001/jama.2010.608	http://dx.doi.org/10.1001/jama.2010.608			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597NJ	20483968	Green Accepted, Bronze			2022-12-28	WOS:000277764500018
J	Li, SC; Chu, LN; Gong, XQ; Diebold, U				Li, Shao-Chun; Chu, Li-Na; Gong, Xue-Qing; Diebold, Ulrike			Hydrogen Bonding Controls the Dynamics of Catechol Adsorbed on a TiO2(110) Surface	SCIENCE			English	Article							RUTILE TIO2(110); DIFFUSION	Direct studies of how organic molecules diffuse on metal oxide surfaces can provide insights into catalysis and molecular assembly processes. We studied individual catechol molecules, C6H4(OH)(2), on a rutile TiO2(110) surface with scanning tunneling microscopy. Surface hydroxyls enhanced the diffusivity of adsorbed catecholates. The capture and release of a proton caused individual molecules to switch between mobile and immobile states within a measurement period of minutes. Density functional theory calculations showed that the transfer of hydrogen from surface hydroxyls to the molecule and its interaction with surface hydroxyls substantially lowered the activation barrier for rotational motion across the surface. Hydrogen bonding can play an essential role in the initial stages of the dynamics of molecular assembly.	[Li, Shao-Chun; Diebold, Ulrike] Tulane Univ, Dept Phys & Engn Phys, New Orleans, LA 70118 USA; [Chu, Li-Na; Gong, Xue-Qing] E China Univ Sci & Technol, Labs Adv Mat, Res Inst Ind Catalysis, Shanghai 200237, Peoples R China; [Diebold, Ulrike] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria	Tulane University; East China University of Science & Technology; Technische Universitat Wien	Li, SC (corresponding author), Tulane Univ, Dept Phys & Engn Phys, New Orleans, LA 70118 USA.	sli1@tulane.edu; diebold@iap.tuwien.ac.at	gong, xue/GYQ-8649-2022; Diebold, Ulrike/A-3681-2010	Diebold, Ulrike/0000-0003-0319-5256; Gong, Xueqing/0000-0002-9566-7427; Li, Shao-Chun/0000-0001-9818-4255	U.S. Department of Energy [DE-FG02-05ER15702]; NSF [CHE-0715576]; National Nature Science Foundation of China [20703017]; 111 project [B08021]	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project)	S. L. and U. D. acknowledge financial support by the U.S. Department of Energy (grant DE-FG02-05ER15702) and by NSF (grant CHE-0715576). X. Q. G. is grateful for financial support from the National Nature Science Foundation of China (grant 20703017) and the 111 project (grant B08021). Valuable discussions with A. Selloni are gratefully acknowledged.	Barth JV, 2000, SURF SCI REP, V40, P75, DOI 10.1016/S0167-5729(00)00002-9; Briner BG, 1997, SCIENCE, V278, P257, DOI 10.1126/science.278.5336.257; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Horch S, 1999, NATURE, V398, P134, DOI 10.1038/18185; Li SC, 2008, J AM CHEM SOC, V130, P9080, DOI 10.1021/ja8012825; Li SC, 2009, J AM CHEM SOC, V131, P980, DOI 10.1021/ja803595u; Matthiesen J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.226101; Mitsui T, 2002, SCIENCE, V297, P1850, DOI 10.1126/science.1075095; ONISHI H, 1994, CHEM PHYS LETT, V226, P111, DOI 10.1016/0009-2614(94)00712-8; Pang CL, 2008, CHEM SOC REV, V37, P2328, DOI 10.1039/b719085a; Schunack M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.156102; Trevethan T, 2008, J PHYS CHEM C, V112, P19577, DOI 10.1021/jp806355m; Wang XY, 2009, J PHYS CHEM C, V113, P2228, DOI 10.1021/jp808342t; Wendt S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.066107; Wong KL, 2007, SCIENCE, V315, P1391, DOI 10.1126/science.1135302; Zhang Z, 2006, J PHYS CHEM B, V110, P21840, DOI 10.1021/jp063619h	16	201	205	1	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					882	884		10.1126/science.1188328	http://dx.doi.org/10.1126/science.1188328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466928				2022-12-28	WOS:000277618800045
J	Checkley, W; West, KP; Wise, RA; Baldwin, MR; Wu, L; LeClerq, SC; Christian, P; Katz, J; Tielsch, JM; Khatry, S; Sommer, A				Checkley, William; West, Keith P., Jr.; Wise, Robert A.; Baldwin, Matthew R.; Wu, Lee; LeClerq, Steven C.; Christian, Parul; Katz, Joanne; Tielsch, James M.; Khatry, Subarna; Sommer, Alfred			Maternal Vitamin A Supplementation and Lung Function in Offspring	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CAROTENE SUPPLEMENTATION; EARLY INFANT-MORTALITY; LOW-BIRTH-WEIGHT; NIGHT BLINDNESS; PULMONARY-FUNCTION; RANDOMIZED-TRIAL; RETINOIC ACID; RISK; PREGNANCY; WOMEN	BACKGROUND Vitamin A is important in regulating early lung development and alveolar formation. Maternal vitamin A status may be an important determinant of embryonic alveolar formation, and vitamin A deficiency in a mother during pregnancy could have lasting adverse effects on the lung health of her offspring. We tested this hypothesis by examining the long-term effects of supplementation with vitamin A or beta carotene in women before, during, and after pregnancy on the lung function of their offspring, in a population with chronic vitamin A deficiency. METHODS We examined a cohort of rural Nepali children 9 to 13 years of age whose mothers had participated in a placebo-controlled, double-blind, cluster-randomized trial of vitamin A or beta-carotene supplementation between 1994 and 1997. RESULTS Of 1894 children who were alive at the end of the original trial, 1658 (88%) were eligible to participate in the follow-up trial. We performed spirometry in 1371 of the children (83% of those eligible) between October 2006 and March 2008. Children whose mothers had received vitamin A had a forced expiratory volume in 1 second (FEV1) and a forced vital capacity (FVC) that were significantly higher than those of children whose mothers had received placebo (FEV1, 46 ml higher with vitamin A; 95% confidence interval [CI], 6 to 86; FVC, 46 ml higher with vitamin A; 95% CI, 8 to 84), after adjustment for height, age, sex, body-mass index, calendar month, caste, and individual spirometer used. Children whose mothers had received beta carotene had adjusted FEV1 and FVC values that were similar to those of children whose mothers had received placebo (FEV1, 14 ml higher with beta carotene; 95% CI, -24 to 54; FVC, 17 ml higher with beta carotene, 95% CI, -21 to 55). CONCLUSIONS In a chronically undernourished population, maternal repletion with vitamin A at recommended dietary levels before, during, and after pregnancy improved lung function in offspring. This public health benefit was apparent in the preadolescent years.	[Checkley, William; Wise, Robert A.; Baldwin, Matthew R.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Checkley, William; Katz, Joanne; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD 21205 USA; [West, Keith P., Jr.; Wu, Lee; LeClerq, Steven C.; Christian, Parul; Katz, Joanne; Tielsch, James M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; [Sommer, Alfred] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Sommer, Alfred] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [LeClerq, Steven C.; Khatry, Subarna] Natl Soc Prevent Blindness, Nepal Nutr Intervent Project Sarlahi, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Checkley, W (corresponding author), Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, 1830 Monument St,5th Fl, Baltimore, MD 21205 USA.	wcheckl1@jhmi.edu	Baldwin, Matthew/GQY-7234-2022	Tielsch, James/0000-0002-1151-060X; Wise, Robert/0000-0002-8353-2349; Katz, Joanne/0000-0002-5997-7823; Checkley, William/0000-0003-1106-8812	Bill and Melinda Gates Foundation [614]; Sight and Life Research Institute, Baltimore; Johns Hopkins University [HRN-A-0097-00015-00]; Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development [HRN-A-0097-00015-00]; Task Force Sight and Life, Basel, Switzerland; National Heart, Lung, and Blood Institute, National Institutes of Health [K99HL096955]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096955] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Sight and Life Research Institute, Baltimore; Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development(United States Agency for International Development (USAID)); Task Force Sight and Life, Basel, Switzerland; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a grant (no. 614) from the Bill and Melinda Gates Foundation and by a grant from the Sight and Life Research Institute, Baltimore. The original maternal vitamin A or beta-carotene supplementation trial (1994-1997) was conducted under the Vitamin A for Health Cooperative Agreement (HRN-A-0097-00015-00) between Johns Hopkins University and the Office of Health, Infectious Diseases and Nutrition of the U.S. Agency for International Development, with additional support from Task Force Sight and Life, Basel, Switzerland. Dr. Checkley is the recipient of a Clinician Scientist Award from Johns Hopkins University and a K99/R00 Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute, National Institutes of Health.	Aird FK, 2006, J CYST FIBROS, V5, P129, DOI 10.1016/j.jcf.2005.11.007; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2009, WHO GLOBAL DATABASE; Barua AB, 2003, INT J VITAM NUTR RES, V73, P267, DOI 10.1024/0300-9831.73.4.267; BEATY TH, 1982, AM J EPIDEMIOL, V116, P102, DOI 10.1093/oxfordjournals.aje.a113385; BIESALSKI HK, 1992, ANN NY ACAD SCI, V669, P325; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BRILLIANT LB, 1985, B WORLD HEALTH ORGAN, V63, P375; Christian P, 2000, AM J EPIDEMIOL, V152, P542, DOI 10.1093/aje/152.6.542; Christian P, 2001, J NUTR, V131, P1510, DOI 10.1093/jn/131.5.1510; Christian P, 1998, INT J EPIDEMIOL, V27, P231, DOI 10.1093/ije/27.2.231; Chytil F, 1996, FASEB J, V10, P986, DOI 10.1096/fasebj.10.9.8801181; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Congdon NG, 2000, AM J CLIN NUTR, V72, P1004; Cook DG, 1998, THORAX, V53, P884, DOI 10.1136/thx.53.10.884; Dimenstein R, 1996, BIOL NEONATE, V70, P248; Dimenstein R, 1996, BIOL NEONATE, V69, P230, DOI 10.1159/000244315; Dirami G, 2004, AM J PHYSIOL-LUNG C, V286, pL249, DOI 10.1152/ajplung.00140.2003; Galambos C, 2008, PATHOLOGY, V40, P124, DOI 10.1080/00313020701818981; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P576, DOI 10.1093/aje/kwg181; Gorstein J, 2003, ASIA PAC J CLIN NUTR, V12, P96; Grievink L, 1998, THORAX, V53, P166, DOI 10.1136/thx.53.3.166; Grievink L, 1999, EUR J CLIN NUTR, V53, P813, DOI 10.1038/sj.ejcn.1600854; HAYES RJ, 2008, CLUSTER RANDOMISED T, P149; Hickenbottom SJ, 2002, AM J CLIN NUTR, V75, P900, DOI 10.1093/ajcn/75.5.900; Hole DJ, 1996, BRIT MED J, V313, P711; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Katz J, 2000, AM J CLIN NUTR, V71, P1570; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL305, DOI 10.1152/ajplung.1996.270.2.L305; Massaro GD, 2000, AM J PHYSIOL-LUNG C, V278, pL955, DOI 10.1152/ajplung.2000.278.5.L955; McCollum EV, 1913, J BIOL CHEM, V15, P167; *MIN HLTH CHILD HL, 1998, NEP MICR STAT SURV 1, P54; MORABIA A, 1990, AM J EPIDEMIOL, V132, P77, DOI 10.1093/oxfordjournals.aje.a115645; Mori S, 1922, B JOHNS HOPKINS HOSP, V33, P357; PEARSON E, 1992, J PEDIATR-US, V121, P420, DOI 10.1016/S0022-3476(05)81800-1; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rahmathullah L, 2003, BMJ-BRIT MED J, V327, P254, DOI 10.1136/bmj.327.7409.254; RICE AI, 2004, COMP QUANTIFICATION, V1, P211; RODRIGUEZ BL, 1994, AM J EPIDEMIOL, V140, P398, DOI 10.1093/oxfordjournals.aje.a117262; Saunders C, 2004, J HEALTH POPUL NUTR, V22, P348; Semba RD, 2003, EUR J CLIN NUTR, V57, P1627, DOI 10.1038/sj.ejcn.1601734; SHARMA HS, 1987, Z ERNAHRUNGSWISS, V26, P116, DOI 10.1007/BF02019607; SHARMA HS, 1986, BIOL NEONATE, V50, P345, DOI 10.1159/000242619; SHENAI JP, 1987, J PEDIATR-US, V111, P269, DOI 10.1016/S0022-3476(87)80086-0; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; Tielsch JM, 2008, J NUTR, V138, P787, DOI 10.1093/jn/138.4.787; Tielsch JM, 2007, J NUTR, V137, P2470, DOI 10.1093/jn/137.11.2470; UPADHYAY MP, 1985, AM J EPIDEMIOL, V121, P71, DOI 10.1093/oxfordjournals.aje.a113985; Wang XD, 1998, SUB CELL BIOCHEM, V30, P159; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; ZACHMAN RD, 1995, J NUTR, V125, pS1634; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705	55	126	129	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1784	1794		10.1056/NEJMoa0907441	http://dx.doi.org/10.1056/NEJMoa0907441			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463338	Bronze			2022-12-28	WOS:000277555500005
J	Collins, GS; Altman, DG				Collins, Gary S.; Altman, Douglas G.			An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLE IMPUTATION; PROGNOSTIC MODELS; PREDICTION; CANCER; PERFORMANCE; FRAMINGHAM; SURGERY	Objective To evaluate the performance of the QRISK2 score for predicting 10-year cardiovascular disease in an independent UK cohort of patients from general practice records and to compare it with the NICE version of the Framingham equation and QRISK1. Design Prospective cohort study to validate a cardiovascular risk score. Setting 365 practices from United Kingdom contributing to The Health Improvement Network (THIN) database. Participants 1.58 million patients registered with a general practice between 1 January 1993 and 20 June 2008, aged 35-74 years (9.4 million person years) with 71 465 cardiovascular events. Main outcome measures First diagnosis of cardiovascular disease (myocardial infarction, angina, coronary heart disease, stroke, and transient ischaemic stroke) recorded in general practice records. Results QRISK2 offered improved prediction of a patient's 10-year risk of cardiovascular disease over the NICE version of the Framingham equation. Discrimination and calibration statistics were better with QRISK2. QRISK2 explained 33% of the variation in men and 40% for women, compared with 29% and 34% respectively for the NICE Framingham and 32% and 38% respectively for QRISK1. The incidence rate of cardiovascular events (per 1000 person years) among men in the high risk group was 27.8 (95% CI 27.4 to 28.2) with QRISK2, 21.9 (21.6 to 22.2) with NICE Framingham, and 24.8 (22.8 to 26.9) with QRISK1. Similarly, the incidence rate of cardiovascular events (per 1000 person years) among women in the high risk group was 24.3 (23.8 to 24.9) with QRISK2, 20.6 (20.1 to 21.0) with NICE Framingham, and 21.8 (18.9 to 24.6) with QRISK1. Conclusions QRISK2 is more accurate in identifying a high risk population for cardiovascular disease in the United Kingdom than the NICE version of the Framingham equation. Differences in performance between QRISK2 and QRISK1 were marginal.	[Collins, Gary S.; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England	University of Oxford	Collins, GS (corresponding author), Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England.	gary.collins@csm.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Altman, Douglas G/A-9714-2012	Collins, Gary Stephen/0000-0002-2772-2316; 				Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; COLLINS GS, 2008, REPORT DEP HLTH INDE; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; Graf E, 1999, STAT MED, V18, P2529; HEMMINGWAY H, 2009, BRIT MED J, V339, pB4184; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Jackson R, 2008, HEART, V94, P1, DOI 10.1136/hrt.2007.138040; Jackson R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2673; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Janssen KJM, 2009, CLIN CHEM, V55, P994, DOI 10.1373/clinchem.2008.115345; Liew SM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3485; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-21; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Marshall RJ, 2009, J CLIN EPIDEMIOL, V62, P998, DOI 10.1016/j.jclinepi.2009.05.004; Mayor S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1774; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; *NICE, 2008, NICE GUID LIQ MOD CA; Omar RZ, 2004, ANN THORAC SURG, V77, P2232, DOI 10.1016/j.athoracsur.2003.10.032; R Development Core Team, R LANG ENV STAT COMP; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; ROYSTON P, 2008, MULTIVARIABLE MODELL; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Tsang VT, 2009, ANN THORAC SURG, V87, P584, DOI 10.1016/j.athoracsur.2008.10.065; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	37	142	146	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2010	340								c2442	10.1136/bmj.c2442	http://dx.doi.org/10.1136/bmj.c2442			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HR	20466793	Green Published, hybrid			2022-12-28	WOS:000277826500003
J	Samuels, MA; Pomerantz, BJ; Sadow, PM				Samuels, Martin A.; Pomerantz, Benjamin J.; Sadow, Peter M.			A Woman with Dizziness and Falls Pheochromocytoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADRENALINE-SECRETING PHAEOCHROMOCYTOMA; ORTHOSTATIC HYPOTENSION; PARAGANGLIOMAS; TACHYCARDIA; TUMORS		[Samuels, Martin A.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Pomerantz, Benjamin J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Samuels, Martin A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Pomerantz, Benjamin J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Samuels, MA (corresponding author), Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.		Sadow, Peter/E-7691-2015; Sadow, Peter/AAO-9878-2020	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367	MC Communications	MC Communications	Dr. Samuels reports receiving consulting fees from MC Communications. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Adler JT, 2008, ONCOLOGIST, V13, P779, DOI 10.1634/theoncologist.2008-0043; Bortnik M, 2008, J CARDIOVASC MED, V9, P839, DOI 10.2459/JCM.0b013e3282f4c88e; CALEJERO BD, 2006, SYNCOPE CASES, P151; CARMICHAEL SW, 1985, SCI AM, V253, P40, DOI 10.1038/scientificamerican0885-40; Dluhy RG, 2002, NEW ENGL J MED, V346, P1486, DOI 10.1056/NEJM200205093461911; Eisenhofer G, 2004, ENDOCR-RELAT CANCER, V11, P423, DOI 10.1677/erc.1.00829; HAMRIN B, 1962, LANCET, V2, P123; LINNOILA RI, 1990, HUM PATHOL, V21, P1168; LLOYD RV, 1986, AM J PATHOL, V125, P45; Low PA, 2009, J CARDIOVASC ELECTR, V20, P352, DOI 10.1111/j.1540-8167.2008.01407.x; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; RICHMOND J, 1961, LANCET, V2, P904; Sadow PM, 2008, ENDOCR PATHOL, V19, P97, DOI 10.1007/s12022-008-9028-0; Streeten DHP, 1996, AM J HYPERTENS, V9, P760, DOI 10.1016/0895-7061(96)00057-X; Tischler AS, 2008, ARCH PATHOL LAB MED, V132, P1272, DOI 10.1043/1543-2165(2008)132[1272:PAEPU]2.0.CO;2; Ueda T, 2005, INTERNAL MED, V44, P222, DOI 10.2169/internalmedicine.44.222; World Health Organisation, 2004, WHO CLASS TUM PATH G	17	5	8	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1815	1823		10.1056/NEJMcpc0910070	http://dx.doi.org/10.1056/NEJMcpc0910070			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463342				2022-12-28	WOS:000277555500010
J	Walensky, RP				Walensky, Rochelle P.			Disclosure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rwalensky@partners.org		Walensky, Rochelle P./0000-0002-8795-379X					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1676	1677		10.1001/jama.2010.535	http://dx.doi.org/10.1001/jama.2010.535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442376				2022-12-28	WOS:000277276600001
J	Samani, NJ; Tomaszewski, M; Schunkert, H				Samani, Nilesh J.; Tomaszewski, Maciej; Schunkert, Heribert			The personal genome-the future of personalised medicine?	LANCET			English	Editorial Material									[Samani, Nilesh J.; Tomaszewski, Maciej] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.; Tomaszewski, Maciej] Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Schunkert, Heribert] Univ Lubeck, Med Klin 2, Lubeck, Germany	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck	Samani, NJ (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England.	njs@le.ac.uk		Tomaszewski, Maciej/0000-0001-8215-6567				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; National Human Genome Research Institute, CAT GEN WID ASS STUD; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Robson M, 2007, NEW ENGL J MED, V357, P154, DOI 10.1056/NEJMcp071286; WAIKAN Y, 1978, P NATL ACAD SCI USA, V75, P5631, DOI 10.1073/pnas.75.11.5631; WALDMAN M, 2008, NATURE, V452, P788; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	15	36	41	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1497	1498		10.1016/S0140-6736(10)60598-3	http://dx.doi.org/10.1016/S0140-6736(10)60598-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435212				2022-12-28	WOS:000277655100004
J	Cui, J; Zhu, L; Xia, XJ; Wang, HY; Legras, X; Hong, J; Ji, JB; Shen, PP; Zheng, S; Chen, ZJJ; Wang, RF				Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Shen, Pingping; Zheng, Shu; Chen, Zhijian J.; Wang, Rong-Fu			NLRC5 Negatively Regulates the NF-kappa B and Type I Interferon Signaling Pathways	CELL			English	Article							PATTERN-RECOGNITION RECEPTORS; RIG-I; TOLL-LIKE; INNATE IMMUNITY; T-CELLS; INFLAMMATORY DISEASE; NALP3 INFLAMMASOME; UBIQUITIN LIGASE; KINASE COMPLEX; RNA	Stringent control of the NF-kappa B and type I interferon signaling pathways is critical to effective host immune responses, yet the molecular mechanisms that negatively regulate these pathways are poorly understood. Here, we show that NLRC5, a member of the highly conserved NOD-like protein family, can inhibit the IKK complex and RIG-I/MDA5 function. NLRC5 inhibited NF-kappa B-dependent responses by interacting with IKK alpha and IKK beta and blocking their phosphorylation. It also interacted with RIG-I and MDA5, but not with MAVS, to inhibit RLR-mediated type I interferon responses. Consistent with these observations, NLRC5-specific siRNA knockdown not only enhanced the activation of NF-kappa B and its responsive genes, TNF-alpha and IL-6, but also promoted type I interferon signaling and antiviral immunity. Our findings identify NLRC5 as a negative regulator that blocks two central components of the NF-kappa B and type I interferon signaling pathways and suggest an important role for NLRC5 in homeostatic control of innate immunity.	[Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Wang, Rong-Fu] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Cui, Jun; Zhu, Liang; Xia, Xiaojun; Wang, Helen Y.; Legras, Xavier; Hong, Jun; Ji, Jiabing; Wang, Rong-Fu] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Cui, Jun; Shen, Pingping] Nanjing Univ, Coll Life Sci, Nanjing 210008, Peoples R China; [Zhu, Liang; Zheng, Shu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Howard Hughes Med Inst, Dallas, TX 75390 USA	Baylor College of Medicine; Baylor College of Medicine; Nanjing University; Zhejiang University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wang, RF (corresponding author), Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	rongfuw@bcm.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	National Cancer Institute [P01CA094237, P50CA126752, R01CA09327, R01CA101795, R01CA116408, R01CA121191]; NIH; Cancer Research Institute; China Scholarship Council;  [NCET-06-0445]; NATIONAL CANCER INSTITUTE [P50CA126752, R01CA121191, R01CA116408, R01CA101795, P01CA094237, R01CA090327] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; China Scholarship Council(China Scholarship Council); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Drs. Michael Karin and Bing Su for IKK alpha, IKK beta, NEMO, and p38 constructs; Yinling Hu and Feng Zhu for constitutively active IKK alpha/beta (EE) mutants and GST-I kappa B (1-54) constructs; Jae U. Jung for RIG-I construct; Hongbin Shu for TRAF6; Kate Fitzgerald for TBK1 and IKKi constructs; and John Hiscott for pISRE-luc construct. We would also like to thank Drs Shao-Cong Sun, Xin Lin, and John Gilbert for their critical reading of this manuscript. This work was supported in part by grants (P01CA094237, P50CA126752, R01CA09327, R01CA101795, R01CA116408, and R01CA121191) from National Cancer Institute, NIH, and Cancer Research Institute ( to R. F. W). J.C. and L.Z. were partially supported by NCET-06-0445 and the China Scholarship Council. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	38	309	341	5	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					483	496		10.1016/j.cell.2010.03.040	http://dx.doi.org/10.1016/j.cell.2010.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434986	Green Accepted, Bronze			2022-12-28	WOS:000277180800019
J	Vegiopoulos, A; Muller-Decker, K; Strzoda, D; Schmitt, I; Chichelnitskiy, E; Ostertag, A; Diaz, MB; Rozman, J; de Angelis, MH; Nusing, RM; Meyer, CW; Wahli, W; Klingenspor, M; Herzig, S				Vegiopoulos, Alexandros; Mueller-Decker, Karin; Strzoda, Daniela; Schmitt, Iris; Chichelnitskiy, Evgeny; Ostertag, Anke; Diaz, Mauricio Berriel; Rozman, Jan; de Angelis, Martin Hrabe; Nuesing, Rolf M.; Meyer, Carola W.; Wahli, Walter; Klingenspor, Martin; Herzig, Stephan			Cyclooxygenase-2 Controls Energy Homeostasis in Mice by de Novo Recruitment of Brown Adipocytes	SCIENCE			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; IDENTIFICATION; RECEPTOR; FAT; CELECOXIB; OBESITY; PRDM16	Obesity results from chronic energy surplus and excess lipid storage in white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) efficiently burns lipids through adaptive thermogenesis. Studying mouse models, we show that cyclooxygenase (COX)-2, a rate-limiting enzyme in prostaglandin (PG) synthesis, is a downstream effector of beta-adrenergic signaling in WAT and is required for the induction of BAT in WAT depots. PG shifted the differentiation of defined mesenchymal progenitors toward a brown adipocyte phenotype. Overexpression of COX-2 in WAT induced de novo BAT recruitment in WAT, increased systemic energy expenditure, and protected mice against high-fat diet-induced obesity. Thus, COX-2 appears integral to de novo BAT recruitment, which suggests that the PG pathway regulates systemic energy homeostasis.	[Vegiopoulos, Alexandros; Strzoda, Daniela; Schmitt, Iris; Chichelnitskiy, Evgeny; Ostertag, Anke; Diaz, Mauricio Berriel; Herzig, Stephan] German Canc Res Ctr DKFZ Heidelberg, Emmy Noether & Marie Curie Res Grp Mol Metab Cont, D-69120 Heidelberg, Germany; [Mueller-Decker, Karin] German Canc Res Ctr DKFZ Heidelberg, Core Facil Tumor Models, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Rozman, Jan; de Angelis, Martin Hrabe] Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [Nuesing, Rolf M.] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60590 Frankfurt, Germany; [Meyer, Carola W.] Univ Marburg, Dept Anim Physiol, D-35043 Marburg, Germany; [Wahli, Walter] Univ Lausanne, Natl Res Ctr Frontiers Genet, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Goethe University Frankfurt; Philipps University Marburg; University of Lausanne; Technical University of Munich	Herzig, S (corresponding author), German Canc Res Ctr DKFZ Heidelberg, Emmy Noether & Marie Curie Res Grp Mol Metab Cont, D-69120 Heidelberg, Germany.	s.herzig@dkfz.de	Wahli, Walter/B-1398-2009; Rozman, Jan/A-2540-2010; Klingenspor, Martin/D-6930-2011; Klingenspor, Martin/K-5033-2019; de Angelis, Martin Hrabe/F-5531-2012; Diaz, Mauricio Berriel/AAF-8285-2021; Meyer, Carola/N-5874-2014; Wahli, Walter/I-3194-2019	Wahli, Walter/0000-0002-5966-9089; Rozman, Jan/0000-0002-8035-8904; Klingenspor, Martin/0000-0002-4502-6664; de Angelis, Martin Hrabe/0000-0002-7898-2353; Meyer, Carola/0000-0001-7959-1218; OSTERTAG, Agnes/0000-0002-1966-3213; Berriel Diaz, Mauricio/0000-0003-4670-919X; Chichelnitskiy, Evgeny/0000-0002-6341-4177; Herzig, Stephan/0000-0003-3950-3652	German National Genome Research Network [01GS0822, 01GS0869]; Deutsche Forschungsgemeinschaft [He3260/2-1]; Network Aging Research Heidelberg/Mannheim; Marie Curie Excellence Grant	German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Network Aging Research Heidelberg/Mannheim; Marie Curie Excellence Grant(European Commission)	We thank K. Hexel, A. Jones, D. Kucher, P. Kulozik, A. Lacher, F. Mattijssen, D. Metzger, A. Pohl-Arnold, A. Reimann, S. Schmitt, B. Steinbauer, M. Willershauser, and A. E. Schwarz for experimental support; A. Rose for comments on the manuscript; J. Masferrer (Pfizer, St. Louis, USA) for providing celecoxib; and S. Narumiya (Kyoto, Japan) for Ptgir knockout mice. This work was supported by the German National Genome Research Network (grants 01GS0822 to M. K. and 01GS0869 to M. K. and M. H.) and by the Deutsche Forschungsgemeinschaft He3260/2-1, the Network Aging Research Heidelberg/Mannheim, and a Marie Curie Excellence Grant to S. H.	Akunda JK, 2007, MOL CARCINOGEN, V46, P354, DOI 10.1002/mc.20290; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Celi FS, 2009, NEW ENGL J MED, V360, P1553, DOI 10.1056/NEJMe0900466; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davis TW, 2004, J PHARMACOL EXP THER, V308, P929, DOI 10.1124/jpet.103.063099; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Falcetti E, 2007, BIOCHEM BIOPH RES CO, V360, P821, DOI 10.1016/j.bbrc.2007.06.135; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lundholm K, 2004, INT J ONCOL, V24, P505; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Palamara Kerri L, 2006, Cardiol Rev, V14, P238, DOI 10.1097/01.crd.0000233903.57946.fd; Penning TD, 1997, J MED CHEM, V40, P1347, DOI 10.1021/jm960803q; RICHELSEN B, 1987, BIOCHEM J, V247, P389, DOI 10.1042/bj2470389; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949	24	338	360	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1158	1161		10.1126/science.1186034	http://dx.doi.org/10.1126/science.1186034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20448152				2022-12-28	WOS:000278104700044
J	Hurtley, S; Ash, C; Roberts, L				Hurtley, Stella; Ash, Caroline; Roberts, Leslie			Landscapes of Infection INTRODUCTION	SCIENCE			English	Editorial Material																			0	14	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					841	841		10.1126/science.328.5980.841	http://dx.doi.org/10.1126/science.328.5980.841			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466914				2022-12-28	WOS:000277618800030
J	London, AJ; Kimmelman, J; Emborg, ME				London, Alex John; Kimmelman, Jonathan; Emborg, Marina Elena			Beyond Access vs. Protection in Trials of Innovative Therapies	SCIENCE			English	Editorial Material							CLINICAL-TRIALS; ETHICS		[Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada; [London, Alex John] Carnegie Mellon Univ, Dept Philosophy, Pittsburgh, PA 15213 USA; [Emborg, Marina Elena] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53705 USA; [Emborg, Marina Elena] Univ Wisconsin, Dept Med Phys, Madison, WI 53705 USA	McGill University; Carnegie Mellon University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ H3A 1X1, Canada.	jonathan.kimmel-man@mcgill.ca		London, Alex/0000-0002-6450-0309	CIHR [NNF 80045, EOG 102824, 102823-1] Funding Source: Medline; NCRR NIH HHS [P51 RR000167, P51RR000167] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alper J, 2009, NAT BIOTECHNOL, V27, P213, DOI 10.1038/nbt0309-213a; Bebarta V, 2003, ACAD EMERG MED, V10, P684, DOI 10.1197/aemj.10.6.684; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Carpenter D., 2009, GOVT MARKETS NEW THE, P164; Couzin J, 2004, SCIENCE, V304, P192, DOI 10.1126/science.304.5668.192; Curt GA, 2008, ONCOLOGIST, V13, P923, DOI 10.1634/theoncologist.2008-0174; Dilts DM, 2006, J CLIN ONCOL, V24, P4545, DOI 10.1200/JCO.2005.05.0104; Dixon-Woods M, 2009, SOC SCI MED, V68, P2215, DOI 10.1016/j.socscimed.2009.03.034; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Kimmelman J, 2009, MOVEMENT DISORD, V24, P1893, DOI 10.1002/mds.22712; Kimmelman Jonathan., 2010, GENE TRANSFER ETHICS; Law Marc, 2004, HIST FOOD DRUG REGUL; Lo B, 2005, STEM CELLS, V23, P1454, DOI 10.1634/stemcells.2005-ed.4; London AJ, 2007, J MED PHILOS, V32, P99, DOI 10.1080/03605310701255727; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935; 2005, LANCET, V365, P1984	19	62	64	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					829	830		10.1126/science.1189369	http://dx.doi.org/10.1126/science.1189369			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466907	Green Accepted, Green Submitted			2022-12-28	WOS:000277618800023
J	Oshima, K; Shin, K; Diensthuber, M; Peng, AW; Ricci, AJ; Heller, S				Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan			Mechanosensitive Hair Cell-like Cells from Embryonic and Induced Pluripotent Stem Cells	CELL			English	Article							OTIC PLACODE INDUCTION; INNER-EAR DEVELOPMENT; DEVELOPMENTAL ACQUISITION; SENSORY TRANSDUCTION; PAX-2 EXPRESSION; ACTIN-FILAMENTS; HEAD INDUCTION; MOUSE COCHLEA; TIP-LINK; IN-VITRO	Mechanosensitive sensory hair cells are the linchpin of our senses of hearing and balance. The inability of the mammalian inner ear to regenerate lost hair cells is the major reason for the permanence of hearing loss and certain balance disorders. Here, we present a step-wise guidance protocol starting with mouse embryonic stem and induced pluripotent stem cells, which were directed toward becoming ectoderm capable of responding to otic-inducing growth factors. The resulting otic progenitor cells were subjected to varying differentiation conditions, one of which promoted the organization of the cells into epithelial clusters displaying hair cell-like cells with stereociliary bundles. Bundle-bearing cells in these clusters responded to mechanical stimulation with currents that were reminiscent of immature hair cell transduction currents.	[Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Oshima, Kazuo; Shin, Kunyoo; Diensthuber, Marc; Peng, Anthony W.; Ricci, Anthony J.; Heller, Stefan] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	hellers@stanford.edu		Peng, Anthony/0000-0002-2208-6779; Shin, Kunyoo/0000-0002-1519-9839; ricci, anthony/0000-0002-1706-8904	National Institutes of Health [DC006167, P30DC010363]; California Institute for Regenerative Medicine [RC1-00119-1]; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006167, R21DC010042, R01DC003896, P30DC010363] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank H. Zeng (Stanford Transgenic Research Center) for help with ESC line derivation; J. Johnson (UT Southwestern) for Math1/nGFP mice; U. Mueller (Scripps) for cadherin 23 antibody; G. Richardson for hair cell antigen antibody; F. Salles (National Institute on Deafness and Other Communication Disorders) for advice in electron microscopy sample preparation; L. Joubert (Stanford EM core facility) for expert assistance; M. Yazawa, R. Dolmetsch, and A. Ootani for help with teratoma assays; and K. Masaki, V. Starlinger, E. Corrales, M. Herget, Z. Guo, T. Jan, and S. Sinkkonen for fruitful discussions; M. D. is a fellow of the Alexander-von-Humboldt Foundation. This work was supported by National Institutes of Health grants DC006167 and P30DC010363, by the California Institute for Regenerative Medicine (grant RC1-00119-1), and by a Neuroscience of Brain Disorders Award from the McKnight Endowment Fund for Neuroscience.	Alsina B, 2004, DEV BIOL, V267, P119, DOI 10.1016/j.ydbio.2003.11.012; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Brown ST, 2005, J COMP NEUROL, V483, P48, DOI 10.1002/cne.20418; Chen P, 1999, DEVELOPMENT, V126, P1581; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Geleoc GSG, 2004, J NEUROSCI, V24, P11148, DOI 10.1523/JNEUROSCI.2662-04.2004; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Heller N, 1999, DEV GENET, V24, P208, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<208::AID-DVG4>3.0.CO;2-J; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Hu ZQ, 2007, P NATL ACAD SCI USA, V104, P16675, DOI 10.1073/pnas.0704576104; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; Li HW, 2004, J NEUROBIOL, V60, P61, DOI 10.1002/neu.20013; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Marcotti W, 1999, PFLUG ARCH EUR J PHY, V439, P113, DOI 10.1007/s004240051134; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Michalski N, 2009, PFLUG ARCH EUR J PHY, V459, P115, DOI 10.1007/s00424-009-0711-x; Michel V, 2005, DEV BIOL, V280, P281, DOI 10.1016/j.ydbio.2005.01.014; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oliver D, 1997, PFLUG ARCH EUR J PHY, V434, P772, DOI 10.1007/s004240050464; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pera EM, 2001, DEV CELL, V1, P655, DOI 10.1016/S1534-5807(01)00069-7; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Ricci A, 2002, J NEUROPHYSIOL, V87, P1738, DOI 10.1152/jn.00574.2001; ROWITCH DH, 1995, MECH DEVELOP, V52, P3, DOI 10.1016/0925-4773(95)00380-J; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TILNEY LG, 1983, J CELL BIOL, V96, P822, DOI 10.1083/jcb.96.3.822; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zou D, 2004, DEVELOPMENT, V131, P5561, DOI 10.1242/dev.01437	61	208	237	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					704	716		10.1016/j.cell.2010.03.035	http://dx.doi.org/10.1016/j.cell.2010.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478259	Bronze, Green Accepted			2022-12-28	WOS:000277623600022
J	Seydel, B; Detry, O				Seydel, Benoit; Detry, Olivier			Morgagni's Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Seydel, Benoit; Detry, Olivier] Univ Liege, Liege, Belgium	University of Liege	Seydel, B (corresponding author), Univ Liege, Liege, Belgium.	oli.detry@chu.ulg.ac.be	Detry, Olivier/I-9333-2019	Detry, Olivier/0000-0002-9436-6673					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					E61	E61		10.1056/NEJMicm0907898	http://dx.doi.org/10.1056/NEJMicm0907898			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463336				2022-12-28	WOS:000277555500009
J	Lichtenstein, AH; Ludwig, DS				Lichtenstein, Alice H.; Ludwig, David S.			Bring Back Home Economics Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BODY-MASS INDEX; FOOD; CHILDREN; US		[Lichtenstein, Alice H.] Tufts Univ, Cardiovasc Res Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Tufts University; United States Department of Agriculture (USDA); Harvard University; Boston Children's Hospital	Lichtenstein, AH (corresponding author), Tufts Univ, Cardiovasc Res Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, 711 Washington St, Boston, MA 02111 USA.	alice.lichtenstein@tufts.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730, K24 DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		DOLNICK S, 2010, NY TIMES        0312; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Larson NI, 2006, J AM DIET ASSOC, V106, P2001, DOI 10.1016/j.jada.2006.09.008; Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; SEVERSON K, 2010, NY TIMES        0316; Taveras EM, 2005, PEDIATRICS, V116, pE518, DOI 10.1542/peds.2004-2732; Thompson OM, 2004, INT J OBESITY, V28, P282, DOI 10.1038/sj.ijo.0802538	10	151	152	1	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1857	1858		10.1001/jama.2010.592	http://dx.doi.org/10.1001/jama.2010.592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460625	Green Accepted, Green Submitted			2022-12-28	WOS:000277513900027
J	Hsiang, MS; Abeyasinghe, R; Whittaker, M; Feachem, RGA				Hsiang, Michelle S.; Abeyasinghe, Rabindra; Whittaker, Maxine; Feachem, Richard G. A.			Malaria elimination in Asia-Pacific: an under-told story	LANCET			English	Editorial Material							ERADICATION		[Hsiang, Michelle S.; Feachem, Richard G. A.] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA; [Abeyasinghe, Rabindra] Sri Lanka Natl Malaria Control Program, Colombo, Sri Lanka; [Whittaker, Maxine] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of California System; University of California San Francisco; University of Queensland	Hsiang, MS (corresponding author), UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA 94105 USA.	hsiangm@peds.ucsf.edu	Whittaker, Maxine/H-1990-2011	Whittaker, Maxine/0000-0002-1677-2991				[Anonymous], 2008 MDG MAL SUMM WO; *APMEN, APMEN 2 M P; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dysoley L, 2008, ACTA TROP, V106, P207, DOI 10.1016/j.actatropica.2007.01.007; Feachem RGA, 2009, SHRINKING MALARIA MA; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; *IRIN, 2008, 6 PROV DECL MAL FREE; Kaneko A, 2000, LANCET, V356, P1560, DOI 10.1016/S0140-6736(00)03127-5; Park J, 2009, IND HEALTH, V47, P50, DOI 10.2486/indhealth.47.50; Pinikahana Jayaratne, 1993, Indian Journal of Malariology, V30, P51; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; *WHO, 2008, MAL SIT SRI LANK; *WHO, 2009, LAUNCH M STRAT CONT; WHO, 2008, GLOB MAL CONTR EL RE; *WHO, WORLD MAL REP 2009; *WHO MEK MAL PROGR, 2009, STRAT PLAN STRENGTH; Yip Ka-che, 2009, DIS COLONIALISM STAT; Zhou YH, 2007, J RARE EARTH, V25, P41; 2009, HINDU           0128	19	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1586	1587		10.1016/S0140-6736(10)60350-9	http://dx.doi.org/10.1016/S0140-6736(10)60350-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452505				2022-12-28	WOS:000277734700007
J	Peleg, S; Sananbenesi, F; Zovoilis, A; Burkhardt, S; Bahari-Javan, S; Agis-Balboa, RC; Cota, P; Wittnam, JL; Gogol-Doering, A; Opitz, L; Salinas-Riester, G; Dettenhofer, M; Kang, H; Farinelli, L; Chen, W; Fischer, A				Peleg, Shahaf; Sananbenesi, Farahnaz; Zovoilis, Athanasios; Burkhardt, Susanne; Bahari-Javan, Sanaz; Agis-Balboa, Roberto Carlos; Cota, Perla; Wittnam, Jessica Lee; Gogol-Doering, Andreas; Opitz, Lennart; Salinas-Riester, Gabriella; Dettenhofer, Markus; Kang, Hui; Farinelli, Laurent; Chen, Wei; Fischer, Andre			Altered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; GENE-EXPRESSION; SYNAPTIC PLASTICITY; CHIP-SEQ; BRAIN; FORMIN-2; PROTEIN; LTP	As the human life span increases, the number of people suffering from cognitive decline is rising dramatically. The mechanisms underlying age-associated memory impairment are, however, not understood. Here we show that memory disturbances in the aging brain of the mouse are associated with altered hippocampal chromatin plasticity. During learning, aged mice display a specific deregulation of histone H4 lysine 12 (H4K12) acetylation and fail to initiate a hippocampal gene expression program associated with memory consolidation. Restoration of physiological H4K12 acetylation reinstates the expression of learning-induced genes and leads to the recovery of cognitive abilities. Our data suggest that deregulated H4K12 acetylation may represent an early biomarker of an impaired genome-environment interaction in the aging mouse brain.	[Peleg, Shahaf; Sananbenesi, Farahnaz; Zovoilis, Athanasios; Burkhardt, Susanne; Bahari-Javan, Sanaz; Agis-Balboa, Roberto Carlos; Cota, Perla; Wittnam, Jessica Lee; Fischer, Andre] European Neurosci Inst, Lab Aging & Cognit Dis, D-37077 Gottingen, Germany; [Gogol-Doering, Andreas; Kang, Hui; Chen, Wei] Max Delbruck Ctr Mol Med, Inst Med Syst Biol, D-13125 Berlin, Germany; [Opitz, Lennart; Salinas-Riester, Gabriella] Univ Gottingen, DNA Microarray Facil, D-37073 Gottingen, Germany; [Dettenhofer, Markus] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Farinelli, Laurent] Fasteris SA, CH-1228 Plan Les Ouates, Switzerland	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Gottingen; Harvard University; Harvard Medical School	Fischer, A (corresponding author), European Neurosci Inst, Lab Aging & Cognit Dis, Grisebach Str 5, D-37077 Gottingen, Germany.	a.fischer@eni-g.de	Chen, Wei/C-1273-2011; Dettenhofer, Markus/ABB-9840-2021; Agís-Balboa, Roberto Carlos/K-5053-2014; Fischer, Andre/AAU-7487-2021	Dettenhofer, Markus/0000-0003-1972-7026; Agís-Balboa, Roberto Carlos/0000-0001-9899-9569; Fischer, Andre/0000-0001-8546-1161; Peleg, Shahaf/0000-0003-2646-3807; Zovoilis, Athanasios/0000-0001-6425-0402; Chen, Wei/0000-0003-3263-1627	European Science Foundation; Hans and Ilse Breuer Foundation; Schramm Foundation; European Research Area (ERA)-Net Neuron project Epitherapy; Minerva fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation); German Academic Exchange Service (DAAD); European Molecular Biology Organization (EMBO); University Medicine Goettingen; Max Planck Society	European Science Foundation(European Science Foundation (ESF)European Commission); Hans and Ilse Breuer Foundation; Schramm Foundation; European Research Area (ERA)-Net Neuron project Epitherapy; Minerva fellowship; Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); University Medicine Goettingen; Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank J. Radulovic, S. Irniger, A Kranz, and W. Fischle for reading the manuscript and helpful comments. Microarray and ChIP-seq data are accessible through GEO Series accession number GSE20270 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20270) and Galaxy data-sharing platform (http://main.g2.bx.psu.edu/u/fischerlab/h/sm1186088; published history sm1186088). This work was partially supported by the following funds to A. F.: The EURYI award of the European Science Foundation, the Hans and Ilse Breuer Foundation, the Schramm Foundation, and the European Research Area (ERA)-Net Neuron project Epitherapy. S. P. is supported by a Minerva fellowship, F. S. is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation), P. C. is supported by a German Academic Exchange Service (DAAD) fellowship, and R. C. A.-B. is supported by a European Molecular Biology Organization (EMBO) long-term fellowship. M. D is a Howard Hughes Medical Institute postdoctoral fellow, and L. F. is a founder and shareholder of Fasteris SA. The European Neuroscience Institute is jointly funded by the University Medicine Goettingen and the Max Planck Society.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jucker M, 1997, BEHAV BRAIN RES, V85, P1, DOI 10.1016/S0166-4328(96)02243-7; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Liang N, 2008, J PROTEOME RES, V7, P3678, DOI 10.1021/pr800439b; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mardis ER, 2007, NAT METHODS, V4, P613, DOI 10.1038/nmeth0807-613; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Xu X, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r234	24	681	709	1	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					753	756		10.1126/science.1186088	http://dx.doi.org/10.1126/science.1186088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448184				2022-12-28	WOS:000277357100040
J	Saiman, L; Anstead, M; Mayer-Hamblett, N; Lands, LC; Kloster, M; Hocevar-Trnka, J; Goss, CH; Rose, LM; Burns, JL; Marshall, BC; Ratjen, F				Saiman, Lisa; Anstead, Michael; Mayer-Hamblett, Nicole; Lands, Larry C.; Kloster, Margaret; Hocevar-Trnka, Jasna; Goss, Christopher H.; Rose, Lynn M.; Burns, Jane L.; Marshall, Bruce C.; Ratjen, Felix		AZ0004 Azithromycin Study Grp	Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM AZITHROMYCIN; MACROLIDE RESISTANCE; STAPHYLOCOCCUS-AUREUS; CLINICAL-TRIAL; MAINTENANCE; CHILDREN; CF	Context Azithromycin is recommended as therapy for cystic fibrosis (CF) patients with chronic Pseudomonas aeruginosa infection, but there has not been sufficient evidence to support the benefit of azithromycin in other patients with CF. Objective To determine if azithromycin treatment improves lung function and reduces pulmonary exacerbations in pediatric CF patients uninfected with P aeruginosa. Design, Setting, and Participants A multicenter, randomized, double-blind placebo-controlled trial was conducted from February 2007 to July 2009 at 40 CF care centers in the United States and Canada. Of the 324 participants screened, 260 were randomized and received study drug. Eligibility criteria included age of 6 to 18 years, a forced expiratory volume in the first second of expiration (FEV1) of at least 50% predicted, and negative respiratory tract cultures for P aeruginosa for at least 1 year. Randomization was stratified by age of 6 to 12 years vs 13 to 18 years and by CF center. Intervention The active group (n=131) received 250 mg (weight 18-35.9 kg) or 500 mg (weight >= 36 kg) of azithromycin 3 days per week (Monday, Wednesday, and Friday) for 168 days. The placebo group (n=129) received identically packaged placebo tablets on the same schedule. Main Outcome Measures The primary outcome was change in FEV1. Exploratory outcomes included additional pulmonary function end points, pulmonary exacerbations, changes in weight and height, new use of antibiotics, and hospitalizations. Changes in microbiology and adverse events were monitored. Results The mean (SD) age of participants was 10.7 (3.17) years. The mean (SD) FEV1 at baseline and 168 days were 2.13 (0.85) L and 2.22 (0.86) L for the azithromycin group and 2.12 (0.85) L and 2.20 (0.88) L for the placebo group. The difference in the change in FEV1 between the azithromycin and placebo groups was 0.02 L (95% confidence interval [CI], -0.05 to 0.08; P=.61). None of the exploratory pulmonary function end points were statistically significant. Pulmonary exacerbations occurred in 21% of the azithromycin group and 39% of the placebo group. Participants in the azithromycin group had a 50% reduction in exacerbations (95% CI, 31%-79%) and an increase in body weight of 0.58 kg (95% CI, 0.14-1.02) compared with placebo participants. There were no significant differences between groups in height, use of intravenous or inhaled antibiotics, or hospitalizations. Participants in the azithromycin group had no increased risk of adverse events, but had less cough (-23% treatment difference; 95% CI, -33% to -11%) and less productive cough (-11% treatment difference; 95% CI, -19% to -3%) compared with placebo participants. Conclusion In children and adolescents with CF uninfected with P aeruginosa, treatment with azithromycin for 24 weeks did not result in improved pulmonary function.	[Saiman, Lisa] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Saiman, Lisa] New York Presbyterian Hosp, New York, NY USA; [Anstead, Michael] Univ Kentucky, Dept Pediat, Lexington, KY 40506 USA; [Mayer-Hamblett, Nicole; Goss, Christopher H.; Rose, Lynn M.; Burns, Jane L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Goss, Christopher H.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Mayer-Hamblett, Nicole; Kloster, Margaret; Hocevar-Trnka, Jasna; Goss, Christopher H.; Rose, Lynn M.] Seattle Childrens Hosp, Cyst Fibrosis Therapeut Dev Network, Coordinating Ctr, Seattle, WA USA; [Burns, Jane L.] Seattle Childrens Hosp, Cyst Fibrosis Therapeut Dev Network, Ctr CF Microbiol, Seattle, WA USA; [Lands, Larry C.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Marshall, Bruce C.] Cyst Fibrosis Fdn, Bethesda, MD USA; [Marshall, Bruce C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ratjen, Felix] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Resp Med, Toronto, ON M5G 1X8, Canada	Columbia University; NewYork-Presbyterian Hospital; University of Kentucky; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; McGill University; Cystic Fibrosis Foundation; Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Saiman, L (corresponding author), Columbia Univ, Dept Pediat, 650 W 168th St,PH 4 W,Room 420, New York, NY 10027 USA.	ls5@columbia.edu		Goss, Christopher/0000-0001-8602-0309; Ratjen, Felix/0000-0003-4057-6592; McIlwaine, Maggie/0000-0002-4646-3209	CF Foundation Therapeutics, Inc. (CFFT); TDN Coordinating Center	CF Foundation Therapeutics, Inc. (CFFT); TDN Coordinating Center	This study was funded by CF Foundation Therapeutics, Inc. (CFFT). The CFFT Therapeutics Development Network (TDN) was funded by the CFFT to manage this trial on behalf of the study principal investigators (LS, MA, LCL, and FR) and the TDN Coordinating Center (CF Foundation Therapeutics Development Network Coordinating Center) was the regulatory sponsor of the study. The CF Foundation Therapeutics Development Network Coordinating Center leadership (NMH and LMR) participated on the executive committee for the study along with the principal investigators and participated in discussions and decisions pertaining to the study. Drug and placebo were supplied by Pfizer, Inc, which	[Anonymous], COCHRANE DATABASE SY, DOI [10.1002/14651858.CD002203.pub2, DOI 10.1002/14651858.CD002203.PUB2]; Cigana C, 2006, BIOCHEM BIOPH RES CO, V350, P977, DOI 10.1016/j.bbrc.2006.09.132; Clement A, 2006, THORAX, V61, P895, DOI 10.1136/thx.2005.057950; *CLIN LAB STAND I, 2009, M100S19 CLIN LAB STA; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Equi A, 2002, LANCET, V360, P978, DOI 10.1016/S0140-6736(02)11081-6; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hansen CR, 2009, J CYST FIBROS, V8, P58, DOI 10.1016/j.jcf.2008.09.001; Legssyer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-134; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Mayer-Hamblett N, 2005, CONTEMP CLIN TRIALS, V26, P2, DOI 10.1016/j.cct.2004.08.008; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Phaff SJ, 2006, J ANTIMICROB CHEMOTH, V57, P741, DOI 10.1093/jac/dkl014; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; Ratjen F, 2006, NEW ENGL J MED, V354, P291, DOI 10.1056/NEJMe058293; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rosenfeld Margaret, 2007, Proc Am Thorac Soc, V4, P299, DOI 10.1513/pats.200611-178HT; Saiman L, 2004, CURR OPIN PULM MED, V10, P515, DOI 10.1097/01.mcp.0000142101.53084.f0; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Tateda Kazuhiro, 2007, Journal of Infection and Chemotherapy, V13, pCP7, DOI 10.1007/s10156-007-0555-2; Tazumi A, 2009, J ANTIMICROB CHEMOTH, V64, P501, DOI 10.1093/jac/dkp213; Tramper-Stranders GA, 2007, PEDIATR INFECT DIS J, V26, P8, DOI 10.1097/01.inf.0000247109.44249.ac; Treggiari MM, 2009, CONTEMP CLIN TRIALS, V30, P256, DOI 10.1016/j.cct.2009.01.003; Tsai WC, 2004, AM J RESP CRIT CARE, V170, P1331, DOI 10.1164/rccm.200402-200OC; Verleden GM, 2006, AM J RESP CRIT CARE, V174, P566, DOI 10.1164/rccm.200601-071OC; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Wolter J, 2002, THORAX, V57, P212, DOI 10.1136/thorax.57.3.212	30	252	257	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1707	1715		10.1001/jama.2010.563	http://dx.doi.org/10.1001/jama.2010.563			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442386	Bronze			2022-12-28	WOS:000277276600023
J	Annas, GJ				Annas, George J.			Justice John Paul Stevens - The Practice of Medicine and the Rule of Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas G., 1993, STANDARD CARE LAW AM; Rosen Jeffrey, 2007, NY TIMES MAGAZI 0923; SILVERSTEIN MARK, 1994, JUDICIOUS CHOICES NE; STEVEN JP, 2007, COMMUNICATION   0622; TOOBIN JEFFREY, 2007, 9 INSIDE SECRET WORL, P118	5	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2246	2249		10.1056/NEJMp1004657	http://dx.doi.org/10.1056/NEJMp1004657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20445165				2022-12-28	WOS:000278816300003
J	Henne, WM; Boucrot, E; Meinecke, M; Evergren, E; Vallis, Y; Mittal, R; McMahon, HT				Henne, William Mike; Boucrot, Emmanuel; Meinecke, Michael; Evergren, Emma; Vallis, Yvonne; Mittal, Rohit; McMahon, Harvey T.			FCHo Proteins Are Nucleators of Clathrin-Mediated Endocytosis	SCIENCE			English	Article							MEMBRANE INVAGINATION; BAR DOMAINS; CURVATURE; CARGO; CELLS	Clathrin-mediated endocytosis, the major pathway for ligand internalization into eukaryotic cells, is thought to be initiated by the clustering of clathrin and adaptors around receptors destined for internalization. However, here we report that the membrane-sculpting F-BAR domain-containing Fer/Cip4 homology domain-only proteins 1 and 2 (FCHo1/2) were required for plasma membrane clathrin-coated vesicle (CCV) budding and marked sites of CCV formation. Changes in FCHo1/2 expression levels correlated directly with numbers of CCV budding events, ligand endocytosis, and synaptic vesicle marker recycling. FCHo1/2 proteins bound specifically to the plasma membrane and recruited the scaffold proteins eps15 and intersectin, which in turn engaged the adaptor complex AP2. The FCHo F-BAR membrane-bending activity was required, leading to the proposal that FCHo1/2 sculpt the initial bud site and recruit the clathrin machinery for CCV formation.	[Henne, William Mike; Boucrot, Emmanuel; Meinecke, Michael; Evergren, Emma; Vallis, Yvonne; Mittal, Rohit; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Boucrot, E (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	eboucrot@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Meinecke, Michael/C-4833-2013; Evergren, Emma/X-3677-2019	Meinecke, Michael/0000-0003-1414-6951; Evergren, Emma/0000-0002-0775-2921; Boucrot, Emmanuel/0000-0001-7312-6462	MRC, UK; MRC-LMB Ph.D. scholarship; Human Frontiers Science Program Organization; European Molecular Biology Organization; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-LMB Ph.D. scholarship; Human Frontiers Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S.-Y. Peak-Chew for mass spectrometry, M. Daly for cell sorting, G. Lingley for movie design, J. E. Tyrrell for summer assistance, and Perkin Elmer for support with spinning-disk microscopy. Support was provided to H.M.M. (MRC, UK), W.M.H. (MRC-LMB Ph.D. scholarship), E. B. (Human Frontiers Science Program Organization and MRC), and M.M. and E.E. (European Molecular Biology Organization fellowships). Core funding for this work was provided by MRC.	Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boettner DR, 2009, CURR BIOL, V19, P1979, DOI 10.1016/j.cub.2009.10.062; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Reider A, 2009, EMBO J, V28, P3103, DOI 10.1038/emboj.2009.248; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Stimpson HEM, 2009, MOL BIOL CELL, V20, P4640, DOI 10.1091/mbc.E09-05-0429; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Uezu A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703815200; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	19	290	308	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1281	1284		10.1126/science.1188462	http://dx.doi.org/10.1126/science.1188462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20448150	Green Accepted			2022-12-28	WOS:000278318600036
J	Finer, NN; Carlo, WA; Walsh, MC; Rich, W; Gantz, MG; Laptook, AR; Yoder, BA; Faix, RG; Das, A; Poole, WK; Donovan, EF; Newman, NS; Ambalavanan, N; Frantz, ID; Buchter, S; Sanchez, PJ; Kennedy, KA; Laroia, N; Poindexter, BB; Cotten, CM; Van Meurs, KP; Duara, S; Narendran, V; Sood, BG; O'Shea, TM; Bell, EF; Bhandari, V; Watterberg, KL; Higgins, RD				Finer, Neil N.; Carlo, Waldemar A.; Walsh, Michele C.; Rich, Wade; Gantz, Marie G.; Laptook, Abbot R.; Yoder, Bradley A.; Faix, Roger G.; Das, Abhik; Poole, W. Kenneth; Donovan, Edward F.; Newman, Nancy S.; Ambalavanan, Namasivayam; Frantz, Ivan D., III; Buchter, Susie; Sanchez, Pablo J.; Kennedy, Kathleen A.; Laroia, Nirupama; Poindexter, Brenda B.; Cotten, C. Michael; Van Meurs, Krisa P.; Duara, Shahnaz; Narendran, Vivek; Sood, Beena G.; O'Shea, T. Michael; Bell, Edward F.; Bhandari, Vineet; Watterberg, Kristi L.; Higgins, Rosemary D.		Eunice Kennedy Shriver NICHD	Early CPAP versus Surfactant in Extremely Preterm Infants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; CHRONIC LUNG-DISEASE; DELIVERY ROOM; INTUBATION; RATES; PRESSURE; TRIAL	Background: There are limited data to inform the choice between early treatment with continuous positive airway pressure (CPAP) and early surfactant treatment as the initial support for extremely-low-birth-weight infants. Methods: We performed a randomized, multicenter trial, with a 2-by-2 factorial design, involving infants who were born between 24 weeks 0 days and 27 weeks 6 days of gestation. Infants were randomly assigned to intubation and surfactant treatment (within 1 hour after birth) or to CPAP treatment initiated in the delivery room, with subsequent use of a protocol-driven limited ventilation strategy. Infants were also randomly assigned to one of two target ranges of oxygen saturation. The primary outcome was death or bronchopulmonary dysplasia as defined by the requirement for supplemental oxygen at 36 weeks (with an attempt at withdrawal of supplemental oxygen in neonates who were receiving less than 30% oxygen). Results: A total of 1316 infants were enrolled in the study. The rates of the primary outcome did not differ significantly between the CPAP group and the surfactant group (47.8% and 51.0%, respectively; relative risk with CPAP, 0.95; 95% confidence interval [CI], 0.85 to 1.05) after adjustment for gestational age, center, and familial clustering. The results were similar when bronchopulmonary dysplasia was defined according to the need for any supplemental oxygen at 36 weeks (rates of primary outcome, 48.7% and 54.1%, respectively; relative risk with CPAP, 0.91; 95% CI, 0.83 to 1.01). Infants who received CPAP treatment, as compared with infants who received surfactant treatment, less frequently required intubation or postnatal corticosteroids for bronchopulmonary dysplasia (P<0.001), required fewer days of mechanical ventilation (P=0.03), and were more likely to be alive and free from the need for mechanical ventilation by day 7 (P=0.01). The rates of other adverse neonatal outcomes did not differ significantly between the two groups. Conclusions: The results of this study support consideration of CPAP as an alternative to intubation and surfactant in preterm infants. (ClinicalTrials.gov number, NCT00233324.) N Engl J Med 2010;362:1970-9.	[Finer, Neil N.; Rich, Wade] Univ Calif San Diego, Div Neonatol, San Diego, CA 92103 USA; [Carlo, Waldemar A.; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL USA; [Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Gantz, Marie G.; Poole, W. Kenneth] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Cotten, C. Michael] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [O'Shea, T. Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Yoder, Bradley A.; Faix, Roger G.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Donovan, Edward F.; Narendran, Vivek] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Frantz, Ivan D., III] Floating Hosp Children, Tufts Med Ctr, Div Newborn Med, Dept Pediat, Boston, MA USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Buchter, Susie] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Buchter, Susie] Childrens Healthcare Atlanta, Atlanta, GA USA; [Kennedy, Kathleen A.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX USA; [Laroia, Nirupama] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Sood, Beena G.] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Duara, Shahnaz] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Bhandari, Vineet] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Research Triangle Institute; Duke University; Wake Forest University; Brown University; Women & Infants Hospital Rhode Island; Utah System of Higher Education; University of Utah; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; University of Cincinnati; Floating Hospital For Children; Tufts Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Children's Healthcare of Atlanta (CHOA); University of Texas System; University of Texas Health Science Center Houston; University of Rochester; Indiana University System; Indiana University Bloomington; Stanford University; Wayne State University; University of Miami; University of Iowa; Yale University; University of New Mexico; University of New Mexico's Health Sciences Center	Finer, NN (corresponding author), Univ Calif San Diego, Div Neonatol, 402 Dickinson St,MPF 1-140, San Diego, CA 92103 USA.	nfiner@ucsd.edu	Das, Abhik/AAF-1883-2020; Ambalavanan, Namasivayam/AAL-3832-2020; Bhandari, Vineet/AAS-3365-2020; Laroia, Nirupama/J-2128-2017	Das, Abhik/0000-0003-2722-0479; Laroia, Nirupama/0000-0002-8844-6378; Gantz, Marie/0000-0001-8528-0184; Bell, Edward/0000-0002-5568-0889; Ambalavanan, Namasivayam/0000-0003-0731-9092	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, U10 HD53124]; National Heart, Lung, and Blood Institute; National Institutes of Health [M01 RR30, M01 RR32, M01 RR39, M01 RR44, M01 RR54, M01 RR59, M01 RR64, M01 RR70, M01 RR80, MO1 RR125, M01 RR633, M01 RR750, M01 RR997, M01 RR6022, M01 RR7122, M01 RR8084, M01 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, UL1 RR25744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD053109, UG1HD034216, U10HD027856, UG1HD053089, U10HD053124, U10HD040461, U10HD034216, U10HD027851, U10HD027904, U10HD053089, U10HD027880, U10HD021373, U10HD053119, U10HD036790, U10HD040492, U10HD021364, U10HD040689, U10HD027853, U10HD021385, U10HD027871] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040498, U01HD036790, U10HD040521, U10HD021397] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016587, UL1RR024979, UL1RR024139, UL1RR025744, M01RR000030, M01RR007122, M01RR008084, M01RR006022, UL1RR025008] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants (U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, U10 HD53124) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, cofunding from the National Heart, Lung, and Blood Institute, and grants ( M01 RR30, M01 RR32, M01 RR39, M01 RR44, M01 RR54, M01 RR59, M01 RR64, M01 RR70, M01 RR80, MO1 RR125, M01 RR633, M01 RR750, M01 RR997, M01 RR6022, M01 RR7122, M01 RR8084, M01 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, UL1 RR25744) from the National Institutes of Health.	Aly H, 2005, PEDIATRICS, V115, P1660, DOI 10.1542/peds.2004-2493; AVERY ME, 1987, PEDIATRICS, V79, P26; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Finer NN, 2004, PEDIATRICS, V114, P651, DOI 10.1542/peds.2004-0394; Gittermann MK, 1997, EUR J PEDIATR, V156, P384, DOI 10.1007/s004310050620; Hardy RJ, 2004, CONTROL CLIN TRIALS, V25, P311, DOI 10.1016/j.cct.2004.03.003; Hentschel R, 2009, ACTA PAEDIATR, V98, P654, DOI 10.1111/j.1651-2227.2008.01216.x; Ho JJ, 2002, COCHRANE DB SYST REV, V2; Jonsson B, 1997, ACTA PAEDIATR, V86, P4; Kattwinkel J, 2006, NEONATAL RESUSCITATI; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Poets CF, 1996, PEDIATRICS, V98, P24; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Soll RF, 2000, COCHRANE DB SYST REV, V2; SOLL RF, 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000510, 10.1002/14651858.CD000510]; Van Marter LJ, 2000, PEDIATRICS, V105, P1194, DOI 10.1542/peds.105.6.1194; Vanpee M, 2007, ACTA PAEDIATR, V96, P10, DOI 10.1111/j.1651-2227.2007.00063.x; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; YOST CC, 2000, COCHRANE DB SYST REV, V2	20	727	757	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1970	1979						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20472939	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000278054000005
J	Fear, NT; Jones, M; Murphy, D; Hull, L; Iversen, AC; Coker, B; Machell, L; Sundin, J; Woodhead, C; Jones, N; Greenberg, N; Landau, S; Dandeker, C; Rona, RJ; Hotopf, M; Wessely, S				Fear, Nicola T.; Jones, Margaret; Murphy, Dominic; Hull, Lisa; Iversen, Amy C.; Coker, Bolaji; Machell, Louise; Sundin, Josefin; Woodhead, Charlotte; Jones, Norman; Greenberg, Neil; Landau, Sabine; Dandeker, Christopher; Rona, Roberto J.; Hotopf, Matthew; Wessely, Simon			What are the consequences of deployment to Iraq and Afghanistan on the mental health of the UK armed forces? A cohort study	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ALCOHOL-USE; COMBAT EXPOSURES; WAR VETERANS; SURVEY SF-36; US VETERANS; GULF-WAR; SYMPTOMS; SOLDIERS; PTSD	Background Concerns have been raised about the psychological effect of continued combat exposure and of repeated deployments. We examined the consequences of deployment to Iraq and Afghanistan on the mental health of UK armed forces from 2003 to 2009, the effect of multiple deployments, and time since return from deployment. Methods We reassessed the prevalence of probable mental disorders in participants of our previous study (2003-05). We also studied two new randomly chosen samples: those with recent deployment to Afghanistan, and those who had joined the UK armed forces since April, 2003, to ensure that the final sample continued to be representative of the UK armed forces. Between November, 2007, and September, 2009, participants completed a questionnaire about their deployment experiences and health outcomes. Findings 9990 (56%) participants completed the study questionnaire (8278 regulars, 1712 reservists). The prevalence of probable post-traumatic stress disorder was 4.0% (95% CI 3.5-4.5; n=376), 19.7% (18.7-20-6; n=1908) for symptoms of common mental disorders, and 13.0% (12.2-13.8; n=1323) for alcohol misuse. Deployment to Iraq or Afghanistan was significantly associated with alcohol misuse for regulars (odds ratio 1.22, 95% CI 1.02-1.46) and with probable post-traumatic stress disorder for reservists (2.83, 1.23-6.51). Regular personnel in combat roles were more likely than were those in support roles to report probable post-traumatic stress disorder (1.87, 1.26-2.78). There was no association with number of deployments for any outcome. There was some evidence for a small increase in the reporting of probable post-traumatic stress disorder with time since return from deployment in regulars (1.13, 1.03-1.24). Interpretation Symptoms of common mental disorders and alcohol misuse remain the most frequently reported mental disorders in UK armed forces personnel, whereas the prevalence of probable post-traumatic stress disorder was low. These findings show the importance of continued health surveillance of UK military personnel.	[Fear, Nicola T.] Kings Coll London, Weston Educ Ctr, Acad Ctr Def Mental Hlth, London SE5 9RJ, England; [Jones, Margaret; Murphy, Dominic; Hull, Lisa; Iversen, Amy C.; Coker, Bolaji; Machell, Louise; Woodhead, Charlotte; Dandeker, Christopher; Rona, Roberto J.; Hotopf, Matthew; Wessely, Simon] Kings Coll London, Kings Ctr Mil Hlth Res, London SE5 9RJ, England; [Landau, Sabine] Kings Coll London, Inst Psychiat, London SE5 9RJ, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Fear, NT (corresponding author), Kings Coll London, Weston Educ Ctr, Acad Ctr Def Mental Hlth, 10 Cutcombe Rd, London SE5 9RJ, England.	nicola.t.fear@kcl.ac.uk	Sundin, Josefin/B-9666-2012; Hotopf, Matthew/E-4971-2010; Fear, Nicola/A-1917-2012; Wessely, Simon C/A-8713-2008; Landau, Sabine/B-9354-2011	Fear, Nicola/0000-0002-5792-2925; Landau, Sabine/0000-0002-3615-8075; Sundin, Josefin/0000-0002-0609-586X; Rona, Roberto/0000-0003-3739-5571; greenberg, neil/0000-0003-4550-2971; Hotopf, Matthew/0000-0002-3980-4466; Wessely, Simon Charles/0000-0002-6743-9929	UK Ministry of Defence; National Institute for Health Research [NF-SI-0507-10088] Funding Source: researchfish	UK Ministry of Defence; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding UK Ministry of Defence.	Andrews B, 2009, J ABNORM PSYCHOL, V118, P767, DOI 10.1037/a0017203; [Anonymous], BBC; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Bliese PD, 2007, PSYCHOL SERV, V4, P141, DOI [DOI 10.1037/1541-1559.4.3.141, 10.1037/1541-1559.4.3.141]; Browne T, 2008, OCCUP ENVIRON MED, V65, P628, DOI 10.1136/oem.2007.036830; Browne T, 2007, BRIT J PSYCHIAT, V190, P484, DOI 10.1192/bjp.bp.106.030544; Brugha T, 2009, ADULT PSYCHIAT MORBI; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; *DASA, UK DEF STAT 2009; *DASA, 2009, TSP 7 UK RES CAD STR; Department of Veterans Affairs, 2010, FED BEN VET DEP SURV; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Duma SJ, 2010, J TRAUMA STRESS, V23, P52, DOI 10.1002/jts.20484; Fear NT, 2007, ADDICTION, V102, P1749, DOI 10.1111/j.1360-0443.2007.01978.x; Frueh BC, 2005, BRIT J PSYCHIAT, V186, P467, DOI 10.1192/bjp.186.6.467; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Hickley M., 2008, MAIL ONLINE     1105; *HLTH PROGR AN EV, 2006, 2003 2004 ACT DUT HL; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper R, 2008, ADDICT BEHAV, V33, P1067, DOI 10.1016/j.addbeh.2008.03.010; Hotopf M, 2005, INT J EPIDEMIOL, V34, P791, DOI 10.1093/ije/dyi102; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Iversen A, 2006, BRIT MED J, V332, P165, DOI 10.1136/bmj.332.7534.165; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jones E, 2001, BRIT J PSYCHIAT, V178, P242, DOI 10.1192/bjp.178.3.242; Kulka R.A., 1990, TRAUMA VIETNAM WAR G; Maguen S, 2010, J TRAUMA STRESS, V23, P86, DOI 10.1002/jts.20434; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; *MIN DEF, OP IR; *MIN DEF NAT AUD O, 2006, CONTR AUD GEN SESS 2; National Collaborating Centre for Mental Health, 2005, NAT CLIN PRACT GUID, V26; Office of the Command Surgeon US Forces Afghanistan (USFOR-A) and Office of the Surgeon General United States Army Medical Command, 2009, MENT HLTH ADV TEAM M; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rona RJ, 2007, BRIT MED J, V335, P603, DOI 10.1136/bmj.39274.585752.BE; Rona RJ, 2006, BMJ-BRIT MED J, V333, P991, DOI 10.1136/BMJ.38985.610949.55; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schell T.L., 2008, INVISIBLE WOUNDS WAR; SMITH M, 2009, SUNDAY TIMES LO 0426; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Solomon Z, 2006, AM J PSYCHIAT, V163, P659, DOI 10.1176/appi.ajp.163.4.659; Sundin J, 2010, PSYCHOL MED, V40, P367, DOI 10.1017/S0033291709990791; Tate AR, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-51; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Vasterling JJ, 2010, J TRAUMA STRESS, V23, P41, DOI 10.1002/jts.20487; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weathers F.W., 1994, PTSD CHECKLIST CIVIL; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044; 2009, BBC NEWS ONLINE  FEB; 2008, BBC RADIO 4      NOV	54	400	405	2	52	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1783	1797		10.1016/S0140-6736(10)60672-1	http://dx.doi.org/10.1016/S0140-6736(10)60672-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20471076				2022-12-28	WOS:000278216500030
J	Pollock, TM				Pollock, Tresa M.			Weight Loss with Magnesium Alloys	SCIENCE			English	Editorial Material							MG ALLOY; GRAIN-REFINEMENT; SUPERPLASTICITY; TEMPERATURE; PLASTICITY; PREDICTION; EXTRUSION; PHASES; SYSTEM; AZ31B		Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Pollock, TM (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	pollock@engineering.ucsb.edu						Aghion E, 2000, MATER SCI FORUM, V350-3, P19, DOI 10.4028/www.scientific.net/MSF.350-351.19; Cao G, 2008, MAT SCI ENG A-STRUCT, V494, P127, DOI 10.1016/j.msea.2008.04.070; Cole GS, 2007, Magnesium Technology 2007, P35; Decker R, 2009, MAGNESIUM TECHNOLOGY, P357; Di HS, 2005, MATER SCI FORUM, V488-489, P615, DOI 10.4028/www.scientific.net/MSF.488-489.615; Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010; Janz A, 2009, ACTA MATER, V57, P682, DOI 10.1016/j.actamat.2008.10.037; Kim WJ, 2009, ADV ENG MATER, V11, P525, DOI 10.1002/adem.200900003; Koike J, 2005, METALL MATER TRANS A, V36A, P1689, DOI 10.1007/s11661-005-0032-4; Levi E, 2010, CHEM MATER, V22, P860, DOI 10.1021/cm9016497; Mathaudhu SN, 2010, MAGNESIUM TECHNOLOGY, P27; Matsubara K, 2003, ACTA MATER, V51, P3073, DOI 10.1016/S1359-6454(03)00118-6; National Research Council, 2008, INT COMP MAT ENG; Neil CJ, 2009, INT J PLASTICITY, V25, P379, DOI 10.1016/j.ijplas.2008.05.003; Olson GB, 2000, SCIENCE, V288, P993, DOI 10.1126/science.288.5468.993; POWELL BR, 2001, 2001010422 SAE; StJohn DH, 2005, METALL MATER TRANS A, V36A, P1669, DOI 10.1007/s11661-005-0030-6; Suzuki A, 2005, ACTA MATER, V53, P2823, DOI 10.1016/j.actamat.2005.03.001; Swiostek J, 2006, MAT SCI ENG A-STRUCT, V424, P223, DOI 10.1016/j.msea.2006.03.021; Yu WY, 2009, SOLID STATE SCI, V11, P1400, DOI 10.1016/j.solidstatesciences.2009.04.017; Zhang SM, 2006, MATER SCI TECH-LOND, V22, P1489, DOI 10.1179/174328406X148822; Zhong Y, 2006, SCRIPTA MATER, V55, P573, DOI 10.1016/j.scriptamat.2006.03.068	22	682	710	11	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					986	987		10.1126/science.1182848	http://dx.doi.org/10.1126/science.1182848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489013				2022-12-28	WOS:000277877100028
J	Sagarin, RD; Alcorta, CS; Atran, S; Blumstein, DT; Dietl, GP; Hochberg, ME; Johnson, DDP; Levin, S; Madin, EMP; Madin, JS; Prescott, EM; Sosis, R; Taylor, T; Tooby, J; Vermeij, GJ				Sagarin, Raphael D.; Alcorta, Candace S.; Atran, Scott; Blumstein, Daniel T.; Dietl, Gregory P.; Hochberg, Michael E.; Johnson, Dominic D. P.; Levin, Simon; Madin, Elizabeth M. P.; Madin, Joshua S.; Prescott, Elizabeth M.; Sosis, Richard; Taylor, Terence; Tooby, John; Vermeij, Geerat J.			Decentralize, adapt and cooperate	NATURE			English	Editorial Material									[Sagarin, Raphael D.] Univ Arizona, Inst Environm, Tucson, AZ 85716 USA	University of Arizona	Sagarin, RD (corresponding author), Univ Arizona, Inst Environm, Tucson, AZ 85716 USA.	rafe@email.arizona.edu	Johnson, Dominic/C-6948-2009; Johnson, Dominic/GXH-1117-2022; Blumstein, Daniel T./B-6199-2012; Levin, Simon A/J-1218-2014	Blumstein, Daniel T./0000-0001-5793-9244; Levin, Simon A/0000-0002-8216-5639; Madin, Joshua/0000-0002-5005-6227				Atran S, 2007, SCIENCE, V317, P1039, DOI 10.1126/science.1144241; Blumstein DT, 2004, P ROY SOC B-BIOL SCI, V271, P1851, DOI 10.1098/rspb.2004.2808; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Endres J, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-47; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gresham L, 2009, BIOSECUR BIOTERROR, V7, P399, DOI 10.1089/bsp.2009.0034; Hochberg ME, 2004, P ROY SOC B-BIOL SCI, V271, pS313, DOI 10.1098/rsbl.2004.0172; Rundus AS, 2007, P NATL ACAD SCI USA, V104, P14372, DOI 10.1073/pnas.0702599104	8	15	16	0	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					292	293		10.1038/465292a	http://dx.doi.org/10.1038/465292a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485417	Green Published			2022-12-28	WOS:000277829200020
J	Ormond, KE; Wheeler, MT; Hudgins, L; Klein, TE; Butte, AJ; Altman, RB; Ashley, EA; Greely, HT				Ormond, Kelly E.; Wheeler, Matthew T.; Hudgins, Louanne; Klein, Teri E.; Butte, Atul J.; Altman, Russ B.; Ashley, Euan A.; Greely, Henry T.			Challenges in the clinical application of whole-genome sequencing	LANCET			English	Editorial Material									[Wheeler, Matthew T.; Ashley, Euan A.] Stanford Univ, Sch Med, Ctr Inherited Cardiovasc Dis, Div Cardiovasc Med, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Hudgins, Louanne] Stanford Univ, Sch Med, Div Med Genet, Stanford, CA 94305 USA; [Butte, Atul J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Ormond, Kelly E.; Klein, Teri E.; Altman, Russ B.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Sch Law, Ctr Law & Biosci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Greely, HT (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	hgreely@stanford.edu	Ormond, Kelly E/I-5676-2019	Ormond, Kelly E/0000-0002-1033-0818; Wheeler, Matthew/0000-0001-8721-3022; Klein, Teri/0000-0001-5527-6475	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009719] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079719-04] Funding Source: Medline; NLM NIH HHS [R01 LM009719, R01 LM009719-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212	3	163	166	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1749	1751		10.1016/S0140-6736(10)60599-5	http://dx.doi.org/10.1016/S0140-6736(10)60599-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20434765				2022-12-28	WOS:000277890200036
J	McEwan, DG; Dikic, I				McEwan, David G.; Dikic, Ivan			Not All Autophagy Membranes Are Created Equal	CELL			English	Editorial Material							ENDOPLASMIC-RETICULUM		[McEwan, David G.; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [McEwan, David G.; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	McEwan, DG (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	mcewan@biochem2.uni-frankfurt.de; ivan.dikic@biochem2.de	McEwan, David/AAY-6264-2020; McEwan, David/A-3754-2015; Dikic, Ivan/O-4650-2015	McEwan, David/0000-0003-0353-6532; Dikic, Ivan/0000-0001-8156-9511				Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; DE DUVE CHRISTIAN, 1963, SCI AMER, V208, P64; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; YAMAMOTO A, 1990, J HISTOCHEM CYTOCHEM, V38, P1571, DOI 10.1177/38.11.2212617	7	18	22	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					564	566		10.1016/j.cell.2010.04.030	http://dx.doi.org/10.1016/j.cell.2010.04.030			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478247	Bronze			2022-12-28	WOS:000277623600007
J	Tehranchi, AK; Blankschien, MD; Zhang, Y; Halliday, JA; Srivatsan, A; Peng, J; Herman, C; Wang, JD				Tehranchi, Ashley K.; Blankschien, Matthew D.; Zhang, Yan; Halliday, Jennifer A.; Srivatsan, Anjana; Peng, Jia; Herman, Christophe; Wang, Jue D.			The Transcription Factor DksA Prevents Conflicts between DNA Replication and Transcription Machinery	CELL			English	Article							COLI RNA-POLYMERASE; HEAD-ON COLLISION; GUANOSINE TETRAPHOSPHATE; TERMINATION EFFICIENCY; BACILLUS-SUBTILIS; FORK PROGRESSION; BETA-SUBUNIT; PPGPP; INITIATION; GENE	Actively dividing cells perform robust and accurate DNA replication during fluctuating nutrient availability, yet factors that prevent disruption of replication remain largely unknown. Here we report that DksA, a nutrient-responsive transcription factor, ensures replication completion in Escherichia coli by removing transcription roadblocks. In the absence of DksA, replication is rapidly arrested upon amino acid starvation. This arrest requires active transcription and is alleviated by RNA polymerase mutants that compensate for DksA activity. This replication arrest occurs independently of exogenous DNA damage, yet it induces the DNA-damage response and recruits the main recombination protein RecA. This function of DksA is independent of its transcription initiation activity but requires its less-studied transcription elongation activity. Finally, GreA/B elongation factors also prevent replication arrest during nutrient stress. We conclude that transcription elongation factors alleviate fundamental conflicts between replication and transcription, thereby protecting replication fork progression and DNA integrity.	[Tehranchi, Ashley K.; Blankschien, Matthew D.; Halliday, Jennifer A.; Srivatsan, Anjana; Peng, Jia; Herman, Christophe; Wang, Jue D.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zhang, Yan; Wang, Jue D.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Herman, Christophe; Wang, Jue D.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Herman, C (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	herman@bcm.edu; jdwang@bcm.edu	Wang, Jue/GVU-0480-2022; Srivatsan, Anjana/Q-6312-2017; Srivatsan, Anjana/S-1518-2017	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075; Wang, Jue/0000-0003-1503-170X	Human Frontier Science Program Young Investigator Grant [HFSP2006-0060]; Welch Research Grant [Q-1698]; NIH [1R01GM084]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084003] Funding Source: NIH RePORTER	Human Frontier Science Program Young Investigator Grant(Human Frontier Science Program); Welch Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Cashel, Marc Drolet, Patrick Piggot, Susan Rosenberg, and Steve Sandler for strains; Adam Breier, Michael Cashel, Herman Dierick, Tamas Gaal, Alasdair Gordon, Rick Gourse, Phil Hastings, Greg Ira, Allison Kriel, Bob Landick, Jeong Hyun Lee, Susan Rosenberg, Wilma Ross, Jonathan Weissman, Ivan Matic, and the anonymous reviewers for critical comments. C. H. is supported by Human Frontier Science Program Young Investigator Grant (HFSP2006-0060). J. D. W. is supported by a Welch Research Grant (Q-1698) and a Public Health Service grant (1R01GM084) from NIH.	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; Blankschien MD, 2009, EMBO J, V28, P1720, DOI 10.1038/emboj.2009.126; Blankschien MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000345; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; BREWER BJ, 1988, CELL, V53, P679, DOI 10.1016/0092-8674(88)90086-4; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; CASHEL M, 1996, ESCHERICHIA COLI SAL; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elias-Arnanz M, 1999, EMBO J, V18, P5675, DOI 10.1093/emboj/18.20.5675; Ferullo DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000300; FISHER RF, 1983, J BIOL CHEM, V258, P8146; FRENCH S, 1992, SCIENCE, V258, P1362, DOI 10.1126/science.1455232; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; Jin DJ, 2006, J STRUCT BIOL, V156, P284, DOI 10.1016/j.jsb.2006.07.005; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P9419, DOI 10.1073/pnas.97.17.9419; KINGSTON RE, 1981, J BIOL CHEM, V256, P2787; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Krohn M, 1996, J BIOL CHEM, V271, P23884, DOI 10.1074/jbc.271.39.23884; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; LANDICK R, 1990, GENE DEV, V4, P1623, DOI 10.1101/gad.4.9.1623; LEVINE A, 1991, J MOL BIOL, V219, P605, DOI 10.1016/0022-2836(91)90657-R; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAALOE O, 1961, J MOL BIOL, V3, P144, DOI 10.1016/S0022-2836(61)80041-7; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mirkin EV, 2005, MOL CELL BIOL, V25, P888, DOI 10.1128/MCB.25.3.888-895.2005; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Neuhard, 1987, ESCHERICHIA COLI SAL, V1, P445; Olavarrieta L, 2002, J MOL BIOL, V322, P1, DOI 10.1016/S0022-2836(02)00740-4; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pennington JM, 2007, NAT GENET, V39, P797, DOI 10.1038/ng2051; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Renzette N, 2005, MOL MICROBIOL, V57, P1074, DOI 10.1111/j.1365-2958.2005.04755.x; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; SCHREIBER G, 1995, CURR MICROBIOL, V30, P27, DOI 10.1007/BF00294520; Srivatsan A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000810; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Torres JZ, 2004, MOL CELL BIOL, V24, P3198, DOI 10.1128/MCB.24.8.3198-3212.2004; TOSA T, 1971, J BACTERIOL, V106, P966, DOI 10.1128/JB.106.3.966-971.1971; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; VOGEL U, 1994, J BIOL CHEM, V269, P16236; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; YAMANAKA K, 1994, MOL MICROBIOL, V13, P301, DOI 10.1111/j.1365-2958.1994.tb00424.x; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	76	111	114	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					595	605		10.1016/j.cell.2010.03.036	http://dx.doi.org/10.1016/j.cell.2010.03.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478253	Bronze, Green Accepted			2022-12-28	WOS:000277623600013
J	van der Meer, JWM; Netea, MG; Galama, JMD; van Kuppeveld, FJM				van der Meer, Jos W. M.; Netea, Mihai G.; Galama, Jochem M. D.; van Kuppeveld, Frank J. M.			Comment on "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome"	SCIENCE			English	Editorial Material							PROSTATE-CANCER PATIENTS; VIRUS-RELATED VIRUS; PREVALENCE; CYTOKINES	Lombardi et al. (Reports, 23 October 2009, p. 585) reported detection of the human gammaretrovirus XMRV in the blood cells of patients with chronic fatigue syndrome (CFS). However, the patient description provided was incomplete. The inclusion of patients from a "CFS outbreak" previously linked with a viral infection, without confirmation in sporadic CFS cases, casts doubt on the role of XMRV in the pathogenesis of CFS.	[van der Meer, Jos W. M.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Galama, Jochem M. D.; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [van der Meer, Jos W. M.; Netea, Mihai G.; Galama, Jochem M. D.; van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van der Meer, JWM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	j.vandermeer@aig.umcn.nl	van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014	van der Meer, Jos W.M./0000-0001-5120-3690; van Kuppeveld, Frank/0000-0001-5800-749X				D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; DAUGHERTY SA, 1991, REV INFECT DIS, V13, pS39; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Fletcher MA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-96; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; Jammes Y, 2009, J INTERN MED, V266, P196, DOI 10.1111/j.1365-2796.2009.02079.x; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; MIKOVITS JA, 2009, C CELL CYT INT HLTH; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Swanink CMA, 1996, J INFECT DIS, V173, P460, DOI 10.1093/infdis/173.2.460; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	17	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980								10.1126/science.1183906	http://dx.doi.org/10.1126/science.1183906			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466904				2022-12-28	WOS:000277618800019
J	Feelders, RA; de Bruin, C; Pereira, AM; Romijn, JA; Netea-Maier, RT; Hermus, AR; Zelissen, PM; van Heerebeek, R; de Jong, FH; van der Lely, AJ; de Herder, WW; Hofland, LJ; Lamberts, SW				Feelders, Richard A.; de Bruin, Christiaan; Pereira, Alberto M.; Romijn, Johannes A.; Netea-Maier, Romana T.; Hermus, Ad R.; Zelissen, Pierre M.; van Heerebeek, Ramona; de Jong, Frank H.; van der Lely, Aart-Jan; de Herder, Wouter W.; Hofland, Leo J.; Lamberts, Steven W.			Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Feelders, Richard A.; de Bruin, Christiaan; van Heerebeek, Ramona; de Jong, Frank H.; van der Lely, Aart-Jan; de Herder, Wouter W.; Hofland, Leo J.; Lamberts, Steven W.] Erasmus MC, Rotterdam, Netherlands; [Pereira, Alberto M.; Romijn, Johannes A.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Netea-Maier, Romana T.; Hermus, Ad R.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Zelissen, Pierre M.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Feelders, RA (corresponding author), Erasmus MC, Rotterdam, Netherlands.	r.feelders@erasmusmc.nl	Netea, Mihai/N-5155-2014; Hermus, A.R.M.M./H-8043-2014; De Jong, Frank H/A-9876-2011; Netea-Maier, R.T./L-4543-2015; Pereira, Alberto M./Q-7175-2017; de+Herder, Wouter/AAN-8429-2021	Hermus, A.R.M.M./0000-0003-1075-2655; De Jong, Frank H/0000-0003-3578-1065; Pereira, Alberto M./0000-0002-1194-9866; 				Boscaro M, 2009, J CLIN ENDOCR METAB, V94, P115, DOI 10.1210/jc.2008-1008; de Bruin C, 2009, J CLIN ENDOCR METAB, V94, P1118, DOI 10.1210/jc.2008-2101; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; Pivonello R, 2009, J CLIN ENDOCR METAB, V94, P223, DOI 10.1210/jc.2008-1533; Schmid HA, 2008, MOL CELL ENDOCRINOL, V286, P69, DOI 10.1016/j.mce.2007.09.006	5	185	190	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1846	1848		10.1056/NEJMc1000094	http://dx.doi.org/10.1056/NEJMc1000094			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463350	Green Published			2022-12-28	WOS:000277555500027
J	Malin, GL; Morris, RK; Khan, KS				Malin, Gemma L.; Morris, Rachel K.; Khan, Khalid S.			Strength of association between umbilical cord pH and perinatal and long term outcomes: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACID-BASE STATUS; NEONATAL NEUROLOGICAL MORBIDITY; CEREBRAL-PALSY; APGAR SCORE; HEALTH-CARE; CAUSAL INFERENCE; PROGNOSTIC VALUE; BIRTH ASPHYXIA; RISK-FACTORS; BLOOD-PH	Objective To evaluate the association between umbilical cord pH at birth and long term outcomes. Design Systematic review and meta-analysis. Data sources Medline (1966-August 2008), Embase (1980-August 2008), the Cochrane Library (2008 issue 8), and Medion, without language restrictions; reference lists of selected articles; and contact with authors. Study selection Studies in which cord pH at birth was compared with any neonatal or long term outcome. Cohort and case-control designs were included. Results 51 articles totalling 481 753 infants met the selection criteria. Studies varied in design, quality, outcome definition, and results. Meta-analysis carried out within predefined groups showed that low arterial cord pH was significantly associated with neonatal mortality (odds ratio 16.9, 95% confidence interval 9.7 to 29.5, I-2=0%), hypoxic ischaemic encephalopathy (13.8, 6.6 to 28.9, I-2=0%), intraventricular haemorrhage or periventricular leucomalacia (2.9, 2.1 to 4.1, I-2=0%), and cerebral palsy (2.3, 1.3 to 4.2, I-2=0%). Conclusions Low arterial cord pH showed strong, consistent, and temporal associations with clinically important neonatal outcomes that are biologically plausible. These data can be used to inform clinical management and justify the use of arterial cord pH as an important outcome measure alongside neonatal morbidity and mortality in obstetric trials.	[Malin, Gemma L.; Morris, Rachel K.; Khan, Khalid S.] Univ Birmingham, Coll Med & Dent Sci, Dept Obstet, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Khan, Khalid S.] Birmingham Womens Fdn NHS Trust, Dept Obstet & Gynaecol, Birmingham, W Midlands, England	University of Birmingham	Malin, GL (corresponding author), Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham B15 2TG, W Midlands, England.	g.l.malin@bham.ac.uk	Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312; Morris, Katie/0000-0003-1247-429X	Birmingham Women's Foundation Trust; Medical Research Council/Royal College of Obstetrics and Gynaecology [RRAK12923]; Medical Research Council [G0700526] Funding Source: researchfish; National Institute for Health Research [CL-2010-09-003] Funding Source: researchfish; MRC [G0700526] Funding Source: UKRI	Birmingham Women's Foundation Trust; Medical Research Council/Royal College of Obstetrics and Gynaecology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: GLM is funded by the Mary Crosse fellowship, Birmingham Women's Foundation Trust. RKM is funded by a Medical Research Council/Royal College of Obstetrics and Gynaecology clinical research training fellowship (RRAK12923).	Akers JA-IR., 2009, SYSTEMATIC REV CRDS; Baenziger O, 1999, BIOL NEONATE, V75, P9, DOI 10.1159/000014072; BEEBY PJ, 1994, ARCH DIS CHILD-FETAL, V71, pF93, DOI 10.1136/fn.71.2.F93; Blackwell SC, 2001, AM J OBSTET GYNECOL, V184, P1422, DOI 10.1067/mob.2001.115120; Blumenthal I, 2001, J ROY SOC MED, V94, P624, DOI 10.1177/014107680109401205; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; BRESADOLA M, 1995, CLIN EXP OBSTET GYN, V3, P235; Casey BM, 2001, AM J OBSTET GYNECOL, V184, P447, DOI 10.1067/mob.2001.109394; Cluett ER, 2004, BMJ-BRIT MED J, V328, P314, DOI 10.1136/bmj.37963.606412.EE; COTTEE C, 2008, OBSTET GYNAECOL REPR, V18, P155; de Dios JG, 2000, REV NEUROLOGIA, V31, P107; Dear P, 2000, BRIT MED J, V320, P1075; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DENNIS J, 1989, AM J OBSTET GYNECOL, V161, P213, DOI 10.1016/0002-9378(89)90269-X; Deville W, 2002, EVIDENCE BASE CLIN D, P145; DIJXHOORN MJ, 1986, BRIT J OBSTET GYNAEC, V93, P217, DOI 10.1111/j.1471-0528.1986.tb07896.x; DIJXHOORN MJ, 1985, EARLY HUM DEV, V11, P33, DOI 10.1016/0378-3782(85)90117-3; DSOUZA SW, 1983, ARCH DIS CHILD, V58, P15, DOI 10.1136/adc.58.1.15; Engle WD, 1999, RESUSCITATION, V42, P11; Ertan AK, 2006, EUR J OBSTET GYN R B, V127, P29, DOI 10.1016/j.ejogrb.2004.06.008; Fahey J, 2005, J MIDWIFERY WOM HEAL, V50, P498, DOI 10.1016/j.jmwh.2005.08.007; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; FOX C, 2006, EUR CLIN OBSTET GYNE, V1, P251; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; GAUDIER FL, 1994, AM J OBSTET GYNECOL, V170, P48; Gea Y, 2007, J PEDIAT-BRAZIL, V83, P186, DOI 10.2223/JPED.1597; Ghosh B, 2003, INT J GYNECOL OBSTET, V81, P267, DOI 10.1016/S0020-7292(03)00124-3; GILSTRAP LC, 1989, AM J OBSTET GYNECOL, V161, P825, DOI 10.1016/0002-9378(89)90410-9; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; GOODWIN TM, 1992, AM J OBSTET GYNECOL, V167, P1506, DOI 10.1016/0002-9378(92)91728-S; Graham E M, 2002, J Matern Fetal Neonatal Med, V12, P123, DOI 10.1080/713605613; Graham EM, 2004, AM J OBSTET GYNECOL, V191, P1305, DOI 10.1016/j.ajog.2004.06.058; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Haddad B, 2000, AM J OBSTET GYNECOL, V182, P1210, DOI 10.1067/mob.2000.104951; Hansen SL, 2002, OBSTET GYNECOL, V99, P29, DOI 10.1016/S0029-7844(01)01642-8; HARBORD R, 2008, S456932 BOST COLL DE; HARBORD RM, 2009, S404901 BOST COLL DP; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; HARRIS R, 2009, S456798 BOST COLL DE; Heller G, 2003, Z Geburtshilfe Neonatol, V207, P84; Hemingway H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4184; HERNANDEZ C, 1993, AM J OBSTET GYNECOL, V169, P61, DOI 10.1016/0002-9378(93)90132-3; HIBBARD JU, 1991, OBSTET GYNECOL, V78, P768; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hogan L, 2007, EUR J OBSTET GYN R B, V130, P169, DOI 10.1016/j.ejogrb.2006.03.002; Holmes P, 2001, J Matern Fetal Med, V10, P264, DOI 10.1080/714904335; Hossain MA, 2008, INT J DEV NEUROSCI, V26, P93, DOI 10.1016/j.ijdevneu.2007.08.013; HUISJES HJ, 1979, EARLY HUM DEV, V3, P155, DOI 10.1016/0378-3782(79)90004-5; Ingemarsson I, 1997, BRIT J OBSTET GYNAEC, V104, P1123, DOI 10.1111/j.1471-0528.1997.tb10934.x; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnston MV, 2000, J CHILD NEUROL, V15, P588, DOI 10.1177/088307380001500904; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; JURGENSVANDERZEE AD, 1979, EARLY HUM DEV, V3, P141, DOI 10.1016/0378-3782(79)90003-3; Kato EH, 1996, J PERINAT MED, V24, P677, DOI 10.1515/jpme.1996.24.6.677; Khan KS, 2003, EUR J OBSTET GYN R B, V108, P121, DOI 10.1016/S0301-2115(03)00098-8; Khan KS, 2001, EUR J OBSTET GYN R B, V95, P6, DOI 10.1016/S0301-2115(00)00463-2; Larma JD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.053; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; LITSCHGI M, 1974, Z GEBURTSH PERINATOL, V178, P23; Loh S. F., 1998, SMJ, V39, P151; Low JA, 1997, AM J OBSTET GYNECOL, V177, P1391, DOI 10.1016/S0002-9378(97)70080-2; LUTHY DA, 1987, AM J OBSTET GYNECOL, V157, P676, DOI 10.1016/S0002-9378(87)80027-3; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054; MURPHY DJ, 1995, LANCET, V346, P1449, DOI 10.1016/S0140-6736(95)92471-X; Perlman JM, 1996, PEDIATRICS, V97, P456; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Ross MG, 2002, AM J OBSTET GYNECOL, V187, P1, DOI 10.1067/mob.2002.123204; SAKURABA M, 1989, J PERINAT MED, V17, P99, DOI 10.1515/jpme.1989.17.2.99; SALAFIA CM, 1995, AM J PERINAT, V12, P429, DOI 10.1055/s-2007-994514; Sankey SS, 1996, COMMUN STAT SIMULAT, V25, P1031, DOI 10.1080/03610919608813357; SCHNEIDER R, 1985, Z KINDER JUG-PSYCH, V13, P24; Shennan A H, 1995, Int J Obstet Anesth, V4, P78, DOI 10.1016/0959-289X(95)82996-N; Silva AM, 2008, J PERINAT MED, V36, P151, DOI 10.1515/JPM.2008.023; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; SOCOL ML, 1994, AM J OBSTET GYNECOL, V170, P991, DOI 10.1016/S0002-9378(94)70092-3; SPINILLO A, 1995, BIOL NEONATE, V67, P39; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Svirko E, 2008, EARLY HUM DEV, V84, P37, DOI 10.1016/j.earlhumdev.2007.02.002; TEJANI N, 1989, OBSTET GYNECOL, V73, P597; Thorp JA, 1999, OBSTET GYN CLIN N AM, V26, P695, DOI 10.1016/S0889-8545(05)70107-8; THOULON JM, 1972, LYON MED, V227, P699; VALENTIN L, 1993, ARCH GYNECOL OBSTET, V253, P103, DOI 10.1007/BF02768736; van de Riet JE, 1999, AM J OBSTET GYNECOL, V180, P1024, DOI 10.1016/S0002-9378(99)70676-9; vandenBerg PP, 1996, AM J OBSTET GYNECOL, V175, P1152, DOI 10.1016/S0002-9378(96)70021-2; VINTZILEOS AM, 1993, OBSTET GYNECOL, V81, P899; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Weed DL, 1998, AM J EPIDEMIOL, V147, P415; Weed DL, 2000, INT J EPIDEMIOL, V29, P387, DOI 10.1093/ije/29.3.387; Weed DL, 1997, INT J EPIDEMIOL, V26, P1137, DOI 10.1093/ije/26.6.1137; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whyte H, 2004, AM J OBSTET GYNECOL, V191, P864, DOI 10.1016/j.ajog.2004.06.056; Wildschut J, 2005, EARLY HUM DEV, V81, P535, DOI 10.1016/j.earlhumdev.2004.11.006; Williams KP, 2002, OBSTET GYNECOL, V100, P557, DOI 10.1016/S0029-7844(02)02090-2; WINKLER CL, 1991, AM J OBSTET GYNECOL, V164, P637, DOI 10.1016/S0002-9378(11)80038-4; WU L, 1998, CHAN KO TSA CHIH, V33, P462; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; YUDKIN PL, 1994, BRIT J OBSTET GYNAEC, V101, P774, DOI 10.1111/j.1471-0528.1994.tb11945.x; ZAMORA J, 2003, BMC MED RES METHODOL, V12, P31	103	265	274	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2010	340								c1471	10.1136/bmj.c1471	http://dx.doi.org/10.1136/bmj.c1471			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HR	20466789	hybrid, Green Published			2022-12-28	WOS:000277826500001
J	Shanklin, J				Shanklin, Jonathan			Reflections on the ozone hole	NATURE			English	Editorial Material									British Antarctic Survey, Meteorol & Ozone Monitoring Unit, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Shanklin, J (corresponding author), British Antarctic Survey, Meteorol & Ozone Monitoring Unit, Cambridge CB3 0ET, England.	j.shanklin@bas.ac.uk			NERC [bas010011, bas0100023] Funding Source: UKRI; Natural Environment Research Council [bas010011, bas0100023] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; STOLARSKI RS, 1986, NATURE, V322, P808, DOI 10.1038/322808a0; Velders GJM, 2007, P NATL ACAD SCI USA, V104, P4814, DOI 10.1073/pnas.0610328104; *WORLD MET ORG, 2007, SCI ASS OZ DEPL 2006	4	19	19	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					34	35		10.1038/465034a	http://dx.doi.org/10.1038/465034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	591OW	20445611				2022-12-28	WOS:000277311900018
J	Chapman, S; Freeman, B				Chapman, Simon; Freeman, Becky			Personal View The cancer emperor's new clothes: Australia's historic legislation for plain tobacco packaging	BRITISH MEDICAL JOURNAL			English	Editorial Material							BRAND IMAGE; PERCEPTIONS		[Chapman, Simon; Freeman, Becky] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009					BARBER K, MORGAN CONSUMER REV; BERKOVIC N, 2010, AUSTRALIAN      0430; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; EINDHOVEN G, 1999, WORLD TOBACCO, V170, P16; Freeman B, 2008, ADDICTION, V103, P580, DOI 10.1111/j.1360-0443.2008.02145.x; Germain D, 2010, J ADOLESCENT HEALTH, V46, P385, DOI 10.1016/j.jadohealth.2009.08.009; *TOB WORK GROUP PR, TOB CONTR AUSTR MAK; Wakefield MA, 2008, TOB CONTROL, V17, P416, DOI 10.1136/tc.2008.026732; P MORRIS DOCUMENT CO; BRIT AM TOBACCO DOCU	10	10	10	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c2436	10.1136/bmj.c2436	http://dx.doi.org/10.1136/bmj.c2436			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594XC	20444830				2022-12-28	WOS:000277572500014
J	Davies, E				Davies, Edward			Should undergraduate medical students be regulated? No	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ Careers, London WC1H 9JR, England		Davies, E (corresponding author), BMJ Careers, London WC1H 9JR, England.	edavies@bmj.com						*DEP HLTH, 2006, IN REG IMP ASS GOOD; *DEP HLTH, 2006, GOOD DOCT SAF PAT; *GMC, MED STUD PROF VAL FI; *GMC ED COMM, 2007, MED STUD ENG REG; SMITH J, 2005, SHIPMAN INQUIRY 5 RE	5	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c1806	10.1136/bmj.c1806	http://dx.doi.org/10.1136/bmj.c1806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594XC	20444833				2022-12-28	WOS:000277572500002
J	Rule, AD; Amer, H; Cornell, LD; Taler, SJ; Cosio, FG; Kremers, WK; Textor, SC; Stegall, MD				Rule, Andrew D.; Amer, Hatem; Cornell, Lynn D.; Taler, Sandra J.; Cosio, Fernando G.; Kremers, Walter K.; Textor, Stephen C.; Stegall, Mark D.			The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; ESTIMATED GFR; CLASSIFICATION; SENESCENCE; DAMAGE	Background: Chronic kidney disease is common with older age and is characterized on renal biopsy by global glomerulosclerosis, tubular atrophy, interstitial fibrosis, and arteriosclerosis. Objective: To see whether the prevalence of these histologic abnormalities in the kidney increases with age in healthy adults and whether histologic findings are explained by age-related differences in kidney function or chronic kidney disease risk factors. Design: Cross-sectional study. Setting: Mayo Clinic, Rochester, Minnesota, from 1999 to 2009. Patients: 1203 adult living kidney donors. Measurements: Core-needle biopsy of the renal cortex obtained during surgical implantation of the kidney, and medical record data of kidney function and risk factors obtained before donation. Results: The prevalence of nephrosclerosis (>= 2 chronic histologic abnormalities) was 2.7% (95% CI, 1.1% to 6.7%) for patients aged 18 to 29 years, 16% (CI, 12% to 20%) for patients aged 30 to 39 years, 28% (CI, 24% to 32%) for patients aged 40 to 49 years, 44% (CI, 38% to 50%) for patients aged 50 to 59 years, 58% (CI, 47% to 67%) for patients aged 60 to 69 years, and 73% (CI, 43% to 90%) for patients aged 70 to 77 years. Adjustment for kidney function and risk factor covariates did not explain the age-related increase in the prevalence of nephrosclerosis. Limitation: Kidney donors are selected for health and lack the spectrum or severity of renal pathologic findings in the general population. Conclusion: Kidney function and chronic kidney disease risk factors do not explain the strong association between age and nephrosclerosis in healthy adults.	[Rule, Andrew D.; Amer, Hatem; Cornell, Lynn D.; Taler, Sandra J.; Cosio, Fernando G.; Kremers, Walter K.; Textor, Stephen C.; Stegall, Mark D.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Rule, AD (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.		Amer, Hatem/AAN-2676-2020; Stegall, Mark/AAX-6496-2020	Amer, Hatem/0000-0002-9570-0506; Stegall, Mark/0000-0002-1392-0792	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [K23 DK078229]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK078229] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (grant K23 DK078229).	ALPERS CE, 2009, ROBINS COTRAN PATHOL; Bang H, 2007, ARCH INTERN MED, V167, P374, DOI 10.1001/archinte.167.4.374; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Choudhury D, 2007, BRENNER RECTORS KIDN, P681; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2007, J AM SOC NEPHROL, V18, P2803, DOI 10.1681/ASN.2007080964; DARMADY EM, 1973, J PATHOL, V109, P195, DOI 10.1002/path.1711090304; Daugirdas JT, 2009, CLIN J AM SOC NEPHRO, V4, P1575, DOI 10.2215/CJN.05581008; de Jong PE, 2006, J AM SOC NEPHROL, V17, P2120, DOI 10.1681/ASN.2006010097; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2009, KIDNEY INT, V75, P1015, DOI 10.1038/ki.2009.53; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Howie AJ, 2001, NEPHROL DIAL TRANSPL, V16, P1163, DOI 10.1093/ndt/16.6.1163; KAPLAN C, 1975, AM J PATHOL, V80, P227; KASISKE BL, 1987, KIDNEY INT, V31, P1153, DOI 10.1038/ki.1987.122; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Poggio ED, 2009, NEPHROL DIAL TRANSPL, V24, P698, DOI 10.1093/ndt/gfn704; Poggio ED, 2009, KIDNEY INT, V75, P1079, DOI 10.1038/ki.2009.11; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Silva Fred G., 2005, International Urology and Nephrology, V37, P419, DOI 10.1007/s11255-004-0874-5; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Stevens LA, 2008, AM J KIDNEY DIS, V51, P353, DOI 10.1053/j.ajkd.2008.01.009; TAKAZAKURA E, 1972, KIDNEY INT, V2, P224, DOI 10.1038/ki.1972.98; Takebayashi S, 2001, CLIN NEPHROL, V55, P349; TAUCHI H, 1971, GERONTOLOGY, V17, P87, DOI 10.1159/000211811; Thomas SE, 1998, J AM SOC NEPHROL, V9, P231; TRACY RE, 1992, VIRCHOWS ARCH A, V420, P479, DOI 10.1007/BF01600252; Tracy RE, 2000, NEPHROL DIAL TRANSPL, V15, P1357, DOI 10.1093/ndt/15.9.1357; WALD HERBERT, 1937, ARCH PATH, V23, P493; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49	37	297	314	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					561	+		10.7326/0003-4819-152-9-201005040-00006	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439574	Green Accepted			2022-12-28	WOS:000277604000003
J	Cabrera, M; Ungermann, C				Cabrera, Margarita; Ungermann, Christian			Guiding Endosomal Maturation	CELL			English	Editorial Material							APOPTOTIC CELLS; COMPLEX; MECHANISM; FUSION		[Cabrera, Margarita; Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, D-49076 Osnabruck, Germany	University Osnabruck	Ungermann, C (corresponding author), Univ Osnabruck, Dept Biol Chem, Barbarastr 13, D-49076 Osnabruck, Germany.	cu@uos.de	Cabrera, Margarita/Y-1225-2019; Cabrera, Margarita/F-3306-2016	Cabrera, Margarita/0000-0002-2978-8255; Cabrera, Margarita/0000-0002-2978-8255				Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551	9	18	21	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					404	406		10.1016/j.cell.2010.04.013	http://dx.doi.org/10.1016/j.cell.2010.04.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434982	Bronze			2022-12-28	WOS:000277180800012
J	Drain, PK; Barry, M				Drain, Paul K.; Barry, Michele			GLOBAL HEALTH Fifty Years of US Embargo: Cuba's Health Outcomes and Lessons	SCIENCE			English	Editorial Material							ECONOMIC-CRISIS; PRIMARY-CARE; MEDICINE; POLITICS; EPIDEMIC; SYSTEM; IMPACT		[Drain, Paul K.; Barry, Michele] Stanford Univ, Sch Med, Palo Alto, CA 94305 USA	Stanford University	Drain, PK (corresponding author), Stanford Univ, Sch Med, Palo Alto, CA 94305 USA.	pkdrain@stanford.edu		Drain, Paul/0000-0003-3300-3817	NIAID NIH HHS [K23 AI108293] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108293] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AM PUBL HLTH ASS, 1993, POL SUFF IMP US EMB; [Anonymous], WORLD POP PROSP 2008; BERN C, 1995, NEW ENGL J MED, V333, P1176; BOURNE PG, 1997, DENIAL FOOD MED IMPA; *C N N, 2009, C N N POLL 3 QUART F; CARDELLE AJF, 1994, INT J HEALTH SERV, V24, P421, DOI 10.2190/2YG8-0P0C-CCYJ-330N; De Vos P, 2005, INT J HEALTH SERV, V35, P189, DOI 10.2190/M72R-DBKD-2XWV-HJWB; DEMERS RY, 1993, FAM PRACT, V10, P164, DOI 10.1093/fampra/10.2.164; Dresang LT, 2005, J AM BOARD FAM PRACT, V18, P297, DOI 10.3122/jabfm.18.4.297; Garfield R, 1997, AM J PUBLIC HEALTH, V87, P15, DOI 10.2105/AJPH.87.1.15; Kirkpatrick AF, 1996, LANCET, V348, P1489, DOI 10.1016/S0140-6736(96)07376-X; KUNTZ D, 1994, INT J HEALTH SERV, V24, P161, DOI 10.2190/L6VN-57RR-AFLK-XW90; LUGAR R, 2009, CHANGING CUBA POLICY; Marquez M, 2009, LANCET, V374, P1574, DOI 10.1016/S0140-6736(09)61919-X; Marrero A, 2000, THORAX, V55, P39, DOI 10.1136/thorax.55.1.39; *MIN PUBL HLTH, 1993, INF ANN 1992; Mullan F, 2004, NEW ENGL J MED, V351, P2680, DOI 10.1056/NEJMp048270; Nayeri K, 2005, INT J HEALTH SERV, V35, P797, DOI 10.2190/C1QG-6Y0X-CJJA-863H; Ochoa FR, 1997, INT J HEALTH SERV, V27, P791, DOI 10.2190/HBXE-6KWM-0H9V-1DCF; *OFF PRESS SECR WH, FACT SHEET REACH OUT; Pastrana SJ, 2008, SCIENCE, V322, P345, DOI 10.1126/science.1162561; [Anonymous], 2008, Bull World Health Organ, V86, P327; Rojas Ochoa F, 2003, REV CUB MED GEN INTE, V19, P56; ROMAN GC, 1995, ANN INTERN MED, V122, P530, DOI 10.7326/0003-4819-122-7-199504010-00009; ROMAN GC, 1994, NEUROLOGY, V44, P1784, DOI 10.1212/WNL.44.10.1784; UBELL RN, 1983, NEW ENGL J MED, V309, P1468, DOI 10.1056/NEJM198312083092334; *UN, 2007, GA10649 UN; *US DEP STAT, US CUB REL; VEEKEN H, 1995, BRIT MED J, V311, P935; WALTE J, 1995, USA TODAY       0307; WEISSERT W, 2008, ASS PRESS       0122; World Health Organization (WHO), 2006, STAT INF SYST	32	22	25	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					572	573		10.1126/science.1189680	http://dx.doi.org/10.1126/science.1189680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589OJ	20430999	Green Accepted			2022-12-28	WOS:000277159800024
J	Hellsten, U; Harland, RM; Gilchrist, MJ; Hendrix, D; Jurka, J; Kapitonov, V; Ovcharenko, I; Putnam, NH; Shu, SQ; Taher, L; Blitz, IL; Blumberg, B; Dichmann, DS; Dubchak, I; Amaya, E; Detter, JC; Fletcher, R; Gerhard, DS; Goodstein, D; Graves, T; Grigoriev, IV; Grimwood, J; Kawashima, T; Lindquist, E; Lucas, SM; Mead, PE; Mitros, T; Ogino, H; Ohta, Y; Poliakov, AV; Pollet, N; Robert, J; Salamov, A; Sater, AK; Schmutz, J; Terry, A; Vize, PD; Warren, WC; Wells, D; Wills, A; Wilson, RK; Zimmerman, LB; Zorn, AM; Grainger, R; Grammer, T; Khokha, MK; Richardson, PM; Rokhsar, DS				Hellsten, Uffe; Harland, Richard M.; Gilchrist, Michael J.; Hendrix, David; Jurka, Jerzy; Kapitonov, Vladimir; Ovcharenko, Ivan; Putnam, Nicholas H.; Shu, Shengqiang; Taher, Leila; Blitz, Ira L.; Blumberg, Bruce; Dichmann, Darwin S.; Dubchak, Inna; Amaya, Enrique; Detter, John C.; Fletcher, Russell; Gerhard, Daniela S.; Goodstein, David; Graves, Tina; Grigoriev, Igor V.; Grimwood, Jane; Kawashima, Takeshi; Lindquist, Erika; Lucas, Susan M.; Mead, Paul E.; Mitros, Therese; Ogino, Hajime; Ohta, Yuko; Poliakov, Alexander V.; Pollet, Nicolas; Robert, Jacques; Salamov, Asaf; Sater, Amy K.; Schmutz, Jeremy; Terry, Astrid; Vize, Peter D.; Warren, Wesley C.; Wells, Dan; Wills, Andrea; Wilson, Richard K.; Zimmerman, Lyle B.; Zorn, Aaron M.; Grainger, Robert; Grammer, Timothy; Khokha, Mustafa K.; Richardson, Paul M.; Rokhsar, Daniel S.			The Genome of the Western Clawed Frog Xenopus tropicalis	SCIENCE			English	Article							MOLECULAR PALEONTOLOGY; TRANSPOSABLE ELEMENTS; IMMUNE-SYSTEM; GENE; IGD	The western clawed frog Xenopus tropicalis is an important model for vertebrate development that combines experimental advantages of the African clawed frog Xenopus laevis with more tractable genetics. Here we present a draft genome sequence assembly of X. tropicalis. This genome encodes more than 20,000 protein-coding genes, including orthologs of at least 1700 human disease genes. Over 1 million expressed sequence tags validated the annotation. More than one-third of the genome consists of transposable elements, with unusually prevalent DNA transposons. Like that of other tetrapods, the genome of X. tropicalis contains gene deserts enriched for conserved noncoding elements. The genome exhibits substantial shared synteny with human and chicken over major parts of large chromosomes, broken by lineage-specific chromosome fusions and fissions, mainly in the mammalian lineage.	[Hellsten, Uffe; Shu, Shengqiang; Dubchak, Inna; Goodstein, David; Grigoriev, Igor V.; Grimwood, Jane; Lindquist, Erika; Lucas, Susan M.; Poliakov, Alexander V.; Salamov, Asaf; Schmutz, Jeremy; Terry, Astrid; Richardson, Paul M.; Rokhsar, Daniel S.] Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Harland, Richard M.; Hendrix, David; Dichmann, Darwin S.; Fletcher, Russell; Kawashima, Takeshi; Mitros, Therese; Wills, Andrea; Grammer, Timothy; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Gilchrist, Michael J.] MRC Natl Inst Med Res, Div Syst Biol, London NW7 1AA, England; [Jurka, Jerzy; Kapitonov, Vladimir] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Ovcharenko, Ivan; Taher, Leila] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Blitz, Ira L.; Blumberg, Bruce] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Amaya, Enrique] Univ Manchester, Healing Fdn Ctr, Manchester M13 9PT, Lancs, England; [Detter, John C.] Los Alamos Natl Lab, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [Gerhard, Daniela S.] NCI, Off Canc Genom, NIH, Dhhs Bethesda, MD 20892 USA; [Graves, Tina; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Joint Genome Inst, Huntsville, AL 35806 USA; [Kawashima, Takeshi] Okinawa Inst Sci & Technol, Okinawa 9042234, Japan; [Mead, Paul E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Ogino, Hajime] Nara Inst Sci & Technol, Nara, Japan; [Ohta, Yuko] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Pollet, Nicolas] Univ Evry Val Essonne, CNRS, Programme Epigenom, F-91058 Evry, France; [Robert, Jacques] Univ Rochester, Dept Microbiol & Immunol, Med Ctr, Rochester, NY 14642 USA; [Sater, Amy K.; Wells, Dan] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Vize, Peter D.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Zorn, Aaron M.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Grainger, Robert] Dept Biol, Charlottesville, VA 22904 USA; [Khokha, Mustafa K.] Yale Univ, Sch Med, Dept Pediat & Genet, New Haven, CT 06520 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Rice University; University of California System; University of California Irvine; University of Manchester; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Washington University (WUSTL); HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint Genome Institute - JGI; Okinawa Institute of Science & Technology Graduate University; St Jude Children's Research Hospital; Nara Institute of Science & Technology; University System of Maryland; University of Maryland Baltimore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Rochester; University of Houston System; University of Houston; University of Calgary; Cincinnati Children's Hospital Medical Center; Yale University	Hellsten, U (corresponding author), Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.	uhellsten@lbl.gov	Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Pollet, Nicolas/A-4746-2013; Ogino, Hajime/G-5279-2019; Kawashima, Takeshi/M-4510-2015; Putnam, Nicholas/B-9968-2008; Dichmann, Darwin/C-7239-2012; Terry, Astrid Y/A-2538-2011; /AAD-2181-2020; Wilson, Richard K./AAF-4139-2019; Robert, Jacques/B-2179-2008	Schmutz, Jeremy/0000-0001-8062-9172; Pollet, Nicolas/0000-0002-9975-9644; Ogino, Hajime/0000-0003-2707-2330; Putnam, Nicholas/0000-0002-1315-782X; Terry, Astrid Y/0000-0002-5234-1224; Wilson, Richard K./0000-0002-1992-1358; Robert, Jacques/0000-0003-4380-1476; Rokhsar, Daniel/0000-0002-8704-2224; Shu, Shengqiang/0000-0002-4336-8994; Goodstein, David/0000-0001-6287-2697; Grigoriev, Igor/0000-0002-3136-8903; Amaya, Enrique/0000-0002-1805-8548; Taher, Leila/0000-0002-2013-5426	U.S. Department of Energy's Office of Science; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; NIH, National Library of Medicine; National Human Genome Research Institute (NHGRI) [U01 HG02155]; National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064556] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045776, R01HD046661, R01HD042294, R21HD065713] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018000] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027877, R24AI059830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086321, R01GM060572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079381] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER; MRC [MC_U117560482] Funding Source: UKRI; Medical Research Council [MC_U117560482] Funding Source: researchfish	U.S. Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NIH, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was performed under the auspices of the U.S. Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory, under contract DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344, and Los Alamos National Laboratory under contract DE-AC02-06NA25396. This research was supported in part by the Intramural Research Program of the NIH, National Library of Medicine, and by a grant to R. K. W. from the National Human Genome Research Institute (NHGRI U01 HG02155) with supplemental funds provided by the National Institute of Child Health and Human Development. We thank R. Gibbs and S. Scherer of the Human Genome Sequencing Center, Baylor College of Medicine, for their contributions to identification and mapping of simple sequence length polymorphisms.	Abu-Daya A, 2009, DEV BIOL, V336, P20, DOI 10.1016/j.ydbio.2009.09.019; Brown DD, 2004, J BIOL CHEM, V279, P45291, DOI 10.1074/jbc.X400008200; CRAIG NL, 2002, MOBILE DNA, V2; DUPASQUIER L, 1989, ANNU REV IMMUNOL, V7, P251, DOI 10.1146/annurev.immunol.7.1.251; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hogben L, 1930, J EXP BIOL, V7, P286; Kapitonov VV, 1999, GENETICA, V107, P27, DOI 10.1023/A:1004030922447; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kapitonov VV, 2003, P NATL ACAD SCI USA, V100, P6569, DOI 10.1073/pnas.0732024100; Kofron M, 1999, DEVELOPMENT, V126, P5759; Kreil G., 1996, BIOL XENOPUS, P263; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; TYMOWSKA J, 1973, CYTOGENET CELL GENET, V12, P297, DOI 10.1159/000130468; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103	23	534	660	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					633	636		10.1126/science.1183670	http://dx.doi.org/10.1126/science.1183670			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431018	Green Submitted, Green Accepted			2022-12-28	WOS:000277159800047
J	Duewell, P; Kono, H; Rayner, KJ; Sirois, CM; Vladimer, G; Bauernfeind, FG; Abela, GS; Franchi, L; Nunez, G; Schnurr, M; Espevik, T; Lien, E; Fitzgerald, KA; Rock, KL; Moore, KJ; Wright, SD; Hornung, V; Latz, E				Duewell, Peter; Kono, Hajime; Rayner, Katey J.; Sirois, Cherilyn M.; Vladimer, Gregory; Bauernfeind, Franz G.; Abela, George S.; Franchi, Luigi; Nunez, Gabriel; Schnurr, Max; Espevik, Terje; Lien, Egil; Fitzgerald, Katherine A.; Rock, Kenneth L.; Moore, Kathryn J.; Wright, Samuel D.; Hornung, Veit; Latz, Eicke			NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals	NATURE			English	Article							LOW-DENSITY-LIPOPROTEIN; NALP3 INFLAMMASOME; ATHEROSCLEROTIC LESIONS; MASSIVE XANTHOMATOSIS; HYPERLIPIDEMIC MICE; APOLIPOPROTEIN-E; ACAT INHIBITION; PROGRESSION; CELLS; HYPERCHOLESTEROLEMIA	The inflammatory nature of atherosclerosis is well established but the agent(s) that incite inflammation in the artery wall remain largely unknown. Germ-free animals are susceptible to atherosclerosis, suggesting that endogenous substances initiate the inflammation(1). Mature atherosclerotic lesions contain macroscopic deposits of cholesterol crystals in the necrotic core, but their appearance late in atherogenesis had been thought to disqualify them as primary inflammatory stimuli. However, using a new microscopic technique, we revealed that minute cholesterol crystals are present in early diet-induced atherosclerotic lesions and that their appearance in mice coincides with the first appearance of inflammatory cells. Other crystalline substances can induce inflammation by stimulating the caspase-1-activating NLRP3 (NALP3 or cryopyrin) inflammasome(2,3), which results in cleavage and secretion of interleukin (IL)-1 family cytokines. Here we show that cholesterol crystals activate the NLRP3 inflammasome in phagocytes in vitro in a process that involves phagolysosomal damage. Similarly, when injected intraperitoneally, cholesterol crystals induce acute inflammation, which is impaired in mice deficient in components of the NLRP3 inflammasome, cathepsin B, cathepsin L or IL-1 molecules. Moreover, when mice deficient in low-density lipoprotein receptor (LDLR) were bone-marrow transplanted with NLRP3-deficient, ASC (also known as PYCARD)-deficient or IL-1 alpha/beta-deficient bone marrow and fed on a high-cholesterol diet, they had markedly decreased early atherosclerosis and inflammasome-dependent IL-18 levels. Minimally modified LDL can lead to cholesterol crystallization concomitant with NLRP3 inflammasome priming and activation in macrophages. Although there is the possibility that oxidized LDL activates the NLRP3 inflammasome in vivo, our results demonstrate that crystalline cholesterol acts as an endogenous danger signal and its deposition in arteries or elsewhere is an early cause rather than a late consequence of inflammation. These findings provide new insights into the pathogenesis of atherosclerosis and indicate new potential molecular targets for the therapy of this disease.	[Duewell, Peter; Sirois, Cherilyn M.; Vladimer, Gregory; Lien, Egil; Fitzgerald, Katherine A.; Latz, Eicke] Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA; [Kono, Hajime; Rock, Kenneth L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Duewell, Peter; Schnurr, Max] Univ Munich, Div Gastroenterol, Dept Med, D-80336 Munich, Germany; [Rayner, Katey J.; Moore, Kathryn J.] NYU, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rayner, Katey J.; Moore, Kathryn J.; Hornung, Veit] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lipid Metab Unit, Boston, MA 02114 USA; [Bauernfeind, Franz G.] Univ Bonn, Inst Clin Chem & Pharmacol, D-53127 Bonn, Germany; [Latz, Eicke] Univ Bonn, Univ Hosp, Inst Innate Immunol, D-53127 Bonn, Germany; [Abela, George S.] Michigan State Univ, Dept Med, Div Cardiol, E Lansing, MI 48824 USA; [Franchi, Luigi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Espevik, Terje; Latz, Eicke] Norwegian Univ Sci & Technol, Inst Canc Res & Mol Med, N-7491 Trondheim, Norway; [Wright, Samuel D.] CSL Ltd, Cardiovasc Therapeut, Parkville, Vic 3052, Australia	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Munich; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Bonn; University of Bonn; Michigan State University; University of Michigan System; University of Michigan; Norwegian University of Science & Technology (NTNU); CSL	Latz, E (corresponding author), Univ Massachusetts, Sch Med, Dept Immunol & Infect Dis, Worcester, MA 01605 USA.	eicke.latz@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Duewell, Peter/C-4576-2014; Bauernfeind, Franz-Georg/ABF-1148-2020; Latz, Eicke/H-3951-2014; Rayner, Katey/K-8914-2012; Hornung, Veit/C-3565-2012; Nuñez, Gabriel/A-7160-2014; Moore, Kathryn/ABE-6416-2020; Vladimer, Gregory/X-4547-2018	Latz, Eicke/0000-0003-1488-5666; Hornung, Veit/0000-0002-4150-194X; Moore, Kathryn/0000-0003-2505-2547; Kono, Hajime/0000-0002-4578-8677; Duewell, Peter/0000-0003-0836-6448; Rayner, Katey/0000-0001-6230-426X; Sirois, Cherilyn M./0000-0002-5472-4288; Vladimer, Gregory/0000-0003-4205-7585; Fitzgerald, Kate/0000-0003-3175-609X	National Institutes of Health; Deutsche Forschungsgemeinschaft [GK 1202]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, R01AI075318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (to E. L. and K. L. R.) and from the Deutsche Forschungsgemeinschaft (GK 1202, to M. S. and P. D.).	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meuwese MC, 2009, JAMA-J AM MED ASSOC, V301, P1131, DOI 10.1001/jama.301.11.1131; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141; Nissen SE, 2006, NEW ENGL J MED, V354, P1253, DOI 10.1056/NEJMoa054699; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; SMALL DM, 1988, ARTERIOSCLEROSIS, V8, P103, DOI 10.1161/01.ATV.8.2.103; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Wright SD, 2000, J EXP MED, V191, P1437, DOI 10.1084/jem.191.8.1437; Yuan XM, 1997, ATHEROSCLEROSIS, V133, P153, DOI 10.1016/S0021-9150(97)00094-4; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	28	2460	2592	18	403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1357	U7		10.1038/nature08938	http://dx.doi.org/10.1038/nature08938			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428172	Green Accepted			2022-12-28	WOS:000277149000048
J	Mackie, S				Mackie, Susan			BECOMING A PHYSICIAN The Value of DNKs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Mackie, S (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1561	1561		10.1056/NEJMp1001459	http://dx.doi.org/10.1056/NEJMp1001459			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20427807				2022-12-28	WOS:000277117400004
J	Song, YJ; Skinner, J; Bynum, J; Sutherland, J; Wennberg, JE; Fisher, ES				Song, Yunjie; Skinner, Jonathan; Bynum, Julie; Sutherland, Jason; Wennberg, John E.; Fisher, Elliott S.			Regional Variations in Diagnostic Practices	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURVIVAL; PREVALENCE; MORTALITY; LESIONS; RISK	BACKGROUND Current methods of risk adjustment rely on diagnoses recorded in clinical and administrative records. Differences among providers in diagnostic practices could lead to bias. METHODS We used Medicare claims data from 1999 through 2006 to measure trends in diagnostic practices for Medicare beneficiaries. Regions were grouped into five quintiles according to the intensity of hospital and physician services that beneficiaries in the region received. We compared trends with respect to diagnoses, laboratory testing, imaging, and the assignment of Hierarchical Condition Categories (HCCs) among beneficiaries who moved to regions with a higher or lower intensity of practice. RESULTS Beneficiaries within each quintile who moved during the study period to regions with a higher or lower intensity of practice had similar numbers of diagnoses and similar HCC risk scores (as derived from HCC coding algorithms) before their move. The number of diagnoses and the HCC measures increased as the cohort aged, but they increased to a greater extent among beneficiaries who moved to regions with a higher intensity of practice than among those who moved to regions with the same or lower intensity of practice. For example, among beneficiaries who lived initially in regions in the lowest quintile, there was a greater increase in the average number of diagnoses among those who moved to regions in a higher quintile than among those who moved to regions within the lowest quintile (increase of 100.8%; 95% confidence interval [CI], 89.6 to 112.1; vs. increase of 61.7%; 95% CI, 55.8 to 67.4). Moving to each higher quintile of intensity was associated with an additional 5.9% increase (95% CI, 5.2 to 6.7) in HCC scores, and results were similar with respect to laboratory testing and imaging. CONCLUSIONS Substantial differences in diagnostic practices that are unlikely to be related to patient characteristics are observed across U.S. regions. The use of clinical or claims-based diagnoses in risk adjustment may introduce important biases in comparative-effectiveness studies, public reporting, and payment reforms.	[Song, Yunjie; Skinner, Jonathan; Bynum, Julie; Sutherland, Jason; Wennberg, John E.; Fisher, Elliott S.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03756 USA; [Bynum, Julie] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Bynum, Julie] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA; [Skinner, Jonathan] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Skinner, Jonathan] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Fisher, Elliott S.] Vet Affairs Outcomes Grp, White River Jct, VT USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; National Bureau of Economic Research	Fisher, ES (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Suite 205, Lebanon, NH 03766 USA.	elliott.fisher@dartmouth.edu			NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG019783, P01 AG019783-10] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; *CTR MED MED SERV, 2009, SKILL NURS FAC PROSP; *CTR MED MED SERV, 2006, 2006 RISK ADJ DAT BA; ELMORE JG, 1994, NEW ENGL J MED, V331, P1493, DOI 10.1056/NEJM199412013312206; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fisher ES, 2006, NEW ENGL J MED, V355, P1845, DOI 10.1056/NEJMp068221; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; *MED PAYM ADV COMM, 2008, MED PAYM BAS HOSP AC; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; SCHNITT SJ, 1992, AM J SURG PATHOL, V16, P1133, DOI 10.1097/00000478-199212000-00001; Silverman E, 2004, J HEALTH ECON, V23, P369, DOI 10.1016/j.jhealeco.2003.09.007; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Skinner JS, 2006, HEALTH AFFAIR, V25, pW34, DOI 10.1377/hlthaff.25.w34; Stafford RS, 2001, ARCH INTERN MED, V161, P2351, DOI 10.1001/archinte.161.19.2351; URBAN BA, 1993, AM J ROENTGENOL, V160, P783, DOI 10.2214/ajr.160.4.8456665; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Wennberg JE, 2008, TRACKING CARE PATIEN	27	313	313	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					45	53		10.1056/NEJMsa0910881	http://dx.doi.org/10.1056/NEJMsa0910881			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618HR	20463332	Green Accepted			2022-12-28	WOS:000279343000007
J	Zuckerman, S; Waidmann, T; Berenson, R; Hadley, J				Zuckerman, Stephen; Waidmann, Timothy; Berenson, Robert; Hadley, Jack			Clarifying Sources of Geographic Differences in Medicare Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGIONAL-VARIATIONS; CARE	BACKGROUND Although geographic differences in Medicare spending are widely considered to be evidence of program inefficiency, policymakers need to understand how differences in beneficiaries' health and personal characteristics and specific geographic factors affect the amount of Medicare spending per beneficiary before formulating policies to reduce geographic differences in spending. METHODS We used Medicare Current Beneficiary Surveys from 2000 through 2002 to examine differences across geographic areas (grouped into quintiles on the basis of Medicare spending per beneficiary over the same period). We estimated multivariate-regression models of individual spending that included demographic and baseline health characteristics, changes in health status, other individual determinants of demand, and area-level measures of the supply of health care resources. Each group of variables was entered into the model sequentially to assess the effect on geographic differences in spending. RESULTS Unadjusted Medicare spending per beneficiary was 52% higher in geographic regions in the highest spending quintile than in regions in the lowest quintile. After adjustment for demographic and baseline health characteristics and changes in health status, the difference in spending between the highest and lowest quintiles was reduced to 33%. Health status accounted for 29% of the unadjusted geographic difference in per-beneficiary spending; additional adjustment for area-level differences in the supply of medical resources did not further reduce the observed differences between the top and bottom quintiles. CONCLUSIONS Policymakers attempting to control Medicare costs by reducing differences in Medicare spending across geographic areas need better information about the specific source of the differences, as well as better methods for adjusting spending levels to account for underlying differences in beneficiaries' health measures.	[Zuckerman, Stephen; Waidmann, Timothy; Berenson, Robert] Urban Inst, Washington, DC 20037 USA; [Hadley, Jack] George Mason Univ, Dept Hlth Adm & Policy, Coll Hlth & Human Serv, Fairfax, VA 22030 USA	Urban Institute; George Mason University	Zuckerman, S (corresponding author), Urban Inst, 2100 M St NW, Washington, DC 20037 USA.	szuckerman@urban.org	Waidmann, Timothy/X-8811-2019	Waidmann, Timothy/0000-0001-7221-5068	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Supported by a grant from the Robert Wood Johnson Foundation Program on Health Care Financing and Organization to George Mason University.	Adler GS, 1998, P SURV RES METH SECT, P153; Baicker K, 2009, HEALTH AFFAIR, V28, P1448, DOI 10.1377/hlthaff.28.5.1448; Centers for Medicare & Medicaid Services, 2009, PROV SERV FIL; CHANDRA A, 2009, HLTH AFFAIRS BL 0617; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; *HLTH RES SERV ADM, 2002, AR RES FIL; McKethan A., 2009, HLTH AFFAIRS BL 0820; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96; ZUCKERMAN S, 2009, VARIATION MEDICARE S	14	141	141	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					54	62		10.1056/NEJMsa0909253	http://dx.doi.org/10.1056/NEJMsa0909253			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20463333	Bronze			2022-12-28	WOS:000279343000008
J	Cifuentes, D; Xue, HL; Taylor, DW; Patnode, H; Mishima, Y; Cheloufi, S; Ma, EB; Mane, S; Hannon, GJ; Lawson, ND; Wolfe, SA; Giraldez, AJ				Cifuentes, Daniel; Xue, Huiling; Taylor, David W.; Patnode, Heather; Mishima, Yuichiro; Cheloufi, Sihem; Ma, Enbo; Mane, Shrikant; Hannon, Gregory J.; Lawson, Nathan D.; Wolfe, Scot A.; Giraldez, Antonio J.			A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity	SCIENCE			English	Article							ZINC-FINGER NUCLEASES; PASSENGER-STRAND; RNA CLEAVAGE; ZEBRAFISH; SIRNAS; DROSOPHILA; SHRNAS; SLICER	Dicer is a central enzyme in microRNA (miRNA) processing. We identified a Dicer-independent miRNA biogenesis pathway that uses Argonaute2 (Ago2) slicer catalytic activity. In contrast to other miRNAs, miR-451 levels were refractory to dicer loss of function but were reduced in MZago2 (maternal-zygotic) mutants. We found that pre-miR-451 processing requires Ago2 catalytic activity in vivo. MZago2 mutants showed delayed erythropoiesis that could be rescued by wild-type Ago2 or miR-451-duplex but not by catalytically dead Ago2. Changing the secondary structure of Dicer-dependent miRNAs to mimic that of pre-miR-451 restored miRNA function and rescued developmental defects in MZdicer mutants, indicating that the pre-miRNA secondary structure determines the processing pathway in vivo. We propose that Ago2-mediated cleavage of pre-miRNAs, followed by uridylation and trimming, generates functional miRNAs independently of Dicer.	[Cifuentes, Daniel; Xue, Huiling; Patnode, Heather; Mishima, Yuichiro; Giraldez, Antonio J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Taylor, David W.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Mishima, Yuichiro] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Cheloufi, Sihem; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Cheloufi, Sihem] SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; [Ma, Enbo] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Mane, Shrikant] Yale Ctr Genome Anal, Orange, CT 06477 USA; [Lawson, Nathan D.; Wolfe, Scot A.] Univ Massachusetts, Program Gene Funct & Express, Sch Med, Worcester, MA 01605 USA; [Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Giraldez, Antonio J.] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT 06520 USA	Yale University; Yale University; Kobe University; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Giraldez, AJ (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	antonio.giraldez@yale.edu	Hannon, Gregory/AAB-3568-2019; Mishima, Yuichiro/I-3881-2019	Mishima, Yuichiro/0000-0002-1075-9454; Taylor, David/0000-0002-6198-1194; Lawson, Nathan/0000-0001-7788-9619; Cifuentes Buira, Daniel/0000-0001-5442-4843; Giraldez, Antonio/0000-0002-6823-137X	Fundacion Ramon Areces; Human Frontier Science Program fellowship; NIH [R01GM081602-03/03S1, R01HL093766]; Yale Scholar program; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081602, R01GM101108] Funding Source: NIH RePORTER	Fundacion Ramon Areces; Human Frontier Science Program fellowship(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Scholar program; Pew Scholars Program in the Biomedical Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Doudna, D. O'Carroll, L. Zon, S. Lacadie, G. Lieschke, D. Krausse, and S. Halene for reagents and protocols; A. Enright, C. Abreu-Goodger, and J. Brennecke for initial small RNA analysis; and B. Schachter, C. Takacs, V. Greco, and D. Cazalla for discussions and manuscript editing. Supported by Fundacion Ramon Areces (D. C.), a Human Frontier Science Program fellowship (H. X.), NIH grants R01GM081602-03/03S1 (A. J. G.) and R01HL093766 (N.D.L. and S. A. W.), the Yale Scholar program, and the Pew Scholars Program in the Biomedical Sciences (A.J.G.). Contributions: D. C. and A.J.G. designed and performed experiments; H. X. performed computational analysis; D. C. and D. W. T. performed in vitro assays; H. P. performed in situ hybridizations; Y.M., G.J.H., and S. C. helped with initial small RNA library sequencing and discussion; E. M. provided recombinant Ago2; S. M. provided small RNA Normalized growth Growth density (au) sequencing; S. A. W. and N.L. designed the zinc finger nucleases; and A.J.G. wrote the manuscript. Sequencing data are deposited in Gene Expression Omnibus (accession number GSE21503). Normalized growth Growth density (au)	Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pase L, 2009, BLOOD, V113, P1794, DOI 10.1182/blood-2008-05-155812; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tan GS, 2009, NUCLEIC ACIDS RES, V37, P7533, DOI 10.1093/nar/gkp812; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251	29	597	643	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1694	1698		10.1126/science.1190809	http://dx.doi.org/10.1126/science.1190809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20448148	Green Accepted			2022-12-28	WOS:000279107400043
J	Ishibashi, J; Seale, P				Ishibashi, Jeff; Seale, Patrick			Beige Can Be Slimming	SCIENCE			English	Editorial Material							BROWN ADIPOSE-TISSUE; ADULT HUMANS; AGONISTS		[Ishibashi, Jeff] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Ishibashi, J (corresponding author), Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	sealep@upenn.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK081605] Funding Source: NIH RePORTER; NIDDK NIH HHS [R00 DK081605-03, DK081605, R00 DK081605] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LONG NC, 1991, J PHYSIOL-LONDON, V444, P363, DOI 10.1113/jphysiol.1991.sp018883; REIMER R, 1992, PROSTAGLANDINS, V44, P485, DOI 10.1016/0090-6980(92)90142-G; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949	12	256	272	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1113	1114		10.1126/science.1190816	http://dx.doi.org/10.1126/science.1190816			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20448151	Green Accepted			2022-12-28	WOS:000278104700029
J	Lu, YH; Wu, KM; Jiang, YY; Xia, B; Li, P; Feng, HQ; Wyckhuys, KAG; Guo, YY				Lu, Yanhui; Wu, Kongming; Jiang, Yuying; Xia, Bing; Li, Ping; Feng, Hongqiang; Wyckhuys, Kris A. G.; Guo, Yuyuan			Mirid Bug Outbreaks in Multiple Crops Correlated with Wide-Scale Adoption of Bt Cotton in China	SCIENCE			English	Article							TRANSGENIC CROPS; PLANTS; BIOTECHNOLOGY; SUPPRESSION; BOLLWORM; POLLEN; IMPACT; RISKS; YIELD; IPM	Long-term ecological effects of transgenic Bacillus thuringiensis (Bt) crops on nontarget pests have received limited attention, more so in diverse small holder-based cropping systems of the developing world. Field trials conducted over 10 years in northern China show that mirid bugs (Heteroptera: Miridae) have progressively increased population sizes and acquired pest status in cotton and multiple other crops, in association with a regional increase in Bt cotton adoption. More specifically, our analyses show that Bt cotton has become a source of mirid bugs and that their population increases are related to drops in insecticide use in this crop. Hence, alterations of pest management regimes in Bt cotton could be responsible for the appearance and subsequent spread of nontarget pests at an agro-landscape level.	[Lu, Yanhui; Wu, Kongming; Feng, Hongqiang; Wyckhuys, Kris A. G.; Guo, Yuyuan] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Jiang, Yuying; Xia, Bing; Li, Ping] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn	Wyckhuys, Kris/AAJ-4352-2020	Wyckhuys, Kris/0000-0003-0922-488X; Lu, Yanhui/0000-0002-6552-0248; Feng, Hongqiang/0000-0002-1171-248X	National Key Basic Research Program [2006CB102004]; National Natural Science Foundation of China [30625028]; Key Project for Breeding Genetically Modified Organisms [2008ZX08012-004]; Commonwealth Agricultural Scientific Research Project [200803011]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project for Breeding Genetically Modified Organisms; Commonwealth Agricultural Scientific Research Project	This work was supported by the National Key Basic Research Program (2006CB102004), the National Natural Science Foundation of China (30625028), the Key Project for Breeding Genetically Modified Organisms (2008ZX08012-004), and the Commonwealth Agricultural Scientific Research Project (200803011). We thank two anonymous reviewers for helpful comments and suggestions.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; CHU H. F., 1958, ACTA ENT SINICA, V8, P97; Dale PJ, 2002, NAT BIOTECHNOL, V20, P567, DOI 10.1038/nbt0602-567; Dutcher J.D., 2007, GEN CONCEPTS INTEGRA, P27, DOI [10.1007/978-1-4020-6061-8_2, DOI 10.1007/978-1-4020-6061-8_2]; Fitt Gary P., 2008, V5, P303, DOI 10.1007/978-1-4020-8373-0_11; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Lu Y., 2008, BIOL CONTROL COTTON; Lu YH, 2009, B ENTOMOL RES, V99, P543, DOI 10.1017/S000748530800655X; Lu YH, 2007, ENVIRON ENTOMOL, V36, P1007, DOI 10.1603/0046-225X(2007)36[1007:FPOLLM]2.0.CO;2; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; Qaim M, 2003, SCIENCE, V299, P900, DOI 10.1126/science.1080609; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; TING Yen-chin, 1963, Acta Phytophylacica Sinica, Peking, V2, P285; Ting YQ, 1964, ACTA ENTOMOL SINICA, V13, P298; WILLIAMS MR, 2006, P BELTW COTT C NAT C, P1151; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Wu K., 1992, ACTA ECOL SIN, V12, P341; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu KongMing, 2007, Chinese Journal of Agricultural Biotechnology, V4, P93, DOI 10.1017/S1479236207001490	31	471	647	5	338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1151	1154		10.1126/science.1187881	http://dx.doi.org/10.1126/science.1187881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20466880				2022-12-28	WOS:000278104700042
J	Muss, HB; D'Alessandro, HA; Brachtel, EF				Muss, Hyman B.; D'Alessandro, Helen Anne; Brachtel, Elena F.			A Woman with Mammographically Detected Early Breast Cancer Invasive ductal carcinoma of the breast, grade 3 of 3, positive for estrogen receptors, progesterone receptors, and HER2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADJUVANT CHEMOTHERAPY; GERIATRIC ASSESSMENT; AMERICAN-SOCIETY; PROGNOSTIC INDEX; OLDER WOMEN; AGE; TRASTUZUMAB; COMORBIDITY; SURVIVAL; MORTALITY		[Muss, Hyman B.] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA; [Muss, Hyman B.] Univ N Carolina, Dept Med, Coll Med, Chapel Hill, NC USA; [D'Alessandro, Helen Anne] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Brachtel, Elena F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [D'Alessandro, Helen Anne] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Brachtel, Elena F.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Muss, HB (corresponding author), Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27515 USA.							Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; American College of Radiology, 2003, BREAST IM REP DAT SY; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Badgwell BD, 2008, J CLIN ONCOL, V26, P2482, DOI 10.1200/JCO.2007.12.8058; Badve SS, 2008, J CLIN ONCOL, V26, P2473, DOI 10.1200/JCO.2007.13.6424; Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x; Carlson Robert W, 2006, J Natl Compr Canc Netw, V4, P971; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chia S, 2008, J CLIN ONCOL, V26, P5697, DOI 10.1200/JCO.2007.15.8659; Extermann M, 2000, EUR J CANCER, V36, P453, DOI 10.1016/S0959-8049(99)00319-6; Extermann M, 2007, J CLIN ONCOL, V25, P1824, DOI 10.1200/JCO.2007.10.6559; Fleming ST, 1999, MED CARE, V37, P601, DOI 10.1097/00005650-199906000-00009; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Hillner BE, 2003, J CLIN ONCOL, V21, P4042, DOI 10.1200/JCO.2003.08.017; Hind D, 2007, BRIT J CANCER, V96, P1025, DOI 10.1038/sj.bjc.6603600; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hughes KS, 2006, BREAST CANCER RES TR, V100, pS8; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Hurria A, 2005, CANCER-AM CANCER SOC, V104, P1998, DOI 10.1002/cncr.21422; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Merchant TE, 1996, INT J RADIAT ONCOL, V34, P565, DOI 10.1016/0360-3016(95)02167-1; Muss HB, 2005, JAMA-J AM MED ASSOC, V293, P1073, DOI 10.1001/jama.293.9.1073; Muss HB, 2007, J CLIN ONCOL, V25, P3699, DOI 10.1200/JCO.2007.10.9710; NYSTROM L, 1993, LANCET, V342, P1372; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Partridge AH, 2008, J CLIN ONCOL, V26, P556, DOI 10.1200/JCO.2007.11.5451; Perez EA, 2008, J CLIN ONCOL, V26, P1231, DOI 10.1200/JCO.2007.13.5467; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rosen P. P., 2008, ROSENS BREAST PATHOL; SATARIANO WA, 1994, ANN INTERN MED, V120, P104, DOI 10.7326/0003-4819-120-2-199401150-00002; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yancik R, 2001, JAMA-J AM MED ASSOC, V285, P885, DOI 10.1001/jama.285.7.885	40	1	1	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1921	1928		10.1056/NEJMcpc0910933	http://dx.doi.org/10.1056/NEJMcpc0910933			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484399				2022-12-28	WOS:000277815600013
J	Rees, M; Koppelman, B; Davison, N				Rees, Martin; Koppelman, Ben; Davison, Neil			Scientific steps to nuclear disarmament	NATURE			English	Editorial Material									[Rees, Martin] Univ Cambridge Trinity Coll, Cambridge CB2 1TQ, England; [Rees, Martin] Royal Soc, London SW1Y 5AG, England	University of Cambridge	Rees, M (corresponding author), Univ Cambridge Trinity Coll, Cambridge CB2 1TQ, England.	ben.koppelman@royalsociety.org							0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					290	291		10.1038/465290a	http://dx.doi.org/10.1038/465290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485416				2022-12-28	WOS:000277829200019
J	Kohler, A; Zimmerman, E; Schneider, M; Hurt, E; Zheng, N				Koehler, Alwin; Zimmerman, Erik; Schneider, Maren; Hurt, Ed; Zheng, Ning			Structural Basis for Assembly and Activation of the Heterotetrameric SAGA Histone H2B Deubiquitinase Module	CELL			English	Article							PROTEIN; UBIQUITIN; COMPLEX; DOMAIN; CHROMATIN; REVEALS; DEUBIQUITYLATION; ASSOCIATION; PROTEASOME; ENZYME	Deubiquitinating enzymes (DUBs) regulate diverse cellular functions by cleaving ubiquitin from specific protein substrates. How their activities are modulated in various cellular contexts remains poorly understood. The yeast deubiquitinase Ubp8 protein is recruited and activated by the SAGA complex and, together with Sgf11, Sus1, and Sgf73, forms a DUB module responsible for deubiquitinating histone H2B during gene expression. Here, we report the crystal structure of the complete SAGA DUB module, which features two functional lobes structurally coupled by Sgf73. In the "assembly lobe,'' a long Sgf11 N-terminal helix is clamped onto the Ubp8 ZnF-UBP domain by Sus1. In the "catalytic lobe,'' an Sgf11 C-terminal zinc-finger domain binds to the Ubp8 catalytic domain next to its active site. Our structural and functional analyses reveal a central role of Sgf11 and Sgf73 in activating Ubp8 for deubiquitinating histone H2B and demonstrate how a DUB can be allosterically regulated by its nonsubstrate partners.	[Zimmerman, Erik; Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zimmerman, Erik; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Koehler, Alwin; Schneider, Maren; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	Kohler, A (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	alwin.koehler@mfpl.ac.at; nzheng@uw.edu	Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255	Howard Hughes Medical Institute; National Institutes of Health [CA107134]; Deutsche Forschungsgemeinschaft [SFB638/B3]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank ALS beamline staff for assistance and all members of the Zheng lab and Andrea Barta (MFPL) for invaluable discussions. This study is supported by the Howard Hughes Medical Institute and National Institutes of Health grant CA107134 to N.Z. and grants of the Deutsche Forschungsgemeinschaft (SFB638/B3) to A. K and E. H.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Allen MD, 2007, PROTEIN SCI, V16, P2072, DOI 10.1110/ps.072967807; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; DeLano WL, 2002, PYMOL USERS MANUAL; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jani DY, 2009, MOL CELL, V33, P727, DOI 10.1016/j.molcel.2009.01.033; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Komander D, 2008, MOL CELL, V29, P451, DOI 10.1016/j.molcel.2007.12.018; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Palhan VB, 2005, P NATL ACAD SCI USA, V102, P8472, DOI 10.1073/pnas.0503505102; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	53	140	144	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					606	617		10.1016/j.cell.2010.04.026	http://dx.doi.org/10.1016/j.cell.2010.04.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20434206	Bronze, Green Accepted			2022-12-28	WOS:000277623600014
J	Green, RE; Krause, J; Briggs, AW; Maricic, T; Stenzel, U; Kircher, M; Patterson, N; Li, H; Zhai, WW; Fritz, MHY; Hansen, NF; Durand, EY; Malaspinas, AS; Jensen, JD; Marques-Bonet, T; Alkan, C; Prufer, K; Meyer, M; Burbano, HA; Good, JM; Schultz, R; Aximu-Petri, A; Butthof, A; Hober, B; Hoffner, B; Siegemund, M; Weihmann, A; Nusbaum, C; Lander, ES; Russ, C; Novod, N; Affourtit, J; Egholm, M; Verna, C; Rudan, P; Brajkovic, D; Kucan, Z; Gusic, I; Doronichev, VB; Golovanova, LV; Lalueza-Fox, C; de la Rasilla, M; Fortea, J; Rosas, A; Schmitz, RW; Johnson, PLF; Eichler, EE; Falush, D; Birney, E; Mullikin, JC; Slatkin, M; Nielsen, R; Kelso, J; Lachmann, M; Reich, D; Paabo, S				Green, Richard E.; Krause, Johannes; Briggs, Adrian W.; Maricic, Tomislav; Stenzel, Udo; Kircher, Martin; Patterson, Nick; Li, Heng; Zhai, Weiwei; Fritz, Markus Hsi-Yang; Hansen, Nancy F.; Durand, Eric Y.; Malaspinas, Anna-Sapfo; Jensen, Jeffrey D.; Marques-Bonet, Tomas; Alkan, Can; Pruefer, Kay; Meyer, Matthias; Burbano, Hernan A.; Good, Jeffrey M.; Schultz, Rigo; Aximu-Petri, Ayinuer; Butthof, Anne; Hoeber, Barbara; Hoeffner, Barbara; Siegemund, Madlen; Weihmann, Antje; Nusbaum, Chad; Lander, Eric S.; Russ, Carsten; Novod, Nathaniel; Affourtit, Jason; Egholm, Michael; Verna, Christine; Rudan, Pavao; Brajkovic, Dejana; Kucan, Zeljko; Gusic, Ivan; Doronichev, Vladimir B.; Golovanova, Liubov V.; Lalueza-Fox, Carles; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Schmitz, Ralf W.; Johnson, Philip L. F.; Eichler, Evan E.; Falush, Daniel; Birney, Ewan; Mullikin, James C.; Slatkin, Montgomery; Nielsen, Rasmus; Kelso, Janet; Lachmann, Michael; Reich, David; Paeaebo, Svante			A Draft Sequence of the Neandertal Genome	SCIENCE			English	Article							DNA-SEQUENCES; ANCIENT DNA; ENZYMATIC AMPLIFICATION; MITOCHONDRIAL GENOME; PATTERNS; GENE; NUCLEOTIDE; CHROMOSOME; DIVERSITY; ADMIXTURE	Neandertals, the closest evolutionary relatives of present-day humans, lived in large parts of Europe and western Asia before disappearing 30,000 years ago. We present a draft sequence of the Neandertal genome composed of more than 4 billion nucleotides from three individuals. Comparisons of the Neandertal genome to the genomes of five present-day humans from different parts of the world identify a number of genomic regions that may have been affected by positive selection in ancestral modern humans, including genes involved in metabolism and in cognitive and skeletal development. We show that Neandertals shared more genetic variants with present-day humans in Eurasia than with present-day humans in sub-Saharan Africa, suggesting that gene flow from Neandertals into the ancestors of non-Africans occurred before the divergence of Eurasian groups from each other.	[Green, Richard E.; Krause, Johannes; Briggs, Adrian W.; Maricic, Tomislav; Stenzel, Udo; Kircher, Martin; Pruefer, Kay; Meyer, Matthias; Burbano, Hernan A.; Good, Jeffrey M.; Schultz, Rigo; Aximu-Petri, Ayinuer; Butthof, Anne; Hoeber, Barbara; Hoeffner, Barbara; Siegemund, Madlen; Weihmann, Antje; Kelso, Janet; Lachmann, Michael; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Patterson, Nick; Li, Heng; Nusbaum, Chad; Lander, Eric S.; Russ, Carsten; Novod, Nathaniel] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Zhai, Weiwei; Durand, Eric Y.; Malaspinas, Anna-Sapfo; Slatkin, Montgomery; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Fritz, Markus Hsi-Yang; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, Cambs, England; [Hansen, Nancy F.; Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Jensen, Jeffrey D.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Alkan, Can; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Brajkovic, Dejana] Croatian Acad Sci & Arts, Inst Quaternary Paleontol & Geol, HR-10000 Zagreb, Croatia; [Affourtit, Jason; Egholm, Michael] 454 Life Sci, Branford, CT 06405 USA; [Doronichev, Vladimir B.; Golovanova, Liubov V.] ANO Lab Prehist, St Petersburg, Russia; [Marques-Bonet, Tomas; Lalueza-Fox, Carles] Inst Evolutionary Biol UPF CSIC, Barcelona 08003, Spain; [de la Rasilla, Marco; Fortea, Javier] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Schmitz, Ralf W.] Landschaftverband Rheinlund Landesmuseum Bonn, D-53115 Bonn, Germany; [Schmitz, Ralf W.] Univ Bonn, Abt Vor & Fruhgeschichtl Archaol, D-5300 Bonn, Germany; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Falush, Daniel] Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Verna, Christine] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Montana System; University of Montana; Croatian Academy of Sciences & Arts; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Bonn; Emory University; University College Cork; Max Planck Society; Harvard University; Harvard Medical School	Green, RE (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	green@eva.mpg.de; reich@genetics.med.harvard.edu; paabo@eva.mpg.de	Ganesh, Dunna Sai/AGX-5170-2022; Liubov, Golovanova V./Q-2995-2016; Marques-Bonet, Tomas/I-4618-2014; Kircher, Martin/H-6909-2019; Krause, Johannes/E-6640-2015; VERNA, Christine/A-2366-2017; Rosas, Antonio/D-9742-2016; VERNA, Christine/H-3235-2013; Krause, Johannes/AFP-2642-2022; Li, Heng/D-9344-2011; LALUEZA-FOX, CARLES/AAG-5341-2020; Kircher, Martin/HDL-9392-2022; Alkan, Can/D-2982-2009; Burbano, Hernán/F-2952-2010; Kelso, Janet/N-1812-2019; Marques-Bonet, Tomas/ABF-3734-2020; Nielsen, Rasmus/D-4405-2009; Jensen, Jeffrey/S-1084-2016	Marques-Bonet, Tomas/0000-0002-5597-3075; Kircher, Martin/0000-0001-9278-5471; Krause, Johannes/0000-0001-5475-4690; VERNA, Christine/0000-0002-4217-5736; Rosas, Antonio/0000-0002-5829-9952; Krause, Johannes/0000-0001-9144-3920; Li, Heng/0000-0003-4874-2874; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Alkan, Can/0000-0002-5443-0706; Kelso, Janet/0000-0002-3618-322X; Marques-Bonet, Tomas/0000-0002-5597-3075; Nielsen, Rasmus/0000-0003-0513-6591; Green, Richard/0000-0003-0516-5827; Birney, Ewan/0000-0001-8314-8497; Golovanova, Liubov/0000-0002-6099-4081; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; de la RASILLA, Marco/0000-0002-5505-0625; Jensen, Jeffrey/0000-0002-4786-8064; Burbano, Hernan A./0000-0003-3433-719X; Doronichev, Vladimir/0000-0003-0198-0250; Zhai, Weiwei/0000-0001-7938-0226	Ministerio de Ciencia e Innovacion; Janggen-Pohn fellowship; National Human Genome Research Institute, National Institutes of Health; Burroughs Wellcome Career Development Award;  [GM40282]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040282] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Janggen-Pohn fellowship; National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Buglione, A. Burke, Y.-J. Chen, J. Salem, P. Schaffer, E. Szekeres, and C. Turcotte at 454 Life Sciences Corp. for production sequencing on the 454 platform; S. Fisher, J. Wilkinson, J. Blye, R. Hegarty, A. Allen, S. K. Young, and J. L. Chang for nine Illumina sequencing runs performed at the Broad Institute; J. Rothberg and E. Rubin for input leading up to this project; O. Bar-Yosef, L. Excoffier, M. Gralle, J.-J. Hublin, D. Lieberman, M. Stoneking, and L. Vigilant for constructive criticism; I. Jankovic for assistance with the Vindija collection; S. Ptak, M. Siebauer, and J. Visagie for help with data analysis, M. Richards and S. Talamo for carbon dating; J. Dabney for editorial assistance; the Genome Center at Washington University for prepublication use of the orangutan genome assembly; and K. Finstermeier for expert graphical design. Neandertal bone extract sequence data have been deposited at European Bioinformatics Institute under STUDY accession ERP000119, alias Neandertal Genome project. HGDP sequence data have been deposited at EBI under STUDY accession ERP000121, alias Human Genome Diversity Project. We are grateful to the Max Planck Society, and particularly the Presidential Innovation Fund, for making this project possible. C. L.-F. was supported by a grant from the Ministerio de Ciencia e Innovacion; E. Y. D. and M. S. were supported in part by grant GM40282; A.-S. M. was supported by a Janggen-Pohn fellowship; N. F. H. and J. C. M. were supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health; and D. R. by a Burroughs Wellcome Career Development Award in the Biomedical Sciences. Author contributions: S. P. conceived and coordinated the project; D. R. coordinated population genetic analyses; R. E. G. and J. Ke. coordinated bioinformatic aspects; R. E. G., J. Kr., A. W. B., M. E., and S. P. developed the initial project strategies; J. Kr. and T. M. collected and analyzed fossil samples; J. Kr., T. M., A. W. B., and M. M. developed the DNA extraction and library preparation protocols and performed laboratory work prior to sequencing; K. P. designed the restriction enzyme enrichment method; A. A.-P., A. B., B. Hb., B. Hff., M. Sg., R. S., A. W., J. A., M. E., and M. K. performed and coordinated DNA sequencing on the 454 and Illumina platforms; J. A. and M. E. organized and coordinated sequence production on the 454 platform; C. N., E. S. L., C. R., and N. N. organized and performed nine sequencing runs on the Illumina platform at the Broad Institute; M. K. and J. Ke. compiled the catalog of human-specific genomic features; U. S., M. K., N. H., J. M., J. Ke., K. P., and R. E. G. developed and implemented the primary sequence alignment and analysis methodologies; R. E. G., U. S., J. Kr., A. W. B., H. B., P. L. F. J. and M. L. developed and implemented the wet lab and bioinformatic assays for human DNA contamination; C. A., T. M.-B., and E. E. E. performed structural variation analyses; H. L., J. M., and D. R. designed and implemented analyses of population divergences; R. E. G., N. P., W. Z., J. M., H. L., M. H.-Y. F., E. Y. D., A. S.-M., P. L. F. J., J. J., J. G., M. L., D. F., M. S., E. B., R. N., S. P., and D. R. developed and implemented population genetics comparisons; R. E. G., M. L., J. G., D. F., J. D. J., D. R., and S. P. designed and implemented the screen for selective sweeps; P. R., D. B., Z. K., I. G., C. V., V. B. D., L. V. G., C. L.-F., M. R., J. F., A. R., and R. S.; provided samples, analyses, and paleontological expertise; . R. and S. P. edited the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Bar-Yosef O, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P39; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BISCHOFF JL, 2007, HIGH RESOLUTION U SE, V34; Brauer G, 2007, VERTEBR PALEOBIOL PA, P269; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs Adrian W, 2009, J Vis Exp, P1573, DOI 10.3791/1573; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Crow TJ, 1995, EUR NEUROPSYCHOPHARM, V5, P59, DOI 10.1016/0924-977X(95)00032-K; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; de Torres T, 2010, ARCHAEOMETRY, V52, P680, DOI 10.1111/j.1475-4754.2009.00491.x; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Greenwood AD, 1999, MOL BIOL EVOL, V16, P1466, DOI 10.1093/oxfordjournals.molbev.a026058; Grun R, 2005, J HUM EVOL, V49, P316, DOI 10.1016/j.jhevol.2005.04.006; Gunz P, 2009, P NATL ACAD SCI USA, V106, P6094, DOI 10.1073/pnas.0808160106; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2006, NATURE, V439, P724, DOI 10.1038/nature04432; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lalueza-Fox C, 2009, BIOL LETTERS, V5, P809, DOI 10.1098/rsbl.2009.0532; Lalueza-Fox C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-342; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; LI WH, 1985, MOL BIOL EVOL, V2, P150; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Matsuyoshi N, 1997, BIOCHEM BIOPH RES CO, V235, P355, DOI 10.1006/bbrc.1997.6707; MERCIER N, 1994, LATE QUATERNARY CHRO, P13; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Orlando L, 2006, CURR BIOL, V16, pR400, DOI 10.1016/j.cub.2006.05.019; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paabo S, 1999, TRENDS CELL BIOL, V9, pM13, DOI 10.1016/S0968-0004(99)01497-8; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Parikh H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-72; Paten B, 2008, GENOME RES, V18, P1829, DOI 10.1101/gr.076521.108; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r47; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Ruff C.B., 2002, TRABALHOS ARQUEOLOGI, V22, P435; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schmitz RW, 2002, P NATL ACAD SCI USA, V99, P13342, DOI 10.1073/pnas.192464099; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Skinner AR, 2005, APPL RADIAT ISOTOPES, V62, P219, DOI 10.1016/j.apradiso.2004.08.008; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Sun JX, 2009, MOL BIOL EVOL, V26, P1017, DOI 10.1093/molbev/msp025; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Voisin JL, 2008, J HUM EVOL, V55, P438, DOI 10.1016/j.jhevol.2008.06.001; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; Wall JD, 2006, CURR OPIN GENET DEV, V16, P606, DOI 10.1016/j.gde.2006.09.006; Wall JD, 2009, MOL BIOL EVOL, V26, P1823, DOI 10.1093/molbev/msp096; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Wood ET, 2005, EUR J HUM GENET, V13, P867, DOI 10.1038/sj.ejhg.5201408; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	87	2275	2358	79	905	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					710	722		10.1126/science.1188021	http://dx.doi.org/10.1126/science.1188021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448178	Green Accepted			2022-12-28	WOS:000277357100030
J	Bautista, E; Chorpitayasunondh, T; Gao, ZC; Harper, SA; Shaw, M; Uyeki, TM; Zaki, SR; Hayden, FG; Hui, DS; Kettner, JD; Kumar, A; Lim, M; Shindo, N; Penn, C; Nicholson, KG				Bautista, Edgar; Chorpitayasunondh, Tawee; Gao, Zhancheng; Harper, Scott A.; Shaw, Michael; Uyeki, Timothy M.; Zaki, Sherif R.; Hayden, Frederick G.; Hui, David S.; Kettner, Joel D.; Kumar, Anand; Lim, Matthew; Shindo, Nahoko; Penn, Charles; Nicholson, Karl G.		WHO Consultation Clinical Aspects	Medical Progress: Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CRITICALLY-ILL PATIENTS; NEW-YORK-CITY; HOUSEHOLD TRANSMISSION; A(H1N1) INFECTION; VIRAL LOAD; DEATH; HOSPITALIZATION; PATHOGENESIS; ZANAMIVIR; OUTBREAK		[Hayden, Frederick G.] Univ Virginia, Charlottesville, VA USA; [Hayden, Frederick G.] Wellcome Trust Res Labs, London, England; [Bautista, Edgar] Natl Inst Resp Dis, Mexico City, DF, Mexico; [Chorpitayasunondh, Tawee] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Gao, Zhancheng] Peking Univ Peoples Hosp, Beijing, Peoples R China; [Harper, Scott A.; Shaw, Michael; Uyeki, Timothy M.; Zaki, Sherif R.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Hui, David S.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Kettner, Joel D.; Kumar, Anand] Univ Manitoba, Winnipeg, MB, Canada; [Kettner, Joel D.] Manitoba Hlth, Winnipeg, MB, Canada; [Lim, Matthew; Shindo, Nahoko; Penn, Charles] WHO, Geneva, Switzerland; [Nicholson, Karl G.] Univ Leicester, Leicester, Leics, England	University of Virginia; Peking University; Centers for Disease Control & Prevention - USA; Chinese University of Hong Kong; University of Manitoba; World Health Organization; University of Leicester	Hayden, FG (corresponding author), Univ Virginia Hlth Syst, POB 800473, Charlottesville, VA 22908 USA.	fgh@virginia.edu	Hui, David Shu-Cheong/O-2754-2015	Hui, David Shu-Cheong/0000-0003-4382-2445	Roche; Baxter; Novartis; GlaxoSmithKline	Roche(Roche Holding); Baxter; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline)	Dr. Kumar reports receiving grant support (to the University of Manitoba) from Roche for studies of oseltamivir; and Dr. Nicholson, receiving travel expenses and lecture and consulting fees from Baxter, Novartis, and GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported. Disclosure Corms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2009, Wkly Epidemiol Rec, V85, P37; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P481; [Anonymous], 2010, WHO GUID PHARM MAN P; Archer B, 2009, EURO SURVEILL, V14; Ariano RE, 2010, CAN MED ASSOC J, V182, P357, DOI 10.1503/cmaj.092127; Bansal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009360; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2009, REC US ANT MED MAN I; Centers for Disease Control and Prevention, 2009, MMWR DISPATCH, V58, P1; Centers for Disease Control and Prevention, 2010, CDC EST 2009 H1N1 IN; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DESERRES G, 2010, EMERG INFECT DIS MAY; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Dulyachai W, 2010, EMERG INFECT DIS, V16, P343, DOI 10.3201/eid1602.091733; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; FDA, 2009, EMERGENCY USE AUTHOR; FLEURY H, 2009, EURO SURVEILL, V14; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaur AH, 2010, NEW ENGL J MED, V362, P88, DOI 10.1056/NEJMc0910893; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Health Protection Agency, 2009, PAND H1N1 2009 ENGL; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kamigaki T, 2009, PLOS CURR INFLUENZA; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kiatboonsri S, 2010, CLIN INFECT DIS, V50, P620, DOI 10.1086/650176; Kidd IM, 2009, LANCET, V374, P1036, DOI 10.1016/S0140-6736(09)61528-2; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; LARCOMBE PJ, 2009, ARCH DIS CHILD  1110; LEE N, 2010, 12 INT S RESP VIR IN; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; LIM ML, 2010, BJOG            0210; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mai LQ, 2010, NEW ENGL J MED, V362, P86, DOI 10.1056/NEJMc0910448; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; NORIEGA LM, 2010, INFLUENZA OTHER 0224; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; PEREZ C, 2009, 47 ANN M INF DIS SOC; Perez-Lopez FR, 2009, REPROD SCI, V16, P7, DOI 10.1177/1933719108327595; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Redelman-Sidi G, 2010, J INFECTION, V60, P257, DOI 10.1016/j.jinf.2010.01.009; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; ROSS T, 2010, PLOS CURR INFLUENZA; *SECR SAL, 2009, EST INFL A H1N1; SHIEH WJ, AM J PATHOL IN PRESS; Shimada T, 2009, EUROSURVEILLANCE, V14; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; VALLI MB, 2010, PLOS CURR INFLU 0303; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; WHO (World Health Organization), 2010, PAND H1N1 2009 UPD 9; Wilson N, 2009, EUROSURVEILLANCE, V14; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2009, WKLY EPIDEMIOL REC, V84, P341; World Health Organization, 2009, CLIN MAN HUM INF PAN; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182; ZARYCHANSKI K, 2010, CMAJ, V182, P257; 2009, WKLY EPIDEMIOL REC, V84, P421	85	775	826	0	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1708	1719						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445182	Bronze, Green Published			2022-12-28	WOS:000277311200008
J	Potter, CJ; Tasic, B; Russler, EV; Liang, L; Luo, LQ				Potter, Christopher J.; Tasic, Bosiljka; Russler, Emilie V.; Liang, Liang; Luo, Liqun			The Q System: A Repressible Binary System for Transgene Expression, Lineage Tracing, and Mosaic Analysis	CELL			English	Article							MALE COURTSHIP BEHAVIOR; NEUROSPORA-CRASSA; DROSOPHILA BRAIN; GENE-EXPRESSION; OLFACTORY MAP; TARGETED EXPRESSION; CELL-PROLIFERATION; NEURAL CIRCUITRY; NEURONS; TRANSCRIPTION	We describe a new repressible binary expression system based on the regulatory genes from the Neurospora qa gene cluster. This "Q system'' offers attractive features for transgene expression in Drosophila and mammalian cells: low basal expression in the absence of the transcriptional activator QF, high QF-induced expression, and QF repression by its repressor QS. Additionally, feeding flies quinic acid can relieve QS repression. The Q system offers many applications, including (1) intersectional "logic gates'' with the GAL4 system for manipulating transgene expression patterns, (2) GAL4-independent MARCM analysis, and (3) coupled MARCM analysis to independently visualize and genetically manipulate siblings from any cell division. We demonstrate the utility of the Q system in determining cell division patterns of a neuronal lineage and gene function in cell growth and proliferation, and in dissecting neurons responsible for olfactory attraction. The Q system can be expanded to other uses in Drosophila and to any organism conducive to transgenesis.	[Potter, Christopher J.; Tasic, Bosiljka; Russler, Emilie V.; Liang, Liang; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Potter, Christopher J.; Tasic, Bosiljka; Russler, Emilie V.; Liang, Liang; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Liang, Liang] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112; Liang, Liang/0000-0001-5718-0717; Luo, Liqun/0000-0001-5467-9264	National Institutes of Health; Human Frontiers Science Program; Damon Runyon Cancer Research Foundation [DRG-1766-03, DRG-1819-04]; Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, R37NS041044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Damon Runyon Cancer Research Foundation; Stanford Graduate Fellowship(Stanford University); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Luginbuhl, M. Tynan La Fontaine, and T. Chou for technical assistance; K. Wehner for HeLa cells and mouse anti-HA and mouse anti-fibrillarin antibodies; M. Simon for S2 cells and adult eye sectioning; T. Clandinin for 24B10 antibodies; S. Block for luminometer usage; the Fungal Genetics Stock Center for cosmids containing QF and QS; the Developmental Biology Hybridoma Bank for monoclonal antibodies; the Bloomington Stock Center for flies; and D. Berdnik, Y.-H. Chou, K. Miyamichi, M. Spletter, L. Sweeney, and W. Hong for comments on the manuscript. This research was supported by grants from the National Institutes of Health and Human Frontiers Science Program. C.J.P. and B.T. were supported by the Damon Runyon Cancer Research Foundation (C.J.P., DRG-1766-03; B.T., DRG-1819-04). L. Liang was supported by the Stanford Graduate Fellowship. L. Luo is an investigator of the Howard Hughes Medical Institute. C.J.P. performed all the Drosophila in vivo experiments, with the help of E.V.R. B.T. identified the qa system from Neurospora as a candidate binary expression system and performed the Drosophila and mammalian cultured cell experiments. L. Liang performed the quantitative analysis in Figure 5. L. Luo supervised the project, and wrote the paper with C.J.P. and B.T.	BAUM JA, 1987, MOL CELL BIOL, V7, P1256, DOI 10.1128/MCB.7.3.1256; Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; GILES NH, 1991, J HERED, V82, P1; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Griffin R, 2009, NAT METHODS, V6, P600, DOI 10.1038/nmeth.1349; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hong WZ, 2009, NAT NEUROSCI, V12, P1542, DOI 10.1038/nn.2442; HUIET L, 1986, P NATL ACAD SCI USA, V83, P3381, DOI 10.1073/pnas.83.10.3381; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Luo L, 2007, BRAIN RES REV, V55, P220, DOI 10.1016/j.brainresrev.2007.01.012; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; NOLLET LML, 2000, FOOD ANAL HLPC; Nordlander R. H., 1969, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V163, P197, DOI 10.1007/BF00576929; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; PATEL VB, 1981, P NATL ACAD SCI-BIOL, V78, P5783, DOI 10.1073/pnas.78.9.5783; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; XU T, 1993, DEVELOPMENT, V117, P1223; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	50	337	339	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					536	548		10.1016/j.cell.2010.02.025	http://dx.doi.org/10.1016/j.cell.2010.02.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434990	Green Accepted, Bronze			2022-12-28	WOS:000277180800023
J	McColl, KEL				McColl, Kenneth E. L.			Helicobacter pylori Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTON-PUMP INHIBITOR; GASTRIC-CANCER; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; TRIPLE THERAPY; ERADICATION; METAANALYSIS; DYSPEPSIA; MANAGEMENT; 1ST-LINE	A 29-year-old man presents with intermittent epigastric discomfort, without weight loss or evidence of gastrointestinal bleeding. He reports no use of aspirin or nonsteroidal antiinflammatory drugs (NSAIDs). Abdominal examination reveals epigastric tenderness. A serologic test for Helicobacter pylori is positive, and he receives a 10-day course of triple therapy (omeprazole, amoxicillin, and clarithromycin). Six weeks later, he returns with the same symptoms. How should his case be further evaluated and managed?	Univ Glasgow, Div Cardiovasc & Med Sci, Gardiner Inst, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McColl, KEL (corresponding author), Univ Glasgow, Div Cardiovasc & Med Sci, Gardiner Inst, 44 Church St, Glasgow G11 6NT, Lanark, Scotland.	k.e.l.mccoll@clinmed.gla.ac.uk	Hug, Balthasar L./G-1568-2010		AstraZeneca; Nycomed; Sacoor	AstraZeneca(AstraZeneca); Nycomed; Sacoor	Dr. McColl reports receiving lecture fees from AstraZeneca and Nycomed and consulting fees from Sacoor. No other potential conflict of interest relevant to this article was reported.	Axon ATR, 1997, BRIT MED J, V314, P565, DOI 10.1136/bmj.314.7080.565; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Chiba N, 2002, BRIT MED J, V324, P1012, DOI 10.1136/bmj.324.7344.1012; de Martel C, 2005, J INFECT DIS, V191, P761, DOI 10.1086/427659; Delaney B. C., 2003, COCHRANE DB SYST REV, V2; DELANEY BC, 2001, COCHRANE DB SYST REV, V3; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Everhart JE, 2000, GASTROENTEROL CLIN N, V29, P559, DOI 10.1016/S0889-8553(05)70130-8; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Fischbach W, 2004, GUT, V53, P34, DOI 10.1136/gut.53.1.34; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gillen D, 1998, GASTROENTEROLOGY, V114, P50, DOI 10.1016/S0016-5085(98)70632-8; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Gisbert JP, 2004, HELICOBACTER, V9, P347, DOI 10.1111/j.1083-4389.2004.00235.x; Gisbert JP, 2002, ALIMENT PHARM THER, V16, P1047, DOI 10.1046/j.1365-2036.2002.01276.x; Hansen S, 1999, SCAND J GASTROENTERO, V34, P353; HENTSCHEL E, 1993, NEW ENGL J MED, V328, P308, DOI 10.1056/NEJM199302043280503; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61, P177; Jafri NS, 2008, ANN INTERN MED, V149, P686, DOI 10.7326/0003-4819-149-9-200811040-00015; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Jarbol DE, 2006, AM J GASTROENTEROL, V101, P1200, DOI 10.1038/ajg2006227; Laine L, 2001, ANN INTERN MED, V134, P361, DOI 10.7326/0003-4819-134-5-200103060-00008; Lamouliatte H, 2003, ALIMENT PHARM THERAP, V18, P791, DOI 10.1046/j.1365-2036.2003.01759.x; Lassen AT, 2000, LANCET, V356, P455, DOI 10.1016/S0140-6736(00)02553-8; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Loy CT, 1996, AM J GASTROENTEROL, V91, P1138; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Manes G, 2003, BRIT MED J, V326, P1118, DOI 10.1136/bmj.326.7399.1118; MARSHALL BJ, 1990, GASTROENTEROLOGY, V99, P697, DOI 10.1016/0016-5085(90)90957-3; McColl K. E. L., 2002, BMJ, V324, P999, DOI 10.1136/bmj.324.7344.999; MCCOLL KE, 2002, BMJ-BRIT MED J, V325, P479; McColl KEL, 2000, NEW ENGL J MED, V342, P589; McColl KEL, 2002, BMJ-BRIT MED J, V325, P580; Midolo P, 2000, GASTROENTEROL CLIN N, V29, P871, DOI 10.1016/S0889-8553(05)70154-0; Moayyedi P, 2000, BRIT MED J, V321, P659, DOI 10.1136/bmj.321.7262.659; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Qasim A, 2005, ALIMENT PHARM THER, V21, P91, DOI 10.1111/j.1365-2036.2004.02210.x; Raghunath A, 2003, BMJ-BRIT MED J, V326, P737, DOI 10.1136/bmj.326.7392.737; Realdi G, 1999, HELICOBACTER, V4, P106, DOI 10.1046/j.1523-5378.1999.99002.x; Rune S, 2001, AM J GASTROENTEROL, V96, P1417; Saad RJ, 2006, AM J GASTROENTEROL, V101, P488, DOI 10.1111/j.1572-0241.2006.00637.x; Sanchez-Delgado J, 2008, AM J GASTROENTEROL, V103, P2220, DOI 10.1111/j.1572-0241.2008.01924.x; Talley NJ, 2005, AM J GASTROENTEROL, V100, P2324, DOI 10.1111/j.1572-0241.2005.00225.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaira D, 2001, GUT, V48, P287, DOI 10.1136/gut.48.3.287; WARREN JR, 1983, LANCET, V1, P1273; Woodward M, 2000, J CLIN EPIDEMIOL, V53, P175, DOI 10.1016/S0895-4356(99)00171-7; YAGHOOBI M, 2010, AM J GASTROENTE 0119	50	494	524	1	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1597	1604		10.1056/NEJMcp1001110	http://dx.doi.org/10.1056/NEJMcp1001110			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20427808				2022-12-28	WOS:000277117400008
J	Marais, BJ; Gupta, A; Starke, JR; El Sony, A				Marais, Ben J.; Gupta, Amita; Starke, Jeffrey R.; El Sony, Asma			Tuberculosis in women and children	LANCET			English	Editorial Material							EPIDEMIOLOGY; INFECTION; COMMUNITY; DISEASE; AGE		[Marais, Ben J.] Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Gupta, Amita] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA; [Starke, Jeffrey R.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [El Sony, Asma] Epidemiol Lab, Khartoum, Sudan	Stellenbosch University; Johns Hopkins University; Baylor College of Medicine	Marais, BJ (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa.	bjmarais@sun.ac.za	El-Sony, Asma/G-9112-2019; Marais, Ben/AAX-2626-2021	El-Sony, Asma/0000-0002-6989-8862; Gupta, Amita/0000-0001-7036-2718				Adhikari M, 2009, SEMIN FETAL NEONAT M, V14, P234, DOI 10.1016/j.siny.2009.02.001; Allotey P, 2008, INT J TUBERC LUNG D, V12, P831; Bates L, 2004, LANCET INFECT DIS, V4, P368, DOI 10.1016/S1473-3099(04)01047-3; Burman WJ, 2008, PLOS MED, V5, P1168, DOI 10.1371/journal.pmed.0050176; DAS P, 2002, LANCET INFECT DIS, V2, P317; Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P259; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Stop TB Partnership, GLOB DRUG FAC; Weiss MG, 2006, GENDER TUBERCULOSIS; *WHO, 2009, GLOB TUB CONTR SHORT	15	40	43	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2057	2059		10.1016/S0140-6736(10)60579-X	http://dx.doi.org/10.1016/S0140-6736(10)60579-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20488522				2022-12-28	WOS:000279069300007
J	Kawabata, KS; Maeda, K; Nomoto, K; Taubenberger, S; Tanaka, M; Deng, J; Pian, E; Hattori, T; Itagaki, K				Kawabata, K. S.; Maeda, K.; Nomoto, K.; Taubenberger, S.; Tanaka, M.; Deng, J.; Pian, E.; Hattori, T.; Itagaki, K.			A massive star origin for an unusual helium-rich supernova in an elliptical galaxy	NATURE			English	Article							CORE-COLLAPSE SUPERNOVAE; NEBULAR SPECTRA; LIGHT CURVES; SN 2002AP; EVOLUTION; NUCLEOSYNTHESIS; 1994I; EXPLOSION; STELLAR; 1998BW	The unusual helium-rich (type Ib) supernova SN 2005E is distinguished from all supernovae hitherto observed by its faint and rapidly fading light curve, prominent calcium lines in late-phase spectra and lack of any mark of recent star formation near the supernova location. These properties are claimed(1) to be explained by a helium detonation in a thin surface layer of an accreting white dwarf. Here we report that the observed properties of SN 2005cz, which appeared in an elliptical galaxy, resemble those of SN 2005E. We argue that these properties are best explained by a core-collapse supernova at the low-mass end (8-12 solar masses) of the range of massive stars that explode(2). Such a low-mass progenitor lost its hydrogen-rich envelope through binary interaction, had very thin oxygen-rich and silicon-rich layers above the collapsing core, and accordingly ejected a very small amount of radioactive (56)Ni and oxygen. Although the host galaxy NGC 4589 is an elliptical, some studies have revealed evidence of recent star-formation activity(3), consistent with the core-collapse model.	[Kawabata, K. S.] Hiroshima Univ, Hiroshima Astrophys Sci Ctr, Hiroshima 7398526, Japan; [Maeda, K.; Nomoto, K.; Tanaka, M.] Univ Tokyo, IPMU, Chiba 2778583, Japan; [Taubenberger, S.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Tanaka, M.] Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan; [Deng, J.] CAS, Natl Astron Observ, Beijing 100012, Peoples R China; [Pian, E.] INAF Osservatorio Astron Trieste, I-3413 Trieste, Italy; [Hattori, T.] Natl Inst Nat Sci, Natl Astron Observ Japan, Subaru Telescope, Hilo, HI 96720 USA; [Itagaki, K.] Itagaki Astron Observ, Teppo, Yamagata 9902492, Japan	Hiroshima University; University of Tokyo; Max Planck Society; University of Tokyo; Chinese Academy of Sciences; National Astronomical Observatory, CAS; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ)	Kawabata, KS (corresponding author), Hiroshima Univ, Hiroshima Astrophys Sci Ctr, 1-3-1 Kagamiyama, Hiroshima 7398526, Japan.	kawabtkj@hiroshima-u.ac.jp	Tanaka, Masaomi/A-4354-2011; Kawabata, Koji S/G-1957-2017	Kawabata, Koji S/0000-0001-6099-9539; Maeda, Keiichi/0000-0003-2611-7269; Pian, Elena/0000-0001-8646-4858	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; Japan Society for the Promotion of Science (JSPS); MEXT; NSFC; 973 Program of China	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China)	We thank D. Leonard for permission to publish his early-time spectrum of SN 2005cz, and S. Valenti for permission to use his spectra of SN2008ha. We acknowledge advice and help from P. A. Mazzali. This work is based on observations collected at the 2.2-m telescope at the Calar Alto Observatory (Sierra de Los Filabres, Spain), at the Keck Telescope, and at the Subaru Telescope (operated by the National Astronomical Observatory of Japan). We are grateful to the staff members at the observatories for their assistance, especially to T. Sasaki, K. Aoki, G. Kosugi, T. Takata and M. Iye. This research is supported by the World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan, and by the Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science (JSPS) and MEXT. M. T. is supported through the JSPS Research Fellowship for Young Scientists. J.D. is supported by the NSFC and by the 973 Program of China.	BARBON R, 1995, ASTRON ASTROPHYS SUP, V110, P513; BOTTICELLA MT, 2009, MON NOT R A IN PRESS; Branch D, 2002, ASTROPHYS J, V566, P1005, DOI 10.1086/338127; Filippenko A. V, 2003, 8159 IAU; FILIPPENKO AV, 1995, ASTROPHYS J, V450, pL11, DOI 10.1086/309659; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; FRANSSON C, 1989, ASTROPHYS J, V343, P323, DOI 10.1086/167707; Hakobyan AA, 2008, ASTRON ASTROPHYS, V488, P523, DOI 10.1051/0004-6361:200809817; IWAMOTO K, 1994, APJ, V437, P115; LEONARD DC, 2005, 8579 IAU; Maeda K, 2007, ASTROPHYS J, V658, pL5, DOI 10.1086/513564; Maeda K, 2008, SCIENCE, V319, P1220, DOI 10.1126/science.1149437; Mazzali PA, 2007, ASTROPHYS J, V670, P592, DOI 10.1086/521873; Mazzali PA, 2001, ASTROPHYS J, V559, P1047, DOI 10.1086/322420; NOMOTO K, 1984, ASTROPHYS J, V277, P791, DOI 10.1086/161749; NOMOTO K, 1988, PHYS REP, V163, P13, DOI 10.1016/0370-1573(88)90032-4; NOMOTO K, 1994, NATURE, V371, P227, DOI 10.1038/371227a0; Nomoto K, 2006, NUCL PHYS A, V777, P424, DOI 10.1016/j.nuclphysa.2006.05.008; Patat F, 2001, ASTROPHYS J, V555, P900, DOI 10.1086/321526; Phillips MM, 2007, PUBL ASTRON SOC PAC, V119, P360, DOI 10.1086/518372; Richmond MW, 1996, ASTRON J, V111, P327, DOI 10.1086/117785; Sauer DN, 2006, MON NOT R ASTRON SOC, V369, P1939, DOI 10.1111/j.1365-2966.2006.10438.x; SHIGEYAMA T, 1994, ASTROPHYS J, V420, P341, DOI 10.1086/173564; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737; Stritzinger M, 2009, ASTROPHYS J, V696, P713, DOI 10.1088/0004-637X/696/1/713; Tanaka M, 2009, ASTROPHYS J, V700, P1680, DOI 10.1088/0004-637X/700/2/1680; Valenti S, 2009, NATURE, V459, P674, DOI 10.1038/nature08023; Yoshii Y, 2003, ASTROPHYS J, V592, P467, DOI 10.1086/375572; Zhang Y, 2008, ASTRON ASTROPHYS, V487, P177, DOI 10.1051/0004-6361:200809660	29	64	65	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					326	328		10.1038/nature09055	http://dx.doi.org/10.1038/nature09055			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485430	Green Submitted			2022-12-28	WOS:000277829200035
J	Mehrotra, A; Adams, JL; Thomas, JW; McGlynn, EA				Mehrotra, Ateev; Adams, John L.; Thomas, J. William; McGlynn, Elizabeth A.			The Effect of Different Attribution Rules on Individual Physician Cost Profiles	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY; CARE; EFFICIENCY; MEDICARE; DESIGN; PAY	Background: Some health plans profile physicians on the basis of their relative costs and use these profiles to assign physicians to cost categories. Physician organizations have questioned whether the rules used to attribute costs to a physician affect the cost category to which that physician is assigned. Objective: To evaluate the effect of 12 different attribution rules on physician cost profiles. Design: Under each of the 12 attribution rules, a cost profile was created for the physicians in the aggregated claims database and the physicians were assigned to a cost category (high cost, average cost, low cost, or low sample size). The attribution rules differed by unit of analysis, signal for responsibility, number of physicians who can be assigned responsibility, and threshold value for assigning responsibility. Setting: Four commercial health plans in Massachusetts. Patients: 1.1 million adults continuously enrolled in 4 commercial health plans in 2004 and 2005. Measurements: Percentage of all episodes assigned to any physician and percentage of costs billed by a physician that were included in his or her own profile were calculated under each rule. The cost category assignments from a commonly used default rule were compared with those from each of the other 11 attribution rules and the rate of disagreement was calculated. Results: Percentage of episodes that could be assigned to a physician varied substantially across the 12 rules (range, 20% to 69%), as did the mean percentage of costs billed by a physician that were included in that physician's own cost profile (range, 13% to 60%). Depending on the alternate rule used, between 17% and 61% of physicians would be assigned to a different cost category than that assigned by using the default rule. Limitation: Results might differ if data from another state or from Medicare were used. Conclusion: The choice of attribution rule affects how costs are assigned to a physician and can substantially affect the cost category to which a physician is assigned.	[Mehrotra, Ateev] RAND Corp, Pittsburgh, PA 15213 USA; RAND Corp, Santa Monica, CA USA; Univ Pittsburgh, Pittsburgh, PA USA; Univ So Maine, Portland, ME 04103 USA	RAND Corporation; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Maine System; University of Southern Maine	Mehrotra, A (corresponding author), RAND Corp, 4570 5th Ave,Suite 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021; Adams, John/ABE-6170-2021	Mehrotra, Ateev/0000-0003-2223-1582; 	U.S. Department of Labor [J-9-P-2-0033]; National Center for Research Resources, National Institutes of Health; Robert Wood Johnson Foundation [60517]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	U.S. Department of Labor; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant Support: By a contract from the U.S. Department of Labor (J-9-P-2-0033); a career development award (KL2 RR024154) from the National Center for Research Resources, a component of the National Institutes of Health (Dr. Mehrotra); and grant 60517 from the Robert Wood Johnson Foundation's Health Care Financing and Organization program (Dr. Thomas).	*ACADEMYHEALTH, 2006, HIGHL NAT C HELD 23; ADAMS JL, 2010, PHYS COST PROFILING; Adams JL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-57; *ATT GEN STAT NY, 2007, AGR PHYS PERF MEAS R; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Brennan TA, 2008, HEALTH AFFAIR, V27, P1160, DOI 10.1377/hlthaff.27.4.1160; *CTR MED MED SERV, 2009, BER EGG TYP SERV BET; Dang D K, 1996, Med Interface, V9, P122; Delmarva Foundation for Medical Care, 2008, ENH PHYS QUAL PERF M; DRAPER DA, 2007, HIGH PERFORMANCE HLT; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; GRAZIER KL, 2006, EFFICIENCY VALUE BAS; GREENE RA, 2006, REV MASSACHUSETTS GR; Greene RA, 2008, HEALTH AFFAIR, V27, pW250, DOI 10.1377/hlthaff.27.4.w250; *ING, 2008, SYMM EP TREATM GROUP; Kautter J, 2007, HEALTH CARE FINANC R, V29, P15; LAKE T, 2007, HLTH PLANS USE PHYS; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; *LEAPFR GROUP BRID, 2004, MEAS PROV EFF VERS 1; Macurdy T., 2008, PROTOTYPE MEDICARE R; *MED PAYM ADV COMM, 2009, PHYS RES US MEAS REP; *MN MED ASS, 2006, TIER MINN PHYS; *NAT COMM QUAL ASS, 2006, QUAL PLUS STAND GUID; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; RAMIREZ A, 2007, NY TIMES        0714; Robinson JC, 2001, MILBANK Q, V79, P149, DOI 10.1111/1468-0009.00202; Rosenblatt RA, 1998, JAMA-J AM MED ASSOC, V279, P1364, DOI 10.1001/jama.279.17.1364; Scholle SH, 2009, AM J MANAG CARE, V15, P67; Thomas JW, 2006, INQUIRY-J HEALTH CAR, V43, P271, DOI 10.5034/inquiryjrnl_43.3.271; Thomas JW, 2006, AM J MANAG CARE, V12, P341; THOMAS JW, 2004, INQUIRY, V218, P31; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711	32	44	44	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					649	+		10.7326/0003-4819-152-10-201005180-00005	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598RJ	20479030	Green Accepted			2022-12-28	WOS:000277855500004
J	Koyanagi, A; Shibuya, K				Koyanagi, Ai; Shibuya, Kenji			What do we really know about adult mortality worldwide?	LANCET			English	Editorial Material									[Koyanagi, Ai; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo 1130033, Japan	University of Tokyo	Shibuya, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo 1130033, Japan.	shibuyak@m.u-tokyo.ac.jp	Koyanagi, Ai/D-3833-2018	Koyanagi, Ai/0000-0002-9565-5004; Shibuya, Kenji/0000-0003-2528-7530				[Anonymous], WORLD POP PROSP 2008; England R, 2009, LANCET, V374, P1595, DOI 10.1016/S0140-6736(09)61951-6; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; KING G, POPUL HLTH IN PRESS; Kirk D, 1996, POP STUD-J DEMOG, V50, P361, DOI 10.1080/0032472031000149536; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; W.H. Organization, 2009, WORLD HLTH STAT 2009; *WORLD BANK, 1993, WORLD DEV REP 1993 I	12	6	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1668	1670		10.1016/S0140-6736(10)60629-0	http://dx.doi.org/10.1016/S0140-6736(10)60629-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	599DK	20434764				2022-12-28	WOS:000277890200005
J	Roesch, A; Fukunaga-Kalabis, M; Schmidt, EC; Zabierowski, SE; Brafford, PA; Vultur, A; Basu, D; Gimotty, P; Vogt, T; Herlyn, M				Roesch, Alexander; Fukunaga-Kalabis, Mizuho; Schmidt, Elizabeth C.; Zabierowski, Susan E.; Brafford, Patricia A.; Vultur, Adina; Basu, Devraj; Gimotty, Phyllis; Vogt, Thomas; Herlyn, Meenhard			A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth	CELL			English	Article							CANCER STEM-CELL; TRANSCRIPTIONAL REPRESSION; METASTATIC MELANOMA; GENE-EXPRESSION; BINDING; PLU-1; IDENTIFICATION; PROGRESSION; LEUKEMIA; REVEALS	Melanomas are highly heterogeneous tumors, but the biological significance of their different subpopulations is not clear. Using the H3K4 demethylase JARID1B (KDM5B/PLU-1/RBP2-H1) as a biomarker, we have characterized a small subpopulation of slow-cycling melanoma cells that cycle with doubling times of >4 weeks within the rapidly proliferating main population. Isolated JARID1B-positive melanoma cells give rise to a highly proliferative progeny. Knockdown of JARID1B leads to an initial acceleration of tumor growth followed by exhaustion which suggests that the JARID1B-positive subpopulation is essential for continuous tumor growth. Expression of JARID1B is dynamically regulated and does not follow a hierarchical cancer stem cell model because JARID1B-negative cells can become positive and even single melanoma cells irrespective of selection are tumorigenic. These results suggest a new understanding of melanoma heterogeneity with tumor maintenance as a dynamic process mediated by a temporarily distinct subpopulation.	[Roesch, Alexander; Fukunaga-Kalabis, Mizuho; Schmidt, Elizabeth C.; Zabierowski, Susan E.; Brafford, Patricia A.; Vultur, Adina; Basu, Devraj; Herlyn, Meenhard] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Basu, Devraj] Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Gimotty, Phyllis] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Vogt, Thomas] Univ Regensburg, Med Ctr, Dept Dermatol, D-93053 Regensburg, Germany	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Regensburg	Herlyn, M (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	herlynm@wistar.org	Gimotty, Phyllis/GWZ-4136-2022; Hu, Ruogu/B-2203-2008	Gimotty, Phyllis/0000-0002-3850-9799; Vultur, Adina/0000-0003-0068-9496	NIH [P50 CA 093372, P01 CA 025874, R01 CA 047159, R01 CA 076674, P30 CA10815]; DFG [R3577/2-1]; NATIONAL CANCER INSTITUTE [R01CA076674, P50CA093372, R01CA047159, P30CA010815, P01CA025874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Hayden and F. Keeney (Wistar Microscopy Facility), D. C. Schultz (Wistar Protein Expression Facility), J. S. Faust, D. Ambrose, and D. Hussey (Wistar Flow Cytometry Facility) for technical support; L. Li, F. Raman, L. Kuenzel, T. Schifferstein, E. Herschberger, and A. Mueller for technical assistance, J. T. Lee for valuable discussion, and D. E. Elder (Hospital of the University of Pennsylvania) for providing patient material. The animals were housed at Wistar's Animal Facility. The research was funded by NIH grants P50 CA 093372, P01 CA 025874, R01 CA 047159, R01 CA 076674, P30 CA10815 and by the DFG grant R3577/ 2- 1.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Blagosklonny MV, 2005, CELL CYCLE, V4, P1693, DOI 10.4161/cc.4.12.2259; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dey BK, 2008, MOL CELL BIOL, V28, P5312, DOI 10.1128/MCB.00128-08; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grichnik JM, 2006, J INVEST DERMATOL, V126, P142, DOI 10.1038/sj.jid.5700017; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2009, MOL CELLS, V27, P497, DOI 10.1007/s10059-009-0068-1; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Lu PJ, 1999, J BIOL CHEM, V274, P15633, DOI 10.1074/jbc.274.22.15633; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2005, MODERN PATHOL, V18, P1249, DOI 10.1038/modpathol.3800413; Roesch A, 2008, INT J CANCER, V122, P1047, DOI 10.1002/ijc.23211; Roesch A, 2006, J INVEST DERMATOL, V126, P1850, DOI 10.1038/sj.jid.5700324; Satyamoorthy K, 1997, MELANOMA RES, V7, pS35; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scibetta AG, 2007, MOL CELL BIOL, V27, P7220, DOI 10.1128/MCB.00274-07; Singh SK, 2003, CANCER RES, V63, P5821; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tan K, 2003, J BIOL CHEM, V278, P20507, DOI 10.1074/jbc.M301994200; Vogt T, 1999, LAB INVEST, V79, P1615; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zabierowski SE, 2008, J CLIN ONCOL, V26, P2890, DOI 10.1200/JCO.2007.15.5465	41	834	854	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					583	594		10.1016/j.cell.2010.04.020	http://dx.doi.org/10.1016/j.cell.2010.04.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478252	Bronze, Green Accepted			2022-12-28	WOS:000277623600012
J	Stohr, K				Stoehr, Klaus			Vaccinate before the next pandemic?	NATURE			English	Editorial Material									[Stoehr, Klaus] Novartis Vaccines & Diagnost Cambridge, Cambridge, MA 02139 USA; [Stoehr, Klaus] WHO, Global Influenza Programme, CH-1211 Geneva, Switzerland	World Health Organization	Stohr, K (corresponding author), Novartis Vaccines & Diagnost Cambridge, Cambridge, MA 02139 USA.	klaus.stohr@novartis.com						Chan M., 2009, WORLD NOW START 2009; *EUR MED AG, 2010, 14 PAND PHARM UPD; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274	4	36	37	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					161	161		10.1038/465161a	http://dx.doi.org/10.1038/465161a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594SS	20463719	Bronze			2022-12-28	WOS:000277558500016
J	Jasanoff, S				Jasanoff, Sheila			Testing Time for Climate Science	SCIENCE			English	Editorial Material									Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University	Jasanoff, S (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	sheila_jasanoff@harvard.edu						Brickman R., 1985, CONTROLLING CHEM POL; Broad W., 1983, BETRAYERS TRUTH FRAU; Gieryn T.F., 1999, CULTURAL BOUNDARIES; Jasanoff Sheila, 1990, 5 BRANCH SCI ADVISER; Jowit J, 2010, GUARDIAN, P9; Merton Robert, 1973, SOCIOL SCI; National Research Council, 1983, RISK ASS FED GOV MAN; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Revkin AC, 2009, NY TIMES        1120, pA1; REVKIN AC, 2010, NY TIMES        0414; Scientific Working Group for Forensic Anthropology, 2010, SESS 2009 10, P3; Shapin S., 1985, LEVIATHAN AIR PUMP H; Stern P. C., 1996, UNDERSTANDING RISK I	13	56	57	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					695	696		10.1126/science.1189420	http://dx.doi.org/10.1126/science.1189420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592DZ	20448170				2022-12-28	WOS:000277357100022
J	Fox, DM; Markel, H				Fox, Daniel M.; Markel, Howard			Is History Relevant to Implementing Health Reform?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Markel, Howard] Univ Michigan, Sch Med, Ctr Hist Med, Simpson Inst 100, Ann Arbor, MI 48109 USA; [Fox, Daniel M.] Milbank Mem Fund, New York, NY USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, Simpson Inst 100, Box 0725,102 Observ, Ann Arbor, MI 48109 USA.	howard@umich.edu						Blumenthal David, 2009, HEART POWER HLTH POL; *CHRIST SCI MON, REF H OB MAK BIG PUS; Fox DM, 2010, CONVERGENCE OF SCIENCE AND GOVERNANCE: RESEARCH, HEALTH POLICY, AND AMERICAN STATES, P104; HACKER JS, 2002, DIVIDED WELFARE STAT, P106; Lasser KE, 2008, J GEN INTERN MED, V23, P1477, DOI 10.1007/s11606-008-0660-7; *PBS NEWSH, OB HOLDS HLTH SUMM W; SCHLESINGER AM, 1959, COMING NEW DEAL, P308; WOOLEY J, PROGR PARTY PLATFORM	8	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1749	1750		10.1001/jama.2010.556	http://dx.doi.org/10.1001/jama.2010.556			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442392				2022-12-28	WOS:000277276600029
J	van der Windt, DAWM; Jellema, P; Mulder, CJ; Kneepkens, CMF; van der Horst, HE				van der Windt, Danielle A. W. M.; Jellema, Petra; Mulder, Chris J.; Kneepkens, C. M. Frank; van der Horst, Henriette E.			Diagnostic Testing for Celiac Disease Among Patients With Abdominal Symptoms A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							IRRITABLE-BOWEL-SYNDROME; ANTI-ENDOMYSIUM ANTIBODIES; PRIMARY-CARE; TISSUE TRANSGLUTAMINASE; SEROLOGIC TESTS; TEST ACCURACY; PREVALENCE; IGA; METAANALYSIS; ASSOCIATION	Context The symptoms and consequences of celiac disease usually resolve with a lifelong gluten-free diet. However, clinical presentation is variable and most patients presenting with abdominal symptoms in primary care will not have celiac disease and unnecessary diagnostic testing should be avoided. Objective To summarize evidence on the performance of diagnostic tests for identifying celiac disease in adults presenting with abdominal symptoms in primary care or similar settings. Data Sources A literature search via MEDLINE (beginning in January 1966) and EMBASE (beginning in January 1947) through December 2009 and a manual search of references for additional relevant studies. Study Selection Diagnostic studies were selected if they had a cohort or nested case-control design, enrolled adults presenting with nonacute abdominal symptoms, the prevalence of celiac disease was 15% or less, and the tests used included gastrointestinal symptoms or serum antibody tests. Data Extraction Quality assessment using the Quality Assessment of Diagnostic Accuracy Studies tool and data extraction were performed by 2 reviewers independently. Sensitivities and specificities were calculated for each study and pooled estimates were computed using bivariate analysis if there was clinical and statistical homogeneity. Data Synthesis Sixteen studies were included in the review (N=6085 patients). The performance of abdominal symptoms varied widely. The sensitivity of diarrhea, for example, ranged from 0.27 to 0.86 and specificity from 0.21 to 0.86. Pooled estimates for IgA antiendomysial antibodies (8 studies) were 0.90 (95% confidence interval [CI], 0.80-0.95) for sensitivity and 0.99 (95% CI, 0.98-1.00) for specificity (positive likelihood ratio [LR] of 171 and negative LR of 0.11). Pooled estimates for IgA antitissue transglutaminase antibodies (7 studies) were 0.89 (95% CI, 0.82-0.94) and 0.98 (95% CI, 0.95-0.99), respectively (positive LR of 37.7 and negative LR of 0.11). The IgA and IgG antigliadin antibodies showed variable results, especially for sensitivity (range, 0.46-0.87 and range, 0.25-0.93, respectively). One recent study using diamidated gliadin peptides showed good specificity (>= 0.94), but evidence is limited in this target population. Conclusion Among adult patients presenting with abdominal symptoms in primary care or other unselected populations, IgA antitissue transglutaminase antibodies and IgA antiendomysial antibodies have high sensitivity and specificity for diagnosing celiac disease. JAMA. 2010;303(17):1738-1746 www.jama.com	[van der Windt, Danielle A. W. M.] Keele Univ, Arthrit Res UK Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England; [van der Windt, Danielle A. W. M.; Jellema, Petra; van der Horst, Henriette E.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice, EMGO Inst, Amsterdam, Netherlands; [Mulder, Chris J.] Vrije Univ Amsterdam Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands; [Kneepkens, C. M. Frank] Vrije Univ Amsterdam Med Ctr, Dept Pediat Gastroenterol, Amsterdam, Netherlands	Keele University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van der Windt, DAWM (corresponding author), Keele Univ, Arthrit Res UK Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England.	d.van.der.windt@cphc.keele.ac.uk	lopez, mal r/G-9564-2011	Kneepkens, C M Frank/0000-0001-5415-7319	Netherlands Organization for Health Research and Development, the Hague, the Netherlands [945-06-001]	Netherlands Organization for Health Research and Development, the Hague, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was supported by grant 945-06-001 from the Netherlands Organization for Health Research and Development, the Hague, the Netherlands.	[Anonymous], 2004, NIH CONSENS STATE SC, V21, P1; Berti I, 2006, DIGEST LIVER DIS, V38, P461, DOI 10.1016/j.dld.2005.12.007; BODE S, 1994, SCAND J GASTROENTERO, V29, P148, DOI 10.3109/00365529409090454; Carroccio A, 2002, CLIN CHEM, V48, P1546; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Chand N, 2006, J CLIN GASTROENTEROL, V40, P3, DOI 10.1097/01.mcg.0000190644.01661.2b; Collin P, 2002, QJM-INT J MED, V95, P75, DOI 10.1093/qjmed/95.2.75; Cranney A, 2005, GASTROENTEROLOGY, V128, pS109, DOI 10.1053/j.gastro.2005.02.019; Creed F, 2001, ANN INTERN MED, V134, P860, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00010; Dickey W, 1997, EUR J GASTROEN HEPAT, V9, P559, DOI 10.1097/00042737-199706000-00002; Dickey W, 1998, SCAND J GASTROENTERO, V33, P491; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Grisolano SW, 2004, J CLIN GASTROENTEROL, V38, P756, DOI 10.1097/01.mcg.0000139034.38568.51; Hadithi M, 2007, ANN INTERN MED, V147, P294, DOI 10.7326/0003-4819-147-5-200709040-00003; Hill ID, 2005, GASTROENTEROLOGY, V128, pS25, DOI 10.1053/j.gastro.2005.02.012; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Jellema P, 2011, COLORECTAL DIS, V13, P239, DOI 10.1111/j.1463-1318.2009.02131.x; Jellema P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1269; Leeflang MMG, 2009, J CLIN EPIDEMIOL, V62, P5, DOI 10.1016/j.jclinepi.2008.04.007; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; *MAAG LEV DARM STI, 2008, CBO RICHTL COEL DERM; *NAT GUID CLEAR, 2007, WORLD GASTR ORG PRAC; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Rashtak S, 2008, ALIMENT PHARM THER, V28, P805, DOI 10.1111/j.1365-2036.2008.03797.x; Rashtak S, 2008, CLIN GASTROENTEROL H, V6, P426, DOI 10.1016/j.cgh.2007.12.030; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Reitsma JB., 2009, COCHRANE HDB SYSTEMA; Rostami K, 1999, EUR J GASTROEN HEPAT, V11, P439, DOI 10.1097/00042737-199904000-00013; Rostom A, 2005, GASTROENTEROLOGY, V128, pS38, DOI 10.1053/j.gastro.2005.02.028; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; Sanders DS, 2001, LANCET, V358, P1504, DOI 10.1016/S0140-6736(01)06581-3; Schweizer JJ, 2004, SCAND J GASTROENTERO, V39, P359, DOI 10.1080/00365520310008503; SCOTT H, 1990, SCAND J GASTROENTERO, V25, P287, DOI 10.1080/00365521.1990.12067105; Shahbazkhani B, 2003, ALIMENT PHARM THER, V18, P231, DOI 10.1046/j.1365-2036.2003.01666.x; Tesei N, 2003, ALIMENT PHARM THERAP, V17, P1415, DOI 10.1046/j.1365-2036.2003.01595.x; Tursi A, 2001, AM J GASTROENTEROL, V96, P1507; Valdimarsson T, 1996, DIGEST DIS SCI, V41, P83, DOI 10.1007/BF02208588; van der Linden M.W., 2004, 2 NATL STUDIE NAAR Z; VANDENHEUVEL HAM, 2001, THESIS MAASTRICHT U; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; Whiting P, 2004, Health Technol Assess, V8, P1; Yagil Y, 2005, DIGEST DIS SCI, V50, P796, DOI 10.1007/s10620-005-2576-y; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zintzaras E, 2006, CLIN VACCINE IMMUNOL, V13, P187, DOI 10.1128/CVI.13.2.187-192.2006	49	111	116	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1738	1746		10.1001/jama.2010.549	http://dx.doi.org/10.1001/jama.2010.549			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442390	Bronze			2022-12-28	WOS:000277276600027
J	Donald, PR; Marais, BJ; Barry, CE				Donald, Peter R.; Marais, Ben J.; Barry, Clifton E., III			Age and the epidemiology and pathogenesis of tuberculosis	LANCET			English	Editorial Material							CHILDHOOD TUBERCULOSIS; IMMUNITY; DEFECTS; CELLS		[Donald, Peter R.; Marais, Ben J.] Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Barry, Clifton E., III] NIAID, TB Res Sect, NIH, Bethesda, MD 20892 USA	Stellenbosch University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Donald, PR (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa.	prd@sun.ac.za	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012; Marais, Ben/AAX-2626-2021	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Basu S, 2009, B MATH BIOL, V71, P1073, DOI 10.1007/s11538-009-9394-x; Bozza VV, 2007, SCAND J IMMUNOL, V66, P97, DOI 10.1111/j.1365-3083.2007.01952.x; Corsini E, 2002, J IMMUNOL, V168, P1753, DOI 10.4049/jimmunol.168.4.1753; Dannenberg AM, 2009, TUBERCULOSIS, V89, P243, DOI 10.1016/j.tube.2009.05.006; DEPERETTI E, 1978, J CLIN ENDOCR METAB, V47, P572, DOI 10.1210/jcem-47-3-572; Donald PR, 2004, INT J TUBERC LUNG D, V8, P627; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; GROTH-PETERSEN E., 1959, BULL WORLD HEALTH ORGAN, V21, P5; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Marais BJ, 2005, ANN TROP PAEDIATR, V25, P79, DOI 10.1179/146532805X45665; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; Rich A., 1951, PATHOGENESIS TUBERCU, V2nd; Smith S, 1997, J PEDIATR-US, V131, P16, DOI 10.1016/S0022-3476(97)70120-3; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106	15	113	118	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY-JUN	2010	375	9729					1852	1854		10.1016/S0140-6736(10)60580-6	http://dx.doi.org/10.1016/S0140-6736(10)60580-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609BC	20488519				2022-12-28	WOS:000278628800007
J	Lucassen, A; Parker, M				Lucassen, Anneke; Parker, Michael			Confidentiality and sharing genetic information with relatives	LANCET			English	Editorial Material							ETHICS		[Lucassen, Anneke] Univ Southampton, Sch Med, Southampton SO16 5YA, Hants, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 5YA, Hants, England; [Parker, Michael] Univ Oxford, Ethox Ctr, Oxford, England	University of Southampton; University of Oxford	Lucassen, A (corresponding author), Univ Southampton, Sch Med, Southampton SO16 5YA, Hants, England.	annekel@soton.ac.uk	Lucassen, Anneke/D-7764-2017	Lucassen, Anneke/0000-0003-3324-4338				Clarke A, 2005, EUR J HUM GENET, V13, P556, DOI 10.1038/sj.ejhg.5201394; *GEN MED COUNC, 2009, DOCT TOLD WARN PAT T; General Medical Council, 2009, NEW GUID CONF; *HL SCI TECHN COMM, 2009, GEN MED, V1; *HUM GEN COMM, 2009, CONF INF SHAR CLIN G; Human Genetics Commission, 2002, INS INF BAL INT US P; LAURIE G, 2006, DISCRETION NOT DUTY; Parker M, 2004, BRIT MED J, V329, P165, DOI 10.1136/bmj.329.7458.165; *ROYAL COLL PATH J, 2006, CONS CONF GEN PRACT; *SECR STAT HLTH, 2009, GOV RESP HOUS LORDS; Suthers GK, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039172; Verkerk M., 2005, CASE ANAL CLIN ETHIC	12	17	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1507	1509		10.1016/S0140-6736(10)60173-0	http://dx.doi.org/10.1016/S0140-6736(10)60173-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435216				2022-12-28	WOS:000277655100010
J	Kolodkin-Gal, I; Romero, D; Cao, SG; Clardy, J; Kolter, R; Losick, R				Kolodkin-Gal, Ilana; Romero, Diego; Cao, Shugeng; Clardy, Jon; Kolter, Roberto; Losick, Richard			D-Amino Acids Trigger Biofilm Disassembly	SCIENCE			English	Article							BACILLUS-SUBTILIS	Bacteria form communities known as biofilms, which disassemble over time. In our studies outlined here, we found that, before biofilm disassembly, Bacillus subtilis produced a factor that prevented biofilm formation and could break down existing biofilms. The factor was shown to be a mixture of D-leucine, D-methionine, D-tyrosine, and D-tryptophan that could act at nanomolar concentrations. D-Amino acid treatment caused the release of amyloid fibers that linked cells in the biofilm together. Mutants able to form biofilms in the presence of D-Amino acids contained alterations in a protein (YqxM) required for the formation and anchoring of the fibers to the cell. D-Amino acids also prevented biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa. D-amino acids are produced by many bacteria and, thus, may be a widespread signal for biofilm disassembly.	[Kolodkin-Gal, Ilana; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Romero, Diego; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Cao, Shugeng; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	losick@mcb.harvard.edu	Romero, Diego/D-3849-2013; Gal, Ilana Kolodkin/AFE-8494-2022	Romero, Diego/0000-0002-2052-6515; Gal, Ilana Kolodkin/0000-0002-8464-5660	NIH [GM58213, GM086258, CA24487, GM18546]; BASF; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018568, R01GM086258, F31GM018546, R01GM058213] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Norman for the analysis of table S2. I. K.-G. and D. R. are postdoctoral fellows of the Human Frontier Science Program and Fulbright/Ministerio de Educacion y Ciencia (Spain), respectively. This work was funded by NIH grants to R. K. (GM58213), J.C. (GM086258 and CA24487), and R. L. (GM18546), as well as grants from BASF to R. K. and R. L. Additionally, we have filed a patent application on the use of D-amino acids for biofilm disassembly.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	11	591	648	14	449	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					627	629		10.1126/science.1188628	http://dx.doi.org/10.1126/science.1188628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431016	Green Accepted			2022-12-28	WOS:000277159800045
J	Primack, J				Primack, Joel			Hidden Growth of Supermassive Black Holes in Galaxy Mergers	SCIENCE			English	Editorial Material							COEVOLUTION; SIMULATIONS; QUASARS; MASS		Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Primack, J (corresponding author), Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA.	joel@scipp.ucsc.edu						Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Hopkins PF, 2008, ASTROPHYS J SUPPL S, V175, P390, DOI 10.1086/524363; Lotz JM, 2008, MON NOT R ASTRON SOC, V391, P1137, DOI 10.1111/j.1365-2966.2008.14004.x; Melia F, 2007, GALACTIC SUPERMASSIV; PRIMACK JR, 2006, VIEW CTR UNIVERSE DI; Somerville RS, 2008, MON NOT R ASTRON SOC, V391, P481, DOI 10.1111/j.1365-2966.2008.13805.x; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Treister E, 2010, SCIENCE, V328, P600, DOI 10.1126/science.1184246; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002	9	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					576	578		10.1126/science.1189695	http://dx.doi.org/10.1126/science.1189695			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431002				2022-12-28	WOS:000277159800027
J	Najafi-Shoushtari, SH; Kristo, F; Li, YX; Shioda, T; Cohen, DE; Gerszten, RE; Naar, AM				Najafi-Shoushtari, S. Hani; Kristo, Fjoralba; Li, Yingxia; Shioda, Toshi; Cohen, David E.; Gerszten, Robert E.; Naeaer, Anders M.			MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis	SCIENCE			English	Article							IN-VIVO; INTRONIC MICRORNAS; METABOLISM; ABCA1; ATHEROSCLEROSIS; COEXPRESSION; MECHANISM; TRANSPORT; EFFLUX; LIVER	Proper coordination of cholesterol biosynthesis and trafficking is essential to human health. The sterol regulatory element-binding proteins (SREBPs) are key transcription regulators of genes involved in cholesterol biosynthesis and uptake. We show here that microRNAs (miR-33a/b) embedded within introns of the SREBP genes target the adenosine triphosphate-binding cassette transporter A1 (ABCA1), an important regulator of high-density lipoprotein (HDL) synthesis and reverse cholesterol transport, for posttranscriptional repression. Antisense inhibition of miR-33 in mouse and human cell lines causes up-regulation of ABCA1 expression and increased cholesterol efflux, and injection of mice on a western-type diet with locked nucleic acid-antisense oligonucleotides results in elevated plasma HDL. Our findings indicate that miR-33 acts in concert with the SREBP host genes to control cholesterol homeostasis and suggest that miR-33 may represent a therapeutic target for ameliorating cardiometabolic diseases.	[Najafi-Shoushtari, S. Hani; Shioda, Toshi; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Najafi-Shoushtari, S. Hani; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kristo, Fjoralba; Gerszten, Robert E.] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Li, Yingxia; Cohen, David E.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Gerszten, Robert E.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu		Najafi-Shoushtari, Hani/0000-0002-7562-4083; Kristo, Fjoralba/0000-0002-8045-9756	NIH [R01GM071449, R21DK084459, R01DK56626, R01DK48873, P30 DK34854]; American Heart Association; Fondation Leducq; Massachusetts Biomedical Research Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056626, R21DK084459, R37DK048873, R01DK048873, P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fondation Leducq(Leducq Foundation); Massachusetts Biomedical Research Corporation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Vasudevan and A. Walker for critical reading of the manuscript and K. Coser for technical assistance. This work was supported by the following funding sources: NIH R01GM071449 and R21DK084459 (A.M.N.), R01DK56626, R01DK48873, and P30 DK34854 (D. E. C.), American Heart Association Established Investigator Award (R. E. G.), the Fondation Leducq (R. E. G.), and Massachusetts Biomedical Research Corporation Tosteson Fellowship Award (S.H.N.-S.). A.M.N. and Massachusetts General Hospital have filed a patent application relating to the therapeutic use of antisense oligonucleotides directed against miR-33.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	29	733	787	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1566	1569		10.1126/science.1189123	http://dx.doi.org/10.1126/science.1189123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20466882	Green Accepted			2022-12-28	WOS:000278859200049
J	Kingsdale, J				Kingsdale, Jon			Health Insurance Exchanges -- Key Link in a Better-Value Chain.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		DAVIS K, 2009, DRIVING COMPETITION; DAY R, 2010, COMMONWEALTH CHOICE; *HJ KAIS FAM FDN, 2009, EXPL HLTH CAR REF WH; *HLTH CONN, 2009, REP MASS LEG IMPL HL; MILLER K, 2010, FY 11 ADMIN BUDGET P	5	12	12	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2147	2150		10.1056/NEJMp1004758	http://dx.doi.org/10.1056/NEJMp1004758			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608AL	20463329				2022-12-28	WOS:000278551500002
J	Rosenbaum, S				Rosenbaum, Sara			A "Customary and Necessary" Program - Medicaid and Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.							[Anonymous], 2010, COMMUNICATION   0320; BARNETT R, 2009, 49 HER FDN; *UN HLTH, 2010, 3 UN HLTH; 2009, KAISER STATE HLTH FA	4	17	17	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1952	1955		10.1056/NEJMp1003890	http://dx.doi.org/10.1056/NEJMp1003890			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601JI	20445164				2022-12-28	WOS:000278054000002
J	Dheda, K; Shean, K; Zumla, A; Badri, M; Streicher, EM; Page-Shipp, L; Willcox, P; John, MA; Reubenson, G; Govindasamy, D; Wong, M; Padanilam, X; Dziwiecki, A; van Helden, PD; Siwendu, S; Jarand, J; Menezes, CN; Burns, A; Victor, T; Warren, R; Grobusch, MP; van der Walt, M; Kvasnovsky, C				Dheda, Keertan; Shean, Karen; Zumla, Alimuddin; Badri, Motasim; Streicher, Elizabeth M.; Page-Shipp, Liesl; Willcox, Paul; John, Melanie-Anne; Reubenson, Gary; Govindasamy, Darshini; Wong, Michelle; Padanilam, Xavier; Dziwiecki, Alicia; van Helden, Paul D.; Siwendu, Sweetness; Jarand, Julie; Menezes, Colin N.; Burns, Avril; Victor, Thomas; Warren, Robin; Grobusch, Martin P.; van der Walt, Martie; Kvasnovsky, Charlotte			Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study	LANCET			English	Article							SUB-SAHARAN AFRICA; MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; XDR-TB; DIAGNOSIS; STRAIN; SUSCEPTIBILITY; MANAGEMENT; MODEL	Background Data from Kwazulu Natal, South Africa, suggest that almost all patients with extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there are few data for the treatment-related outcomes of XDR tuberculosis in settings with a high HIV prevalence, we investigated the associations of these diseases in such settings to formulate recommendations for control programmes. Methods In a retrospective cohort study, we analysed the case records of patients (>16 years old) with XDR tuberculosis (culture-proven at diagnosis) between August, 2002, and February, 2008, at four designated provincial treatment facilities in South Africa. We used Cox proportional hazards regression models to assess risk factors associated with the outcomes mortality and culture conversion. Findings 195 of 227 patients were analysed. 21 died before initiation of any treatment, and 174 patients (82 with HIV infection) were treated. 62 (36%) of these patients died during follow-up. The number of deaths was not significantly different in patients with or without HIV infection: 34 (41%) of 82 versus 28 (30%) of 92 (p=0.13). Treatment with moxifloxacin (hazard ratio 0.11, 95% CI 0.01-0.82; p=0.03), previous culture-proven multidrug-resistant tuberculosis (5.21, 1.93-14.1; p=0.001), and number of drugs used in a regimen (0.59, 0.45-0.78, p<0.0001) were independent predictors of death. Fewer deaths occurred in patients with HIV infection given highly active antiretroviral therapy than in those who were not (0.38, 0.18-0.80; p=0.01). 33 (19%) of 174 patients showed culture conversion, of which 23 (70%) converted within 6 months of initiation of treatment. Interpretation In South Africa, patients with XDR tuberculosis, a substantial proportion of whom are not infected with HIV, have poor management outcomes. Nevertheless, survival in patients with HIV infection is better than previously reported. The priorities for the country are still prevention of XDR tuberculosis, and early detection and management of multidrug-resistant and XDR tuberculosis through strengthened programmes and laboratory capacity.	[Dheda, Keertan; Shean, Karen; Badri, Motasim; Willcox, Paul; Govindasamy, Darshini] Univ Cape Town, Dept Med, Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Shean, Karen; Badri, Motasim; Willcox, Paul; Govindasamy, Darshini] Div Pulmonol, Lung Infect & Immun Unit, Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan; Zumla, Alimuddin] UCL, Dept Infect, Ctr Infect Dis & Int Hlth, London, England; [Padanilam, Xavier; Dziwiecki, Alicia; Grobusch, Martin P.] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Div Clin Microbiol & Infect Dis, Johannesburg, South Africa; [John, Melanie-Anne; Menezes, Colin N.; Grobusch, Martin P.] Univ Witwatersrand, Fac Hlth Sci, Div Infect Dis, Johannesburg, South Africa; [Reubenson, Gary] Univ Witwatersrand, Dept Paediat, Johannesburg, South Africa; [Menezes, Colin N.] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Wong, Michelle] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Johannesburg, South Africa; [Streicher, Elizabeth M.; van Helden, Paul D.; Victor, Thomas; Warren, Robin] Univ Stellenbosch, Dept Sci & Technol, Natl Res Fdn Ctr Excellence Biomed TB Res,Fac Hlt, Med Res Council Ctr Mol & Cellular Biol,Div Mol B, ZA-7505 Tygerberg, South Africa; [Siwendu, Sweetness; Burns, Avril] Brooklyn TB Chest Hosp, Cape Town, South Africa; [Page-Shipp, Liesl] Right Care, Johannesburg, South Africa; [Jarand, Julie] Univ Calgary, Calgary, AB, Canada; [van der Walt, Martie; Kvasnovsky, Charlotte] Med Res Council Pretoria, TB Epidemiol & Intervent Res Unit, Pretoria, South Africa; [Kvasnovsky, Charlotte] Emory Sch Med, Atlanta, GA USA; [Kvasnovsky, Charlotte] Rollins Sch Publ Hlth, Atlanta, GA USA	University of Cape Town; University of Cape Town; University of London; University College London; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; University of Calgary; Emory University; Emory University; Rollins School Public Health	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, H Floor,Old Main Bldg, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	ZUMLA, Alimuddin/ABA-8208-2020; Streicher, Elizabeth M/I-7780-2018; Streicher, Elizabeth/O-9597-2019; van der Walt, Martie/CAH-0101-2022; Badri, Motasim/E-1141-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Streicher, Elizabeth M/0000-0003-3901-1981; Streicher, Elizabeth/0000-0003-3901-1981; van der Walt, Martie/0000-0001-9987-3167; Warren, Robin/0000-0001-5741-7358; Badri, Motasim/0000-0002-5268-6492; Menezes, Colin/0000-0003-3838-5359	South African Research Chair Initiative; South African Medical Research Council; EU; European Developing Countries Clinical Trials Partnership (EDCTP); UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre; EuropeAID	South African Research Chair Initiative; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); European Developing Countries Clinical Trials Partnership (EDCTP); UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre; EuropeAID	KD and this work was supported by a South African Research Chair Initiative award, a South African Medical Research Council Career Development Fellowship, the EU (FW7-TBsusgent) and the European Developing Countries Clinical Trials Partnership (EDCTP). AZ acknowledges support from the UK University College London Hospital National Health Service-Comprehensive Biomedical Research Centre, EU(FW7-TBsusgent and TrDNA), EDCTP, and EuropeAID. We thank the management and staff of the following provincial tuberculosis facilities where the data was obtained: Brooklyn Chest Hospital (Cape Town, Western Cape), Josie Pearson Hospital (Port Elizabeth, Eastern Cape), Sizwe Hospital (Johannesburg, Gauteng), and Gordonia Hospital (Upington, Northern Cape). We are grateful for the assistance of the staff of the national and provincial tuberculosis programme, including Marlein Bosman, Gerrit Coetzee, Lindiwe Mvusi, Krish Vallabhjee, Jimmy Ledwaba, John Simpson, and Phyllis Baitiswe; and Gary Maartens for his helpful suggestions about the report.	Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Chan ED, 2008, NEW ENGL J MED, V359, P657, DOI 10.1056/NEJMc0706556; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Isenberg HD, 2004, CLIN MICROBIOLOGY PR; Jones KDJ, 2008, T ROY SOC TROP MED H, V102, P219, DOI 10.1016/j.trstmh.2007.11.014; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Kam KM, 2006, MICROB DRUG RESIST, V12, P7, DOI 10.1089/mdr.2006.12.7; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Migliori GB, 2008, EUR RESPIR J, V31, P904, DOI 10.1183/09031936.00159807; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2008, CAN J INFECT DIS MED, V19, P169, DOI 10.1155/2008/857901; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Padayatchi N, 2008, INT J TUBERC LUNG D, V12, P978; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2007, J INFECT DIS, V196, P191, DOI 10.1086/518937; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; van Rie A, 1999, J INFECT DIS, V180, P1608, DOI 10.1086/315054; Via LE, 2010, J CLIN MICROBIOL, V48, P402, DOI 10.1128/JCM.01476-09; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; WHO, 2004, INT POL COLL TB HIV	41	188	194	1	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1798	1807		10.1016/S0140-6736(10)60492-8	http://dx.doi.org/10.1016/S0140-6736(10)60492-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20488525	Green Accepted			2022-12-28	WOS:000278216500031
J	Nelson, KE; Weinstock, GM; Highlander, SK; Worley, KC; Creasy, HH; Wortman, JR; Rusch, DB; Mitreva, M; Sodergren, E; Chinwalla, AT; Feldgarden, M; Gevers, D; Haas, BJ; Madupu, R; Ward, DV; Birren, B; Gibbs, RA; Methe, B; Petrosino, JF; Strausberg, RL; Sutton, GG; White, OR; Wilson, RK; Durkin, S; Gujja, S; Howarth, C; Kodira, CD; Kyrpides, N; Madupu, R; Mehta, T; Mitreva, M; Muzny, DM; Pearson, M; Pepin, K; Pati, A; Qin, X; Yandava, C; Zeng, QD; Zhang, L; Berlin, AM; Chen, L; Hepburn, TA; Johnson, J; McCorrison, J; Miller, J; Minx, P; Nusbaum, C; Russ, C; Sutton, GG; Sykes, SM; Tomlinson, CM; Young, S; Warren, WC; Badger, J; Crabtree, J; Madupu, R; Markowitz, VM; Orvis, J; Rusch, DB; Sutton, GG; Cree, A; Ferriera, S; Gillis, M; Hemphill, LD; Joshi, V; Kovar, C; Wetterstrand, KA; Abouellleil, A; Wollam, AM; Buhay, CJ; Ding, Y; Dugan, S; Fulton, LL; Fulton, RS; Holder, M; Hostetler, J; Sutton, GG; Allen-Vercoe, E; Badger, J; Clifton, SW; Earl, AM; Farmer, CN; Giglio, MG; Liolios, K; Surette, MG; Sutton, GG; Torralba, M; Xu, Q; Pohl, C; Durkin, S; Sutton, GG; Wilczek-Boney, K; Zhu, DH				Nelson, Karen E.; Weinstock, George M.; Highlander, Sarah K.; Worley, Kim C.; Creasy, Heather Huot; Wortman, Jennifer Russo; Rusch, Douglas B.; Mitreva, Makedonka; Sodergren, Erica; Chinwalla, Asif T.; Feldgarden, Michael; Gevers, Dirk; Haas, Brian J.; Madupu, Ramana; Ward, Doyle V.; Birren, BruceW.; Gibbs, Richard A.; Methe, Barbara; Petrosino, Joseph F.; Strausberg, Robert L.; Sutton, Granger G.; White, Owen R.; Wilson, Richard K.; Durkin, Scott; Gujja, Sharvari; Howarth, Clint; Kodira, Chinnappa D.; Kyrpides, Nikos; Madupu, Ramana; Mehta, Teena; Mitreva, Makedonka; Muzny, Donna M.; Pearson, Matthew; Pepin, Kymberlie; Pati, Amrita; Qin, Xiang; Yandava, Chandri; Zeng, Qiandong; Zhang, Lan; Berlin, Aaron M.; Chen, Lei; Hepburn, Theresa A.; Johnson, Justin; McCorrison, Jamison; Miller, Jason; Minx, Pat; Nusbaum, Chad; Russ, Carsten; Sutton, Granger G.; Sykes, Sean M.; Tomlinson, Chad M.; Young, Sarah; Warren, Wesley C.; Badger, Jonathan; Crabtree, Jonathan; Madupu, Ramana; Markowitz, Victor M.; Orvis, Joshua; Rusch, Douglas B.; Sutton, Granger G.; Cree, Andrew; Ferriera, Steve; Gillis, Marcus; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Wetterstrand, Kris A.; Abouellleil, Amr; Wollam, Aye M.; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Fulton, Lucinda L.; Fulton, Robert S.; Holder, Mike; Hostetler, Jessica; Sutton, Granger G.; Allen-Vercoe, Emma; Badger, Jonathan; Clifton, Sandra W.; Earl, Ashlee M.; Farmer, Candace N.; Giglio, Michelle Gwinn; Liolios, Konstantinos; Surette, Michael G.; Sutton, Granger G.; Torralba, Manolito; Xu, Qiang; Pohl, Craig; Durkin, Scott; Sutton, Granger G.; Wilczek-Boney, Katarzyna; Zhu, Dianhui		Human Microbiome Jumpstart	A Catalog of Reference Genomes from the Human Microbiome	SCIENCE			English	Article							GUT MICROBIOME; PAN-GENOME	The human microbiome refers to the community of microorganisms, including prokaryotes, viruses, and microbial eukaryotes, that populate the human body. The National Institutes of Health launched an initiative that focuses on describing the diversity of microbial species that are associated with health and disease. The first phase of this initiative includes the sequencing of hundreds of microbial reference genomes, coupled to metagenomic sequencing from multiple body sites. Here we present results from an initial reference genome sequencing of 178 microbial genomes. From 547,968 predicted polypeptides that correspond to the gene complement of these strains, previously unidentified ("novel") polypeptides that had both unmasked sequence length greater than 100 amino acids and no BLASTP match to any nonreference entry in the nonredundant subset were defined. This analysis resulted in a set of 30,867 polypeptides, of which 29,987 (similar to 97%) were unique. In addition, this set of microbial genomes allows for similar to 40% of random sequences from the microbiome of the gastrointestinal tract to be associated with organisms based on the match criteria used. Insights into pan-genome analysis suggest that we are still far from saturating microbial species genetic data sets. In addition, the associated metrics and standards used by our group for quality assurance are presented.	[Nelson, Karen E.; Rusch, Douglas B.; Methe, Barbara; Strausberg, Robert L.; Sutton, Granger G.; Durkin, Scott; Johnson, Justin; McCorrison, Jamison; Miller, Jason; Ferriera, Steve; Gillis, Marcus; Hostetler, Jessica; Torralba, Manolito] J Craig Venter Inst, Rockville, MD 20850 USA; [Weinstock, George M.; Mitreva, Makedonka; Sodergren, Erica; Chinwalla, Asif T.; Wilson, Richard K.; Pepin, Kymberlie; Chen, Lei; Minx, Pat; Tomlinson, Chad M.; Warren, Wesley C.; Wollam, Aye M.; Fulton, Lucinda L.; Fulton, Robert S.; Clifton, Sandra W.; Farmer, Candace N.; Pohl, Craig] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Highlander, Sarah K.; Worley, Kim C.; Gibbs, Richard A.; Petrosino, Joseph F.; Muzny, Donna M.; Qin, Xiang; Zhang, Lan; Cree, Andrew; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Holder, Mike; Wilczek-Boney, Katarzyna; Zhu, Dianhui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Highlander, Sarah K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Gibbs, Richard A.; Qin, Xiang; Zhang, Lan; Cree, Andrew; Hemphill, Lisa D.; Joshi, Vandita; Kovar, Christie; Buhay, Christian J.; Ding, Yan; Dugan, Shannon; Holder, Mike; Wilczek-Boney, Katarzyna; Zhu, Dianhui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Creasy, Heather Huot; Wortman, Jennifer Russo; White, Owen R.; Crabtree, Jonathan; Orvis, Joshua; Giglio, Michelle Gwinn] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Genet, Dept Med, Baltimore, MD 21201 USA; [Feldgarden, Michael; Gevers, Dirk; Haas, Brian J.; Ward, Doyle V.; Birren, BruceW.; Gujja, Sharvari; Howarth, Clint; Mehta, Teena; Mitreva, Makedonka; Pearson, Matthew; Yandava, Chandri; Zeng, Qiandong; Berlin, Aaron M.; Hepburn, Theresa A.; Nusbaum, Chad; Russ, Carsten; Sykes, Sean M.; Young, Sarah; Abouellleil, Amr; Earl, Ashlee M.] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA; Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Kodira, Chinnappa D.] Genome Sequencing & Anal Program, Branford, CT 06405 USA; [Kyrpides, Nikos; Pati, Amrita; Liolios, Konstantinos] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Badger, Jonathan] J Craig Venter Inst, La Jolla, CA 92121 USA; [Markowitz, Victor M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Biol Data Management & Technol Ctr, Berkeley, CA 94720 USA; [Wetterstrand, Kris A.] NHGRI, Bethesda, MD 20892 USA; [Allen-Vercoe, Emma] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Surette, Michael G.] Univ Calgary, Calgary, AB T2N 4N1, Canada; [Xu, Qiang] Osel Inc, Santa Clara, CA 95054 USA	J. Craig Venter Institute; Washington University (WUSTL); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Guelph; University of Calgary	Nelson, KE (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	kenelson@jcvi.org	Gevers, Dirk/C-1451-2009; Weinstock, George M/C-6314-2013; Berlin, Aaron M/AFY-6549-2022; Wilson, Richard K./AAF-4139-2019; Kyrpides, Nikos C./A-6305-2014; Petrosino, Joseph F./AAF-1621-2019; Zeng, Qiandong/AAF-3305-2019; Surette, Michael G/AAE-8825-2020	Weinstock, George M/0000-0002-2997-4592; Berlin, Aaron M/0000-0002-0714-2808; Wilson, Richard K./0000-0002-1992-1358; Kyrpides, Nikos C./0000-0002-6131-0462; Chinwalla, Asif/0000-0001-7831-3996; Worley, Kim/0000-0002-0282-1000; Earl, Ashlee/0000-0001-7857-9145; Wortman, Jennifer/0000-0002-8713-1227; Mitreva, Makedonka/0000-0001-9572-3436	NIH [N01 AI 30071, U54-AI084844, U54-HG003079, U54-HG004968, U54-HG003273, U54-HG004973, HHSN272200900017C, U54-HG004969]; Crohn's and Colitis Foundation of Canada; Fund for Scientific Research, Flanders (Belgium); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG003273, U54HG004973, U54HG003067, U54HG004969, U54HG003079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI084844] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of Canada; Fund for Scientific Research, Flanders (Belgium)(FWO); Canadian Cystic Fibrosis Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge J. Warren, J. Zhang, R. G. Fowler, P. Pham, D. Haft, J. Selengut, T. Davidsen, P. Goetz, D. Harkins, S. Shrivastava, S. Koren, B. Walenz, L. Foster, I. Singh, Y.-h. Rogers, and the J. Craig Venter Institute Joint Technology Center. We thank J. Xu, S.-P. Yang, and S. Schobel for bioinformatics support; the Broad Genome Sequencing Platform, Y. Han, V. Korchina, M. Scheel, R. Thornton and the BCM-HGSC production team, L. Courntey, C. Fronick, O. Hall, M. O'Laughlin, M. Cunningham, D. O'Brien, B. Theising, and the GCWU production team for sequencing; J. Gordon, F. Dewhirst, B. Wilson, B. White, R. Mandrell, M. Blaser, R. H. Stevens, S. Hillier, Y. Liu, Z. Shen, D. Schauer, J. Fox, M. Allison, C. D. Sibley, D. M. Saulnier, and G. R. Gibson for providing strains; and M. Y. Giovanni, C. L. Baker, V. Bonazzi, C. D. Deal, S. Garges, R. W. Karp, R. W. Lunsford, J. Peterson, M. Wright, T. T. Belachew, and C. R. Wellington for funding agency management. We acknowledge NIH for funding this project with grants to the J. Craig Venter Institute (grants N01 AI 30071 and U54-AI084844), Washington University (grants U54-HG003079 and U54-HG004968), Baylor College of Medicine (grants U54-HG003273 and U54-HG004973), and the Broad Institute (grants HHSN272200900017C and U54-HG004969). Funding for E. A.-V. was from the Crohn's and Colitis Foundation of Canada; D. G. had secondary affiliation at the Laboratory of Microbiology (WE 10), Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, KL Ledeganckstraat 35, 9000 Ghent, Belgium, and is indebted to the Fund for Scientific Research, Flanders (Belgium), for a postdoctoral fellowship and research funding for the duration of this project; M. S. acknowledges the Canadian Cystic Fibrosis Foundation and the Canadian Institutes of Health Research for funding of his research for this project.	Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GIOVANNI MY, GENOME SEQUENCING CT; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Li WZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003375; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	15	467	481	1	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					994	999		10.1126/science.1183605	http://dx.doi.org/10.1126/science.1183605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489017	Green Accepted			2022-12-28	WOS:000277877100032
J	Perets, HB; Gal-Yam, A; Mazzali, PA; Arnett, D; Kagan, D; Filippenko, AV; Li, W; Arcavi, I; Cenko, SB; Fox, DB; Leonard, DC; Moon, DS; Sand, DJ; Soderberg, AM; Anderson, JP; James, PA; Foley, RJ; Ganeshalingam, M; Ofek, EO; Bildsten, L; Nelemans, G; Shen, KJ; Weinberg, NN; Metzger, BD; Piro, AL; Quataert, E; Kiewe, M; Poznanski, D				Perets, H. B.; Gal-Yam, A.; Mazzali, P. A.; Arnett, D.; Kagan, D.; Filippenko, A. V.; Li, W.; Arcavi, I.; Cenko, S. B.; Fox, D. B.; Leonard, D. C.; Moon, D. -S.; Sand, D. J.; Soderberg, A. M.; Anderson, J. P.; James, P. A.; Foley, R. J.; Ganeshalingam, M.; Ofek, E. O.; Bildsten, L.; Nelemans, G.; Shen, K. J.; Weinberg, N. N.; Metzger, B. D.; Piro, A. L.; Quataert, E.; Kiewe, M.; Poznanski, D.			A faint type of supernova from a white dwarf with a helium-rich companion	NATURE			English	Article							CORE-COLLAPSE SUPERNOVAE; IA SUPERNOVA; GALAXIES; MODELS; STAR; TELESCOPE	Supernovae are thought to arise from two different physical processes. The cores of massive, short-lived stars undergo gravitational core collapse and typically eject a few solar masses during their explosion. These are thought to appear as type Ib/c and type II supernovae, and are associated with young stellar populations. In contrast, the thermonuclear detonation of a carbon-oxygen white dwarf, whose mass approaches the Chandrasekhar limit, is thought to produce type Ia supernovae(1,2). Such supernovae are observed in both young and old stellar environments. Here we report a faint type Ib supernova, SN 2005E, in the halo of the nearby isolated galaxy, NGC 1032. The 'old' environment near the supernova location, and the very low derived ejected mass (similar to 0.3 solar masses), argue strongly against a core-collapse origin. Spectroscopic observations and analysis reveal high ejecta velocities, dominated by helium-burning products, probably excluding this as a subluminous(3,4) or a regular(1) type Ia supernova. We conclude that it arises from a low-mass, old progenitor, likely to have been a helium-accreting white dwarf in a binary. The ejecta contain more calcium than observed in other types of supernovae and probably large amounts of radioactive (44)Ti.	[Perets, H. B.; Gal-Yam, A.; Arcavi, I.; Kiewe, M.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, Fac Phys, IL-76100 Rehovot, Israel; [Perets, H. B.; Sand, D. J.; Soderberg, A. M.; Foley, R. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Mazzali, P. A.] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Mazzali, P. A.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Mazzali, P. A.] INAF Oss Astron Padova, I-35122 Padua, Italy; [Arnett, D.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Kagan, D.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Filippenko, A. V.; Li, W.; Cenko, S. B.; Ganeshalingam, M.; Weinberg, N. N.; Metzger, B. D.; Piro, A. L.; Quataert, E.; Poznanski, D.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Fox, D. B.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Leonard, D. C.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Moon, D. -S.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Sand, D. J.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Anderson, J. P.] Univ Chile, Dept Astron, Camino El Observ, Santiago, Chile; [Anderson, J. P.; James, P. A.] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Ofek, E. O.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Bildsten, L.; Shen, K. J.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Bildsten, L.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Nelemans, G.] Radboud Univ Nijmegen, Dept Astrophys, NL-6500 GL Nijmegen, Netherlands; [Poznanski, D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Weizmann Institute of Science; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Scuola Normale Superiore di Pisa; Max Planck Society; University of Padua; University of Arizona; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; California State University System; San Diego State University; University of Toronto; Universidad de Chile; Liverpool John Moores University; California Institute of Technology; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Radboud University Nijmegen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Gal-Yam, A (corresponding author), Weizmann Inst Sci, Dept Particle Phys & Astrophys, Fac Phys, IL-76100 Rehovot, Israel.	hperets@cfa.harvard.edu; avishay.gal-yam@weizmann.ac.il	Nelemans, Gijs/D-3177-2012; Perets, Hagai B/K-9605-2015	Nelemans, Gijs/0000-0002-0752-2974; Perets, Hagai B/0000-0002-5004-199X; Foley, Ryan/0000-0002-2445-5275; James, Philip/0000-0003-4131-5183; Anderson, Joseph/0000-0003-0227-3451; Weinberg, Nevin/0000-0001-9194-2084; Fox, Derek/0000-0002-3714-672X; Shen, Ken/0000-0002-9632-6106; Mazzali, Paolo/0000-0001-6876-8284; Poznanski, Dovi/0000-0003-1470-7173	ISF/FIRST Fellowship; Ilan Ramon-Fulbright Fellowship; Weizmann-Minerva grant; Israeli Science Foundation; EU; Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; US National Science Foundation; US Department of Energy; Richard and Rhoda Goldman Fund; Sylvia & Jim Katzman Foundation; TABASGO Foundation; Science and Technology Facilities Council [PP/E001149/1, ST/H002391/1] Funding Source: researchfish; STFC [PP/E001149/1, ST/H002391/1] Funding Source: UKRI	ISF/FIRST Fellowship(Israel Science Foundation); Ilan Ramon-Fulbright Fellowship; Weizmann-Minerva grant; Israeli Science Foundation(Israel Science Foundation); EU(European Commission); Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; US National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Richard and Rhoda Goldman Fund; Sylvia & Jim Katzman Foundation; TABASGO Foundation; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank P. Podsiadlowski, E. Nakar and D. Maoz for comments. We acknowledge observations with the Liverpool Telescope, and various telescopes at the Lick, Palomar and Keck Observatories. We are grateful to the staffs of these observatories, as well as to the institutions, agencies and companies funding these facilities. This research also made use of the NASA/IPAC Extragalactic Database (NED). H. B. P. acknowledges the ISF/FIRST and Ilan Ramon-Fulbright Fellowships, and is a Harvard-Smithsonian Center for Astrophysics Fellow. The collaborative work of A.G.-Y. and P. A. M. is supported by a Weizmann-Minerva grant. A.G.-Y. acknowledges further support by the Israeli Science Foundation, an EU Seventh Framework Programme Marie Curie IRG Fellowship, the Benoziyo Center for Astrophysics, and the Peter and Patricia Gruber Awards. A. V. F. is grateful for the support of the US National Science Foundation, the US Department of Energy, Gary and Cynthia Bengier, the Richard and Rhoda Goldman Fund, the Sylvia & Jim Katzman Foundation, and the TABASGO Foundation. R.J.F. is a Clay Fellow.	Bildsten L, 2007, ASTROPHYS J, V662, pL95, DOI 10.1086/519489; CHAN K, 1993, ASTROPHYS J, V405, P614, DOI 10.1086/172393; de Plaa J, 2007, ASTRON ASTROPHYS, V465, P345, DOI 10.1051/0004-6361:20066382; Filippenko A. V, 2003, IAU CIRC, V8159, P2; FILIPPENKO AV, 1992, ASTRON J, V104, P1543, DOI 10.1086/116339; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Filippenko AV, 2001, ASTR SOC P, V246, P121; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Hakobyan AA, 2008, ASTRON ASTROPHYS, V488, P523, DOI 10.1051/0004-6361:200809817; IBEN I, 1987, ASTROPHYS J, V317, P717, DOI 10.1086/165318; Kasliwal MM, 2008, ASTROPHYS J LETT, V683, pL29, DOI 10.1086/591521; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Knodlseder J, 2005, ASTRON ASTROPHYS, V441, P513, DOI 10.1051/0004-6361:20042063; Kondo Y., 1991, APJ, V367, pL19; Lai DK, 2009, ASTROPHYS J LETT, V697, pL63, DOI 10.1088/0004-637X/697/1/L63; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; LIVNE E, 1995, ASTROPHYS J, V452, P62, DOI 10.1086/176279; Maund JR, 2005, MON NOT R ASTRON SOC, V360, P288, DOI [10.1111/j.1365-2966.2005.09034.x, 10.1111/j.1365-2966.20O5.09034.x]; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; Metzger BD, 2009, MON NOT R ASTRON SOC, V396, P1659, DOI 10.1111/j.1365-2966.2009.14909.x; Prada F, 2003, ASTROPHYS J, V598, P260, DOI 10.1086/378669; The LS, 2006, ASTRON ASTROPHYS, V450, P1037, DOI 10.1051/0004-6361:20054626; Timmes FX, 1996, ASTROPHYS J, V464, P332, DOI 10.1086/177323; Valenti S, 2009, NATURE, V459, P674, DOI 10.1038/nature08023; van den Bergh S, 2005, PUBL ASTRON SOC PAC, V117, P773, DOI 10.1086/431435; WOOSLEY SE, 1994, ASTROPHYS J, V423, P371, DOI 10.1086/173813; WOOSLEY SE, 1986, ASTROPHYS J, V301, P601, DOI 10.1086/163926; WOOSLEY SE, 1973, ASTROPHYS J SUPPL S, V26, P231, DOI 10.1086/190282	28	236	236	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					322	325		10.1038/nature09056	http://dx.doi.org/10.1038/nature09056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485429	Green Submitted, Green Accepted			2022-12-28	WOS:000277829200034
J	Ren, DJ				Ren, Dejian			Sperm and the Proton Channel	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FERTILITY; MOTILITY		Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania	Ren, DJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	5	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1934	1935		10.1056/NEJMcibr1001843	http://dx.doi.org/10.1056/NEJMcibr1001843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484401				2022-12-28	WOS:000277815600016
J	Dispenzieri, A; Katzmann, JA; Kyle, RA; Larson, DR; Melton, LJ; Colby, CL; Therneau, TM; Clark, R; Kumar, SK; Bradwell, A; Fonseca, R; Jelinek, DF; Rajkumar, SV				Dispenzieri, Angela; Katzmann, Jerry A.; Kyle, Robert A.; Larson, Dirk R.; Melton, L. Joseph, III; Colby, Colin L.; Therneau, Terry M.; Clark, Raynell; Kumar, Shaji K.; Bradwell, Arthur; Fonseca, Rafael; Jelinek, D. F.; Rajkumar, S. Vincent			Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study	LANCET			English	Article							PRECEDES MULTIPLE-MYELOMA; LONG-TERM; SIGNIFICANCE MGUS; SERUM	Background Monoclonal gammopathy of undetermined significance (MGUS) is defined by expression of heavy-chain immunoglobulin (IgH) and is the precursor lesion for 80% of cases of multiple myeloma. The remaining 20% are characterised by absence of IgH expression; we aimed to assess prevalence of a corresponding precursor entity, light-chain MGUS. Methods We used a population-based cohort, previously assembled to estimate MGUS prevalence, of 21 463 residents of Olmsted County, MN, USA, aged 50 years and older. We did a serum free light-chain assay on all samples with sufficient serum remaining, and immunofixation electrophoresis was done for all samples with an abnormal free light-chain ratio or abnormal protein electrophoresis results from the original study. Light-chain MGUS was defined as an abnormal free light-chain ratio with no IgH expression, plus increased concentration of the involved light chain. We calculated age-specific and sex-specific prevalence and rates of progression to lymphoproliferative disorders for light-chain and conventional MGUS and assessed incidence of renal disorders in patients with light-chain MGUS. Findings 610 (3.3%) of 18 357 people tested had an abnormal free light-chain ratio, of whom 213 had IgH expression that was diagnostic of conventional MGUS. 146 of the remaining 397 individuals had an increase of at least one free light chain and met criteria for light-chain MGUS. Prevalence of light-chain MGUS was 0.8% (95% CI 0.7-0.9), contributing to an overall MGUS prevalence of 4.2% (3.9-4.5). Risk of progression to multiple myeloma in patients with light-chain MGUS was 0.3% (0.1-0.8) per 100 person-years. 30 (23%) of 129 patients with light-chain MGUS were diagnosed with renal disease. Interpretation We define a clinical entity representing the light-chain equivalent of conventional MGUS and posing a risk of progression to light-chain multiple myeloma and related disorders.	[Dispenzieri, Angela; Katzmann, Jerry A.; Kyle, Robert A.; Larson, Dirk R.; Melton, L. Joseph, III; Colby, Colin L.; Therneau, Terry M.; Clark, Raynell; Kumar, Shaji K.; Jelinek, D. F.; Rajkumar, S. Vincent] Mayo Clin, Rochester, MN 55905 USA; [Bradwell, Arthur] Univ Birmingham, Birmingham, W Midlands, England; [Fonseca, Rafael] Mayo Clin, Scottsdale, AZ USA	Mayo Clinic; University of Birmingham; Mayo Clinic; Mayo Clinic Phoenix	Dispenzieri, A (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	dispenzieri.angela@mayo.edu	Kumar, Shaji K/A-9853-2008; Rajkumar, S. Vincent/AAV-1834-2021	Kumar, Shaji K/0000-0001-5392-9284; Rajkumar, S. Vincent/0000-0002-5862-1833; Dispenzieri, Angela/0000-0001-8780-9512; Fonseca, Rafael/0000-0002-5938-3769; Bradwell, Arthur/0000-0002-1562-1606	US National Cancer Institute [CA 125614, CA062242, CA107476, CA150831, CA93842, CA83724, CA100080, CA100707]; Robert A Kyle Hematologic Malignancies Fund; NATIONAL CANCER INSTITUTE [R01CA107476, P50CA100707, R01CA100080, R01CA093842, R01CA083724, R01CA125614, P01CA062242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A Kyle Hematologic Malignancies Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Investigators were supported in part by the US National Cancer Institute (grant numbers CA 125614, CA062242, CA107476, CA150831, CA93842, CA83724, CA100080, and CA100707). Support was also provided by the Robert A Kyle Hematologic Malignancies Fund. We thank The Binding Site, UK, for providing reagents and Tara Phelps and Carol Shipman for their work maintaining the samples and the Dysproteinemia database, respectively.	Ayliffe MJ, 2007, HAEMATOLOGICA, V92, P1135, DOI 10.3324/haematol.11133; Bida JP, 2009, MAYO CLIN PROC, V84, P685, DOI 10.1016/S0025-6196(11)60518-1; Bradwell AR, 2001, CLIN CHEM, V47, P673; Bradwell AR, 2003, LANCET, V361, P489, DOI 10.1016/S0140-6736(03)12457-9; Drayson M, 2001, BLOOD, V97, P2900, DOI 10.1182/blood.V97.9.2900; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Katzmann JA, 2006, MAYO CLIN PROC, V81, P1575, DOI 10.4065/81.12.1575; Katzmann JA, 2009, CLIN CHEM, V55, P1517, DOI 10.1373/clinchem.2009.126664; Kyle RA, 2004, CANCER-AM CANCER SOC, V101, P2667, DOI 10.1002/cncr.20652; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; KYLE RA, 1982, NEW ENGL J MED, V306, P564, DOI 10.1056/NEJM198203113061002; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Magrangeas F, 2004, BLOOD, V103, P3869, DOI 10.1182/blood-2003-07-2501; Mead G P, 2003, Clin Lab, V49, P25; Melton LJ, 1998, OSTEOPOROSIS INT, V8, P68; Rajkumar SV, 2006, BLOOD, V108, p354B; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Therneau TM, 2000, MODELING SURVIVAL DA; Tsai HT, 2009, BLOOD, V114, P4928, DOI 10.1182/blood-2009-08-237651; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008	28	238	245	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1721	1728		10.1016/S0140-6736(10)60482-5	http://dx.doi.org/10.1016/S0140-6736(10)60482-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472173	Green Accepted			2022-12-28	WOS:000277890200033
J	Sudlow, C; Macleod, M; Salman, RAS; Stone, J				Sudlow, Cathie; Macleod, Malcolm; Salman, Rustam Al-Shahi; Stone, Jon			Comment on "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome"	SCIENCE			English	Editorial Material							VIRUS-RELATED VIRUS	Lombardi et al. (Reports, 23 October 2009, p. 585) reported an association between the human gammaretrovirus XMRV and chronic fatigue syndrome. However, their results may be misleading because of various potential sources of bias and confounding. If real, the association may lack generalizability because of the specific characteristics of the cases studied and could be due to reverse causality.	[Sudlow, Cathie; Macleod, Malcolm; Salman, Rustam Al-Shahi; Stone, Jon] Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Sudlow, Cathie] Univ Edinburgh, Inst Genet & Mol Med, Ctr Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Macleod, Malcolm] NHS Forth Valley, Dept Neurol, Stirling, Scotland	University of Edinburgh; University of Edinburgh	Sudlow, C (corresponding author), Univ Edinburgh, Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	cathie.sudlow@ed.ac.uk	Stone, Jon/C-3119-2014; van der Meer, Jos W.M./C-8521-2013; Sudlow, Cathie LM/F-3420-2010; Macleod, Malcolm Robert/B-2052-2010	Stone, Jon/0000-0001-9829-8092; van der Meer, Jos W.M./0000-0001-5120-3690; Macleod, Malcolm Robert/0000-0001-9187-9839; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Sudlow, Cathie/0000-0002-7725-7520	Medical Research Council [G108/613] Funding Source: Medline; MRC [G108/613] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	6	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980								10.1126/science.1183545	http://dx.doi.org/10.1126/science.1183545			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466906				2022-12-28	WOS:000277618800017
J	Theobald, DL				Theobald, Douglas L.			A formal test of the theory of universal common ancestry	NATURE			English	Article							GENETIC CODE; EVOLUTION; HYPOTHESES; LIKELIHOOD; SELECTION; PROTEINS; HOMOLOGY; ORIGIN; LIFE	Universal common ancestry (UCA) is a central pillar of modern evolutionary theory(1). As first suggested by Darwin(2), the theory of UCA posits that all extant terrestrial organisms share a common genetic heritage, each being the genealogical descendant of a single species from the distant past(3-6). The classic evidence for UCA, although massive, is largely restricted to 'local' common ancestry-for example, of specific phyla rather than the entirety of life-and has yet to fully integrate the recent advances from modern phylogenetics and probability theory. Although UCA is widely assumed, it has rarely been subjected to formal quantitative testing(7-10), and this has led to critical commentary emphasizing the intrinsic technical difficulties in empirically evaluating a theory of such broad scope(1,5,8,9,11-15). Furthermore, several researchers have proposed that early life was characterized by rampant horizontal gene transfer, leading some to question the monophyly of life(11,14,15). Here I provide the first, to my knowledge, formal, fundamental test of UCA, without assuming that sequence similarity implies genetic kinship. I test UCA by applying model selection theory(5,16,17) to molecular phylogenies, focusing on a set of ubiquitously conserved proteins that are proposed to be orthologous. Among a wide range of biological models involving the independent ancestry of major taxonomic groups, the model selection tests are found to overwhelmingly support UCA irrespective of the presence of horizontal gene transfer and symbiotic fusion events. These results provide powerful statistical evidence corroborating the monophyly of all known life.	Brandeis Univ, Dept Biochem, Waltham, MA 01778 USA	Brandeis University	Theobald, DL (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 01778 USA.	dtheobald@brandeis.edu	Theobald, Douglas L/F-3514-2013	Theobald, Douglas L/0000-0002-2695-8343				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; CRICK FHC, 1963, PROGR NUCL ACID RES, P163; DARWIN C, 1859, ORIGIN SPECIES NATUR, pCH14; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Doolittle WF, 2009, PHILOS T R SOC B, V364, P2221, DOI 10.1098/rstb.2009.0032; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; Futuyma D. J., 1998, EVOLUTIONARY BIOL; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harlow LL., 1997, WHAT THERE WERE NO S; HINEGARDNER RT, 1963, SCIENCE, V142, P1083, DOI 10.1126/science.142.3595.1083; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; HUXLEY JS, 1943, EVOLUTION MODERN SYN, P397; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Mindell DP, 2001, TRENDS ECOL EVOL, V16, P434, DOI 10.1016/S0169-5347(01)02206-6; Murzin AG, 1998, CURR OPIN STRUC BIOL, V8, P380, DOI 10.1016/S0959-440X(98)80073-0; Penny D, 2003, J THEOR BIOL, V223, P377, DOI 10.1016/S0022-5193(03)00099-7; PENNY D, 1982, NATURE, V297, P197, DOI 10.1038/297197a0; Poole AM, 2007, BIOESSAYS, V29, P74, DOI 10.1002/bies.20516; Popper Karl., 1976, UNENDED QUEST INTELL; RAUP DM, 1983, P NATL ACAD SCI-BIOL, V80, P2981, DOI 10.1073/pnas.80.10.2981; REECK GR, 1987, CELL, V50, P667, DOI 10.1016/0092-8674(87)90322-9; Sober E, 2002, J THEOR BIOL, V218, P395, DOI 10.1006/jtbi.2002.3086; SOBER E, 2008, EVIDENCE EVOLUTION, pCH4; Syvanen M, 2002, J MOL EVOL, V54, P258, DOI 10.1007/s0023901-0007-z; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; ZUCKERKANDL EMILE, 1965, P97; 1981, NATURE, V290, P75	36	131	134	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					219	U104		10.1038/nature09014	http://dx.doi.org/10.1038/nature09014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463738				2022-12-28	WOS:000277558500035
J	Gordon, RY				Gordon, Ram Y.			With Appreciation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ram.gordon@gmail.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1790	1791		10.1001/jama.2010.551	http://dx.doi.org/10.1001/jama.2010.551			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460608				2022-12-28	WOS:000277513900001
J	Horton, R				Horton, Richard			Offline: A Centre for Social Contradictions	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1594	1594		10.1016/S0140-6736(10)60682-4	http://dx.doi.org/10.1016/S0140-6736(10)60682-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452510				2022-12-28	WOS:000277734700012
J	Sharma, N; Patel, M; Gladman, MA; Ahmed, S; Dorudi, S				Sharma, Neel; Patel, Minal; Gladman, Marc A.; Ahmed, Shafi; Dorudi, Sina			Not one, but two, unexpected findings in a young man	LANCET			English	Editorial Material							CANCER		[Sharma, Neel; Patel, Minal; Gladman, Marc A.; Ahmed, Shafi; Dorudi, Sina] Royal London Hosp, Acad Surg Unit, Ctr Digest Dis, Barts & London Sch Med & Dent, London E1 1BB, England	Barts Health NHS Trust; Royal London Hospital; University of London; Queen Mary University London	Dorudi, S (corresponding author), Royal London Hosp, Acad Surg Unit, Ctr Digest Dis, Barts & London Sch Med & Dent, 3rd Floor,Alexandra Wing, London E1 1BB, England.	s.dorudi@qmul.ac.uk		gladman, marc/0000-0001-8412-9570				Ahmed S, 2005, COLORECTAL DIS, V7, P571, DOI 10.1111/j.1463-1318.2005.00818.x; Balarajan R, 1997, Ethn Health, V2, P5; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X	3	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1664	1664		10.1016/S0140-6736(10)60321-2	http://dx.doi.org/10.1016/S0140-6736(10)60321-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452523				2022-12-28	WOS:000277734700033
J	Tao, CG; Cullen, WG; Williams, ED				Tao, Chenggang; Cullen, W. G.; Williams, E. D.			Visualizing the Electron Scattering Force in Nanostructures	SCIENCE			English	Article							SURFACE RESISTIVITY; WIND FORCE; ELECTROMIGRATION; STEP; FLUCTUATIONS; DIFFUSION; TRANSPORT; COPPER	In nanoscale metal wires, electrical current can cause structural changes through electromigration, in which the momentum of electrons biases atomic motion, but the microscopic details are complex. Using in situ scanning tunneling microscopy, we examined the effects of thermally excited defects on the current-biased displacement of monatomic islands of radius 2 to 50 nanometers on single-crystal Ag(III). The islands move opposite to the current direction, with velocity varying inversely with radius. The force is thus in the same direction as electron flow and acts on atomic defect sites at the island edge. The unexpectedly large force on the boundary atoms can be decreased by over a factor of 10 by adding a mildly electron-withdrawing adsorbate, C-60, which also modifies the step geometry. The low coordination of the identified scattering sites is the likely origin of the large force.	Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Maryland, Mat Res Sci & Engn Ctr, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Tao, CG (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.		Tao, Chenggang/U-6800-2017; Williams, Ellen D D/ABC-9244-2021	Tao, Chenggang/0000-0002-6609-0219; 	University of Maryland NSF Materials Research Science and Engineering Center [DMR 05-20471]; University of Maryland NanoCenter; Center for Nanophysics and Advanced Materials	University of Maryland NSF Materials Research Science and Engineering Center; University of Maryland NanoCenter; Center for Nanophysics and Advanced Materials	This work has been supported by the University of Maryland NSF Materials Research Science and Engineering Center under grant DMR 05-20471, including use of the Shared Experimental Facilities. Infrastructure support is also provided by the University of Maryland NanoCenter and the Center for Nanophysics and Advanced Materials.	Bondarchuk O, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.206801; Briner BG, 1996, PHYS REV B, V54, pR5283, DOI 10.1103/PhysRevB.54.R5283; Chen KC, 2008, SCIENCE, V321, P1066, DOI 10.1126/science.1160777; Dundas D, 2009, NAT NANOTECHNOL, V4, P99, DOI [10.1038/nnano.2008.411, 10.1038/NNANO.2008.411]; Giesen M, 2001, PROG SURF SCI, V68, P1, DOI 10.1016/S0079-6816(00)00021-6; Hedouin MFG, 2000, PHYS REV B, V62, P8473, DOI 10.1103/PhysRevB.62.8473; Heinze S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.186802; HO PS, 1989, REP PROG PHYS, V52, P301, DOI 10.1088/0034-4885/52/3/002; Hoekstra J, 2000, PHYS REV B, V62, P8568, DOI 10.1103/PhysRevB.62.8568; Homoth J, 2009, NANO LETT, V9, P1588, DOI 10.1021/nl803783g; Ichimiya A, 2000, PHYS REV LETT, V84, P3662, DOI 10.1103/PhysRevLett.84.3662; Jin C, 2008, NANO LETT, V8, P1127, DOI 10.1021/nl0732676; Kizuka T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.075003; Mehmood F, 2006, SURF SCI, V600, P4501, DOI 10.1016/j.susc.2006.07.034; Mo YN, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.216101; Morgenstern K, 2001, PHYS REV LETT, V86, P5739, DOI 10.1103/PhysRevLett.86.5739; Morgenstern K, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.045412; Park H, 1999, APPL PHYS LETT, V75, P301, DOI 10.1063/1.124354; Park JY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.136802; Pierre-Louis O, 2000, PHYS REV B, V62, P13697, DOI 10.1103/PhysRevB.62.13697; Pierre-Louis O, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.062601; Rous PJ, 1999, PHYS REV B, V59, P7719, DOI 10.1103/PhysRevB.59.7719; Rusanen M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.245423; Sorbello R., 1997, SOLID STATE PHYS SER, V51, P159; Sperl A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.085422; Stasevich TJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.085501; Stasevich TJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.245414; Sun T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.041402; Tao C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125436; Tao CG, 2007, NANO LETT, V7, P1495, DOI 10.1021/nl070210a; Taychatanapat T, 2007, NANO LETT, V7, P652, DOI 10.1021/nl062631i; Taylor J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.245407; Thurmer K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.186102; Thurmer K, 1999, PHYS REV LETT, V83, P5531, DOI 10.1103/PhysRevLett.83.5531; Wang L, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.094412; Williams ED, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/387; Yang ZQ, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161311; YASUNAGA H, 1992, SURF SCI REP, V15, P205, DOI 10.1016/0167-5729(92)90007-X; Zhang YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2398883	39	62	62	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					736	740		10.1126/science.1186648	http://dx.doi.org/10.1126/science.1186648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448180				2022-12-28	WOS:000277357100035
J	Collins, ME; Hariprasad, SM				Collins, Megan E.; Hariprasad, Seenu M.			Free-Floating Iris Cyst.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Collins, Megan E.; Hariprasad, Seenu M.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Collins, ME (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	retina@uchicago.edu							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1720	1720		10.1056/NEJMicm0907948	http://dx.doi.org/10.1056/NEJMicm0907948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445183				2022-12-28	WOS:000277311200009
J	Gillet, N; Jault, D; Canet, E; Fournier, A				Gillet, Nicolas; Jault, Dominique; Canet, Elisabeth; Fournier, Alexandre			Fast torsional waves and strong magnetic field within the Earth's core	NATURE			English	Article							LENGTH-OF-DAY; SECULAR VARIATION; ANGULAR-MOMENTUM; MOTIONS; OSCILLATIONS; ROTATION; FLOWS	The magnetic field inside the Earth's fluid and electrically conducting outer core cannot be directly probed. The root-mean-squared (r.m.s.) intensity for the resolved part of the radial magnetic field at the core-mantle boundary is 0.3 mT, but further assumptions are needed to infer the strength of the field inside the core. Recent diagnostics obtained from numerical geodynamo models(1) indicate that the magnitude of the dipole field at the surface of a fluid dynamo is about ten times weaker than the r.m.s. field strength in its interior, which would yield an intensity of the order of several millitesla within the Earth's core. However, a 60-year signal found in the variation in the length of day(2) has long been associated with magneto-hydrodynamic torsional waves carried by a much weaker internal field(3,4). According to these studies, the r.m.s. strength of the field in the cylindrical radial direction (calculated for all length scales) is only 0.2 mT, a figure even smaller than the r.m.s. strength of the large-scale (spherical harmonic degree n <= 13) field visible at the core-mantle boundary. Here we reconcile numerical geodynamo models with studies of geostrophic motions in the Earth's core that rely on geomagnetic data. From an ensemble inversion of core flow models, we find a torsional wave recurring every six years, the angular momentum of which accounts well for both the phase and the amplitude of the six-year signal for change in length of day detected over the second half of the twentieth century(5). It takes about four years for the wave to propagate throughout the fluid outer core, and this travel time translates into a slowness for Alfven waves that corresponds to a r.m.s. field strength in the cylindrical radial direction of approximately 2 mT. Assuming isotropy, this yields a r.m.s. field strength of 4 mT inside the Earth's core.	[Gillet, Nicolas; Jault, Dominique; Canet, Elisabeth] Univ Grenoble 1, CNRS, Lab Geophys Interne & Tectonophys, F-38041 Grenoble 9, France; [Fournier, Alexandre] Univ Paris Diderot, CNRS, Inst Phys Globe Paris, Equipe Geomagnetisme, F-75252 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Gillet, N (corresponding author), Univ Grenoble 1, CNRS, Lab Geophys Interne & Tectonophys, BP 53, F-38041 Grenoble 9, France.	nicolas.gillet@obs.ujf-grenoble.fr	Fournier, Alexandre/A-5774-2011; Jault, Dominique/B-8820-2017	Fournier, Alexandre/0000-0003-3276-0496; Jault, Dominique/0000-0001-5592-5746	French Agence Nationale de la Recherche [BLAN06-2.155316]; French Centre National d'Etudes Spatiales	French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	We thank M. Dumberry and P. Roberts for discussions. We also thank A. Jackson, who helped improve the quality of the manuscript. N. G. was funded by a grant from the French Agence Nationale de la Recherche, Research program VS-QG (grant number BLAN06-2.155316). The IPGP contribution number for A. F. is 2618. The study has also been supported in part by the French Centre National d'Etudes Spatiales.	Alfven H, 1942, NATURE, V150, P405, DOI 10.1038/150405d0; Aubert J, 2009, GEOPHYS J INT, V179, P1414, DOI 10.1111/j.1365-246X.2009.04361.x; Bloxham J, 2002, NATURE, V420, P65, DOI 10.1038/nature01134; Braginskiy S. I., 1970, Geomagnetism and Aeronomy, V10, P1; Buffett BA, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000056; Buffett BA, 2009, GEOPHYS J INT, V177, P878, DOI 10.1111/j.1365-246X.2009.04129.x; Canet E, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006189; del Rio RA, 2000, ANN GEOPHYS-ATM HYDR, V18, P347, DOI 10.1007/s005850050894; Dumberry M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005135; Fournier A, 2007, NONLINEAR PROC GEOPH, V14, P163, DOI 10.5194/npg-14-163-2007; Friis-Christensen E, 2006, EARTH PLANETS SPACE, V58, P351, DOI 10.1186/BF03351933; Gillet N, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002290; Gross RS, 2001, PHYS EARTH PLANET IN, V123, P65, DOI 10.1016/S0031-9201(00)00217-X; Jackson A, 2000, PHILOS T ROY SOC A, V358, P957, DOI 10.1098/rsta.2000.0569; Jackson A, 1997, PHYS EARTH PLANET IN, V103, P293, DOI 10.1016/S0031-9201(97)00039-3; JACKSON A, 1993, DYNAMICS EARTHS DEEP, V72, P97; Jackson A, 2009, GEOPHYS J INT, V177, P367, DOI 10.1111/j.1365-246X.2008.04008.x; JAULT D, 1988, NATURE, V333, P353, DOI 10.1038/333353a0; Jault D, 2008, PHYS EARTH PLANET IN, V166, P67, DOI 10.1016/j.pepi.2007.11.001; JORDI C, 1994, GEOPHYS J INT, V117, P811, DOI 10.1111/j.1365-246X.1994.tb02471.x; Mound JE, 2006, EARTH PLANET SC LETT, V243, P383, DOI 10.1016/j.epsl.2006.01.043; Ohta K, 2010, EARTH PLANET SC LETT, V289, P497, DOI 10.1016/j.epsl.2009.11.042; Olsen N, 2008, NAT GEOSCI, V1, P390, DOI 10.1038/ngeo203; Pais MA, 2008, GEOPHYS J INT, V173, P421, DOI 10.1111/j.1365-246X.2008.03741.x; Pais MA, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003012; RHINES PB, 1975, J FLUID MECH, V69, P417, DOI 10.1017/S0022112075001504; Roberts PH, 2007, GEOPHYS ASTRO FLUID, V101, P11, DOI 10.1080/03091920601083820; TAYLOR JB, 1963, PROC R SOC LON SER-A, V274, P274, DOI 10.1098/rspa.1963.0130; Zatman S, 1997, NATURE, V388, P760, DOI 10.1038/41987; Zhang J, 2008, GEOPHYS J INT, V174, P993, DOI 10.1111/j.1365-246X.2008.03856.x	30	198	199	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					74	77		10.1038/nature09010	http://dx.doi.org/10.1038/nature09010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445627				2022-12-28	WOS:000277311900033
J	Rahl, PB; Lin, CY; Seila, AC; Flynn, RA; McCuine, S; Burge, CB; Sharp, PA; Young, RA				Rahl, Peter B.; Lin, Charles Y.; Seila, Amy C.; Flynn, Ryan A.; McCuine, Scott; Burge, Christopher B.; Sharp, Phillip A.; Young, Richard A.			c-Myc Regulates Transcriptional Pause Release	CELL			English	Article							RNA-POLYMERASE-II; EMBRYONIC STEM-CELLS; HEAT-SHOCK GENES; INHIBITS P-TEFB; IN-VIVO; TERMINAL DOMAIN; DROSOPHILA-MELANOGASTER; PRODUCTIVE ELONGATION; SELF-RENEWAL; PROCESSING FACTORS	Recruitment of the RNA polymerase II (Pol II) transcription initiation apparatus to promoters by specific DNA-binding transcription factors is well recognized as a key regulatory step in gene expression. We report here that promoter-proximal pausing is a general feature of transcription by Pol II in mammalian cells and thus an additional step where regulation of gene expression occurs. This suggests that some transcription factors recruit the transcription apparatus to promoters, whereas others effect promoter-proximal pause release. Indeed, we find that the transcription factor c-Myc, a key regulator of cellular proliferation, plays a major role in Pol II pause release rather than Pol II recruitment at its target genes. We discuss the implications of these results for the role of c-Myc amplification in human cancer.	[Rahl, Peter B.; Lin, Charles Y.; McCuine, Scott; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.; Burge, Christopher B.; Sharp, Phillip A.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Seila, Amy C.; Flynn, Ryan A.; Sharp, Phillip A.] MIT, Koch Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Burge, Christopher B./AAH-2177-2020	Young, Richard A/0000-0001-8855-8647; Flynn, Ryan/0000-0001-5013-0442	National Institutes of Health [RO1-HG002668, RO1-GM34277, RO1-CA133404, 5-F32-HD051190]; National Cancer Institute [PO1-CA42063, P30-CA14051]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD051190] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA133404, R01CA146445, P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Garrett Frampton for help with Solexa data analysis; David Price for antibodies and discussions; Hiroshi Handa for antibodies; Tom Volkert, Jennifer Love, Jeong-Ah Kwon, and Sumeet Gupta at the Whitehead Institute Sequencing Core for help with Solexa sequencing; and John Lis and members of the Young, Sharp, and Burge laboratories for helpful discussions. This work was supported by grants RO1-HG002668 (R.A.Y.), RO1-GM34277 (P.A.S.), RO1-CA133404 (P.A.S.) from the National Institutes of Health, PO1-CA42063 from the National Cancer Institute (P.A.S.), and Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute (P.A.S.). A.C.S. was supported by a National Institutes of Health postdoctoral fellowship 5-F32-HD051190.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hanyu-Nakamura K, 2008, NATURE, V451, P730, DOI 10.1038/nature06498; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lis JT, 2000, GENE DEV, V14, P792; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OBRIEN T, 1991, MOL CELL BIOL, V11, P5285, DOI 10.1128/MCB.11.10.5285; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang F, 2003, GENE DEV, V17, P748, DOI 10.1101/gad.1068203; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	77	900	931	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					432	445		10.1016/j.cell.2010.03.030	http://dx.doi.org/10.1016/j.cell.2010.03.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434984	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000277180800015
J	Simonson, TS; Yang, YZ; Huff, CD; Yun, HX; Qin, G; Witherspoon, DJ; Bai, ZZ; Lorenzo, FR; Xing, JC; Jorde, LB; Prchal, JT; Ge, RL				Simonson, Tatum S.; Yang, Yingzhong; Huff, Chad D.; Yun, Haixia; Qin, Ga; Witherspoon, David J.; Bai, Zhenzhong; Lorenzo, Felipe R.; Xing, Jinchuan; Jorde, Lynn B.; Prchal, Josef T.; Ge, RiLi			Genetic Evidence for High-Altitude Adaptation in Tibet	SCIENCE			English	Article							CHRONIC MOUNTAIN-SICKNESS; POSITIVE SELECTION; EXERCISE PERFORMANCE; HAN RESIDENTS; HEMOGLOBIN; SEQUENCE; SIGNALS	Tibetans have lived at very high altitudes for thousands of years, and they have a distinctive suite of physiological traits that enable them to tolerate environmental hypoxia. These phenotypes are clearly the result of adaptation to this environment, but their genetic basis remains unknown. We report genome-wide scans that reveal positive selection in several regions that contain genes whose products are likely involved in high-altitude adaptation. Positively selected haplotypes of EGLN1 and PPARA were significantly associated with the decreased hemoglobin phenotype that is unique to this highland population. Identification of these genes provides support for previously hypothesized mechanisms of high-altitude adaptation and illuminates the complexity of hypoxia-response pathways in humans.	[Simonson, Tatum S.; Huff, Chad D.; Witherspoon, David J.; Xing, Jinchuan; Jorde, Lynn B.; Prchal, Josef T.] Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Yang, Yingzhong; Yun, Haixia; Qin, Ga; Bai, Zhenzhong; Ge, RiLi] Qinghai Univ, Sch Med, Res Ctr High Altitude Med, Xining 810001, Qinghai, Peoples R China; [Lorenzo, Felipe R.; Prchal, Josef T.] Univ Utah, Sch Med, Div Hematol, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Prchal, Josef T.] Univ Utah, Sch Med, Dept Pathol ARUP, Salt Lake City, UT 84112 USA; [Lorenzo, Felipe R.; Prchal, Josef T.] VAH, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Qinghai University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Jorde, LB (corresponding author), Univ Utah, Sch Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu; josef.prchal@hsc.utah.edu; geriligao@hotmail.com	Xing, Jinchuan/A-2489-2012		National Basic Research Program of China [2006CB504100]; National Natural Science Foundation of China [30393133]; University of Utah Research Foundation [51003402]; NIH [GM059290, T32]; NIH Heart, Lung, and Blood Institute [HL50077]; National Cancer Institute [1P01CA108671-01A2]; The Primary Children's Medical Digestive and Kidney Diseases [DK069513]; University of Luxembourg-Institute; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050077] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R00HG005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK069513] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Utah Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Primary Children's Medical Digestive and Kidney Diseases; University of Luxembourg-Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all participants of this study. We are grateful to A. R. Rogers, J. Seger, D. J. Grunwald, and W. S. Watkins, who provided helpful comments for the manuscript, and S. R. Woodward and J. E. Gomez (from the Sorenson Molecular Genealogy Foundation) for providing samples used for comparative analyses. This work was supported by the National Basic Research Program of China number 2006CB504100, the National Natural Science Foundation of China number 30393133, and the University of Utah Research Foundation Seed Grant number 51003402. Funding was also provided by GM059290 (NIH) to L. B. J., HL50077 (NIH Heart, Lung, and Blood Institute) and 1P01CA108671-01A2 (National Cancer Institute) Merit Review Award to J. T. P., and DK069513 (The Primary Children's Medical Digestive and Kidney Diseases) and The University of Luxembourg-Institute for Systems Biology Program to C. D. H. T. S. S. was supported by NIH Genetics Training Grant T32. All studies have been performed with informed consent approved by the Institutional Board of Qinghai Medical College of Qinghai University in Xining, Qinghai Province, People's Republic of China. All SNP genoptypes are deposited in Gene Expression Omnibus, with accession code GSE21661. These data, as well as phenotype data, are also available on our laboratory Web site, http://jorde-lab.genetics.utah.edu. Please contact R. L. G. for access to DNA samples.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham Abigail W., 2009, Human Genomics, V4, P79; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Chen QH, 1997, J APPL PHYSIOL, V83, P661, DOI 10.1152/jappl.1997.83.2.661; GE RL, 1994, J APPL PHYSIOL, V77, P684, DOI 10.1152/jappl.1994.77.2.684; Ge RL, 2002, J APPL PHYSIOL, V92, P2361, DOI 10.1152/japplphysiol.00684.2001; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; GROVES BM, 1993, J APPL PHYSIOL, V74, P312, DOI 10.1152/jappl.1993.74.1.312; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; He JZ, 2010, J BIOL CHEM, V285, P9452, DOI 10.1074/jbc.M109.077230; Huff CD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-8; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Mejia OM, 2005, HAEMATOLOGICA, V90, P13; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Narravula S, 2001, J IMMUNOL, V166, P7543, DOI 10.4049/jimmunol.166.12.7543; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Vargas EE, 2006, HIGH ALT MED BIOL, V7, P138, DOI 10.1089/ham.2006.7.138; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wilding John P H, 2007, Diab Vasc Dis Res, V4, P194; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; ZHUANG J, 1993, J APPL PHYSIOL, V74, P303, DOI 10.1152/jappl.1993.74.1.303; Zundel W, 2000, GENE DEV, V14, P391	32	746	814	13	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					72	75		10.1126/science.1189406	http://dx.doi.org/10.1126/science.1189406			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20466884				2022-12-28	WOS:000279402700034
J	Marais, BJ; Raviglione, MC; Donald, PR; Harries, AD; Kritski, AL; Graham, SM; El-Sadr, WM; Harrington, M; Churchyard, G; Mwaba, P; Sanne, I; Kaufmann, SHE; Whitty, CJM; Atun, R; Zumla, A				Marais, Ben J.; Raviglione, Mario C.; Donald, Peter R.; Harries, Anthony D.; Kritski, Afranio L.; Graham, Stephen M.; El-Sadr, Wafaa M.; Harrington, Mark; Churchyard, Gavin; Mwaba, Peter; Sanne, Ian; Kaufmann, Stefan H. E.; Whitty, Christopher J. M.; Atun, Rifat; Zumla, Alimuddin			Tuberculosis 8 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action	LANCET			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; NEGATIVE PULMONARY TUBERCULOSIS; ISONIAZID PREVENTIVE THERAPY; ANTIRETROVIRAL THERAPY; HIV-INFECTION; DRUG-RESISTANCE; INITIAL DEFAULT; HEALTH SYSTEMS; GLOBAL BURDEN; SOUTH-AFRICA	The Millennium Development Goal target for tuberculosis control is to halt the spread of tuberculosis by 2015, and begin to reverse the worldwide incidence. After the introduction of standard control practices in 1995, 36 million people were cured and about 6 million deaths were averted. However, substantial scientific advances and innovative solutions are urgently needed together with creative new strategies. Strong international and national political commitment is essential. Urgent action is needed by national governments to fund their own programmes, and for the G8 countries and other donor governments and organisations to support governmental and non-governmental efforts. To foster the global need for urgent action to control the tuberculosis epidemic, The Lancet, in collaboration with the Stop TB Partnership, WHO, Global Fund to Fight AIDS, Tuberculosis and Malaria, and the experts participating in this Series, is launching The Lancet TB Observatory, which will assess and monitor progress in tuberculosis control and research, assess domestic and global financing, regularly disseminate information, and advocate for intensified efforts with stakeholders at all levels.	[Marais, Ben J.; Donald, Peter R.] Univ Stellenbosch, Tygerberg Childrens Hosp, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Raviglione, Mario C.] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Harries, Anthony D.; Graham, Stephen M.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England; [Kritski, Afranio L.] Univ Fed Rio de Janeiro, Sch Med, TB Acad Program, Rio De Janeiro, Brazil; [Kritski, Afranio L.] Brazilian TB Res Network Rede TB, Rio De Janeiro, Brazil; [Graham, Stephen M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA; [Harrington, Mark] Treatment Act Grp, New York, NY USA; [Churchyard, Gavin] Aurum Inst Hlth Res, Marshalltown, South Africa; [Mwaba, Peter; Zumla, Alimuddin] Univ Teaching Hosp, UNZA UCLMS Res & Training Project, Lusaka, Zambia; [Sanne, Ian] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Berlin, Germany; [Whitty, Christopher J. M.] Dept Int Dev, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, London, England; [Zumla, Alimuddin] Univ Coll London Med Sch, Dept Infect, London, England	Stellenbosch University; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; Universidade Federal do Rio de Janeiro; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Columbia University; Columbia University; University of Zambia; University of Witwatersrand; Max Planck Society; Imperial College London; University of London; University College London	Marais, BJ (corresponding author), Univ Stellenbosch, Fac Hlth Sci, Dept Paediat & Child Hlth, POB 19063, ZA-7505 Tygerberg, South Africa.	bjmarais@sun.ac.za	Sanne, Ian/ABH-2231-2020; Mwaba, Peter/V-6017-2019; Kritski, Afranio/I-6760-2016; Whitty, Christopher/C-7740-2012; Marais, Ben/AAX-2626-2021; ZUMLA, Alimuddin/ABA-8208-2020; Atun, Rifat/AAH-5537-2021; Kaufmann, Stefan HE/I-5454-2014	ZUMLA, Alimuddin/0000-0002-5111-5735; kritski, afranio/0000-0002-5900-6007; Churchyard, Gavin/0000-0002-4269-3699; Atun, Rifat/0000-0002-1531-5983; RAVIGLIONE, Mario/0000-0002-9331-2067; Graham, Stephen/0000-0003-3525-2294; Kaufmann, Stefan HE/0000-0001-9866-8268; Whitty, Christopher/0000-0002-6076-5027	US President's Emergency Plan For AIDS Relief (PEPFAR); European Union; European Developing Country Clinical Trials Partnership; Global Alliance for TB Drug development; EuropeAID Active Detection of Active TB Project; UK Medical Research Council; National Institute of Health Research; University College London Hospitals NHS Trust-Comprehensive Biomedical Research Centre	US President's Emergency Plan For AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); European Union(European Commission); European Developing Country Clinical Trials Partnership; Global Alliance for TB Drug development; EuropeAID Active Detection of Active TB Project; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); University College London Hospitals NHS Trust-Comprehensive Biomedical Research Centre	BIM and PRO have no financial support or other conflicts of interest to declare; MCR is head of the Stop TB Partnership; ADH is senior advisor to the International Union Against Tuberculosis and Lung disease (The Union); ALK works with the Brazilian Tuberculosis Research Network (Rede-TB); SMG chairs the lung health section of the International Union Against Tuberculosis and Lung disease (The Union); WME directs the International Center for AIDS Care and Treatment Programs and receives support from the US President's Emergency Plan For AIDS Relief (PEPFAR); MH directs the Treatment Action Group; GC directs the Aurum Institute for Health Research; PM is involved in University of Zambia-University College London Medical School Research and Training Projects; IS receives support from PEPFAR; SHEK is co-inventor of the rBCG Delta UreC:Hly vaccine candidate and member of the Scientific Advisory Boards of Intercell, and Vaccine Project Management; CJMW is a Chief Scientific Advisor at the UK Department for International Development; RA is Director of Strategy, Performance and Evaluation at the Global Fund to Fight AIDS, Tuberculosis and Malaria; AZ receives support from the European Union Framework Programme 7, European Developing Country Clinical Trials Partnership, Global Alliance for TB Drug development, EuropeAID Active Detection of Active TB Project, UK Medical Research Council, and National Institute of Health Research, University College London Hospitals NHS Trust-Comprehensive Biomedical Research Centre.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Babu BS, 2008, INT J TUBERC LUNG D, V12, P1055; BIGNALL JR, 1983, B INT UNION TUBERC, V57, P122; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Chen XY, 2004, LANCET, V364, P417; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Churchyard GJ, 2007, J INFECT DIS, V196, pS52, DOI 10.1086/518662; Cobelens FGJ, 2008, PLOS MED, V5, P1037, DOI 10.1371/journal.pmed.0050150; DHEDA K, 2009, TUBERCULOSIS COMPREH, P746; Donabedian P., 2007, RENAISSANCE ARCHITEC, P124; Donald PR, 2009, NEW ENGL J MED, V360, P2393, DOI 10.1056/NEJMp0903806; Donald RR, 2007, INT J TUBERC LUNG D, V11, P370; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; El-Sadr WM, 2008, NEW ENGL J MED, V359, P553, DOI 10.1056/NEJMp0803762; Enarson DA, 2009, INT J TUBERC LUNG D, V13, P804; Fauci AS, 2008, J INFECT DIS, V197, P1493, DOI 10.1086/587904; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Gie RP, 2009, INT J TUBERC LUNG D, V13, P277; *GLOBAL FUND, INN FIN; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Harries AD, 2009, INT J TUBERC LUNG D, V13, P1194; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hesseling AC, 2007, VACCINE, V25, P6565, DOI 10.1016/j.vaccine.2007.06.045; Hill S, 2008, B WORLD HEALTH ORGAN, V86, P658, DOI 10.2471/BLT.08.056804; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; KAUFMANN SHE, 2010, AM J PUBLIC HEALTH, DOI DOI 10.1016/S0140-6736(10)60393-5; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; LAWN SD, LANCET INFE IN PRESS; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; MA Z, 2010, AM J PUBLIC HEALTH, DOI DOI 10.1016/S0140-6736(10(60359-9; Marais BJ, 2008, CLIN INFECT DIS, V47, P203, DOI 10.1086/589248; Marais BJ, 2007, PAEDIATR RESPIR REV, V8, P124, DOI 10.1016/j.prrv.2007.04.002; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Marais BJ, 2009, CLIN CHEST MED, V30, P827, DOI 10.1016/j.ccm.2009.08.012; Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305; MARAIS BJ, INFECT DIS IN PRESS; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Mello FCD, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-43; MIDDELKOOP K, 2009, 5 INT AIDS SOC C HIV; *MILL FDN, MASSIVEGOOD; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray EJ, 2009, INT J TUBERC LUNG D, V13, P767; Onyebujoh P, 2006, LANCET, V367, P940, DOI 10.1016/S0140-6736(06)68385-2; ONYEBUJOH P, 2006, REICHMAN HERSHFIELDS, P1169; PIO A, 1983, B INT UNION TUBERC, V58, P191; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rusen ID, 2010, INT J TUBERC LUNG D, V14, P253; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schaaf HS, 2009, AM J PUBLIC HEALTH, V99, P1486, DOI 10.2105/AJPH.2008.143271; Singh M, 2005, ARCH DIS CHILD, V90, P624, DOI 10.1136/adc.2003.044255; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Solari L, 2008, INT J TUBERC LUNG D, V12, P619; *STOP TB PARTN, RES MOV; STYBLO K, 1991, TUBERCULOSIS CAN BE; STYBLO K, 1983, B INT UNION TUBERC, V58, P179; *TREATM ACT GROUP, 2009 REP TUB RES FUN; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P560; VANDEMI A, 2007, INT J TUBERC LUNG D, V11, P485; VERRNA G, 2004, BMC MED ETHICS, V5, pE2; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2006, WHO REV TB REP REC R; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2008, JOINT WHO HIV AIDS T; World Health Organization, 2009, WHOSTMTB2009411; World Health Organization, 2009, RAP ADV ANT THER HIV	85	93	98	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2179	2191		10.1016/S0140-6736(10)60554-5	http://dx.doi.org/10.1016/S0140-6736(10)60554-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20488521				2022-12-28	WOS:000279255100029
J	Ma, ZK; Lienhardt, C; McIlleron, H; Nunn, AJ; Wang, XX				Ma, Zhenkun; Lienhardt, Christian; McIlleron, Helen; Nunn, Andrew J.; Wang, Xiexiu			Global tuberculosis drug development pipeline: the need and the reality	LANCET			English	Article							EARLY BACTERICIDAL ACTIVITY; HIV-INFECTED PATIENTS; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; DIARYLQUINOLINE TMC207; RESISTANT TUBERCULOSIS; RECEIVING RIFAMPICIN; HEALTHY-VOLUNTEERS; TREATMENT OUTCOMES; MURINE MODEL	Drugs for tuberculosis are inadequate to address the many inherent and emerging challenges of treatment. In the past decade, ten compounds have progressed into the clinical development pipeline, including six new compounds specifically developed for tuberculosis. Despite this progress, the global drug pipeline for tuberculosis is still insufficient to address the unmet needs of treatment. Additional and sustainable efforts, and funding are needed to further improve the pipeline. The key challenges in the development of new treatments are the needs for novel drug combinations, new trial designs, studies in paediatric populations, increased clinical trial capacity, clear regulatory guidelines, and biomarkers for prediction of long-term outcome. Despite substantial progress in efforts to control tuberculosis, the global burden of this disease remains high. To eliminate tuberculosis as a public health concern by 2050, all responsible parties need to work together to strengthen the global antituberculosis drug pipeline and support the development of new antituberculosis drug regimens.	[Ma, Zhenkun] Global Alliance TB Drug Dev, New York, NY 10005 USA; [Lienhardt, Christian] WHO, Stop TB Dept, Stop TB Partnership Secretariat, CH-1211 Geneva, Switzerland; [McIlleron, Helen] Univ Cape Town, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa; [Nunn, Andrew J.] MRC, Clin Trials Unit, London, England; [Wang, Xiexiu] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China	World Health Organization; University of Cape Town; Medical Research Council Clinical Trials Unit; Tianjin Center for Disease Control & Prevention	Ma, ZK (corresponding author), Global Alliance TB Drug Dev, 40 Wall St, New York, NY 10005 USA.	zhenkun.ma@tballiance.org	Lienhardt, Christian/AAU-4969-2021	Lienhardt, Christian/0000-0003-0233-893X; McIlleron, Helen/0000-0002-0982-6226; Nunn, Andrew/0000-0002-9158-4595	Medical Research Council [MC_U122888469] Funding Source: Medline; MRC [MC_U122888469] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; Brown D, 2003, DRUG DISCOV TODAY, V8, P1067, DOI 10.1016/S1359-6446(03)02902-7; Burki T, 2009, LANCET INFECT DIS, V9, P731, DOI 10.1016/S1473-3099(09)70312-3; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Burman WJ, 2008, PLOS MED, V5, P1168, DOI 10.1371/journal.pmed.0050176; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Chen P, 2006, J ANTIMICROB CHEMOTH, V58, P332, DOI 10.1093/jac/dkl227; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Cox HS, 2008, BMJ-BRIT MED J, V336, P484, DOI 10.1136/bmj.39463.640787.BE; Cynamon MH, 1999, ANTIMICROB AGENTS CH, V43, P1189, DOI 10.1128/AAC.43.5.1189; Diacon AH, 2007, ANTIMICROB AGENTS CH, V51, P2994, DOI 10.1128/AAC.01474-06; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1; Dietze R, 2008, AM J RESP CRIT CARE, V178, P1180, DOI 10.1164/rccm.200806-892OC; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Ehlers S, 2009, INFECTION, V37, P87, DOI 10.1007/s15010-009-8450-7; Ena J, 2005, CLIN INFECT DIS, V40, P670, DOI 10.1086/427802; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3720, DOI 10.1128/AAC.00106-09; Ginsberg AM, 2009, ANTIMICROB AGENTS CH, V53, P3726, DOI 10.1128/AAC.00112-09; Gray DM, 2009, COCHRANE DB SYST REV, V1; GROSSET J, 1981, CHEST, V80, P719, DOI 10.1378/chest.80.6.719; GROSSET J, 1990, B INT J TUBERC LUNG, V2, P86; Haas DW, 2009, JAIDS-J ACQ IMM DEF, V50, P290, DOI 10.1097/QAI.0b013e318189a7df; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Jia L, 2006, BRIT J PHARMACOL, V147, P476, DOI 10.1038/sj.bjp.0706650; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Keung ACF, 1999, ANTIMICROB AGENTS CH, V43, P1230, DOI 10.1128/AAC.43.5.1230; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; KREIS B, 1976, Bulletin of the International Union Against Tuberculosis, V51, P71; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lee RE, 2003, J COMB CHEM, V5, P172, DOI 10.1021/cc020071p; Li AP, 1997, CHEM-BIOL INTERACT, V107, P17, DOI 10.1016/S0009-2797(97)00071-9; MA Z, 2007, COMPREHENSIVE MED CH, V2; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Marais BJ, 2006, INT J TUBERC LUNG D, V10, P732; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; McIlleron H, 2009, CLIN INFECT DIS, V48, P1547, DOI 10.1086/598192; MITCHISON DA, 1985, TUBERCLE, V66, P219, DOI 10.1016/0041-3879(85)90040-6; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Moadebi S, 2007, DRUGS, V67, P2077, DOI 10.2165/00003495-200767140-00007; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Nijland HMJ, 2008, AIDS, V22, P931, DOI 10.1097/QAD.0b013e3282faa71e; Nikonenko BV, 2007, ANTIMICROB AGENTS CH, V51, P1563, DOI 10.1128/AAC.01326-06; Ntziora F, 2007, INT J TUBERC LUNG D, V11, P606; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger E, 2008, ANTIMICROB AGENTS CH, V52, P1522, DOI 10.1128/AAC.00074-08; Nunn AJ, 2008, TUBERCULOSIS, V88, pS85, DOI 10.1016/S1472-9792(08)70039-8; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Ormerod P, 2000, THORAX, V55, P887; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Piscitelli SC, 2001, NEW ENGL J MED, V344, P984, DOI 10.1056/NEJM200103293441307; Prasad R, 2006, Indian J Chest Dis Allied Sci, V48, P183; Rodriguez JC, 2001, INT J ANTIMICROB AG, V17, P229, DOI 10.1016/S0924-8579(00)00337-X; Rosenthal IM, 2007, PLOS MED, V4, P1931, DOI 10.1371/journal.pmed.0040344; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Schluger N, 2007, PLOS MED, V4, P1726, DOI 10.1371/journal.pmed.0040302; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Spyridis NP, 2007, CLIN INFECT DIS, V45, P715, DOI 10.1086/520983; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Tasneen R, 2008, ANTIMICROB AGENTS CH, V52, P3664, DOI 10.1128/AAC.00686-08; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; van Niekerk C, 2009, INT J TUBERC LUNG D, V13, P1367; Vernon A, 1999, LANCET, V353, P1843, DOI 10.1016/S0140-6736(98)11467-8; Veziris N, 2009, AM J RESP CRIT CARE, V179, P75, DOI 10.1164/rccm.200711-1736OC; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Weiner M, 2005, CLIN INFECT DIS, V40, P1481, DOI 10.1086/429321; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Williams KN, 2009, AM J RESP CRIT CARE, V180, P371, DOI 10.1164/rccm.200904-0611OC; WOLDEHANNA S, 2006, COCHRANE DB SYST REV, V3; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	86	284	298	0	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2100	2109		10.1016/S0140-6736(10)60359-9	http://dx.doi.org/10.1016/S0140-6736(10)60359-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20488518				2022-12-28	WOS:000279069300023
J	Butchart, SHM; Walpole, M; Collen, B; van Strien, A; Scharlemann, JPW; Almond, REA; Baillie, JEM; Bomhard, B; Brown, C; Bruno, J; Carpenter, KE; Carr, GM; Chanson, J; Chenery, AM; Csirke, J; Davidson, NC; Dentener, F; Foster, M; Galli, A; Galloway, JN; Genovesi, P; Gregory, RD; Hockings, M; Kapos, V; Lamarque, JF; Leverington, F; Loh, J; McGeoch, MA; McRae, L; Minasyan, A; Morcillo, MH; Oldfield, TEE; Pauly, D; Quader, S; Revenga, C; Sauer, JR; Skolnik, B; Spear, D; Stanwell-Smith, D; Stuart, SN; Symes, A; Tierney, M; Tyrrell, TD; Vie, JC; Watson, R				Butchart, Stuart H. M.; Walpole, Matt; Collen, Ben; van Strien, Arco; Scharlemann, Joern P. W.; Almond, Rosamunde E. A.; Baillie, Jonathan E. M.; Bomhard, Bastian; Brown, Claire; Bruno, John; Carpenter, Kent E.; Carr, Genevieve M.; Chanson, Janice; Chenery, Anna M.; Csirke, Jorge; Davidson, Nick C.; Dentener, Frank; Foster, Matt; Galli, Alessandro; Galloway, James N.; Genovesi, Piero; Gregory, Richard D.; Hockings, Marc; Kapos, Valerie; Lamarque, Jean-Francois; Leverington, Fiona; Loh, Jonathan; McGeoch, Melodie A.; McRae, Louise; Minasyan, Anahit; Morcillo, Monica Hernandez; Oldfield, Thomasina E. E.; Pauly, Daniel; Quader, Suhel; Revenga, Carmen; Sauer, John R.; Skolnik, Benjamin; Spear, Dian; Stanwell-Smith, Damon; Stuart, Simon N.; Symes, Andy; Tierney, Megan; Tyrrell, Tristan D.; Vie, Jean-Christophe; Watson, Reg			Global Biodiversity: Indicators of Recent Declines	SCIENCE			English	Article							CONSERVATION; FOREST; IMPACT; BIRDS	In 2002, world leaders committed, through the Convention on Biological Diversity, to achieve a significant reduction in the rate of biodiversity loss by 2010. We compiled 31 indicators to report on progress toward this target. Most indicators of the state of biodiversity (covering species' population trends, extinction risk, habitat extent and condition, and community composition) showed declines, with no significant recent reductions in rate, whereas indicators of pressures on biodiversity (including resource consumption, invasive alien species, nitrogen pollution, overexploitation, and climate change impacts) showed increases. Despite some local successes and increasing responses (including extent and biodiversity coverage of protected areas, sustainable forest management, policy responses to invasive alien species, and biodiversity-related aid), the rate of biodiversity loss does not appear to be slowing.	[Butchart, Stuart H. M.; Walpole, Matt; Scharlemann, Joern P. W.; Almond, Rosamunde E. A.; Chenery, Anna M.; Kapos, Valerie; Morcillo, Monica Hernandez; Stanwell-Smith, Damon; Stuart, Simon N.; Tierney, Megan; Tyrrell, Tristan D.] UN, Environm Programme, World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; [Butchart, Stuart H. M.; Symes, Andy] BirdLife Int, Cambridge CB3 0NA, England; [Collen, Ben; Baillie, Jonathan E. M.; McRae, Louise] Zool Soc London, Inst Zool, London NW1 4RY, England; [van Strien, Arco] Stat Netherlands, NL-2490 HA The Hague, Netherlands; [Bruno, John] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Carpenter, Kent E.] Old Dominion Univ, Norfolk, VA 23529 USA; [Carr, Genevieve M.] Natl Water Res Inst Branch, United Nations Environm Programme, Burlington, ON L7R 4A6, Canada; [Chanson, Janice] Conservat Int, Ctr Appl Biodivers Sci, Biodivers Assessment Unit, IUCN Species Survival Commiss, Arlington, VA 22202 USA; [Csirke, Jorge] UN, Food & Agr Org, Fisheries & Aquaculture Management Div, I-00153 Rome, Italy; [Davidson, Nick C.] Secretariat Ramsar Convent Wetlands, CH-1196 Gland, Switzerland; [Dentener, Frank] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, VA, Italy; [Galli, Alessandro] Global Footprint Network, Oakland, CA 94607 USA; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Genovesi, Piero] Ist Super Protez & Ric Ambientale, I-00185 Rome, Italy; [Gregory, Richard D.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Hockings, Marc; Leverington, Fiona] Univ Queensland, Sch Integrat Syst, Brisbane, Qld 4067, Australia; [Kapos, Valerie] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Lamarque, Jean-Francois] Natl Ctr Atmospher Res, Boulder, CO 80301 USA; [Loh, Jonathan] World Wildlife Fund Int, CH-1196 Gland, Switzerland; [McGeoch, Melodie A.] S African Natl Pk, Ctr Invas Biol, ZA-7947 Steenberg, South Africa; [McGeoch, Melodie A.] S African Natl Pk, Global Invas Species Programme, ZA-7947 Steenberg, South Africa; [Minasyan, Anahit] United Nations Educ Sci & Cultural Org, F-75352 Paris, France; [Oldfield, Thomasina E. E.] TRAFFIC Int, Cambridge CB3 0DL, England; [Pauly, Daniel; Watson, Reg] Univ British Columbia, Fisheries Ctr, Sea Us Project, Vancouver, BC V6T 1Z4, Canada; [Quader, Suhel] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore 560065, Karnataka, India; [Revenga, Carmen] Nature Conservancy, Arlington, VA 22203 USA; [Sauer, John R.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Skolnik, Benjamin] Amer Bird Conservancy, Washington, DC 20009 USA; [Spear, Dian] Univ Stellenbosch, Ctr Invas Biol, ZA-7602 Matieland, South Africa; [Stuart, Simon N.] Univ Bath, Dept Biol & Biochem, IUCN Species Survival Commiss, Bath BA2 7AY, Avon, England; [Stuart, Simon N.] Al Ain Wildlife Pk & Resort, Abu Dhabi, U Arab Emirates; [Vie, Jean-Christophe] IUCN, CH-1196 Gland, Switzerland	United Nations Environment Programme; BirdLife International; Zoological Society of London; University of North Carolina; University of North Carolina Chapel Hill; Old Dominion University; Environment & Climate Change Canada; National Water Research Institute; Conservation International; Food & Agriculture Organization of the United Nations (FAO); European Commission Joint Research Centre; EC JRC ISPRA Site; University of Virginia; Italian Institute for Environmental Protection & Research (ISPRA); Royal Society for Protection of Birds; University of Queensland; University of Cambridge; National Center Atmospheric Research (NCAR) - USA; World Wildlife Fund; University of British Columbia; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Nature Conservancy; United States Department of the Interior; United States Geological Survey; Stellenbosch University; University of Bath	Butchart, SHM (corresponding author), UN, Environm Programme, World Conservat Monitoring Ctr, 219 Huntingdon Rd, Cambridge CB3 0DL, England.	stuart.butchart@birdlife.org	Collen, Ben/F-2543-2016; van Strien, Arco/AAG-1843-2020; Quader, Suhel/D-4454-2011; Genovesi, Piero/Z-1571-2019; Butchart, Stuart HM/Y-2711-2018; Watson, Reg A/F-4850-2012; Bertzky, Bastian/I-6909-2013; Kapos, Valerie/G-3136-2010; Butchart, Stuart/AAJ-1852-2021; Galloway, James N/C-2769-2013; Lamarque, Jean-Francois/L-2313-2014; Collen, Ben/D-5055-2011; Galli, Alessandro/AAV-5906-2020; Carneiro, Fernanda/E-9513-2013; Hockings, Marc/A-1283-2007; Scharlemann, Jorn/A-4737-2008; Spear, Dian/B-2469-2009; Davidson, Nicholas/AAA-9921-2019; McGeoch, Melodie A/F-8353-2011; Pauly, Daniel Marc/AAY-2316-2021	Collen, Ben/0000-0003-2564-4243; Watson, Reg A/0000-0001-7201-8865; Bertzky, Bastian/0000-0001-7025-4733; Kapos, Valerie/0000-0002-5739-8262; Butchart, Stuart/0000-0002-1140-4049; Galloway, James N/0000-0001-7676-8698; Lamarque, Jean-Francois/0000-0002-4225-5074; Carneiro, Fernanda/0000-0001-6389-4564; Hockings, Marc/0000-0003-4419-8963; Scharlemann, Jorn/0000-0002-2834-6367; Spear, Dian/0000-0002-2417-3980; Davidson, Nicholas/0000-0002-2466-0658; McGeoch, Melodie A/0000-0003-3388-2241; Gregory, Richard/0000-0002-7419-5053; Pauly, Daniel/0000-0003-3756-4793; Csirke, Jorge/0000-0002-0253-3535; Galli, Alessandro/0000-0001-9503-4104	Global Environment Facility; Shell Foundation; European Commission; University of British Columbia/Pew Environment Group; Nature Conservancy; University of Queensland; New Hampshire Charitable Foundation; National Science Foundation (NSF)	Global Environment Facility; Shell Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); University of British Columbia/Pew Environment Group; Nature Conservancy; University of Queensland(University of Queensland); New Hampshire Charitable Foundation; National Science Foundation (NSF)(National Science Foundation (NSF))	We are grateful for comments, data, or help from R. Akcakaya, L. Alvarez-Filip, A. Angulo, L. Bennun, L. Coad, N. Cox, M. Dube, C. Estreguil, M. Evans, B. Galil, V. Gaveau, F. Gherardi, S. Goldfinger, R. Green, A. Grigg, P. Herkenrath, C. Hilton-Taylor, M. Hoffmann, E. Kleynhans, J. Lamoreux, S. Livingstone, E. Marais, P. Martin, I. May, A. Milam, K. Noonan-Mooney, H. Pavese, B. Polidoro, C. Pollock, D. Pritchard, J. Schipper, F. Schutyser, V. Shutte, S. Simons, J. Skorpilova, A. Stattersfield, P. Vorisek, R. Wright, M. Wackernagel, and M. Waycott. We acknowledge support from the Global Environment Facility to the 2010 Biodiversity Indicators Partnership; Shell Foundation; European Commission; the Sea Around Us Project (University of British Columbia/Pew Environment Group) to D. P. and R. W.; World Wildlife Fund, The Nature Conservancy, and the University of Queensland to M. H. and F. L.; T. Haas and the New Hampshire Charitable Foundation to K. E. C.; and the National Science Foundation (NSF) to J.-F.L. Opinions and findings expressed here do not necessarily reflect the views of the NSF or other funding bodies.	Balmford A, 2005, PHILOS T ROY SOC B, V360, P221, DOI 10.1098/rstb.2004.1599; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; Butchart SHM, 2006, ORYX, V40, P266, DOI 10.1017/S0030605306000950; Chowdhury J. A., 2006, BETTER FOREST MANAGE; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Collen B, 2008, TROP CONSERV SCI, V1, P75, DOI 10.1177/194008290800100202; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Gilbert N, 2009, NATURE, V462, P263, DOI 10.1038/462263a; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; McGeoch MA, 2010, DIVERS DISTRIB, V16, P95, DOI 10.1111/j.1472-4642.2009.00633.x; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; SCBD (SECRETARIAT OF THE CONVENTION ON BIOLOGICAL DIVERSITY), 2009, CONV BIOL DIV PLANT; Secretariat of the Convention on Biological Diversity, 2003, HDB CONV BIOL DIV; Soldaat L, 2007, J ORNITHOL, V148, pS351, DOI 10.1007/s10336-007-0176-7; United Nations, 2008, MILL DEV GOALS IND; Vie J.C., 2009, WILDLIFE CHANGING WO, DOI 10.2305/IUCN.CH.2009.17.en; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466	26	2903	3070	126	3848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2010	328	5982					1164	1168		10.1126/science.1187512	http://dx.doi.org/10.1126/science.1187512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20430971	Green Published			2022-12-28	WOS:000278104700046
J	Saver, JL; Levine, SR				Saver, Jeffrey L.; Levine, Steven R.			Alteplase for ischaemic stroke-much sooner is much better	LANCET			English	Editorial Material							TIME		[Levine, Steven R.] Mt Sinai Sch Med, Stroke Ctr, New York, NY 10029 USA; [Levine, Steven R.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Stroke Ctr, Los Angeles, CA 90095 USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Levine, SR (corresponding author), Mt Sinai Sch Med, Stroke Ctr, New York, NY 10029 USA.	steven.levine@mssm.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Saver, Jeffrey/0000-0001-9141-2251	NHLBI NIH HHS [R01 HL096944] Funding Source: Medline; NINDS NIH HHS [T32 NS051147, R01 NS052417, U01 NS 44364, U01 NS044364, P50 NS044378] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS044364, T32NS051147, P50NS044378, R01NS052417] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexandrov AV, 2010, J INTERN MED, V267, P209, DOI 10.1111/j.1365-2796.2009.02206.x; DEVITO C, 2008, YOGI LIFE TIMES AM O; Donnan GA, 2009, LANCET NEUROL, V8, P261, DOI 10.1016/S1474-4422(09)70041-9; Hacke W, 2004, LANCET, V363, P768; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Lansberg MG, 2009, STROKE, V40, P2079, DOI 10.1161/STROKEAHA.108.540708; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Schwamm LH, 2005, STROKE, V36, P690, DOI 10.1161/01.STR.0000158165.42884.4F; The European Stroke Organization (ESO), 2009, GUID MAN ISCH STROK; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2	12	43	50	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1667	1668		10.1016/S0140-6736(10)60634-4	http://dx.doi.org/10.1016/S0140-6736(10)60634-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472152				2022-12-28	WOS:000277890200004
J	Holloway, RG; Quill, TE				Holloway, Robert G.; Quill, Timothy E.			Treatment Decisions after Brain Injury - Tensions among Quality, Preference, and Cost	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OF-LIFE CARE		[Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Holloway, Robert G.; Quill, Timothy E.] Univ Rochester, Med Ctr, Palliat Care Program, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Holloway, RG (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.							Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Carlet J, 2004, INTENS CARE MED, V30, P770, DOI 10.1007/s00134-004-2241-5; Epstein RM, 2009, JAMA-J AM MED ASSOC, V302, P195, DOI 10.1001/jama.2009.984; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716	5	33	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1757	1759		10.1056/NEJMp0907808	http://dx.doi.org/10.1056/NEJMp0907808			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594RQ	20463337				2022-12-28	WOS:000277555500002
J	Maruyama, H; Morino, H; Ito, H; Izumi, Y; Kato, H; Watanabe, Y; Kinoshita, Y; Kamada, M; Nodera, H; Suzuki, H; Komure, O; Matsuura, S; Kobatake, K; Morimoto, N; Abe, K; Suzuki, N; Aoki, M; Kawata, A; Hirai, T; Kato, T; Ogasawara, K; Hirano, A; Takumi, T; Kusaka, H; Hagiwara, K; Kaji, R; Kawakami, H				Maruyama, Hirofumi; Morino, Hiroyuki; Ito, Hidefumi; Izumi, Yuishin; Kato, Hidemasa; Watanabe, Yasuhito; Kinoshita, Yoshimi; Kamada, Masaki; Nodera, Hiroyuki; Suzuki, Hidenori; Komure, Osamu; Matsuura, Shinya; Kobatake, Keitaro; Morimoto, Nobutoshi; Abe, Koji; Suzuki, Naoki; Aoki, Masashi; Kawata, Akihiro; Hirai, Takeshi; Kato, Takeo; Ogasawara, Kazumasa; Hirano, Asao; Takumi, Toru; Kusaka, Hirofumi; Hagiwara, Koichi; Kaji, Ryuji; Kawakami, Hideshi			Mutations of optineurin in amyotrophic lateral sclerosis	NATURE			English	Article							OPEN-ANGLE GLAUCOMA; MYOSIN-VI; PROTEIN; GENE; EXPRESSION; COMPLEX; NEMO	Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of motor neurons of the primary motor cortex, brainstem and spinal cord(1). Most cases of ALS are sporadic, but about 10% are familial. Genes known to cause classic familial ALS (FALS) are superoxide dismutase 1 (SOD1)(2), ANG encoding angiogenin(3), TARDP encoding transactive response (TAR) DNA-binding protein TDP-43 (ref. 4) and fused in sarcoma/translated in liposarcoma (FUS, also known as TLS)(5,6). However, these genetic defects occur in only about 20-30% of cases of FALS, and most genes causing FALS are unknown. Here we show that there are mutations in the gene encoding optineurin (OPTN), earlier reported to be a causative gene of primary open-angle glaucoma (POAG)(7), in patients with ALS. We found three types of mutation of OPTN: a homozygous deletion of exon 5, a homozygous Q398X nonsense mutation and a heterozygous E478G missense mutation within its ubiquitin-binding domain. Analysis of cell transfection showed that the nonsense and missense mutations of OPTN abolished the inhibition of activation of nuclear factor kappa B (NF-kappa B), and the E478G mutation revealed a cytoplasmic distribution different from that of the wild type or a POAG mutation. A case with the E478G mutation showed OPTN-immunoreactive cytoplasmic inclusions. Furthermore, TDP-43- or SOD1-positive inclusions of sporadic and SOD1 cases of ALS were also noticeably immunolabelled by anti-OPTN antibodies. Our findings strongly suggest that OPTN is involved in the pathogenesis of ALS. They also indicate that NF-kB inhibitors could be used to treat ALS and that transgenic mice bearing various mutations of OPTN will be relevant in developing new drugs for this disorder.	[Maruyama, Hirofumi; Morino, Hiroyuki; Kamada, Masaki; Kawakami, Hideshi] Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; [Ito, Hidefumi; Kinoshita, Yoshimi; Kusaka, Hirofumi] Kansai Med Univ, Dept Neurol, Moriguchi, Osaka 5708506, Japan; [Izumi, Yuishin; Kamada, Masaki; Nodera, Hiroyuki; Kaji, Ryuji] Univ Tokushima, Grad Sch, Dept Clin Neurosci, Tokushima 7708503, Japan; [Kato, Hidemasa] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Saitama 3501241, Japan; [Watanabe, Yasuhito] Hiroshima Univ, Grad Sch Biomed Sci, Lab Integrat Biosci, Hiroshima 7348553, Japan; [Suzuki, Hidenori] Hiroshima Bunkyo Womens Univ, Fac Human Sci, Hiroshima 7310295, Japan; [Komure, Osamu] S Osaka Neurosurg Hosp, Osakasayama 5890011, Japan; [Matsuura, Shinya] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Genet & Cell Biol, Hiroshima 7348553, Japan; [Kobatake, Keitaro] Kobatake Hosp, Dept Neurol, Fukuyama, Hiroshima 7201142, Japan; [Morimoto, Nobutoshi; Abe, Koji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol, Okayama 7008558, Japan; [Suzuki, Naoki; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 9808574, Japan; [Kawata, Akihiro; Hirai, Takeshi] Tokyo Metropolitan Neurol Hosp, Dept Neurol, Tokyo 1830042, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol Haematol Metab Endocrinol & Diabetol, Yamagata 9909585, Japan; [Ogasawara, Kazumasa] Shiga Univ Med Sci, Sch Med, Dept Pathol, Otsu, Shiga 5202192, Japan; [Hirano, Asao] Montefiore Med Ctr, Dept Pathol, Div Neuropathol, New York, NY 10467 USA; [Hagiwara, Koichi] Saitama Med Univ, Dept Resp Med, Saitama 3500495, Japan	Hiroshima University; Kansai Medical University; Tokushima University; Saitama Medical University; Hiroshima University; Hiroshima University; Okayama University; Tohoku University; Tokyo Metropolitan Institute for Neuroscience; Yamagata University; Shiga University of Medical Science; Montefiore Medical Center; Saitama Medical University	Kawakami, H (corresponding author), Hiroshima Univ, Dept Epidemiol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan.	hkawakam@hiroshima-u.ac.jp	Suzuki, Naoki/J-6331-2019; Matsuura, Shinya/U-4182-2017; Kawakami, Hideshi/A-2086-2009; Kawakami, Hideshi/ABE-4077-2021; Maruyama, Hirofumi/B-9333-2011; Morino, Hiroyuki/H-9583-2013	Suzuki, Naoki/0000-0001-8880-8554; Matsuura, Shinya/0000-0001-5294-081X; Kawakami, Hideshi/0000-0002-1405-0901; Kawakami, Hideshi/0000-0002-1405-0901; Maruyama, Hirofumi/0000-0001-7613-8717; Morino, Hiroyuki/0000-0002-5190-3547	Ministry of Education, Science, and Culture of Japan; Smoking Research Foundation; Japan Science and Technology Agency, Core Research for Evolutional Science Technology	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation; Japan Science and Technology Agency, Core Research for Evolutional Science Technology(Japan Science & Technology Agency (JST))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture of Japan, by a grant from the Smoking Research Foundation to H. Kawakami, and by the Japan Science and Technology Agency, Core Research for Evolutional Science & Technology to T. T. We thank E. Nakajima for technical support, K. Nakayama, H. W. Shin, M. Omi and H. Nakamura for conducting some of the experiments, and T. Miki and K. Noda for providing some DNA samples and clinical information. This paper is dedicated to the patients and families who contributed to this project.	Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Huqun, 2007, AM J RESP CRIT CARE, V175, P263, DOI 10.1164/rccm.200609-1274OC; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Leigh P Nigel, 2007, Handb Clin Neurol, V82, P249, DOI 10.1016/S0072-9752(07)80016-9; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Mrowka R, 2008, FEBS J, V275, P3178, DOI 10.1111/j.1742-4658.2008.06471.x; Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takarada T, 2009, J NEUROCHEM, V110, P1457, DOI 10.1111/j.1471-4159.2009.06225.x; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Yoshimura A, 2006, CURR BIOL, V16, P2345, DOI 10.1016/j.cub.2006.10.024; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	23	901	943	4	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					223	U109		10.1038/nature08971	http://dx.doi.org/10.1038/nature08971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20428114				2022-12-28	WOS:000277558500036
J	Mbulaiteye, SM; Talisuna, AO; Ogwang, MD; McKenzie, FE; Ziegler, JL; Parkin, DM				Mbulaiteye, Sam M.; Talisuna, Ambrose O.; Ogwang, Martin D.; McKenzie, F. Ellis; Ziegler, John L.; Parkin, Donald M.			African Burkitt's lymphoma: could collaboration with HIV-1 and malaria programmes reduce the high mortality rate?	LANCET			English	Editorial Material							CHILDREN; UGANDA; INFECTION; PEPFAR; BURDEN; MALAWI		[Talisuna, Ambrose O.] Uganda Malaria Surveillance Programme, Kampala, Uganda; [Ogwang, Martin D.] St Marys Hosp, Dept Surg, Lacor, Gulu, Uganda; [McKenzie, F. Ellis] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Ziegler, John L.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Parkin, Donald M.] Univ Oxford, Clin Trial Serv Unit, Oxford, England	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California San Francisco; University of Oxford	Mbulaiteye, SM (corresponding author), 2302 Cranberry Terrace, Silver Spring, MD 20906 USA.	sammwiidu@hotmail.com	Mbulaiteye, Sam/O-3056-2019	Mbulaiteye, Sam/0000-0002-8273-9831				Bristol N, 2008, LANCET, V372, P277, DOI 10.1016/S0140-6736(08)61093-4; BURKITT D, 1965, CANCER-AM CANCER SOC, V18, P399, DOI 10.1002/1097-0142(196504)18:4<399::AID-CNCR2820180402>3.0.CO;2-G; BURKITT D, 1958, BRIT J SURG, V46, P218, DOI 10.1002/bjs.18004619704; Hesseling PB, 2008, LANCET ONCOL, V9, P512, DOI 10.1016/S1470-2045(08)70139-6; Kamwi R, 2006, LANCET, V367, P1978, DOI 10.1016/S0140-6736(06)68879-X; Klein G, 2009, SEMIN CANCER BIOL, V19, P347, DOI 10.1016/j.semcancer.2009.07.001; Molyneux E, 2003, LANCET, V362, P2117, DOI 10.1016/S0140-6736(03)15116-1; Ogwang MD, 2008, INT J CANCER, V123, P2658, DOI 10.1002/ijc.23800; OLWENY CL, 1985, IARC SCI PUBL, V60, P375; Orem J, 2009, PEDIATR BLOOD CANCER, V52, P455, DOI 10.1002/pbc.21769; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Patte C, 2001, BLOOD, V97, P3370, DOI 10.1182/blood.V97.11.3370; Phillips JA, 2006, LANCET, V368, P2251, DOI 10.1016/S0140-6736(06)69898-X; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Ribeiro RC, 2008, PEDIATR BLOOD CANCER, V50, P1125, DOI 10.1002/pbc.21528; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; *UG MIN HLTH, 2008, ANN HLTH SECT PERF R; Wakabi W, 2008, LANCET ONCOL, V9, P319, DOI 10.1016/S1470-2045(08)70088-3; Wolitz R, 2009, LANCET, V374, P847, DOI 10.1016/S0140-6736(09)60320-2; ZIEGLER JL, 1981, NEW ENGL J MED, V305, P735, DOI 10.1056/NEJM198109243051305; ZIEGLER JL, 1979, LANCET, V2, P936; 2006, LANCET, V368, P1	22	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1661	1663		10.1016/S0140-6736(10)60134-1	http://dx.doi.org/10.1016/S0140-6736(10)60134-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452522				2022-12-28	WOS:000277734700032
J	Lee, HK; Yang, Y; Su, ZL; Hyeon, C; Lee, TS; Lee, HW; Kweon, DH; Shin, YK; Yoon, TY				Lee, Han-Ki; Yang, Yoosoo; Su, Zengliu; Hyeon, Changbong; Lee, Tae-Sun; Lee, Hong-Won; Kweon, Dae-Hyuk; Shin, Yeon-Kyun; Yoon, Tae-Young			Dynamic Ca2+-Dependent Stimulation of Vesicle Fusion by Membrane-Anchored Synaptotagmin 1	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; PHOSPHOLIPIDS; PENETRATION; MACHINERY; CALCIUM; BINDING; SNARES; DOMAIN; CA2+	In neurons, synaptotagmin 1 (Syt1) is thought to mediate the fusion of synaptic vesicles with the plasma membrane when presynaptic Ca2+ levels rise. However, in vitro reconstitution experiments have failed to recapitulate key characteristics of Ca2+-triggered membrane fusion. Using an in vitro single-vesicle fusion assay, we found that membrane-anchored Syt1 enhanced Ca2+ sensitivity and fusion speed. This stimulatory activity of membrane-anchored Syt1 dropped as the Ca2+ level rose beyond physiological levels. Thus, Syt1 requires the membrane anchor to stimulate vesicle fusion at physiological Ca2+ levels and may function as a dynamic presynaptic Ca2+ sensor to control the probability of neurotransmitter release.	[Su, Zengliu; Shin, Yeon-Kyun] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Lee, Han-Ki; Lee, Tae-Sun; Lee, Hong-Won; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Yang, Yoosoo; Kweon, Dae-Hyuk] Sungkyunkwan Univ, Dept Genet Engn, Suwon 4400746, Gyeonggi Do, South Korea; [Hyeon, Changbong] Korea Inst Adv Study, Sch Computat Sci, Seoul 130722, South Korea; [Shin, Yeon-Kyun] POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea	Iowa State University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Sungkyunkwan University (SKKU); Korea Institute for Advanced Study (KIAS); Pohang University of Science & Technology (POSTECH)	Shin, YK (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, 4152 Mol Biol Bldg, Ames, IA 50011 USA.	colishin@iastate.edu; tyyoon@kaist.ac.kr	Yoon, Tae-Young/C-1687-2011; Hyeon, Changbong/H-3295-2011; Su, Zengliu/E-3156-2010; Hyeon, Changbong/AAU-7862-2021	Yoon, Tae-Young/0000-0002-5184-7725; Hyeon, Changbong/0000-0002-4844-7237; Lee, Hong-won/0000-0003-0627-9850; Lee, Hanki/0000-0002-3479-1651	Korea Research Foundation [KRF-2008-313-C00365, KRF-C00142, KRF-C00180]; Korean government [2009-0087691, R01-2008-00010920-0, 2007-D00243]; National Institutes of Health [R01 GM051290]; World Class University program in Korea [R31-2008-000-10105-0, R33-10163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051290] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Korean government(Korean Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University program in Korea; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.-Y. Y. thanks W. Bae and J. Ryu for writing analysis programs, K. Kim for help with the supporting movie, and T. Ha and W. Jones for critical reading of the manuscript. This work was supported by Korea Research Foundation grants (KRF-2008-313-C00365 to T.-Y. Y.; KRF-C00142 and KRF-C00180 to C. H.), and National Research Foundation of Korea grants funded by the Korean government (2009-0087691 to T.-Y. Y.; R01-2008-00010920-0 to C. H.; 2007-D00243 to D.-H. K.). This work was also supported by a National Institutes of Health grant (R01 GM051290 to Y.-K. S.) and the World Class University program in Korea (R31-2008-000-10105-0 to Y.-K. S. and R33-10163 to T.-Y. Y.).	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2	29	101	101	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					760	763		10.1126/science.1187722	http://dx.doi.org/10.1126/science.1187722			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448186	Green Accepted			2022-12-28	WOS:000277357100042
J	Hurley, LP; Lindley, MC; Harpaz, R; Stokley, S; Daley, MF; Crane, LA; Dong, F; Beaty, BL; Tan, L; Babbel, C; Dickinson, LM; Kempe, A				Hurley, Laura P.; Lindley, Megan C.; Harpaz, Rafael; Stokley, Shannon; Daley, Matthew F.; Crane, Lori A.; Dong, Fran; Beaty, Brenda L.; Tan, Litjen; Babbel, Christine; Dickinson, L. Miriam; Kempe, Allison			Barriers to the Use of Herpes Zoster Vaccine	ANNALS OF INTERNAL MEDICINE			English	Article							POSTHERPETIC NEURALGIA; COST-EFFECTIVENESS; IMMUNIZATION; PHYSICIANS; INFLUENZA; ADULTS	Background: The herpes zoster vaccine is the most expensive vaccine recommended for older adults and the first vaccine to be reimbursed through Medicare Part D. Early uptake has been 2% to 7% nationally. Objective: To assess current vaccination practices, knowledge and practice regarding reimbursement, and barriers to vaccination among general internists and family medicine physicians. Design: Mail and Internet-based survey, designed through an iterative process and conceptually based on the Health Belief Model. Setting: National survey conducted from July to September 2008. Participants: General internists and family medicine physicians. Measurements: Survey responses on current vaccination practices, knowledge and practice regarding reimbursement, and barriers to vaccination. Results: Response rates were 72% in both specialties (301 general internists and 297 family medicine physicians). Physicians in both specialties reported similar methods for delivering vaccine, which included stocking and administering the vaccine in their offices (49%), referring patients to a pharmacy to purchase the vaccine and bring it back to the office for administration (36%), and referring patients to a pharmacy for vaccine administration (33%). Eighty-eight percent of providers recommend herpes zoster vaccine and 41% strongly recommend it, compared with more than 90% who strongly recommend influenza and pneumococcal vaccines. For physicians in both specialties, the most frequently reported barriers to vaccination were financial. Only 45% of respondents knew that herpes zoster vaccine is reimbursed through Medicare Part D. Of respondents who began administering herpes zoster vaccine in their office, 12% stopped because of cost and reimbursement issues. Limitations: Survey results represent reported but not observed practice. Surveyed providers may not be representative of all providers. Conclusion: Physicians are making efforts to provide herpes zoster vaccine but are hampered by barriers, particularly financial ones. Efforts to facilitate the financing of herpes zoster vaccine could help increase its use.	[Hurley, Laura P.] Denver Hlth, Wellington Webb Ctr Primary Care, Childrens Outcomes Res Program, Denver, CO 80204 USA; Childrens Hosp, Denver, CO 80218 USA; Univ Colorado, Colorado Sch Publ Hlth, Denver, CO 80202 USA; Univ Colorado, Colorado Hlth Outcomes Program, Denver, CO 80202 USA; Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; Amer Med Assoc, Chicago, IL 60610 USA	Denver Health Medical Center; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Denver; Centers for Disease Control & Prevention - USA; American Medical Association	Hurley, LP (corresponding author), Denver Hlth, Wellington Webb Ctr Primary Care, Childrens Outcomes Res Program, 301 W 6th Ave,MC 3251, Denver, CO 80204 USA.			Lindley, Megan/0000-0002-8368-7375; Tan, Litjen/0000-0001-9054-6696	CDC [CDC SIP 5 U48 DP000054-03]	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Grant Support: By the CDC (CDC SIP 5 U48 DP000054-03).	Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; BABBIE ER, 1986, PRACTICE SOCIAL RES; Bell KN, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e100; BRISSON M, 2008, HUM VACCIN, V4; Crane LA, 2008, EVAL HEALTH PROF, V31, P43, DOI 10.1177/0163278707311872; Davis MM, 2003, PEDIATRICS, V112, P521, DOI 10.1542/peds.112.3.521; DePue R, 2008, J MANAGE CARE PHARM, V14, P50, DOI 10.18553/jmcp.2008.14.1.50; Dillman DA., 2000, MAIL INTERNET SURVEY, P464; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Freed GL, 2008, PEDIATRICS, V122, P1325, DOI 10.1542/peds.2008-2038; Gilderman LI, 2008, CLIN VACCINE IMMUNOL, V15, P314, DOI 10.1128/CVI.00310-07; Glanz K., 2002, HLTH BEHAV THEORY RE; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Hornberger J, 2006, ANN INTERN MED, V145, P317, DOI 10.7326/0003-4819-145-5-200609050-00004; Hurley LP, 2008, J INFECT DIS, V197, pS216, DOI 10.1086/522153; Kempe A, 2007, PEDIATRICS, V119, P1, DOI 10.1542/peds.2006-1874; Kilgore Paul E., 2003, Journal of Medical Virology, V70, pS111, DOI 10.1002/jmv.10364; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Medicare Payment Advisory Commission, 2007, REP C PROM GREAT FIC REP C PROM GREAT FIC, P157; Nichol KL, 1996, J GEN INTERN MED, V11, P673, DOI 10.1007/BF02600158; Opstelten W, 2009, VACCINE, V27, P192, DOI 10.1016/j.vaccine.2008.10.047; Orenstein WA, 2007, CLIN PHARMACOL THER, V82, P764, DOI 10.1038/sj.clpt.6100401; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Prosser LA, 2008, PHARMACOECONOMICS, V26, P163, DOI 10.2165/00019053-200826020-00006; Rothberg MB, 2007, CLIN INFECT DIS, V44, P1280, DOI 10.1086/514342; Schiller JS, 2008, VACCINATION COVERAGE; Schuman H., 1996, QUESTIONS ANSWERS AT, V2nd; Shenson Douglas, 2008, Prev Chronic Dis, V5, pA20; *THOMS REUT, 2009, RED BOOK 2009 PHARM; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024	30	89	89	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					555	+		10.7326/0003-4819-152-9-201005040-00005	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439573				2022-12-28	WOS:000277604000002
J	Meinhardt, U; Nelson, AE; Hansen, JL; Birzniece, V; Clifford, D; Leung, KC; Graham, K; Ho, KKY				Meinhardt, Udo; Nelson, Anne E.; Hansen, Jennifer L.; Birzniece, Vita; Clifford, David; Leung, Kin-Chuen; Graham, Kenneth; Ho, Ken K. Y.			The Effects of Growth Hormone on Body Composition and Physical Performance in Recreational Athletes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							EXTRACELLULAR WATER; DOUBLE-BLIND; TESTOSTERONE; MUSCLE; INCREASES; ABUSE; PROTEIN; ADULTS; WOMEN; AXIS	Background: Growth hormone is widely abused by athletes, frequently with androgenic steroids. Its effects on performance are unclear. Objective: To determine the effect of growth hormone alone or with testosterone on body composition and measures of performance. Design: Randomized, placebo-controlled, blinded study of 8 weeks of treatment followed by a 6-week washout period. Randomization was computer-generated with concealed allocation. (Australian-New Zealand Clinical Trials Registry registration number: ACTRN012605000508673) Setting: Clinical research facility in Sydney, Australia. Participants: 96 recreationally trained athletes (63 men and 33 women) with a mean age of 27.9 years (SD, 5.7). Intervention: Men were randomly assigned to receive placebo, growth hormone (2 mg/d subcutaneously), testosterone (250 mg/wk intramuscularly), or combined treatments. Women were randomly assigned to receive either placebo or growth hormone (2 mg/d). Measurements: Body composition variables (fat mass, lean body mass, extracellular water mass, and body cell mass) and physical performance variables (endurance [maximum oxygen consumption], strength [dead lift], power [jump height], and sprint capacity [Wingate value]). Results: Body cell mass was correlated with all measures of performance at baseline. Growth hormone significantly reduced fat mass, increased lean body mass through an increase in extracellular water, and increased body cell mass in men when coadministered with testosterone. Growth hormone significantly increased sprint capacity, by 0.71 kJ (95% CI, 0.1 to 1.3 kJ; relative increase, 3.9% [CI, 0.0% to 7.7%]) in men and women combined and by 1.7 kJ (CI, 0.5 to 3.0 kJ; relative increase, 8.3% [CI, 3.0% to 13.6%]) when coadministered with testosterone to men; other performance measures did not significantly change. The increase in sprint capacity was not maintained 6 weeks after discontinuation of the drug. Limitations: Growth hormone dosage may have been lower than that used covertly by competitive athletes. The athletic significance of the observed improvements in sprint capacity is unclear, and the study was too small to draw conclusions about safety. Conclusion: Growth hormone supplementation influenced body composition and increased sprint capacity when administered alone and in combination with testosterone.	St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia; Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2052, Australia; CSIRO Math & Informat Sci, N Ryde, NSW, Australia; New S Wales Inst Sports, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ho, KKY (corresponding author), St Vincents Hosp, Garvan Inst Med Res, 384 Victoria St, Sydney, NSW 2010, Australia.	k.ho@garvan.org.au	Clifford, David/A-4400-2009; Ho, Ken/AAA-7428-2019; Ho, Ken KY/E-5832-2011	Clifford, David/0000-0003-4130-4134; Ho, Ken/0000-0002-2508-9588; Birzniece, Vita/0000-0003-1609-4358	World Anti-Doping Agency, Australian Government (through the Department of Communications, Information Technology, and the Arts); Swiss National Foundation; Federal Council of Sports	World Anti-Doping Agency, Australian Government (through the Department of Communications, Information Technology, and the Arts); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Federal Council of Sports	Grant Support: By the World Anti-Doping Agency, Australian Government (through the Anti-Doping Research Program of the Department of Communications, Information Technology, and the Arts), and the Swiss National Foundation and the Federal Council of Sports (Dr. Meinhardt). Novo Nordisk and Organon provided the study medication.	Astrand PO., 1986, TXB WORK PHYSL, P391; BAXTER RC, 1982, CLIN CHEM, V28, P488; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Dall R, 2000, J CLIN ENDOCR METAB, V85, P4193, DOI 10.1210/jc.85.11.4193; Davison AC, 2006, CAMBRIDGE SERIES STA; DEYSSIG R, 1993, ACTA ENDOCRINOL-COP, V128, P313, DOI 10.1530/acta.0.1280313; Eiholzer U, 1998, EUR J PEDIATR, V157, P368, DOI 10.1007/s004310050832; Giannoulis MG, 2006, J CLIN ENDOCR METAB, V91, P477, DOI 10.1210/jc.2005-0957; Gibney J, 2005, AM J PHYSIOL-ENDOC M, V289, pE266, DOI 10.1152/ajpendo.00483.2004; Gibney J, 2007, ENDOCR REV, V28, P603, DOI 10.1210/er.2006-0052; Graham MR, 2008, HORM RES, V69, P343, DOI 10.1159/000117390; Hoffman DM, 1996, J CLIN ENDOCR METAB, V81, P1123, DOI 10.1210/jc.81.3.1123; HOLM S, 1979, SCAND J STAT, V6, P65; Johannsson G, 2005, J CLIN ENDOCR METAB, V90, P3989, DOI 10.1210/jc.2005-0553; Lange KHW, 2002, J CLIN ENDOCR METAB, V87, P4966, DOI 10.1210/jc.2001-011797; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Longobardi S, 2000, J CLIN ENDOCR METAB, V85, P1505, DOI 10.1210/jc.85.4.1505; Micklewright D, 2006, EUR J APPL PHYSIOL, V96, P748, DOI 10.1007/s00421-006-0145-5; Nelson AE, 2008, J CLIN ENDOCR METAB, V93, P2213, DOI 10.1210/jc.2008-0402; Nelson AE, 2007, NAT CLIN PRACT ENDOC, V3, P198, DOI 10.1038/ncpendmet0429; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; OSULLIVAN AJ, 1994, J CLIN ENDOCR METAB, V78, P381, DOI 10.1210/jc.78.2.381; PARKHOUSE WS, 1984, MED SCI SPORT EXER, V16, P328; Saugy M, 2006, BRIT J SPORT MED, V40, P35, DOI 10.1136/bjsm.2006.027573; Sjogren K, 2007, AM J PHYSIOL-ENDOC M, V293, pE364, DOI 10.1152/ajpendo.00054.2007; Woodhouse LJ, 2006, ENDOCR REV, V27, P287, DOI 10.1210/er.2004-0022; YARASHESKI KE, 1992, AM J PHYSIOL, V262, pE261, DOI 10.1152/ajpendo.1992.262.3.E261; YARASHESKI KE, 1993, J APPL PHYSIOL, V74, P3073, DOI 10.1152/jappl.1993.74.6.3073	29	95	97	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					568	+		10.7326/0003-4819-152-9-201005040-00007	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00007			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439575				2022-12-28	WOS:000277604000004
J	Harries, AD; Zachariah, R; Corbett, EL; Lawn, SD; Santos, ET; Chimzizi, R; Harrington, M; Maher, D; Williams, BG; De Cock, KM				Harries, Anthony D.; Zachariah, Rony; Corbett, Elizabeth L.; Lawn, Stephen D.; Santos-Filho, Ezio T.; Chimzizi, Rhehab; Harrington, Mark; Maher, Dermot; Williams, Brian G.; De Cock, Kevin M.			Tuberculosis 3 The HIV-associated tuberculosis epidemic-when will we act?	LANCET			English	Article							ISONIAZID PREVENTIVE THERAPY; SUB-SAHARAN AFRICA; RECEIVING ANTIRETROVIRAL TREATMENT; RESOURCE-LIMITED SETTINGS; RIO-DE-JANEIRO; COTRIMOXAZOLE PROPHYLAXIS; INFECTED PATIENTS; SOUTH-AFRICA; TREATMENT OUTCOMES; INTEGRATING TUBERCULOSIS	Despite policies, strategies, and guidelines, the epidemic of HIV-associated tuberculosis continues to rage, particularly in southern Africa. We focus our attention on the regions with the greatest burden of disease, especially sub-Saharan Africa, and concentrate on prevention of tuberculosis in people with HIV infection, a challenge that has been greatly neglected. We argue for a much more aggressive approach to early diagnosis and treatment of HIV infection in affected communities, and propose urgent assessment of frequent testing for HIV and early start of antiretroviral treatment (ART). This approach should result in short-term and long-term declines in tuberculosis incidence through individual immune reconstitution and reduced HIV transmission. Implementation of the 3Is policy (intensified tuberculosis case finding, infection control, and isoniazid preventive therapy) for prevention of HIV-associated tuberculosis, combined with earlier start of ART, will reduce the burden of tuberculosis in people with HIV infection and provide a safe clinical environment for delivery of ART. Some progress is being made in provision of HIV care to HIV-infected patients with tuberculosis, but too few receive co-trimoxazole prophylaxis and ART We make practical recommendations about how to improve this situation. Early HIV diagnosis and treatment, the 3Is, and a comprehensive package of HIV care, in association with directly observed therapy, short-course (DOTS) for tuberculosis, form the basis of prevention and control of HIV-associated tuberculosis. This call to action recommends that both HIV and tuberculosis programmes exhort implementation of strategies that are known to be effective, and test innovative strategies that could work. The continuing HIV-associated tuberculosis epidemic needs bold but responsible action, without which the future will simply mirror the past.	[Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.; Corbett, Elizabeth L.; Lawn, Stephen D.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Maher, Dermot] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Zachariah, Rony] Brussels Operat Ctr, Operat Res Unit, Dept Med, Luxembourg, Luxembourg; [Corbett, Elizabeth L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Santos-Filho, Ezio T.] Parceria Brasileira TB Stop TB Brazil, Grp Pela VIDDA RJ, Rio De Janeiro, Brazil; [Santos-Filho, Ezio T.] Rede TB TB Network, Rio De Janeiro, Brazil; [Chimzizi, Rhehab] Management Sci Hlth, Accra, Ghana; [Harrington, Mark] Treatment Act Grp, New York, NY USA; [Maher, Dermot] Uganda Virus Res Inst, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Williams, Brian G.] S African Ctr Epidemiol Modelling & Anal, Stellenbosch, South Africa; [De Cock, Kevin M.] Ctr Dis Control & Prevent, Nairobi, Kenya	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Cape Town; Uganda Virus Research Institute; National Research Foundation - South Africa	Harries, AD (corresponding author), Vears Lane, Winchester SO21 1TQ, Hants, England.	adharries@theunion.org		Williams, Brian/0000-0002-3174-4876; Corbett, Elizabeth/0000-0002-3552-3181; Maher, Dermot/0000-0003-0466-1976; zachariah, rony/0000-0002-2915-9328	Bill & Melinda Gates Foundation; WHO Strategic and Technical Advisory Group for TB; WHO Strategic and Technical Advisory Committee for HIV; Stop TB Partnership; Results Educational Fund; Institute of Medicine; Wellcome Trust; US Agency for International Development (USAID) through Management Sciences for Health; Medical Research Council [MC_U950080926] Funding Source: researchfish; MRC [MC_U950080926] Funding Source: UKRI	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO Strategic and Technical Advisory Group for TB; WHO Strategic and Technical Advisory Committee for HIV; Stop TB Partnership; Results Educational Fund; Institute of Medicine; Wellcome Trust(Wellcome TrustEuropean Commission); US Agency for International Development (USAID) through Management Sciences for Health(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MH's institution has received grant support from the Bill & Melinda Gates Foundation; and travel and accommodation expenses from the WHO Strategic and Technical Advisory Croup for TB and the WHO Strategic and Technical Advisory Committee for HIV, the Stop TB Partnership, the Results Educational Fund, and the Institute of Medicine. MH has received honoraria for a presentation from the Center for Tuberculosis Research, Johns Hopkins University; and travel and accommodation expenses from the WHO Strategic and Technical Advisory Group for TB and the WHO Strategic and Technical Advisory Committee for HIV. All other authors declare that they have no conflicts of interest. The views expressed in this paper are the sole responsibility of the authors and may not necessarily reflect the positions and views of their affiliated institutions.; ELC and SDL are funded by the Wellcome Trust. RC is funded by the US Agency for International Development (USAID) through Management Sciences for Health.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Anderson S R, 2001, ANAL INTERACTION TB; [Anonymous], 2009, GUID MON EV COLL TB; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Badri M, 2006, LANCET, V368, P1254, DOI 10.1016/S0140-6736(06)69117-4; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Bunnell R, 2006, JAMA-J AM MED ASSOC, V296, P855, DOI 10.1001/jama.296.7.855; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; Chheng R, 2008, INT J TUBERC LUNG D, V12, pS54; Churchyard GJ, 2007, J INFECT DIS, V196, pS52, DOI 10.1086/518662; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; CORBETT EL, 2009, 40 UN WORLD C LUNG H; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Corbett EL, 2007, CLIN INFECT DIS, V44, P317, DOI 10.1086/509926; *CREATE, THRIO TB HIV NO RIO; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; DIERO L, 2008, 17 INT AIDS C MEX CI; Drasar B, 2009, INT HEALTH, V1, P1, DOI 10.1016/j.inhe.2009.06.001; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; El-Sadr WM, 2009, JAIDS-J ACQ IMM DEF, V52, pS1, DOI 10.1097/QAI.0b013e3181bbcd7a; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Friedland G, 2004, CLIN INFECT DIS, V38, pS421, DOI 10.1086/421407; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2009, JAIDS-J ACQ IMM DEF, V50, P37, DOI 10.1097/QAI.0b013e31818ce6c4; Gasana M, 2008, INT J TUBERC LUNG D, V12, pS39; *GHAN HLTH SERV, 2009, NAT TUB HLTH SECT ST; *GLOB ADV COMM VAC, 2007, WKLY EPIDEMIOL REC, V82, P193; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Golub JE, 2008, AIDS, V22, P2527, DOI 10.1097/QAD.0b013e328311ac4e; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; GREEN RA, 2006, J INFECT DIS, V193, P1437; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Gyapong JO, 2010, LANCET, V375, P160, DOI 10.1016/S0140-6736(09)61249-6; Harries AD, 2009, INT J TUBERC LUNG D, V13, P1194; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Hawken M, 1999, INT J TUBERC LUNG D, V3, P540; Heijnders Miriam, 2006, Psychol Health Med, V11, P353, DOI 10.1080/13548500600595327; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Horton R, 2009, LANCET, V374, P10, DOI 10.1016/S0140-6736(09)61195-8; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Makombe SD, 2008, B WORLD HEALTH ORGAN, V86, P310, DOI 10.2471/BLT.07.044685; Makombe SD, 2007, B WORLD HEALTH ORGAN, V85, P851; Makwiza I, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-13; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MIDDELKOOP K, 2009, INT AIDS SOC C HIV P; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; *NIH, 2009, START ANT THER EARL; Nunn AJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a257; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; NUNN P, 1991, LANCET, V337, P627; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; *OP SOC I, 2006, CIV SOC PERSP TB POL, P17; Opoku-Okrah C, 2000, T ROY SOC TROP MED H, V94, P582, DOI 10.1016/S0035-9203(00)90097-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Rekha B, 2007, PAEDIATR RESPIR REV, V8, P99, DOI 10.1016/j.prrv.2007.04.010; SAMANDARI T, 2009, 40 UN WORLD C LUNG H; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Santos Filho Ezio Tavora dos, 2007, Rev Saude Publica, V41 Suppl 1, P111; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; SMART T, 2009, HIV AIDS TREAT PRACT, V147, P2; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; *STOP TB PARTN, 2008, WHO HIV TB DEP ISSJO; STOP TB Partnership, GLOB PLAN STOP TB 20; Tabarsi P, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-14; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Rensburg W, 2008, EDUC CHANGE, V12, P1; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Westreich DJ, 2009, CLIN INFECT DIS, V48, P1617, DOI 10.1086/598977; *WHO, 2002, STRAT FRAM DECR BURD; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2004, INT POL COLL TB HIV; WHO, 1998, POL STAT PREV THER T; *WHO, GLOB TUB CONTR 2009; WHO, ANT THER HIV INF AD; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2003, GUID IMPL COLL TB HI; World Health Organization, 2007, GUID PROV IN HIV TES; World Health Organization, 2006, GLOB PLAN STOP TB 20; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Zachariah R, 2006, TROP DOCT, V36, P79, DOI 10.1258/004947506776593314; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2006, T ROY SOC TROP MED H, V100, P167, DOI 10.1016/j.trstmh.2005.07.008; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	137	201	209	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1906	1919		10.1016/S0140-6736(10)60409-6	http://dx.doi.org/10.1016/S0140-6736(10)60409-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20488516				2022-12-28	WOS:000278628800032
J	Gunawardena, J				Gunawardena, Jeremy			Biological Systems Theory	SCIENCE			English	Editorial Material							PHOSPHORYLATION; ROBUSTNESS		Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Gunawardena, J (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	jeremy@hms.harvard.edu						Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Mitchison G, 2004, CURR BIOL, V14, pR97, DOI 10.1016/S0960-9822(04)00026-0; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Slack JMW, 2002, NAT REV GENET, V3, P889, DOI 10.1038/nrg933; Thom R., 2018, STRUCTURAL STABILITY; Waddington C H, 1957, STRATEGY GENES DISCU	11	26	26	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					581	582		10.1126/science.1188974	http://dx.doi.org/10.1126/science.1188974			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431005				2022-12-28	WOS:000277159800030
J	McGill, BJ				McGill, Brian J.			Matters of Scale	SCIENCE			English	Editorial Material									Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA	University of Arizona	McGill, BJ (corresponding author), Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA.	mcgillb@u.arizona.edu	McGill, Brian/A-3476-2008	McGill, Brian/0000-0002-0850-1913				CAUGHLEY G, 1987, J ANIM ECOL, V56, P751, DOI 10.2307/4946; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; MacArthur R.H., 1972, pvii; McGill BJ, 2008, AM NAT, V172, P88, DOI 10.1086/588044; Newton I, 1687, PHILOS NATURALIS PRI; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; ROOT T, 1988, J BIOGEOGR, V15, P489, DOI 10.2307/2845278; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Russell R, 2006, AM NAT, V167, pE158, DOI 10.1086/504603; Schneider DC, 2001, BIOSCIENCE, V51, P545, DOI 10.1641/0006-3568(2001)051[0545:TROTCO]2.0.CO;2; SHMIDA A, 1984, VEGETATIO, V58, P29; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Veech JA, 2006, J BIOGEOGR, V33, P2145, DOI 10.1111/j.1365-2699.2006.01571.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	16	254	259	6	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					575	576		10.1126/science.1188528	http://dx.doi.org/10.1126/science.1188528			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431001				2022-12-28	WOS:000277159800026
J	Srour, M; Riviere, JB; Pham, JMT; Dube, MP; Girard, S; Morin, S; Dion, PA; Asselin, G; Rochefort, D; Hince, P; Diab, S; Sharafaddinzadeh, N; Chouinard, S; Theoret, H; Charron, F; Rouleau, GA				Srour, Myriam; Riviere, Jean-Baptiste; Pham, Jessica M. T.; Dube, Marie-Pierre; Girard, Simon; Morin, Steves; Dion, Patrick A.; Asselin, Geraldine; Rochefort, Daniel; Hince, Pascale; Diab, Sabrina; Sharafaddinzadeh, Naser; Chouinard, Sylvain; Theoret, Hugo; Charron, Frederic; Rouleau, Guy A.			Mutations in DCC Cause Congenital Mirror Movements	SCIENCE			English	Article									[Srour, Myriam; Riviere, Jean-Baptiste; Dube, Marie-Pierre; Girard, Simon; Dion, Patrick A.; Rochefort, Daniel; Hince, Pascale; Diab, Sabrina; Chouinard, Sylvain; Rouleau, Guy A.] Univ Montreal, Ctr Excellence Neur, Montreal, PQ H2L 2W5, Canada; [Pham, Jessica M. T.; Morin, Steves; Charron, Frederic] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Dube, Marie-Pierre; Asselin, Geraldine] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Sharafaddinzadeh, Naser] Jundishapour Univ Med Sci, Dept Neurol, Ahvaz, Iran; [Theoret, Hugo] Univ Montreal, Montreal, PQ H2V 2S9, Canada	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; Universite de Montreal	Rouleau, GA (corresponding author), Univ Montreal, Ctr Excellence Neur, Montreal, PQ H2L 2W5, Canada.	guy.rouleau@umontreal.ca	Charron, Frederic/D-2140-2009; Charron, Frederic/O-8017-2019; Dubé, Marie-Pierre/B-9364-2008	Charron, Frederic/0000-0003-3483-8672; Charron, Frederic/0000-0003-3483-8672; Dubé, Marie-Pierre/0000-0001-8442-4393; Girard, Simon/0000-0002-4089-2280; Theoret, Hugo/0000-0002-7458-8797				FARMER SF, 1990, J PHYSIOL-LONDON, V428, P467, DOI 10.1113/jphysiol.1990.sp018222; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Sharafaddinzadeh N, 2008, NEUROL INDIA, V56, P482, DOI 10.4103/0028-3886.44813; Srour M, 2009, NEUROLOGY, V73, P729, DOI 10.1212/WNL.0b013e3181b59bda	7	115	117	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					592	592		10.1126/science.1186463	http://dx.doi.org/10.1126/science.1186463			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431009				2022-12-28	WOS:000277159800034
J	Sun, QF; Iwasa, J; Ogawa, D; Ishido, Y; Sato, S; Ozeki, T; Sei, Y; Yamaguchi, K; Fujita, M				Sun, Qing-Fu; Iwasa, Junji; Ogawa, Daichi; Ishido, Yoshitaka; Sato, Sota; Ozeki, Tomoji; Sei, Yoshihisa; Yamaguchi, Kentaro; Fujita, Makoto			Self-Assembled M24L48 Polyhedra and Their Sharp Structural Switch upon Subtle Ligand Variation	SCIENCE			English	Article							METAL-ORGANIC POLYHEDRA; BUILDING-BLOCKS; MASS-SPECTROMETRY; COMPONENTS; CHEMISTRY; TOPOLOGY; SYMMETRY; VIRUSES; CAPSULE; DESIGN	Self-assembly is a powerful technique for the bottom-up construction of discrete, well-defined nanoscale structures. Large multicomponent systems (with more than 50 components) offer mechanistic insights into biological assembly but present daunting synthetic challenges. Here we report the self-assembly of giant M24L48 coordination spheres from 24 palladium ions (M) and 48 curved bridging ligands (L). The structure of this multicomponent system is highly sensitive to the geometry of the bent ligands. Even a slight change in the ligand bend angle critically switches the final structure observed across the entire ensemble of building blocks between M24L48 and M12L24 coordination spheres. The amplification of this small initial difference into an incommensurable difference in the resultant structures is a key mark of emergent behavior.	[Sun, Qing-Fu; Iwasa, Junji; Ogawa, Daichi; Ishido, Yoshitaka; Sato, Sota; Fujita, Makoto] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Sun, Qing-Fu; Iwasa, Junji; Ogawa, Daichi; Ishido, Yoshitaka; Sato, Sota; Fujita, Makoto] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1138656, Japan; [Ozeki, Tomoji] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Sei, Yoshihisa; Yamaguchi, Kentaro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Kagawa 7692193, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Tokushima Bunri University	Fujita, M (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	mfujita@appchem.t.u-tokyo.ac.jp	Fujita, Makoto/E-6350-2012; Sun, Qing-Fu/R-7322-2019; Sun, Qing-Fu/C-9406-2011; SATO, Sota/V-2817-2019	Sun, Qing-Fu/0000-0002-6419-8904; Sun, Qing-Fu/0000-0002-6419-8904; Sato, Sota/0000-0002-7395-2112; Fujita, Makoto/0000-0001-6105-7340	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20111007, 21685007]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) via Grant-in-Aids for Scientific Research on Innovative Areas "Emergence in Chemistry" (20111007) and for Young Scientists (A) (21685007). The experiments of synchrotron x-ray crystallography were performed at the BL38B1 in the SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (proposal number 2009B1967) and at the NW2A beamline in the advanced ring for pulse x-rays (PF-AR) with the approval of the High Energy Accelerator Research Organization (KEK) (proposal number 2009G502). We thank N. Iwasaki and M. Pelzing (Bruker Daltonics) for the support of CSI-TOF-MS measurements and K. Miura (JASRI) for the support of synchrotron x-ray measurements.	Abrahams BF, 1999, J AM CHEM SOC, V121, P3535, DOI 10.1021/ja990016t; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Casjens S., 1985, VIRUS STRUCTURE ASSE; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Caulder DL, 1999, ACCOUNTS CHEM RES, V32, P975, DOI 10.1021/ar970224v; Caulder DL, 1998, ANGEW CHEM INT EDIT, V37, P1840, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1840::AID-ANIE1840>3.0.CO;2-D; Conn MM, 1997, CHEM REV, V97, P1647, DOI 10.1021/cr9603800; Coxeter H, 1973, REGULAR POLYTOPES; Eddaoudi M, 2001, J AM CHEM SOC, V123, P4368, DOI 10.1021/ja0104352; FUJITA M, 1995, NATURE, V378, P469, DOI 10.1038/378469a0; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Horne R. W., 1974, VIRUS STRUCTURE; Jensen H. J., 2003, CAMBRIDGE LECT NOTES; Krasnogor N, 2008, STUD MULTIDISCIP, V5, pXI, DOI 10.1016/S1571-0831(07)00015-9; MacGillivray LR, 1997, NATURE, V389, P469, DOI 10.1038/38985; Moulton B, 2001, CHEM COMMUN, P863, DOI 10.1039/b102714j; Muller A, 2003, COORDIN CHEM REV, V245, P153, DOI 10.1016/S0010-8545(03)00110-3; Muller A, 2001, COORDIN CHEM REV, V222, P193, DOI 10.1016/S0010-8545(01)00391-5; Olenyuk B, 1999, NATURE, V398, P796, DOI 10.1038/19740; Olenyuk B, 1999, J AM CHEM SOC, V121, P10434, DOI 10.1021/ja9931933; PRICE P, 1991, J AM SOC MASS SPECTR, V2, P336, DOI 10.1016/1044-0305(91)80025-3; SAALFRANK RW, 1988, ANGEW CHEM INT EDIT, V27, P851, DOI 10.1002/anie.198808511; Sato S, 2006, SCIENCE, V313, P1273, DOI 10.1126/science.1129830; Seidel SR, 2002, ACCOUNTS CHEM RES, V35, P972, DOI 10.1021/ar010142d; Stang PJ, 1997, ORGANOMETALLICS, V16, P3094, DOI 10.1021/om9702993; Suzuki K, 2009, CHEM COMMUN, P1638, DOI 10.1039/b822311d; Takeda N, 1999, NATURE, V398, P794, DOI 10.1038/19734; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Tranchemontagne DJL, 2008, ANGEW CHEM INT EDIT, V47, P5136, DOI 10.1002/anie.200705008; Twarock R, 2006, PHILOS T R SOC A, V364, P3357, DOI 10.1098/rsta.2006.1900; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yamaguchi K, 2003, J MASS SPECTROM, V38, P473, DOI 10.1002/jms.488	32	601	612	11	415	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1144	1147		10.1126/science.1188605	http://dx.doi.org/10.1126/science.1188605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20430973				2022-12-28	WOS:000278104700040
J	Carlo, WA; Finer, NN; Walsh, MC; Rich, W; Gantz, MG; Laptook, AR; Yoder, BA; Faix, RG; Das, A; Poole, WK; Schibler, K; Newman, NS; Ambalavanan, N; Frantz, ID; Piazza, AJ; Sanchez, PJ; Morris, BH; Laroia, N; Phelps, DL; Poindexter, BB; Cotten, CM; Van Meurs, KP; Duara, S; Narendran, V; Sood, BG; O'Shea, TM; Bell, EF; Ehrenkranz, RA; Watterberg, KL; Higgins, RD; Jobe, AH; Caplan, MS; Oh, W; Hensman, AM; Gingras, D; Barnett, S; Lillie, S; Francis, K; Andrews, D; Angela, K; Fanaroff, AA; Siner, BS; Zadell, A; DiFiore, J; Donovan, EF; Bridges, K; Alexander, B; Grisby, C; Mersmann, MW; Mincey, HL; Hessling, J; Goldberg, RN; Auten, KJ; Fisher, KA; Foy, KA; Siaw, G; Stoll, BJ; Buchter, S; Carlton, DP; Hale, EC; Hutchinson, AK; Archer, SW; Lemons, JA; Hamer, F; Herron, DE; Miller, LC; Wilson, LD; Berberich, MA; Blaisdell, CJ; Gail, DB; Kiley, JP; Cunningham, M; Hastings, BK; Irene, AR; Auman, JO; Huitema, CP; Pickett, JW; Wallace, D; Zaterka-Baxter, KM; Stevenson, DK; Ball, MB; Proud, MS; Fiascone, JM; Furey, A; MacKinnon, BL; Nylen, E; Collins, MV; Cosby, SS; Phillips, VA; Rasmussen, MR; Wozniak, PR; Arnell, K; Bridge, R; Demetrio, C; Widness, JA; Klein, JM; Johnson, KJ; Everett-Thomas, R; Ohls, RK; Rohr, J; Lacy, CB; Markowitz, GD; Reubens, LJ; Burnell, E; Rosenfeld, CR; Salhab, WA; Guzman, A; Hensley, G; Lepps, MH; Miller, NA; Allen, J; Grau, L; Martin, M; Solis, A; Vasil, DM; Wilder, K; Kennedy, KA; Tyson, JE; Harris, BF; Lis, AE; Martin, S; McDavid, GE; Tate, PL; Wright, SL; Burnett, J; Jensen, JJ; Osborne, KA; Spencer, C; Weaver-Lewis, K; Peters, NJ; Shankaran, S; Bara, R; Billian, E; Johnson, M; Bhandari, V; Jacobs, HC; Cervone, P; Gettner, P; Konstantino, M; Poulsen, J; Taft, J; Avery, G; Gleason, CA; Allen, MC; Bangdiwala, SI; Blaisdell, CJ; Boyle, RJ; Clemons, T; D'Alton, ME; Das, A; Gail, DB; Hunt, C; Keszler, M; Poole, WK; Redmond, CK; Ross, MG; Thomson, MA; Weiner, SJ; Willinger, M; Markowitz, GD; Hutchinson, AK; Wallace, DK; Freedman, SF				Carlo, Waldemar A.; Finer, Neil N.; Walsh, Michele C.; Rich, Wade; Gantz, Marie G.; Laptook, Abbot R.; Yoder, Bradley A.; Faix, Roger G.; Das, Abhik; Poole, W. Kenneth; Schibler, Kurt; Newman, Nancy S.; Ambalavanan, Namasivayam; Frantz, Ivan D., III; Piazza, Anthony J.; Sanchez, Pablo J.; Morris, Brenda H.; Laroia, Nirupama; Phelps, Dale L.; Poindexter, Brenda B.; Cotten, C. Michael; Van Meurs, Krisa P.; Duara, Shahnaz; Narendran, Vivek; Sood, Beena G.; O'Shea, T. Michael; Bell, Edward F.; Ehrenkranz, Richard A.; Watterberg, Kristi L.; Higgins, Rosemary D.; Jobe, A. H.; Caplan, M. S.; Oh, W.; Hensman, A. M.; Gingras, D.; Barnett, S.; Lillie, S.; Francis, K.; Andrews, D.; Angela, K.; Fanaroff, A. A.; Siner, B. S.; Zadell, A.; DiFiore, J.; Donovan, E. F.; Bridges, K.; Alexander, B.; Grisby, C.; Mersmann, M. W.; Mincey, H. L.; Hessling, J.; Goldberg, R. N.; Auten, K. J.; Fisher, K. A.; Foy, K. A.; Siaw, G.; Stoll, B. J.; Buchter, S.; Carlton, D. P.; Hale, E. C.; Hutchinson, A. K.; Archer, S. W.; Lemons, J. A.; Hamer, F.; Herron, D. E.; Miller, L. C.; Wilson, L. D.; Berberich, M. A.; Blaisdell, C. J.; Gail, D. B.; Kiley, J. P.; Cunningham, M.; Hastings, B. K.; Irene, A. R.; Auman, J. O'D.; Huitema, C. P.; Pickett, J. W., II; Wallace, D.; Zaterka-Baxter, K. M.; Stevenson, D. K.; Ball, M. B.; Proud, M. S.; Fiascone, J. M.; Furey, A.; MacKinnon, B. L.; Nylen, E.; Collins, M. V.; Cosby, S. S.; Phillips, V. A.; Rasmussen, M. R.; Wozniak, P. R.; Arnell, K.; Bridge, R.; Demetrio, C.; Widness, J. A.; Klein, J. M.; Johnson, K. J.; Everett-Thomas, R.; Ohls, R. K.; Rohr, J.; Lacy, C. B.; Markowitz, G. D.; Reubens, L. J.; Burnell, E.; Rosenfeld, C. R.; Salhab, W. A.; Guzman, A.; Hensley, G.; Lepps, M. H.; Miller, N. A.; Allen, J.; Grau, L.; Martin, M.; Solis, A.; Vasil, D. M.; Wilder, K.; Kennedy, K. A.; Tyson, J. E.; Harris, B. F.; Lis, A. E.; Martin, S.; McDavid, G. E.; Tate, P. L.; Wright, S. L.; Burnett, J.; Jensen, J. J.; Osborne, K. A.; Spencer, C.; Weaver-Lewis, K.; Peters, N. J.; Shankaran, S.; Bara, R.; Billian, E.; Johnson, M.; Bhandari, V.; Jacobs, H. C.; Cervone, P.; Gettner, P.; Konstantino, M.; Poulsen, J.; Taft, J.; Avery, G.; Gleason, C. A.; Allen, M. C.; Bangdiwala, S. I.; Blaisdell, C. J.; Boyle, R. J.; Clemons, T.; D'Alton, M. E.; Das, A.; Gail, D. B.; Hunt, C.; Keszler, M.; Poole, W. K.; Redmond, C. K.; Ross, M. G.; Thomson, M. A.; Weiner, S. J.; Willinger, M.; Markowitz, G. D.; Hutchinson, A. K.; Wallace, D. K.; Freedman, S. F.		Eunice Kennedy Shriver NICHD	Target Ranges of Oxygen Saturation in Extremely Preterm Infants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BRONCHOPULMONARY DYSPLASIA; SEVERE RETINOPATHY; PATHOGENESIS; PREMATURITY; INJURY	Background: Previous studies have suggested that the incidence of retinopathy is lower in preterm infants with exposure to reduced levels of oxygenation than in those exposed to higher levels of oxygenation. However, it is unclear what range of oxygen saturation is appropriate to minimize retinopathy without increasing adverse outcomes. Methods: We performed a randomized trial with a 2-by-2 factorial design to compare target ranges of oxygen saturation of 85 to 89% or 91 to 95% among 1316 infants who were born between 24 weeks 0 days and 27 weeks 6 days of gestation. The primary outcome was a composite of severe retinopathy of prematurity (defined as the presence of threshold retinopathy, the need for surgical ophthalmologic intervention, or the use of bevacizumab), death before discharge from the hospital, or both. All infants were also randomly assigned to continuous positive airway pressure or intubation and surfactant. Results: The rates of severe retinopathy or death did not differ significantly between the lower-oxygen-saturation group and the higher-oxygen-saturation group (28.3% and 32.1%, respectively; relative risk with lower oxygen saturation, 0.90; 95% confidence interval [CI], 0.76 to 1.06; P=0.21). Death before discharge occurred more frequently in the lower-oxygen-saturation group (in 19.9% of infants vs. 16.2%; relative risk, 1.27; 95% CI, 1.01 to 1.60; P=0.04), whereas severe retinopathy among survivors occurred less often in this group (8.6% vs. 17.9%; relative risk, 0.52; 95% CI, 0.37 to 0.73; P<0.001). There were no significant differences in the rates of other adverse events. Conclusions: A lower target range of oxygenation (85 to 89%), as compared with a higher range (91 to 95%), did not significantly decrease the composite outcome of severe retinopathy or death, but it resulted in an increase in mortality and a substantial decrease in severe retinopathy among survivors. The increase in mortality is a major concern, since a lower target range of oxygen saturation is increasingly being advocated to prevent retinopathy of prematurity. (ClinicalTrials.gov number, NCT00233324.) N Engl J Med 2010;362:1959-69.	[Carlo, Waldemar A.; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL 35294 USA; [Finer, Neil N.; Rich, Wade] Univ Calif San Diego, San Diego, CA 92103 USA; [Walsh, Michele C.; Newman, Nancy S.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Gantz, Marie G.; Poole, W. Kenneth] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Cotten, C. Michael] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [O'Shea, T. Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Laptook, Abbot R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Yoder, Bradley A.; Faix, Roger G.] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Schibler, Kurt; Narendran, Vivek] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA; [Frantz, Ivan D., III] Floating Hosp Children, Tufts Med Ctr, Div Newborn Med, Dept Pediat, Boston, MA USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Piazza, Anthony J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Piazza, Anthony J.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Morris, Brenda H.] Univ Texas Med Sch Houston, Dept Pediat, Houston, TX USA; [Laroia, Nirupama; Phelps, Dale L.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Poindexter, Brenda B.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [Van Meurs, Krisa P.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [Duara, Shahnaz] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Sood, Beena G.] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Bell, Edward F.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Watterberg, Kristi L.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Caplan, M. S.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Oh, W.; Hensman, A. M.; Gingras, D.; Barnett, S.; Lillie, S.; Francis, K.; Andrews, D.; Angela, K.] Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Fanaroff, A. A.; Siner, B. S.; Zadell, A.; DiFiore, J.] Univ Cincinnati Hosp, Cincinnati, OH USA; [Fanaroff, A. A.; Siner, B. S.; Zadell, A.; DiFiore, J.] Good Samaritan Hosp, Cincinnati, OH USA; [Fanaroff, A. A.; Siner, B. S.; Zadell, A.; DiFiore, J.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Donovan, E. F.; Bridges, K.; Alexander, B.; Grisby, C.; Mersmann, M. W.; Mincey, H. L.; Hessling, J.] Duke Univ, Sch Med, Univ Hosp, Alamance Reg Med Ctr, Durham, NC USA; [Donovan, E. F.; Bridges, K.; Alexander, B.; Grisby, C.; Mersmann, M. W.; Mincey, H. L.; Hessling, J.] Durham Reg Hosp, Durham, NC USA; [Goldberg, R. N.; Auten, K. J.; Fisher, K. A.; Foy, K. A.; Siaw, G.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Goldberg, R. N.; Auten, K. J.; Fisher, K. A.; Foy, K. A.; Siaw, G.] Grady Mem Hosp, Atlanta, GA USA; [Goldberg, R. N.; Auten, K. J.; Fisher, K. A.; Foy, K. A.; Siaw, G.] Emory Crawford Long Hosp, Atlanta, GA USA; [Archer, S. W.] Indiana Univ Hosp, Indianapolis, IN 46202 USA; [Archer, S. W.] Methodist Hosp, Indianapolis, IN USA; [Archer, S. W.] Riley Hosp Children, Indianapolis, IN USA; [Archer, S. W.] Wishard Hlth Serv, Indianapolis, IN USA; [Lemons, J. A.; Hamer, F.; Herron, D. E.; Miller, L. C.; Wilson, L. D.] NHLBI, Bethesda, MD 20892 USA; [Cunningham, M.; Hastings, B. K.; Irene, A. R.; Auman, J. O'D.; Huitema, C. P.; Pickett, J. W., II; Wallace, D.; Zaterka-Baxter, K. M.] Stanford Univ, Lucile Packard Childrens Hosp, Palo Alto, CA 94304 USA; [Stevenson, D. K.; Ball, M. B.; Proud, M. S.] Floating Hosp Children, Tufts Med Ctr, Boston, MA USA; [Fiascone, J. M.; Furey, A.; MacKinnon, B. L.; Nylen, E.] Univ Alabama Birmingham Hlth Syst, Birmingham, AL USA; [Fiascone, J. M.; Furey, A.; MacKinnon, B. L.; Nylen, E.] Childrens Hosp Alabama, Birmingham, AL USA; [Collins, M. V.; Cosby, S. S.; Phillips, V. A.] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Collins, M. V.; Cosby, S. S.; Phillips, V. A.] Sharp Mary Birch Hosp Women, San Diego, CA USA; [Rasmussen, M. R.; Wozniak, P. R.; Arnell, K.; Bridge, R.; Demetrio, C.] Univ Iowa Childrens Hosp, Iowa City, IA USA; [Widness, J. A.; Klein, J. M.; Johnson, K. J.] Univ Miami, Holtz Childrens Hosp, Miami, FL USA; [Everett-Thomas, R.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Ohls, R. K.; Rohr, J.; Lacy, C. B.] Univ Rochester, Med Ctr, Golisano Childrens Hosp, Rochester, NY 14642 USA; [Markowitz, G. D.; Reubens, L. J.; Burnell, E.] Univ Texas SW Med Ctr Dallas, Parkland Hlth & Hosp Syst, Dallas, TX 75390 USA; [Markowitz, G. D.; Reubens, L. J.; Burnell, E.] Childrens Med Ctr, Dallas, TX 75235 USA; [Rosenfeld, C. R.; Salhab, W. A.; Guzman, A.; Hensley, G.; Lepps, M. H.; Miller, N. A.; Allen, J.; Grau, L.; Martin, M.; Solis, A.; Vasil, D. M.; Wilder, K.] Univ Texas Hlth Sci Ctr, Houston Med Sch, Houston, TX USA; [Rosenfeld, C. R.; Salhab, W. A.; Guzman, A.; Hensley, G.; Lepps, M. H.; Miller, N. A.; Allen, J.; Grau, L.; Martin, M.; Solis, A.; Vasil, D. M.; Wilder, K.] Childrens Mem Hermann Hosp, Houston, TX USA; [Kennedy, K. A.; Tyson, J. E.; Harris, B. F.; Lis, A. E.; Martin, S.; McDavid, G. E.; Tate, P. L.; Wright, S. L.] Intermt Med Ctr, Salt Lake City, UT USA; [Kennedy, K. A.; Tyson, J. E.; Harris, B. F.; Lis, A. E.; Martin, S.; McDavid, G. E.; Tate, P. L.; Wright, S. L.] LDS Hosp, Salt Lake City, UT USA; [Martin, M.; Kennedy, K. A.; Tyson, J. E.; Harris, B. F.; Lis, A. E.; McDavid, G. E.; Tate, P. L.; Wright, S. L.] Primary Childrens Med Ctr, Salt Lake City, UT 84103 USA; [Burnett, J.; Jensen, J. J.; Osborne, K. A.; Spencer, C.; Weaver-Lewis, K.] Wake Forest Univ, Baptist Med Ctr, Brenner Childrens Hosp, Winston Salem, NC 27109 USA; [Burnett, J.; Jensen, J. J.; Osborne, K. A.; Spencer, C.; Weaver-Lewis, K.] Forsyth Med Ctr, Winston Salem, NC USA; [Peters, N. J.] Wayne State Univ, Hutzel Womens Hosp, Detroit, MI USA; [Peters, N. J.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Shankaran, S.; Bara, R.; Billian, E.; Johnson, M.] Yale New Haven Childrens Hosp, New Haven, CT USA; [Shankaran, S.; Bara, R.; Billian, E.; Johnson, M.] Bridgeport Hosp, Bridgeport, CT USA; [Avery, G.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Gleason, C. A.] Univ Washington, Seattle, WA 98195 USA; [Allen, M. C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bangdiwala, S. I.] Univ N Carolina, Chapel Hill, NC USA; [Blaisdell, C. J.] NHLBI, Bethesda, MD 20892 USA; [Boyle, R. J.] Univ Virginia Hlth Syst, Charlottesville, VA USA; [Clemons, T.] EMMES Corp, Baltimore, MD USA; [D'Alton, M. E.] Columbia Univ, New York, NY USA; [Keszler, M.] Georgetown Univ Hosp, Washington, DC 20007 USA; [Redmond, C. K.] Univ Pittsburgh, Pittsburgh, PA USA; [Ross, M. G.] Univ Calif Los Angeles, Sch Med & Publ Hlth, Los Angeles, CA USA; [Thomson, M. A.] Hammersmith Hosp, London, England; [Weiner, S. J.] George Washington Univ, Washington, DC USA; [Markowitz, G. D.] Univ Rochester, Rochester, NY USA; [Hutchinson, A. K.] Emory Univ, Atlanta, GA 30322 USA; [Wallace, D. K.; Freedman, S. F.] Duke Univ, Durham, NC USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Research Triangle Institute; Duke University; Wake Forest University; Brown University; Women & Infants Hospital Rhode Island; Utah System of Higher Education; University of Utah; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Ohio; University of Cincinnati; Floating Hospital For Children; Tufts Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University; Children's Healthcare of Atlanta (CHOA); University of Texas System; University of Texas Health Science Center Houston; University of Rochester; Indiana University System; Indiana University Bloomington; Stanford University; University of Miami; Wayne State University; University of Iowa; Yale University; University of New Mexico; University of New Mexico's Health Sciences Center; University of Chicago; Brown University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University System of Ohio; University of Cincinnati; Good Samaritan Hospital - Cincinnati; Cincinnati Children's Hospital Medical Center; Duke University; Children's Healthcare of Atlanta (CHOA); Indiana University System; Indiana University System; James Whitcomb Riley Hospital Children; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Lucile Packard Children's Hospital (LPCH); Stanford University; Floating Hospital For Children; Tufts Medical Center; University of California System; University of California San Diego; University of Iowa; University of Miami; University of New Mexico; University of New Mexico's Health Sciences Center; University of Rochester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; Intermountain Healthcare; Intermountain Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wayne State University; Children's Hospital of Michigan; Yale University; Children's National Health System; University of Washington; University of Washington Seattle; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Virginia; Emmes Corporation; Columbia University; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Imperial College London; George Washington University; University of Rochester; Emory University; Duke University	Carlo, WA (corresponding author), Univ Alabama Birmingham, Div Neonatol, 176F Suite 9380,619 S 19th St, Birmingham, AL 35294 USA.	wcarlo@peds.uab.edu	Laroia, Nirupama/J-2128-2017; Bhandari, Vineet/AAS-3365-2020; Ambalavanan, Namasivayam/AAL-3832-2020; Das, Abhik/AAF-1883-2020; Ambalavanan, Namasivayam/AAI-4088-2020	Laroia, Nirupama/0000-0002-8844-6378; Das, Abhik/0000-0003-2722-0479; Ambalavanan, Namasivayam/0000-0003-0731-9092; Bell, Edward/0000-0002-5568-0889; Gantz, Marie/0000-0001-8528-0184	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, U10 HD53124]; National Heart, Lung, and Blood Institute; National Institutes of Health [M01 RR30, M01 RR32, M01 RR39, M01 RR44, M01 RR54, M01 RR59, M01 RR64, M01 RR70, M01 RR80, MO1 RR125, M01 RR633, M01 RR750, M01 RR997, M01 RR6022, M01 RR7122, M01 RR8084, M01 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, UL1 RR25744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027853, U10HD027880, UG1HD034216, U10HD027856, U10HD036790, U10HD053124, U10HD027851, UG1HD053089, U10HD021385, U10HD053119, U10HD040689, U10HD027871, U10HD021373, U10HD053089, U10HD040461, U10HD021364, U10HD053109, U10HD027904, U10HD040492, U10HD034216] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD040521, K23HD041423, U10HD021397, U10HD040498] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006022, UL1RR025008, M01RR016587, UL1RR025744, UL1RR024979, M01RR008084, M01RR007122, M01RR000030, UL1RR024139] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants (U10 HD21364, U10 HD21373, U10 HD21385, U10 HD21397, U10 HD27851, U10 HD27853, U10 HD27856, U10 HD27880, U10 HD27871, U10 HD27904, U10 HD34216, U10 HD36790, U10 HD40461, U10 HD40492, U10 HD40498, U10 HD40521, U10 HD40689, U10 HD53089, U10 HD53109, U10 HD53119, and U10 HD53124) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, cofunding from the National Heart, Lung, and Blood Institute, and grants (M01 RR30, M01 RR32, M01 RR39, M01 RR44, M01 RR54, M01 RR59, M01 RR64, M01 RR70, M01 RR80, MO1 RR125, M01 RR633, M01 RR750, M01 RR997, M01 RR6022, M01 RR7122, M01 RR8084, M01 RR16587, UL1 RR25008, UL1 RR24139, UL1 RR24979, and UL1 RR25744) from the National Institutes of Health.	Anderson Christina G, 2004, J Perinatol, V24, P164, DOI 10.1038/sj.jp.7211067; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Askie LM, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001077.PUB2; BOLTON DPG, 1974, LANCET, V1, P445; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; Cole CH, 2003, PEDIATRICS, V112, P1415, DOI 10.1542/peds.112.6.1415; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Davis JM, 2002, ACTA PAEDIATR, V91, P23, DOI 10.1080/08035250260095762; Deulofeut R, 2007, ACTA PAEDIATR, V96, P990, DOI 10.1111/j.1651-2227.2007.00365.x; Duc Gabriel, 1992, P178; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; FLYNN JT, 1992, NEW ENGL J MED, V326, P1050, DOI 10.1056/NEJM199204163261603; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Hardy RJ, 2004, CONTROL CLIN TRIALS, V25, P311, DOI 10.1016/j.cct.2004.03.003; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KINSEY VE, 1977, PEDIATRICS, V60, P655; Phelps DL, 2000, PEDIATRICS, V105, P295; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Saugstad OD, 1997, ACTA PAEDIATR, V86, P1277, DOI 10.1111/j.1651-2227.1997.tb14897.x; Silvers KM, 1998, ARCH DIS CHILD-FETAL, V78, pF214, DOI 10.1136/fn.78.3.F214; Tin W, 2007, ARCH DIS CHILD-FETAL, V92, pF143, DOI 10.1136/adc.2005.092726; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Wright Kenneth W, 2006, Trans Am Ophthalmol Soc, V104, P78	25	596	617	0	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1959	1969		10.1056/NEJMoa0911781	http://dx.doi.org/10.1056/NEJMoa0911781			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601JI	20472937	Green Accepted			2022-12-28	WOS:000278054000004
J	Vladeck, BC				Vladeck, Bruce C.			Fixing Medicare's Physician Payment System.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		Nexera, New York, NY USA		Vladeck, BC (corresponding author), Nexera, New York, NY USA.							*CTR MED MED SERV, 2009, EST SUST GROWTH RAT; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; Lee TH, 2008, NEW ENGL J MED, V359, P2085, DOI 10.1056/NEJMp0805766; *MED PAYM ADV COMM, 2007, REP C ASS ALT SUST G, P11; Wilensky GR, 2009, NEW ENGL J MED, V360, P653, DOI 10.1056/NEJMp0808003	5	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 27	2010	362	21					1955	1957		10.1056/NEJMp1004709	http://dx.doi.org/10.1056/NEJMp1004709			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	601JI	20445166	Bronze			2022-12-28	WOS:000278054000003
J	Kosmrlj, A; Read, EL; Qi, Y; Allen, TM; Altfeld, M; Deeks, SG; Pereyra, F; Carrington, M; Walker, BD; Chakraborty, AK				Kosmrlj, Andrej; Read, Elizabeth L.; Qi, Ying; Allen, Todd M.; Altfeld, Marcus; Deeks, Steven G.; Pereyra, Florencia; Carrington, Mary; Walker, Bruce D.; Chakraborty, Arup K.			Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; RESPONSES; PEPTIDE; BINDING; MOLECULES; ANTIGEN; CD4(+); LYMPHOCYTES; DIVERSITY; EPITOPES	Without therapy, most people infected with human immunodeficiency virus (HIV) ultimately progress to AIDS. Rare individuals ('elite controllers') maintain very low levels of HIV RNA without therapy, thereby making disease progression and transmission unlikely. Certain HLA class I alleles are markedly enriched in elite controllers, with the highest association observed for HLA-B57 (ref. 1). Because HLA molecules present viral peptides that activate CD8(+) T cells, an immune-mediated mechanism is probably responsible for superior control of HIV. Here we describe how the peptide-binding characteristics of HLA-B57 molecules affect thymic development such that, compared to other HLA-restricted T cells, a larger fraction of the naive repertoire of B57-restricted clones recognizes a viral epitope, and these T cells are more cross-reactive to mutants of targeted epitopes. Our calculations predict that such a T-cell repertoire imposes strong immune pressure on immunodominant HIV epitopes and emergent mutants, thereby promoting efficient control of the virus. Supporting these predictions, in a large cohort of HLA-typed individuals, our experiments show that the relative ability of HLA-B alleles to control HIV correlates with their peptide-binding characteristics that affect thymic development. Our results provide a conceptual framework that unifies diverse empirical observations, and have implications for vaccination strategies.	[Kosmrlj, Andrej; Read, Elizabeth L.; Allen, Todd M.; Altfeld, Marcus; Pereyra, Florencia; Carrington, Mary; Walker, Bruce D.; Chakraborty, Arup K.] Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA; [Kosmrlj, Andrej] MIT, Dept Phys, Cambridge, MA 02139 USA; [Read, Elizabeth L.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Read, Elizabeth L.; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Qi, Ying; Carrington, Mary] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Chakraborty, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA.	bwalker@partners.org; arupc@mit.edu	Altfeld, Marcus/AAE-7306-2019; Allen, Todd/F-5473-2011	Altfeld, Marcus/0000-0001-5972-2997; Allen, Todd/0000-0002-6609-1318; Read, Elizabeth/0000-0002-9186-284X; Kosmrlj, Andrej/0000-0001-6137-9200	Mark and Lisa Schwartz Foundation; National Institutes of Health (NIH); Philip T and Susan M Ragon Foundation; Jane Coffin Childs Foundation; Bill and Melinda Gates Foundation; NIAID; National Cancer Institute, NIH [HHSN261200800001E]; NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC011237, ZIABC010791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030914, P30AI060354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD001022] Funding Source: NIH RePORTER	Mark and Lisa Schwartz Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip T and Susan M Ragon Foundation; Jane Coffin Childs Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the Mark and Lisa Schwartz Foundation, the National Institutes of Health (NIH) Director's Pioneer award (A. K. C.), Philip T and Susan M Ragon Foundation, Jane Coffin Childs Foundation (E. L. R.), the Bill and Melinda Gates Foundation, and the NIAID (B. D. W., T. M. A. and M. A.). This project has been funded in whole or in part with federal funds from the National Cancer Institute, NIH, under contract no. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Chao DL, 2005, EUR J IMMUNOL, V35, P3452, DOI 10.1002/eji.200535098; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Gulukota K, 1997, J MOL BIOL, V267, P1258, DOI 10.1006/jmbi.1997.0937; HOSMER DW, 1989, BIOMETRICS, V45, P1265, DOI 10.2307/2531779; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Kosmrlj A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.068103; de Castro JAL, 2007, IMMUNOL LETT, V108, P27, DOI 10.1016/j.imlet.2006.10.004; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Naeher D, 2007, J EXP MED, V204, P2553, DOI 10.1084/jem.20070254; NOWAK MA, 1995, NATURE, V375, P606, DOI 10.1038/375606a0; Parera M, 2007, MOL BIOL EVOL, V24, P382, DOI 10.1093/molbev/msl168; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09; Thio CL, 2002, J VIROL, V76, P4792, DOI 10.1128/JVI.76.10.4792-4797.2002; Turnbull EL, 2006, J IMMUNOL, V176, P6130, DOI 10.4049/jimmunol.176.10.6130; Wodarz D, 2005, INT IMMUNOL, V17, P1269, DOI 10.1093/intimm/dxh303; Yu XG, 2007, J VIROL, V81, P1619, DOI 10.1128/JVI.01580-06	40	205	207	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					350	U107		10.1038/nature08997	http://dx.doi.org/10.1038/nature08997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20445539	Green Accepted, Green Submitted			2022-12-28	WOS:000277829200041
J	Dye, C; Williams, BG				Dye, Christopher; Williams, Brian G.			The Population Dynamics and Control of Tuberculosis	SCIENCE			English	Review							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; EPIDEMICS; EVOLUTION; SMOKING; RISK; HIV; PREVALENCE; MUTATIONS; MORTALITY; INFECTION	More than 36 million patients have been successfully treated via the World Health Organization's strategy for tuberculosis (TB) control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010. Here we review the changing relationship between the causative agent, Mycobacterium tuberculosis, and its human host and examine a range of factors that could explain the persistence of TB. Although there are ways to reduce susceptibility to infection and disease, and a high-efficacy vaccine would boost TB prevention, early diagnosis and drug treatment to interrupt transmission remain the top priorities for control. Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied.	[Dye, Christopher] WHO, CH-1211 Geneva 27, Switzerland; [Williams, Brian G.] SACEMA, ZA-7600 Stellenbosch, South Africa	World Health Organization	Dye, C (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Williams, Brian/0000-0002-3174-4876; Dye, Christopher/0000-0002-2957-1793				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Barrett CB, 2010, SCIENCE, V327, P825, DOI 10.1126/science.1182768; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chadha VK, 2005, INT J TUBERC LUNG D, V9, P116; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dye C, 2007, INT J TUBERC LUNG D, V11, P1225; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000346; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; HONG YP, 1993, TUBERCLE LUNG DIS, V74, P323, DOI 10.1016/0962-8479(93)90107-9; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P534, DOI 10.1016/0962-8479(95)90530-8; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lipsitch M, 2002, GENETICS, V161, P1599; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; McEvoy CRE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-237; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; MURRAY M, 2009, TUBERCULOSIS ESSENTI, P23; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2007, EXPERT REV ANTI-INFE, V5, P385, DOI 10.1586/14787210.5.3.385; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Rodriguez-Ojea A, 2002, PUBLIC HEALTH NUTR, V5, P129, DOI 10.1079/PHN2001284; Shafey O., 2010, TOBACCO ATLAS; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; UNFPA, 2007, STAT WORLD POP 2007; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; Vashishtha VM, 2009, INDIAN PEDIATR, V46, P875; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2010, M XDR TB SURV RESP 2; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams B, 2007, AM J RESP CRIT CARE, V175, P6, DOI 10.1164/rccm.200609-1376ED; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	51	447	468	3	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					856	861		10.1126/science.1185449	http://dx.doi.org/10.1126/science.1185449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466923				2022-12-28	WOS:000277618800039
J	Scurr, LL; Pupo, GM; Becker, TM; Lai, K; Schrama, D; Haferkamp, S; Irvine, M; Scolyer, RA; Mann, GJ; Becker, JC; Kefford, RF; Rizos, H				Scurr, Lyndee L.; Pupo, Gulietta M.; Becker, Therese M.; Lai, Ken; Schrama, David; Haferkamp, Sebastian; Irvine, Mal; Scolyer, Richard A.; Mann, Graham J.; Becker, Juergen C.; Kefford, Richard F.; Rizos, Helen			IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; COLORECTAL-CANCER; DOWN-REGULATION; PROTEIN; GROWTH; NEVI; GENE; EXPRESSION; MUTATIONS	Induction of senescence permanently restricts cellular proliferation after oncogenic stimulation thereby acting as a potent barrier to tumor development. The relevant effector proteins may therefore be fundamental to cancer development. A recent study identified IGFBP7 as a secreted factor mediating melanocyte senescence induced by oncogenic B-RAF, which is found commonly in cutaneous nevi. In contrast to the previous report, we demonstrate that B-RAF signaling does not induce IGFBP7 expression, nor the expression of the IGFBP7 targets, BNIP3L, SMARCB1, or PEA15, in human melanocytes or fibroblasts. We also found no correlation between B-RAF mutational status and IGFBP7 protein expression levels in 22 melanoma cell lines, 90 melanomas, and 46 benign nevi. Furthermore, using a lentiviral silencing strategy we show that B-RAF induces senescence in melanocytes and fibroblasts, irrespective of the presence of IGFBP7. Therefore, we conclude that the secreted protein IGFBP7 is dispensable for B-RAF (V600E)-induced senescence in human melanocytes.	[Scurr, Lyndee L.; Pupo, Gulietta M.; Becker, Therese M.; Haferkamp, Sebastian; Irvine, Mal; Mann, Graham J.; Kefford, Richard F.; Rizos, Helen] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Lai, Ken; Scolyer, Richard A.; Kefford, Richard F.] Melanoma Inst Australia, Sydney Melanoma Unit, Sydney, NSW 2050, Australia; [Schrama, David; Becker, Juergen C.] Univ Hosp Wurzburg, Dept Dermatol, D-97080 Wurzburg, Germany; [Lai, Ken; Scolyer, Richard A.] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW 2050, Australia; [Scolyer, Richard A.] Univ Sydney, Fac Med, Discipline Pathol, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; Melanoma Institute Australia; University of Wurzburg; University of Sydney; University of Sydney	Scurr, LL (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia.	lyndee_scurr@wmi.usyd.edu.au; helen_rizos@wmi.usyd.edu.au	Haferkamp, Sebastian/AAN-3649-2021; Rizos, Helen/AAE-5010-2020; Haferkamp, Sebastian/ABD-7390-2021; Scolyer, Richard/AAE-8511-2019; Mann, Graham J/G-4758-2014	Rizos, Helen/0000-0002-2094-9198; Haferkamp, Sebastian/0000-0002-3894-8345; Scolyer, Richard/0000-0002-8991-0013; Mann, Graham J/0000-0003-1301-405X; Kefford, Richard/0000-0001-9251-9229; Becker, Therese/0000-0002-5636-9902; Schrama, David/0000-0002-6931-8194	National Health and Medical Research Council of Australia (NHMRC) [402761]; Australian Cancer Research Foundation; Melanoma and Skin Cancer Research Institute, University of Sydney; Melanoma Foundation of the University of Sydney; Department of Anatomical Pathology at the Royal Prince Alfred Hospital	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation; Melanoma and Skin Cancer Research Institute, University of Sydney(University of Sydney); Melanoma Foundation of the University of Sydney(University of Sydney); Department of Anatomical Pathology at the Royal Prince Alfred Hospital	This work is supported by Program Grant 402761, project grants of the National Health and Medical Research Council of Australia (NHMRC), and an infrastructure grant to Westmead Millennium Institute by the Health Department of NSW through Sydney West Area Health Service. Westmead Institute for Cancer Research is the recipient of capital grant funding from the Australian Cancer Research Foundation. L. L. S. is a Cameron Melanoma Research Fellow, supported by the Melanoma and Skin Cancer Research Institute, University of Sydney. H.R. is a Cancer Institute New South Wales Research Fellow. R.A.S. is a Cancer Institute New South Wales Clinical Research Fellow. We thank Eva-Maria Stuhl, Claudia Siedel, James Wilmott, Suzanah Philipsz, Branka Mijatov, Svetlana Pianova, and Jason Todd for excellent technical assistance and Dr. Hermann Kneitz for staining evaluation. The support of the Melanoma Foundation of the University of Sydney and colleagues from the Melanoma Institute Australia (incorporating the Sydney Melanoma Unit) and the Department of Anatomical Pathology at the Royal Prince Alfred Hospital are also gratefully acknowledged.	Acosta JC, 2008, CELL CYCLE, V7, P2956, DOI 10.4161/cc.7.19.6780; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Degeorges A, 1999, CANCER RES, V59, P2787; Denoyelle C, 2006, NAT CELL BIOL, V8, P1053, DOI 10.1038/ncb1471; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Haferkamp S, 2009, AGING-US, V1, P542, DOI 10.18632/aging.100051; Haferkamp S, 2009, J INVEST DERMATOL, V129, P1983, DOI 10.1038/jid.2009.5; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; Harrison SL, 2008, CANCER EPIDEM BIOMAR, V17, P2318, DOI 10.1158/1055-9965.EPI-07-2801; Herlyn M, 2007, CANCER BIOL THER, V6, P467, DOI 10.4161/cbt.6.3.4118; Jiang W, 2008, NEOPLASIA, V10, P1335, DOI 10.1593/neo.08694; Kelly JW, 1997, MED J AUSTRALIA, V167, P191, DOI 10.5694/j.1326-5377.1997.tb138843.x; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Papp T, 1999, J MED GENET, V36, P610; Pen A, 2008, ONCOGENE, V27, P6834, DOI 10.1038/onc.2008.287; Pen A, 2007, GLIA, V55, P559, DOI 10.1002/glia.20481; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Ruan WJ, 2007, CANCER BIOL THER, V6, P354, DOI 10.4161/cbt.6.3.3702; Schrama D, 2010, J INVEST DERMATOL, V130, P897, DOI 10.1038/jid.2009.304; Shao L, 2004, ENDOCR-RELAT CANCER, V11, P141, DOI 10.1677/erc.0.0110141; Suzuki H, 2010, CARCINOGENESIS, V31, P342, DOI 10.1093/carcin/bgp179; Sviderskaya EV, 2003, J NATL CANCER I, V95, P723, DOI 10.1093/jnci/95.10.723; SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472; Takeno A, 2008, BRIT J CANCER, V99, P1307, DOI 10.1038/sj.bjc.6604682; Thompson JF, 2005, LANCET, V365, P687, DOI 10.1016/S0140-6736(05)17951-3; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wajapeyee N, 2009, MOL CANCER THER, V8, P3009, DOI 10.1158/1535-7163.MCT-09-0470; Ye F, 2007, J CANCER RES CLIN, V133, P305, DOI 10.1007/s00432-006-0171-z; Yu H, 2009, AM J PATHOL, V174, P2367, DOI 10.2353/ajpath.2009.081057; Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258	43	51	53	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					717	727		10.1016/j.cell.2010.04.021	http://dx.doi.org/10.1016/j.cell.2010.04.021			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478260	Bronze			2022-12-28	WOS:000277623600023
J	Lund, K; Manzo, AJ; Dabby, N; Michelotti, N; Johnson-Buck, A; Nangreave, J; Taylor, S; Pei, RJ; Stojanovic, MN; Walter, NG; Winfree, E; Yan, H				Lund, Kyle; Manzo, Anthony J.; Dabby, Nadine; Michelotti, Nicole; Johnson-Buck, Alexander; Nangreave, Jeanette; Taylor, Steven; Pei, Renjun; Stojanovic, Milan N.; Walter, Nils G.; Winfree, Erik; Yan, Hao			Molecular robots guided by prescriptive landscapes	NATURE			English	Article							DNA; ENZYME; DEOXYRIBOZYME; COMPUTATION; DEVICES; MOTORS	Traditional robots(1) rely for their function on computing, to store internal representations of their goals and environment and to coordinate sensing and any actuation of components required in response. Moving robotics to the single-molecule level is possible in principle, but requires facing the limited ability of individual molecules to store complex information and programs. One strategy to overcome this problem is to use systems that can obtain complex behaviour from the interaction of simple robots with their environment(2-4). A first step in this direction was the development of DNA walkers(5), which have developed from being non-autonomous(6,7) to being capable of directed but brief motion on one-dimensional tracks(8-11). Here we demonstrate that previously developed random walkers(12)-so-called molecular spiders that comprise a streptavidin molecule as an inert 'body' and three deoxyribozymes as catalytic 'legs'-show elementary robotic behaviour when interacting with a precisely defined environment. Single-molecule microscopy observations confirm that such walkers achieve directional movement by sensing and modifying tracks of substrate molecules laid out on a two-dimensional DNA origami landscape(13). When using appropriately designed DNA origami, the molecular spiders autonomously carry out sequences of actions such as 'start', 'follow', 'turn' and 'stop'. We anticipate that this strategy will result in more complex robotic behaviour at the molecular level if additional control mechanisms are incorporated. One example might be interactions between multiple molecular robots leading to collective behaviour(14,15); another might be the ability to read and transform secondary cues on the DNA origami landscape as a means of implementing Turing-universal algorithmic behaviour(2,16,17).	[Taylor, Steven; Pei, Renjun; Stojanovic, Milan N.] Columbia Univ, Dept Med, Div Expt Therapeut, New York, NY 10032 USA; [Lund, Kyle; Nangreave, Jeanette; Yan, Hao] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Lund, Kyle; Nangreave, Jeanette; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA; [Manzo, Anthony J.; Michelotti, Nicole; Johnson-Buck, Alexander; Walter, Nils G.] Univ Michigan, Dept Chem, Single Mol Anal Grp, Ann Arbor, MI 48109 USA; [Dabby, Nadine; Winfree, Erik] CALTECH, Pasadena, CA 91125 USA; [Michelotti, Nicole] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Stojanovic, Milan N.] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA	Columbia University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Michigan System; University of Michigan; California Institute of Technology; University of Michigan System; University of Michigan; Columbia University	Stojanovic, MN (corresponding author), Columbia Univ, Dept Med, Div Expt Therapeut, New York, NY 10032 USA.	mns18@columbia.edu; nwalter@umich.edu; winfree@caltech.edu; hao.yan@asu.edu	Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016; Winfree, Erik/L-4002-2013	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Winfree, Erik/0000-0002-5899-7523; Johnson-Buck, Alexander/0000-0003-3748-6000	US National Science Foundation (NSF) EMT; US National Science Foundation (NSF) CBC; Kinship Foundation (Searle); Leukemia & Lymphoma Society; Juvenile Diabetes Research Foundation; NSF ITR; US Army Research Office; NSF; US Office of Naval Research; US National Institutes of Health; US Department of Energy; Sloan Research Fellowship; NIH; Division of Computing and Communication Foundations [0829744] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008270, R01GM062357] Funding Source: NIH RePORTER	US National Science Foundation (NSF) EMT(National Science Foundation (NSF)); US National Science Foundation (NSF) CBC(National Science Foundation (NSF)); Kinship Foundation (Searle); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NSF ITR(National Science Foundation (NSF)); US Army Research Office; NSF(National Science Foundation (NSF)); US Office of Naval Research(Office of Naval Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); Sloan Research Fellowship(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the US National Science Foundation (NSF) EMT and CBC grants (all authors); fellowships and grants from the Kinship Foundation (Searle), the Leukemia & Lymphoma Society, the Juvenile Diabetes Research Foundation and NSF ITR (M.N.S.); awards from the US Army Research Office, the NSF, the US Office of Naval Research, the US National Institutes of Health, the US Department of Energy and a Sloan Research Fellowship (H.Y.); an NSF Graduate Fellowship (N.D.); and Molecular Biophysics and Microfluidics in Biomedical Sciences Training Fellowships from the NIH (A.J.-B. and N.M., respectively). M.N.S. is grateful to T. E. Mitchell and M. Olah for inspiration, discussions and help.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Antal T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021121; Bath J, 2005, ANGEW CHEM INT EDIT, V44, P4358, DOI 10.1002/anie.200501262; Bath J, 2007, NAT NANOTECHNOL, V2, P275, DOI 10.1038/nnano.2007.104; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Hess H, 2006, SCIENCE, V312, P860, DOI 10.1126/science.1126399; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Li J, 2000, NUCLEIC ACIDS RES, V28, P481, DOI 10.1093/nar/28.2.481; Neumann J.V.A.W., 1966, THEORY SELF REPRODUC; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Pei R, 2006, J AM CHEM SOC, V128, P12693, DOI 10.1021/ja058394n; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rus D, 2002, COMMUN ACM, V45, P39, DOI 10.1145/504729.504752; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Siegwart R., 2004, INTRO AUTONOMOUS MOB; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tian Y, 2005, ANGEW CHEM INT EDIT, V44, P4355, DOI 10.1002/anie.200500703; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Walter NG, 2008, NAT METHODS, V5, P475, DOI 10.1038/nmeth.1215; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524	30	673	698	15	670	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					206	210		10.1038/nature09012	http://dx.doi.org/10.1038/nature09012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463735	Green Accepted			2022-12-28	WOS:000277558500032
J	Zhao, YF; Terry, D; Shi, L; Weinstein, H; Blanchard, SC; Javitch, JA				Zhao, Yongfang; Terry, Daniel; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.; Javitch, Jonathan A.			Single-molecule dynamics of gating in a neurotransmitter transporter homologue	NATURE			English	Article							BACTERIAL HOMOLOG; LEUT; FLUORESCENCE; SUBSTRATE; BINDING; NA+; RNA; MECHANISM; REVEALS; PROTEIN	Neurotransmitter: Na+ symporters (NSS) remove neurotransmitters from the synapse in a reuptake process that is driven by the Na+ gradient. Drugs that interfere with this reuptake mechanism, such as cocaine and antidepressants, profoundly influence behaviour and mood. To probe the nature of the conformational changes that are associated with substrate binding and transport, we have developed a single-molecule fluorescence imaging assay and combined it with functional and computational studies of the prokaryotic NSS homologue LeuT. Here we show molecular details of the modulation of intracellular gating of LeuT by substrates and inhibitors, as well as by mutations that alter binding, transport or both. Our direct observations of single-molecule transitions, reflecting structural dynamics of the intracellular region of the transporter that might be masked by ensemble averaging or suppressed under crystallographic conditions, are interpreted in the context of an allosteric mechanism that couples ion and substrate binding to transport.	[Zhao, Yongfang; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Zhao, Yongfang; Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Zhao, Yongfang; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Terry, Daniel; Shi, Lei; Weinstein, Harel; Blanchard, Scott C.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA; [Shi, Lei; Weinstein, Harel] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA; [Javitch, Jonathan A.] Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; Cornell University; Cornell University; Columbia University	Javitch, JA (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, 630 W 168th, New York, NY 10032 USA.	scb2005@med.cornell.edu; jaj2@columbia.edu	Shi, Lei/AAV-1321-2020; WEINSTEIN, HAREL/O-8245-2019; Zhao, Yongfang/B-5437-2010; Terry, Daniel/B-3521-2008; Blanchard, Scott C./A-5804-2009	Shi, Lei/0000-0002-4137-096X; WEINSTEIN, HAREL/0000-0003-3473-9818; Blanchard, Scott C./0000-0003-2717-9365; Terry, Daniel/0000-0001-9021-0084; Javitch, Jonathan/0000-0001-7395-2967	National Institutes of Health [DA17293, DA022413, DA12408, DA023694]; Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413, P01DA012408, R01DA017293, K99DA023694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tri-Institutional Training Program in Computational Biology and Medicine; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Altman for assistance with reagents for single-molecule experiments; F. Carvalho for the preparation of membranes; J. Munro for help measuring anisotropy; R. Dave for preliminary photobleaching optimization studies; and M. Quick for helpful discussion and comments on the manuscript. Molecular graphic figures and movies were prepared with PyMOL (DeLano Scientific; http://www.pymol.org). Computations were performed on Ranger at the Texas Advanced Computing Center (TG-MCB090022) and the David A. Cofrin computational infrastructure of the Institute for Computational Biomedicine at Weill Cornell Medical College. This work was supported in part by National Institutes of Health Grants DA17293 and DA022413 (J. A. J.), DA12408 (H. W.), and DA023694 (L. S.). D. S. T. is supported by the Tri-Institutional Training Program in Computational Biology and Medicine.	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Caplan DA, 2008, BIOPHYS J, V95, P4613, DOI 10.1529/biophysj.108.139741; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Cornish PV, 2007, ACS CHEM BIOL, V2, P53, DOI 10.1021/cb600342a; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; GU H, 1994, J BIOL CHEM, V269, P7124; Ha T, 2007, CELL, V129, P1249, DOI 10.1016/j.cell.2007.06.007; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Ishii Y, 2004, CURR PROTEIN PEPT SC, V5, P81, DOI 10.2174/1389203043486838; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; KARSTENS T, 1980, J PHYS CHEM-US, V84, P1871, DOI 10.1021/j100451a030; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krause S, 2005, MOL PHARMACOL, V68, P1728, DOI 10.1124/mol.105.013870; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Majumdar DS, 2007, P NATL ACAD SCI USA, V104, P12640, DOI 10.1073/pnas.0700969104; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Nie W, 2008, J MOL BIOL, V379, P695, DOI 10.1016/j.jmb.2008.04.015; Noskov SY, 2008, J MOL BIOL, V377, P804, DOI 10.1016/j.jmb.2008.01.015; Park H, 2007, Q REV BIOPHYS, V40, P87, DOI 10.1017/S0033583507004611; Peterman EJG, 2004, ANNU REV PHYS CHEM, V55, P79, DOI 10.1146/annurev.physchem.55.091602.094340; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Rudnick G., 2002, MECH BIOGENIC AMINE; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; WILLIAMS ATR, 1983, ANALYST, V108, P1067, DOI 10.1039/an9830801067; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641	51	202	207	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					188	U73		10.1038/nature09057	http://dx.doi.org/10.1038/nature09057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463731	Green Accepted			2022-12-28	WOS:000277558500028
J	Vichinsky, EP; Neumayr, LD; Gold, JI; Weiner, MW; Rule, RR; Truran, D; Kasten, J; Eggleston, B; Kesler, K; McMahon, L; Orringer, EP; Harrington, T; Kalinyak, K; De Castro, LM; Kutlar, A; Rutherford, CJ; Johnson, C; Bessman, JD; Jordan, LB; Armstrong, FD				Vichinsky, Elliott P.; Neumayr, Lynne D.; Gold, Jeffrey I.; Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey; Eggleston, Barry; Kesler, Karen; McMahon, Lillian; Orringer, Eugene P.; Harrington, Thomas; Kalinyak, Karen; De Castro, Laura M.; Kutlar, Abdullah; Rutherford, Cynthia J.; Johnson, Cage; Bessman, Joel David; Jordan, Lanetta B.; Armstrong, F. Daniel		Neuropsychological Dysfunction Neu	Neuropsychological Dysfunction and Neuroimaging Abnormalities in Neurologically Intact Adults With Sickle Cell Anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMAGING FINDINGS; BLOOD-FLOW; DISEASE; CHILDREN; BRAIN; SEGMENTATION; RISK; PERFUSION; MEMORY	Context Sickle cell anemia (SCA) is a chronic illness causing progressive deterioration in quality of life. Brain dysfunction may be the most important and least studied problem affecting individuals with this disease. Objective To measure neurocognitive dysfunction in neurologically asymptomatic adults with SCA vs healthy control individuals. Design, Setting, and Participants Cross-sectional study comparing neuropsychological function and neuroimaging findings in neurologically asymptomatic adults with SCA and controls from 12 SCA centers, conducted between December 2004 and May 2008. Participants were patients with SCA (hemoglobin [Hb] SS and hemoglobin level <= 10 mg/dL) aged 19 to 55 years and of African descent (n=149) or community controls (Hb AA and normal hemoglobin level) (n=47). Participants were stratified on age, sex, and education. Main Outcome Measures The primary outcome measure was nonverbal function assessed by the Wechsler Adult Intelligence Scale, third edition (WAIS-III) Performance IQ Index. Secondary exploratory outcomes included performance on neurocognitive tests of executive function, memory, attention, and language and magnetic resonance imaging measurement of total intracranial and hippocampal volume, cortical gray and white matter, and lacunae. Results The mean WAIS-III Performance IQ score of patients with SCA was significantly lower than that of controls (adjusted mean, 86.69 for patients with SCA vs 95.19 for controls [mean difference, -5.50; 95% confidence interval {CI}, -9.55 to -1.44]; P=.008), with 33% performing more than 1 SD (<85) below the population mean. Among secondary measures, differences were observed in adjusted mean values for global cognitive function (full-scale IQ) (90.47 for patients with SCA vs 95.66 for controls [mean difference, -5.19; 95% CI, -9.24 to -1.13]; P=.01), working memory (90.75 vs 95.25 [mean difference, -4.50; 95% CI, -8.55 to -0.45]; P=.03), processing speed (86.50 vs 97.95 [mean difference, -11.46; 95% CI, -15.51 to -7.40]; P<.001), and measures of executive function. Anemia was associated with poorer neurocognitive function in older patients. No differences in total gray matter or hippocampal volume were observed. Lacunae were more frequent in patients with SCA but not independently related to neurocognitive function. Conclusion Compared with healthy controls, adults with SCA had poorer cognitive performance, which was associated with anemia and age. JAMA. 2010;303(18):1823-1831 www.jama.com	[Vichinsky, Elliott P.; Neumayr, Lynne D.; Rutherford, Cynthia J.] Childrens Hosp & Res Ctr Oakland, Dept Hematol Oncol, Oakland, CA 94609 USA; [Gold, Jeffrey I.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Gold, Jeffrey I.] Childrens Hosp Los Angeles, Dept Anesthesiol, Los Angeles, CA 90027 USA; [Gold, Jeffrey I.] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey] Univ Calif San Francisco, Vet Adm Med Ctr, San Francisco, CA USA; [Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Weiner, Michael W.; Rule, Randall R.; Truran, Diana; Kasten, Jeffrey] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Eggleston, Barry; Kesler, Karen] Rho Inc, Res Triangle Pk, NC USA; [McMahon, Lillian] Boston Med Ctr, Boston, MA USA; [Orringer, Eugene P.] Univ N Carolina, Dept Med, Div Hematol & Oncol, Chapel Hill, NC USA; [Harrington, Thomas] Univ Miami, Dept Med, Div Hematol & Oncol, Miami, FL USA; [Armstrong, F. Daniel] Univ Miami, Dept Pediat, Miami, FL 33152 USA; [Kalinyak, Karen] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kalinyak, Karen] Univ Hosp Cincinnati, Cincinnati, OH USA; [De Castro, Laura M.] Duke Univ, Med Ctr, Durham, NC USA; [Kutlar, Abdullah] Med Coll Georgia, Augusta, GA 30912 USA; [Rutherford, Cynthia J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Johnson, Cage] Univ So Calif, Dept Med, Div Hematol, Los Angeles, CA USA; [Bessman, Joel David] Univ Texas Med Branch, Galveston, TX USA; [Jordan, Lanetta B.] Mem Canc Inst, Hollywood, FL USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rho; Boston Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; University of Miami; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Duke University; University System of Georgia; Augusta University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Southern California; University of Texas System; University of Texas Medical Branch Galveston	Vichinsky, EP (corresponding author), Childrens Hosp & Res Ctr Oakland, Dept Hematol Oncol, 747 52nd St, Oakland, CA 94609 USA.	evichinsky@mail.cho.org	Lascola, Christopher D/B-9126-2017; Vichinsky, Elliott P/F-8541-2011	Lascola, Christopher D/0000-0002-8031-782X; Vichinsky, Elliott P/0000-0002-0500-9579; McMahon, Lillian/0000-0001-7079-2478	National Heart, Lung, and Blood Institute [U54HL070587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL070583, U54HL070587] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Heart, Lung, and Blood Institute Award No. U54HL070587.	Adams RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1567, DOI 10.1001/archneur.64.11.1567; [Anonymous], INT C HARM TECHN REQ; Armstrong FD, 1996, PEDIATRICS, V97, P864; Bernaudin F, 2000, J CHILD NEUROL, V15, P333, DOI 10.1177/088307380001500510; Christensen GE, 1997, IEEE T MED IMAGING, V16, P864, DOI 10.1109/42.650882; Dawant BM, 1999, IEEE T MED IMAGING, V18, P909, DOI 10.1109/42.811271; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grueneich R, 2004, J PEDIATR PSYCHOL, V29, P83, DOI 10.1093/jpepsy/jsh012; Helton KJ, 2009, PEDIATR BLOOD CANCER, V52, P85, DOI 10.1002/pbc.21745; Hogan AM, 2006, DEVELOPMENTAL SCI, V9, P379, DOI 10.1111/j.1467-7687.2006.00503.x; Karvanen J, 2003, DRUG INF J, V37, P101, DOI 10.1177/009286150303700112; Kral MC, 2006, J CHILD NEUROL, V21, P37, DOI 10.1177/08830738060210010701; Manfre L, 1999, AM J ROENTGENOL, V173, P1477, DOI 10.2214/ajr.173.6.10584785; Marouf R, 2003, AM J HEMATOL, V73, P240, DOI 10.1002/ajh.10376; McClish Donna K, 2005, Health Qual Life Outcomes, V3, P50, DOI 10.1186/1477-7525-3-50; McNair D.M., 1992, REVISED MANUAL PROFI; MERCURI E, 1995, EUR J PEDIATR, V154, P150; Nahavandi M, 2004, EUR J CLIN INVEST, V34, P143, DOI 10.1111/j.1365-2362.2004.01307.x; Ohene-Frempong K, 1998, BLOOD, V91, P288; Pegelow CH, 2002, BLOOD, V99, P3014, DOI 10.1182/blood.V99.8.3014; Pegelow CH, 1997, AM J MED, V102, P171; Pickett JL, 1999, AM J KIDNEY DIS, V33, P1122, DOI 10.1016/S0272-6386(99)70150-2; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Puffer E, 2007, CHILD NEUROPSYCHOL, V13, P142, DOI 10.1080/09297040600584626; Quinn CT, 2009, BRIT J HAEMATOL, V145, P500, DOI 10.1111/j.1365-2141.2009.07652.x; Schatz J, 2002, J CHILD NEUROL, V17, P891, DOI 10.1177/08830738020170122401; Schatz J, 2006, MENT RETARD DEV D R, V12, P200, DOI 10.1002/mrdd.20115; Silva GS, 2009, STROKE, V40, P2408, DOI 10.1161/STROKEAHA.108.537415; Steen RG, 2005, J CHILD NEUROL, V20, P102, DOI 10.1177/08830738050200020301; Steen RG, 2003, AM J NEURORADIOL, V24, P382; Steen RG, 1999, ANN NEUROL, V45, P279, DOI 10.1002/1531-8249(199903)45:3<279::AID-ANA2>3.0.CO;2-7; Studholme C, 2003, NEUROIMAGE, V19, P1638, DOI 10.1016/S1053-8119(03)00183-6; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Weiskopf RB, 2000, ANESTHESIOLOGY, V92, P1646, DOI 10.1097/00000542-200006000-00023	37	189	191	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1823	1831		10.1001/jama.2010.562	http://dx.doi.org/10.1001/jama.2010.562			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460621	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000277513900023
J	Germain, A; Dixon-Mueller, R				Germain, Adrienne; Dixon-Mueller, Ruth			HIV is the biggest killer of women-but is it?	LANCET			English	Editorial Material							REPRODUCTIVE HEALTH; HIV/AIDS		[Germain, Adrienne] Int Womens Hlth Coalit, New York, NY USA		Dixon-Mueller, R (corresponding author), Int Womens Hlth Coalit, New York, NY USA.	dixonmueller@yahoo.com						Germain A, 2009, B WORLD HEALTH ORGAN, V87, P840, DOI 10.2471/BLT.09.065425; Horton R, 2008, LANCET, V372, P421, DOI 10.1016/S0140-6736(08)60882-X; Horton R, 2006, LANCET, V368, P1549, DOI 10.1016/S0140-6736(06)69484-1; Knight Lindsay, 2008, UNAIDS 1 10 YEARS 19; *UNAIDS, 2009, WHO REP HLTH WOM AID; *WHO, DIS INJ REG EST 2004; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, 2007, MAT MORT 2005 EST DE	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1592	1593		10.1016/S0140-6736(10)60312-1	http://dx.doi.org/10.1016/S0140-6736(10)60312-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452509				2022-12-28	WOS:000277734700011
J	Anderson, WF; Camargo, MC; Fraumeni, JF; Correa, P; Rosenberg, PS; Rabkin, CS				Anderson, William F.; Camargo, M. Constanza; Fraumeni, Joseph F., Jr.; Correa, Pelayo; Rosenberg, Philip S.; Rabkin, Charles S.			Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HELICOBACTER-PYLORI INFECTION; UNITED-STATES; TEMPORAL VARIATION; COHORT MODELS; RATES; PERIOD; EPIDEMIOLOGY; ESOPHAGEAL; RISK	Context For the last 50 years, overall age-standardized incidence rates for noncardia gastric cancer have steadily declined in most populations. However, overall rates are summary measures that may obscure important age-specific trends. Objective To examine effects of age at diagnosis on noncardia gastric cancer incidence trends in the United States. Design, Setting, and Participants Descriptive study with age-period-cohort analysis of cancer registration data from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program, which covers approximately 26% of the US population. From 1977 through 2006, there were 83 225 adults with incident primary gastric cancer, including 39 003 noncardia cases. Main Outcome Measures Overall and age-specific incidence rates, adjusted for period and cohort effects using age-period-cohort models. Results were stratified by race, sex, and socioeconomic status. Results Overall age-standardized annual incidence per 100 000 population declined during the study period from 5.9 (95% confidence interval [CI], 5.7-6.1) to 4.0 (95% CI, 3.9-4.1) in whites, from 13.7 (95% CI, 12.5-14.9) to 9.5 (95% CI, 9.1-10.0) in blacks, and from 17.8 (95% CI, 16.1-19.4) to 11.7 (95% CI, 11.2-12.1) in other races. Age-specific trends among whites varied significantly between older and younger age groups (P < .001 for interaction by age): incidence per 100 000 declined significantly from 19.8 (95% CI, 19.0-20.6) to 12.8 (95% CI, 12.5-13.1) for ages 60 to 84 years and from 2.6 (95% CI, 2.4-2.8) to 2.0 (95% CI, 1.9-2.1) for ages 40 to 59 years but increased significantly from 0.27 (95% CI, 0.19-0.35) to 0.45 (95% CI, 0.39-0.50) for ages 25 to 39 years. Conversely, rates for all age groups declined or were stable among blacks and other races. Age-period-cohort analysis confirmed a significant increase in whites among younger cohorts born since 1952 (P < .001). Conclusions From 1977 through 2006, the incidence rate for noncardia gastric cancer declined among all race and age groups except for whites aged 25 to 39 years, for whom it increased. Additional surveillance and analytical studies are warranted to identify risk factors that may explain this unfavorable trend. JAMA. 2010;303(17):1723-1728 www.jama.com	[Rabkin, Charles S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Camargo, M. Constanza] Univ Illinois, Div Epidemiol & Biostat, Chicago, IL USA; [Correa, Pelayo] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Vanderbilt University	Rabkin, CS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, 6120 Execut Blvd,Ste 7082, Rockville, MD 20852 USA.	rabkinc@mail.nih.gov	Camargo, M. Constanza/R-9891-2016	Camargo, M. Constanza/0000-0002-1065-2198; Rosenberg, Philip/0000-0001-6349-9126	National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010142, ZIACP010212, P01CA028842] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.	Abnet CC, 2008, EUR J CANCER, V44, P465, DOI 10.1016/j.ejca.2007.12.009; Anderson WF, 2008, JNCI-J NATL CANCER I, V100, P1804, DOI 10.1093/jnci/djn411; BANATVALA N, 1993, J INFECT DIS, V168, P219, DOI 10.1093/infdis/168.1.219; Blaser MJ, 2007, PLOS MED, V4, P53, DOI 10.1371/journal.pmed.0040007; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Blaser MJ, 2007, PLOS MED, V4, P397, DOI 10.1371/journal.pmed.0040100; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; CLAYTON D, 1987, STAT MED, V6, P469, DOI 10.1002/sim.4780060406; CORREA P, 1975, LANCET, V2, P58; Everhart JE, 2000, J INFECT DIS, V181, P1359, DOI 10.1086/315384; FORMAN D, 1993, LANCET, V341, P1359; Forman D, 2006, ASS FOOD NUTR PHYS A, P1; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, V83; Kim CC, 2000, ELECTROCHEM SOLID ST, V3, P335; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; Kuller LH, 1999, ANN EPIDEMIOL, V9, P91; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Parker S, 2005, HIST TODAY, V55, P2; Rosenberg PS, 2010, STAT MED, V29, P1228, DOI 10.1002/sim.3865; Singh GK, 2003, NCI CANC SURVEILLANC, V4; Singh GK, 2003, NIH PUBLICATION; Surveillance Epidemiology and End Results (SEER) Program, 1969, SURV EP END RES SEER; Tarone RE, 1996, AM J EPIDEMIOL, V143, P85; U.S. Food and Drug Administration, 2009, OR BOOK APPR DRUG PR; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; ZIPPIN C, 1995, CANCER, V76, P2343, DOI 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#	31	304	316	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1723	1728		10.1001/jama.2010.496	http://dx.doi.org/10.1001/jama.2010.496			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442388	Green Accepted, Bronze			2022-12-28	WOS:000277276600025
J	Davies, J				Davies, Justine			Exploring the Science-Policy Interface	CELL			English	Editorial Material													Dimmer, Kathleen/G-9797-2012	Davies, Justine/0000-0001-6834-1838					0	1	1	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 30	2010	141	3					390	391		10.1016/j.cell.2010.04.017	http://dx.doi.org/10.1016/j.cell.2010.04.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434977	Bronze			2022-12-28	WOS:000277180800007
J	Papes, F; Logan, DW; Stowers, L				Papes, Fabio; Logan, Darren W.; Stowers, Lisa			The Vomeronasal Organ Mediates Interspecies Defensive Behaviors through Detection of Protein Pheromone Homologs	CELL			English	Article							MALE URINARY PROTEINS; OLFACTORY-BULB; FEMALE MICE; GENE; ODOR; NEURONS; SMELL; REPERTOIRES; PRIMATES; RODENTS	Potential predators emit uncharacterized chemosignals that warn receiving species of danger. Neurons that sense these stimuli remain unknown. Here we show that detection and processing of fear-evoking odors emitted from cat, rat, and snake require the function of sensory neurons in the vomeronasal organ. To investigate the molecular nature of the sensory cues emitted by predators, we isolated the salient ligands from two species using a combination of innate behavioral assays in naive receiving animals, calcium imaging, and c-Fos induction. Surprisingly, the defensive behavior-promoting activity released by other animals is encoded by species-specific ligands belonging to the major urinary protein (Mup) family, homologs of aggression-promoting mouse pheromones. We show that recombinant Mup proteins are sufficient to activate sensory neurons and initiate defensive behavior similarly to native odors. This co-option of existing sensory mechanisms provides a molecular solution to the difficult problem of evolving a variety of species-specific molecular detectors.	[Papes, Fabio; Logan, Darren W.; Stowers, Lisa] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Papes, Fabio] Univ Estadual Campinas, Dept Genet & Evolut, BR-13083970 Campinas, SP, Brazil	Scripps Research Institute; Universidade Estadual de Campinas	Stowers, L (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stowers@scripps.edu	Papes, Fabio/E-3774-2013; Stowers, Lisa/K-6137-2015; Logan, Darren/D-5629-2009	Papes, Fabio/0000-0001-5034-4088; Logan, Darren/0000-0003-1545-5510; Stowers, Lisa/0000-0002-4403-1269	FAPESP; Skaggs Foundation; NIH-NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009413, R01DC006885] Funding Source: NIH RePORTER	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Skaggs Foundation; NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank F. Langone, G.A.G. Pereira, F.T.M. Costa, P. Arruda, A.T. Yamada, M.J. da Silva, M.G. Paniago, J.A. Yunes, and S.T.O. Saad for resources and K. Spencer, A. Roberts, C. Levy, K. Lloyd, T.S. Nakahara, F.B. Beato, E. Kiyota, and K.A. Flanagan for technical support. We also thank our volunteer cats Mitsy, Chewy, Cringer, Holiday, and Dolce. C. S. Zuker, A. Patapoutian, and K.K. Baldwin commented on the manuscript. This work was supported by a Young Investigator Grant from FAPESP (F.P.), the Skaggs Foundation (D.W.L. and L.S.), and NIH-NIDCD (L.S.). F.P. and L.S. initiated the study, F.P. and D.W.L. performed the experiments, and all authors wrote the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Buron G, 2007, BEHAV NEUROSCI, V121, P1063, DOI 10.1037/0735-7044.121.5.1063; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Dielenberg RA, 2001, BRAIN RES, V897, P228, DOI 10.1016/S0006-8993(01)02227-2; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; Flower DR, 1996, BIOCHEM J, V318, P1; HALPERN M, 1979, PHYSIOL BEHAV, V22, P1183, DOI 10.1016/0031-9384(79)90274-9; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Hurst JL, 1998, ANIM BEHAV, V55, P1289, DOI 10.1006/anbe.1997.0650; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Lane RP, 2002, P NATL ACAD SCI USA, V99, P291, DOI 10.1073/pnas.012608399; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Mao Y, 1998, CHEM RES TOXICOL, V11, P953, DOI 10.1021/tx9800405; Marchlewska-Koj A, 2000, J CHEM ECOL, V26, P2355, DOI 10.1023/A:1005578911652; McLennan Deborah A., 2008, Evolution Education and Outreach, V1, P247, DOI 10.1007/s12052-008-0053-8; Miller LR, 1999, ANIM BEHAV, V58, P53, DOI 10.1006/anbe.1999.1126; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Smith W, 2004, CLIN EXP ALLERGY, V34, P1732, DOI 10.1111/j.1365-2222.2004.02090.x; STOWE MK, 1995, P NATL ACAD SCI USA, V92, P23, DOI 10.1073/pnas.92.1.23; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; SZOKA PR, 1978, GENETICS, V90, P597; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Virtanen T, 1999, INT ARCH ALLERGY IMM, V120, P247, DOI 10.1159/000024277; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; WANG D, 1993, BRAIN BEHAV EVOLUT, V41, P246, DOI 10.1159/000113846; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Young JM, 2005, GENOME RES, V15, P231, DOI 10.1101/gr.3339905; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	45	223	229	3	75	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					692	703		10.1016/j.cell.2010.03.037	http://dx.doi.org/10.1016/j.cell.2010.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478258	Green Accepted, Bronze			2022-12-28	WOS:000277623600021
J	Tomkins, JL; Penrose, MA; Greeff, J; Lebas, NR				Tomkins, Joseph L.; Penrose, Marissa A.; Greeff, Johan; Lebas, Natasha R.			RETRACTED: Additive Genetic Breeding Values Correlate with the Load of Partially Deleterious Mutations (Retracted article. See vol. 333, pg. 1220, 2011)	SCIENCE			English	Article; Retracted Publication							CALLOSOBRUCHUS-MACULATUS; INBREEDING DEPRESSION; SEXUAL SELECTION; FITNESS COMPONENTS; MIMULUS-GUTTATUS; FEEDING BEETLES; LEK PARADOX; LIFE-SPAN; MAINTENANCE; SIZE	The mutation-selection-balance model predicts most additive genetic variation to arise from numerous mildly deleterious mutations of small effect. Correspondingly, "good genes" models of sexual selection and recent models for the evolution of sex are built on the assumption that mutational loads and breeding values for fitness-related traits are correlated. In support of this concept, inbreeding depression was negatively genetically correlated with breeding values for traits under natural and sexual selection in the weevil Callosobruchus maculatus. The correlations were stronger in males and strongest for condition. These results confirm the role of existing, partially recessive mutations in maintaining additive genetic variation in outbred populations, reveal the nature of good genes under sexual selection, and show how sexual selection can offset the cost of sex.	[Tomkins, Joseph L.; Penrose, Marissa A.; Greeff, Johan; Lebas, Natasha R.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Nedlands, WA 6009, Australia; [Greeff, Johan] Dept Agr & Food, S Perth, WA 6151, Australia	University of Western Australia; Government of Western Australia; Department of Agriculture & Food - Western Australia	Tomkins, JL (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Nedlands, WA 6009, Australia.	jtomkins@cyllene.uwa.edu.au	Tomkins, Joseph L/A-8091-2011; LeBas, Natasha R/E-7339-2015	Tomkins, Joseph L/0000-0003-1259-7898; LeBas, Natasha R/0000-0003-4706-3909	Australian Research Council	Australian Research Council(Australian Research Council)	We thank J. Chan for the maintenance of the pedigree and the collection and management of the data set; R. Black and F. Gonzalez for statistical advice; B. Booth, A. Sutton, and S. Jennings for their assistance with the experiment; and N. Colegrave, W. Hazel, M. Puurtinen, J. Radwan, M. Ritchie, and L. Simmons for their comments on the manuscript. This work was supported by Australian Research Council fellowships to J. L. T. and N. R. L.	Agrawal AF, 2001, NATURE, V411, P692, DOI 10.1038/35079590; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Charlesworth B, 1999, EVOL GENET, P369; Charlesworth B, 2007, GENET RES, V89, P85, DOI 10.1017/S001667230700866X; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; EADY PE, 1995, BEHAV ECOL SOCIOBIOL, V36, P25, DOI 10.1007/BF00175725; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Fox CW, 2006, FUNCT ECOL, V20, P1003, DOI 10.1111/j.1365-2435.2006.01197.x; Fox CW, 2007, B ENTOMOL RES, V97, P49, DOI 10.1017/S0007485307004737; Fox CW, 2006, GENETICS, V174, P763, DOI 10.1534/genetics.106.060392; Fox CW, 2004, J EVOLUTION BIOL, V17, P1007, DOI 10.1111/j.1420-9101.2004.00752.x; Fox CW, 2005, AM J BOT, V92, P1929, DOI 10.3732/ajb.92.11.1929; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Kelly JK, 2003, GENETICS, V164, P1071; Kelly JK, 2001, EVOLUTION, V55, P937, DOI 10.1554/0014-3820(2001)055[0937:DMAGVF]2.0.CO;2; Lynch M, 1998, EVOLUTION, V52, P727, DOI 10.1111/j.1558-5646.1998.tb03697.x; Lynch M., 1998, GENETICS ANAL QUANTI; MESSINA FJ, 1993, HEREDITY, V71, P623, DOI 10.1038/hdy.1993.187; Paukku S, 2005, J INSECT PHYSIOL, V51, P1220, DOI 10.1016/j.jinsphys.2005.06.012; Radwan J, 2008, GENETICA, V134, P113, DOI 10.1007/s10709-007-9203-0; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Savalli UM, 1999, ETHOL ECOL EVOL, V11, P49, DOI 10.1080/08927014.1999.9522841; SCHULTZ ST, 1995, GENETICS, V141, P1209; Siller S, 2001, NATURE, V411, P689, DOI 10.1038/35079578; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029	27	20	20	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					892	894		10.1126/science.1188013	http://dx.doi.org/10.1126/science.1188013			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466931				2022-12-28	WOS:000277618800049
J	Zeng, LY; Skinner, SO; Zong, CH; Sippy, J; Feiss, M; Golding, I				Zeng, Lanying; Skinner, Samuel O.; Zong, Chenghang; Sippy, Jean; Feiss, Michael; Golding, Ido			Decision Making at a Subcellular Level Determines the Outcome of Bacteriophage Infection	CELL			English	Article							TO-CELL VARIABILITY; GENE-EXPRESSION; ESCHERICHIA-COLI; KINETIC-ANALYSIS; LAMBDA; NOISE; MOLECULE; LYSOGENIZATION; STOCHASTICITY; DYNAMICS	When the process of cell-fate determination is examined at single-cell resolution, it is often observed that individual cells undergo different fates even when subject to identical conditions. This "noisy'' phenotype is usually attributed to the inherent stochasticity of chemical reactions in the cell. Here we demonstrate how the observed single-cell heterogeneity can be explained by a cascade of decisions occurring at the subcellular level. We follow the postinfection decision in bacteriophage lambda at single-virus resolution, and show that a choice between lysis and lysogeny is first made at the level of the individual virus. The decisions by all viruses infecting a single cell are then integrated in a precise (noise-free) way, such that only a unanimous vote by all viruses leads to the establishment of lysogeny. By detecting and integrating over the subcellular "hidden variables,'' we are able to predict the level of noise measured at the single-cell level.	[Zeng, Lanying; Skinner, Samuel O.; Zong, Chenghang; Golding, Ido] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Golding, Ido] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Golding, Ido] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Sippy, Jean; Feiss, Michael] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Baylor College of Medicine; University of Iowa	Golding, I (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	igolding@illinois.edu	Zong, Chenghang/F-3243-2013	Zong, Chenghang/0000-0002-8337-8038; Zeng, Lanying/0000-0002-8074-5824	National Institutes of Health [R01GM082837-01A1, GM-51611]; Human Frontier Science Program [RGY70/2008]; National Science Foundation [MCB-0717620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082837, R01GM051611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to A. Campbell, D. Court, J. Cronan, I. Dodd, R. Edgar, M. Elowitz, D. Endy, R. Hendrix, J. Little, R. Moldovan, A. Rokney, F. St- Pierre, P. Thomen, and R. Y. Tsien for generous advice and for providing reagents. We thank members of the Golding, Feiss, and Selvin laboratories for providing help with experiments. We thank A. Arkin, R. Phillips, L. Weinberger, J. Weitz, R. Joh, D. Endy, and F. St- Pierre for commenting on earlier versions of the manuscript. Work in the Golding lab was supported by grants from the National Institutes of Health (R01GM082837-01A1) and Human Frontier Science Program (RGY70/2008). J. S. and M. F. were supported in part by National Institutes of Health grant GM-51611 and National Science Foundation grant MCB-0717620.	Alberts B, 2009, ESSENTIAL CELL BIOL; Alon U, 2007, INTRO SYSTEMS BIOL D; Alvarez LJ, 2007, BIOTECHNOL BIOENG, V96, P615, DOI 10.1002/bit.21110; Arkin A, 1998, GENETICS, V149, P1633; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Cohen J, 2007, SCIENCE, V317, P1315, DOI 10.1126/science.317.5843.1315; Court DL, 2007, J BACTERIOL, V189, P298, DOI 10.1128/JB.01215-06; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Goldenfeld N., 2019, LECT PHASE TRANSITIO, DOI [https://doi.org/10.1201/9780429493492, DOI 10.1201/9780429493492]; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; HECHT MH, 1983, P NATL ACAD SCI-BIOL, V80, P2676, DOI 10.1073/pnas.80.9.2676; Hendrix R. W, 1983, LAMBDA, VII; Hershey A. D., 1971, BACTERIOPHAGE LAMBDA; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kobiler O, 2005, P NATL ACAD SCI USA, V102, P4470, DOI 10.1073/pnas.0500670102; Koster S, 2009, BIOPHYS J, V97, P1525, DOI 10.1016/j.bpj.2009.07.007; KOURILSKY P, 1973, MOL GEN GENET, V122, P183, DOI 10.1007/BF00435190; KOURILSKY P, 1974, BIOCHIMIE, V56, P1517; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; MACKAY DJ, 1976, VIROLOGY, V72, P154, DOI 10.1016/0042-6822(76)90320-2; Michalowski CB, 2004, J BACTERIOL, V186, P7988, DOI 10.1128/JB.186.23.7988-7999.2004; Moldovan R, 2007, BIOPHYS J, V93, P303, DOI 10.1529/biophysj.106.102962; Munoz-Espin D, 2009, P NATL ACAD SCI USA, V106, P13347, DOI 10.1073/pnas.0906465106; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ptashne M, 2004, GENETIC SWITCH PHAGE; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Russell JH, 2009, P NATL ACAD SCI USA, V106, P16405, DOI 10.1073/pnas.0904904106; Sambrook J., 2001, MOL CLONING LAB MANU; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Singh A, 2009, CURR OPIN MICROBIOL, V12, P460, DOI 10.1016/j.mib.2009.06.016; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; SUNSHINE M, 1977, MOL GEN GENET, V151, P27, DOI 10.1007/BF00446909; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zanghi CN, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni158	55	153	156	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					682	691		10.1016/j.cell.2010.03.034	http://dx.doi.org/10.1016/j.cell.2010.03.034			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478257	Green Accepted, Bronze			2022-12-28	WOS:000277623600020
J	Will, S; Best, T; Schneider, U; Hackermuller, L; Luhmann, DS; Bloch, I				Will, Sebastian; Best, Thorsten; Schneider, Ulrich; Hackermueller, Lucia; Luehmann, Dirk-Soeren; Bloch, Immanuel			Time-resolved observation of coherent multi-body interactions in quantum phase revivals	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; OPTICAL LATTICES; STATES; FIELD; ATOM	Interactions lie at the heart of correlated many-body quantum phases(1-3). Typically, the interactions between microscopic particles are described as two-body interactions. However, it has been shown that higher-order multi-body interactions could give rise to novel quantum phases with intriguing properties. So far, multi-body interactions have been observed as inelastic loss resonances in three-and four-body recombinations of atom-atom and atom-molecule collisions(4-6). Here we demonstrate the presence of effective multi-body interactions(7) in a system of ultracold bosonic atoms in a three-dimensional optical lattice, emerging through virtual transitions of particles from the lowest energy band to higher energy bands. We observe such interactions up to the six-body case in time-resolved traces of quantum phase revivals(8-11), using an atom interferometric technique that allows us to precisely measure the absolute energies of atom number states at a lattice site. In addition, we show that the spectral content of these time traces can reveal the atom number statistics at a lattice site, similar to foundational experiments in cavity quantum electrodynamics that yield the statistics of a cavity photon field(12). Our precision measurement of multi-body interaction energies provides crucial input for the comparison of optical-lattice quantum simulators with many-body quantum theory.	[Will, Sebastian; Best, Thorsten; Schneider, Ulrich; Hackermueller, Lucia; Bloch, Immanuel] Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany; [Will, Sebastian; Schneider, Ulrich; Bloch, Immanuel] Univ Munich, Fac Phys, D-80799 Munich, Germany; [Luehmann, Dirk-Soeren] Univ Hamburg, Inst Theoret Phys, D-20355 Hamburg, Germany; [Bloch, Immanuel] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Johannes Gutenberg University of Mainz; University of Munich; University of Hamburg; Max Planck Society	Will, S (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys, D-55099 Mainz, Germany.	sebastian.will@lmu.de	Schneider, Ulrich/N-4820-2015; Will, Sebastian/B-8933-2011; Bloch, Immanuel/N-9169-2019; Bloch, Immanuel/G-3174-2010	Schneider, Ulrich/0000-0003-4345-9498; Will, Sebastian/0000-0003-2672-5264; Bloch, Immanuel/0000-0002-0679-4759; Hackermueller, Lucia/0000-0001-9880-2914	Deutsche Forschungsgemeinschaft; European Union, EuroQUAM; Defense Advanced Research Projects Agency; US Air Force Office of Scientific Research, MATCOR; Gutenberg Akademie; EPSRC [EP/E036473/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E036473/1] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union, EuroQUAM; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US Air Force Office of Scientific Research, MATCOR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gutenberg Akademie; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Deutsche Forschungsgemeinschaft, the European Union (Integrated Project SCALA), EuroQUAM (L. H.), the US Army Research Office with funding from the Defense Advanced Research Projects Agency (Optical Lattice Emulator programme), the US Air Force Office of Scientific Research, MATCOR (S. W.) and the Gutenberg Akademie (S. W.).	Alon OE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030405; Auerbach A., 1994, INTERACTING ELECT QU; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Campbell GK, 2006, SCIENCE, V313, P649, DOI 10.1126/science.1130365; Capogrosso-Sansone B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.020503; Castin Y, 1997, PHYS REV A, V55, P4330, DOI 10.1103/PhysRevA.55.4330; Cheinet P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.090404; CHIN C, 2009, FESHBACH RESONANCES; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Fischer UR, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061603; Gerbier F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.050404; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Hazzard KRA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.031602; Imamoglu A, 1997, PHYS REV LETT, V78, P2511, DOI 10.1103/PhysRevLett.78.2511; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Johnson PR, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093022; Knoop S, 2009, NAT PHYS, V5, P227, DOI 10.1038/NPHYS1203; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Li JB, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/154; Luhmann DS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.050402; Mazets IE, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.210403; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Muryshev A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.110401; Paredes B, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.053611; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Sebby-Strabley J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200405; SORENSEN A, 2001, NATURE, V63, P409; Wright EM, 1996, PHYS REV LETT, V77, P2158, DOI 10.1103/PhysRevLett.77.2158; YURKE B, 1986, PHYS REV LETT, V57, P13, DOI 10.1103/PhysRevLett.57.13; Zaccanti M, 2009, NAT PHYS, V5, P586, DOI 10.1038/NPHYS1334	33	230	231	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					197	201		10.1038/nature09036	http://dx.doi.org/10.1038/nature09036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463733				2022-12-28	WOS:000277558500030
J	Bleakley, CM; O'Connor, SR; Tully, MA; Rocke, LG; MacAuley, DC; Bradbury, I; Keegan, S; McDonough, SM				Bleakley, Chris M.; O'Connor, Sean R.; Tully, Mark A.; Rocke, Laurence G.; MacAuley, Domhnall C.; Bradbury, Ian; Keegan, Stephen; McDonough, Suzanne M.			Effect of accelerated rehabilitation on function after ankle sprain: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							JOINT EFFUSION; INSTABILITY; INJURIES; STRENGTH; KINEMATICS; MANAGEMENT; SUPPORT; SYSTEM	Objective To compare an accelerated intervention incorporating early therapeutic exercise after acute ankle sprains with a standard protection, rest, ice, compression, and elevation intervention. Design Randomised controlled trial with blinded outcome assessor. Setting Accident and emergency department and university based sports injury clinic. Participants 101 patients with an acute grade 1 or 2 ankle sprain. Interventions Participants were randomised to an accelerated intervention with early therapeutic exercise (exercise group) or a standard protection, rest, ice, compression, and elevation intervention (standard group). Main outcome measures The primary outcome was subjective ankle function (lower extremity functional scale). Secondary outcomes were pain at rest and on activity, swelling, and physical activity at baseline and at one, two, three, and four weeks after injury. Ankle function and rate of reinjury were assessed at 16 weeks. Results An overall treatment effect was in favour of the exercise group (P=0.0077); this was significant at both week 1 (baseline adjusted difference in treatment 5.28, 98.75% confidence interval 0.31 to 10.26; P=0.008) and week 2 (4.92, 0.27 to 9.57; P=0.0083). Activity level was significantly higher in the exercise group as measured by time spent walking (1.2 hours, 95% confidence interval 0.9 to 1.4 v 1.6, 1.3 to 1.9), step count (5621 steps, 95% confidence interval 4399 to 6843 v 7886, 6357 to 9416), and time spent in light intensity activity (53 minutes, 95% confidence interval 44 to 60 v 76, 58 to 95). The groups did not differ at any other time point for pain at rest, pain on activity, or swelling. The reinjury rate was 4% (two in each group). Conclusion An accelerated exercise protocol during the first week after ankle sprain improved ankle function; the group receiving this intervention was more active during that week than the group receiving standard care.	[Bleakley, Chris M.; O'Connor, Sean R.; MacAuley, Domhnall C.; McDonough, Suzanne M.] Univ Ulster, Hlth & Rehabil Sci Res Inst, Sch Hlth Sci, Newtownabbey BT37 0QB, Antrim, North Ireland; [Tully, Mark A.] Queens Univ Belfast, Royal Victoria Hosp, UKCRC Ctr Excellence Publ Hlth NI, Belfast, Antrim, North Ireland; [Rocke, Laurence G.] Royal Victoria Hosp, Dept Emergency Med, Belfast BT12 6BA, Antrim, North Ireland; [Bradbury, Ian; Keegan, Stephen] Frontier Sci Scotland, Inverness, Scotland	Ulster University; Queens University Belfast	Bleakley, CM (corresponding author), Univ Ulster, Hlth & Rehabil Sci Res Inst, Sch Hlth Sci, Newtownabbey BT37 0QB, Antrim, North Ireland.	chrisbleakley@hotmail.com	Tully, Mark/AAB-2939-2019	Tully, Mark/0000-0001-9710-4014; O'Connor, Sean R/0000-0001-6805-8899; Bleakley, Chris/0000-0001-9032-9691; McDonough, Suzanne/0000-0003-3758-3302	Physiotherapy Research Foundation and Strategic Priority Fund (Department of Employment and Learning, Northern Ireland); Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI	Physiotherapy Research Foundation and Strategic Priority Fund (Department of Employment and Learning, Northern Ireland); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding: This trial was funded by grants from the Physiotherapy Research Foundation and Strategic Priority Fund (Department of Employment and Learning, Northern Ireland). The researchers were independent of the funding agency.	Akbari M, 2006, J REHABIL RES DEV, V43, P819, DOI 10.1682/JRRD.2006.01.0001; Anandacoomarasamy A, 2005, BRIT J SPORT MED, V39, DOI 10.1136/bjsm.2004.011676; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Beynnon BD, 2006, AM J SPORT MED, V34, P1401, DOI 10.1177/0363546506288676; Binkley JM, 1999, PHYS THER, V79, P371; Bleakley CM, 2006, BRIT J SPORT MED, V40, P700, DOI 10.1136/bjsm.2006.025932; Bleakley CM, 2008, AUST J PHYSIOTHER, V54, P7, DOI 10.1016/S0004-9514(08)70061-8; Bleakley CM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-125; Boyce SH, 2005, BRIT J SPORT MED, V39, P91, DOI 10.1136/bjsm.2003.009233; Braun BL, 1999, ARCH FAM MED, V8, P143, DOI 10.1001/archfami.8.2.143; Bridgman SA, 2003, EMERG MED J, V20, P508, DOI 10.1136/emj.20.6.508; Bring DKI, 2009, J ORTHOP RES, V27, P274, DOI 10.1002/jor.20657; Cooke FJ, 2009, INT J INFECT DIS, V13, P1, DOI 10.1016/S1201-9712(08)01705-0; Cooke MW, 2003, EMERG MED J, V20, P505, DOI 10.1136/emj.20.6.505; deBie RA, 1997, INT J SPORTS MED, V18, P285, DOI 10.1055/s-2007-972635; Delahunt E, 2006, J ORTHOP RES, V24, P1991, DOI 10.1002/jor.20235; Delahunt E, 2006, AM J SPORT MED, V34, P1970, DOI 10.1177/0363546506290989; Freeman M A, 1965, J Bone Joint Surg Br, V47, P678; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hall RC, 1999, J ORTHOP SPORT PHYS, V29, P339, DOI 10.2519/jospt.1999.29.6.339; Holme E, 1999, SCAND J MED SCI SPOR, V9, P104; Hopkins JT, 2004, CLIN J SPORT MED, V14, P1, DOI 10.1097/00042752-200401000-00001; Hopkins JT, 2001, MED SCI SPORT EXER, V33, P123; Hubbard TJ, 2002, J ATHL TRAINING, V37, P481; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Jones MH, 2007, CLIN ORTHOP RELAT R, P169, DOI 10.1097/BLO.0b01e31802f5468; Karlsson J, 1991, FOOT, V1, P15, DOI DOI 10.1016/0958-2592(91)90006-W; Katz J, 1999, SURG CLIN N AM, V79, P231, DOI 10.1016/S0039-6109(05)70381-9; Kerkhoffs G.M., 2002, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD003762, DOI 10.1002/14651858.CD003762]; Kerkhoffs GMMJ, 2002, COCHRANE DB SYST REV, V3; KERKHOFFSGM, 2002, COCHRANE DB SYST REV, V3; Knight KL, 1995, CRYOTHERAPY SPORTS I; Konradsen L, 1998, AM J SPORT MED, V26, P72, DOI 10.1177/03635465980260013001; Lamb SE, 2009, LANCET, V373, P575, DOI 10.1016/S0140-6736(09)60206-3; Lamb SE, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-1; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; Palmieri RM, 2004, BRIT J SPORT MED, V38, P26, DOI 10.1136/bjsm.2002.001677; Palmieri-Smith RM, 2009, AM J SPORT MED, V37, P982, DOI 10.1177/0363546508330147; Perron M, 2007, CLIN REHABIL, V21, P73, DOI 10.1177/0269215506071288; Rohner-Spengler M, 2007, J ORTHOP SPORT PHYS, V37, P199, DOI 10.2519/jospt.2007.2371; Rosner B., 2000, FUNDAMENTALS BIOSTAT; See EKN, 2004, BRIT J SPORT MED, V38, P597, DOI 10.1136/bjsm.2003.007120; STIELL IG, 1994, JAMA-J AM MED ASSOC, V271, P827, DOI 10.1001/jama.271.11.827; van Rijn RM, 2008, AM J MED, V121, P324, DOI 10.1016/j.amjmed.2007.11.018; vanDijk CN, 1996, J BONE JOINT SURG BR, V78B, P958, DOI 10.1302/0301-620X78B6.1283; Verhagen EALM, 2005, BRIT J SPORT MED, V39, P111, DOI 10.1136/bjsm.2003.011031; Watts BL, 2001, EMERG MED J, V18, P46, DOI 10.1136/emj.18.1.46; Wester JU, 1996, J ORTHOP SPORT PHYS, V23, P332, DOI 10.2519/jospt.1996.23.5.332; Williams GN, 2003, FOOT ANKLE INT, V24, P274, DOI 10.1177/107110070302400314; YEUNG MS, 1994, BRIT J SPORT MED, V28, P112, DOI 10.1136/bjsm.28.2.112	50	96	104	1	58	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2010	340								c1964	10.1136/bmj.c1964	http://dx.doi.org/10.1136/bmj.c1964			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HL	20457737	hybrid			2022-12-28	WOS:000277825900001
J	Zhang, X; Rashid, R; Wang, K; Shan, SO				Zhang, Xin; Rashid, Rumana; Wang, Kai; Shan, Shu-ou			Sequential Checkpoints Govern Substrate Selection During Cotranslational Protein Targeting	SCIENCE			English	Article							SIGNAL-RECOGNITION PARTICLE; ESCHERICHIA-COLI; TRIGGER FACTOR; ENDOPLASMIC-RETICULUM; RIBOSOME; RECEPTOR; SRP; RNA; TRANSLOCATION; SEQUENCES	Proper protein localization is essential for all cells. However, the precise mechanism by which high fidelity is achieved is not well understood for any protein-targeting pathway. To address this fundamental question, we investigated the signal recognition particle (SRP) pathway in Escherichia coli, which delivers proteins to the bacterial inner membrane through recognition of signal sequences on cargo proteins. Fidelity was thought to arise from the inability of SRP to bind strongly to incorrect cargos. Using biophysical assays, we found that incorrect cargos were also rejected through a series of checkpoints during subsequent steps of targeting. Thus, high fidelity of substrate selection is achieved through the cumulative effect of multiple checkpoints; this principle may be generally applicable to other pathways involving selective signal recognition.	[Zhang, Xin; Rashid, Rumana; Wang, Kai; Shan, Shu-ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu	Zhang, Xin/B-2185-2016	Zhang, Xin/0000-0001-6686-1645	NIH [GM078024]; Burroughs Wellcome Foundation; Henry and Camille Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Henry and Camille Dreyfus Foundation; Arnold and Mabel Beckman Foundation; Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Schaffitzel and N. Ban for help with the purification of RNCs and Trigger factor; J. Luirink for plasmids encoding the phoA signal sequence variants; L. Randall for the plasmid encoding luciferase; B. Bukau and E. Deuerling for the plasmid encoding Trigger factor; F. Nataro for the plasmid encoding EspP; H. D. Bernstein for the strain HDB51; and R. J. Deshaies, A. Varshavsky, W. Zhong, N. Pierce, and the Shan laboratory for comments on the manuscript. This work was supported by NIH grant GM078024, and career awards from the Burroughs Wellcome Foundation, the Henry and Camille Dreyfus Foundation, the Arnold and Mabel Beckman Foundation, and the Packard Foundation to S.	Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; DeGier JWL, 1997, FEBS LETT, V408, P1, DOI 10.1016/S0014-5793(97)00402-X; DOUD SK, 1993, BIOCHEMISTRY-US, V32, P1251, DOI 10.1021/bi00056a008; FERSHT AR, 1976, BIOCHEMISTRY-US, V15, P3342, DOI 10.1021/bi00660a026; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Halic M, 2006, SCIENCE, V312, P745, DOI 10.1126/science.1124864; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Shan SO, 2007, J CELL BIOL, V178, P611, DOI 10.1083/jcb.200702018; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Zhang X, 2008, J MOL BIOL, V381, P581, DOI 10.1016/j.jmb.2008.05.049; Zhang X, 2009, P NATL ACAD SCI USA, V106, P1754, DOI 10.1073/pnas.0808573106; Zheng N, 1996, CELL, V86, P849, DOI 10.1016/S0092-8674(00)80159-2	28	86	87	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					757	760		10.1126/science.1186743	http://dx.doi.org/10.1126/science.1186743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448185	Green Accepted			2022-12-28	WOS:000277357100041
J	House, AA; Eliasziw, M; Cattran, DC; Churchill, DN; Oliver, MJ; Fine, A; Dresser, GK; Spence, JD				House, Andrew A.; Eliasziw, Misha; Cattran, Daniel C.; Churchill, David N.; Oliver, Matthew J.; Fine, Adrian; Dresser, George K.; Spence, J. David			Effect of B-Vitamin Therapy on Progression of Diabetic Nephropathy A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR EVENTS; FOLIC-ACID; RISK-FACTOR; HOMOCYSTEINE; MORTALITY; HYPERHOMOCYSTEINEMIA; CREATININE; INTERVENTION; PREDICTION; DISEASE	Context Hyperhomocysteinemia is frequently observed in patients with diabetic nephropathy. B-vitamin therapy (folic acid, vitamin B-6, and vitamin B-12) has been shown to lower the plasma concentration of homocysteine. Objective To determine whether B-vitamin therapy can slow progression of diabetic nephropathy and prevent vascular complications. Design, Setting, and Participants A multicenter, randomized, double-blind, placebo-controlled trial (Diabetic Intervention with Vitamins to Improve Nephropathy [DIVINe]) at 5 university medical centers in Canada conducted between May 2001 and July 2007 of 238 participants who had type 1 or 2 diabetes and a clinical diagnosis of diabetic nephropathy. Intervention Single tablet of B vitamins containing folic acid (2.5 mg/d), vitamin B-6 (25 mg/d), and vitamin B-12 (1 mg/d), or matching placebo. Main Outcome Measures Change in radionuclide glomerular filtration rate (GFR) between baseline and 36 months. Secondary outcomes were dialysis and a composite of myocardial infarction, stroke, revascularization, and all-cause mortality. Plasma total homocysteine was also measured. Results The mean (SD) follow-up during the trial was 31.9 (14.4) months. At 36 months, radionuclide GFR decreased by a mean (SE) of 16.5 (1.7) mL/min/1.73 m(2) in the B-vitamin group compared with 10.7 (1.7) mL/min/1.73 m(2) in the placebo group (mean difference, -5.8; 95% confidence interval [CI], -10.6 to -1.1; P=.02). There was no difference in requirement of dialysis (hazard ratio [HR], 1.1; 95% CI, 0.4-2.6; P=.88). The composite outcome occurred more often in the B-vitamin group (HR, 2.0; 95% CI, 1.0-4.0; P=.04). Plasma total homocysteine decreased by a mean (SE) of 2.2 (0.4) mu mol/L at 36 months in the B-vitamin group compared with a mean (SE) increase of 2.6 (0.4) mu mol/L in the placebo group (mean difference, -4.8; 95% CI, -6.1 to -3.7; P<.001, in favor of B vitamins). Conclusion Among patients with diabetic nephropathy, high doses of B vitamins compared with placebo resulted in a greater decrease in GFR and an increase in vascular events.	[Spence, J. David] Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, London, ON N6G 2V2, Canada; [House, Andrew A.] Univ Western Ontario, Div Nephrol, London, ON N6G 2V2, Canada; [Dresser, George K.; Spence, J. David] Univ Western Ontario, Div Clin Pharmacol, London, ON N6G 2V2, Canada; [Eliasziw, Misha] Univ Calgary, Dept Community Hlth Sci Clin Neurosci & Oncol, Calgary, AB, Canada; [Cattran, Daniel C.; Oliver, Matthew J.] Univ Toronto, Div Nephrol, Toronto, ON, Canada; [Churchill, David N.] McMaster Univ, Div Nephrol, Hamilton, ON, Canada; [Fine, Adrian] Univ Manitoba, Div Nephrol, Winnipeg, MB, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Calgary; University of Toronto; McMaster University; University of Manitoba	Spence, JD (corresponding author), Univ Western Ontario, Robarts Res Inst, Stroke Prevent & Atherosclerosis Res Ctr, 1400 Western Rd, London, ON N6G 2V2, Canada.	dspence@robarts.ca	House, Andrew/G-3304-2011; Spence, J. David/K-6396-2013; Dresser, George/G-3291-2011	Spence, J. David/0000-0001-7478-1098; 	Pan American Laboratories in the United States; Medice Arzneimittel Putter GmbH Co in Germany; Canadian Institutes of Health Research [MCT-41551]; Kidney Foundation of Canada	Pan American Laboratories in the United States; Medice Arzneimittel Putter GmbH Co in Germany; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada	Financial Disclosures: Dr Spence reported receiving in the past consulting fees from Pan American Laboratories in the United States and from Medice Arzneimittel Putter GmbH & Co in Germany. Drs House and Spence have a patent pending on the use of mesna, a thiol, to reduce homocysteine levels in patients receiving dialysis. No other authors reported any financial disclosures.; Funding/Support: This work was funded by grant MCT-41551 from the Canadian Institutes of Health Research and by the Kidney Foundation of Canada. Pan American Laboratories (Covington, Louisiana) provided in-kind the B vitamins and matching placebos.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; Amos AF, 1997, DIABETIC MED, V14, pS7, DOI 10.1002/(SICI)1096-9136(199712)14:5+<S7::AID-DIA522>3.3.CO;2-I; Becker A, 2003, METAB SYNDR RELAT D, V1, P105, DOI 10.1089/154041903322294434; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Chambers JC, 1999, CIRCULATION, V99, P1156, DOI 10.1161/01.CIR.99.9.1156; Chambers JC, 2000, CIRCULATION, V102, P2479, DOI 10.1161/01.CIR.102.20.2479; Chaturvedi N, 2007, DIABETES RES CLIN PR, V76, pS3, DOI 10.1016/j.diabres.2007.01.019; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dayal S, 2008, ARTERIOSCL THROM VAS, V28, P1596, DOI 10.1161/ATVBAHA.108.166421; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; Imasa Marcelo Severino B, 2009, Asian Cardiovasc Thorac Ann, V17, P13, DOI 10.1177/0218492309102494; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Looker HC, 2003, DIABETOLOGIA, V46, P766, DOI 10.1007/s00125-003-1104-x; Loscalzo J, 2006, NEW ENGL J MED, V354, P1629, DOI 10.1056/NEJMe068060; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Mallett C, 2009, ULTRASOUND MED BIOL, V35, P367, DOI 10.1016/j.ultrasmedbio.2008.09.008; McCully KS, 2005, CLIN CHEM LAB MED, V43, P980, DOI 10.1515/CCLM.2005.172; Palmer AJ, 2008, NEPHROL DIAL TRANSPL, V23, P1216, DOI 10.1093/ndt/gfn082; PARVING HH, 1995, AM J KIDNEY DIS, V26, P99, DOI 10.1016/0272-6386(95)90162-0; Poddar R, 2001, CIRCULATION, V103, P2717; Refsum H, 2006, J NUTR, V136, p1731S, DOI 10.1093/jn/136.6.1731S; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Spence JD, 2007, LANCET NEUROL, V6, P830, DOI 10.1016/S1474-4422(07)70219-3; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Urquhart BL, 2007, J CLIN PHARMACOL, V47, P991, DOI 10.1177/0091270007303767; *US REN DAT SYST, USRDS 2009 ANN DAT R; Zaltzman JS, 1996, AM J KIDNEY DIS, V27, P504, DOI 10.1016/S0272-6386(96)90160-2	34	207	215	4	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1603	1609		10.1001/jama.2010.490	http://dx.doi.org/10.1001/jama.2010.490			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424250	Bronze			2022-12-28	WOS:000277085200023
J	Lin, SC; Lo, YC; Wu, H				Lin, Su-Chang; Lo, Yu-Chih; Wu, Hao			Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling	NATURE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; NF-KAPPA-B; DEATH DOMAIN; RECEPTOR SUPERFAMILY; SPLICE VARIANT; TOLL; INTERLEUKIN-1; MYD88; IRAK-4; MECHANISM	MyD88, IRAK4 and IRAK2 are critical signalling mediators of the TLR/IL1-R superfamily. Here we report the crystal structure of the MyD88-IRAK4-IRAK2 death domain (DD) complex, which surprisingly reveals a left-handed helical oligomer that consists of 6 MyD88, 4 IRAK4 and 4 IRAK2 DDs. Assembly of this helical signalling tower is hierarchical, in which MyD88 recruits IRAK4 and the MyD88-IRAK4 complex recruits the IRAK4 substrates IRAK2 or the related IRAK1. Formation of these Myddosome complexes brings the kinase domains of IRAKs into proximity for phosphorylation and activation. Composite binding sites are required for recruitment of the individual DDs in the complex, which are confirmed by mutagenesis and previously identified signalling mutations. Specificities in Myddosome formation are dictated by both molecular complementarity and correspondence of surface electrostatics. The MyD88-IRAK4-IRAK2 complex provides a template for Toll signalling in Drosophila and an elegant mechanism for versatile assembly and regulation of DD complexes in signal transduction.	[Lin, Su-Chang; Lo, Yu-Chih; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Lin, Su-Chang/F-2899-2016	Lin, Su-Chang/0000-0003-0687-3139	NIH; Cancer Research Institute; American Heart Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank K. Rajashankar, I. Kourinov and N. Sukumar for data collection and X. Ma for help with the manuscript. This work was supported by NIH (H. W.), the Cancer Research Institute (S.-C. L. and Y.-C.L.), and the American Heart Association (Y.-C.L.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; DeLano W.L, PYMOL MOL GRAPHICS S; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horner AA, 2003, CURR OPIN IMMUNOL, V15, P614, DOI 10.1016/j.coi.2003.09.021; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Marta M, 2009, AUTOIMMUN REV, V8, P506, DOI 10.1016/j.autrev.2009.01.006; Marx J, 2007, SCIENCE, V315, P33, DOI 10.1126/science.315.5808.33; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LA, 2008, NAT CLIN PRACT RHEUM, V4, P319, DOI 10.1038/ncprheum0802; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Verstak B, 2007, INFLAMM RES, V56, P1, DOI 10.1007/s00011-007-6093-7; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	58	730	773	10	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					885	U2		10.1038/nature09121	http://dx.doi.org/10.1038/nature09121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20485341	Green Accepted			2022-12-28	WOS:000278804500029
J	Sasaki, J; Kofuji, S; Itoh, R; Momiyama, T; Takayama, K; Murakami, H; Chida, S; Tsuya, Y; Takasuga, S; Eguchi, S; Asanuma, K; Horie, Y; Miura, K; Davies, EM; Mitchell, C; Yamazaki, M; Hirai, H; Takenawa, T; Suzuki, A; Sasaki, T				Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Momiyama, Toshihiko; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Horie, Yasuo; Miura, Kouichi; Davies, Elizabeth Michele; Mitchell, Christina; Yamazaki, Masakazu; Hirai, Hirokazu; Takenawa, Tadaomi; Suzuki, Akira; Sasaki, Takehiko			The PtdIns(3,4)P-2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death	NATURE			English	Article							INOSITOL POLYPHOSPHATE 4-PHOSPHATASE; HUNTINGTONS-DISEASE; LENTIVIRAL VECTORS; NMDA RECEPTORS; PURKINJE-CELL; IN-VIVO; SYSTEM; PTEN; MICE; PHOSPHOINOSITIDES	Phosphorylated derivatives of phosphatidylinositol, collectively referred to as phosphoinositides, occur in the cytoplasmic leaflet of cellular membranes and regulate activities such as vesicle transport, cytoskeletal reorganization and signal transduction(1,2). Recent studies have indicated an important role for phosphoinositide metabolism in the aetiology of diseases such as cancer, diabetes, myopathy and inflammation(3-5). Although the biological functions of the phosphatases that regulate phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P-3)have been well characterized, little is known about the functions of the phosphatases regulating the closely related molecule phosphatidylinositol-3,4-bisphosphate (PtdIns(3,4)P-2). Here we show that inositol polyphosphate phosphatase 4A (INPP4A), a PtdIns(3,4)P2 phosphatase, is a suppressor of glutamate excitotoxicity in the central nervous system. Targeted disruption of the Inpp4a gene in mice leads to neurodegeneration in the striatum, the input nucleus of the basal ganglia that has a central role inmotor and cognitive behaviours. Notably, Inpp4a(-/-) mice show severe involuntary movement disorders. In vitro, Inpp4a gene silencing via short hairpin RNA renders cultured primary striatal neurons vulnerable to cell death mediated by N-methyl-D-aspartatetype glutamate receptors (NMDARs). Mechanistically, INPP4A is found at the postsynaptic density and regulates synaptic NMDAR localization and NMDAR-mediated excitatory postsynaptic current. Thus, INPP4A protects neurons from excitotoxic cell death and thereby maintains the functional integrity of the brain. Our study demonstrates that PtdIns(3,4)P-2, PtdIns(3,4,5)P-3 and the phosphatases acting on them can have distinct regulatory roles, and provides insight into the unique aspects and physiological significance of PtdIns(3,4)P-2 metabolism. INPP4A represents, to our knowledge, the first signalling protein with a function in neurons to suppress excitotoxic cell death. The discovery of a direct link between PtdIns(3,4)P-2 metabolism and the regulation of neurodegeneration and involuntary movements may aid the development of new approaches for the treatment of neurodegenerative disorders.	[Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Yamazaki, Masakazu; Hirai, Hirokazu; Suzuki, Akira; Sasaki, Takehiko] Gunma Univ, Global COE Program, Gunma 3718511, Japan; [Sasaki, Junko; Kofuji, Satoshi; Itoh, Reietsu; Takayama, Kiyohiko; Murakami, Haruka; Chida, Shinsuke; Tsuya, Yuko; Takasuga, Shunsuke; Eguchi, Satoshi; Asanuma, Ken; Yamazaki, Masakazu; Hirai, Hirokazu; Suzuki, Akira; Sasaki, Takehiko] Akita Univ, Gunma 3718511, Japan; [Momiyama, Toshihiko] Jikei Univ, Sch Med, Dept Pharmacol, Tokyo 1058461, Japan; [Takayama, Kiyohiko; Hirai, Hirokazu] Gunma Univ, Dept Neurophysiol, Grad Sch Med, Gunma 3718511, Japan; [Horie, Yasuo; Miura, Kouichi] Akita Univ, Grad Sch Med, Dept Gastroenterol & Neurol, Akita 0108543, Japan; [Davies, Elizabeth Michele; Mitchell, Christina] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Lipid Biochem, Kobe, Hyogo 6500017, Japan; [Takenawa, Tadaomi] Kobe Univ, Grad Sch Med, Global COE Program, Kobe, Hyogo 6500017, Japan; [Suzuki, Akira] Kyushu Univ, Med Inst Bioregulat, Div Embryon & Genet Engn, Fukuoka 8128582, Japan	Akita University; Gunma University; Akita University; Jikei University; Gunma University; Akita University; Monash University; Kobe University; Kobe University; Kyushu University	Sasaki, J (corresponding author), Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan.	sasakij@med.akita-u.ac.jp; tsasaki@med.akita-u.ac.jp	Suzuki, Akira/GYD-6697-2022; Hirai, Hirokazu/ABP-1143-2022	Suzuki, Akira/0000-0002-5950-8808; Mitchell, Christina A/0000-0001-9372-3192; Hirai, Hirokazu/0000-0002-0721-4293; Sasaki, Takehiko/0000-0003-1837-3748	Ministry of Education, Culture, Sports and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Corporation (JST); Naito Foundation; Toray Science Foundation; MEXT	Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Toray Science Foundation(Toray Industries, Inc.); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Shigemoto, T. Iwatsubo, I. Kanazawa, T. Shimizu, H. Ichijo, K. Yamada, Y. Imai, K. Kawamura, Y. Kanaho and T. Itoh for discussions; and H. Takahashi, K. Sasaki, Y. Sugihara, S. Kumagai, A. Kato, C. Horie, M. Nishio, S. Sato, T. Sugawara, R. Nakamura and K. Mizoi for technical support. Anti-Met-enkephalin antibody was provided by T. Kaneko and T. Furuta, and anti-NR2C antibody was provided by B. S. Chen and W. Roche. This work was supported by research grants from the Ministry of Education, Culture, Sports and Technology of Japan (MEXT); the Japan Society for the Promotion of Science (JSPS); the Japan Science and Technology Corporation (JST); the Naito Foundation; and the Toray Science Foundation. H. H., T. T., A. S. and T. S. are supported by the Global Centers of Excellence Program of MEXT. T. T. and T. S. are supported by a Grant-in-Aid for Creative Scientific Research from MEXT.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Furuta T, 2002, NEUROSCIENCE, V114, P611, DOI 10.1016/S0306-4522(02)00312-3; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Inagaki S, 2001, J BIOL CHEM, V276, P9174, DOI 10.1074/jbc.M009051200; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kok K, 2009, TRENDS BIOCHEM SCI, V34, P115, DOI 10.1016/j.tibs.2009.01.003; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Martin LJ, 1998, BRAIN RES BULL, V46, P281, DOI 10.1016/S0361-9230(98)00024-0; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Nystuen A, 2001, NEURON, V32, P203, DOI 10.1016/S0896-6273(01)00468-8; Oda M, 2007, STROKE, V38, P2157, DOI 10.1161/STROKEAHA.106.477026; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sanchez AME, 2008, ARCH MED RES, V39, P265, DOI 10.1016/j.arcmed.2007.11.011; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; SASAKI T, 2009, J LIPID RES, V48, P307; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; Torashima T, 2006, EUR J NEUROSCI, V24, P371, DOI 10.1111/j.1460-9568.2006.04927.x; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhang S, 2008, J NEUROSCI, V28, P415, DOI 10.1523/JNEUROSCI.1900-07.2008	40	73	76	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 27	2010	465	7297					497	U127		10.1038/nature09023	http://dx.doi.org/10.1038/nature09023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20463662				2022-12-28	WOS:000278043700039
J	Patel, V; Prince, M				Patel, Vikram; Prince, Martin			Global Mental Health A New Global Health Field Comes of Age	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISORDERS		London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; Kings Hlth Partners, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London	Patel, V (corresponding author), Sangath Ctr, Alto Porvorim 403521, Goa, India.	vikram.patel@lshtm.ac.uk	Thornicroft, Graham/B-4027-2010; Prince, Martin J/A-9170-2010	Thornicroft, Graham/0000-0003-0662-0879; Prince, Martin J/0000-0003-1379-7146; Patel, Vikram/0000-0003-1066-8584	Wellcome Trust [091834] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; *GLOB MENT HLTH, MOV GLOB MENT HLTH; Kebede D, 2003, SOC PSYCH PSYCH EPID, V38, P625, DOI 10.1007/s00127-003-0678-4; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; WHO, 2001, WORLD HLTH REPORT 20	10	169	173	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1976	1977		10.1001/jama.2010.616	http://dx.doi.org/10.1001/jama.2010.616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483977	Green Accepted			2022-12-28	WOS:000277764500027
J	Piacentini, J; Woods, DW; Scahill, L; Wilhelm, S; Peterson, AL; Chang, S; Ginsburg, GS; Deckersbach, T; Dziura, J; Levi-Pearl, S; Walkup, JT				Piacentini, John; Woods, Douglas W.; Scahill, Lawrence; Wilhelm, Sabine; Peterson, Alan L.; Chang, Susanna; Ginsburg, Golda S.; Deckersbach, Thilo; Dziura, James; Levi-Pearl, Sue; Walkup, John T.			Behavior Therapy for Children With Tourette Disorder A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIC DISORDERS; HABIT REVERSAL; RISPERIDONE; SEVERITY; ADOLESCENTS; PREVALENCE; REDUCTION; PIMOZIDE; MODEL; SCALE	Context Tourette disorder is a chronic and typically impairing childhood-onset neurologic condition. Antipsychotic medications, the first-line treatments for moderate to severe tics, are often associated with adverse effects. Behavioral interventions, although promising, have not been evaluated in large-scale controlled trials. Objective To determine the efficacy of a comprehensive behavioral intervention for reducing tic severity in children and adolescents. Design, Setting, and Participants Randomized, observer-blind, controlled trial of 126 children recruited from December 2004 through May 2007 and aged 9 through 17 years, with impairing Tourette or chronic tic disorder as a primary diagnosis, randomly assigned to 8 sessions during 10 weeks of behavior therapy (n=61) or a control treatment consisting of supportive therapy and education (n=65). Responders received 3 monthly booster treatment sessions and were reassessed at 3 and 6 months following treatment. Intervention Comprehensive behavioral intervention. Main Outcome Measures Yale Global Tic Severity Scale (range 0-50, score >15 indicating clinically significant tics) and Clinical Global Impressions-Improvement Scale (range 1 [very much improved] to 8 [very much worse]). Results Behavioral intervention led to a significantly greater decrease on the Yale Global Tic Severity Scale (24.7 [95% confidence interval {CI}, 23.1-26.3] to 17.1 [95% CI, 15.1-19.1]) from baseline to end point compared with the control treatment (24.6 [95% CI, 23.2-26.0] to 21.1 [95% CI, 19.2-23.0]) (P<.001; difference between groups, 4.1; 95% CI, 2.0-6.2) (effect size=0.68). Significantly more children receiving behavioral intervention compared with those in the control group were rated as being very much improved or much improved on the Clinical Global Impressions-Improvement scale (52.5% vs 18.5%, respectively; P<.001; number needed to treat=3). Attrition was low (12/126, or 9.5%); tic worsening was reported by 4% of children (5/126). Treatment gains were durable, with 87% of available responders to behavior therapy exhibiting continued benefit 6 months following treatment. Conclusion A comprehensive behavioral intervention, compared with supportive therapy and education, resulted in greater improvement in symptom severity among children with Tourette and chronic tic disorder.	[Piacentini, John] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Woods, Douglas W.] Univ Wisconsin, Milwaukee, WI 53201 USA; [Scahill, Lawrence; Dziura, James] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Wilhelm, Sabine; Deckersbach, Thilo] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cambridge, MA 02138 USA; [Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Ginsburg, Golda S.; Walkup, John T.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Levi-Pearl, Sue] Tourette Syndrome Assoc, Bayside, NY USA	University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Milwaukee; Yale University; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; Johns Hopkins Medicine	Piacentini, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, 760 Westwood Plaza,Room 68-251, Los Angeles, CA 90024 USA.	jpiacentini@mednet.ucla.edu	Piacentini, John/C-4645-2011	Scahill, Lawrence/0000-0001-5073-1707	NIMH; Seaside Therapeutics; Shire Pharmaceuticals; National Institutes of Health (NIH); Janssen; Forest Research Institute; Shire Development Inc; Medtronic; Cyberonics; Northstar; Eli Lilly; JAZZ Pharmaceuticals; CMP Media; Medical Education Reviews; McMahon Group; DiMedix; Tourette Syndrome Association; National Institute of Mental Health [R01MH070802]; National Center for Research Resources, NIH [UL1 RR024139]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH080914, R01MH070802] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Seaside Therapeutics; Shire Pharmaceuticals; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Forest Research Institute; Shire Development Inc; Medtronic(Medtronic); Cyberonics; Northstar; Eli Lilly(Eli Lilly); JAZZ Pharmaceuticals(Jazz Pharmaceuticals); CMP Media; Medical Education Reviews; McMahon Group; DiMedix; Tourette Syndrome Association; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Drs Piacentini, Woods, Scahill, Wilhelm, Peterson, Chang, Ginsburg, Deckersbach, and Walkup report receiving royalties from Oxford University Press for treatment manuals on tic disorders. Drs Piacentini, Woods, Scahill, Wilhelm, Peterson, Chang, and Walkup report receiving honoraria for CME presentations from the Tourette Syndrome Association. Drs Piacentini, Woods, and Walkup receive royalties from Guilford Press for a book on Tourette disorder. Dr Piacentini reports receiving royalties from Oxford University Press for treatment manuals on child obsessive-compulsive disorder and APA Books for other books on child mental health, speaking honoraria from Janssen-Cilag, and support in the form of free medication and matching placebo from Pfizer for clinical trials funded by NIMH. Dr Woods reports receiving book royalties from New Harbinger and Springer Publications. Dr Scahill reports receiving royalties from Oxford University Press for a textbook on pediatric psychopharmacology; serving as a consultant for Janssen Pharmaceuticals, Bristol-Myers Squibb, Neuropharm, Supernus, and Shire Pharmaceuticals; receiving research support from Seaside Therapeutics and Shire Pharmaceuticals; and receiving support in the form of free medication and matching placebo from Janssen Pharmaceuticals and Shire Pharmaceuticals for clinical trials funded by NIMH. Dr Wilhelm reports receiving support in the form of free medication and matching placebo from Forest Laboratories for clinical trials funded by the National Institutes of Health (NIH) and receiving book royalties from Guilford Publications, New Harbinger Publications, and Oxford University Press and speaking honoraria from PRIMEDIA Healthcare, a publicly traded company working as a logistics collaborator for the MGH Psychiatry Academy (the education programs conducted by the MGH Psychiatry Academy were supported through Independent Medical Education grants from pharmaceutical companies cosupporting the overall program, along with participant tuition). Dr Deckersbach reports receiving consulting fees from the Constella Group for serving as a reviewer for the Congressionally Directed Medical Research Program. He also reports receiving honoraria, consulting fees, and/or royalties from Medacorp, MGH Psychiatry Academy, BrainCells Inc, Systems Research and Applications Corp, Boston University, the Catalan Agency for Health Technology Assessment and Research, and National Association of Social Workers-Massachusetts. He reports participating in research funded by Janssen, Forest Research Institute, Shire Development Inc, Medtronic, Cyberonics, and Northstar. Dr Walkup reports receiving consulting fees from Eli Lilly and JAZZ Pharmaceuticals and lecture fees from CMP Media, Medical Education Reviews, McMahon Group, DiMedix, and the Tourette Syndrome Association. He reports receiving free drug and matching placebo from Pfizer and Lilly and free drugs from Abbott for NIMH-funded clinical trials. He reports receiving fees for consultation with defense counsel and submission of written reports in litigation involving GlaxoSmithKline. No other disclosures relevant to this article were reported.; Funding/Support: This work was supported by grant R01MH070802 from the National Institute of Mental Health to Dr Piacentini, with subcontracts to Drs Woods, Scahill, Wilhelm, Peterson, and Walkup. Drs Scahill and Dziura receive support from the Yale University Clinical and Translational Sciences Award grant UL1 RR024139 from the National Center for Research Resources, NIH.	Allison PD, 2001, MISSING DATA U PAPER; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baym CL, 2008, BRAIN, V131, P165, DOI 10.1093/brain/awm278; BORENSTEIN M, 1997, POWER PRECISION; Brown H., 1999, APPL MIXED MODELS ME; BURD L, 1987, DEV MED CHILD NEUROL, V29, P831; CARPENTER J, 2008, MISSING DATA RANDOMI; Chang S, 2009, CHILD FAM BEHAV THER, V31, P181, DOI 10.1080/07317100903099100; Church JA, 2009, BRAIN, V132, P225, DOI 10.1093/brain/awn223; Conelea CA, 2008, J PSYCHOSOM RES, V65, P487, DOI 10.1016/j.jpsychores.2008.04.010; Cook CR, 2007, CLIN PSYCHOL-SCI PR, V14, P252, DOI 10.1111/j.1468-2850.2007.00085.x; EVERS RAF, 1994, J BEHAV THER EXP PSY, V25, P255, DOI 10.1016/0005-7916(94)90026-4; Gaffney GR, 2002, J AM ACAD CHILD PSY, V41, P330, DOI 10.1097/00004583-200203000-00013; Gilbert DL, 2005, J NEUROPSYCH CLIN N, V17, P324, DOI 10.1176/appi.neuropsych.17.3.324; Gilbert DL, 2004, J AM ACAD CHILD PSY, V43, P206, DOI 10.1097/00004583-200402000-00017; Goetz C., 2005, HDB TOURETTES SYNDRO, P411; Graybiel A, 2001, ADV NEUROLOGY TOURET, V99, P123; GUY W, 1970, CGI CLIN GLOBAL IMPR; Hanley GP, 2003, J APPL BEHAV ANAL, V36, P147, DOI 10.1901/jaba.2003.36-147; Himle MB, 2006, J CHILD NEUROL, V21, P719, DOI 10.1177/08830738060210080101; Jankovic J, 2010, J NEUROL NEUROSUR PS, V81, P70, DOI 10.1136/jnnp.2009.185348; Jankovic J, 2001, NEW ENGL J MED, V345, P1184, DOI 10.1056/NEJMra010032; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Khalifa N, 2003, DEV MED CHILD NEUROL, V45, P315, DOI 10.1017/S0012162203000598; Kushner Howard I., 1999, CURSING BRAIN HIST T; Leckman James F, 2006, Adv Neurol, V99, P1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LECKMAN JF, 1993, AM J PSYCHIAT, V150, P98; Marsh R, 2009, AM J PSYCHIAT, V166, P664, DOI 10.1176/appi.ajp.2009.08091354; McCracken JT, 2002, NEW ENGL J MED, V347, P314, DOI 10.1056/NEJMoa013171; MIGUEL EC, 1995, J CLIN PSYCHIAT, V56, P246; Mink Jonathan W, 2006, Adv Neurol, V99, P89; Pediatric O. C. D., 2004, JAMA-J AM MED ASSOC, V292, P1969, DOI DOI 10.1001/JAMA.292.16.1969; Peterson A. L., 2007, TREATING TOURETTE SY, P154; ROSS MS, 1978, AM J PSYCHIAT, V135, P585; Sallee FR, 2000, J AM ACAD CHILD PSY, V39, P292, DOI 10.1097/00004583-200003000-00010; Samsa G, 1999, PHARMACOECONOMICS, V15, P141, DOI 10.2165/00019053-199915020-00003; Scahill L, 2003, NEUROLOGY, V60, P1130, DOI 10.1212/01.WNL.0000055434.39968.67; Scahill L., 2009, Morbidity and Mortality Weekly Report, V58, P581; Scahill Lawrence, 2006, NeuroRx, V3, P192, DOI 10.1007/BF03207049; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Silverman W, 1996, ANXIETY DISORDERS IN; STEVENS JR, 1966, AM J DIS CHILD, V112, P541, DOI 10.1001/archpedi.1966.02090150085006; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Walkup JT, 2008, NEW ENGL J MED, V359, P2753, DOI 10.1056/NEJMoa0804633; Watson TS, 2005, BEHAV MODIF, V29, P839, DOI 10.1177/0145445505279252; Wilhelm S, 2003, AM J PSYCHIAT, V160, P1175, DOI 10.1176/appi.ajp.160.6.1175; WOODS DW, 2007, TREATING TOURETTE SY, P265; Woods DW, 2008, MANAGING TOURETTES S, DOI 10.1093/med:psych/9780195341294.001.0001	49	392	397	1	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1929	1937		10.1001/jama.2010.607	http://dx.doi.org/10.1001/jama.2010.607			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597NJ	20483969	Green Accepted, Bronze			2022-12-28	WOS:000277764500019
J	Carrier, M; Le Gal, G; Wells, PS; Rodger, MA				Carrier, Marc; Le Gal, Gregoire; Wells, Philip S.; Rodger, Marc A.			Systematic Review: Case-Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding Events Among Patients Treated for Venous Thromboembolism	ANNALS OF INTERNAL MEDICINE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; INTRAVENOUS UNFRACTIONATED HEPARIN; ORAL ANTICOAGULANT-THERAPY; LONG-TERM TREATMENT; ONCE-DAILY ENOXAPARIN; OUTPATIENT TREATMENT; PULMONARY-EMBOLISM; INITIAL TREATMENT; HOME TREATMENT	Background: Case-fatality rates are important for assessing the risks and benefits of anticoagulation in patients with venous thromboembolism (VTE). Purpose: To summarize case-fatality rates of recurrent VTE and major bleeding events during anticoagulation and recurrent VTE after anticoagulation. Data Sources: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials, and all evidence-based medicine reviews in the Ovid interface through the second quarter of 2008. Study Selection: 69 articles (13 prospective cohort studies and 56 randomized, controlled trials) that reported on patients with symptomatic VTE who received anticoagulation therapy for at least 3 months and on the rate of fatal recurrent VTE and fatal major bleeding. Data Extraction: Two reviewers independently extracted data onto standardized forms. Data Synthesis: During the initial 3 months of anticoagulation, the rate of recurrent fatal VTE was 0.4% (95% CI, 0.3% to 0.6%), with a case-fatality rate of 11.3% (CI, 8.0% to 15.2%). The rate of fatal major bleeding events was 0.2% (CI, 0.1% to 0.3%), with a case-fatality rate of 11.3% (CI, 7.5% to 15.9%). After anticoagulation, the rate of fatal recurrent VTE was 0.3 per 100 patient-years (CI, 0.1% to 0.4%), with a case-fatality rate of 3.6% (CI, 1.9% to 5.7%). Limitations: Estimates come from heterogeneous trial and cohort populations and are not derived from patient-level longitudinal data. Differences in case-fatality rates during and after anticoagulation may be attributable to unmeasured patient characteristics. Conclusion: The case-fatality rates of recurrent VTE and major bleeding events are similar during the initial period of VTE treatment. The case-fatality rate of recurrent VTE decreases after completion of the initial period of anticoagulation. When combined with absolute rates of recurrent VTE and major bleeding events, case-fatality rates provide clinicians with a surrogate measure of mortality to balance the risks and benefits of anticoagulant therapy in patients with VTE.	Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON, Canada; Brest Univ Hosp, Brest, France	University of Ottawa; Ottawa Hospital Research Institute; CHU Brest	Rodger, MA (corresponding author), Ottawa Hosp, Ottawa Hlth Res Inst, Inst Eye, Gen Campus,501 Smyth Rd,Room W6116, Ottawa, ON K1H 8L6, Canada.	mrodger@ohri.ca		LE GAL, Gregoire/0000-0002-9253-248X; Rodger, Marc/0000-0001-8166-3487	Canadian Institute for Health Research; Heart and Stroke Foundation of Ontario	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Grant Support: By a Canadian Institute for Health Research Randomized Controlled Trials Mentoring Program Award (Dr. Carrier) and a Career Scientist Award from the Heart and Stroke Foundation of Ontario (Dr. Rodger). Dr. Wells is a recipient of a Canada Research Chair.	Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; [Anonymous], 1991, Thromb Haemost, V65, P251; Beckman JA, 2003, THROMB HAEMOSTASIS, V89, P953, DOI 10.1055/s-0037-1613395; Beer JH, 2003, J THROMB HAEMOST, V1, P186, DOI 10.1046/j.1538-7836.2003.00005.x; Belcaro G, 1999, ANGIOLOGY, V50, P781; Bellosta R, 2007, ANGIOLOGY, V58, P316, DOI 10.1177/0003319707301757; Bishop B, 2006, J MANAGE CARE PHARM, V12, P70, DOI 10.18553/jmcp.2006.12.1.70; Boccalon H, 2000, ARCH INTERN MED, V160, P1769, DOI 10.1001/archinte.160.12.1769; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; BRATT G, 1990, THROMB HAEMOSTASIS, V64, P506; Breddin HK, 2001, NEW ENGL J MED, V344, P626, DOI 10.1056/NEJM200103013440902; Buller HR, 2007, NEW ENGL J MED, V357, P1105; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Campbell A, 2007, BMJ-BRIT MED J, V334, P674, DOI 10.1136/bmj.39098.583356.55; Charbonnier BA, 1998, THROMB HAEMOSTASIS, V79, P897; Chong BH, 2005, J THROMB THROMBOLYS, V19, P173, DOI 10.1007/s11239-005-1848-x; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; Daskalopoulos ME, 2005, EUR J VASC ENDOVASC, V29, P638, DOI 10.1016/j.ejvs.2004.02.029; de Llano LAP, 2003, ARCH BRONCONEUMOL, V39, P341; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Eriksson H, 2005, THROMB HAEMOSTASIS, V94, P522, DOI 10.1160/TH05-02-0096; Fiessinger JN, 1996, THROMB HAEMOSTASIS, V76, P195; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Findik S, 2002, RESPIRATION, V69, P440, DOI 10.1159/000064023; Girolami A, 2004, ARCH INTERN MED, V164, P1077; Gonzalez-Fajardo JA, 1999, J VASC SURG, V30, P283, DOI 10.1016/S0741-5214(99)70139-4; Grau E, 1998, HAEMATOLOGICA, V83, P438; Groce James B. III, 1998, Pharmacotherapy, V18, p175S; Harenberg J, 2000, THROMB HAEMOSTASIS, V83, P652; Harenberg J, 2006, EUR J CLIN PHARMACOL, V62, P173, DOI 10.1007/s00228-005-0076-9; Harrison L, 1998, ARCH INTERN MED, V158, P2001, DOI 10.1001/archinte.158.18.2001; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hull RD, 2000, ARCH INTERN MED, V160, P229, DOI 10.1001/archinte.160.2.229; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; Hull RD, 2007, AM J MED, V120, P72, DOI 10.1016/j.amjmed.2006.03.030; Kakkar VV, 2003, THROMB HAEMOSTASIS, V89, P674; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; Kirchmaier CM, 1998, INT ANGIOL, V17, P135; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Kovacs MJ, 2000, THROMB HAEMOSTASIS, V83, P209; Kovacs MJ, 2003, ANN INTERN MED, V138, P714, DOI 10.7326/0003-4819-138-9-200305060-00007; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Leroyer C, 1998, HAEMOSTASIS, V28, P70; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; LEVINE MN, 1992, CHEST, V102, pS364, DOI 10.1378/chest.102.4_Supplement.364S; LINDMARKER P, 1994, THROMB HAEMOSTASIS, V72, P186; Lindmarker P, 1996, J INTERN MED, V240, P395, DOI 10.1046/j.1365-2796.1996.81877000.x; Linkins LA, 2003, ANN INTERN MED, V139, P893, DOI 10.7326/0003-4819-139-11-200312020-00007; LOPACIUK S, 1992, THROMB HAEMOSTASIS, V68, P14; Lopaciuk S, 1999, THROMB HAEMOSTASIS, V81, P26; Merli G, 2001, ANN INTERN MED, V134, P191, DOI 10.7326/0003-4819-134-3-200102060-00009; Meyer G, 1995, THROMB HAEMOSTASIS, V74, P1432; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; MONREAL M, 1994, THROMB HAEMOSTASIS, V71, P7; O'Shaughnessy DF, 1998, J ACCID EMERG MED, V15, P292; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Prandoni P, 2007, HAEMATOLOGICA, V92, P199, DOI 10.3324/haematol.10516; Ramacciotti E, 2004, THROMB RES, V114, P149, DOI 10.1016/j.thromres.2004.05.009; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Riess H, 2003, THROMB HAEMOSTASIS, V90, P252, DOI 10.1160/TH02-09-0061; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; SIMONNEAU G, 1993, ARCH INTERN MED, V153, P1541, DOI 10.1001/archinte.153.13.1541; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Ting SBN, 1998, MED J AUSTRALIA, V168, P272, DOI 10.5694/j.1326-5377.1998.tb140160.x; Van Der Heijden J.F., 2002, COCHRANE DB SYST REV, pCD002001, DOI [10.1002/14651858.cd002001, DOI 10.1002/14651858.CD002001]; van Dongen CJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003074.pub2; Veiga F, 2000, THROMB HAEMOSTASIS, V84, P559; Wells G., NEWCASTLE OTTAWA SCA; Wells PS, 2005, ARCH INTERN MED, V165, P733, DOI 10.1001/archinte.165.7.733; Wells PS, 1998, ARCH INTERN MED, V158, P1809, DOI 10.1001/archinte.158.16.1809; Zidane M, 2006, HAEMATOLOGICA, V91, P1052	81	334	344	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					578	+		10.7326/0003-4819-152-9-201005040-00008	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00008			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439576				2022-12-28	WOS:000277604000005
J	Wohri, AB; Katona, G; Johansson, LC; Fritz, E; Malmerberg, E; Andersson, M; Vincent, J; Eklund, M; Cammarata, M; Wulff, M; Davidsson, J; Groenhof, G; Neutze, R				Wohri, Annemarie B.; Katona, Gergely; Johansson, Linda C.; Fritz, Emelie; Malmerberg, Erik; Andersson, Magnus; Vincent, Jonathan; Eklund, Mattias; Cammarata, Marco; Wulff, Michael; Davidsson, Jan; Groenhof, Gerrit; Neutze, Richard			Light-Induced Structural Changes in a Photosynthetic Reaction Center Caught by Laue Diffraction	SCIENCE			English	Article							TIME-RESOLVED CRYSTALLOGRAPHY; VIRIDIS REACTION CENTERS; RHODOPSEUDOMONAS-VIRIDIS; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSFER; SPECIAL PAIR; PROTEIN; CYTOCHROME; SPECTROSCOPY; TEMPERATURE		[Katona, Gergely; Johansson, Linda C.; Fritz, Emelie; Malmerberg, Erik; Neutze, Richard] Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden; [Wohri, Annemarie B.; Andersson, Magnus] Chalmers, Dept Biol & Chem Engn, SE-40530 Gothenburg, Sweden; [Vincent, Jonathan; Eklund, Mattias; Davidsson, Jan] Uppsala Univ, Dept Photochem & Mol Sci, SE-75120 Uppsala, Sweden; [Cammarata, Marco; Wulff, Michael] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Groenhof, Gerrit] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, Computat Biomol Chem Grp, D-37077 Gottingen, Germany	University of Gothenburg; Chalmers University of Technology; Uppsala University; European Synchrotron Radiation Facility (ESRF); Max Planck Society	Neutze, R (corresponding author), Univ Gothenburg, Dept Chem Biochem & Biophys, Box 462, SE-40530 Gothenburg, Sweden.	Richard.Neutze@chem.gu.se	Johansson, Linda/B-1240-2011; Neutze, Richard/A-7573-2010; Cammarata, Marco/C-2322-2008; Katona, Gergely/B-3491-2008; Malmerberg, Erik/A-1114-2010; Johansson, Linda/O-6893-2019; Vincent, Jonathan/HHY-9994-2022	Johansson, Linda/0000-0003-4776-5142; Neutze, Richard/0000-0003-0986-6153; Cammarata, Marco/0000-0003-3013-1186; Katona, Gergely/0000-0002-2031-8716; Johansson, Linda/0000-0003-4776-5142; Johansson, Linda/0000-0002-8931-0683; Groenhof, Gerrit/0000-0001-8148-5334; Andersson, Magnus/0000-0002-3364-6647	Swedish Science Research Council; European Commission; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP); University of Gothenburg	Swedish Science Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); University of Gothenburg	Refined crystallographic coordinates and structure factor amplitudes are deposited within the Protein Data Bank (PDB) with codes 2x5u (dark state) and 2x5v (photoactivated state). We thank L. Hammarstrom for valuable discussions and acknowledge financial support from the Swedish Science Research Council (Vetenskapsradet), European Commission [Research Training Network (RTN) "Fast light-actuated structural changes" (FLASH), and Integrated Project, the European Membrane Protein Consortium (EMEP)], European Molecular Biology Organization (EMBO), Human Frontier Science Program (HFSP), and the University of Gothenburg Quantitative Biology Platform.	Allen JF, 2007, NATURE, V445, P610, DOI 10.1038/445610a; Andresson U, 2003, PHOTOSYNTH RES, V75, P223, DOI 10.1023/A:1023944605460; BARRY BA, 1987, P NATL ACAD SCI USA, V84, P7099, DOI 10.1073/pnas.84.20.7099; Baxter RHG, 2004, P NATL ACAD SCI USA, V101, P5982, DOI 10.1073/pnas.0306840101; BUCHANAN S, 1992, BIOCHEMISTRY-US, V31, P1314, DOI 10.1021/bi00120a006; CARTLING B, 1992, CHEM PHYS LETT, V196, P128, DOI 10.1016/0009-2614(92)85941-3; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DOHSE B, 1995, BIOCHEMISTRY-US, V34, P11335, DOI 10.1021/bi00036a006; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Genick UK, 1997, SCIENCE, V275, P1471, DOI 10.1126/science.275.5305.1471; Gong XM, 2003, BIOCHEMISTRY-US, V42, P14492, DOI 10.1021/bi035603c; Hammarstrom L, 2008, PHILOS T R SOC B, V363, P1283, DOI 10.1098/rstb.2007.2225; Katona G, 2005, NAT STRUCT MOL BIOL, V12, P630, DOI 10.1038/nsmb948; LEONHARD M, 1993, BIOCHEMISTRY-US, V32, P4532, DOI 10.1021/bi00068a007; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; McMahon BH, 1998, BIOPHYS J, V74, P2567, DOI 10.1016/S0006-3495(98)77964-0; Narvaez AJ, 2004, BIOCHEMISTRY-US, V43, P14379, DOI 10.1021/bi048691p; Ohtsuka Y, 2001, J COMPUT CHEM, V22, P521, DOI 10.1002/1096-987X(20010415)22:5<521::AID-JCC1023>3.0.CO;2-J; Ortega JM, 1998, BIOPHYS J, V74, P1135, DOI 10.1016/S0006-3495(98)77831-2; PERMAN B, 1946, SCIENCE, V279, P1998; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; SEBBAN P, 1989, BIOCHIM BIOPHYS ACTA, V974, P54, DOI 10.1016/S0005-2728(89)80165-3; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; van Mourik F, 2001, BBA-BIOENERGETICS, V1504, P311, DOI 10.1016/S0005-2728(00)00259-0; WACHTVEITL J, 1993, BIOCHEMISTRY-US, V32, P10894, DOI 10.1021/bi00091a045; Wohri AB, 2009, BIOCHEMISTRY-US, V48, P9831, DOI 10.1021/bi900545e	28	76	77	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					630	633		10.1126/science.1186159	http://dx.doi.org/10.1126/science.1186159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431017	Green Published			2022-12-28	WOS:000277159800046
J	Zheludev, NI				Zheludev, Nikolay I.			The Road Ahead for Metamaterials	SCIENCE			English	Editorial Material									[Zheludev, Nikolay I.] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England; [Zheludev, Nikolay I.] Univ Southampton, Ctr Nanostruct Photon Metamat, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton	Zheludev, NI (corresponding author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	niz@orc.soton.ac.uk	Zheludev, Nikolay I/C-2284-2014; Metamaterials, Nanophotonics and/AAF-3156-2019; ZHELUDEV, Nikolay I./Z-1553-2019	Zheludev, Nikolay I/0000-0002-1013-6636; ZHELUDEV, Nikolay I./0000-0002-1013-6636	EPSRC [EP/G060363/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G060363/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Ahmadi A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045104; Dicken MJ, 2009, OPT EXPRESS, V17, P18330, DOI 10.1364/OE.17.018330; Driscoll T, 2009, SCIENCE, V325, P1518, DOI 10.1126/science.1176580; MacDonald KF, 2009, NAT PHOTONICS, V3, P55, DOI 10.1038/nphoton.2008.249; Nikolaenko AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.153902; Noginov MA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226806; *OPT SOC AM VID PO, MET NEXT PHOT REV; Padilla WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107401; Papasimakis N, 2010, OPT EXPRESS, V18, P8353, DOI 10.1364/OE.18.008353; Plum E, 2009, OPT EXPRESS, V17, P8548, DOI 10.1364/OE.17.008548; Ricci M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1996844; Samson ZL, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3355544; Temnov VV, 2010, NAT PHOTONICS, V4, P107, DOI 10.1038/NPHOTON.2009.265; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82	15	511	520	13	220	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					582	583		10.1126/science.1186756	http://dx.doi.org/10.1126/science.1186756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431006				2022-12-28	WOS:000277159800031
J	Sattur, AP; Goyal, M				Sattur, Atul P.; Goyal, Megha			Koilonychia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sattur, Atul P.; Goyal, Megha] Sri Dharamsthala Manjunatheswara Coll Dent Sci &, Dharwad, India		Sattur, AP (corresponding author), Sri Dharamsthala Manjunatheswara Coll Dent Sci &, Dharwad, India.	dratulomr@yahoo.com	Sattur, Atul/AAF-3158-2021	Sattur, Atul/0000-0003-3252-3773					0	3	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					E59	E59		10.1056/NEJMicm0910534	http://dx.doi.org/10.1056/NEJMicm0910534			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20427806				2022-12-28	WOS:000277117400011
J	Oren-Suissa, M; Hall, DH; Treinin, M; Shemer, G; Podbilewicz, B				Oren-Suissa, Meital; Hall, David H.; Treinin, Millet; Shemer, Gidi; Podbilewicz, Benjamin			The Fusogen EFF-1 Controls Sculpting of Mechanosensory Dendrites	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; HOMOTYPIC FUSION; NERVOUS-SYSTEM; GENE; CELL; EXPRESSION; RECEPTORS; MEMBRANES; REQUIRES	The mechanisms controlling the formation and maintenance of neuronal trees are poorly understood. We examined the dynamic development of two arborized mechanoreceptor neurons (PVDs) required for reception of strong mechanical stimuli in Caenorhabditis elegans. The PVDs elaborated dendritic trees comprising structural units we call "menorahs." We studied how the number, structure, and function of menorahs were maintained. EFF-1, an essential protein mediating cell fusion, acted autonomously in the PVDs to trim developing menorahs. eff-1 mutants displayed hyperbranched, disorganized menorahs. Overexpression of EFF-1 in the PVD reduced branching. Neuronal pruning appeared to involve EFF-1-dependent branch retraction and neurite-neurite autofusion. Thus, EFF-1 activities may act as a quality control mechanism during the sculpting of dendritic trees.	[Oren-Suissa, Meital; Shemer, Gidi; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Hall, David H.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Ctr C Elegans Anat, New York, NY 10461 USA; [Treinin, Millet] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Physiol, IL-91120 Jerusalem, Israel	Technion Israel Institute of Technology; Yeshiva University; Hebrew University of Jerusalem	Shemer, G (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	bishemer@email.unc.edu; podbilew@tx.technion.ac.il	Oren-Suissa, Meital/GXG-0736-2022; Podbilewicz, Benjamin/N-4825-2014	Oren-Suissa, Meital/0000-0001-9937-8326; Podbilewicz, Benjamin/0000-0002-0411-4182	Israel Science Foundation (ISF) [1542/07, 493/01-16.6]; NIH [RR12596]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER	Israel Science Foundation (ISF)(Israel Science Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank A. Fire for vectors; N. Assaf and T. Gattegno for eff-1 alleles; E. Shmukler for preliminary phenotypic characterization of the PVD in eff-1(hy21ts); T. Stiernagle and the CGC for nematode strains; J. White and J. Hodgkin for donation of the MRC/LMB archival prints to DHH; C. Crocker for TEM cartoon; and O. Avinoam, D. Cassel, M. Kozlov, A. Sapir, and I. Yanai for critically reading the manuscript. Supported by grants from the FIRST program of the Israel Science Foundation (ISF 1542/07 to B.P.), ISF 493/01-16.6 to M.T., and NIH RR12596 (WormImage Web site) to D.H.H.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen JH, 1999, BRAIN RES, V846, P243, DOI 10.1016/S0006-8993(99)01883-1; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Ghosh-Roy A, 2010, J NEUROSCI, V30, P3175, DOI 10.1523/JNEUROSCI.5464-09.2010; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Tobin DM, 2004, J NEUROBIOL, V61, P161, DOI 10.1002/neu.20082; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	17	108	111	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1285	1288		10.1126/science.1189095	http://dx.doi.org/10.1126/science.1189095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20448153	Green Accepted			2022-12-28	WOS:000278318600037
J	de Jager, J; Kooy, A; Lehert, P; Wulffele, MG; van der Kolk, J; Bets, D; Verburg, J; Donker, AJM; Stehouwer, CDA				de Jager, Jolien; Kooy, Adriaan; Lehert, Philippe; Wulffele, Michiel G.; van der Kolk, Jan; Bets, Daniel; Verburg, Joop; Donker, Ab J. M.; Stehouwer, Coen D. A.			Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SERUM CONCENTRATIONS; PLASMA HOMOCYSTEINE; INSULIN; DIAGNOSIS; COBALAMIN; FOLATE; MALABSORPTION; DISEASE	Objectives To study the effects of metformin on the incidence of vitamin B-12 deficiency (< 150 pmol/l), low concentrations of vitamin B-12 (150-220 pmol/l), and folate and homocysteine concentrations in patients with type 2 diabetes receiving treatment with insulin. Design Multicentre randomised placebo controlled trial. Setting Outpatient clinics of three non-academic hospitals in the Netherlands. Participants 390 patients with type 2 diabetes receiving treatment with insulin. Intervention 850 mg metformin or placebo three times a day for 4.3 years. Main outcome measures Percentage change in vitamin B-12, folate, and homocysteine concentrations from baseline at 4, 17, 30, 43, and 52 months. Results Compared with placebo, metformin treatment was associated with a mean decrease in vitamin B-12 concentration of -19% (95% confidence interval -24% to -14%; P<0.001) and in folate concentration of -5% (95% CI -10% to -0.4%; P=0.033), and an increase in homocysteine concentration of 5% (95% CI -1% to 11%; P=0.091). After adjustment for body mass index and smoking, no significant effect of metformin on folate concentrations was found. The absolute risk of vitamin B-12 deficiency (< 150 pmol/l) at study end was 7.2 percentage points higher in the metformin group than in the placebo group (95% CI 2.3 to 12.1; P=0.004), with a number needed to harm of 13.8 per 4.3 years (95% CI 43.5 to 8.3). The absolute risk of low vitamin B-12 concentration (150-220 pmol/l) at study end was 11.2 percentage points higher in the metformin group (95% CI 4.6 to 17.9; P=0.001), with a number needed to harm of 8.9 per 4.3 years (95% CI 21.7 to 5.6). Patients with vitamin B-12 deficiency at study end had a mean homocysteine level of 23.7 mu mol/l (95% CI 18.8 to 30.0 mu mol/l), compared with a mean homocysteine level of 18.1 mu mol/l (95% CI 16.7 to 19.6 mu mol/l; P=0.003) for patients with a low vitamin B-12 concentration and 14.9 mu mol/l (95% CI 14.3 to 15.5 mu mol/l; P<0.001 compared with vitamin B-12 deficiency; P=0.005 compared with low vitamin B-12) for patients with a normal vitamin B-12 concentration (>220 pmol/l). Conclusions Long term treatment with metformin increases the risk of vitamin B-12 deficiency, which results in raised homocysteine concentrations. Vitamin B-12 deficiency is preventable; therefore, our findings suggest that regular measurement of vitamin B-12 concentrations during long term metformin treatment should be strongly considered.	[Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [de Jager, Jolien] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, NL-1105 AZ Amsterdam, Netherlands; [Kooy, Adriaan; Wulffele, Michiel G.] Bethesda Gen Hosp, Dept Internal Med, Hoogeveen, Netherlands; [de Jager, Jolien; Kooy, Adriaan; Wulffele, Michiel G.] Bethesda Gen Hosp, Bethesda Diabet Res Ctr, Hoogeveen, Netherlands; [Lehert, Philippe] Fac Univ Catholiques Mons, Louvain Acad, Dept Stat, Fac Econ, Mons, Belgium; [van der Kolk, Jan; Verburg, Joop] Bethesda Gen Hosp, Clin Lab, Hoogeveen, Netherlands; [Bets, Daniel] Merck Netherlands, Clin Res & Dev, Amsterdam, Netherlands; [Donker, Ab J. M.] Free Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands	Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Mons; Merck & Company; Vrije Universiteit Amsterdam	Stehouwer, CDA (corresponding author), Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands.	cda.stehouwer@mumc.nl	Stehouwer, Coen/AAB-3435-2021	Stehouwer, Coen/0000-0001-8752-3223	Altana; Lifescan; Merck Sante; Merck Sharp Dohme; Novo Nordisk	Altana; Lifescan; Merck Sante; Merck Sharp Dohme(Merck & Company); Novo Nordisk(Novo Nordisk)	Hyperinsulinaemia: the Outcome of its Metabolic Effects (HOME) trial was supported by grants from Altana, Lifescan, Merck Sante, Merck Sharp & Dohme, and Novo Nordisk. The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.; Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and all authors want to declare: (1) Financial support for the submitted work from Merck Sharp & Dohme. All authors also declare: (2) No financial relationships with commercial entities that might have an interest in the submitted work; (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and (4) No non-financial interests that may be relevant to the submitted work.	ADAMS JF, 1983, DIABETOLOGIA, V24, P16, DOI 10.1007/BF00275941; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Carlsen SM, 1997, SCAND J CLIN LAB INV, V57, P521, DOI 10.3109/00365519709084603; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Derosa G, 2003, DIABETES RES CLIN PR, V60, P161, DOI 10.1016/S0168-8227(03)00057-3; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Hermann LS, 2001, DIABETES OBES METAB, V3, P428, DOI 10.1046/j.1463-1326.2001.00160.x; Herrmann W, 2008, DTSCH ARZTEBL INT, V105, P680, DOI 10.3238/arztebl.2008.0680; Hoogeveen EK, 1997, J INTERN MED, V242, P389, DOI 10.1046/j.1365-2796.1997.00231.x; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; Marks PW, 2004, NEW ENGL J MED, V351, P1333, DOI 10.1056/NEJMcpc040921; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; Pongchaidecha Manat, 2004, Journal of the Medical Association of Thailand, V87, P780; PYORALA K, 1987, Diabetes Metabolism Reviews, V3, P463; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Snow CF, 1999, ARCH INTERN MED, V159, P1289, DOI 10.1001/archinte.159.12.1289; STABLER SP, 1990, BLOOD, V76, P871; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TOMKIN GH, 1971, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5763.685; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Wulffele MG, 2003, J INTERN MED, V254, P455, DOI 10.1046/j.1365-2796.2003.01213.x; Wulffele MG, 2002, DIABETES CARE, V25, P2133, DOI 10.2337/diacare.25.12.2133	26	297	305	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2010	340								c2181	10.1136/bmj.c2181	http://dx.doi.org/10.1136/bmj.c2181			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LV	20488910	Green Published, hybrid			2022-12-28	WOS:000278061900001
J	Lourido, S; Shuman, J; Zhang, C; Shokat, KM; Hui, R; Sibley, LD				Lourido, Sebastian; Shuman, Joel; Zhang, Chao; Shokat, Kevan M.; Hui, Raymond; Sibley, L. David			Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma	NATURE			English	Article							HOST-CELLS; APICOMPLEXAN PARASITES; MICRONEME DISCHARGE; GONDII; INVASION; SECRETION; TRANSFORMATION; GENETICS; MOTILITY; REVEALS	Calcium-regulated exocytosis is a ubiquitous process in eukaryotes, whereby secretory vesicles fuse with the plasma membrane and release their contents in response to an intracellular calcium surge(1). This process regulates various cellular functions such as plasma membrane repair in plants and animals(2,3), the discharge of defensive spikes in Paramecium 4, and the secretion of insulin from pancreatic cells, immune modulators from lymphocytes, and chemical transmitters from neurons(5). In animal cells, serine/threonine kinases including cAMP-dependent protein kinase, protein kinase C and calmodulin kinases have been implicated in calcium-signal transduction leading to regulated secretion(1,6,7). Although plants and protozoa also regulate secretion by means of intracellular calcium, the method by which these signals are relayed has not been explained. Here we show that the Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) is an essential regulator of calcium-dependent exocytosis in this opportunistic human pathogen. Conditional suppression of TgCDPK1 revealed that it controls calcium-dependent secretion of specialized organelles called micronemes, resulting in a block of essential phenotypes including parasite motility, host-cell invasion, and egress. These phenotypes were recapitulated by using a chemical biology approach in which pyrazolopyrimidine-derived compounds specifically inhibited TgCDPK1 and disrupted the parasite's life cycle at stages dependent on microneme secretion. Inhibition was specific to TgCDPK1, because expression of a resistant mutant kinase reversed sensitivity to the inhibitor. TgCDPK1 is conserved among apicomplexans and belongs to a family of kinases shared with plants and ciliates(8), suggesting that related CDPKs may have a function in calcium-regulated secretion in other organisms. Because this kinase family is absent from mammalian hosts, it represents a validated target that may be exploitable for chemotherapy against T. gondii and related apicomplexans.	[Lourido, Sebastian; Shuman, Joel; Sibley, L. David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Toronto; Structural Genomics Consortium	Sibley, LD (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu		Lourido, Sebastian/0000-0002-5237-1095	American Heart Association; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034036] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank O. Billker, G. Ward, S. Moreno and V. Carruthers for discussions; F. Dzierszinski for the DsRed plasmid; D. Soldati for the Tet-transactivator system; and K. Tang for technical assistance. This work was supported by a predoctoral fellowship from the American Heart Association (S. L.) and a grant from the National Institutes of Health (L. D. S.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Choi WS, 2002, ANN NY ACAD SCI, V968, P198, DOI 10.1111/j.1749-6632.2002.tb04336.x; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Easom RA, 1999, DIABETES, V48, P675, DOI 10.2337/diabetes.48.4.675; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; ROOS DS, 1994, METHOD CELL BIOL, V45, P28; Schapire AL, 2009, TRENDS PLANT SCI, V14, P645, DOI 10.1016/j.tplants.2009.09.004; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Starnes GL, 2009, CELL HOST MICROBE, V5, P353, DOI 10.1016/j.chom.2009.03.005; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; Vayssie L, 2000, BIOCHIMIE, V82, P269, DOI 10.1016/S0300-9084(00)00201-7; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	33	250	264	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					359	U118		10.1038/nature09022	http://dx.doi.org/10.1038/nature09022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485436	Green Accepted, Green Submitted			2022-12-28	WOS:000277829200043
J	Hartley, J; Harnden, A; Kelly, D				Hartley, Jane; Harnden, Anthony; Kelly, Deirdre			Easily Missed? Biliary atresia	BRITISH MEDICAL JOURNAL			English	Editorial Material							KASAI OPERATION; MANAGEMENT; JAUNDICE		[Hartley, Jane; Kelly, Deirdre] Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; [Harnden, Anthony] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Birmingham; University of Oxford	Hartley, J (corresponding author), Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England.	Jane.Hartley@bch.nhs.uk						Crofts DJ, 1999, ACTA PAEDIATR, V88, P969, DOI 10.1080/08035259950168478; Davenport M, 2004, J PEDIATR SURG, V39, P575, DOI 10.1016/j.jpedsurg.2003.12.014; Davenport M, 2004, LANCET, V363, P1354, DOI 10.1016/S0140-6736(04)16045-5; Davenport M, 2006, J PEDIATR-US, V149, P393, DOI 10.1016/j.jpeds.2006.05.030; Hannam S, 2000, ACTA PAEDIATR, V89, P694, DOI 10.1080/080352500750044025; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; LAWRENCE M, 2001, J PERINATOLOGY, V21, pS25; Livesey E, 2009, ARCH DIS CHILD-FETAL, V94, pF451, DOI 10.1136/adc.2009.159780; McKiernan PJ, 2009, J PEDIATR GASTR NUTR, V48, P78, DOI 10.1097/MPG.0b013e31817d80de; National Institute for Health and Clinical Excellence, 2010, CLIN GUID NAT I HLTH, V98; Serinet MO, 2009, PEDIATRICS, V123, P1280, DOI 10.1542/peds.2008-1949; Shinkai M, 2009, J PEDIATR GASTR NUTR, V48, P443, DOI 10.1097/MPG.0b013e318189f2d5	12	25	27	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 19	2010	340								c2383	10.1136/bmj.c2383	http://dx.doi.org/10.1136/bmj.c2383			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484362				2022-12-28	WOS:000278061800003
J	Rodriguez, I				Rodriguez, Ivan			The chemical MUPpeteer	CELL			English	Editorial Material							BEHAVIOR; PHEROMONES; RECEPTORS; PROTEINS; FAMILIES		Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Geneva, Switzerland	University of Geneva	Rodriguez, I (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Geneva, Switzerland.	ivan.rodriguez@unige.ch		rodriguez, ivan/0000-0002-6468-0565				Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Fendt M, 2006, J CHEM ECOL, V32, P2617, DOI 10.1007/s10886-006-9186-9; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; 2009, P NATL ACAD SCI US, V106, P9842	9	2	2	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					568	570		10.1016/j.cell.2010.04.032	http://dx.doi.org/10.1016/j.cell.2010.04.032			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478249	Bronze			2022-12-28	WOS:000277623600009
J	Russell, DG; Barry, CE; Flynn, JL				Russell, David G.; Barry, Clifton E., III; Flynn, JoAnne L.			Tuberculosis: What We Don't Know Can, and Does, Hurt Us	SCIENCE			English	Review							MYCOBACTERIUM-BOVIS BCG; CHRONIC MURINE TUBERCULOSIS; BACILLE CALMETTE-GUERIN; NECROSIS-FACTOR-ALPHA; ENVIRONMENTAL MYCOBACTERIA; PROTECTIVE IMMUNITY; METHYLCITRATE CYCLE; VACCINE DEVELOPMENT; INFECTED PATIENTS; TB VACCINE	Mycobacterium tuberculosis has a penetrance of its host population that would be the envy of most human pathogens. About one-third of the human population would have a positive skin test for the infection and is thus thought to harbor the bacterium. Globally, 22 "high-burden" countries account for more than 80% of the active tuberculosis cases in the world, which shows the inequitable distribution of the disease. There is no effective vaccine against infection, and current drug therapies are fraught with problems, predominantly because of the protracted nature of the treatment and the increasing occurrence of drug resistance. Here we focus on the biology of the host-pathogen interaction and discuss new and evolving strategies for intervention.	[Russell, David G.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019; Flynn, JoAnne/ABC-7371-2020; Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	NIH [AI067027, AI057086, AI080651, HL055936, HL100928, AI50732, HL71241, HL092883, HL075845]; NIAID, NIH; Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL092883, R01HL055936, R01HL100928, R01HL071241, R01HL075845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050732, ZIAAI000783, R01AI037859, ZIAAI000734, R01AI067027, R01AI057086, R01AI080651] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the authors' laboratories is supported by NIH grants AI067027, AI057086, AI080651, HL055936, and HL100928 (D. G. R.) and AI50732, HL71241, HL092883, and HL075845 (J.L.F.) and by the Intramural Research Program of the NIAID, NIH (C. E. B.). All three authors receive support from the Bill and Melinda Gates Foundation.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; de Noronha ALL, 2008, PATHOL RES PRACT, V204, P155, DOI 10.1016/j.prp.2007.10.008; Demangel C, 2005, INFECT IMMUN, V73, P2190, DOI 10.1128/IAI.73.4.2190-2196.2005; Dietrich J, 2009, APMIS, V117, P440, DOI 10.1111/j.1600-0463.2009.02458.x; Doenhoff MJ, 1998, IMMUNOL TODAY, V19, P462, DOI 10.1016/S0167-5699(98)01310-3; Doherty M, 2009, CURR OPIN PULM MED, V15, P181, DOI 10.1097/MCP.0b013e328326f42c; Doherty TM, 2009, CLIN CHEST MED, V30, P783, DOI 10.1016/j.ccm.2009.08.008; Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Horwitz MA, 2005, MICROBES INFECT, V7, P947, DOI 10.1016/j.micinf.2005.04.002; Jones KDJ, 2008, T ROY SOC TROP MED H, V102, P219, DOI 10.1016/j.trstmh.2007.11.014; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Ledru E, 1999, IMMUNOL TODAY, V20, P336, DOI 10.1016/S0167-5699(98)01436-4; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Lozes E, 1997, SCAND J IMMUNOL, V46, P16, DOI 10.1046/j.1365-3083.1997.d01-99.x; Ly LH, 2009, INDIAN J EXP BIOL, V47, P432; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Manabe YC, 2008, TUBERCULOSIS, V88, P187, DOI 10.1016/j.tube.2007.10.006; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nathan C, 2006, SCIENCE, V312, P1874; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Plessner HL, 2007, J INFECT DIS, V195, P1643, DOI 10.1086/517519; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; Tchilian EZ, 2009, INFECT IMMUN, V77, P622, DOI 10.1128/IAI.00685-08; Tsenova L, 1999, P NATL ACAD SCI USA, V96, P5657, DOI 10.1073/pnas.96.10.5657; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Verma I, 2009, EXPERT REV VACCINES, V8, P1547, DOI [10.1586/erv.09.111, 10.1586/ERV.09.111]; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Whelan KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005934; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009; Yang XX, 2009, BIOCHEMISTRY-US, V48, P3819, DOI 10.1021/bi9005418	61	368	388	0	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					852	856		10.1126/science.1184784	http://dx.doi.org/10.1126/science.1184784			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466922	Green Accepted			2022-12-28	WOS:000277618800038
J	Hagn, F; Eisoldt, L; Hardy, JG; Vendrely, C; Coles, M; Scheibel, T; Kessler, H				Hagn, Franz; Eisoldt, Lukas; Hardy, John G.; Vendrely, Charlotte; Coles, Murray; Scheibel, Thomas; Kessler, Horst			A conserved spider silk domain acts as a molecular switch that controls fibre assembly	NATURE			English	Article							TERMINAL DOMAIN; EXCHANGE-RATES; PROTEIN; DRAGLINE; ASSIGNMENT; STABILITY; MECHANISM; SEQUENCE; SHIFT	A huge variety of proteins are able to form fibrillar structures(1), especially at high protein concentrations. Hence, it is surprising that spider silk proteins can be stored in a soluble form at high concentrations and transformed into extremely stable fibres on demand(2,3). Silk proteins are reminiscent of amphiphilic block copolymers containing stretches of polyalanine and glycine-rich polar elements forming a repetitive core flanked by highly conserved non-repetitive amino-terminal(4,5) and carboxy-terminal(6) domains. The N-terminal domain comprises a secretion signal, but further functions remain unassigned. The C-terminal domain was implicated in the control of solubility and fibre formation(7) initiated by changes in ionic composition(8,9) and mechanical stimuli known to align the repetitive sequence elements and promote beta-sheet formation(10-14). However, despite recent structural data(15), little is known about this remarkable behaviour in molecular detail. Here we present the solution structure of the C-terminal domain of a spider dragline silk protein and provide evidence that the structural state of this domain is essential for controlled switching between the storage and assembly forms of silk proteins. In addition, the C-terminal domain also has a role in the alignment of secondary structural features formed by the repetitive elements in the backbone of spider silk proteins, which is known to be important for the mechanical properties of the fibre.	[Hagn, Franz; Kessler, Horst] Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-85747 Garching, Germany; [Hagn, Franz; Kessler, Horst] Tech Univ Munich, Inst Adv Study, D-85747 Garching, Germany; [Eisoldt, Lukas; Hardy, John G.; Vendrely, Charlotte; Scheibel, Thomas] Univ Bayreuth, Fak Angew Nat Wissensch, Lehrstuhl Biomat, D-95440 Bayreuth, Germany; [Coles, Murray] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany	Technical University of Munich; Technical University of Munich; University of Bayreuth; Max Planck Society	Kessler, H (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci CIPSM, D-85747 Garching, Germany.	thomas.scheibel@uni-bayreuth.de; horst.kessler@ch.tum.de	Hardy, John George/D-1501-2009; Scheibel, Thomas/I-1170-2014; Hagn, Franz X/N-9553-2016	Hardy, John George/0000-0003-0655-2167; Scheibel, Thomas/0000-0002-0457-2423; Hagn, Franz X/0000-0002-1315-459X	Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>); Deutsche Forschungsgemeinschaft [SCHE 603/4-3]; Elitenetzwerk Bayern, CompInt; Alexander von Humboldt Foundation	Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern, CompInt; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This paper is in memoriam of R. Rudolph who triggered spider silk research in the lab of T. S. We want to thank D. Hummerich and J. Exler for initial work on the project, S. Quedzuweit for sample preparation in early stages of the project, M. Heim and M. Suhre for cloning work, and H. Krause for mass spectrometry. This work was supported by the Center for Integrated Protein Science Munich (CIPS<SUP>M</SUP>) (to H. K. and T. S.) and the Deutsche Forschungsgemeinschaft SCHE 603/4-3 (to T. S.). F. H. was supported by the Elitenetzwerk Bayern, CompInt. J. G. H. was supported by the Alexander von Humboldt Foundation.	BROWM JC, 1995, INT ARCH ALLERGY IMM, V107, P484, DOI 10.1159/000237090; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Diercks T, 1999, J BIOMOL NMR, V15, P177, DOI 10.1023/A:1008367912535; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Exler JH, 2007, ANGEW CHEM INT EDIT, V46, P3559, DOI 10.1002/anie.200604718; GEMMECKER G, 1993, J AM CHEM SOC, V115, P11620, DOI 10.1021/ja00077a080; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; KOIDE S, 1995, J BIOMOL NMR, V6, P306; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavinder JJ, 2009, J AM CHEM SOC, V131, P3794, DOI 10.1021/ja8049063; LEES JF, 1994, J BIOL CHEM, V269, P24354; Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; PRIVALOV PL, 1979, ADV PROTEIN CHEM, V167, P241; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048; Truffault V, 2001, J MOL BIOL, V309, P949, DOI 10.1006/jmbi.2001.4683; Vezy C, 2009, BIOINTERPHASES, V4, P43, DOI 10.1116/1.3174930; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	36	300	315	6	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					239	U131		10.1038/nature08936	http://dx.doi.org/10.1038/nature08936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463741	Green Accepted			2022-12-28	WOS:000277558500040
J	Lester, H; Schmittdiel, J; Selby, J; Fireman, B; Campbell, S; Lee, J; Whippy, A; Madvig, P				Lester, Helen; Schmittdiel, Julie; Selby, Joe; Fireman, Bruce; Campbell, Stephen; Lee, Janelle; Whippy, Alan; Madvig, Philip			The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; HEALTH-CARE; PAY; PERFORMANCE	Objective To evaluate the effect of financial incentives on four clinical quality indicators common to pay for performance plans in the United Kingdom and at Kaiser Permanente in California. Design Longitudinal analysis. Setting 35 medical facilities of Kaiser Permanente Northern California, 1997-2007. Participants 2 523 659 adult members of Kaiser Permanente Northern California. Main outcomes measures Yearly assessment of patient level glycaemic control (HbA(1c) <8%), screening for diabetic retinopathy, control of hypertension (systolic blood pressure <140 mm Hg), and screening for cervical cancer. Results Incentives for two indicators-screening for diabetic retinopathy and for cervical cancer-were removed during the study period. During the five consecutive years when financial incentives were attached to screening for diabetic retinopathy (1999-2003), the rate rose from 84.9% to 88.1%. This was followed by four years without incentives when the rate fell year on year to 80.5%. During the two initial years when financial incentives were attached to cervical cancer screening (1999-2000), the screening rate rose slightly, from 77.4% to 78.0%. During the next five years when financial incentives were removed, screening rates fell year on year to 74.3%. Incentives were then reattached for two years (2006-7) and screening rates began to increase. Across the 35 facilities, the removal of incentives was associated with a decrease in performance of about 3% per year on average for screening for diabetic retinopathy and about 1.6% per year for cervical cancer screening. Conclusion Policy makers and clinicians should be aware that removing facility directed financial incentives from clinical indicators may mean that performance levels decline.	[Lester, Helen] NIHR Sch Primary Care Res, Manchester M13 9PL, Lancs, England; [Schmittdiel, Julie; Selby, Joe; Fireman, Bruce; Lee, Janelle] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Campbell, Stephen] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Whippy, Alan] Permanente Med Grp Inc, Qual & Operat Support, Oakland, CA USA; [Madvig, Philip] Permanente Med Grp Inc, Oakland, CA USA	University of Manchester; Kaiser Permanente; University of Manchester; Permanente Medical Groups; Permanente Medical Groups	Lester, H (corresponding author), NIHR Sch Primary Care Res, Manchester M13 9PL, Lancs, England.	Helen.lester@manchester.ac.uk		Campbell, Stephen/0000-0002-2328-4136				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Deci E., 1975, INTRINSIC MOTIVATION; *DEP HLTH, 2008, DEV QUAL OUTC FRAM P; Department of Health (2009e), 2009, DEV QUAL OUTC FRAM P; Ferlie EB, 2001, MILBANK Q, V79, P281, DOI 10.1111/1468-0009.00206; Gagne M, 2005, J ORGAN BEHAV, V26, P331, DOI 10.1002/job.322; Ganz DA, 2007, MED CARE, V45, P8, DOI 10.1097/01.mlr.0000241115.31531.15; LEATHERMAN S, 2003, QUEST QUALITY NHS; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schmittdiel J, 2008, J GEN INTERN MED, V23, P77, DOI 10.1007/s11606-007-0452-5	14	81	84	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2010	340								c1898	10.1136/bmj.c1898	http://dx.doi.org/10.1136/bmj.c1898			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598HO	20460330	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000277826200004
J	Atkin, WS; Edwards, R; Kralj-Hans, I; Wooldrage, K; Hart, AR; Northover, JMA; Parkin, DM; Wardle, J; Duffy, SW; Cuzick, J				Atkin, Wendy S.; Edwards, Rob; Kralj-Hans, Ines; Wooldrage, Kate; Hart, Andrew R.; Northover, John M. A.; Parkin, D. Max; Wardle, Jane; Duffy, Stephen W.; Cuzick, Jack		UK Flexible Sigmoidoscopy Trial	Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial	LANCET			English	Article							BASE-LINE FINDINGS; ASYMPTOMATIC ADULTS; UNITED-KINGDOM; FOLLOW-UP; RISK; NEOPLASIA; COLONOSCOPY; DEATH	Background Colorectal cancer is the third most common cancer worldwide and has a high mortality rate. We tested the hypothesis that only one flexible sigmoidoscopy screening between 55 and 64 years of age can substantially reduce colorectal cancer incidence and mortality. Methods This randomised controlled trial was undertaken in 14 UK centres. 170 432 eligible men and women, who had indicated on a previous questionnaire that they would accept an invitation for screening, were randomly allocated to the intervention group (offered flexible sigmoidoscopy screening) or the control group (not contacted). Randomisation by sequential number generation was done centrally in blocks of 12, with stratification by trial centre, general practice, and household type. The primary outcomes were the incidence of colorectal cancer, including prevalent cases detected at screening, and mortality from colorectal cancer. Analyses were intention to treat and per protocol. The trial is registered, number ISRCTN28352761. Findings 113 195 people were assigned to the control group and 57 237 to the intervention group, of whom 112 939 and 57099, respectively, were included in the final analyses. 40 674 (71%) people underwent flexible sigmoidoscopy. During screening and median follow-up of 11.2 years (IQR 10.7-11.9), 2524 participants were diagnosed with colorectal cancer (1818 in control group vs 706 in intervention group) and 20 543 died (13 768 vs 6775; 727 certified from colorectal cancer [538 vs 189]). In intention-to-treat analyses, colorectal cancer incidence in the intervention group was reduced by 23% (hazard ratio 0.77, 95% CI 0 70-0.84) and mortality by 31% (0.69, 0.59-0.82). In perprotocol analyses, adjusting for self-selection bias in the intervention group, incidence of colorectal cancer in people attending screening was reduced by 33% (0.67, 0.60-0.76) and mortality by 43% (0.57, 0.45-0.72). Incidence of distal colorectal cancer (rectum and sigmoid colon) was reduced by 50% (0.50, 0.42-0.59; secondary outcome). The numbers needed to be screened to prevent one colorectal cancer diagnosis or death, by the end of the study period, were 191 (95% CI 145-277) and 489 (343-852), respectively. Interpretation Flexible sigmoidoscopy is a safe and practical test and, when offered only once between ages 55 and 64 years, confers a substantial and longlasting benefit.	[Atkin, Wendy S.; Kralj-Hans, Ines; Wooldrage, Kate] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W2 1PG, England; [Edwards, Rob; Duffy, Stephen W.; Cuzick, Jack] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, London, England; [Hart, Andrew R.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Northover, John M. A.] St Marks Hosp, Dept Surg, Harrow, Middx, England; [Parkin, D. Max] Univ Oxford, Clin Trials Serv Unit, Oxford, England; [Parkin, D. Max] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Wardle, Jane] UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, London, England	Imperial College London; Cancer Research UK; University of London; Queen Mary University London; University of East Anglia; Imperial College London; University of Oxford; University of Oxford; University of London; University College London	Atkin, WS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, St Marys Campus,Norfolk Pl, London W2 1PG, England.	w.atkin@imperial.ac.uk		Brewster, David/0000-0002-5346-5608; Wooldrage, Kate/0000-0001-8209-3113; Kralj-Hans, Ines/0000-0001-7401-6281; Quirke, Philip/0000-0002-3597-5444; Mayberry, John/0000-0002-4117-8740; Atkin, Wendy/0000-0001-9073-9658	Medical Research Council; National Health Service RD; Cancer Research UK; KeyMed; MRC [G9615910] Funding Source: UKRI; Medical Research Council [G9615910] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health Service RD; Cancer Research UK(Cancer Research UK); KeyMed; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This trial is funded by the Medical Research Council, National Health Service R&D, Cancer Research UK, and KeyMed. We thank the general practitioners, hospital staff, and the men and women who took part in this study	Atkin W, 2004, GASTROENTEROLOGY, V126, P1247, DOI 10.1053/j.gastro.2004.01.023; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2001, J MED SCREEN, V8, P137, DOI 10.1136/jms.8.3.137; Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Benson VS, 2008, INT J CANCER, V122, P1357, DOI 10.1002/ijc.23273; Brotherstone H, 2007, J MED SCREEN, V14, P76, DOI 10.1258/096914107781261972; Cancer Research UK, 2009, STAG DIAGN; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Cuzick J, 2007, J MED SCREEN, V14, P178, DOI 10.1258/096914107782912059; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Miles A, 2003, CANCER EPIDEM BIOMAR, V12, P651; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; *NHS CANC SCREEN P, 2010, NHS BCSP PUBL, V6; *NHS CANC SCREEN P, ACCR SCREEN COL 2009; *OFF NAT STAT, 2005, ENGL SER MBI, V34; Pinsky PF, 2005, CLIN GASTROENTEROL H, V3, P792, DOI 10.1053/S1542-3565(05)00286-7; Robinson MH, 2000, J MED SCREEN, V7, P97, DOI 10.1136/jms.7.2.97; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Schoenfeld P, 1999, GASTROENTEROLOGY, V117, P312, DOI 10.1053/gast.1999.0029900312; Schoenfeld PS, 1999, GASTROINTEST ENDOSC, V49, P158, DOI 10.1016/S0016-5107(99)70480-3; Segnan N, 2002, J NATL CANCER I, V94, P1763; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Tabar L, 2004, J MED SCREEN, V11, P126, DOI 10.1258/0969141041732175; Tappenden P, 2007, GUT, V56, P677, DOI 10.1136/gut.2006.095109; Tappenden P, 2009, INT J TECHNOL ASSESS, V25, P470, DOI 10.1017/S0266462309990407; Taylor T, 2000, J MED SCREEN, V7, P38, DOI 10.1136/jms.7.1.38; Wardle J, 2003, HEALTH PSYCHOL, V22, P54, DOI 10.1037/0278-6133.22.1.54; Weissfeld JL, 2005, JNCI-J NATL CANCER I, V97, P989, DOI 10.1093/jnci/dji175; *WHO, 2009, 297 WHO	38	1193	1227	1	102	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1624	1633		10.1016/S0140-6736(10)60551-X	http://dx.doi.org/10.1016/S0140-6736(10)60551-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20430429	Bronze			2022-12-28	WOS:000277734700028
J	Dejnirattisai, W; Jumnainsong, A; Onsirisakul, N; Fitton, P; Vasanawathana, S; Limpitikul, W; Puttikhunt, C; Edwards, C; Duangchinda, T; Supasa, S; Chawansuntati, K; Malasit, P; Mongkolsapaya, J; Screaton, G				Dejnirattisai, Wanwisa; Jumnainsong, Amonrat; Onsirisakul, Naruthai; Fitton, Patricia; Vasanawathana, Sirijitt; Limpitikul, Wannee; Puttikhunt, Chunya; Edwards, Carolyn; Duangchinda, Thaneeya; Supasa, Sunpetchuda; Chawansuntati, Kriangkrai; Malasit, Prida; Mongkolsapaya, Juthathip; Screaton, Gavin			Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans	SCIENCE			English	Article							CONSERVED RESIDUES; ENVELOPE PROTEIN; FUSION-LOOP; MATURATION; FLAVIVIRUSES; VIRIONS; CELLS; CUBA	Dengue virus co-circulates as four serotypes, and sequential infections with more than one serotype are common. One hypothesis for the increased severity seen in secondary infections is antibody-dependent enhancement (ADE) leading to increased replication in Fc receptor-bearing cells. In this study, we have generated a panel of human monoclonal antibodies to dengue virus. Antibodies to the structural precursor-membrane protein (prM) form a major component of the response. These antibodies are highly cross-reactive among the dengue virus serotypes and, even at high concentrations, do not neutralize infection but potently promote ADE. We propose that the partial cleavage of prM from the viral surface reduces the density of antigen available for viral neutralization, leaving dengue viruses susceptible to ADE by antibody to prM, a finding that has implications for future vaccine design.	[Dejnirattisai, Wanwisa; Jumnainsong, Amonrat; Onsirisakul, Naruthai; Fitton, Patricia; Edwards, Carolyn; Chawansuntati, Kriangkrai; Mongkolsapaya, Juthathip; Screaton, Gavin] Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England; [Onsirisakul, Naruthai] Mahidol Univ, Fac Med Technol, Bangkok 10700, Thailand; [Vasanawathana, Sirijitt] Khon Kaen Hosp, Dept Pediat, Khon Kaen 4000, Thailand; [Limpitikul, Wannee] Songkhla Hosp, Dept Pediat, Songkhla 90100, Thailand; [Puttikhunt, Chunya; Duangchinda, Thaneeya; Malasit, Prida] NSTDA, BIOTEC, Phatumthani 12120, Thailand; [Supasa, Sunpetchuda; Malasit, Prida; Mongkolsapaya, Juthathip] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand	Imperial College London; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Screaton, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, London W12 0NN, England.	j.mongkolsapaya@imperial.ac.uk; g.screaton@imperial.ac.uk	Puttikhunt, Chunya/E-1030-2011	Screaton, Gavin/0000-0002-3549-4309	Medical Research Council, UK; Wellcome Trust, UK; National Institute for Health Research Biomedical Research Centre; Thailand Tropical Disease Research Program T2; Thailand National Centre for Genetic Engineering and Biotechnology; MRC [G0400720, G0600000, G0801508] Funding Source: UKRI; Medical Research Council [G0600000] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Thailand Tropical Disease Research Program T2; Thailand National Centre for Genetic Engineering and Biotechnology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank W. Supanchaimat, V. Jarupoonphol, S. Jinathongthai, K. Sriruksa, P. Wongsilarat, T. Suphachaiyakit, K. Ratarpa, Y. Sutvigit, and the staff of Khon Kaen and Songkhla hospitals for sample collection; L. Damrikarnlerd, P. Suriyapol, C. Komoltri, S. Udompunturak, N. Tangthawornchaikul, A. Jairangsri, K. Sae-Jang, and S. Supajitkasem for data and clinical database management and statistical analysis; N. Sittisombut and P. Keelapang from Chiang Mai University for sharing knowledge; and C. P. Simmons and B. Wills from the Oxford University Clinical Research Unit, Ho Chi Minh City for samples. This work was supported by the Medical Research Council, UK; the Wellcome Trust, UK; the National Institute for Health Research Biomedical Research Centre funding scheme; the Thailand Tropical Disease Research Program T2; and the Thailand National Centre for Genetic Engineering and Biotechnology.	Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323; Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; *WHO, 2008, 117 WHO; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	17	618	658	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					745	748		10.1126/science.1185181	http://dx.doi.org/10.1126/science.1185181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448183	Green Accepted			2022-12-28	WOS:000277357100038
J	Lee, SWS; Schwarz, N				Lee, Spike W. S.; Schwarz, Norbert			Washing Away Postdecisional Dissonance	SCIENCE			English	Article									[Lee, Spike W. S.; Schwarz, Norbert] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lee, SWS (corresponding author), Univ Michigan, Dept Psychol, 580 Union Dr, Ann Arbor, MI 48109 USA.	spikelee@umich.edu	Schwarz, Norbert/B-3591-2008; Lee, Spike W. S./U-8606-2019	Schwarz, Norbert/0000-0002-8868-7067; Lee, Spike W. S./0000-0002-3357-0179				Cooper J., 2007, COGNITIVE DISSONANCE, P1; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Kitayama S, 2004, PSYCHOL SCI, V15, P527, DOI 10.1111/j.0956-7976.2004.00714.x; Lakoff G., 1999, PHILOS FLESH; Schnall S, 2008, PSYCHOL SCI, V19, P1219, DOI 10.1111/j.1467-9280.2008.02227.x; Zhong CB, 2006, SCIENCE, V313, P1451, DOI 10.1126/science.1130726	6	95	103	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					709	709		10.1126/science.1186799	http://dx.doi.org/10.1126/science.1186799			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	592DZ	20448177				2022-12-28	WOS:000277357100029
J	Poon, EG; Keohane, CA; Yoon, CS; Ditmore, M; Bane, A; Levtzion-Korach, O; Moniz, T; Rothschild, JM; Kachalia, AB; Hayes, J; Churchill, WW; Lipsitz, S; Whittemore, AD; Bates, DW; Gandhi, TK				Poon, Eric G.; Keohane, Carol A.; Yoon, Catherine S.; Ditmore, Matthew; Bane, Anne; Levtzion-Korach, Osnat; Moniz, Thomas; Rothschild, Jeffrey M.; Kachalia, Allen B.; Hayes, Judy; Churchill, William W.; Lipsitz, Stuart; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.			Effect of Bar-Code Technology on the Safety of Medication Administration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVERSE DRUG EVENTS; PHYSICIAN ORDER ENTRY; PATIENT SAFETY; INFORMATION-TECHNOLOGY; ERRORS; PREVENTION; SYSTEMS; CARE; HOSPITALS; IMPACT	Background: Serious medication errors are common in hospitals and often occur during order transcription or administration of medication. To help prevent such errors, technology has been developed to verify medications by incorporating bar-code verification technology within an electronic medication-administration system (bar-code eMAR). Methods: We conducted a before-and-after, quasi-experimental study in an academic medical center that was implementing the bar-code eMAR. We assessed rates of errors in order transcription and medication administration on units before and after implementation of the bar-code eMAR. Errors that involved early or late administration of medications were classified as timing errors and all others as nontiming errors. Two clinicians reviewed the errors to determine their potential to harm patients and classified those that could be harmful as potential adverse drug events. Results: We observed 14,041 medication administrations and reviewed 3082 order transcriptions. Observers noted 776 nontiming errors in medication administration on units that did not use the bar-code eMAR (an 11.5% error rate) versus 495 such errors on units that did use it (a 6.8% error rate) -- a 41.4% relative reduction in errors (P<0.001). The rate of potential adverse drug events (other than those associated with timing errors) fell from 3.1% without the use of the bar-code eMAR to 1.6% with its use, representing a 50.8% relative reduction (P<0.001). The rate of timing errors in medication administration fell by 27.3% (P<0.001), but the rate of potential adverse drug events associated with timing errors did not change significantly. Transcription errors occurred at a rate of 6.1% on units that did not use the bar-code eMAR but were completely eliminated on units that did use it. Conclusions: Use of the bar-code eMAR substantially reduced the rate of errors in order transcription and in medication administration as well as potential adverse drug events, although it did not eliminate such errors. Our data show that the bar-code eMAR is an important intervention to improve medication safety. (ClinicalTrials.gov number, NCT00243373.) N Engl J Med 2010;362:1698-707.	[Poon, Eric G.] Brigham & Womens Hosp, Div Gen Med Primary Care, Boston, MA 02120 USA; [Poon, Eric G.; Rothschild, Jeffrey M.; Kachalia, Allen B.; Whittemore, Anthony D.; Bates, David W.; Gandhi, Tejal K.] Harvard Univ, Sch Med, Boston, MA USA; [Poon, Eric G.; Bates, David W.] Partners Informat Syst, Boston, MA USA; [Hayes, Judy] Faulkner Hosp, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Poon, EG (corresponding author), Brigham & Womens Hosp, Div Gen Med Primary Care, 3-F,1620 Tremont St, Boston, MA 02120 USA.	epoon@partners.org	Bates, David/AAE-7283-2019	Poon, Eric/0000-0002-7251-5842	Healthcare Research and Quality [HS14053-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS014053] Funding Source: NIH RePORTER	Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant (HS14053-02) from the Agency for Healthcare Research and Quality.	Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cochran GL, 2007, JT COMM J QUAL PATIE, V33, P293, DOI 10.1016/S1553-7250(07)33034-1; DiConsiglio John, 2008, Mater Manag Health Care, V17, P26; FLYNN EA, 1999, MED ERRORS CAUSES PR; FOLLI HL, 1987, PEDIATRICS, V79, P718; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Greenberg CC, 2008, ANN SURG, V247, P612, DOI 10.1097/SLA.0b013e3181656cd5; *HLTH IT POL COMM, 2009, FIN MEAN US OBJ MEAS; JOHNSON CL, 2003, J HEALTHC INF MANAG, V16, P46; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Koppel R, 2008, J AM MED INFORM ASSN, V15, P408, DOI 10.1197/jamia.M2616; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Mahoney CD, 2007, AM J HEALTH-SYST PH, V64, P1969, DOI 10.2146/ajhp060617; McDonald CJ, 2006, ANN INTERN MED, V145, P235, DOI 10.7326/0003-4819-145-3-200608010-00022; Neuenschwander M, 2003, AM J HEALTH-SYST PH, V60, P1219; Paoletti RD, 2007, AM J HEALTH-SYST PH, V64, P536, DOI 10.2146/ajhp060140; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; Poon EG, 2006, ANN INTERN MED, V145, P426, DOI 10.7326/0003-4819-145-6-200609190-00006; Poon EG, 2008, J NURS ADMIN, V38, P541, DOI 10.1097/NNA.0b013e31818ebf1c; PUCKETT F, 1995, AM J HEALTH-SYST PH, V52, P1305, DOI 10.1093/ajhp/52.12.1305; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Woods D. D., 2007, HDB HUMAN FACTORS ER, P459; Wright AA, 2005, NEW ENGL J MED, V353, P329, DOI 10.1056/NEJMp058101; Yang M, 2002, IMPACT INFORM TECHNO, P37; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	326	343	2	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1698	1707		10.1056/NEJMsa0907115	http://dx.doi.org/10.1056/NEJMsa0907115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445181				2022-12-28	WOS:000277311200007
J	Boyd, R; Gintis, H; Bowles, S				Boyd, Robert; Gintis, Herbert; Bowles, Samuel			Coordinated Punishment of Defectors Sustains Cooperation and Can Proliferate When Rare	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; STRONG RECIPROCITY; SIZABLE GROUPS; EVOLUTION; ENFORCEMENT; DOMINANCE; BEHAVIOR; HUMANS	Because mutually beneficial cooperation may unravel unless most members of a group contribute, people often gang up on free-riders, punishing them when this is cost-effective in sustaining cooperation. In contrast, current models of the evolution of cooperation assume that punishment is uncoordinated and unconditional. These models have difficulty explaining the evolutionary emergence of punishment because rare unconditional punishers bear substantial costs and hence are eliminated. Moreover, in human behavioral experiments in which punishment is uncoordinated, the sum of costs to punishers and their targets often exceeds the benefits of the increased cooperation that results from the punishment of free-riders. As a result, cooperation sustained by punishment may actually reduce the average payoffs of group members in comparison with groups in which punishment of free-riders is not an option. Here, we present a model of coordinated punishment that is calibrated for ancestral human conditions and captures a further aspect of reality missing from both models and experiments: The total cost of punishing a free-rider declines as the number of punishers increases. We show that punishment can proliferate when rare, and when it does, it enhances group-average payoffs.	[Boyd, Robert] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90064 USA; [Boyd, Robert; Gintis, Herbert; Bowles, Samuel] Santa Fe Inst, Behav Sci Program, Santa Fe, NM 87501 USA; [Gintis, Herbert] Cent European Univ, Dept Econ, H-1051 Budapest, Hungary; [Gintis, Herbert] Coll Budapest, H-1014 Budapest, Hungary; [Bowles, Samuel] Univ Siena, Dept Econ, I-53100 Siena, Italy	University of California System; University of California Los Angeles; The Santa Fe Institute; Central European University; University of Siena	Boyd, R (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90064 USA.	rboyd@anthro.ucla.edu; hgintis@comcast.net; samuel.bowles@gmail.com			Santa Fe Institute; U.S. National Science Foundation; European Science Foundation; University of Siena	Santa Fe Institute; U.S. National Science Foundation(National Science Foundation (NSF)); European Science Foundation(European Science Foundation (ESF)European Commission); University of Siena	We thank the Behavioral Sciences Program of the Santa Fe Institute, the U.S. National Science Foundation, the European Science Foundation, and the University of Siena for research support. The authors declare no competing interests.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; BOEHM C, 1993, CURR ANTHROPOL, V34, P227, DOI 10.1086/204166; Boehm C, 2000, HIERARCHY FOREST EVO; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Boyd R, 2007, SCIENCE, V316, P1858, DOI 10.1126/science.1144339; Cinyabuguma M, 2006, EXP ECON, V9, P265, DOI 10.1007/s10683-006-9127-z; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Guzman RA, 2007, EVOL HUM BEHAV, V28, P112, DOI 10.1016/j.evolhumbehav.2006.08.002; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; MAHDI NQ, 1986, ETHOL SOCIOBIOL, V7, P295, DOI 10.1016/0162-3095(86)90055-5; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; PANCHANATHAN K, 2003, NATURE, V224, P115; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Van Doorn GS, 2003, BEHAVIOUR, V140, P1333, DOI 10.1163/156853903771980611; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; Wiessner P, 2002, EVOL HUM BEHAV, V23, P407, DOI 10.1016/S1090-5138(02)00096-X	29	365	371	1	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					617	620		10.1126/science.1183665	http://dx.doi.org/10.1126/science.1183665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589OJ	20431013				2022-12-28	WOS:000277159800042
J	Morais-de-Sa, E; Mirouse, V; St Johnston, D				Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel			aPKC Phosphorylation of Bazooka Defines the Apical/Lateral Border in Drosophila Epithelial Cells	CELL			English	Article							POLARITY PROTEIN PAR-3; ADHESION MOLECULE JAM; TIGHT-JUNCTION; CAENORHABDITIS-ELEGANS; ADHERENS JUNCTIONS; NEUROEPITHELIAL CELLS; SPINDLE ORIENTATION; APICAL DOMAIN; PDZ DOMAINS; KINASE-C	Bazooka (PAR-3), PAR-6, and aPKC form a complex that plays a key role in the polarization of many cell types. In epithelial cells, however, Bazooka localizes below PAR-6 and aPKC at the apical/lateral junction. Here, we show that Baz is excluded from the apical aPKC domain in epithelia by aPKC phosphorylation, which disrupts the Baz/aPKC interaction. Removal of Baz from the complex is epithelial-specific because it also requires the Crumbs complex, which prevents the Baz/PAR-6 interaction. In the absence of Crumbs or aPKC phosphorylation of Baz, mislocalized Baz recruits adherens junction components apically, leading to a loss of the apical domain and an expansion of lateral. Thus, apical exclusion of Baz by Crumbs and aPKC defines the apical/lateral border. Although Baz acts as an aPKC targeting and specificity factor in nonepithelial cells, our results reveal that it performs a complementary function in positioning the adherens junction in epithelia.	[Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Morais-de-Sa, Eurico; Mirouse, Vincent; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk	St Johnston, Daniel/C-9568-2009; Morais-de-Sá, Eurico/I-2157-2013	Morais-de-Sá, Eurico/0000-0003-3525-8231; MIrouse, Vincent/0000-0001-5823-342X; St Johnston, Daniel/0000-0001-5582-3301	Wellcome Trust; Portuguese Foundation for Science and Technology	Wellcome Trust(Wellcome TrustEuropean Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We wish to thank Andreas Wodarz, David Bilder, Eli Knust, Jurgen Knoblich, Kate Beckingham, Ulrich Tepass, and the Bloomington stock centre for reagents, Benedicte Sanson for help with the movies of embryos, and Antonio Vega-Rioja for help with Kinase assays. This work was supported by a Wellcome Trust Principal Fellowship to D.StJ. E.M. received support from the Portuguese Foundation for Science and Technology as a student from the Graduate Program in Areas of Basic and Applied Biology.	Abdelilah-Seyfried S, 2003, DEVELOPMENT, V130, P1927, DOI 10.1242/dev.00420; Afonso C, 2006, J CELL SCI, V119, P4293, DOI 10.1242/jcs.03170; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Atwood SX, 2009, CURR BIOL, V19, P723, DOI 10.1016/j.cub.2009.03.056; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Horikoshi Y, 2009, J CELL SCI, V122, P1595, DOI 10.1242/jcs.043174; Hung TJ, 1999, DEVELOPMENT, V126, P127; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Ito K, 1997, DEVELOPMENT, V124, P761; Itoh M, 2001, J CELL BIOL, V154, P491, DOI 10.1083/jcb.200103047; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Kohjima M, 2002, BIOCHEM BIOPH RES CO, V299, P641, DOI 10.1016/S0006-291X(02)02698-0; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McGill MA, 2009, J CELL BIOL, V185, P787, DOI 10.1083/jcb.200812146; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Satohisa S, 2005, EXP CELL RES, V310, P66, DOI 10.1016/j.yexcr.2005.06.025; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tian AG, 2008, DEVELOPMENT, V135, P463, DOI 10.1242/dev.016253; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; XU T, 1993, DEVELOPMENT, V117, P1223; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	56	199	202	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					509	523		10.1016/j.cell.2010.02.040	http://dx.doi.org/10.1016/j.cell.2010.02.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434988	Green Published, hybrid			2022-12-28	WOS:000277180800021
J	Swanson-Hysell, NL; Rose, CV; Calmet, CC; Halverson, GP; Hurtgen, MT; Maloof, AC				Swanson-Hysell, Nicholas L.; Rose, Catherine V.; Calmet, Claire C.; Halverson, Galen P.; Hurtgen, Matthew T.; Maloof, Adam C.			Cryogenian Glaciation and the Onset of Carbon-Isotope Decoupling	SCIENCE			English	Article							MODEL; EVOLUTION; OCEAN; PHOSPHORUS; OXIDATION; DYNAMICS; CLIMATE	Global carbon cycle perturbations throughout Earth history are frequently linked to changing paleogeography, glaciation, ocean oxygenation, and biological innovation. A pronounced carbonate carbon-isotope excursion during the Ediacaran Period (635 to 542 million years ago), accompanied by invariant or decoupled organic carbon-isotope values, has been explained with a model that relies on a large oceanic reservoir of organic carbon. We present carbonate and organic matter carbon-isotope data that demonstrate no decoupling from approximately 820 to 760 million years ago and complete decoupling between the Sturtian and Marinoan glacial events of the Cryogenian Period (approximately 720 to 635 million years ago). Growth of the organic carbon pool may be related to iron-rich and sulfate-poor deep-ocean conditions facilitated by an increase in the Fe:S ratio of the riverine flux after Sturtian glacial removal of a long-lived continental regolith.	[Swanson-Hysell, Nicholas L.; Rose, Catherine V.; Calmet, Claire C.; Maloof, Adam C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Halverson, Galen P.] Univ Adelaide, Mawson Labs, Adelaide, SA 5005, Australia; [Hurtgen, Matthew T.] Northwestern Univ, Dept Earth & Planetary Sci, Evanston, IL 60208 USA	Princeton University; University of Adelaide; Northwestern University	Maloof, AC (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	maloof@princeton.edu	Hurtgen, Matthew/R-4977-2016	Hurtgen, Matthew/0000-0003-1564-7192; Halverson, Galen/0000-0003-3061-7928; Swanson-Hysell, Nicholas/0000-0003-3215-4648; Rose, Catherine/0000-0001-8149-0977	NSF [EAR-0514657, EAR-084294, EAR-0720045]; American Association of Petroleum Geologists; NSF East Asia and Pacific Summer Institute; Directorate For Geosciences [0842946] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); American Association of Petroleum Geologists; NSF East Asia and Pacific Summer Institute(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank K. Bovee, R. Levin, W. Jacobsen, L. Wingate, and L. Godfrey for assistance with sample preparation and analysis and D. Rothman, L. Kah, R. Kopp, N. Cassar, J. Higgins, J. Husson, and D. Sigman for comments and discussions. This work was supported by NSF grants EAR-0514657 and EAR-084294 to A. C. M., EAR-0720045 to M. T. H., an American Association of Petroleum Geologists Grant to C. V. R., and an NSF East Asia and Pacific Summer Institute fellowship to N. L. S.-H.	AHNERT F, 1987, GEOMORPHOLOGICAL MOD, P31; Calver CR, 2000, PRECAMBRIAN RES, V100, P121, DOI 10.1016/S0301-9268(99)00072-8; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Ernst RE, 2001, GEOL SOC AM SPEC PAP, P483; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Gabet EJ, 2009, GEOLOGY, V37, P151, DOI 10.1130/G25270A.1; Godderis Y, 2007, CR GEOSCI, V339, P212, DOI 10.1016/j.crte.2005.12.002; Halverson GP, 2007, PALAEOGEOGR PALAEOCL, V256, P103, DOI 10.1016/j.palaeo.2007.02.028; Halverson GP, 2005, GEOL SOC AM BULL, V117, P1181, DOI 10.1130/B25630.1; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Kah LC, 2007, GEOLOGY, V35, P799, DOI 10.1130/G23680A.1; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Lyons TW, 2009, ANNU REV EARTH PL SC, V37, P507, DOI 10.1146/annurev.earth.36.031207.124233; Macdonald FA, 2010, SCIENCE, V327, P1241, DOI 10.1126/science.1183325; Macdonald FA, 2009, GEOLOGY, V37, P123, DOI 10.1130/G24797A.1; Maloof AC, 2006, GEOL SOC AM BULL, V118, P1099, DOI 10.1130/B25892.1; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Prave AR, 2009, J GEOL SOC LONDON, V166, P845, DOI 10.1144/0016-76492008-131; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Sannigrahi P, 2006, GEOCHIM COSMOCHIM AC, V70, P5868, DOI 10.1016/j.gca.2006.08.037; Schrag D.P., 2002, GEOCHEM GEOPHYS GEOS, V10; VANCAPPELLEN P, 1994, PALEOCEANOGRAPHY, V9, P677, DOI 10.1029/94PA01455; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2	27	130	142	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					608	611		10.1126/science.1184508	http://dx.doi.org/10.1126/science.1184508			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431011				2022-12-28	WOS:000277159800039
J	Verhulst, EC; Beukeboom, LW; van de Zande, L				Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis			Maternal Control of Haplodiploid Sex Determination in the Wasp Nasonia	SCIENCE			English	Article							DOUBLESEX GENE; DROSOPHILA-MELANOGASTER; DETERMINATION PATHWAY; TRANSFORMER GENE; DETERMINING MECHANISMS; BACTROCERA-OLEAE; MUSCA-DOMESTICA; VITRIPENNIS; EVOLUTION; INSECTS	All insects in the order Hymenoptera have haplodiploid sex determination, in which males emerge from haploid unfertilized eggs and females are diploid. Sex determination in the honeybee Apis mellifera is controlled by the complementary sex determination (csd) locus, but the mechanisms controlling sex determination in other Hymenoptera without csd are unknown. We identified the sex-determination system of the parasitic wasp Nasonia, which has no csd locus. Instead, maternal input of Nasonia vitripennis transformer (Nvtra) messenger RNA, in combination with specific zygotic Nvtra transcription, in which Nvtra autoregulates female-specific splicing, is essential for female development. Our data indicate that males develop as a result of maternal imprinting that prevents zygotic transcription of the maternally derived Nvtra allele in unfertilized eggs. Upon fertilization, zygotic Nvtra transcription is initiated, which autoregulates the female-specific transcript, leading to female development.	[Verhulst, Eveline C.; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9700 AB Groningen, Netherlands	University of Groningen	van de Zande, L (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, NL-9700 AB Groningen, Netherlands.	louis.van.de.zande@rug.nl	Verhulst, Eveline/J-2641-2013; Beukeboom, L.W./D-1808-2012	Verhulst, Eveline/0000-0002-4781-535X; van de Zande, Louis/0000-0001-5687-3220	Netherlands Organization for Scientific Research (NWO) [ALW 833.02.003]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The authors thank the Werren lab (University of Rochester, United States), D. Bopp, M. H. Linskens, A. Rensink, and A. Kamping for technical assistance and discussions and four anonymous reviewers for helpful suggestions. This work was partly funded by Pioneer grant ALW 833.02.003 from the Netherlands Organization for Scientific Research (NWO).	BELOTE JM, 1989, DEV GENET, V10, P143, DOI 10.1002/dvg.1020100304; Bertossa RC, 2009, MOL BIOL EVOL, V26, P1557, DOI 10.1093/molbev/msp067; Beukeboom LW, 2007, SEMIN CELL DEV BIOL, V18, P371, DOI 10.1016/j.semcdb.2006.12.015; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beukeboom LW, 2006, GENETICS, V172, P981, DOI 10.1534/genetics.105.044743; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Dubendorfer A, 2002, INT J DEV BIOL, V46, P75; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Kuhn S, 2000, GENOME, V43, P1011, DOI 10.1139/gen-43-6-1011; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Lagos D, 2005, GENE, V348, P111, DOI 10.1016/j.gene.2004.12.053; Lynch JA, 2006, NAT PROTOC, V1, P486, DOI 10.1038/nprot.2006.70; Oliveira DCSG, 2009, INSECT MOL BIOL, V18, P315, DOI 10.1111/j.1365-2583.2009.00874.x; Pane A, 2005, GENETICS, V171, P615, DOI 10.1534/genetics.105.041004; Pane A, 2002, DEVELOPMENT, V129, P3715; Pultz MA, 2005, DEVELOPMENT, V132, P3705, DOI 10.1242/dev.01939; Rosenberg MI, 2009, BBA-GENE REGUL MECH, V1789, P333, DOI 10.1016/j.bbagrm.2008.09.007; Saccone G, 1996, P 1 RES COORD M ENH, P16; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Scali C, 2005, J EXP BIOL, V208, P3701, DOI 10.1242/jeb.01819; Shearman DCA, 1998, INSECT MOL BIOL, V7, P355, DOI 10.1046/j.1365-2583.1998.740355.x; van Wilgenburg Ellen, 2006, Frontiers in Zoology, V3, P1, DOI 10.1186/1742-9994-3-1; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; WILKINS AS, 1995, BIOESSAYS, V17, P71, DOI 10.1002/bies.950170113	30	138	148	8	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					620	623		10.1126/science.1185805	http://dx.doi.org/10.1126/science.1185805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431014	Green Submitted			2022-12-28	WOS:000277159800043
J	Baumann, K; Guerlin, C; Brennecke, F; Esslinger, T				Baumann, Kristian; Guerlin, Christine; Brennecke, Ferdinand; Esslinger, Tilman			Dicke quantum phase transition with a superfluid gas in an optical cavity	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; SELF-ORGANIZATION; ULTRACOLD ATOMS; ENTANGLEMENT; MODEL; SUPERRADIANCE; LATTICES; SYSTEMS; LIGHT	A phase transition describes the sudden change of state of a physical system, such as melting or freezing. Quantum gases provide the opportunity to establish a direct link between experiments and generic models that capture the underlying physics. The Dicke model describes a collective matter-light interaction and has been predicted to show an intriguing quantum phase transition. Here we realize the Dicke quantum phase transition in an open system formed by a Bose-Einstein condensate coupled to an optical cavity, and observe the emergence of a self-organized supersolid phase. The phase transition is driven by infinitely long-range interactions between the condensed atoms, induced by two-photon processes involving the cavity mode and a pump field. We show that the phase transition is described by the Dicke Hamiltonian, including counter-rotating coupling terms, and that the supersolid phase is associated with a spontaneously broken spatial symmetry. The boundary of the phase transition is mapped out in quantitative agreement with the Dicke model. Our results should facilitate studies of quantum gases with long-range interactions and provide access to novel quantum phases.	[Baumann, Kristian; Guerlin, Christine; Brennecke, Ferdinand; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Baumann, Kristian/M-9653-2013	Esslinger, Tilman/0000-0002-8333-107X; 	NAME-QUAM (European Commission) [225187]; QSIT (ETH Zurich); ETH	NAME-QUAM (European Commission)(European CommissionEuropean Commission Joint Research Centre); QSIT (ETH Zurich)(ETH Zurich); ETH(ETH Zurich)	We thank G. Blatter, I. Carusotto, P. Domokos, A. Imamoglu, S. Leinss, R. Mottl, L. Pollet, H. Ritsch and M. Troyer for discussions. Financial funding from NAME-QUAM (European Commission Seventh Framework Programme Future and Emerging Technologies Open Scheme, grant number 225187) and QSIT (ETH Zurich) is acknowledged. C.G. acknowledges support from an ETH Fellowship.	Amico L, 2008, REV MOD PHYS, V80, P517, DOI 10.1103/RevModPhys.80.517; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; ANDREEV AF, 1969, SOV PHYS JETP, V56, P2057; Asboth JK, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.203008; Asboth JK, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.013414; Asboth JK, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053417; Bartenstein M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.203201; Black AT, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203001; BONIFACIO R, 1994, NUCL INSTRUM METH A, V341, P360, DOI 10.1016/0168-9002(94)90382-4; BOTET R, 1982, PHYS REV LETT, V49, P478, DOI 10.1103/PhysRevLett.49.478; Brennecke F, 2008, SCIENCE, V322, P235, DOI 10.1126/science.1163218; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Buchler HP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130404; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Dimer F, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013804; Domokos P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.253003; Domokos P, 2003, J OPT SOC AM B, V20, P1098, DOI 10.1364/JOSAB.20.001098; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Gopalakrishnan S, 2009, NAT PHYS, V5, P845, DOI 10.1038/NPHYS1403; Greiner M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160405; GREINER M, 2002, NATURE, V39, P415; HEPP K, 1973, ANN PHYS-NEW YORK, V76, P360, DOI 10.1016/0003-4916(73)90039-0; Inouye S, 1999, SCIENCE, V285, P571, DOI 10.1126/science.285.5427.571; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lambert N, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.073602; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Maschler C, 2008, EUR PHYS J D, V46, P545, DOI 10.1140/epjd/e2008-00016-4; Maschler C, 2007, OPT COMMUN, V273, P446, DOI 10.1016/j.optcom.2007.01.069; Mekhov IB, 2007, NAT PHYS, V3, P319, DOI 10.1038/nphys571; Mekhov IB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020403; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Nagy D, 2008, EUR PHYS J D, V48, P127, DOI 10.1140/epjd/e2008-00074-6; Nagy D, 2006, EUROPHYS LETT, V74, P254, DOI 10.1209/epl/i2005-10521-4; Nagy D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.130401; Ottl A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216907; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Osterloh A, 2002, NATURE, V416, P608, DOI 10.1038/416608a; PITAEVSKII L, 2003, BOSEEINSTEIN CONDENS, P161; Regal CA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.040403; Sachdev S., 1999, QUANTUM PHASE TRANSI; Slama S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.053603; Vidal J, 2006, EUROPHYS LETT, V74, P817, DOI 10.1209/epl/i2006-10041-9; WANG YK, 1973, PHYS REV A, V7, P831, DOI 10.1103/PhysRevA.7.831; Yoshikawa Y, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.083602; Zwierlein MW, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.120403	48	1007	1016	1	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1301	U1		10.1038/nature09009	http://dx.doi.org/10.1038/nature09009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428162	Green Submitted			2022-12-28	WOS:000277149000036
J	Dinan, MA; Curtis, LH; Hammill, BG; Patz, EF; Abernethy, AP; Shea, AM; Schulman, KA				Dinan, Michaela A.; Curtis, Lesley H.; Hammill, Bradley G.; Patz, Edward F., Jr.; Abernethy, Amy P.; Shea, Alisa M.; Schulman, Kevin A.			Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TRENDS; TECHNOLOGY; ACCURACY; ICD-9-CM; PATIENT; ISSUES	Context Emerging technologies, changing diagnostic and treatment patterns, and changes in Medicare reimbursement are contributing to increasing use of imaging in cancer. Imaging is the fastest growing expense for Medicare but has not been examined among beneficiaries with cancer. Objective To examine changes in the use of imaging and how those changes contribute to the overall cost of cancer care. Design, Setting, and Patients Analysis of a nationally representative 5% sample of claims from the US Centers for Medicare & Medicaid Services from 1999 through 2008. Patients were Medicare beneficiaries with incident breast cancer, colorectal cancer, leukemia, lung cancer, non-Hodgkin lymphoma, or prostate cancer. Main Outcome Measures Use and cost of imaging by modality, year, and cancer type. Results There were 100 954 incident cases of breast cancer, colorectal cancer, leukemia, lung cancer, non-Hodgkin lymphoma, and prostate cancer from 1999 through 2006. Significant mean annual increases in imaging use occurred among all cancer types for positron emission tomography (35.9%-53.6%), bone density studies (6.3%-20.0%), echocardiograms (5.0%-7.8%), magnetic resonance imaging (4.4%-11.5%), and ultrasound (0.7%-7.4%). Conventional radiograph rates decreased or stayed the same. As of 2006, beneficiaries with lung cancer and beneficiaries with lymphoma incurred the largest overall imaging costs, exceeding a mean of $3000 per beneficiary within 2 years of diagnosis. By 2005, one-third of beneficiaries with breast cancer underwent bone scans and half of beneficiaries with lung cancer or lymphoma underwent positron emission tomography scans. Mean 2-year imaging costs per beneficiary increased at a rate greater than the increase in mean total costs per beneficiary for all cancer types. Conclusion Imaging costs among Medicare beneficiaries with cancer increased from 1999 through 2006, outpacing the rate of increase in total costs among Medicare beneficiaries with cancer. JAMA. 2010;303(16):1625-1631 www.jama.com	[Dinan, Michaela A.; Curtis, Lesley H.; Hammill, Bradley G.; Shea, Alisa M.; Schulman, Kevin A.] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.; Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Patz, Edward F., Jr.] Duke Univ, Sch Med, Dept Radiol, Durham, NC 27715 USA; [Patz, Edward F., Jr.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC 27715 USA; [Patz, Edward F., Jr.; Abernethy, Amy P.] Duke Univ, Sch Med, Duke Comprehens Canc Ctr, Durham, NC 27715 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu		Patz, Edward/0000-0003-3374-1596	Allergan; Eli Lilly and Company; GlaxoSmithKline; Medtronic; Merck Co; Johnson & Johnson (Ortho Biotech); Novartis; OSI Eyetech; Sanofi-Aventis; Actelion Pharmaceuticals; Amgen; Arthritis Foundation; Astellas Pharma; Bristol-Myers Squibb; The Duke Endowment; Genentech; Inspire Pharmaceuticals; Kureha Corporation; Nabi Biopharmaceuticals; National Patient Advocate Foundation; Nova-Cardia; Pfizer; Scios; Tengion; Theravance; Thomson Healthcare; Vertex Pharmaceuticals	Allergan(AbbVieAllergan); Eli Lilly and Company(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck Co(Merck & Company); Johnson & Johnson (Ortho Biotech)(Johnson & JohnsonJohnson & Johnson USA); Novartis(Novartis); OSI Eyetech; Sanofi-Aventis(Sanofi-Aventis); Actelion Pharmaceuticals; Amgen(Amgen); Arthritis Foundation; Astellas Pharma(Astellas Pharmaceuticals); Bristol-Myers Squibb(Bristol-Myers Squibb); The Duke Endowment; Genentech(Roche HoldingGenentech); Inspire Pharmaceuticals; Kureha Corporation; Nabi Biopharmaceuticals; National Patient Advocate Foundation; Nova-Cardia; Pfizer(Pfizer); Scios; Tengion; Theravance; Thomson Healthcare; Vertex Pharmaceuticals(Vertex Pharmaceuticals)	Dr Curtis reported receiving research support from Allergan, Eli Lilly and Company, GlaxoSmithKline, Medtronic, Merck & Co, Johnson & Johnson (Ortho Biotech), Novartis, OSI Eyetech, and Sanofi-Aventis. Dr Curtis has made available online a detailed listing of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Dr Schulman reported receiving research support from Actelion Pharmaceuticals, Allergan, Amgen, Arthritis Foundation, Astellas Pharma, Bristol-Myers Squibb, The Duke Endowment, Genentech, Inspire Pharmaceuticals, Johnson & Johnson, Kureha Corporation, Medtronic, Merck & Co, Nabi Biopharmaceuticals, National Patient Advocate Foundation, Nova-Cardia, Novartis, OSI Eyetech, Pfizer, Sanofi-Aventis, Scios, Tengion, Theravance, Thomson Healthcare, and Vertex Pharmaceuticals; receiving personal income for consulting from McKinsey & Company and the National Pharmaceutical Council; having equity in Alnylam Pharmaceuticals; having equity in and serving on the board of directors of Cancer Consultants Inc; and having equity in and serving on the executive board of Faculty Connection LLC. Dr Schulman has made available online a detailed listing of financial disclosures (http: // www. dcri. duke. edu/ research/ coi. jsp). No other disclosures were reported.	American Cancer Society, CANC FACTS FIG 2009; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Baker L, 2003, HLTH AFF MILLWOOD S; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; BERENSON A, 2007, NY TIMES        0612, pC6; Bhargavan M, 2005, RADIOLOGY, V234, P824, DOI 10.1148/radiol.2343031536; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Centers for Medicare & Medicaid Services, CMS MAN SYST PUB 100; Feldmon MD, 2008, J GEN INTERN MED, V23, P57, DOI 10.1007/s11606-007-0275-4; Flanagan FL, 1998, SEMIN NUCL MED, V28, P290, DOI 10.1016/S0001-2998(98)80034-2; GINSBURG PB, 2005, HLTH AFF MILLWOOD S; Golub RM, 2004, J CLIN ONCOL, V22, P2430, DOI 10.1200/jco.2004.06.154; Herrmann K, 2009, SEMIN NUCL MED, V39, P210, DOI 10.1053/j.semnuclmed.2008.12.001; Iglehart JK, 2006, NEW ENGL J MED, V354, P2822, DOI 10.1056/NEJMhpr061219; Kaa K, 2007, J MANAGE CARE PHARM, V13, pS19; Knuuti J, 2008, HEART, V94, P360, DOI 10.1136/hrt.2007.118992; Maitino AJ, 2003, RADIOLOGY, V227, P113, DOI 10.1148/radiol.2272020617; Medicare Payment Advisory Commission, REP C MED PAYM POL; Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081; Miletich RS, 2009, NEUROL CLIN, V27, P61, DOI 10.1016/j.ncl.2008.09.004; Mitchell JM, 2008, MED CARE, V46, P460, DOI 10.1097/MLR.0b013e31815dc5ae; National Cancer Institute, CANC TRENDS PROGR RE; PODOLOFF A, 2007, J NATL COMPR CANC S1, V5, pS1; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shea AM, 2008, JAMA-J AM MED ASSOC, V300, P189, DOI 10.1001/jama.300.2.189; Sistrom Christopher Lee, 2005, J Am Coll Radiol, V2, P511, DOI 10.1016/j.jacr.2004.09.013; TYNAN A, 2008, ISSUE BRIEF CENT STU, P1; *US DEP HHS, MED REIMB PRESCR DRU; *US DEP HHS, EX MED PAYM PRESCR D; *US GOV ACC OFF, 2001, PUB US GOV ACC OFF	31	169	170	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1625	1631		10.1001/jama.2010.460	http://dx.doi.org/10.1001/jama.2010.460			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424253	Bronze			2022-12-28	WOS:000277085200026
J	Rayner, KJ; Suarez, Y; Davalos, A; Parathath, S; Fitzgerald, ML; Tamehiro, N; Fisher, EA; Moore, KJ; Fernandez-Hernando, C				Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fitzgerald, Michael L.; Tamehiro, Norimasa; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos			MiR-33 Contributes to the Regulation of Cholesterol Homeostasis	SCIENCE			English	Article							CASSETTE TRANSPORTER 1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; LIPID-METABOLISM; IN-VIVO; HDL; MUTATIONS	Cholesterol metabolism is tightly regulated at the cellular level. Here we show that miR-33, an intronic microRNA (miRNA) located within the gene encoding sterol-regulatory element-binding factor-2 (SREBF-2), a transcriptional regulator of cholesterol synthesis, modulates the expression of genes involved in cellular cholesterol transport. In mouse and human cells, miR-33 inhibits the expression of the adenosine triphosphate-binding cassette (ABC) transporter, ABCA1, thereby attenuating cholesterol efflux to apolipoprotein A1. In mouse macrophages, miR-33 also targets ABCG1, reducing cholesterol efflux to nascent high-density lipoprotein (HDL). Lentiviral delivery of miR-33 to mice represses ABCA1 expression in the liver, reducing circulating HDL levels. Conversely, silencing of miR-33 in vivo increases hepatic expression of ABCA1 and plasma HDL levels. Thus, miR-33 appears to regulate both HDL biogenesis in the liver and cellular cholesterol efflux.	[Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, Leon H Charney Div Cardiol, New York, NY 10016 USA; [Rayner, Katey J.; Suarez, Yajaira; Davalos, Alberto; Parathath, Saj; Fisher, Edward A.; Moore, Kathryn J.; Fernandez-Hernando, Carlos] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY 10016 USA; [Rayner, Katey J.; Fitzgerald, Michael L.; Tamehiro, Norimasa; Moore, Kathryn J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA	New York University; New York University; New York University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Moore, KJ (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	kathryn.moore@nyumc.org; carlos.fernandez-hernando@nyumc.org	Fisher, Edward/ABE-7469-2020; Rayner, Katey/K-8914-2012; Parathath, Saj/ABE-2183-2021; Davalos, Alberto/AAA-9949-2021; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Fisher, Edward/0000-0001-9802-143X; Suarez, Yajaira/0000-0003-4549-2953; Parathath, Sajesh/0000-0003-3431-297X; Davalos, Alberto/0000-0001-5709-6443; Rayner, Katey/0000-0001-6230-426X	American Heart Association [SDG-0835585D, SDG-0835481N, 09GRNT2260352]; NIH [R01AG02055, R01HL074136, R01HL084312, 1P30HL101270-01]; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074136, P30HL101270, R01HL084312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020255] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Hernando-Monje for assisting with lentiviral experiments and M. Freeman and L. Stuart for discussions. This work was supported by the American Heart Association (grant SDG-0835585D to C. F.-H., grant SDG-0835481N to Y.S., and grant 09GRNT2260352 to M. L. F.); NIH (grant R01AG02055 to K.J.M., grant R01HL074136 to M. L. F., grant R01HL084312 to E. A. F., and grant 1P30HL101270-01 to C. F.-H.); and the Heart and Stroke Foundation of Canada (K.J.R.). The authors (C. F.-H. and K.J.M) and New York University School of Medicine are preparing a patent application relating to the use of miR-33 as a therapeutic.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421	14	933	1018	5	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1570	1573		10.1126/science.1189862	http://dx.doi.org/10.1126/science.1189862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20466885	Green Accepted			2022-12-28	WOS:000278859200050
J	Tormo-Mas, MA; Mir, I; Shrestha, A; Tallent, SM; Campoy, S; Lasa, I; Barbe, J; Novick, RP; Christie, GE; Penades, JR				Angeles Tormo-Mas, Maria; Mir, Ignacio; Shrestha, Archana; Tallent, Sandra M.; Campoy, Susana; Lasa, Inigo; Barbe, Jordi; Novick, Richard P.; Christie, Gail E.; Penades, Jose R.			Moonlighting bacteriophage proteins derepress staphylococcal pathogenicity islands	NATURE			English	Article							GRAM-POSITIVE BACTERIA; HELPER PHAGE; AUREUS; PARTICLES; DUTPASE; VECTOR; TOXIN	Staphylococcal superantigen-carrying pathogenicity islands (SaPIs) are discrete, chromosomally integrated units of similar to 15 kilobases that are induced by helper phages to excise and replicate. SaPI DNA is then efficiently encapsidated in phage-like infectious particles, leading to extremely high frequencies of intra-as well as intergeneric transfer(1-3). In the absence of helper phage lytic growth, the island is maintained in a quiescent prophage-like state by a global repressor, Stl, which controls expression of most of the SaPI genes(4). Here we show that SaPI derepression is effected by a specific, non-essential phage protein that binds to Stl, disrupting the Stl-DNA complex and thereby initiating the excision-replication-packaging cycle of the island. Because SaPIs require phage proteins to be packaged(5,6), this strategy assures that SaPIs will be transferred once induced. Several different SaPIs are induced by helper phage 80 alpha and, in each case, the SaPI commandeers a different non-essential phage protein for its derepression. The highly specific interactions between different SaPI repressors and helper-phage-encoded anti-repressors represent a remarkable evolutionary adaptation involved in pathogenicity island mobilization.	[Angeles Tormo-Mas, Maria; Mir, Ignacio; Penades, Jose R.] Inst Valenciano Invest Agr, CITA, Segorbe 12400, Castellon, Spain; [Shrestha, Archana; Tallent, Sandra M.; Christie, Gail E.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA 23298 USA; [Campoy, Susana; Barbe, Jordi] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; [Lasa, Inigo] Univ Publ Navarra, CSIC, Inst Agrobiotecnol, Navarra 31006, Spain; [Novick, Richard P.] NYU, Med Ctr, Skirball Inst Program Mol Pathogenesis, New York, NY 10016 USA; [Novick, Richard P.] NYU, Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Novick, Richard P.] NYU, Med Ctr, Dept Med, New York, NY 10016 USA; [Penades, Jose R.] Univ Cardenal Herrera CEU, Dept Quim Bioquim & Biol Mol, Valencia 46113, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA); Virginia Commonwealth University; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; New York University; New York University; New York University; Universidad CEU Cardenal Herrera	Penades, JR (corresponding author), Inst Valenciano Invest Agr, CITA, Apdo 187, Segorbe 12400, Castellon, Spain.	penades_jos@gva.es	Mas, Maria Angeles Tormo/K-5085-2014; Campoy, Susana/C-7335-2008; Lasa, Iñigo/F-2947-2011; Barbe, Jordi/G-5212-2015; Tormo-Mas, María Ángeles/ABF-5881-2020; Mir Sanchis, Ignacio/L-6759-2016; campoy, susana/E-4346-2010; Penadés, José R/W-9685-2019	Mas, Maria Angeles Tormo/0000-0001-8928-2697; Campoy, Susana/0000-0003-1369-0197; Lasa, Iñigo/0000-0002-6625-9221; Barbe, Jordi/0000-0003-4408-013X; Tormo-Mas, María Ángeles/0000-0001-8928-2697; Mir Sanchis, Ignacio/0000-0002-6536-0045; campoy, susana/0000-0003-1369-0197; Penadés, José R/0000-0002-6439-5262; Novick, richard/0000-0003-4418-7893	Ministerio de Ciencia e Innovacion (MICINN) [CSD2009-00006, BIO2005-08399-C02-02, BIO2008-05284-C02-02, BIO2008-00642-E/C, BFU2008-01078]; Cardenal Herrera-CEU University [PRCEU-UCH25/08]; Conselleria de Agricultura, Pesca i Alimentacio (CAPiA); Generalitat Valenciana [ACOMP07/258]; Generalitat de Catalunya [2009SGR1106]; NIH [R21AI067654, R01AI022159-23A2]; A. D. Williams Trust; Baruch Foundation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022159, R21AI067654] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cardenal Herrera-CEU University; Conselleria de Agricultura, Pesca i Alimentacio (CAPiA); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Generalitat de Catalunya(Generalitat de Catalunya); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A. D. Williams Trust; Baruch Foundation Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Casadesus and J. M. Ghigo for comments on the manuscript. This work was supported by grants Consolider-Ingenio CSD2009-00006, BIO2005-08399-C02-02, BIO2008-05284-C02-02 and BIO2008-00642-E/C from the Ministerio de Ciencia e Innovacion (MICINN), grants from the Cardenal Herrera-CEU University (PRCEU-UCH25/08 and Copernicus program), from the Conselleria de Agricultura, Pesca i Alimentacio (CAPiA) and from the Generalitat Valenciana (ACOMP07/258) to J. R. P.; grants BFU2008-01078 from the MICINN and 2009SGR1106 from the Generalitat de Catalunya to J. B.; NIH grant R21AI067654 and a grant-in-aid from the A. D. Williams Trust and the Baruch Foundation Trust to G. E. C.; and NIH grant R01AI022159-23A2 to R.P.N. Fellowship support for M. A. T.-M. from the Generalitat Valenciana is gratefully acknowledged.	Tormo MA, 2008, J BACTERIOL, V190, P2434, DOI 10.1128/JB.01349-07; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; Chan S, 2004, J MOL BIOL, V341, P503, DOI 10.1016/j.jmb.2004.06.028; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Liu J, 2004, NAT BIOTECHNOL, V22, P185, DOI 10.1038/nbt932; NOVICK RP, 2010, NATURE REV IN PRESS; Tallent SM, 2007, J BACTERIOL, V189, P7520, DOI 10.1128/JB.00738-07; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Ubeda C, 2007, MOL MICROBIOL, V65, P41, DOI 10.1111/j.1365-2958.2007.05758.x; Varga B, 2008, BIOCHEM BIOPH RES CO, V373, P8, DOI 10.1016/j.bbrc.2008.05.130	15	124	127	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					779	U7		10.1038/nature09065	http://dx.doi.org/10.1038/nature09065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20473284	Green Accepted, Green Submitted			2022-12-28	WOS:000278551800045
J	Afek, I; Ambar, O; Silberberg, Y				Afek, Itai; Ambar, Oron; Silberberg, Yaron			High-NOON States by Mixing Quantum and Classical Light	SCIENCE			English	Article							LIMIT	Precision measurements can be brought to their ultimate limit by harnessing the principles of quantum mechanics. In optics, multiphoton entangled states, known as NOON states, can be used to obtain high-precision phase measurements, becoming more and more advantageous as the number of photons grows. We generated "high-NOON" states (N = 5) by multiphoton interference of quantum down-converted light with a classical coherent state in an approach that is inherently scalable. Super-resolving phase measurements with up to five entangled photons were produced with a visibility higher than that obtainable using classical light only.	[Afek, Itai; Ambar, Oron; Silberberg, Yaron] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Silberberg, Y (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	yaron.silberberg@weizmann.ac.il	SILBERBERG, YARON/K-1564-2012		Ilan Ramon Fellowship; German-Israeli Foundation for Scientific Research and Development	Ilan Ramon Fellowship; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	We thank B. Dayan for helpful discussions. Supported by an Ilan Ramon Fellowship (I.A.) and the German-Israeli Foundation for Scientific Research and Development.	Afek I, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123602; Aolita L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.080501; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; Cable H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163604; Chen YA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043601; D'Angelo M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.013602; Dowling JP, 2008, CONTEMP PHYS, V49, P125, DOI 10.1080/00107510802091298; Eisenberg HS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.193901; Fiurasek J, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.053818; Gerry C. C., 2005, INTRO QUANTUM OPTICS; Hofmann HF, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.023812; Hofmann HF, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.031806; Jones JA, 2009, SCIENCE, V324, P1166, DOI 10.1126/science.1170730; Kapale KT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.053602; Kim H, 2009, OPT EXPRESS, V17, P19720, DOI 10.1364/OE.17.019720; Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032; Liu BH, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.023815; McCusker KT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.163602; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Mosley PJ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/093011; Mosley PJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133601; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Okamoto R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073033; Pezze L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073601; Pryde GJ, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.052315; Resch KJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.223601; Schrodinger E, 1935, NATURWISSENSCHAFTEN, V23, P807, DOI 10.1007/BF01491891; Silberhorn C, 2007, CONTEMP PHYS, V48, P143, DOI 10.1080/00107510701662538; Valencia A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.243601; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552	31	392	395	6	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					879	881		10.1126/science.1188172	http://dx.doi.org/10.1126/science.1188172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466927				2022-12-28	WOS:000277618800044
J	Martienssen, R				Martienssen, Rob			Small RNA Makes Its Move	SCIENCE			English	Editorial Material							MOBILE		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu						BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Carlsbecker A, 2010, NATURE, V465, P316, DOI 10.1038/nature08977; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Dunoyer P, 2009, TRENDS PLANT SCI, V14, P643, DOI 10.1016/j.tplants.2009.09.003; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; MARTIENSSEN R, 1994, GENETICS, V136, P1157; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Olmedo-Monfil V, 2010, NATURE, V464, P628, DOI 10.1038/nature08828; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Slotkin RK, 2005, NAT GENET, V37, P641, DOI 10.1038/ng1576	15	15	15	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					834	835		10.1126/science.1190510	http://dx.doi.org/10.1126/science.1190510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466910				2022-12-28	WOS:000277618800026
J	Marteau, TM; Mann, E; Prevost, AT; Vasconcelos, JC; Kellar, I; Sanderson, S; Parker, M; Griffin, S; Sutton, S; Kinmonth, AL				Marteau, Theresa M.; Mann, Eleanor; Prevost, A. Toby; Vasconcelos, Joana C.; Kellar, Ian; Sanderson, Simon; Parker, Michael; Griffin, Simon; Sutton, Stephen; Kinmonth, Ann Louise			Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL IMPACT; DECISION AID; FOLLOW-UP; TYPE-2; CANCER; INTERVENTION; INDIVIDUALS; ATTENDANCE; PROGRAMS; RISK	Objective To compare the effect of an invitation promoting informed choice for screening with a standard invitation on attendance and motivation to engage in preventive action. Design Randomised controlled trial. Setting Four English general practices. Participants 1272 people aged 40-69 years, at risk for diabetes, identified from practice registers using a validated risk score and invited to attend for screening. Intervention Intervention was a previously validated invitation to inform the decision to attend screening, presenting diabetes as a serious potential problem, and providing details of possible costs and benefits of screening and treatment in text and pie charts. This was compared with a brief, standard invitation simply describing diabetes as a serious potential problem. Main outcome measures The primary end point was attendance for screening. The secondary outcome measures were intention to make changes to lifestyle and satisfaction with decisions made among attenders. Results The primary end point was analysed for all 1272 participants. 55.8% (353/633) of those in the informed choice group attended for screening, compared with 57.6% (368/639) in the standard invitation group (mean difference -1.8%, 95% confidence interval -7.3% to 3.6%; P=0.51). Attendance was lower among the more deprived group (most deprived third 47.5% v least deprived third 64.3%; P<0.001). Interaction between deprivation and effect of invitation type on attendance was not significant. Among attenders, intention to change behaviour was strong and unaffected by invitation type. Conclusions Providing information to support choice did not adversely affect attendance for screening for diabetes. Those from more socially deprived groups were, however, less likely to attend, regardless of the type of invitation received. Further attention to invitation content alone is unlikely to achieve equity in uptake of preventive services.	[Marteau, Theresa M.; Mann, Eleanor] Kings Coll London, Psychol Dept Guys, Hlth Psychol Sect, Psychol & Genet Res Grp, London SE1 9RT, England; [Vasconcelos, Joana C.; Kellar, Ian; Sanderson, Simon; Sutton, Stephen; Kinmonth, Ann Louise] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Parker, Michael] Univ Oxford, Ethox Ctr, Div Publ Hlth & Primary Hlth Care, Oxford OX1 2JD, England; [Griffin, Simon] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge CB2 0QQ, England; [Prevost, A. Toby] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London SE1 3QD, England	University of London; King's College London; University of Cambridge; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London	Marteau, TM (corresponding author), Kings Coll London, Psychol Dept Guys, Hlth Psychol Sect, Psychol & Genet Res Grp, Guys Campus, London SE1 9RT, England.	theresa.marteau@kcl.ac.uk	Kellar, Ian/F-5536-2015; Griffin, Simon J/K-3106-2013	Kellar, Ian/0000-0003-1608-5216; Griffin, Simon J/0000-0002-2157-4797; Prevost, A. Toby/0000-0003-1723-0796; Marteau, Theresa/0000-0003-3025-1129; Sutton, Stephen/0000-0003-1610-0404	Wellcome Trust [076838]; Department of Health National Institute for Health Research [RP-PG-0606-1259]; National Institute for Health Research; Medical Research Council [RG35746]; Medical Research Council [MC_U106179474, G0200391] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1259] Funding Source: researchfish; MRC [G0200391, MC_U106179474] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Department of Health National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This trial was funded by the Wellcome Trust (grant No 076838 "Didactic versus informed choice invitations: balancing public health benefits and individual choice" principal investigator TMM). The funding body had no role in study design, data collection, analysis, interpretation, or writing of the report.; We thank study participants and the staff at Bretton Medical Practice, Peterborough; Old Fletton Surgery, Peterborough; The Rookery Medical Centre, Newmarket; and Thorney Medical Practice, Peterborough; the nurses who conducted the screening clinics led by Marian Bosman; the Medical Research Council field epidemiology team; Nicola Popplewell, Helen Morris, Kate Williams, and Rachel Crockett for their contribution to the development of the study and the materials; and Irwin Nazareth, Graham Watt, and Dan Mason for their contribution to discussion of the results. ALK, TMM, SG, and SS are founder members of the National Institute for Health Research School for Primary Care Research. ALK and SS are National Institute of Health Research senior investigators. SG receives support from the Department of Health National Institute for Health Research programme grant funding scheme (RP-PG-0606-1259). The General Practice and Primary Care Research Unit is supported by funds from the National Institute for Health Research. IK is supported by a Medical Research Council co-op grant (RG35746).	Adriaanse MC, 2006, DIABETES-METAB RES, V22, P20, DOI 10.1002/dmrr.590; Atri J, 1997, BRIT MED J, V315, P1356, DOI 10.1136/bmj.315.7119.1356; Cooke R, 2008, PSYCHOL HEALTH, V23, P745, DOI 10.1080/08870440701544437; CROCKETT R, 2009, PSYCHOL HEALTH, V24, P18; *DEP HLTH, 2008, PUTT PREV 1; Dormandy E, 2006, PATIENT EDUC COUNS, V61, P56, DOI 10.1016/j.pec.2005.02.006; Echouffo-Tcheugui JB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-136; Entwistle VA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1591; Fox R, 2006, J PUBLIC HEALTH-UK, V28, P309, DOI 10.1093/pubmed/fdl066; GALLO C, 1995, LANCET, V346, P1060, DOI 10.1016/S0140-6736(95)91741-1; General Medical Council (UK), 1998, SEEK PAT CONS ETH CO; Goyder E, 2008, FAM PRACT, V25, P370, DOI 10.1093/fampra/cmn054; Goyder EC, 2008, BRIT MED J, V336, P1140, DOI 10.1136/bmj.39553.480706.80; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jorgensen KJ, 2006, BMJ-BRIT MED J, V332, P538, DOI 10.1136/bmj.332.7540.538; Kellar I, 2008, PATIENT EDUC COUNS, V72, P232, DOI 10.1016/j.pec.2008.04.005; Kim LG, 2004, J MED SCREEN, V11, P50, DOI 10.1258/096914104772950772; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Kreuter MW, 1999, HEALTH PSYCHOL, V18, P487, DOI 10.1037/0278-6133.18.5.487; Mann E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-63; MARSH GN, 1988, BRIT MED J, V296, P173, DOI 10.1136/bmj.296.6616.173; MARTEAU T, 2009, SHARED DECISION MAKI, P87; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; Marteau TM, 2002, FAM PRACT, V19, P18, DOI 10.1093/fampra/19.1.18; Mathieu E, 2007, ARCH INTERN MED, V167, P2039, DOI 10.1001/archinte.167.19.2039; McCaffery K, 2002, J MED SCREEN, V9, P104, DOI 10.1136/jms.9.3.104; MUIR J, 1994, BMJ-BRIT MED J, V308, P308; Noar SM, 2007, PSYCHOL BULL, V133, P673, DOI 10.1037/0033-2909.133.4.673; OConnor AM, 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431, DOI 10.1002/14651858.CD001431]; *OFF NAT STAT, 2009, STAT B          0828; Orbell S, 2006, HEALTH PSYCHOL, V25, P537, DOI 10.1037/0278-6133.25.4.537; Patel VL, 2001, INT J MED INFORM, V63, P147, DOI 10.1016/S1386-5056(01)00165-4; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Shaw C, 1999, SOC SCI MED, V49, P1571, DOI 10.1016/S0277-9536(99)00244-0; Skaner Ylva, 2005, BMC Fam Pract, V6, P4, DOI 10.1186/1471-2296-6-4; Trevena LJ, 2008, J MED SCREEN, V15, P76, DOI 10.1258/jms.2008.007110; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WOOD DA, 1994, BRIT MED J, V308, P313, DOI 10.1136/bmj.308.6924.313; 2007, FLESCH JAVA PROGRAM	42	33	33	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2010	340								c2138	10.1136/bmj.c2138	http://dx.doi.org/10.1136/bmj.c2138			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598HR	20466791	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000277826500002
J	Van Roy, P; Orr, PJ; Botting, JP; Muir, LA; Vinther, J; Lefebvre, B; el Hariri, K; Briggs, DEG				Van Roy, Peter; Orr, Patrick J.; Botting, Joseph P.; Muir, Lucy A.; Vinther, Jakob; Lefebvre, Bertrand; el Hariri, Khadija; Briggs, Derek E. G.			Ordovician faunas of Burgess Shale type	NATURE			English	Article							DEVONIAN HUNSRUCK SLATE; PRESERVATION; LAGERSTATTE; ARTHROPOD; MOROCCO; BIOTAS	The renowned soft-bodied faunas of the Cambrian period, which include the Burgess Shale, disappear from the fossil record in the late Middle Cambrian, after which the Palaeozoic fauna(1) dominates. The disappearance of faunas of Burgess Shale type curtails the stratigraphic record of a number of iconic Cambrian taxa. One possible explanation for this loss is a major extinction(2,3), but more probably it reflects the absence of preservation of similar soft-bodied faunas in later periods(4). Here we report the discovery of numerous diverse soft-bodied assemblages in the Lower and Upper Fezouata Formations (Lower Ordovician) of Morocco, which include a range of remarkable stem-group morphologies normally considered characteristic of the Cambrian. It is clear that biotas of Burgess Shale type persisted after the Cambrian and are preserved where suitable facies occur. The Fezouata biota provides a link between the Burgess Shale communities and the early stages of the Great Ordovician Biodiversification Event.	[Van Roy, Peter; Vinther, Jakob; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Van Roy, Peter; Orr, Patrick J.] Univ Coll Dublin, Sch Geol Sci, Dublin 4, Ireland; [Botting, Joseph P.] Leeds Museum Discovery Ctr, Leeds LS10 1LB, W Yorkshire, England; [Lefebvre, Bertrand] Univ Lyon 1, CNRS, UMR PEPS 5125, F-69622 Villeurbanne, France; [el Hariri, Khadija] Univ Cadi Ayyad, Fac Sci & Tech Gueliz, Dept Sci Terre, Marrakech 40000, Morocco; [Briggs, Derek E. G.] Yale Univ, Yale Peabody Museum Nat Hist, New Haven, CT 06520 USA	Yale University; University College Dublin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Cadi Ayyad University of Marrakech; Yale University	Van Roy, P (corresponding author), Yale Univ, Dept Geol & Geophys, POB 208109, New Haven, CT 06520 USA.	peter.vanroy@yale.edu; derek.briggs@yale.edu		Orr, Patrick/0000-0002-6740-1656; Vinther, Jakob/0000-0002-3584-9616; Van Roy, Peter/0000-0001-5330-8402	Agency for Innovation, Science and Technology (IWT); Irish Research Council for Science, Engineering and Technology (IRCSET); National Geographic Society	Agency for Innovation, Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); National Geographic Society(National Geographic Society)	S. Butts (Yale Peabody Museum of Natural History), A. Prieur (Lyon1 University), D. Berthet (Natural History Museum of Lyon), A. Medard-Blondel and S. Pichard (Natural History Museum of Marseille), G. Fleury (Natural History Museum of Toulouse), the National Museums of Scotland and the Sedgwick Museum provided access to specimens. M. Ben Said Ben Moula, W. and D. De Winter, B. MacGabhann, R. and V. Reboul-Baron, C. Upton, B. Van Bocxlaer, and D. and K. Van Damme assisted with fieldwork, and B. Tahiri arranged logistical support. E. Champion helped with the preparation of figures. J. De Grave and B. Van Bocxlaer (Ghent University) provided photographic equipment, and the Palaeontology and Petrology Research Units of Ghent University allowed use of their imaging facilities. P. and O. Van Roy-Lassaut financially aided fieldwork. This research was funded by an Agency for Innovation by Science and Technology (IWT) doctoral fellowship and by an Irish Research Council for Science, Engineering and Technology (IRCSET) - EMPOWER postdoctoral fellowship awarded to P. V. R. Fieldwork was supported by a National Geographic Society Research and Exploration grant.	Aldridge R.J., 2001, P340, DOI 10.1002/9780470999295.ch79; Alessandrello Anna, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P337; ALLISON PA, 1993, GEOLOGY, V21, P527, DOI 10.1130/0091-7613(1993)021<0527:EFRDOS>2.3.CO;2; ALLISON PA, 1993, LETHAIA, V26, P184, DOI 10.1111/j.1502-3931.1993.tb01813.x; ALLISON PA, 1991, TAPHONOMY RELEASING, P25; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; Bambach RK, 2004, PALEOBIOLOGY, V30, P522, DOI 10.1666/0094-8373(2004)030<0522:OEAMDO>2.0.CO;2; Botting JP, 2007, GEOBIOS-LYON, V40, P737, DOI 10.1016/j.geobios.2007.02.006; BUTTERFIELD NJ, 1995, LETHAIA, V28, P1, DOI 10.1111/j.1502-3931.1995.tb01587.x; Caron JB, 2004, J PALEONTOL, V78, P1138, DOI 10.1666/0022-3360(2004)078<1138:ANLSPN>2.0.CO;2; Clausen S, 2010, PALAEOGEOGR PALAEOCL, V294, P133, DOI 10.1016/j.palaeo.2010.01.001; Destombes J., 1985, LOWER PALAEOZOIC ROC, V4, P91; Droser ML, 2003, INTEGR COMP BIOL, V43, P178, DOI 10.1093/icb/43.1.178; Farrell UC, 2009, GEOLOGY, V37, P907, DOI 10.1130/G30177A.1; Friend D., 2002, PALEONTOL J, V36, P20; Gabbott SE, 2004, GEOLOGY, V32, P901, DOI 10.1130/G20640.1; Harper DAT, 2006, PALAEOGEOGR PALAEOCL, V232, P148, DOI 10.1016/j.palaeo.2005.07.010; Kuhl G, 2009, SCIENCE, V323, P771, DOI 10.1126/science.1166586; Kuhl G, 2008, PALAEONTOGR ABT A, V286, P123; Liu HPB, 2006, GEOLOGY, V34, P969, DOI 10.1130/G22911A.1; MORRIS SC, 1989, T RSE EARTH, V80, P271; MORRIS SC, 1985, PHILOS T ROY SOC B, V311, P49, DOI 10.1098/rstb.1985.0138; Orr PJ, 2003, GEOLOGY, V31, P769, DOI 10.1130/G19193.1; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; Van Roy P, 2006, T ROY SOC EDIN-EARTH, V96, P327; Vandenbroucke TRA, 2009, J MICROPALAEONTOL, V28, P53, DOI 10.1144/jm.28.1.53; Vinther J, 2008, NATURE, V451, P185, DOI 10.1038/nature06474; Webby B.D., 2004, GREAT ORDOVICIAN BIO, DOI DOI 10.7312/WEBB12678; Young GA, 2007, GEOLOGY, V35, P883, DOI 10.1130/G23947A.1; Zhang XG, 2007, TERRA NOVA, V19, P407, DOI 10.1111/j.1365-3121.2007.00765.x	30	230	233	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					215	218		10.1038/nature09038	http://dx.doi.org/10.1038/nature09038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463737				2022-12-28	WOS:000277558500034
J	Kurien, M; McAlindon, ME; Westaby, D; Sanders, DS				Kurien, Matthew; McAlindon, Mark E.; Westaby, David; Sanders, David S.			Percutaneous endoscopic gastrostomy (PEG) feeding	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ENTERAL NUTRITION; TUBE; GUIDELINES; CANCER; IMPACT; HEAD		[Kurien, Matthew] Chesterfield Royal Hosp, Dept Gastroenterol, Chesterfield S44 5BL, England; [McAlindon, Mark E.; Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; [Westaby, David] Imperial Coll Healthcare NHS Trust, Dept Gastroenterol, London, England	University of Sheffield; Imperial College London	Kurien, M (corresponding author), Chesterfield Royal Hosp, Dept Gastroenterol, Chesterfield S44 5BL, England.	matthew.kurien@chesterfieldroyal.nhs.uk		Kurien, Matthew/0000-0002-4227-9500				Abuksis G, 2004, CLIN NUTR, V23, P341, DOI 10.1016/j.clnu.2003.08.001; [Anonymous], 2006, DEM SUPP PEOPL DEM T; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Constable G, 2003, GUT, V52, pA74; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; General Medical Council, 2006, WITHH WITHDR LIF PRO; Green C. J., 1999, Clinical Nutrition (Edinburgh), V18, P3; Jones B, 2008, ANN BANS REPORT 2008; Loser C, 2005, CLIN NUTR, V24, P848, DOI 10.1016/j.clnu.2005.06.013; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; Mekhail TM, 2001, CANCER-AM CANCER SOC, V91, P1785, DOI 10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>3.3.CO;2-T; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Monteleoni C, 2004, BMJ-BRIT MED J, V329, P491, DOI 10.1136/bmj.329.7464.491; MORAN BJ, 1990, BRIT J SURG, V77, P858, DOI 10.1002/bjs.1800770805; *NAT PAT SAF AG, EARL DET COMPL GASTR; National Collaborating Centre for Acute Care, 2006, NUTR SUPP AD OR NUTR; NCEPOD, 2005, SCOP OUR PRACT 2004; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; Norton B, 1996, BRIT MED J, V312, P13, DOI 10.1136/bmj.312.7022.13; Nugent B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007904.pub2; PARK RHR, 1992, BRIT MED J, V304, P1406, DOI 10.1136/bmj.304.6839.1406; Royal College of Physicians and British Society of Gastroenterology, 2010, OR FEED DIFF DIL GUI; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Sanders DS, 2002, AM J GASTROENTEROL, V97, P2239; Sanders DS, 2000, AM J GASTROENTEROL, V95, P1472, DOI 10.1111/j.1572-0241.2000.02079.x; Schrag SP, 2007, J GASTROINTEST LIVER, V16, P407; SENFT M, 1993, SUPPORT CARE CANCER, V1, P272, DOI 10.1007/BF00366049; WATTS DT, 1986, J AM GERIATR SOC, V34, P607, DOI 10.1111/j.1532-5415.1986.tb05767.x; WICKS C, 1992, GUT, V33, P613, DOI 10.1136/gut.33.5.613; Wiggenraad RGJ, 2007, CLIN OTOLARYNGOL, V32, P384, DOI 10.1111/j.1749-4486.2007.01533.x	30	48	50	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2010	340								c2414	10.1136/bmj.c2414	http://dx.doi.org/10.1136/bmj.c2414			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XE	20453010				2022-12-28	WOS:000277572800002
J	Zweibel, K				Zweibel, Ken			The Impact of Tellurium Supply on Cadmium Telluride Photovoltaics	SCIENCE			English	Editorial Material									George Washington Univ, Washington, DC 20052 USA	George Washington University	Zweibel, K (corresponding author), George Washington Univ, Washington, DC 20052 USA.	zweibel@gwu.edu						COHEN BL, 1984, GEOCHIM COSMOCHIM AC, V48, P203, DOI 10.1016/0016-7037(84)90363-6; Cooper W.C., 1971, TELLURIUM; Fthenakis V, 2009, RENEW SUST ENERG REV, V13, P2746, DOI 10.1016/j.rser.2009.05.001; Green MA, 2006, PROG PHOTOVOLTAICS, V14, P743, DOI 10.1002/pip.703; Hein JR, 2003, GEOCHIM COSMOCHIM AC, V67, P1117, DOI 10.1016/S0016-7037(02)01279-6; OJEBUOBOH F, 2008, WORLD METALLURGY ERZ, V61, P1; U.S. Energy Information Administration, 2010, EL POW MONTHL	7	108	110	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					699	701		10.1126/science.1189690	http://dx.doi.org/10.1126/science.1189690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448173				2022-12-28	WOS:000277357100025
J	Barash, Y; Calarco, JA; Gao, WJ; Pan, Q; Wang, XC; Shai, O; Blencowe, BJ; Frey, BJ				Barash, Yoseph; Calarco, John A.; Gao, Weijun; Pan, Qun; Wang, Xinchen; Shai, Ofer; Blencowe, Benjamin J.; Frey, Brendan J.			Deciphering the splicing code	NATURE			English	Article							TRACT BINDING-PROTEIN; REGULATORY ELEMENTS; EXPORTIN 4; RNA; EXONS; IDENTIFICATION; EXPRESSION; EXCLUSION; INSIGHTS; PATHWAY	Alternative splicing has a crucial role in the generation of biological complexity, and its misregulation is often involved in human disease. Here we describe the assembly of a 'splicing code', which uses combinations of hundreds of RNA features to predict tissue-dependent changes in alternative splicing for thousands of exons. The code determines new classes of splicing patterns, identifies distinct regulatory programs in different tissues, and identifies mutation-verified regulatory sequences. Widespread regulatory strategies are revealed, including the use of unexpectedly large combinations of features, the establishment of low exon inclusion levels that are overcome by features in specific tissues, the appearance of features deeper into introns than previously appreciated, and the modulation of splice variant levels by transcript structure characteristics. The code detected a class of exons whose inclusion silences expression in adult tissues by activating nonsense-mediated messenger RNA decay, but whose exclusion promotes expression during embryogenesis. The code facilitates the discovery and detailed characterization of regulated alternative splicing events on a genome-wide scale.	[Barash, Yoseph; Gao, Weijun; Wang, Xinchen; Shai, Ofer; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Barash, Yoseph; Calarco, John A.; Pan, Qun; Wang, Xinchen; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Barash, Yoseph; Calarco, John A.; Pan, Qun; Wang, Xinchen; Blencowe, Benjamin J.; Frey, Brendan J.] Univ Toronto, Donnelly Ctr, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Frey, Brendan J.] Microsoft Res, Cambridge, England	University of Toronto; University of Toronto; University of Toronto; Microsoft	Frey, BJ (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	b.blencowe@utoronto.ca; frey@psi.toronto.edu	Gao, Weijun/A-6350-2011	Barash, Yoseph/0000-0003-3005-5048; Wang, Xinchen/0000-0002-5198-6581	Genome Canada through the OGI; NSERC/CFI/OIT CRC; CIHR; NCIC; NSERC EWR Steacie; Canadian Institute for Advanced Research	Genome Canada through the OGI(Genome Canada); NSERC/CFI/OIT CRC(Natural Sciences and Engineering Research Council of Canada (NSERC)Canada Foundation for Innovation); CIHR(Canadian Institutes of Health Research (CIHR)); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSERC EWR Steacie; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	We thank D. L. Black, D. Botstein, S. E. Brenner, C. B. Burge, B. Chabot, R. Durbin, X.-D. Fu, B. R. Graveley, T. R. Hughes, N. Jojic, C. W. J. Smith, S. Tavazoie and members of our various laboratories for discussions or comments on the manuscript; D. D. Licatalosi and R. B. Darnell for communicating unpublished results; and S. Chaudhry for RT-PCR work. B. J. F. also thanks C. M. Bishop and D. J. C. MacKay for hosting him during his sabbatical in Cambridge. This research was funded by a grant from Genome Canada through the OGI to B. J. B., B. J. F. and others; an NSERC/CFI/OIT CRC grant to B. J. F.; CIHR grants to B. J. F. and B. J. B.; an NCIC grant to B. J. B.; and NSERC EWR Steacie and Canadian Institute for Advanced Research Fellowships to B. J. F.	Ashiya M, 1997, RNA, V3, P996; Bishop C.M., 2006, PATTERN RECOGN; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Calarco JA, 2009, CELL, V138, P898, DOI 10.1016/j.cell.2009.06.012; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Cote J, 2001, P NATL ACAD SCI USA, V98, P938, DOI 10.1073/pnas.031564098; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Gontan C, 2009, J CELL BIOL, V185, P27, DOI 10.1083/jcb.200810106; Gooding C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r1; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; Hartmann B, 2009, CURR OPIN CELL BIOL, V21, P377, DOI 10.1016/j.ceb.2009.02.006; Hayakawa M, 2002, J BIOL CHEM, V277, P6974, DOI 10.1074/jbc.M110138200; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kawamoto S, 1996, J BIOL CHEM, V271, P17613; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Perez I, 1997, RNA, V3, P764; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Shai O, 2006, BIOINFORMATICS, V22, P606, DOI 10.1093/bioinformatics/btk028; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shepard PJ, 2008, RNA, V14, P1463, DOI 10.1261/rna.1069408; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stadler MB, 2006, PLOS GENET, V2, P1849, DOI 10.1371/journal.pgen.0020191; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wei N, 1997, RNA, V3, P1275; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Xiao XS, 2007, P NATL ACAD SCI USA, V104, P18583, DOI 10.1073/pnas.0707349104; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	50	560	587	0	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					53	59		10.1038/nature09000	http://dx.doi.org/10.1038/nature09000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445623				2022-12-28	WOS:000277311900029
J	Hansson, MG				Hansson, Mats G.			Need for a wider view of autonomy in epidemiological research	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSENT; CONFIDENTIALITY		Uppsala Univ, Ctr Res Eth & Bioeth, Dept Publ Hlth & Caring Sci, SE-75122 Uppsala, Sweden	Uppsala University	Hansson, MG (corresponding author), Uppsala Univ, Ctr Res Eth & Bioeth, Dept Publ Hlth & Caring Sci, POB 563, SE-75122 Uppsala, Sweden.	Mats.Hansson@crb.uu.se						Arnason V, 2004, BIOETHICS, V18, P27, DOI 10.1111/j.1467-8519.2004.00377.x; Caulfield T, 2007, KINGS LAW J, V18, P209, DOI DOI 10.1080/09615768.2007.11427674; Coleman MP, 2003, CLIN MED, V3, P219, DOI 10.7861/clinmedicine.3-3-219; COLLINS R, 1992, INTRO NEW TREATMENTS, P54; Council for International Organizations of Medical Sciences, 2009, INT ETH GUID EP STUD; Elger B., 2008, ETHICAL ISSUES GOVER, P57; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Hansson MO, 1998, J MED ETHICS, V24, P182, DOI 10.1136/jme.24.3.182; Helgesson G, 2007, NAT BIOTECHNOL, V25, P973, DOI 10.1038/nbt0907-973b; Hofmann B, 2009, J MED ETHICS, V35, P125, DOI 10.1136/jme.2008.024851; Hultman CM, 2009, PUBLIC HEALTH ETH-UK, V2, P30, DOI 10.1093/phe/php003; Iversen A, 2006, BRIT MED J, V332, P165, DOI 10.1136/bmj.332.7534.165; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; TUSHNET M, 2000, RIGHT PRIVACY, P141; Ward HJT, 2004, BRIT MED J, V329, P277, DOI 10.1136/bmj.329.7460.277	15	18	18	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c2335	10.1136/bmj.c2335	http://dx.doi.org/10.1136/bmj.c2335			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594XC	20444822				2022-12-28	WOS:000277572500005
J	Shortell, SM; Casalino, LP				Shortell, Stephen M.; Casalino, Lawrence P.			Implementing Qualifications Criteria and Technical Assistance for Accountable Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; [Casalino, Lawrence P.] Weill Cornell Med Coll, Div Outcomes & Effectiveness Res, New York, NY USA	University of California System; University of California Berkeley; Cornell University	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkeley.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859				Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; *I MED, 2006, MED QUAL IMPR ORG PR; *NAT CTR HEALTHC L, 2004, COMP MOD 2 0; Rittenhouse DR, 2008, HEALTH AFFAIR, V27, P1246, DOI 10.1377/hlthaff.27.5.1246; Shortell SM, 2010, PARTNERS HLTH PHYS H; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95	7	33	33	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1747	1748		10.1001/jama.2010.575	http://dx.doi.org/10.1001/jama.2010.575			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591CR	20442391				2022-12-28	WOS:000277276600028
J	Maxmen, A				Maxmen, Amy			Science Networking Gets Serious	CELL			English	Editorial Material																			0	7	7	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 30	2010	141	3					387	389		10.1016/j.cell.2010.04.019	http://dx.doi.org/10.1016/j.cell.2010.04.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434976	Bronze			2022-12-28	WOS:000277180800006
J	Fenniche, S; Badri, T				Fenniche, Samy; Badri, Talel			Nevoid Hyperkeratosis of the Nipple and Areola	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fenniche, Samy; Badri, Talel] Habib Thameur Hosp, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Habib Thameur	Fenniche, S (corresponding author), Habib Thameur Hosp, Tunis, Tunisia.	fenniche.samy@planet.tn							0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1618	1618		10.1056/NEJMicm0909467	http://dx.doi.org/10.1056/NEJMicm0909467			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	589AX	20427810				2022-12-28	WOS:000277117400010
J	LeLeiko, NS; Gee, MS; Sadow, PM				LeLeiko, Neal S.; Gee, Michael S.; Sadow, Peter M.			Case 13-2010: An 18.5-Month-Old Girl with Watery Diarrhea and Poor Weight Gain - Ganglioneuroma with immunoreactivity to vasoactive intestinal peptide antigen	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYSTIC-FIBROSIS; NEUROBLASTOMA; TUMORS; PHEOCHROMOCYTOMA; AEROMONAS; SYMPTOMS; CHILDREN; GLAND		[LeLeiko, Neal S.] Brown Univ, Dept Pediat, Alpert Sch Med, Providence, RI 02912 USA; [LeLeiko, Neal S.] Brown Univ, Rhode Isl Hosp, Div Pediat Gastroenterol Nutr & Liver Dis, Hasbro Childrens Hosp, Providence, RI 02903 USA; [Gee, Michael S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Gee, Michael S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Brown University; Brown University; Hasbro Children's Hospital; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LeLeiko, NS (corresponding author), Brown Univ, Dept Pediat, Alpert Sch Med, Providence, RI 02912 USA.		LeLeiko, Neal/GRJ-6855-2022; Sadow, Peter/E-7691-2015; Sadow, Peter/AAO-9878-2020	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367; leleiko, neal/0000-0001-7699-1400				Ai-Awqati Q, 2002, J CLIN INVEST, V110, P1599, DOI 10.1172/JCI200217301; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; [Anonymous], 2004, WHO CLASSIFICATION T; BIJMAN J, 1984, AM J PHYSIOL, V247, pC3, DOI 10.1152/ajpcell.1984.247.1.C3; Bostwick DG, 2008, UROLOGIC SURG PATHOL; Bourdeaut F, 2009, PEDIATR BLOOD CANCER, V52, P585, DOI 10.1002/pbc.21912; Brouwers FM, 2006, ENDOCRIN METAB CLIN, V35, P699, DOI 10.1016/j.ecl.2006.09.014; CARLSEN NLT, 1987, ANTICANCER RES, V7, P465; DAGNELIE PC, 1989, EUR J CLIN NUTR, V43, P325; Fletcher CD, 2007, DIAGNOSTIC HISTOPATH; HANSEN LP, 1980, ACTA PAEDIATR SCAND, V69, P419, DOI 10.1111/j.1651-2227.1980.tb07104.x; Koch CA, 2003, ENDOCR-RELAT CANCER, V10, P99, DOI 10.1677/erc.0.0100099; LeGrys VA, 1996, J PEDIATR-US, V129, P892, DOI 10.1016/S0022-3476(96)70034-3; Lonergan GJ, 2002, RADIOGRAPHICS, V22, P911, DOI 10.1148/radiographics.22.4.g02jl15911; LUCAS K, 1994, MED PEDIATR ONCOL, V22, P240, DOI 10.1002/mpo.2950220405; Ning Y, 2004, CLIN EXP PHARMACOL P, V31, P424, DOI 10.1111/j.1440-1681.2004.04015.x; Onozawa M, 2005, JPN J CLIN ONCOL, V35, P559, DOI 10.1093/jjco/hyi139; Przkora R, 2006, EUR SPINE J, V15, P363, DOI 10.1007/s00586-005-0964-9; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; RICCI A, 1984, AM J SURG PATHOL, V8, P19, DOI 10.1097/00000478-198401000-00002; SCHWARTZ CJ, 1974, J CLIN INVEST, V54, P536, DOI 10.1172/JCI107790; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; Sonawane ND, 2005, FASEB J, V19, P130, DOI 10.1096/fj.05-4818fje; Strenger V, 2007, PEDIATR BLOOD CANCER, V48, P504, DOI 10.1002/pbc.20888; Tischler AS, 2000, SEMIN DIAGN PATHOL, V17, P120; WILCOX MH, 1992, J CLIN PATHOL, V45, P959, DOI 10.1136/jcp.45.11.959; Wildhaber B, 2003, EUR J PEDIATR, V162, P511, DOI 10.1007/s00431-003-1212-0	27	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1619	1626		10.1056/NEJMcpc0910932	http://dx.doi.org/10.1056/NEJMcpc0910932			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20427811				2022-12-28	WOS:000277117400012
J	Roehr, B				Roehr, Bob			US Global Health Initiative takes shape	BRITISH MEDICAL JOURNAL			English	News Item																			0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 19	2010	340								c2131	10.1136/bmj.c2131	http://dx.doi.org/10.1136/bmj.c2131			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589HK	20460316				2022-12-28	WOS:000277137500011
J	Yvan-Charvet, L; Pagler, T; Gautier, EL; Avagyan, S; Siry, RL; Han, S; Welch, CL; Wang, N; Randolph, GJ; Snoeck, HW; Tall, AR				Yvan-Charvet, Laurent; Pagler, Tamara; Gautier, Emmanuel L.; Avagyan, Serine; Siry, Read L.; Han, Seongah; Welch, Carrie L.; Wang, Nan; Randolph, Gwendalyn J.; Snoeck, Hans W.; Tall, Alan R.			ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation	SCIENCE			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; GENE-EXPRESSION; MACROPHAGE ABCA1; LIPID RAFTS; CHOLESTEROL; ATHEROSCLEROSIS; ACCUMULATION; MICE; ABCG1	Elevated leukocyte cell numbers (leukocytosis), and monocytes in particular, promote atherosclerosis; however, how they become increased is poorly understood. Mice deficient in the adenosine triphosphate-binding cassette (ABC) transporters ABCA1 and ABCG1, which promote cholesterol efflux from macrophages and suppress atherosclerosis in hypercholesterolemic mice, displayed leukocytosis, a transplantable myeloproliferative disorder, and a dramatic expansion of the stem and progenitor cell population containing Lin(-)Sca-1(+)Kit(+) (LSK) in the bone marrow. Transplantation of Abca1(-/-) Abcg1(-/-) bone marrow into apolipoprotein A-1 transgenic mice with elevated levels of high-density lipoprotein (HDL) suppressed the LSK population, reduced leukocytosis, reversed the myeloproliferative disorder, and accelerated atherosclerosis. The findings indicate that ABCA1, ABCG1, and HDL inhibit the proliferation of hematopoietic stem and multipotential progenitor cells and connect expansion of these populations with leukocytosis and accelerated atherosclerosis.	[Yvan-Charvet, Laurent; Pagler, Tamara; Siry, Read L.; Han, Seongah; Welch, Carrie L.; Wang, Nan; Tall, Alan R.] Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA; [Gautier, Emmanuel L.; Avagyan, Serine; Randolph, Gwendalyn J.; Snoeck, Hans W.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA	Columbia University; Icahn School of Medicine at Mount Sinai	Yvan-Charvet, L (corresponding author), Columbia Univ, Dept Med, Div Mol Med, New York, NY 10032 USA.	ly2159@columbia.edu	Gautier, Emmanuel L./E-2259-2017; Tall, Alan/AAT-8528-2021	Gautier, Emmanuel L./0000-0003-2976-7566; Yvan-Charvet, Laurent/0000-0002-7748-4942; , Ngobrolgame.com/0000-0001-6815-9112	NIH [HL54591, R01A1061741, R01AG016327]; American Heart Association [SDG2160053]; FWF Austrian Science Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073760, P01HL054591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049653, R01AI061741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016327, R01AG029626] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); FWF Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by a Program Project grant from the NIH to A. R. T. (HL54591) and a grant from the American Heart Association to L.Y.-C. (SDG2160053), by the FWF Austrian Science Fund (T. P.), and by NIH grants R01A1061741 (E. L. G. and G.J.R.) and R01AG016327 (H. W. S.). A. R. T. serves on scientific advisory boards for Merck and Arisaph Pharmaceuticals and provides paid consulting services to Roche, Merck, Arisaph Pharmaceuticals, and CSL Limited related to the development of drugs that would increase HDL levels.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; AVERILL LE, 1989, AM J PATHOL, V135, P369; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; de Grouw EPLM, 2006, LEUKEMIA, V20, P750, DOI 10.1038/sj.leu.2404131; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; Nichols BJ, 2003, CURR BIOL, V13, P686, DOI 10.1016/S0960-9822(03)00209-4; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Peeters SDPWM, 2006, EXP HEMATOL, V34, P622, DOI 10.1016/j.exphem.2006.01.020; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Testa U, 2004, LEUKEMIA, V18, P219, DOI 10.1038/sj.leu.2403224; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372	30	525	540	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1689	1693		10.1126/science.1189731	http://dx.doi.org/10.1126/science.1189731			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20488992	Green Accepted			2022-12-28	WOS:000279107400042
J	Guyatt, G; Akl, EA; Hirsh, J; Kearon, C; Crowther, M; Gutterman, D; Lewis, SZ; Nathanson, I; Jaeschke, R; Schunemann, H				Guyatt, Gordon; Akl, Elie A.; Hirsh, Jack; Kearon, Clive; Crowther, Mark; Gutterman, David; Lewis, Sandra Zelman; Nathanson, Ian; Jaeschke, Roman; Schuenemann, Holger			The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLINICAL-PRACTICE GUIDELINES; INDUSTRY	Issues of financial and intellectual conflict of interest in clinical practice guidelines have raised increasing concern. Professional organizations have responded by more rigorous regulation of conflict of interest. Nevertheless, tension remains between the competing goals of optimizing guideline quality by using the experience and insight of experts and ensuring that financial and intellectual conflicts of interest do not influence recommendations. The executive committee of the American College of Chest Physicians' Antithrombotic Guidelines has developed a strategy comprising 3 innovative aspects to address this tension: First, place equal emphasis on intellectual and financial conflicts and provide explicit criteria for both; second, a methodologist without important conflicts of interest should have primary responsibility for each chapter; and third, experts with important financial or intellectual conflicts of interest can collect and interpret evidence, but only panel members without important conflicts can be involved in developing the recommendation for a specific question. These strategies may help to achieve the benefits of expert input without conflicts of interest influencing recommendations.	McMaster Univ, Henderson Gen Hosp, Hlth Sci Ctr, St Josephs Healthcare, Hamilton, ON L8N 3Z5, Canada; St Josephs Hosp, Hamilton, ON L8P 3B6, Canada; SUNY Buffalo, Buffalo, NY 14260 USA; Med Coll Wisconsin, Milwaukee, WI 53226 USA; Amer Coll Chest Phys, Northbrook, IL 60062 USA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McGill University; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Medical College of Wisconsin	Guyatt, G (corresponding author), McMaster Univ, Hlth Sci Ctr, 1200 Main St W,Room 2C12, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Lewis, Sandra Zelman/ABF-5277-2021; Akl, Elie/K-5269-2019; Akl, Elie A/R-2079-2016	Akl, Elie A/0000-0002-3444-8618; Schunemann, Holger/0000-0003-3211-8479				*AM COLL PHYS, ACP CONFL INT POL PR; American Heart Association, METH MAN ACC AHA GUI; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Guyatt GH, 2008, USERS GUIDES MED LIT, P597; Hirsh J, 2009, LANCET, V374, P273, DOI 10.1016/S0140-6736(09)60787-X; Lenzer J, 2002, BRIT MED J, V324, P723, DOI 10.1136/bmj.324.7339.723; MARSHALL E, 1992, SCIENCE, V257, P620, DOI 10.1126/science.257.5070.620-a; *NIH CLIN EXC, COD PRACT DECL DEAL; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; Schunemann HJ, 2009, AM J RESP CRIT CARE, V180, P564, DOI 10.1164/rccm.200901-0126ST; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shrier I, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-19; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Steinbrook R, 2009, NEW ENGL J MED, V360, P2160, DOI 10.1056/NEJMp0810200; World Health Organization, WHO HDB GUID DEV; NATL GUIDELINE CLEAR	17	229	241	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					738	741		10.7326/0003-4819-152-11-201006010-00254	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00254			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20479011				2022-12-28	WOS:000278560000008
J	Levy, ED; Landry, CR; Michnick, SW				Levy, Emmanuel D.; Landry, Christian R.; Michnick, Stephen W.			Signaling Through Cooperation	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; NETWORK; SPECIFICITY		[Levy, Emmanuel D.; Michnick, Stephen W.] Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada; [Landry, Christian R.] Univ Laval, Dept Biol, PROTEO, Quebec City, PQ G1K 7P4, Canada; [Landry, Christian R.] Inst Integrat & Syst Biol, Quebec City, PQ, Canada	Universite de Montreal; Laval University	Levy, ED (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3T 1J4, Canada.	stephen.michnick@umontreal.ca	Landry, Christian R/F-3890-2011	Landry, Christian/0000-0003-3028-6866				Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Bhardwaj N, 2010, P NATL ACAD SCI USA, V107, P6841, DOI 10.1073/pnas.0910867107; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Euskirchen G, 2004, NAT GENET, V36, P325, DOI 10.1038/ng0404-325; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Friedman A, 2007, CELL, V128, P225, DOI 10.1016/j.cell.2007.01.007; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203	16	42	44	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					983	984		10.1126/science.1190993	http://dx.doi.org/10.1126/science.1190993			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489011				2022-12-28	WOS:000277877100026
J	Jennings, MD; Pavitt, GD				Jennings, Martin D.; Pavitt, Graham D.			eIF5 has GDI activity necessary for translational control by eIF2 phosphorylation	NATURE			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; C-TERMINAL DOMAIN; EUKARYOTIC TRANSLATION; RIBOSOMAL-SUBUNIT; GTPASE ACTIVATION; GCN4 TRANSLATION; INITIATION; YEAST; COMPLEX; BINDING	In protein synthesis initiation, the eukaryotic translation initiation factor (eIF) 2 (a G protein) functions in its GTP-bound state to deliver initiator methionyl-tRNA (tRNA(i)(Met)) to the small ribosomal subunit and is necessary for protein synthesis in all cells(1,2). Phosphorylation of eIF2 [eIF2(alpha P)] is critical for translational control in diverse settings including nutrient deprivation, viral infection and memory formation(3-5). eIF5 functions in start site selection as a GTPase accelerating protein (GAP) for the eIF2.GTP.tRNA(i)(Met) ternary complex within the ribosome-bound pre-initiation complex(6-8). Here we define new regulatory functions of eIF5 in the recycling of eIF2 from its inactive eIF2.GDP state between successive rounds of translation initiation. First we show that eIF5 stabilizes the binding of GDP to eIF2 and is therefore a bi-functional protein that acts as a GDP dissociation inhibitor (GDI). We find that this activity is independent of the GAP function and identify conserved residues within eIF5 that are necessary for this role. Second we show that eIF5 is a critical component of the eIF2(alpha P) regulatory complex that inhibits the activity of the guanine-nucleotide exchange factor (GEF) eIF2B. Together our studies define a new step in the translation initiation pathway, one that is critical for normal translational controls.	[Jennings, Martin D.; Pavitt, Graham D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Pavitt, GD (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	graham.pavitt@manchester.ac.uk	Pavitt, Graham D/A-1363-2010; Jennings, martin/E-5240-2010	Pavitt, Graham D/0000-0002-8593-2418; Jennings, Martin/0000-0001-6173-0988	BBSRC [BB/E002005/1, BB/H010599/1]; Biotechnology and Biological Sciences Research Council [BB/H010599/1, BB/E002005/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Asano for plasmids and yeast strains, and discussions, and M. Ashe and members of the Pavitt and Ashe labs for discussions. This work was supported by grants BB/E002005/1 and BB/H010599/1 from the BBSRC to G. D. P.	Algire MA, 2005, MOL CELL, V20, P251, DOI 10.1016/j.molcel.2005.09.008; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; Conte MR, 2006, BIOCHEMISTRY-US, V45, P4550, DOI 10.1021/bi052387u; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Das S, 2001, J BIOL CHEM, V276, P6720, DOI 10.1074/jbc.M008863200; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DEVER TE, 1995, MOL CELL BIOL, V15, P6351; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Mohammad-Qureshi SS, 2007, MOL CELL BIOL, V27, P5225, DOI 10.1128/MCB.00495-07; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Paulin FEM, 2001, CURR BIOL, V11, P55, DOI 10.1016/S0960-9822(00)00025-7; Pavitt GD, 1997, MOL CELL BIOL, V17, P1298, DOI 10.1128/MCB.17.3.1298; Pavitt GD, 1998, GENE DEV, V12, P514, DOI 10.1101/gad.12.4.514; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Singh CR, 2006, EMBO J, V25, P4537, DOI 10.1038/sj.emboj.7601339; Singh CR, 2005, MOL CELL BIOL, V25, P5480, DOI 10.1128/MCB.25.13.5480-5491.2005; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037	29	77	78	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					378	U142		10.1038/nature09003	http://dx.doi.org/10.1038/nature09003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485439	Green Accepted			2022-12-28	WOS:000277829200047
J	Wilson, CA; Tsuchida, MA; Allen, GM; Barnhart, EL; Applegate, KT; Yam, PT; Ji, L; Keren, K; Danuser, G; Theriot, JA				Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Applegate, Kathryn T.; Yam, Patricia T.; Ji, Lin; Keren, Kinneret; Danuser, Gaudenz; Theriot, Julie A.			Myosin II contributes to cell-scale actin network treadmilling through network disassembly	NATURE			English	Article							F-ACTIN; MIGRATING CELLS; MOTILITY; CYTOKINESIS; FILAMENTS; TURNOVER; DYNAMICS; BLEBBISTATIN; LOCALIZATION; PROTRUSION	Crawling locomotion of eukaryotic cells is achieved by a process dependent on the actin cytoskeleton(1): protrusion of the leading edge requires assembly of a network of actin filaments(2), which must be disassembled at the cell rear for sustained motility. Although ADF/cofilin proteins have been shown to contribute to actin disassembly(3), it is not clear how activity of these locally acting proteins could be coordinated over the distance scale of the whole cell. Here we show that non-muscle myosin II has a direct role in actin network disassembly in crawling cells. In fish keratocytes undergoing motility, myosin II is concentrated in regions at the rear with high rates of network disassembly. Activation of myosin II by ATP in detergent-extracted cytoskeletons results in rear-localized disassembly of the actin network. Inhibition of myosin II activity and stabilization of actin filaments synergistically impede cell motility, suggesting the existence of two disassembly pathways, one of which requires myosin II activity. Our results establish the importance of myosin II as an enzyme for actin network disassembly; we propose that gradual formation and reorganization of an actomyosin network provides an intrinsic destruction timer, enabling long-range coordination of actin network treadmilling in motile cells.	[Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Yam, Patricia T.; Keren, Kinneret; Theriot, Julie A.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Wilson, Cyrus A.; Tsuchida, Mark A.; Allen, Greg M.; Barnhart, Erin L.; Yam, Patricia T.; Keren, Kinneret; Theriot, Julie A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Applegate, Kathryn T.; Ji, Lin; Danuser, Gaudenz] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Theriot, Julie A.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Scripps Research Institute; Stanford University	Theriot, JA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	theriot@stanford.edu	Theriot, Julie/HHN-2034-2022; Tsuchida, Mark/B-8180-2008	Tsuchida, Mark/0000-0003-4048-6220; Danuser, Gaudenz/0000-0001-8583-2014; Allen, Gregory/0000-0002-0032-8140; Theriot, Julie/0000-0002-2334-2535; Yam, Patricia/0000-0002-3631-3151; Keren, Kinneret/0000-0002-2962-6977	National Institutes of Health [R01AI067712, T32GM007276, U54GM64346, U01GM67230]; Stanford Medical Scientist Training Program; Howard Hughes Medical Institute; Stanford Graduate Fellowship; Skye International Foundation; National Science Foundation; Damon Runyon Cancer Research Foundation (DRG) [1854-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, T32GM007276, U01GM067230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stanford Graduate Fellowship(Stanford University); Skye International Foundation; National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation (DRG); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. J. Footer for the gift of purified GST-villin, A. Mogilner and S. Sivaramakrishnan for discussions, and Z. Pincus, N. Dye and T.Y.-C. Tsai for reading the manuscript. C. A. W. and J. A. T. were supported by National Institutes of Health grant R01AI067712 (J. A. T.). M. A. T. and E. L. B. were supported by National Institutes of Health grant T32GM007276. G. M. A. was supported by the Stanford Medical Scientist Training Program. P.T.Y. was supported by a Howard Hughes Medical Institute Predoctoral Fellowship, Stanford Graduate Fellowship and a Skye International Foundation Scholarship. K. T. A. was supported by a National Science Foundation Graduate Research Fellowship. K. K. was a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-#1854-05). K. T. A., L. J. and G. D. were supported by National Institutes of Health grants U54GM64346 and U01GM67230 (G. D.). J. A. T. was supported by the Howard Hughes Medical Institute.	ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; BRETSCHER A, 1980, CELL, V20, P839, DOI 10.1016/0092-8674(80)90330-X; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; EUTENEUER U, 1984, NATURE, V310, P58, DOI 10.1038/310058a0; GLENNEY JR, 1981, CELL, V24, P471, DOI 10.1016/0092-8674(81)90338-X; Guha M, 2005, CURR BIOL, V15, P732, DOI 10.1016/j.cub.2005.03.042; Haviv L, 2008, J MOL BIOL, V375, P325, DOI 10.1016/j.jmb.2007.09.066; Ji L, 2005, J MICROSC-OXFORD, V220, P150, DOI 10.1111/j.1365-2818.2005.01522.x; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Sai X, 2008, CURR BIOL, V18, P976, DOI 10.1016/j.cub.2008.05.049; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; SMALL JV, 1994, J STRUCT BIOL, V113, P135, DOI 10.1006/jsbi.1994.1043; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2004, P NATL ACAD SCI USA, V101, P9660, DOI 10.1073/pnas.0300552101; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; Wilson CA, 2006, IEEE T IMAGE PROCESS, V15, P1939, DOI 10.1109/TIP.2006.873434; Yam PT, 2007, J CELL BIOL, V178, P1207, DOI 10.1083/jcb.200706012; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894	29	277	280	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					373	U137		10.1038/nature08994	http://dx.doi.org/10.1038/nature08994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485438	Green Accepted			2022-12-28	WOS:000277829200046
J	Costello, EJ; Erkanli, A; Copeland, W; Angold, A				Costello, E. Jane; Erkanli, Alaattin; Copeland, William; Angold, Adrian			Association of Family Income Supplements in Adolescence With Development of Psychiatric and Substance Use Disorders in Adulthood Among an American Indian Population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHILDRENS MENTAL-HEALTH; ASSESSMENT CAPA; CONDUCT DISORDER; TAX EXPERIMENT; POVERTY; AGE; COMMUNITY; PSYCHOPATHOLOGY; TRAJECTORIES; COMORBIDITY	Context In a natural experiment in which some families received income supplements, prevalence of adolescent behavioral symptoms decreased significantly. These adolescents are now young adults. Objective To examine the effects of income supplements in adolescence and adulthood on the prevalence of adult psychiatric disorders. Design Quasi-experimental, longitudinal. Population and Setting A representative sample of children aged 9, 11, or 13 years in 1993 (349 [25%] of whom are American Indian) were assessed for psychiatric and substance use disorders through age 21 years (1993-2006). Of the 1420 who participated in 1993, 1185 were interviewed as adults. From 1996, when a casino opened on the Indian reservation, every American Indian but no non-Indians received an annual income supplement that increased from $500 to around $9000. Main Outcome Measures Prevalence of adult psychiatric disorders and substance use disorders based on the Diagnostic and Statistical Manual of Mental Disorders in 3 age cohorts, adjusted for age, sex, length of time in the family home, and number of Indian parents. Results As adults, significantly fewer Indians than non-Indians had a psychiatric disorder (106 Indians [weighted 30.2%] vs 337 non-Indians [weighted 36.0%]; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.30-0.72; P=.001), particularly alcohol and cannabis abuse, dependence, or both. The youngest age-cohort of Indian youth had the longest exposure to the family income. Interactions between race/ethnicity and age cohort were significant. Planned comparisons showed that fewer of the youngest Indian age-cohort had any psychiatric disorder (31.4%) than the Indian middle cohort (41.7%; OR, 0.43; 95% CI, 0.24-0.78; P=.005) or oldest cohort (41.3%; OR, 0.69; 95% CI, 0.51-0.94; P=.01) or the youngest non-Indian cohort (37.1%; OR, 0.66; 95% CI, 0.48-0.90; P=.008). Study hypotheses were not upheld for nicotine or other drugs, or emotional or behavioral disorders. The income supplement received in adulthood had no impact on adult psychopathology. Conclusion Lower prevalence of psychopathology in American Indian youth following a family income supplement, compared with the nonexposed, non-Indian population, persisted into adulthood. JAMA. 2010; 303(19): 1954-1960	[Costello, E. Jane] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Duke Univ, Sch Med, Dev Epidemiol Program, Durham, NC 27710 USA	Duke University; Duke University	Costello, EJ (corresponding author), Duke Univ, Sch Med, Dept Psychiat & Behav Sci, POB 3454, Durham, NC 27710 USA.	jcostell@psych.duhs.duke.edu	Copeland, William E/N-5413-2014; Duran, Bonnie m/A-3029-2009	Copeland, William E/0000-0002-1348-7781; 	National Institute of Mental Health [MH63970, MH63671, MH48085]; National Institute on Drug Abuse [DA11301, DA023026]; National Alliance for Research on Schizophrenia and Depression; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048085, K23MH080230, R01MH063671, R01MH063970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA023026, R01DA011301] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Alliance for Research on Schizophrenia and Depression(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding/Support: The study was supported by grants MH63970, MH63671, and MH48085 from the National Institute of Mental Health, DA11301 and DA023026 from the National Institute on Drug Abuse, and National Alliance for Research on Schizophrenia and Depression. These institutions provided financial support for every aspect of the study.	Akee RKQ, 2010, AM ECON J-APPL ECON, V2, P86, DOI 10.1257/app.2.1.86; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X; ANGOLD A, 1995, PSYCHOL MED, V25, P755, DOI 10.1017/S0033291700034991; Angold A, 2000, J AM ACAD CHILD PSY, V39, P39, DOI 10.1097/00004583-200001000-00015; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berger LM, 2009, CHILD YOUTH SERV REV, V31, P978, DOI 10.1016/j.childyouth.2009.04.013; BURNS BJ, 1995, HEALTH AFFAIR, V14, P147, DOI 10.1377/hlthaff.14.3.147; BURTLESS G, 1978, J POLIT ECON, V86, P1103, DOI 10.1086/260730; Conger RD, 1999, AM J COMMUN PSYCHOL, V27, P519, DOI 10.1023/A:1022133228206; Costello EJ, 2007, DRUG ALCOHOL DEPEN, V88, pS50, DOI 10.1016/j.drugalcdep.2006.12.009; Costello EJ, 2007, AM J PSYCHIAT, V164, P36, DOI 10.1176/appi.ajp.164.1.36; Costello EJ, 1996, ARCH GEN PSYCHIAT, V53, P1129; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DUNCAN GJ, 1988, J MARRIAGE FAM, V50, P1007, DOI 10.2307/352111; Elder G. H., 1999, CHILDREN GREAT DEPRE; ELESH D, 1977, J HEALTH SOC BEHAV, V18, P391, DOI 10.2307/2955347; Epps SR, 2007, SOC SCI QUART, V88, P344, DOI 10.1111/j.1540-6237.2007.00461.x; Evans W. N., 2002, SOCIAL EC IMPACT NAT; Foster EM, 2005, AM J PUBLIC HEALTH, V95, P1767, DOI 10.2105/AJPH.2004.061424; Foster H, 2010, DEVIANT BEHAV, V31, P440, DOI 10.1080/01639620903231340; Gennetian LA, 2002, CHILD DEV, V73, P601, DOI 10.1111/1467-8624.00426; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; Insel TR, 2005, JAMA-J AM MED ASSOC, V294, P2221, DOI 10.1001/jama.294.17.2221; Kellam SG, 2008, DRUG ALCOHOL DEPEN, V95, pS5, DOI 10.1016/j.drugalcdep.2008.01.004; Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674; Kessler RC, 2008, AM J PSYCHIAT, V165, P703, DOI 10.1176/appi.ajp.2008.08010126; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McLeod JD, 1996, J HEALTH SOC BEHAV, V37, P207, DOI 10.2307/2137292; Perkonigg A, 2006, EUR ADDICT RES, V12, P187, DOI 10.1159/000094421; Rutter M, 2003, JAMA-J AM MED ASSOC, V290, P2063, DOI 10.1001/jama.290.15.2063; RUTTER M, 1989, INT J BEHAV DEV, V12, P1, DOI 10.1177/016502548901200101; *SAS I INC, 2004, SAS STAT SOFTW COMP; SCHAIE K W, 1965, Psychol Bull, V64, P92, DOI 10.1037/h0022371; Schweinhart LJ, 1997, EARLY CHILD RES Q, V12, P117, DOI 10.1016/S0885-2006(97)90009-0; Scott S, 2001, BRIT MED J, V323, P191, DOI 10.1136/bmj.323.7306.191; SPIEGELMAN RG, 1980, J HUM RESOUR, V15, P463, DOI 10.2307/145397; Sung MJ, 2004, DRUG ALCOHOL DEPEN, V75, P287, DOI 10.1016/j.drugalcdep.2004.03.013; von Sydow K, 2001, DRUG ALCOHOL DEPEN, V64, P347, DOI 10.1016/S0376-8716(01)00137-5; WRIGHT S, 1974, SOC FORCES, V53, P552	41	113	113	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1954	1960		10.1001/jama.2010.621	http://dx.doi.org/10.1001/jama.2010.621			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597NJ	20483972	Bronze, Green Accepted			2022-12-28	WOS:000277764500022
J	Han, JC; Lawlor, DA; Kimm, SYS				Han, Joan C.; Lawlor, Debbie A.; Kimm, Sue Y. S.			Childhood obesity	LANCET			English	Article							BODY-MASS INDEX; EARLY-ONSET OBESITY; LOW-CARBOHYDRATE DIET; WEIGHT-LOSS; RISK-FACTORS; PHYSICAL-ACTIVITY; PROOPIOMELANOCORTIN POMC; NEUROTROPHIC FACTOR; SUBSEQUENT OBESITY; MISSENSE MUTATION	Worldwide prevalence of childhood obesity has increased greatly during the past three decades. The increasing occurrence in children of disorders such as type 2 diabetes is believed to be a consequence of this obesity epidemic. Much progress has been made in understanding of the genetics and physiology of appetite control and from these advances, elucidation of the causes of some rare obesity syndromes. However, these rare disorders have so far taught us few lessons about prevention or reversal of obesity in most children. Calorie intake and activity recommendations need reassessment and improved quantification at a population level because of sedentary lifestyles of children nowadays. For individual treatment, currently recommended calorie prescriptions might be too conservative in view of evolving insight into the so-called energy gap. Although quality of research into both prevention and treatment has improved, high-quality multicentre trials with long-term follow-up are needed. Meanwhile, prevention and treatment approaches to increase energy expenditure and decrease intake should continue. Recent data suggest that the spiralling increase in childhood obesity prevalence might be abating; increased efforts should be made on all fronts to continue this potentially exciting trend.	[Kimm, Sue Y. S.] Univ New Mexico, Hlth Sci Ctr, Dept Internal Med Epidemiol, Sch Med, Albuquerque, NM 87131 USA; [Han, Joan C.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Growth & Obes, Program Dev Endocrinol & Genet, NIH,DHHS, Bethesda, MD USA; [Lawlor, Debbie A.] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Dept Social Med, Bristol, Avon, England	University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Bristol	Kimm, SYS (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Internal Med Epidemiol, Sch Med, MSC 10 5550, Albuquerque, NM 87131 USA.	kimm@pitt.edu		Han, Joan/0000-0003-4252-2678; Lawlor, Debbie A/0000-0002-6793-2262	Eunice Kennedy Shriver National Institute of Child Health and Human Development; US National Institutes of Health [R01 DK077659]; UK Medical Research Council [G0600705, G0801456]; National Institute for Health Research [RP-PG-0407-10044]; MRC [G0801456, G0600705] Funding Source: UKRI; Medical Research Council [G0600705, G0801456] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077659] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JCH receives research support from the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and is a commissioned officer in the US Public Health Service, Department of Health and Human Services. The funding source had no direct role in writing of this Seminar. DAL receives funding from the US National Institutes of Health (R01 DK077659), UK Medical Research Council (G0600705 and G0801456), and National Institute for Health Research (RP-PG-0407-10044) for her work in the area of childhood obesity and determining causality from observational research. The opinions and assertions expressed in this report are those of the authors and are not to be construed as reflecting the views of the US Public Health Service or any other funding body.	Al Mamun A, 2007, AM J EPIDEMIOL, V166, P1368, DOI 10.1093/aje/kwm224; Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Atkinson RL, 2005, INT J OBESITY, V29, P281, DOI 10.1038/sj.ijo.0802830; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bassett DR, 2008, APPL PHYSIOL NUTR ME, V33, P831, DOI 10.1139/H08-044; Bau AM, 2009, EUR J ENDOCRINOL, V160, P107, DOI 10.1530/EJE-08-0594; Berkowitz JM, 2008, AM J PREV MED, V34, pS257, DOI 10.1016/j.amepre.2008.03.005; Berkowitz RI, 2006, ANN INTERN MED, V145, P81, DOI 10.7326/0003-4819-145-2-200607180-00005; Berman Y, 2001, J BIOL CHEM, V276, P1466, DOI 10.1074/jbc.M008499200; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bonny AE, 2006, ARCH PEDIAT ADOL MED, V160, P40, DOI 10.1001/archpedi.160.1.40; Braet C, 2003, EUR J PEDIATR, V162, P391, DOI 10.1007/s00431-003-1155-5; Braet C, 2006, OBESITY, V14, P148, DOI 10.1038/oby.2006.18; Brion MJA, 2010, AM J CLIN NUTR, V91, P748, DOI 10.3945/ajcn.2009.28623; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Butte NF, 2003, SCIENCE, V301; Calcaterra V, 2008, CLIN ENDOCRINOL, V68, P868, DOI 10.1111/j.1365-2265.2007.03115.x; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Chanoine JP, 2005, JAMA-J AM MED ASSOC, V293, P2873, DOI 10.1001/jama.293.23.2873; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Cole T J, 2004, BMC Pediatr, V4, P6; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Correll CU, 2009, JAMA-J AM MED ASSOC, V302, P1765, DOI 10.1001/jama.2009.1549; Creemers JWM, 2008, J CLIN ENDOCR METAB, V93, P4494, DOI 10.1210/jc.2008-0954; Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Daniels SR, 2009, CIRCULATION, V119, pE489, DOI 10.1161/CIRCULATIONAHA.109.192216; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Demol S, 2009, ACTA PAEDIATR, V98, P346, DOI 10.1111/j.1651-2227.2008.01051.x; Denzer C, 2007, INT J OBESITY, V31, P1509, DOI 10.1038/sj.ijo.0803691; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; Doyle AC, 2008, J ADOLESCENT HEALTH, V43, P172, DOI 10.1016/j.jadohealth.2008.01.011; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Ebbeling CB, 2003, ARCH PEDIAT ADOL MED, V157, P773, DOI 10.1001/archpedi.157.8.773; EPSTEIN LH, 1990, JAMA-J AM MED ASSOC, V264, P2519, DOI 10.1001/jama.264.19.2519; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Feigerlova E, 2008, J CLIN ENDOCR METAB, V93, P2800, DOI 10.1210/jc.2007-2138; Feng NP, 2005, DIABETES, V54, P2663, DOI 10.2337/diabetes.54.9.2663; FIGUEROACOLON R, 1993, AM J DIS CHILD, V147, P160, DOI 10.1001/archpedi.1993.02160260050021; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Freedman DS, 2008, INT J OBESITY, V32, P749, DOI 10.1038/sj.ijo.0803798; Freedman DS, 2006, OBESITY, V14, P301, DOI 10.1038/oby.2006.39; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gately PJ, 2005, PEDIATRICS, V116, P73, DOI 10.1542/peds.2004-0397; Gilliland FD, 2003, AM J EPIDEMIOL, V158, P406, DOI 10.1093/aje/kwg175; Gonzalez-Suarez C, 2009, AM J PREV MED, V37, P418, DOI 10.1016/j.amepre.2009.07.012; Gordon JE, 2006, J BONE JOINT SURG BR, V88B, P100, DOI 10.1302/0301-620X.88B1.16918; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Hawkins SS, 2009, J EPIDEMIOL COMMUN H, V63, P147, DOI 10.1136/jech.2008.077917; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Hughes AR, 2008, PEDIATRICS, V121, pE539, DOI 10.1542/peds.2007-1786; Huhman ME, 2007, AM J PREV MED, V32, P38, DOI 10.1016/j.amepre.2006.08.030; Inge TH, 2005, J PEDIATR-US, V147, P10, DOI 10.1016/j.jpeds.2005.03.021; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Johnston CA, 2007, PEDIATRICS, V120, pE1450, DOI 10.1542/peds.2006-3321; Jouret B, 2009, INT J OBESITY, V33, P1075, DOI 10.1038/ijo.2009.166; Justus MB, 2007, J SCHOOL HEALTH, V77, P706, DOI 10.1111/j.1746-1561.2007.00255.x; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kipping RR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1824; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2009, J NUTR, V139, p417S, DOI 10.3945/jn.108.097675; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lawlor DA, 2008, PLOS MED, V5, P484, DOI 10.1371/journal.pmed.0050033; Lee M, 2009, PITUITARY, V12, P87, DOI 10.1007/s11102-008-0096-4; Lee YS, 2002, J CLIN ENDOCR METAB, V87, P1423, DOI 10.1210/jc.87.3.1423; LI L, 2009, J EPIDEMIOL COMMU S2, V63, pA11; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Long DN, 2007, J CLIN ENDOCR METAB, V92, P1073, DOI 10.1210/jc.2006-1497; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P2586, DOI 10.1210/jc.2002-030003; MacMahon B, 1970, EPIDEMIOLOGY PRINCIP; Malone M, 2005, ANN PHARMACOTHER, V39, P2046, DOI 10.1345/aph.1G333; Mamun AA, 2009, INT J OBESITY, V33, P14, DOI 10.1038/ijo.2008.220; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Mayer EIE, 2000, HORM RES, V53, P193, DOI 10.1159/000023566; McClung JP, 2009, NUTR REV, V67, P100, DOI 10.1111/j.1753-4887.2008.00145.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moreno LA, 2007, CURR OPIN CLIN NUTR, V10, P336, DOI 10.1097/MCO.0b013e3280a94f59; Moussa NM, 1999, OBES RES, V7, P506, DOI 10.1002/j.1550-8528.1999.tb00440.x; Murray AW, 2008, J BONE JOINT SURG BR, V90B, P92, DOI 10.1302/0301-620X.90B1.19502; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; National Institute for HealthandClinical Excellence, 2006, OB PREV ID ASS MAN O; Nead KG, 2004, PEDIATRICS, V114, P104, DOI 10.1542/peds.114.1.104; NEEL JV, 1962, AM J HUM GENET, V14, P353; Neovius MG, 2004, AM J CLIN NUTR, V80, P597; Nielsen SJ, 2002, OBES RES, V10, P370, DOI 10.1038/oby.2002.51; Nihiser AJ, 2009, PEDIATRICS, V124, pS89, DOI 10.1542/peds.2008-3586L; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Owen CG, 2009, INT J OBESITY, V33, P866, DOI 10.1038/ijo.2009.102; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Pfeifer SM, 2009, OBSTET GYN CLIN N AM, V36, P129, DOI 10.1016/j.ogc.2008.12.004; Resnicow K, 2006, J AM DIET ASSOC, V106, P2024, DOI 10.1016/j.jada.2006.09.015; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Rose G., 2008, ROSES STRATEGY PREVE; Rosenfield RL, 2009, PEDIATRICS, V123, P84, DOI 10.1542/peds.2008-0146; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Santamaria F, 2007, J ALLERGY CLIN IMMUN, V120, P965, DOI 10.1016/j.jaci.2007.06.002; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shalitin S, 2009, HORM RES, V72, P287, DOI 10.1159/000245931; Sondike SB, 2003, J PEDIATR-US, V142, P253, DOI 10.1067/mpd.2003.4; Sothern MS, 2000, ACTA PAEDIATR, V89, P1036, DOI 10.1080/713794562; Spear BA, 2007, PEDIATRICS, V120, pS254, DOI 10.1542/peds.2007-2329F; Stamler J, 2008, J AM DIET ASSOC, V108, P228, DOI 10.1016/j.jada.2007.12.033; Stewart L, 2005, J AM DIET ASSOC, V105, P1810, DOI 10.1016/j.jada.2005.08.006; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Sutherland ER, 2008, IMMUNOL ALLERGY CLIN, V28, P589, DOI 10.1016/j.iac.2008.03.003; Swinburn BA, 2009, AM J CLIN NUTR, V89, P1723, DOI 10.3945/ajcn.2008.27061; Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832; Taylor RW, 2005, CURR OPIN CLIN NUTR, V8, P607, DOI 10.1097/01.mco.0000168391.60884.93; Timpson NJ, 2009, J BONE MINER RES, V24, P522, DOI 10.1359/JBMR.081109; Treadwell JR, 2008, ANN SURG, V248, P763, DOI 10.1097/SLA.0b013e31818702f4; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Weaver JU, 2008, FRONT HORM RES, V36, P212, DOI 10.1159/000115367; Welsh Anne, 1993, USDAS FOOD GUIDE BAC; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wong Faye, 2004, Prev Chronic Dis, V1, pA10; Yajnik CS, 2002, J CLIN ENDOCR METAB, V87, P5575, DOI 10.1210/jc.2002-020434; Yamamoto JA, 2005, J ADOLESCENT HEALTH, V37, P397, DOI 10.1016/j.jadohealth.2004.10.002; Yanoff LB, 2006, CLIN ENDOCRINOL, V64, P523, DOI 10.1111/j.1365-2265.2006.02502.x; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	140	1020	1063	4	265	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1737	1748		10.1016/S0140-6736(10)60171-7	http://dx.doi.org/10.1016/S0140-6736(10)60171-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20451244	Green Accepted			2022-12-28	WOS:000277890200035
J	Zebaze, RMD; Ghasem-Zadeh, A; Bohte, A; Iuliano-Burns, S; Mirams, M; Price, RI; Mackie, EJ; Seeman, E				Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Mirams, Michiko; Price, Roger Ian; Mackie, Eleanor J.; Seeman, Ego			Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study	LANCET			English	Article							BONE-MINERAL DENSITY; CORTICAL BONE; FRACTURE; OSTEOPOROSIS; PROPORTION; MORPHOLOGY; STRENGTH; RISK	Background Osteoporosis research has focused on vertebral fractures and trabecular bone loss. However, non-vertebral fractures at predominantly cortical sites account for 80% of all fractures and most fracture-related morbidity and mortality in old age. We aimed to re-examine cortical bone as a source of bone loss in the appendicular skeleton. Methods In this cross-sectional study, we used high-resolution peripheral CT to quantify and compare cortical and trabecular bone loss from the distal radius of adult women, and measured porosity using scanning electron microscopy. Exclusion criteria were diseases or prescribed drugs affecting bone metabolism. We also measured bone mineral density of post-mortem hip specimens from female cadavers using densitometry. Age-related differences in total, cortical, and trabecular bone mass, trabecular bone of cortical origin, and cortical and trabecular densities were calculated. Findings We investigated 122 white women with a mean age of 62.8 (range 27-98) years. Between ages 50 and 80 years (n=89), 72.1 mg (95% CI 67.7-76.4) hydroxyapatite (68%) of 106.5 mg hydroxyapatite of bone lost at the distal radius was cortical and 34.3 mg (30.5-37.8) hydroxyapatite (32%) was trabecular; 17.1 mg (11-7-22.5) hydroxyapatite (16%) of total bone loss occurred between ages 50 and 64 years (n=34) and 89.4 mg (83.7-101.1) hydroxyapatite (84%) after age 65 years (n=55). Remodelling within cortex adjacent to the marrow accounted for 49.9 mg (45.4-53.7) hydroxyapatite (47%) of bone loss. Between ages 50-64 years (n=34) and 80 years and older (n=33), cortical density decreased by 127.8 mg (93.1-162.1) hydroxyapatite per cm(3) (15%, p<0.0001) before porosity trabecularising the cortex was included, but 374.3 mg (318.2-429.5) hydroxyapatite per cm(3) (43%, p<0.0001) after; trabecular density decreased by 18.2 mg (-1.4 to 38.2) hydroxyapatite per cm(3) (14%, p=0.06) before cortical remnants were excluded, but 68.7 mg (37.7-90.4) hydroxyapatite per cm(3) (52%, p<0.0001) after. Interpretation Accurate assessment of bone structure, especially porosity producing cortical remnants, could improve identification of individuals at high and low risk of fracture and therefore assist targeting of treatment.	[Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Seeman, Ego] Univ Melbourne, Dept Med, Austin Hlth, Melbourne, Vic, Australia; [Zebaze, Roger M. D.; Ghasem-Zadeh, Ali; Bohte, Ann; Iuliano-Burns, Sandra; Seeman, Ego] Univ Melbourne, Dept Endocrinol, Austin Hlth, Melbourne, Vic, Australia; [Price, Roger Ian] Univ Western Australia, Dept Med Technol & Phys, Perth, WA 6009, Australia; [Mirams, Michiko; Mackie, Eleanor J.] Univ Melbourne, Dept Vet Sci, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Western Australia; University of Melbourne	Zebaze, RMD (corresponding author), Austin Hlth, Dept Endocrinol, Centaur Bldg,Repatriat Campus,Waterdale Rd, Heidelberg, Vic 3084, Australia.	zebaze@unimelb.edu.au	Seeman, Ego/AAC-3656-2019; Mackie, Eleanor J/B-2045-2008	Seeman, Ego/0000-0002-9692-048X; Mackie, Eleanor J/0000-0002-8057-5407	Australia National Health and Medical Research Council [400139, 566916]	Australia National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australia National Health and Medical Research Council (project grants 400139 and 566916).	Albright F, 1941, J AMER MED ASSOC, V116, P2465, DOI 10.1001/jama.1941.02820220007002; BARTH RW, 1992, CLIN ORTHOP RELAT R, P178; Borah B, 2010, J BONE MINER RES, V25, P41, DOI 10.1359/jbmr.090711; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; BURGHARDT AJ, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091104; De Geronimo S, 2006, EUR J ENDOCRINOL, V155, P415, DOI 10.1530/eje.1.02225; Delmas PD, 2002, LANCET, V359, P2018, DOI 10.1016/S0140-6736(02)08827-X; DEMPSTER DW, 1994, J CLIN ENDOCR METAB, V84, P1562; Diab T, 2005, BONE, V37, P96, DOI 10.1016/j.bone.2005.03.014; EASTELL R, 1990, J BONE MINER RES, V5, P1237; Eswaran SK, 2007, COMPUT METHOD APPL M, V196, P3025, DOI 10.1016/j.cma.2006.06.017; FOLDES J, 1991, J BONE MINER RES, V6, P759; Han ZH, 1996, J BONE MINER RES, V11, P1967; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P989, DOI 10.1007/s001980170006; Laib A, 1998, Technol Health Care, V6, P329; Martin RB., 1989, STRUCTURE FUNCTION; MAZESS RB, 1982, CLIN ORTHOP RELAT R, P239; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; NISHIYAMA KK, 2009, J BONE MINER RES, DOI DOI 10.1359/JBMR.091020; NOTTESTAD SY, 1987, J BONE MINER RES, V2, P221; Parfitt A. M., 1996, P315; PARFITT AM, 1989, CLIN DISORDERS BONE; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; RIGGS BL, 1981, J CLIN INVEST, V67, P328, DOI 10.1172/JCI110039; ROCKOFF SD, 1969, CALC TISS RES, V3, P163, DOI 10.1007/BF02058659; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; Seeman E, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P3; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7	30	573	601	1	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1729	1736		10.1016/S0140-6736(10)60320-0	http://dx.doi.org/10.1016/S0140-6736(10)60320-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472174				2022-12-28	WOS:000277890200034
J	Larrea, AA; Lujan, SA; Kunkel, TA				Larrea, Andres A.; Lujan, Scott A.; Kunkel, Thomas A.			SnapShot: DNA Mismatch Repair	CELL			English	Editorial Material									[Larrea, Andres A.; Lujan, Scott A.; Kunkel, Thomas A.] NIEHS, NIH, DHHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Larrea, AA (corresponding author), NIEHS, NIH, DHHS, POB 12233, Res Triangle Pk, NC 27709 USA.		Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Lujan, Scott/0000-0003-2400-8325	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065089] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Kadyrov FA, 2009, P NATL ACAD SCI USA, V106, P8495, DOI 10.1073/pnas.0903654106; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin Z, 2007, NUCLEIC ACIDS RES, V35, P7591, DOI 10.1093/nar/gkm921	9	68	75	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4								10.1016/j.cell.2010.05.002	http://dx.doi.org/10.1016/j.cell.2010.05.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478261	Bronze			2022-12-28	WOS:000277623600025
J	Mackinnon, MJ; Marsh, K				Mackinnon, M. J.; Marsh, K.			The Selection Landscape of Malaria Parasites	SCIENCE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; RETROSPECTIVE EXAMINATION; REPRODUCTIVE RESTRAINT; ANTIGENIC DIVERSITY; PATHOGEN VIRULENCE; CLINICAL IMMUNITY; HOST ERYTHROCYTE; DRUG-RESISTANCE; GENOME; GENE	Malaria parasites have to survive and transmit within a highly selective and ever-changing host environment. Because immunity to malaria is nonsterilizing and builds up slowly through repeated infections, commonly the parasite invades a host that is immunologically and physiologically different from its previous host. During the course of infection, the parasite must also keep pace with changes in host immune responses and red-blood-cell physiology. Here, we describe the "selection landscape" of the most virulent of the human malaria parasites, Plasmodium falciparum, and the adaptive mechanisms it uses to navigate through that landscape. Taking a cost-benefit view of parasite fitness, we consider the evolutionary outcomes of the most important forces of selection operating on the parasite, namely immunity, host death, drugs, mosquito availability, and coinfection. Given the huge potential for malaria parasite evolution in the context of the recently renewed effort to eradicate malaria, a deeper understanding of P. falciparum adaptation is essential.	[Mackinnon, M. J.; Marsh, K.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Mackinnon, M. J.; Marsh, K.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England	Kenya Medical Research Institute; University of Oxford	Mackinnon, MJ (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, POB 230, Kilifi, Kenya.	mmackinnon@kilifi.kemri-wellcome.org	Mackinnon, Margaret/L-3155-2013	Mackinnon, Margaret/0000-0003-1279-9625	Wellcome Trust [088634, 077092]	Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to P. Bull, V. Thathy, S. Gandon, and an anonymous reviewer for useful comments. M.J.M. is supported by Wellcome Trust Project Grant 088634, and both authors are supported by Wellcome Trust Core Programme Grant 077092. M.J.M. is a member of the GlaxoSmithKline Biologicals advisory board for modeling malaria vaccines. This paper is published with the permission of the director of the Kenya Medical Research Institute.	ANDERS RF, 1993, ACTA TROP, V53, P239, DOI 10.1016/0001-706X(93)90032-7; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Buckee CO, 2009, P ROY SOC B-BIOL SCI, V276, P477, DOI 10.1098/rspb.2008.1122; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Collins WE, 2003, AM J TROP MED HYG, V68, P366, DOI 10.4269/ajtmh.2003.68.366; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Ferguson HM, 2003, EVOLUTION, V57, P2792, DOI 10.1111/j.0014-3820.2003.tb01521.x; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Francis SE, 2007, INFECT IMMUN, V75, P4838, DOI 10.1128/IAI.00635-07; Frank M, 2008, INT J PARASITOL, V38, P1099, DOI 10.1016/j.ijpara.2008.01.010; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gonzales JM, 2008, PLOS BIOL, V6, P2016, DOI 10.1371/journal.pbio.0060238; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; HENIKOFF S, 1994, GENETICS, V138, P1; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Hughes AL, 2004, J MOL EVOL, V59, P528, DOI 10.1007/s00239-004-2645-4; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Kidgell C, 2006, PLOS PATHOG, V2, P562, DOI 10.1371/journal.ppat.0020057; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; Mackinnon MJ, 2004, PLOS BIOL, V2, P1286, DOI 10.1371/journal.pbio.0020230; Mackinnon MJ, 2005, ACTA TROP, V94, P207, DOI 10.1016/j.actatropica.2005.04.006; Mackinnon MJ, 2004, PHILOS T R SOC B, V359, P965, DOI 10.1098/rstb.2003.1414; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mideo N, 2008, P ROY SOC B-BIOL SCI, V275, P1217, DOI 10.1098/rspb.2007.1545; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mota REM, 2009, AM J TROP MED HYG, V81, P935, DOI 10.4269/ajtmh.2009.08-0361; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; POLOGE LG, 1988, CELL, V55, P869, DOI 10.1016/0092-8674(88)90142-0; Porco TC, 2005, J THEOR BIOL, V233, P91, DOI 10.1016/j.jtbi.2004.09.009; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Recker M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-18; Ribacke U, 2007, MOL BIOCHEM PARASIT, V155, P33, DOI 10.1016/j.molbiopara.2007.05.005; Rieckmann KH, 2006, ANN TROP MED PARASIT, V100, P647, DOI 10.1179/136485906X112185; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Taylor LH, 1997, PARASITOL TODAY, V13, P135, DOI 10.1016/S0169-4758(97)89810-9; Timms R, 2001, PARASITOLOGY, V123, P1, DOI 10.1017/S0031182001008083; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wargo AR, 2007, P NATL ACAD SCI USA, V104, P19914, DOI 10.1073/pnas.0707766104; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; WELLEMS TE, 1990, NATURE, V345, P253, DOI 10.1038/345253a0; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6	59	110	116	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					866	871		10.1126/science.1185410	http://dx.doi.org/10.1126/science.1185410			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466925				2022-12-28	WOS:000277618800041
J	Chafen, JJS; Newberry, SJ; Riedl, MA; Bravata, DM; Maglione, M; Suttorp, MJ; Sundaram, V; Paige, NM; Towfigh, A; Hulley, BJ; Shekelle, PG				Chafen, Jennifer J. Schneider; Newberry, Sydne J.; Riedl, Marc A.; Bravata, Dena M.; Maglione, Margaret; Suttorp, Marika J.; Sundaram, Vandana; Paige, Neil M.; Towfigh, Ali; Hulley, Benjamin J.; Shekelle, Paul G.			Diagnosing and Managing Common Food Allergies A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COWS MILK ALLERGY; PLACEBO-CONTROLLED TRIAL; HIGH-RISK INFANTS; ATOPY PATCH TEST; BREAST-FED INFANTS; RANDOMIZED CONTROLLED-TRIAL; BRIEF NEONATAL EXPOSURE; DOUBLE-BLIND TRIAL; SKIN-PRICK TESTS; 1ST 2 YEARS	Context There is heightened interest in food allergies but no clear consensus exists regarding the prevalence or most effective diagnostic and management approaches to food allergies. Objective To perform a systematic review of the available evidence on the prevalence, diagnosis, management, and prevention of food allergies. Data Sources Electronic searches of PubMed, Cochrane Database of Systematic Reviews, Cochrane Database of Abstracts of Reviews of Effects, and Cochrane Central Register of Controlled Trials. Searches were limited to English-language articles indexed between January 1988 and September 2009. Study Selection Diagnostic tests were included if they had a prospective, defined study population, used food challenge as a criterion standard, and reported sufficient data to calculate sensitivity and specificity. Systematic reviews and randomized controlled trials (RCTs) for management and prevention outcomes were also used. For foods where anaphylaxis is common, cohort studies with a sample size of more than 100 participants were included. Data Extraction Two investigators independently reviewed all titles and abstracts to identify potentially relevant articles and resolved discrepancies by repeated review and discussion. Quality of systematic reviews and meta-analyses was assessed using the AMSTAR criteria, the quality of diagnostic studies using the QUADAS criteria most relevant to food allergy, and the quality of RCTs using the Jadad criteria. Data Synthesis A total of 12 378 citations were identified and 72 citations were included. Food allergy affects more than 1% to 2% but less than 10% of the population. It is unclear if the prevalence of food allergies is increasing. Summary receiver operating characteristic curves comparing skin prick tests (area under the curve [AUC], 0.87; 95% confidence interval [CI], 0.81-0.93) and serum food-specific IgE (AUC, 0.84; 95% CI, 0.78-0.91) to food challenge showed no statistical superiority for either test. Elimination diets are the mainstay of therapy but have been rarely studied. Immunotherapy is promising but data are insufficient to recommend use. In high-risk infants, hydrolyzed formulas may prevent cow's milk allergy but standardized definitions of high risk and hydrolyzed formula do not exist. Conclusion The evidence for the prevalence and management of food allergy is greatly limited by a lack of uniformity for criteria for making a diagnosis. JAMA. 2010; 303(18): 1848-1856	[Chafen, Jennifer J. Schneider; Bravata, Dena M.; Sundaram, Vandana] Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Chafen, Jennifer J. Schneider; Sundaram, Vandana] VA Palo Alto Healthcare Syst, Palo Alto, CA USA; [Newberry, Sydne J.; Maglione, Margaret; Suttorp, Marika J.; Paige, Neil M.; Towfigh, Ali; Hulley, Benjamin J.; Shekelle, Paul G.] Rand Hlth, So Calif Evidence Based Practice Ctr, Santa Monica, CA USA; [Riedl, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Paige, Neil M.; Towfigh, Ali; Shekelle, Paul G.] W Los Angeles VA Med Ctr, Los Angeles, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Chafen, JJS (corresponding author), Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, 117 Encina Commons, Stanford, CA 94305 USA.	jjschnei@stanford.edu			National Institutes of Health [HHSN272200800065C]; National Institute of Allergy and Infectious Diseases	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding/Support: This work was funded in part by contract HHSN272200800065C from the National Institutes of Health. This work was commissioned by National Institute of Allergy and Infectious Diseases in support of the development of practice guidelines.	Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; AGATA H, 1993, J ALLERGY CLIN IMMUN, V91, P668, DOI 10.1016/0091-6749(93)90273-I; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; BARDARE M, 1993, ANN ALLERGY, V71, P366; Ben-Shoshan M, 2009, J ALLERGY CLIN IMMUN, V123, P783, DOI 10.1016/j.jaci.2009.02.004; BINDSLEVJENSEN C, 1991, ALLERGY, V46, P610, DOI 10.1111/j.1398-9995.1991.tb00631.x; BIRD JA, 2010, ANN M AM AC ALL ASTH; Bollinger ME, 2006, ANN ALLERG ASTHMA IM, V96, P415, DOI 10.1016/S1081-1206(10)60908-8; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Branum Amy M, 2008, NCHS Data Brief, P1; Bucher X, 2004, ALLERGY, V59, P1272, DOI 10.1111/j.1398-9995.2004.00626.x; BURKS AW, 1988, J ALLERGY CLIN IMMUN, V81, P417, DOI [10.1016/0091-6749(88)90910-4, 10.1016/0091-6749(88)90185-6]; BURR ML, 1993, ARCH DIS CHILD, V68, P724, DOI 10.1136/adc.68.6.724; BUSINCO L, 1990, ALLERGOL IMMUNOPATH, V18, P339; Canani RB, 2007, ALLERGY, V62, P738, DOI 10.1111/j.1398-9995.2007.01351.x; CANT AJ, 1986, BRIT MED J, V293, P231, DOI 10.1136/bmj.293.6541.231; CAVAGNI G, 1989, IMMUNOPHARM IMMUNOT, V11, P131, DOI 10.3109/08923978909082147; CHANDRA RK, 1989, BMJ-BRIT MED J, V299, P228, DOI 10.1136/bmj.299.6693.228; CHANDRA RK, 1991, ANN ALLERGY, V67, P129; CHANDRA RK, 1989, ANN ALLERGY, V63, P102; CHANDRA RK, 1986, CLIN ALLERGY, V16, P563, DOI 10.1111/j.1365-2222.1986.tb01995.x; Cudowska B, 2005, Rocz Akad Med Bialymst, V50, P261; de Boissieu D, 2003, J PEDIATR-US, V142, P203, DOI 10.1067/mpd.2003.92; de Jong MH, 1998, ARCH DIS CHILD, V79, P126, DOI 10.1136/adc.79.2.126; de Jong MH, 2002, ARCH DIS CHILD, V86, P365, DOI 10.1136/adc.86.5.365; Dieguez MC, 2008, PEDIAT ALLERG IMM-UK, V19, P319, DOI 10.1111/j.1399-3038.2007.00652.x; Enrique E, 2005, J ALLERGY CLIN IMMUN, V116, P1073, DOI 10.1016/j.jaci.2005.08.027; Estelle F, 2001, J ALLERGY CLIN IMMUN, V107, P703, DOI 10.1067/mai.2001.113866; Ewan PW, 2001, LANCET, V357, P111, DOI 10.1016/S0140-6736(00)03543-1; FALTHMAGNUSSON K, 1992, J ALLERGY CLIN IMMUN, V89, P709, DOI 10.1016/0091-6749(92)90378-F; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; Garcia-Ara C, 2001, J ALLERGY CLIN IMMUN, V107, P185, DOI 10.1067/mai.2001.111592; Garzi A, 2002, Allergol Immunopathol (Madr), V30, P36; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Halken S, 1993, Pediatr Allergy Immunol, V4, P173, DOI 10.1111/j.1399-3038.1993.tb00088.x; Halken S, 2000, PEDIATR ALLERGY IMMU, V11, P149, DOI 10.1034/j.1399-3038.2000.00081.x; Halmerbauer G, 2002, PEDIAT ALLERG IMM-UK, V13, P47, DOI 10.1034/j.1399-3038.13.s.15.11.x; HATTEVIG G, 1989, CLIN EXP ALLERGY, V19, P27, DOI 10.1111/j.1365-2222.1989.tb02339.x; Hays T, 2005, ARCH PEDIAT ADOL MED, V159, P810, DOI 10.1001/archpedi.159.9.810; Hill DJ, 2005, PEDIATRICS, V116, pE709, DOI 10.1542/peds.2005-0147; Huurre A, 2008, CLIN EXP ALLERGY, V38, P1342, DOI 10.1111/j.1365-2222.2008.03008.x; Iacono G, 1998, NEW ENGL J MED, V339, P1100, DOI 10.1056/NEJM199810153391602; Isolauri E, 1996, J ALLERGY CLIN IMMUN, V97, P9, DOI 10.1016/S0091-6749(96)70277-4; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jarvinen KM, 2003, CLIN EXP ALLERGY, V33, P1060, DOI 10.1046/j.1365-2222.2003.01741.x; Jirapinyo P, 2007, ASIA PAC J CLIN NUTR, V16, P711; Juvonen P, 1996, ACTA PAEDIATR, V85, P1047, DOI 10.1111/j.1651-2227.1996.tb14215.x; Kagan RS, 2003, J ALLERGY CLIN IMMUN, V112, P1223, DOI 10.1016/j.jaci.2003.09.026; Kajosaari M, 1994, Pediatr Allergy Immunol, V5, P26, DOI 10.1111/j.1399-3038.1994.tb00344.x; Keskin O, 2005, ANN ALLERG ASTHMA IM, V94, P553, DOI 10.1016/S1081-1206(10)61133-7; Klemola T, 2002, J PEDIATR-US, V140, P219, DOI 10.1067/mpd.2002.121935; Koplin J, 2008, PEDIAT ALLERG IMM-UK, V19, P682, DOI 10.1111/j.1399-3038.2008.00731.x; KRAMER MS, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000133.PUB2; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; Kukkonen K, 2007, J ALLERGY CLIN IMMUN, V119, P192, DOI 10.1016/j.jaci.2006.09.009; Kvenshagen B, 2008, ACTA PAEDIATR, V97, P196, DOI 10.1111/j.1651-2227.2007.00599.x; Laubereau B, 2004, J PEDIATR-US, V144, P602, DOI 10.1016/j.jpeds.2003.12.029; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LILJA G, 1991, CLIN EXP ALLERGY, V21, P195, DOI 10.1111/j.1365-2222.1991.tb00830.x; LILJA G, 1989, CLIN EXP ALLERGY, V19, P473, DOI 10.1111/j.1365-2222.1989.tb02416.x; LINDFORS ATB, 1992, ALLERGY, V47, P207, DOI 10.1111/j.1398-9995.1992.tb00652.x; LITTENBERG B, 1993, MED DECIS MAKING, V13, P313, DOI 10.1177/0272989X9301300408; LIU H, 2009, ANN M AM AC ALL ASTH; LOVEGROVE JA, 1994, BRIT J NUTR, V71, P223, DOI 10.1079/BJN19940129; Marini A, 1996, ACTA PAEDIATR, V85, P1, DOI 10.1111/j.1651-2227.1996.tb14267.x; Mauro C, 2007, PEDIATR ALLERGY IMMU, V18, P583, DOI 10.1111/j.1399-3038.2007.00564.x; Mehl A, 2006, J ALLERGY CLIN IMMUN, V118, P923, DOI 10.1016/j.jaci.2006.07.003; Monti G, 2002, CLIN EXP ALLERGY, V32, P1515, DOI 10.1046/j.1365-2745.2002.01454.x; Morisset M, 2007, Eur Ann Allergy Clin Immunol, V39, P12; MUDD KE, 2010, ANN M AM AC ALL ASTH; Nelson HS, 1997, J ALLERGY CLIN IMMUN, V99, P744, DOI 10.1016/S0091-6749(97)80006-1; Nentwich I, 2001, ALLERGY, V56, P1144, DOI 10.1111/j.1398-9995.2001x.00926.x; Niggemann B, 2008, PEDIAT ALLERG IMM-UK, V19, P348, DOI 10.1111/j.1399-3038.2007.00653.x; Odelram H, 1996, ALLERGY, V51, P192, DOI 10.1111/j.1398-9995.1996.tb00063.x; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003741.pub4; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; Osterballe M, 2004, J AM ACAD DERMATOL, V51, P556, DOI 10.1016/j.jaad.2004.03.025; Patriarca G, 2007, DIGEST DIS SCI, V52, P1662, DOI 10.1007/s10620-006-9245-7; PERRY TT, 2009, ANN M AM AC ALL ASTH; POYSA L, 1988, ACTA PAEDIATR SCAND, V77, P563, DOI 10.1111/j.1651-2227.1988.tb10701.x; POYSA L, 1991, ALLERGY PROC, V12, P107, DOI 10.2500/108854191779011800; Rance F, 2002, J ALLERGY CLIN IMMUN, V109, P1027, DOI 10.1067/mai.2002.124775; Rautava S, 2002, J ALLERGY CLIN IMMUN, V109, P119, DOI 10.1067/mai.2002.120273; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Saarinen KM, 1999, J ALLERGY CLIN IMMUN, V104, P457, DOI 10.1016/S0091-6749(99)70393-3; Saarinen KM, 2000, ADV EXP MED BIOL, V478, P121; Saarinen KM, 2001, CLIN EXP ALLERGY, V31, P423, DOI 10.1046/j.1365-2222.2001.01015.x; Salpietro C D, 2005, Minerva Pediatr, V57, P173; Sampson HA, 2001, J ALLERGY CLIN IMMUN, V107, P891, DOI 10.1067/mai.2001.114708; Savino F, 2005, ACTA PAEDIATR, V94, P115, DOI 10.1080/08035320510043664; Schoetzau A, 2002, PEDIAT ALLERG IMM-UK, V13, P234, DOI 10.1034/j.1399-3038.2002.01050.x; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; SHEKELLE P, FOOD ALLERGY EVIDENC; SIGURS N, 1992, PEDIATRICS, V89, P735; Skripak JM, 2008, J ALLERGY CLIN IMMUN, V122, P1154, DOI 10.1016/j.jaci.2008.09.030; Staden U, 2007, ALLERGY, V62, P1261, DOI 10.1111/j.1398-9995.2007.01501.x; Szajewska H, 2007, J PEDIATR GASTR NUTR, V45, P247, DOI 10.1097/MPG.0b013e31804c505b; Szajewska H, 2004, ACTA PAEDIATR, V93, P1159, DOI 10.1080/08035250410026554; TAINIO VM, 1990, ALLERGY, V45, P189, DOI 10.1111/j.1398-9995.1990.tb00482.x; VANDENPLAS Y, 1992, ANN ALLERGY, V68, P419; VANDENPLAS Y, 1995, EUR J PEDIATR, V154, P488, DOI 10.1007/BF02029362; Viljanen M, 2005, ALLERGY, V60, P494, DOI 10.1111/j.1398-9995.2004.00514.x; Vita D, 2007, PEDIAT ALLERG IMM-UK, V18, P594, DOI 10.1111/j.1399-3038.2007.00567.x; von Berg A, 2003, J ALLERGY CLIN IMMUN, V111, P533, DOI 10.1067/mai.2003.101; von Berg A, 2008, J ALLERGY CLIN IMMUN, V121, P1442, DOI 10.1016/j.jaci.2008.04.021; von Berg A, 2007, J ALLERGY CLIN IMMUN, V119, P718, DOI 10.1016/j.jaci.2006.11.017; Wainstein BK, 2007, PEDIAT ALLERG IMM-UK, V18, P231, DOI 10.1111/j.1399-3038.2007.00517.x; Wananukul S, 2005, ASIAN PAC J ALLERGY, V23, P175; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; WILLEMS R, 1993, ANN ALLERGY, V71, P147	113	306	319	0	70	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1848	1856		10.1001/jama.2010.582	http://dx.doi.org/10.1001/jama.2010.582			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460624	Bronze			2022-12-28	WOS:000277513900026
J	Duprat, J; Dobrica, E; Engrand, C; Aleon, J; Marrocchi, Y; Mostefaoui, S; Meibom, A; Leroux, H; Rouzaud, JN; Gounelle, M; Robert, F				Duprat, J.; Dobrica, E.; Engrand, C.; Aleon, J.; Marrocchi, Y.; Mostefaoui, S.; Meibom, A.; Leroux, H.; Rouzaud, J. -N.; Gounelle, M.; Robert, F.			Extreme Deuterium Excesses in Ultracarbonaceous Micrometeorites from Central Antarctic Snow	SCIENCE			English	Article							MOLECULAR-CLOUD MATERIAL; ISOTOPIC COMPOSITIONS; ORGANIC-MATTER; INTERSTELLAR; DUST; MINERALOGY; CHEMISTRY; DISK	Primitive interplanetary dust is expected to contain the earliest solar system components, including minerals and organic matter. We have recovered, from central Antarctic snow, ultracarbonaceous micrometeorites whose organic matter contains extreme deuterium (D) excesses ( 10 to 30 times terrestrial values), extending over hundreds of square micrometers. We identified crystalline minerals embedded in the micrometeorite organic matter, which suggests that this organic matter reservoir could have formed within the solar system itself rather than having direct interstellar heritage. The high D/H ratios, the high organic matter content, and the associated minerals favor an origin from the cold regions of the protoplanetary disk. The masses of the particles range from a few tenths of a microgram to a few micrograms, exceeding by more than an order of magnitude those of the dust fragments from comet 81P/Wild 2 returned by the Stardust mission.	[Duprat, J.; Dobrica, E.; Engrand, C.; Aleon, J.] Univ Paris 11, CNRS, IN2P3, Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France; [Marrocchi, Y.; Mostefaoui, S.; Meibom, A.; Gounelle, M.; Robert, F.] Museum Natl Hist Nat, LMCM, CNRS, UMR 7202,INSU, F-75231 Paris 05, France; [Leroux, H.] Univ Lille 1, Unite Mat & Transformat, F-59655 Villeneuve Dascq, France; [Leroux, H.] Univ Lille 1, Ctr Hyperfrequences & Semicond, CNRS, F-59655 Villeneuve Dascq, France; [Rouzaud, J. -N.] Ecole Normale Super, UMR 8538, CNRS, Geol Lab, F-75231 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Museum National d'Histoire Naturelle (MNHN); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Duprat, J (corresponding author), Univ Paris 11, CNRS, IN2P3, Ctr Spectrometrie Nucl & Spectrometrie Masse, F-91405 Orsay, France.	jean.duprat@csnsm.in2p3.fr	Leroux, Hugues/S-4570-2017	Leroux, Hugues/0000-0002-8806-8434; Dobrica, Elena/0000-0002-7653-3431; ROUZAUD, Jean-Noel/0000-0002-1933-2617; Meibom, Anders/0000-0002-4542-2819	ANR [05-JC05-51407]; INSU (PNP); IN2P3; CNES; CNRS; French and Italian polar institutes; IPEV; PNRA; Region Ile de France; MESR; MNHN	ANR(French National Research Agency (ANR)); INSU (PNP); IN2P3; CNES(Centre National D'etudes Spatiales); CNRS(Centre National de la Recherche Scientifique (CNRS)); French and Italian polar institutes; IPEV; PNRA; Region Ile de France(Region Ile-de-France); MESR(Ministry of Research, France); MNHN	Supported by ANR grant 05-JC05-51407, FP6 Marie Curie Research Training Network " ORIGINS," ANR T-Tauri Chem, INSU (PNP), IN2P3, CNES, and CNRS. We are grateful to the French and Italian polar institutes, IPEV and PNRA, for their financial and logistic support. The NanoSIMS facility was established with funding from the CNRS, Region Ile de France, MESR, and MNHN. The electron microscopy work in Lille is a national facility instrument INSU-CNRS. We are grateful to M. Maurette for stimulating exchanges and pioneering the micrometeorite research in Orsay; S. Derenne, E. Jacquet, E. Quirico, and G. Slodzian for enlightening discussions; and M. Horlok for careful reading of the manuscript.	Aleon M, 2001, GEOCHIM COSMOCHIM AC, V65, P4399, DOI 10.1016/S0016-7037(01)00720-7; Bradley JP, 2005, TREATISE GEOCHEM, V1, P689; BRADLEY JP, 1994, GEOCHIM COSMOCHIM AC, V58, P2123, DOI 10.1016/0016-7037(94)90290-9; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; Busemann H, 2009, EARTH PLANET SC LETT, V288, P44, DOI 10.1016/j.epsl.2009.09.007; Derenne S, 2005, GEOCHIM COSMOCHIM AC, V69, P3911, DOI 10.1016/j.gca.2005.02.029; Duprat J, 2007, ADV SPACE RES, V39, P605, DOI 10.1016/j.asr.2006.05.029; Gilmour I, 2005, TREATISE GEOCHEM, V1, P269; Keller LP, 2004, GEOCHIM COSMOCHIM AC, V68, P2577, DOI 10.1016/j.gca.2003.10.044; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; LAWLER ME, 1992, NATURE, V359, P810, DOI 10.1038/359810a0; Liou JC, 1996, ICARUS, V123, P491, DOI 10.1006/icar.1996.0174; MAURETTE M, 1991, NATURE, V351, P44, DOI 10.1038/351044a0; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Meier R, 1999, SPACE SCI REV, V90, P33, DOI 10.1023/A:1005269208310; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; MILLAR TJ, 1989, ASTROPHYS J, V340, P906, DOI 10.1086/167444; Nakamura T., 2005, MAPS, V40, P5046; Qi CH, 2008, ASTROPHYS J, V681, P1396, DOI 10.1086/588516; Remusat L, 2006, EARTH PLANET SC LETT, V243, P15, DOI 10.1016/j.epsl.2005.12.010; Remusat L, 2009, ASTROPHYS J, V698, P2087, DOI 10.1088/0004-637X/698/2/2087; Scott E.R.D., 2005, ASTRONOMICAL SOC PAC, V341, P15; THOMAS KL, 1992, METEORITICS, V27, P296; THOMAS KL, 1993, GEOCHIM COSMOCHIM AC, V57, P1551, DOI 10.1016/0016-7037(93)90012-L; Wooden DH, 2008, SPACE SCI REV, V138, P75, DOI 10.1007/s11214-008-9424-2; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842	29	151	152	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					742	745		10.1126/science.1184832	http://dx.doi.org/10.1126/science.1184832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448182				2022-12-28	WOS:000277357100037
J	Britton, KA; Stevenson, WG; Levy, BD; Katz, JT; Loscalzo, J				Britton, Kathryn A.; Stevenson, William G.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph			The Beat Goes On.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC SARCOIDOSIS; ENDOMYOCARDIAL BIOPSY; MAGNETIC-RESONANCE; DIAGNOSIS; HEART		[Britton, Kathryn A.; Stevenson, William G.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Britton, Kathryn A.; Stevenson, William G.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA; [Britton, Kathryn A.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Britton, Kathryn A.] Boston Med Ctr, Div Cardiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Boston Medical Center	Katz, JT (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021					Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Doughan AR, 2006, HEART, V92, P282, DOI 10.1136/hrt.2005.080481; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Ishimaru S, 2005, EUR HEART J, V26, P1538, DOI 10.1093/eurheartj/ehi180; MASON JW, 1989, CIRCULATION, V79, P971, DOI 10.1161/01.CIR.79.5.971; MASON JW, 1994, J AM COLL CARDIOL, V23, P591, DOI 10.1016/0735-1097(94)90741-2; Nunes H, 2007, SEMIN RESP CRIT CARE, V28, P102, DOI 10.1055/s-2007-970336; OKAYAMA K, 1995, CHEST, V107, P330, DOI 10.1378/chest.107.2.330; Okumura W, 2004, J NUCL MED, V45, P1989; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Sharma OP, 2003, CHEST, V123, P18, DOI 10.1378/chest.123.1.18; Shimada T, 2001, AM J MED, V110, P520, DOI 10.1016/S0002-9343(01)00677-5; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Thomas KW, 2003, JAMA-J AM MED ASSOC, V289, P3300, DOI 10.1001/jama.289.24.3300; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8	17	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1721	1726		10.1056/NEJMcps0801473	http://dx.doi.org/10.1056/NEJMcps0801473			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445184				2022-12-28	WOS:000277311200011
J	Moran, NA; Jarvik, T				Moran, Nancy A.; Jarvik, Tyler			Lateral Transfer of Genes from Fungi Underlies Carotenoid Production in Aphids	SCIENCE			English	Article							ACYRTHOSIPHON-PISUM; PEA APHID; BIOSYNTHESIS; COLOR; ENDOSYMBIONT; RESISTANCE; PARASITISM; SYMBIONTS; EVOLUTION; PATTERNS	Carotenoids are colored compounds produced by plants, fungi, and microorganisms and are required in the diet of most animals for oxidation control or light detection. Pea aphids display a red-green color polymorphism, which influences their susceptibility to natural enemies, and the carotenoid torulene occurs only in red individuals. Unexpectedly, we found that the aphid genome itself encodes multiple enzymes for carotenoid biosynthesis. Phylogenetic analyses show that these aphid genes are derived from fungal genes, which have been integrated into the genome and duplicated. Red individuals have a 30-kilobase region, encoding a single carotenoid desaturase that is absent from green individuals. A mutation causing an amino acid replacement in this desaturase results in loss of torulene and of red body color. Thus, aphids are animals that make their own carotenoids.	[Moran, Nancy A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Jarvik, Tyler] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Moran, NA (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, 1041 E Lowell St, Tucson, AZ 85721 USA.	nancy.moran@yale.edu	Moran, Nancy A/G-1591-2010		NSF [0626716]	NSF(National Science Foundation (NSF))	We are indebted to K. Vogel for samples of aphids, including crosses he performed for other experiments. We thank N. Craft and staff at Craft Technologies for high-performance liquid chromatography analyses of aphid samples, K. Hammond for care of pea aphid colonies, K. Hammond and H. Dunbar for noticing the mutant 5AY female, J. Russell and S. Via for aphid clones, B. Nankivell for preparation of figures and of the manuscript, H. Ochman for comments on the paper, members of the Ochman-Moran laboratory for comments on the project, and A. Badyaev for discussions of carotenoids in animals. This project was funded by NSF 0626716 to N. M. GenBank accession for the DNA sequence is GU456379.	ANDREWES AG, 1971, ACTA CHEM SCAND, V25, P3878, DOI 10.3891/acta.chem.scand.25-3878; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; Badyaev AV, 2007, EVOL BIOL, V34, P61, DOI 10.1007/s11692-007-9004-5; Brisson JA, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-22; BROWN KS, 1975, CHEM SOC REV, V4, P263, DOI 10.1039/cs9750400263; CZECZUGA B, 1976, Zoologica Poloniae, V25, P27; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; DEGNAN PH, ENV MICROBIOL; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; Harmon JP, 1998, OECOLOGIA, V115, P287, DOI 10.1007/s004420050518; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HOUK EJ, 1974, J INSECT PHYSIOL, V20, P471, DOI 10.1016/0022-1910(74)90155-3; Jenkins RL, 1999, PHYSIOL ENTOMOL, V24, P171, DOI 10.1046/j.1365-3032.1999.00128.x; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Linnemannstons P, 2002, MOL GENET GENOMICS, V267, P593, DOI 10.1007/s00438-002-0690-5; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; MULLER F. P., 1962, Z. PflKrarikh., V69, P129; Muller F. P., 1961, Archiv des Vereins der Freunde der Naturgeschichte in Mecklenburg, V7, P228; Nikoh N, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-12; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rodriguez-Saiz M, 2004, APPL ENVIRON MICROB, V70, P5589, DOI 10.1128/AEM.70.9.5589-5594.2004; Rothschild M., 1975, COEVOLUTION ANIMALS, P20; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; TAKADA H, 1981, APPL ENTOMOL ZOOL, V16, P242, DOI 10.1303/aez.16.242; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Verdoes JC, 1999, MOL GEN GENET, V262, P453, DOI 10.1007/s004380051105; Verdoes JC, 2003, APPL ENVIRON MICROB, V69, P3728, DOI 10.1128/AEM.69.7.3728-3738.2003	33	401	427	14	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					624	627		10.1126/science.1187113	http://dx.doi.org/10.1126/science.1187113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431015				2022-12-28	WOS:000277159800044
J	Tomlinson, P; Stranks, GJ				Tomlinson, Pat; Stranks, Geoffrey J.			A Patient's Journey Two hip replacements	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Stranks, Geoffrey J.] Basingstoke & N Hampshire Hosp, Basingstoke RG24 9NA, Hants, England		Tomlinson, P (corresponding author), 26 Church Lane, Holybourne GU34 4HD, Alton, England.	pat@jptomlinson.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 29	2010	340								c1502	10.1136/bmj.c1502	http://dx.doi.org/10.1136/bmj.c1502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591PO	20430831				2022-12-28	WOS:000277314300001
J	Zisman, DA; Schwarz, M; Anstrom, KJ; Collard, HR; Flaherty, KR; Hunninghake, GW				Zisman, David A.; Schwarz, Marvin; Anstrom, Kevin J.; Collard, Harold R.; Flaherty, Kevin R.; Hunninghake, Gary W.		Idiopathic Pulm Fibrosis Clinical	A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERTENSION	BACKGROUND Sildenafil, a phosphodiesterase-5 inhibitor, may preferentially improve blood flow to well-ventilated regions of the lung in patients with advanced idiopathic pulmonary fibrosis, which could result in improvements in gas exchange. We tested the hypothesis that treatment with sildenafil would improve walk distance, dyspnea, and quality of life in patients with advanced idiopathic pulmonary fibrosis, defined as a carbon monoxide diffusion capacity of less than 35% of the predicted value. METHODS We conducted a double-blind, randomized, placebo-controlled trial of sildenafil in two periods. The first period consisted of 12 weeks of a double-blind comparison between sildenafil and a placebo control. The primary outcome was the proportion of patients with an increase in the 6-minute walk distance of 20% or more. Key secondary outcomes included changes in oxygenation, degree of dyspnea, and quality of life. The second period was a 12-week open-label evaluation involving all patients receiving sildenafil. RESULTS A total of 180 patients were enrolled in the study. The difference in the primary outcome was not significant, with 9 of 89 patients (10%) in the sildenafil group and 6 of 91 (7%) in the placebo group having an improvement of 20% or more in the 6-minute walk distance (P = 0.39). There were small but significant differences in arterial oxygenation, carbon monoxide diffusion capacity, degree of dyspnea, and quality of life favoring the sildenafil group. Serious adverse events were similar in the two study groups. CONCLUSIONS This study did not show a benefit for sildenafil for the primary outcome. The presence of some positive secondary outcomes creates clinical equipoise for further research. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov number, NCT00517933.)	[Zisman, David A.] Sansum Clin, Santa Barbara, CA 93105 USA; [Schwarz, Marvin] Natl Jewish Hlth, Denver, CO USA; [Schwarz, Marvin] Univ Colorado, Denver, CO 80202 USA; [Anstrom, Kevin J.] Duke Clin Res Inst, Durham, NC USA; [Collard, Harold R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Flaherty, Kevin R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Hunninghake, Gary W.] Univ Iowa, Iowa City, IA USA	National Jewish Health; University of Colorado System; University of Colorado Denver; Duke University; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; University of Iowa	Zisman, DA (corresponding author), Sansum Clin, 301 W Pueblo St, Santa Barbara, CA 93105 USA.	dzisman@sansumclinic.org		Ryu, Jay/0000-0002-9576-2272; Moore, Bethany/0000-0003-3051-745X; Loyd, James/0000-0002-5042-7390	National Heart, Lung, and Blood Institute (NHLBI) [U10HL080509, U10HL80413, U10HL80274, U10HL80370, U10HL80371, U10HL80383, U10HL80411, U10HL80509, U10HL80510, U10HL80513, U10HL80543, U10HL80571, U10HL80685]; Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL080411, U10HL080513, U10HL080509, U10HL080510, U10HL080274, U10HL080685, U10HL080371, U10HL080383, R01HL067967, U10HL080413, U10HL080543, U10HL080571, U10HL080370] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U10HL080509 [data coordinating center], U10HL80413, U10HL80274, U10HL80370, U10HL80371, U10HL80383, U10HL80411, U10HL80509, U10HL80510, U10HL80513, U10HL80543, U10HL80571, and U10HL80685 [clinical centers]) from the National Heart, Lung, and Blood Institute (NHLBI); by the Cowlin Fund at the Chicago Community Trust; by Pfizer, which donated sildenafil and matching placebo; and by Masimo, which donated pulse oximeters.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Collard HR, 2007, CHEST, V131, P897, DOI 10.1378/chest.06-2101; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; Giaid A, 1998, CHEST, V114, p208S, DOI 10.1378/chest.114.3_Supplement.208S; Holland AE, 2009, RESP MED, V103, P1430, DOI 10.1016/j.rmed.2009.04.024; Kupferberg David H, 2005, J Cardiopulm Rehabil, V25, P370, DOI 10.1097/00008483-200511000-00011; Madden BP, 2006, VASC PHARMACOL, V44, P372, DOI 10.1016/j.vph.2006.01.013; Nicholson AG, 2002, HISTOPATHOLOGY, V41, P381, DOI 10.1046/j.1365-2559.2002.01421.x; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Pickard AS, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-4; Ries Andrew L, 2005, COPD, V2, P105; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Swigris JJ, 2010, THORAX, V65, P173, DOI 10.1136/thx.2009.113498; Ware JE, 2000, SCORE VERSION 2 SF 3, P27	15	396	408	3	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					620	628		10.1056/NEJMoa1002110	http://dx.doi.org/10.1056/NEJMoa1002110			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20484178	Green Accepted			2022-12-28	WOS:000280764600005
J	Black, RE; Cousens, S; Johnson, HL; Lawn, JE; Rudan, I; Bassani, DG; Jha, P; Campbell, H; Walker, CF; Cibulskis, R; Eisele, T; Liu, L; Mathers, C				Black, Robert E.; Cousens, Simon; Johnson, Hope L.; Lawn, Joy E.; Rudan, Igor; Bassani, Diego G.; Jha, Prabhat; Campbell, Harry; Walker, Christa Fischer; Cibulskis, Richard; Eisele, Thomas; Liu, Li; Mathers, Colin		WHO UNICEF	Global, regional, and national causes of child mortality in 2008: a systematic analysis	LANCET			English	Article							DEATHS; UNDERNUTRITION; YOUNGER; BURDEN; INTERVENTIONS; HEALTH	Background Up-to-date information on the causes of child deaths is crucial to guide global efforts to improve child survival. We report new estimates for 2008 of the major causes of death in children younger than 5 years. Methods We used multicause proportionate mortality models to estimate deaths in neonates aged 0-27 days and children aged 1-59 months, and selected single-cause disease models and analysis of vital registration data when available to estimate causes of child deaths. New data from China and India permitted national data to be used for these countries instead of predictions based on global statistical models, as was done previously. We estimated proportional causes of death for 193 countries, and by application of these proportions to the country-specific mortality rates in children younger than 5 years and birth rates, the numbers of deaths by cause were calculated for countries, regions, and the world. Findings Of the estimated 8.795 million deaths in children younger than 5 years worldwide in 2008, infectious diseases caused 68% (5.970 million), with the largest percentages due to pneumonia (18%, 1.575 million, uncertainty range [UR] 1.046 million-1..874 million), diarrhoea (15%, 1-336 million, 0.822 million-2-004 million), and malaria (8%, 0 732 million, 0.601 million-0.851 million). 41% (3 575 million) of deaths occurred in neonates, and the most important single causes were preterm birth complications (12%, 1-033 million, UR 0.717 million-1.216 million), birth asphyxia (9%, 0.814 million, 0.563 million-0.997 million), sepsis (6%, 0.521 million, 0.356 million-0.735 million), and pneumonia (4%, 0.386 million, 0.264 million-0.545 million). 49% (4 294 million) of child deaths occurred in five countries: India, Nigeria, Democratic Republic of the Congo, Pakistan, and China. Interpretation These country-specific estimates of the major causes of child deaths should help to focus national programmes and donor assistance. Achievement of Millennium Development Goal 4, to reduce child mortality by two-thirds, is only possible if the high numbers of deaths are addressed by maternal, newborn, and child health interventions.	[Black, Robert E.; Johnson, Hope L.; Walker, Christa Fischer; Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Bassani, Diego G.; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Cibulskis, Richard] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Mathers, Colin] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Eisele, Thomas] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Save the Children; University of Edinburgh; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; World Health Organization; World Health Organization; Tulane University	Black, RE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.		Bassani, Diego/G-2827-2015; Campbell, Harry/E-2959-2010; Lawn, Joy/ABE-6382-2020; liu, li/HGC-0900-2022; Rudan, Igor/I-1467-2012; Eisele, Thom/AAE-8958-2020; Theodoratou, Evropi/C-3430-2014	Bassani, Diego/0000-0001-6704-3820; Campbell, Harry/0000-0002-6169-6262; Lawn, Joy/0000-0002-4573-1443; Rudan, Igor/0000-0001-6993-6884; Theodoratou, Evropi/0000-0001-5887-9132; Black, Robert/0000-0001-9926-7984; Mathers, Colin/0000-0002-0617-6731	WHO; UNICEF; Bill & Melinda Gates Foundation; Medical Research Council [G0700704B] Funding Source: researchfish	WHO(World Health Organization); UNICEF; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding WHO, UNICEF, and Bill & Melinda Gates Foundation.	*AM COLL OBST GYN, 1998, INT J GYNECOL OBSTET, V61, P309; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], WORLD POP PROSP 2008; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; JOHNSON HL, INT J EPIDE IN PRESS; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; *UN, 2008 REP GLOB AIDS E; UNICEF, 2009, STATE WORLDS CHILDRE; UNICEF, LEV TRENDS CHILD MOR; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; *WHO, INP DAT NEON MORT ES; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, WHO UNICEF EST NAT I; World Health Organization, WHO MORT DAT; World Health Organization UNICEF, 2009, WHO UNICEF REV NAT I; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	30	1892	1989	5	247	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2010	375	9730					1969	1987		10.1016/S0140-6736(10)60549-1	http://dx.doi.org/10.1016/S0140-6736(10)60549-1			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609WT	20466419				2022-12-28	WOS:000278689600026
J	Gething, PW; Smith, DL; Patil, AP; Tatem, AJ; Snow, RW; Hay, SI				Gething, Peter W.; Smith, David L.; Patil, Anand P.; Tatem, Andrew J.; Snow, Robert W.; Hay, Simon I.			Climate change and the global malaria recession	NATURE			English	Article							INSECTICIDE-TREATED NETS; COMBINATION THERAPY; INOCULATION RATE; TRANSMISSION; IMPACT; POPULATIONS; ELIMINATION; INFECTION; AFRICA; BURDEN	The current and potential future impact of climate change on malaria is of major public health interest(1,2). The proposed effects of rising global temperatures on the future spread and intensification of the disease(3-5), and on existing malaria morbidity and mortality rates(3), substantively influence global health policy(6,7). The contemporary spatial limits of Plasmodium falciparum malaria and its endemicity within this range(8), when compared with comparable historical maps, offer unique insights into the changing global epidemiology of malaria over the last century. It has long been known that the range of malaria has contracted through a century of economic development and disease control(9). Here, for the first time, we quantify this contraction and the global decreases in malaria endemicity since approximately 1900. We compare the magnitude of these changes to the size of effects on malaria endemicity proposed under future climate scenarios and associated with widely used public health interventions. Our findings have two key and often ignored implications with respect to climate change and malaria. First, widespread claims that rising mean temperatures have already led to increases in worldwide malaria morbidity and mortality are largely at odds with observed decreasing global trends in both its endemicity and geographic extent. Second, the proposed future effects of rising temperatures on endemicity are at least one order of magnitude smaller than changes observed since about 1900 and up to two orders of magnitude smaller than those that can be achieved by the effective scale-up of key control measures. Predictions of an intensification of malaria in a warmer world, based on extrapolated empirical relationships or biological mechanisms, must be set against a context of a century of warming that has seen marked global declines in the disease and a substantial weakening of the global correlation between malaria endemicity and climate.	[Gething, Peter W.; Patil, Anand P.; Hay, Simon I.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Smith, David L.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Smith, David L.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Snow, Robert W.] KEMRI Univ Oxford Wellcome Trust Collaborat Progr, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, Nairobi, Kenya; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, CCVTM, Oxford OX3 7LJ, England	University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Oxford	Hay, SI (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Tinbergen Bldg,S Parks Rd, Oxford OX1 3PS, England.	peter.gething@zoo.ox.ac.uk; simon.hay@zoo.ox.ac.uk	Smith, David L/L-8850-2013; Snow, Robert William/AFR-1436-2022; Hay, Simon Iain/F-8967-2015; Gething, Peter/GQR-1884-2022; Gething, Peter/ABD-2110-2020	Smith, David L/0000-0003-4367-3849; Snow, Robert William/0000-0003-3725-6088; Hay, Simon Iain/0000-0002-0611-7272; Gething, Peter/0000-0001-6759-5449; Tatem, Andrew/0000-0002-7270-941X	Wellcome Trust [079091, 079080]; Bill and Melinda Gates Foundation [49446]; Science & Technology Directorate, Department of Homeland Security; Fogarty International Center, National Institutes of Health; Wellcome Trust, UK	Wellcome Trust(Wellcome TrustEuropean Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Science & Technology Directorate, Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Wellcome Trust, UK(Wellcome Trust)	We thank A. Bibby, H. C. J. Godfray, G. D. Shanks and G. R. W. Wint for comments on the manuscript. S. I. H. is funded by a Senior Research Fellowship from the Wellcome Trust (#079091) that also supports P. W. G. and previously A. J. T. R. W. S. is funded by a Principal Research Fellowship from the Wellcome Trust (#079080) that also supports A. P. P. D. L. S. and A. J. T. are supported by a grant from the Bill and Melinda Gates Foundation (#49446). D. L. S. and S. I. H. also acknowledge funding support from the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. This work forms part of the output of the Malaria Atlas Project (MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, UK.	[Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2004, BIODIVERSITE PALUDIS; Antosiewicz H.A., 1964, HDB MATH FUNCTIONS, P435; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; DAVIS GM, 1964, HDB MATH FUNCTION, P253; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Killeen GF, 2006, AM J TROP MED HYG, V75, P38, DOI 10.4269/ajtmh.2006.75.2_suppl.0750038; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kouznetsov R L, 1977, Trop Doct, V7, P81; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lysenko A.J., 1968, MEDICINSKAJA GEOGRAF, P25; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Okell LC, 2008, PLOS MED, V5, P1617, DOI 10.1371/journal.pmed.0050226; Parry M. L., 2007, CLIMATE CHANGE 2007; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Reiter P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S3; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Solomon S., 2007, PHYS SCI BASIS WORKI; Stein ML, 2005, J AM STAT ASSOC, V100, P310, DOI 10.1198/016214504000000854; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009	38	231	235	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					342	U94		10.1038/nature09098	http://dx.doi.org/10.1038/nature09098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485434	Green Accepted			2022-12-28	WOS:000277829200039
J	Altschuler, SJ; Wu, LF				Altschuler, Steven J.; Wu, Lani F.			Cellular Heterogeneity: Do Differences Make a Difference?	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; CONTEXT; NOISE; IDENTIFICATION; ARCHITECTURE; VARIABILITY; SWITCH; MODEL	A central challenge of biology is to understand how individual cells process information and respond to perturbations. Much of our knowledge is based on ensemble measurements. However, cell-to-cell differences are always present to some degree in any cell population, and the ensemble behaviors of a population may not represent the behaviors of any individual cell. Here, we discuss examples of when heterogeneity cannot be ignored and describe practical strategies for analyzing and interpreting cellular heterogeneity.	[Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Altschuler, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu			NIH [R01 GM081549, R01 GM085442]; Endowed Scholars program at UT Southwestern Medical Center; Welch Foundation [I-1619, I-1644]; Rita Allen Foundation; Mary Kay Ash Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081549, R01GM085442] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowed Scholars program at UT Southwestern Medical Center; Welch Foundation(The Welch Foundation); Rita Allen Foundation; Mary Kay Ash Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Altschuler and Wu labs, Mike Brown, Nuno Lages, Tom Maniatis, David Mangelsdorf, Rama Ranganathan, and Gurol Suel for helpful feedback. This research was supported by NIH grants R01 GM081549 (L.F.W.) and R01 GM085442 (S.J.A.), the Endowed Scholars program at UT Southwestern Medical Center (L.F.W. and S.J.A.), the Welch Foundation I-1619 (S.J.A.) and I-1644 (L.F.W.), the Rita Allen Foundation (S.J.A.), and the Mary Kay Ash Charitable Foundation (S.J.A.).	Anselmetti D, 2009, SINGLE CELL ANAL TEC; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Campbell LL, 2007, CELL CYCLE, V6, P2332, DOI 10.4161/cc.6.19.4914; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Duda R. O., 2001, PATTERN CLASSIFICATI; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ELSASSER WM, 1984, P NATL ACAD SCI-BIOL, V81, P5126, DOI 10.1073/pnas.81.16.5126; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; HEPPNER GH, 1984, CANCER RES, V44, P2259; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; KIMURA M, 1964, GENETICS, V49, P561; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Loo LH, 2009, J CELL BIOL, V187, P375, DOI 10.1083/jcb.200904140; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oved K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.15; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ramo P, 2009, BIOINFORMATICS, V25, P3028, DOI 10.1093/bioinformatics/btp524; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; RUBIN H, 1990, CANCER METAST REV, V9, P1, DOI 10.1007/BF00047585; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Yin Z, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-264	44	678	683	9	179	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					559	563		10.1016/j.cell.2010.04.033	http://dx.doi.org/10.1016/j.cell.2010.04.033			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478246	Green Accepted, Bronze			2022-12-28	WOS:000277623600006
J	Sinervo, B; Mendez-de-la-Cruz, F; Miles, DB; Heulin, B; Bastiaans, E; Cruz, MVS; Lara-Resendiz, R; Martinez-Mendez, N; Calderon-Espinosa, ML; Meza-Lazaro, RN; Gadsden, H; Avila, LJ; Morando, M; De la Riva, IJ; Sepulveda, PV; Rocha, CFD; Ibarguengoytia, N; Puntriano, CA; Massot, M; Lepetz, V; Oksanen, TA; Chapple, DG; Bauer, AM; Branch, WR; Clobert, J; Sites, JW				Sinervo, Barry; Mendez-de-la-Cruz, Fausto; Miles, Donald B.; Heulin, Benoit; Bastiaans, Elizabeth; Villagran-Santa Cruz, Maricela; Lara-Resendiz, Rafael; Martinez-Mendez, Norberto; Lucia Calderon-Espinosa, Martha; Nelsi Meza-Lazaro, Rubi; Gadsden, Hector; Javier Avila, Luciano; Morando, Mariana; De la Riva, Ignacio J.; Victoriano Sepulveda, Pedro; Duarte Rocha, Carlos Frederico; Ibargueengoytia, Nora; Aguilar Puntriano, Cesar; Massot, Manuel; Lepetz, Virginie; Oksanen, Tuula A.; Chapple, David G.; Bauer, Aaron M.; Branch, William R.; Clobert, Jean; Sites, Jack W., Jr.			Erosion of Lizard Diversity by Climate Change and Altered Thermal Niches	SCIENCE			English	Article							EXTINCTION RISK; EVOLUTION; UNCERTAINTY; ECOLOGY; TEMPERATURE; PREDICTIONS; ECTOTHERMS; PHYSIOLOGY; SELECTION; MODELS	It is predicted that climate change will cause species extinctions and distributional shifts in coming decades, but data to validate these predictions are relatively scarce. Here, we compare recent and historical surveys for 48 Mexican lizard species at 200 sites. Since 1975, 12% of local populations have gone extinct. We verified physiological models of extinction risk with observed local extinctions and extended projections worldwide. Since 1975, we estimate that 4% of local populations have gone extinct worldwide, but by 2080 local extinctions are projected to reach 39% worldwide, and species extinctions may reach 20%. Global extinction projections were validated with local extinctions observed from 1975 to 2009 for regional biotas on four other continents, suggesting that lizards have already crossed a threshold for extinctions caused by climate change.	[Sinervo, Barry; Bastiaans, Elizabeth] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Mendez-de-la-Cruz, Fausto; Lara-Resendiz, Rafael; Martinez-Mendez, Norberto; Nelsi Meza-Lazaro, Rubi] Univ Nacl Autonoma Mexico, Inst Biol, Lab Herpetol, Mexico City 04510, DF, Mexico; [Miles, Donald B.] Ohio Univ, Dept Biol, Athens, OH 45701 USA; [Heulin, Benoit] CNRS, UMR 6553, Stn Biol, F-35380 Paimpont, France; [Villagran-Santa Cruz, Maricela] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Comparada, Lab Biol Reprod Anim, Mexico City 04510, DF, Mexico; [Lucia Calderon-Espinosa, Martha] Univ Nacl Colombia, Inst Ciencias Nat, Bogota, Colombia; [Gadsden, Hector] Inst Ecol AC, Chihuahua 31109, Mexico; [Javier Avila, Luciano; Morando, Mariana] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [De la Riva, Ignacio J.] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Victoriano Sepulveda, Pedro] Univ Concepcion, Dpto Zool, Concepcion, Chile; [Duarte Rocha, Carlos Frederico] Univ Estado Rio de Janeiro, Inst Biol, Dept Ecol, BR-20550019 Rio De Janeiro, Brazil; [Ibargueengoytia, Nora] Univ Nacl Comahue, Ctr Reg Univ Bariloche, Consejo Nacl Invest Cient & Tecn, INIBIOMA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Aguilar Puntriano, Cesar] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Herpetol, Lima 14, Peru; [Massot, Manuel] Univ UPMC, CNRS, UMR 7625, Lab Ecol Evolut, F-75005 Paris, France; [Lepetz, Virginie; Clobert, Jean] CNRS, USR 2936, Stat Ecol Expt, F-09200 Moulis, Saint Girons, France; [Oksanen, Tuula A.] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, FI-40014 Jyvaskyla, Finland; [Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Branch, William R.] Bayworld, ZA-6013 Humewood, South Africa; [Sites, Jack W., Jr.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Sites, Jack W., Jr.] Brigham Young Univ, Bean Life Sci Museum, Provo, UT 84602 USA	University of California System; University of California Santa Cruz; Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universidad Nacional Autonoma de Mexico; Universidad Nacional de Colombia; Instituto de Ecologia - Mexico; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Concepcion; Universidade do Estado do Rio de Janeiro; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Nacional Mayor de San Marcos; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Jyvaskyla; Monash University; Villanova University; Brigham Young University; Brigham Young University	Sinervo, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	lizardrps@gmail.com	Aguilar, Cesar/Q-6148-2018; Martínez-Méndez, Norberto/AAQ-5330-2021; Massot, Manuel/AGH-2703-2022; Lara-Resendiz, Rafael A./AAG-5451-2021; Mendez, Fausto R./O-3512-2018; Gadsden, Hector/A-2066-2015; Miles, Donald B./AFW-0480-2022; Rocha, Carlos Frederico D/A-6225-2013; Mendez, Fausto/HGD-1205-2022; Lara-Resendiz, Rafael A/K-3764-2013; Martínez-Méndez, Norberto/AAB-2710-2021; Chapple, David/B-9073-2008	Aguilar, Cesar/0000-0001-6372-7926; Lara-Resendiz, Rafael A./0000-0002-6922-0330; Mendez, Fausto R./0000-0002-5084-1276; Gadsden, Hector/0000-0002-1164-0578; Rocha, Carlos Frederico D/0000-0003-3000-1242; Lara-Resendiz, Rafael A/0000-0002-6922-0330; Martínez-Méndez, Norberto/0000-0002-4029-4387; Oksanen, Tuula/0000-0003-3481-6158; Chapple, David/0000-0002-7720-6280; Massot, Manuel/0000-0002-2762-4417; Avila, Luciano Javier/0000-0003-4641-6581; Calderon Espinosa, Martha/0000-0002-3602-013X; Miles, Donald/0000-0001-5768-179X; Bastiaans, Elizabeth/0000-0002-7322-1088	National Geographic Society, UC Mexus; UCSC Committee-On-Research; NSF [DEB 0108577, IBN 0213179, LTREB DEB 051597, DEB 0515909, 0844523, OISE 0530267]; CNRS; Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III [PAPIIT-UNAM IN213405, 224208]; Universite Paul Sabatier Toulouse III; CONACYT [4171N, 52852Q]; CONACYT-SEP [43142-Q]; ANR Blanche; FONDYCET [1090664]; SMSI [CGL2005-03156, CLG2008-04164, APCT-PICT1086]; Universidad Nacional Autonoma de Mexico; American Museum of Natural History; Academy of Finland [108955]; Australian Research Council; PIRE-Patagonia; Brigham Young University; Direct For Biological Sciences [0844523] Funding Source: National Science Foundation	National Geographic Society, UC Mexus(National Geographic Society); UCSC Committee-On-Research; NSF(National Science Foundation (NSF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III; Universite Paul Sabatier Toulouse III; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-SEP(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ANR Blanche(French National Research Agency (ANR)); FONDYCET; SMSI; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); American Museum of Natural History; Academy of Finland(Academy of Finland); Australian Research Council(Australian Research Council); PIRE-Patagonia; Brigham Young University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Research of B. S. was funded by the National Geographic Society, UC Mexus, UCSC Committee-On-Research, NSF awards (DEB 0108577, IBN 0213179, LTREB DEB 051597), CNRS fellowships, and visiting professorships (Museum Nationale d'Histoire Naturelle, Universite Paris 6, Universite Paul Sabatier Toulouse III), PAPIIT-UNAM IN213405 and 224208 to F. M.-C., a Universite Paul Sabatier Toulouse III Visiting Professorship to D. B. M., CONACYT grants (4171N and 52852Q) to M.V.-S.C., grant CONACYT-SEP (43142-Q) to H. G., a CONACYT fellowship to R.N.M.-L., CNRS funding to B. H., and M. M., Biodivera: Tenlamas and from ANR Blanche: DIAME to J.C., CONICET grants to L.J.A. and M. M., FONDYCET 1090664 grants to P. V. S., CGL2005-03156 and CLG2008-04164 grant from SMSI to I.J.R., APCT-PICT1086 grant to N.I., scholarships and grants from Universidad Nacional Autonoma de Mexico and American Museum of Natural History to M.V.-S.C., Academy of Finland grant (108955) to T.A.O., Australian Research Council grants to D. G. C., NSF awards DEB 0515909 and 0844523 to A. M. B., NSF award OISE 0530267, PIRE-Patagonia grant to J.W.S., L.J.A., M. M., and P. V. S. and Brigham Young University funding (Biology Department, Kennedy Center for International Studies, Bean Life Science Museum) to J.W.S.	Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; BERGER PJ, 1975, J ANIM SCI, V40, P38, DOI 10.2527/jas1975.40138x; BEUCHAT CA, 1986, COPEIA, P971, DOI 10.2307/1445294; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dzialowski EM, 2005, J THERM BIOL, V30, P317, DOI 10.1016/j.jtherbio.2005.01.005; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; GUILLETTE LJ, 1993, BIOSCIENCE, V43, P742, DOI 10.2307/1312318; Hare B, 2006, CLIMATIC CHANGE, V75, P111, DOI 10.1007/s10584-005-9027-9; Harte John, 2004, Nature, V430, P33; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; PORTER WP, 1989, PHYSIOL ZOOL, V62, P286, DOI 10.1086/physzool.62.2.30156172; Pounds JA, 2004, NATURE, V427, P107, DOI 10.1038/427107a; Sinervo B, 1996, EVOLUTION, V50, P1314, DOI 10.1111/j.1558-5646.1996.tb02371.x; SINERVO B, 1990, OECOLOGIA, V83, P228, DOI 10.1007/BF00317757; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; Stott PA, 2002, NATURE, V416, P723, DOI 10.1038/416723a; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	28	1180	1233	17	693	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					894	899		10.1126/science.1184695	http://dx.doi.org/10.1126/science.1184695			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466932				2022-12-28	WOS:000277618800050
J	Stott, PA; Thorne, PW				Stott, Peter A.; Thorne, Peter W.			How best to log local temperatures?	NATURE			English	Editorial Material									[Stott, Peter A.] Met Off, Hadley Ctr, Climate Monitoring & Attribut Grp, Exeter EX1 3PB, Devon, England; [Thorne, Peter W.] Cooperat Inst Climate & Satellites, Asheville, NC 28801 USA	Met Office - UK; Hadley Centre	Stott, PA (corresponding author), Met Off, Hadley Ctr, Climate Monitoring & Attribut Grp, Exeter EX1 3PB, Devon, England.	peter.stott@metoffice.gov.uk	Thorne, Peter/F-2225-2014; Thorne, Peter W/R-6823-2017; Scott, Peter/GYA-5335-2022; Stott, Peter/N-1228-2016	Thorne, Peter/0000-0003-0485-9798; Thorne, Peter W/0000-0003-0485-9798; Stott, Peter/0000-0003-4853-7686				KENNEDY JJ, 2010, B AM METEOR IN PRESS, V91; Titchner HA, 2009, J CLIMATE, V22, P465, DOI 10.1175/2008JCLI2419.1	2	13	13	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					158	159		10.1038/465158a	http://dx.doi.org/10.1038/465158a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463718	Green Accepted			2022-12-28	WOS:000277558500015
J	Hemenway, D				Hemenway, David			Why We Don't Spend Enough on Public Health.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HOMICIDE; HOME		Harvard Univ, Sch Publ Hlth, Harvard Injury Control Res Ctr, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hemenway, D (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Injury Control Res Ctr, 665 Huntington Ave, Boston, MA 02115 USA.							Evans R. G., 1994, WHY ARE SOME PEOPLE; Kellermann AL, 1998, NEW ENGL J MED, V339, P928, DOI 10.1056/NEJM199809243391320; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Winslow C. E. A., 1923, EVOLUTION SIGNIFICAN	6	35	35	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1657	1658		10.1056/NEJMp1001784	http://dx.doi.org/10.1056/NEJMp1001784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591OQ	20445178				2022-12-28	WOS:000277311200002
J	Gornall, J				Gornall, Jonathan			Stem cell treatment Stem cell renegades or pioneers?	BRITISH MEDICAL JOURNAL			English	Editorial Material							LATERAL-SCLEROSIS PATIENTS; 1-YEAR FOLLOW-UP; TRANSPLANTATION					jgornall@mac.com						[Anonymous], 2010, ECONOMIST       0114; Deda H, 2008, CYTOTHERAPY, V10, P565, DOI 10.1080/14653240802241797; Deda H, 2009, CYTOTHERAPY, V11, P18, DOI 10.1080/14653240802549470; *DEP HLTH, 2008, WARN UNPR STEM CELL; Dyer C, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2009; Hawkes N, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2069; *INT SOC STEM CELL, 2008, ISSCR REL NEW GUID S; Martinez HR, 2009, CYTOTHERAPY, V11, P26, DOI 10.1080/14653240802644651; *NAT I HLTH CLIN E, 2001, GUID US RIL RIL TREA; *NAT I HLTH CLIN E, GUID US RIL RIL TREA; *NAT STEM CELL NET, STEN CELL TOUR POS S; *NHS DIR, 2008, WARN FREE ONL STEM C; Rowley E., 2009, BARRIERS COMMERCIALI; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; *U MICH, 2009, 1 STEM CELL TRIAL AL; WATERS R, 2008, ROGUE STEM CELL CLIN	16	6	6	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c2041	10.1136/bmj.c2041	http://dx.doi.org/10.1136/bmj.c2041			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XC	20444823				2022-12-28	WOS:000277572500004
J	Kennedy, MJ; Davison, IG; Robinson, CG; Ehlers, MD				Kennedy, Matthew J.; Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.			Syntaxin-4 Defines a Domain for Activity-Dependent Exocytosis in Dendritic Spines	CELL			English	Article							LONG-TERM POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; AMPA-RECEPTORS; RECYCLING ENDOSOMES; MEMBRANE-FUSION; POSTSYNAPTIC PLASTICITY; SYNAPTIC PLASTICITY; LATERAL DIFFUSION; PLASMA-MEMBRANE; ENDOCYTIC ZONES	Changes in postsynaptic membrane composition underlie many forms of learning-related synaptic plasticity in the brain. At excitatory glutamatergic synapses, fusion of intracellular vesicles at or near the postsynaptic plasma membrane is critical for dendritic spine morphology, retrograde synaptic signaling, and long-term synaptic plasticity. Whereas the molecular machinery for exocytosis in presynaptic terminals has been defined in detail, little is known about the location, kinetics, regulation, or molecules involved in postsynaptic exocytosis. Here, we show that an exocytic domain adjacent to the postsynaptic density (PSD) enables fusion of large, AMPA receptor-containing recycling compartments during elevated synaptic activity. Exocytosis occurs at microdomains enriched in the plasma membrane t-SNARE syntaxin 4 (Stx4), and disruption of Stx4 impairs both spine exocytosis and long-term potentiation (LTP) at hippocampal synapses. Thus, Stx4 defines an exocytic zone that directs membrane fusion for postsynaptic plasticity, revealing a novel specialization for local membrane traffic in dendritic spines.	[Kennedy, Matthew J.; Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Davison, Ian G.; Robinson, Camenzind G.; Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X	NIMH; NINDS; NIA; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Marguerita Klein, Irina Lebedeva, and Haiwei Zhang for excellent technical assistance. We thank Ben Arenkiel, Cyril Hanus, Juliet Hernandez, Tom Newpher, Michael Patterson, Joel Schwartz, Chandra Tucker, Ryohei Yasuda, and Richard Weinberg for critical discussion and review of this manuscript. This work was supported by grants from NIMH, NINDS, and NIA to M.D.E. M.D.E. is an Investigator of the Howard Hughes Medical Institute.	Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2008, J BIOL CHEM, V283, P10716, DOI 10.1074/jbc.M709876200; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Kopec CD, 2007, J NEUROSCI, V27, P13706, DOI 10.1523/JNEUROSCI.3503-07.2007; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Low SH, 2006, MOL BIOL CELL, V17, P977, DOI 10.1091/mbc.E05-05-0462; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Ohara-Imaizumi M, 2004, J BIOL CHEM, V279, P8403, DOI 10.1074/jbc.M308954200; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Petrini EM, 2009, NEURON, V63, P92, DOI 10.1016/j.neuron.2009.05.025; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	44	199	202	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					524	535		10.1016/j.cell.2010.02.042	http://dx.doi.org/10.1016/j.cell.2010.02.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434989	Green Accepted, Bronze			2022-12-28	WOS:000277180800022
J	Bluestone, JA; Herold, K; Eisenbarth, G				Bluestone, Jeffrey A.; Herold, Kevan; Eisenbarth, George			Genetics, pathogenesis and clinical interventions in type 1 diabetes	NATURE			English	Review							REGULATORY T-CELLS; ANTI-CD3 MONOCLONAL-ANTIBODY; B-LYMPHOCYTE DEPLETION; NOD MICE; RECENT-ONSET; COMBINATION THERAPY; PANCREATIC-ISLETS; INCREASED RISK; SINGLE COURSE; HUMAN THYMUS	Type 1 diabetes is an autoimmune disorder afflicting millions of people worldwide. Once diagnosed, patients require lifelong insulin treatment and can experience numerous disease-associated complications. The last decade has seen tremendous advances in elucidating the causes and treatment of the disease based on extensive research both in rodent models of spontaneous diabetes and in humans. Integrating these advances has led to the recognition that the balance between regulatory and effector T cells determines disease risk, timing of disease activation, and disease tempo. Here we describe current progress, the challenges ahead and the new interventions that are being tested to address the unmet need for preventative or curative therapies.	[Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Bluestone, Jeffrey A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Herold, Kevan] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Eisenbarth, George] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus	Bluestone, JA (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	jbluest@diabetes.ucsf.edu			NIAID; NIDDK; JDRF; CDF; Brehm Coalition; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107328, R01AI046643] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JDRF(Juvenile Diabetes Research Foundation); CDF; Brehm Coalition; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the many people in our laboratories and the community who have made significant contributions to the research highlighted in this review. We owe special thanks to L. Lanier, M. Anderson and M. Atkinson as well as the members of the Brehm Coalition for many discussions and critiques of the manuscript. Additionally, we thank J. Matthews for putting together Fig. 4. We acknowledge support from NIAID, NIDDK, JDRF, CDF and the Brehm Coalition.	Akerblom HK, 2005, DIABETOLOGIA, V48, P829, DOI 10.1007/s00125-005-1733-3; Allen HF, 1999, DIABETES CARE, V22, P1703, DOI 10.2337/diacare.22.10.1703; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; Bresson D, 2006, J CLIN INVEST, V116, P1371, DOI 10.1172/JCI27191; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Devendra D, 2005, DIABETES, V54, P2549, DOI 10.2337/diabetes.54.9.2549; DiLorenzo TP, 2005, IMMUNOL REV, V204, P250, DOI 10.1111/j.0105-2896.2005.00244.x; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; EISENBARTH GS, 1985, DIABETES RES CLIN EX, V2, P271; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Esensten JH, 2009, J IMMUNOL, V183, P75, DOI 10.4049/jimmunol.0804154; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; FEUTREN G, 1986, LANCET, V2, P119; Gardner JM, 2009, CURR OPIN IMMUNOL, V21, P582, DOI 10.1016/j.coi.2009.08.007; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Greeley SAW, 2002, NAT MED, V8, P399, DOI 10.1038/nm0402-399; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Herold KC, 2009, CLIN IMMUNOL, V132, P166, DOI 10.1016/j.clim.2009.04.007; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Jun HS, 2004, ILAR J, V45, P349, DOI 10.1093/ilar.45.3.349; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Kobayashi M, 2008, P NATL ACAD SCI USA, V105, P10090, DOI 10.1073/pnas.0801648105; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Lieberman SM, 2003, TISSUE ANTIGENS, V62, P359, DOI 10.1034/j.1399-0039.2003.00152.x; LORENZEN T, 1994, DIABETOLOGIA, V37, P321, DOI 10.1007/BF00398061; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Maahs DM, 2006, J CLIN ENDOCR METAB, V91, P3757, DOI 10.1210/jc.2006-1730; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Matthews JB, 2010, CLIN EXP IMMUNOL, V160, P176, DOI 10.1111/j.1365-2249.2010.04153.x; Medarova Z, 2008, MAGN RESON MED, V59, P712, DOI 10.1002/mrm.21494; Mordes JP, 1996, DIABETES METAB REV, V12, P103, DOI 10.1002/(SICI)1099-0895(199607)12:2<103::AID-DMR161>3.0.CO;2-2; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Norris JM, 2007, JAMA-J AM MED ASSOC, V298, P1420, DOI 10.1001/jama.298.12.1420; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Qin HY, 1997, J AUTOIMMUN, V10, P271, DOI 10.1006/jaut.1997.0136; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Serreze DV, 1998, J IMMUNOL, V161, P3912; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; STILLER CR, 1984, SCIENCE, V223, P1362, DOI 10.1126/science.6367043; Strom TB, 2008, CURR OPIN IMMUNOL, V20, P676, DOI 10.1016/j.coi.2008.10.003; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; TANG Q, 2008, NATURE IMMUNOL, V9, P339; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Vauzelle-Kervroedan F, 1999, DIABETES METAB, V25, P404; Virtanen SM, 2006, DIABETOLOGIA, V49, P1512, DOI 10.1007/s00125-006-0236-1; Voltarelli JC, 2009, DIABETOL METAB SYNDR, V1, DOI [10.1186/1758-5996-1-19, 10.1186/1758-5996-1-4]; Waldmann H, 1998, ANNU REV IMMUNOL, V16, P619, DOI 10.1146/annurev.immunol.16.1.619; Weintrob N, 2001, DIABETES CARE, V24, P650, DOI 10.2337/diacare.24.4.650; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wise M, 1999, EUR J IMMUNOL, V29, P156, DOI 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K; Wong FS, 2004, DIABETES, V53, P2581, DOI 10.2337/diabetes.53.10.2581; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693	87	774	812	5	250	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1293	1300		10.1038/nature08933	http://dx.doi.org/10.1038/nature08933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20432533	Green Accepted			2022-12-28	WOS:000277149000035
J	Suzuki, T; Uchida, H; Nakajima, S				Suzuki, Takefumi; Uchida, Hiroyuki; Nakajima, Shinichiro			Depression Severity and Effect of Antidepressant Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Suzuki, Takefumi; Uchida, Hiroyuki; Nakajima, Shinichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan	Keio University	Suzuki, T (corresponding author), Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan.	takefumi@oak.dti.ne.jp	Uchida, Hiroyuki/I-4867-2015; Nakajima, Shinichiro/V-1282-2019; Nakajima, Shinichiro/O-3011-2018	Uchida, Hiroyuki/0000-0002-0628-7036; 				Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Glick ID, 2009, J CLIN PSYCHOPHARM, V29, P542, DOI 10.1097/JCP.0b013e3181befa2a; Nakajima S, 2010, PROG NEURO-PSYCHOPH, V34, P259, DOI 10.1016/j.pnpbp.2009.12.001	4	3	3	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1597	1598		10.1001/jama.2010.507	http://dx.doi.org/10.1001/jama.2010.507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424244				2022-12-28	WOS:000277085200015
J	Chappie, JS; Acharya, S; Leonard, M; Schmid, SL; Dyda, F				Chappie, Joshua S.; Acharya, Sharmistha; Leonard, Marilyn; Schmid, Sandra L.; Dyda, Fred			G domain dimerization controls dynamin's assembly-stimulated GTPase activity	NATURE			English	Article							DEPENDENT CONFORMATIONAL-CHANGES; ISOMORPHOUS REPLACEMENT; CRYSTAL-STRUCTURE; PROTEINS; BINDING; CONSTRICTION; MECHANISM; MODEL; SUPERFAMILY; HYDROLYSIS	Dynamin is an atypical GTPase that catalyses membrane fission during clathrin-mediated endocytosis. The mechanisms of dynamin's basal and assembly-stimulated GTP hydrolysis are unknown, though both are indirectly influenced by the GTPase effector domain (GED). Here we present the 2.0 angstrom resolution crystal structure of a human dynamin 1-derived minimal GTPase-GED fusion protein, which was dimeric in the presence of the transition state mimic GDP.AlF4-. The structure reveals dynamin's catalytic machinery and explains how assembly-stimulated GTP hydrolysis is achieved through G domain dimerization. A sodium ion present in the active site suggests that dynamin uses a cation to compensate for the developing negative charge in the transition state in the absence of an arginine finger. Structural comparison to the rat dynamin G domain reveals key conformational changes that promote G domain dimerization and stimulated hydrolysis. The structure of the GTPase-GED fusion protein dimer provides insight into the mechanisms underlying dynamin-catalysed membrane fission.	[Chappie, Joshua S.; Acharya, Sharmistha; Leonard, Marilyn; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Chappie, Joshua S.; Dyda, Fred] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	slschmid@scripps.edu; dyda@helix.nih.gov	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Schmid, Sandra/0000-0002-1690-7024	NIH [GM42455, MH61345]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH; NIMH [MH081419]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH081419, R01MH061345, R37MH061345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Lukiyanchuk for assistance in cloning and purification; A. Hickman, J. Mindell and R. Ramachandran for discussions and technical advice; T. Pucadyil and R. Ramachandran for critical reading of the manuscript; J. Hinshaw and J. Mears for providing the unpublished coordinates for the GTPase docking model derived from their cryo-EM docking studies; and R. Stevens and I. Wilson for structural advice, guidance and the use of their laboratory facilities in the early stages of this work. This work was supported by NIH grants GM42455 and MH61345 (to S. L. S.) and the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the NIH. J. S. C. was supported by a Ruth Kirschstein individual predoctoral fellowship from the NIMH (MH081419) and by a postdoctoral Intramural Research Training Award from NIDDK. Data were collected at the SER-CAT 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; *BRUK, 2001, BRUK AXS DAT PREP RE; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carr JF, 1997, J BIOL CHEM, V272, P28030, DOI 10.1074/jbc.272.44.28030; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Damke H, 2001, MOL BIOL CELL, V12, P2578, DOI 10.1091/mbc.12.9.2578; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Diederichs K, 2003, ACTA CRYSTALLOGR D, V59, P903, DOI 10.1107/S0907444903006516; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W., 2001, INT TABLES CRYSTALLO, VF; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Li GP, 2004, J MOL BIOL, V340, P921, DOI 10.1016/j.jmb.2004.06.007; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Scrima A, 2006, EMBO J, V25, P2940, DOI 10.1038/sj.emboj.7601171; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Sheldrick GM, 1998, NATO ADV SCI I C-MAT, V507, P401; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TERWILLIGER TC, 1994, ACTA CRYSTALLOGR D, V50, P17, DOI 10.1107/S0907444993008236; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; YAP K, INTERHLX; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	55	203	205	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					435	U54		10.1038/nature09032	http://dx.doi.org/10.1038/nature09032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20428113	Green Accepted			2022-12-28	WOS:000278043700025
J	Gao, S; von der Malsburg, A; Paeschke, S; Behlke, J; Haller, O; Kochs, G; Daumke, O				Gao, Song; von der Malsburg, Alexander; Paeschke, Susann; Behlke, Joachim; Haller, Otto; Kochs, Georg; Daumke, Oliver			Structural basis of oligomerization in the stalk region of dynamin-like MxA	NATURE			English	Article							GTP-BINDING; PROTEIN; VIRUS; PROGRAM; SYSTEM; MODEL; VISUALIZATION; LOCALIZES; MECHANISM; COMPLEX	The interferon-inducible dynamin-like myxovirus resistance protein 1 (MxA; also called MX1) GTPase is a key mediator of cell-autonomous innate immunity against pathogens such as influenza viruses(1). MxA partially localizes to COPI-positive membranes of the smooth endoplasmic reticulum-Golgi intermediate compartment(2). At the point of infection, it redistributes to sites of viral replication and promotes missorting of essential viral constituents(3,4). It has been proposed that the middle domain and the GTPase effector domain of dynamin-like GTPases constitute a stalk that mediates oligomerization and transmits conformational changes from the G domain to the target structure(5-7); however, the molecular architecture of this stalk has remained elusive. Here we report the crystal structure of the stalk of human MxA, which folds into a four-helical bundle. This structure tightly oligomerizes in the crystal in a criss-cross pattern involving three distinct interfaces and one loop. Mutations in each of these interaction sites interfere with native assembly, oligomerization, membrane binding and antiviral activity of MxA. On the basis of these results, we propose a structural model for dynamin oligomerization and stimulated GTP hydrolysis that is consistent with previous structural predictions and has functional implications for all members of the dynamin family.	[Gao, Song; Paeschke, Susann; Behlke, Joachim; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Gao, Song] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [von der Malsburg, Alexander; Haller, Otto; Kochs, Georg] Univ Freiburg, Dept Virol, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany; [Daumke, Oliver] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	oliver.daumke@mdc-berlin.de		Gao, Song/0000-0001-7427-6681	Deutsche Forschungsgemeinschaft [SFB 740]; The International Human Frontier Science Program Organization; German-Israeli-Research foundation [GIF-841/04]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); The International Human Frontier Science Program Organization(Human Frontier Science Program); German-Israeli-Research foundation(German-Israeli Foundation for Scientific Research and Development)	This project was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB 740-From Molecules to Modules) and by a Career Development Fellowship of 'The International Human Frontier Science Program Organization' to O. D., and by the German-Israeli-Research foundation (GIF-841/04) to G. K. and O.H. We are grateful to J. Hinshaw and J. Mears for providing the EM maps and model fittings of oligomerized dynamin. We would also like to acknowledge help and support of O. Ristau and K. Schilling/ Nanolytics (analytical ultracentrifugation), M. Dahte and H. Nikolenko (fluorescence measurements), A. Herrmann, T. Korte and P. Muller (stopped-flow analysis), G. Dittmar (mass spectrometry analysis), S. Werner and S. Gruber (technical assistance) and the BESSY staff at BL14.1 (data collection). This work was conducted by A. v. M. in partial fulfilment for a PhD degree from the Faculty of Biology at the University of Freiburg, Germany.	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; ARNHEITER H, 1988, EMBO J, V7, P1315, DOI 10.1002/j.1460-2075.1988.tb02946.x; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Behlke J, 1997, BIOCHEMISTRY-US, V36, P5149, DOI 10.1021/bi962755h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; DeLano W.L, PYMOL MOL GRAPHICS S; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hefti HP, 1999, J VIROL, V73, P6984, DOI 10.1128/JVI.73.8.6984-6991.1999; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MELEN K, 1994, J BIOL CHEM, V269, P2009; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; SCHWEMMLE M, 1995, J BIOL CHEM, V270, P13518, DOI 10.1074/jbc.270.22.13518; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Steinkellner G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-32; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; ZURCHER T, 1992, EMBO J, V11, P1657, DOI 10.1002/j.1460-2075.1992.tb05212.x	49	176	185	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					502	U134		10.1038/nature08972	http://dx.doi.org/10.1038/nature08972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20428112	Green Accepted			2022-12-28	WOS:000278043700040
J	Iwase, T; Uehara, Y; Shinji, H; Tajima, A; Seo, H; Takada, K; Agata, T; Mizunoe, Y				Iwase, Tadayuki; Uehara, Yoshio; Shinji, Hitomi; Tajima, Akiko; Seo, Hiromi; Takada, Koji; Agata, Toshihiko; Mizunoe, Yoshimitsu			Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization	NATURE			English	Article							REAL-TIME PCR; METHICILLIN-RESISTANT; BACTERIAL INTERFERENCE; MOLECULAR ANALYSIS; VANCOMYCIN RESISTANCE; UNITED-STATES; CARRIAGE; IDENTIFICATION; ENDOPEPTIDASE; PREVALENCE	Commensal bacteria are known to inhibit pathogen colonization; however, complex host-microbe and microbe-microbe interactions have made it difficult to gain a detailed understanding of the mechanisms involved in the inhibition of colonization(1). Here we show that the serine protease Esp(2,3) secreted by a subset of Staphylococcus epidermidis, a commensal bacterium, inhibits biofilm formation and nasal colonization by Staphylococcus aureus, a human pathogen(4). Epidemiological studies have demonstrated that the presence of Esp-secreting S. epidermidis in the nasal cavities of human volunteers correlates with the absence of S. aureus. Purified Esp inhibits biofilm formation and destroys pre-existing S. aureus biofilms. Furthermore, Esp enhances the susceptibility of S. aureus in biofilms to immune system components. In vivo studies have shown that Esp-secreting S. epidermidis eliminates S. aureus nasal colonization. These findings indicate that Esp hinders S. aureus colonization in vivo through a novel mechanism of bacterial interference, which could lead to the development of novel therapeutics to prevent S. aureus colonization and infection.	[Iwase, Tadayuki; Shinji, Hitomi; Tajima, Akiko; Mizunoe, Yoshimitsu] Jikei Univ, Sch Med, Dept Bacteriol, Tokyo 1058461, Japan; [Takada, Koji] Jikei Univ, Sch Med, Dept Biochem, Tokyo 1058461, Japan; [Agata, Toshihiko] Jikei Univ, Sch Med, Dept Environm Hlth, Tokyo 1058461, Japan; [Uehara, Yoshio; Seo, Hiromi] Kochi Med Sch, Dept Gen Med, Nankoku, Kochi 7838505, Japan	Jikei University; Jikei University; Jikei University; Kochi University	Iwase, T (corresponding author), Jikei Univ, Sch Med, Dept Bacteriol, Tokyo 1058461, Japan.	iwase.tadayuki@jikei.ac.jp		Iwase, Tadayuki/0000-0003-4915-3983	Jikei University	Jikei University(Jikei University)	We thank K. Hiramatsu and T. Bae for providing materials and M. Sekiguchi, T. Bae, S. N. Wai, B. E. Uhlin, L. Cui, T. Ito, M. Yoneda, M. Urashima and S. Masuda for discussions, critical comments and advice. Thanks also go to S. Kuramoto, K. Seki, F. Sato, S. Hoshina, T. Ohashi, H. Ikeshima-Kataoka, Y. Yoshizawa, M. Murai and M. Kono for their comments on the study, and to J. Fitzpatrick and M. Okazaki for their comments on the manuscript, and to our colleagues for their assistance. Finally, we thank all persons involved in the study. A part of the study was supported by The Jikei University Research Fund and by The Jikei University Graduate Research Fund.	AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; Carroll KC, 1996, AM J CLIN PATHOL, V106, P600; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; Dubin G, 2001, BIOL CHEM, V382, P1575, DOI 10.1515/BC.2001.192; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falagas ME, 2008, INT J ANTIMICROB AG, V31, P518, DOI 10.1016/j.ijantimicag.2008.01.024; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Ikeda Y, 2004, CAN J MICROBIOL, V50, P493, DOI [10.1139/w04-055, 10.1139/W04-055]; Iwase T, 2008, DIAGN MICR INFEC DIS, V60, P217, DOI 10.1016/j.diagmicrobio.2007.08.009; Iwase T, 2007, J MED MICROBIOL, V56, P1346, DOI 10.1099/jmm.0.47235-0; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MACHIN DCM, 1997, SAMPLE SIZE TABLES C, pCH3; MACKOWIAK PA, 1982, NEW ENGL J MED, V307, P83, DOI 10.1056/NEJM198207083070203; Midorikawa K, 2003, INFECT IMMUN, V71, P3730, DOI 10.1128/IAI.71.7.3730-3739.2003; Moon JL, 2001, BIOL CHEM, V382, P1095, DOI 10.1515/BC.2001.138; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; NICOLL TR, 1987, AVIAN DIS, V31, P140, DOI 10.2307/1590787; Ohara-Nemoto Y, 2002, MICROB PATHOGENESIS, V33, P33, DOI 10.1006/mpat.2002.0515; Otto M, 2001, PEPTIDES, V22, P1603, DOI 10.1016/S0196-9781(01)00495-8; Paule SM, 2005, AM J CLIN PATHOL, V124, P404, DOI 10.1309/6EA3U9V8NCLLGKQN; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; POUTREL B, 1980, ANN RECH VET, V11, P327; Shinji H, 1997, J IMMUNOL, V158, P1370; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; SPECK WT, 1978, J CLIN PATHOL, V31, P153, DOI 10.1136/jcp.31.2.153; Srinivasan A, 2002, CLIN MICROBIOL REV, V15, P430, DOI 10.1128/CMR.15.3.430-438.2002; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Uehara Y, 2001, CLIN INFECT DIS, V32, P1408, DOI 10.1086/320179; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	47	577	609	5	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					346	U100		10.1038/nature09074	http://dx.doi.org/10.1038/nature09074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485435				2022-12-28	WOS:000277829200040
J	Wei, L; Struthers, AD; Fahey, T; Watson, AD; MacDonald, TM				Wei, Li; Struthers, Allan D.; Fahey, Tom; Watson, Alexander D.; MacDonald, Thomas M.			Spironolactone use and renal toxicity: population based longitudinal analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; ALDOSTERONE ANTAGONISTS; RENIN RATIO; HYPERKALEMIA; HYPERTENSION; THERAPY; EVENTS	Objective To determine the safety of spironolactone prescribing in the setting of the UK National Health Service. Design Population based longitudinal analysis using a record linkage database. Setting Tayside, Scotland. Population All patients who received one or more dispensed prescriptions for spironolactone between 1994 and 2007. Main outcome measures Rates of prescribing for spironolactone, hospital admissions for hyperkalaemia, and hyperkalaemia and renal function without admission, before and after the publication of results from the Randomised Aldactone Evaluation Study (RALES). Results Prescriptions for spironolactone and measurements of serum creatinine and serum potassium all increased in parallel in Tayside after the release of the RALES results in 1999 ( from 2847, 5345, and 5246 in the first half of 1999 to 6582, 10 753, and 10 534 by the second half of 2001, and to 8619, 17 844, and 17 649 by 2007). These increases occurred in patients with and without heart failure. Few hospital admissions for hyperkalaemia occurred over this time: three in the first quarter of 1995, two in the last quarter of 2001, and three in 2007. Among patients who were taking angiotensin converting enzyme inhibitors and who had recently been admitted to hospital for heart failure, the rate of spironolactone use was 19.8 per 100 patients in early 1999 rising to 70.1 per 100 patients by late 2001 (P<0.01) and 61.3 by 2007. The rate of outpatient measured hyperkalaemia ( serum K+>6 mmol/l) did not increase over time (9.9 per 100 patients in early 1999, 6.9 per 100 patients in late 2001, and 2.9 per 100 patients in 2007) despite the increased use of spironolactone. Conclusions Despite a marked increased in the use of spironolactone in patients with and without heart failure, no increase was seen in hospital admissions for hyperkalaemia and outpatient hyperkalaemia actually fell. Careful monitoring of patients prescribed spironolactone seems to have been associated with no increase in risk of hyperkalaemia.	[Wei, Li; MacDonald, Thomas M.] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland; [Fahey, Tom] Royal Coll Surgeons Ireland, Mercers Med Ctr, Dept Gen Practice, Dublin 2, Ireland; [Watson, Alexander D.] Westgate Hlth Ctr, Dundee DD2 4AD, Scotland	University of Dundee; Royal College of Surgeons - Ireland; University of Dundee	MacDonald, TM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Med Monitoring Unit MEMO, Dundee DD1 9SY, Scotland.	t.m.macdonald@dundee.ac.uk	Fahey, Tom/C-9367-2012	Fahey, Tom/0000-0002-5896-5783; Struthers, Allan/0000-0002-2926-2528; MacDonald, Thomas/0000-0001-5189-6669	TENOVUS Scotland [T06/44]; UK Medical Research Council [G106/1249]; Pfizer; Servier; Novartis; Wyeth; Kaiser Permanante; Takeda; Recordati; NiCox; Quintiles; Speedel; MRC [G106/1249] Funding Source: UKRI; Medical Research Council [G106/1249] Funding Source: researchfish	TENOVUS Scotland; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Servier(Servier); Novartis(Novartis); Wyeth(Wyeth); Kaiser Permanante; Takeda(Takeda Pharmaceutical Company Ltd); Recordati; NiCox; Quintiles; Speedel; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the TENOVUS Scotland (T06/44). LW holds a special training fellowship in health services and health of the public research award from the UK Medical Research Council (G106/1249). The funding body did not have any role in study design, data analysis, result interpretations, or report submission.; (All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf ( available on request from the corresponding author) and declare ( 1) no financial support from any commercial company for the submitted work; ( 2) TMM received consultancy fees, honoraria, and travel expenses in the past three years from Pfizer, Servier, Novartis, Wyeth, Kaiser Permanante, Takeda, Recordati, NiCox, Quintiles, and Speedel; ADS received consultancy fees, honoraria, and travel expenses from Pfizer in the past three years; ADW received consultancy fees, honoraria, and travel expenses from Servier and Pfizer in the past three years; ( 3) no spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; and ( 4) no non-financial interests that may be relevant to the submitted work.	Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Calhoun DA, 2006, PROG CARDIOVASC DIS, V48, P387, DOI 10.1016/j.pcad.2006.02.002; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; GISSI Prevenzione Investigators, 2000, ITAL HEART J, V1, P810; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Lim PO, 1999, LANCET, V353, P40, DOI 10.1016/S0140-6736(05)74868-6; Lim PO, 2002, J HYPERTENS, V20, P11, DOI 10.1097/00004872-200201000-00003; Lim PO, 2002, J HUM HYPERTENS, V16, P153, DOI 10.1038/sj.jhh.1001320; Lim PO, 2001, J HYPERTENS, V19, P353, DOI 10.1097/00004872-200103000-00001; Lim PO, 1999, BRIT J CLIN PHARMACO, V48, P756; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Obialo CI, 2002, AM J CARDIOL, V90, P663, DOI 10.1016/S0002-9149(02)02581-X; Ouzan J, 2002, AM J HYPERTENS, V15, P333, DOI 10.1016/S0895-7061(01)02342-1; PEDERSEN TR, 1994, LANCET, V344, P1383; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Verhamme KMC, 2006, BMJ-BRIT MED J, V333, P330, DOI 10.1136/bmj.38883.479549.2F; Wei L, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P323; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634	25	72	72	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2010	340								c1768	10.1136/bmj.c1768	http://dx.doi.org/10.1136/bmj.c1768			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LR	20483947	Green Submitted, hybrid			2022-12-28	WOS:000278061500003
J	Fuchs, VR				Fuchs, Victor R.			Health Care Is Different-That's Why Expenditures Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Natl Bur Econ Res, Stanford, CA 94305 USA	National Bureau of Economic Research	Fuchs, VR (corresponding author), Natl Bur Econ Res, 30 Alta Rd, Stanford, CA 94305 USA.	vfuchs@stanford.edu						ARROW KJ, 1963, AM ECON REV, V53, P941; Auerbach A. J., 2002, HDB PUBLIC EC, P1347; Centers for Medicare Medicaid Services, NAT HLTH EXP DAT; Chernew ME, 2010, NEW ENGL J MED, V362, P1166, DOI 10.1056/NEJMp1002873; LEONHARDT D, 2010, NY TIMES        1215, pA1; Newhouse JP, 1993, FREE ALL LESSONS RAN; *US C, LONG TERM OUTL HLTH	7	3	3	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1859	1860		10.1001/jama.2010.593	http://dx.doi.org/10.1001/jama.2010.593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460626				2022-12-28	WOS:000277513900028
J	Karki, BB; Stixrude, LP				Karki, Bijaya B.; Stixrude, Lars P.			Viscosity of MgSiO3 Liquid at Earth's Mantle Conditions: Implications for an Early Magma Ocean	SCIENCE			English	Article							TRANSPORT-PROPERTIES; PRESSURE-DEPENDENCE; MOLECULAR-DYNAMICS; SEISMIC EVIDENCE; SILICATE MELTS; TEMPERATURE; DIFFUSION; GLASSES; BASE	Understanding the chemical and thermal evolution of Earth requires knowledge of transport properties of silicate melts at high pressure and high temperature. Here, first-principles molecular dynamics simulations show that the viscosity of MgSiO3 liquid varies by two orders of magnitude over the mantle pressure regime. Addition of water systematically lowers the viscosity, consistent with enhanced structural depolymerization. The combined effects of pressure and temperature along model geotherms lead to a 10-fold increase in viscosity with depth from the surface to the base of the mantle. Based on these calculations, efficient heat flux from a deep magma ocean may have exceeded the incoming solar flux early in Earth's history.	[Karki, Bijaya B.] Louisiana State Univ, Dept Geol & Geophys, Dept Comp Sci, Baton Rouge, LA 70803 USA; [Stixrude, Lars P.] UCL, Dept Earth Sci, London WC1E 6BT, England	Louisiana State University System; Louisiana State University; University of London; University College London	Karki, BB (corresponding author), Louisiana State Univ, Dept Geol & Geophys, Dept Comp Sci, Baton Rouge, LA 70803 USA.	karki@csc.lsu.edu	Stixrude, Lars/C-5625-2012	Stixrude, Lars/0000-0003-3778-2432	NSF [EAR-0809489]; UK National Environmental Research Council [NE/F01787/1]; NERC [NE/F017871/1] Funding Source: UKRI; Natural Environment Research Council [NE/F017871/1] Funding Source: researchfish; Division Of Earth Sciences [0809489] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); UK National Environmental Research Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF (EAR-0809489) and the UK National Environmental Research Council (NE/F01787/1). Computing facilities were provided by the Center of Computation and Technology at Louisiana State University. The authors thank J. Brodholt, M. Ghiorso, and S. Karato for useful comments and suggestions.	ANGELL CA, 1982, SCIENCE, V218, P885, DOI 10.1126/science.218.4575.885; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Behrens H, 2003, AM MINERAL, V88, P1351; BOTTINGA Y, 1995, GEOCHIM COSMOCHIM AC, V59, P2725, DOI 10.1016/0016-7037(95)00168-Y; Canup RM, 2004, ICARUS, V168, P433, DOI 10.1016/j.icarus.2003.09.028; Giordano D, 2003, EARTH PLANET SC LETT, V208, P337, DOI 10.1016/S0012-821X(03)00042-6; HAGGERTY SE, 1990, SCIENCE, V248, P993, DOI 10.1126/science.248.4958.993; Harris KR, 2005, J CHEM ENG DATA, V50, P1777, DOI 10.1021/je050147b; Hofmeister AM, 2009, CONTRIB MINERAL PETR, V158, P381, DOI 10.1007/s00410-009-0388-3; Karki BB, 2010, PHYS CHEM MINER, V37, P103, DOI 10.1007/s00269-009-0315-1; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KUSHIRO I, 1976, J GEOPHYS RES, V81, P6351, DOI 10.1029/JB081i035p06351; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Lacks DJ, 2007, GEOCHIM COSMOCHIM AC, V71, P1312, DOI 10.1016/j.gca.2006.11.030; LANGE LA, 1994, REV MINERAL, V30, P331; Liebske C, 2005, EARTH PLANET SC LETT, V240, P589, DOI 10.1016/j.epsl.2005.10.004; Mookherjee M, 2008, NATURE, V452, P983, DOI 10.1038/nature06918; Mungall JE, 2002, GEOCHIM COSMOCHIM AC, V66, P125, DOI 10.1016/S0016-7037(01)00736-0; Nevins D, 2009, AM MINERAL, V94, P975, DOI 10.2138/am.2009.3092; Reid JE, 2003, PHYS EARTH PLANET IN, V139, P45, DOI 10.1016/S0031-9201(03)00143-2; REVENAUGH J, 1994, NATURE, V369, P474, DOI 10.1038/369474a0; RIVERS ML, 1987, J GEOPHYS RES-SOLID, V92, P9247, DOI 10.1029/JB092iB09p09247; SHRAIMAN BI, 1990, PHYS REV A, V42, P3650, DOI 10.1103/PhysRevA.42.3650; Solomatov V. S., 2007, TREATISE GEOPHYS, V9, P91, DOI DOI 10.1016/B978-044452748-6.00141-3); Stixrude L, 2005, SCIENCE, V310, P297, DOI 10.1126/science.1116952; Stixrude L, 2009, EARTH PLANET SC LETT, V278, P226, DOI 10.1016/j.epsl.2008.12.006; STOLPER E, 1982, GEOCHIM COSMOCHIM AC, V46, P2609, DOI 10.1016/0016-7037(82)90381-7; Tinker D, 2004, AM MINERAL, V89, P1701, DOI 10.2138/am-2004-11-1216; URBAIN G, 1982, GEOCHIM COSMOCHIM AC, V46, P1061, DOI 10.1016/0016-7037(82)90059-X; Wan JTK, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004135; WASSERMAN EA, 1993, EARTH PLANET SC LETT, V114, P373, DOI 10.1016/0012-821X(93)90037-A; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528	32	97	103	4	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					740	742		10.1126/science.1188327	http://dx.doi.org/10.1126/science.1188327			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448181				2022-12-28	WOS:000277357100036
J	Stone, GW; Rizvi, A; Newman, W; Mastali, K; Wang, JC; Caputo, R; Doostzadeh, J; Cao, S; Simonton, CA; Sudhir, K; Lansky, AJ; Cutlip, DE; Kereiakes, DJ				Stone, Gregg W.; Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John C.; Caputo, Ronald; Doostzadeh, Julie; Cao, Sherry; Simonton, Charles A.; Sudhir, Krishnankutty; Lansky, Alexandra J.; Cutlip, Donald E.; Kereiakes, Dean J.		SPIRIT IV Investigators	Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BARE-METAL STENTS; DIABETES-MELLITUS; FOLLOW-UP; RANDOMIZED-TRIALS; POOLED ANALYSIS; RESTENOSIS; IMPACT; INTERVENTION; IMPLANTATION; METAANALYSIS	Background: Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points. Methods: We randomly assigned 3687 patients at 66 U.S. sites to receive everolimus-eluting stents or paclitaxel-eluting stents without routine follow-up angiography. The primary end point was the 1-year composite rate of target-lesion failure (defined as cardiac death, target-vessel myocardial infarction, or ischemia-driven target-lesion revascularization). Results: Everolimus-eluting stents were superior to paclitaxel-eluting stents with respect to the primary end point of target-lesion failure (4.2% vs. 6.8%; relative risk, 0.62; 95% confidence interval, 0.46 to 0.82; P=0.001). Everolimus-eluting stents were also superior with respect to the major secondary end point of the 1-year rate of ischemia-driven target-lesion revascularization (P=0.001) and were noninferior with respect to the major secondary end point of the 1-year composite rate of cardiac death or target-vessel myocardial infarction (P<0.001 for noninferiority; P=0.09 for superiority). The 1-year rates of myocardial infarction and stent thrombosis were also lower with everolimus-eluting stents than with paclitaxel-eluting stents (1.9% vs. 3.1%, P=0.02 for myocardial infarction; 0.17% vs. 0.85%, P=0.004 for stent thrombosis). Target-lesion failure was consistently reduced with everolimus-eluting stents as compared with paclitaxel-eluting stents in 12 prespecified subgroups, except in the subgroup of patients with diabetes (6.4% vs. 6.9%, P=0.80). Conclusions: Everolimus-eluting stents, as compared with paclitaxel-eluting stents, resulted in reduced rates of target-lesion failure at 1 year, results that were consistent in all patients except those with diabetes, in whom the results were nonsignificantly different. (ClinicalTrials.gov number, NCT00307047.) N Engl J Med 2010;362:1663-74.	[Stone, Gregg W.] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY 10022 USA; [Stone, Gregg W.; Lansky, Alexandra J.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Rizvi, Ali] Heart Ctr Indiana, Indianapolis, IN USA; [Newman, William] Wake Med Ctr, Raleigh, NC USA; [Mastali, Kourosh] St Joseph Med Ctr, Towson, MD USA; [Wang, John C.] Union Mem Hosp, Baltimore, MD USA; [Caputo, Ronald] St Josephs Hosp Syracuse, Syracuse, NY USA; [Doostzadeh, Julie; Cao, Sherry; Simonton, Charles A.; Sudhir, Krishnankutty] Abbott Vasc, Santa Clara, CA USA; [Cutlip, Donald E.] Harvard Clin Res Inst, Boston, MA USA; [Kereiakes, Dean J.] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA	Cardiovascular Research Foundation (CRF); Columbia University; Columbia University; NewYork-Presbyterian Hospital; Union Memorial Hospital; Harvard University; Harvard Medical School; Christ Hospital - Ohio	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Fl, New York, NY 10022 USA.	gs2184@columbia.edu			Abbott Vascular; TherOx; Medicines Company; Atrium; Osprey Medical; IntraReDx; Reva Medical; Merck; CoreValve; Boston Scientific; St. Jude Medical, Edwards; Volcano; Accelerated Technologies; Radiant Medical; AstraZeneca; Prescient Medical; Medtronic; Eli Lilly; Bristol-Myers Squibb; Bingen idec; XTENT; Bioabsorbable Therapeutics; Asten BioPharma; SB Medical; Ovalum and Biosensors	Abbott Vascular(Abbott Laboratories); TherOx; Medicines Company; Atrium; Osprey Medical; IntraReDx; Reva Medical; Merck(Merck & Company); CoreValve; Boston Scientific(Boston Scientific); St. Jude Medical, Edwards(St. Jude Medical); Volcano; Accelerated Technologies; Radiant Medical; AstraZeneca(AstraZeneca); Prescient Medical; Medtronic(Medtronic); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Bingen idec(Biogen); XTENT; Bioabsorbable Therapeutics; Asten BioPharma; SB Medical; Ovalum and Biosensors	Sponsored by Abbott Vascular.; Dr. Stone reports receiving research grants from Abbott Vascular, TherOx, the Medicines Company, Atrium, and Boston Scientific consulting fees from Osprey Medical, IntraReDx, Reva Medical, Merck, CoreValve (now part of Medtronic), Boston Scientific, Abbott Vascular, St. Jude Medical, Edwards, Volcano, Accelerated Technologies, Radiant Medical, AstraZeneca, Prescient Medical, Medtronic, Eli Lilly, Bristol-Myers Squibb, Bingen idec, XTENT, Bioabsorbable Therapeutics, Asten BioPharma, SB Medical, Ovalum and Biosensors, and honoraria from Ru ton Sciendfic and Abbott Vascular and holding equity in Devax, CoreValve, Savacor, BioStar I and II funds, NtedFocus I, II and Accelerator funds, Prescient, Xtent, Setagon, AorTx, Ultimate IVUS, Caliber Medical, FlowCardia, Ovalum, MediGuide, Guided Delivery Systems, Arstasis, and holding hoard membership in Devax; Dr. Wang, receiving consulting fees, lecture fees, honoraria, and travel-expense reimbursements from Abbott Vascular; Dr. Caputo, receiving consulting fees from Boston Scientific, Cordis, Medtronic, and Terumo and speaking fees from Abbott and Terumo; Drs. Doostzadeh and Cao, being employed by and holding equity in Abbott Vascular; Dr. Simonton, being employed by Abbott Vascular; Dr. Sudhir, being employed by and holding equity in Abbott Vascular and receiving travelexpense reimbursements from Abbott Vascular; and Dr. Kereiakes, receiving consulting fees or honoraria from Abbott Vascular. No other potential conflict of interest relevant to this article was reported.	Airoldi F, 2007, CIRCULATION, V116, P745, DOI 10.1161/CIRCULATIONAHA.106.686048; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, EUR HEART J, V28, P26, DOI 10.1093/eurheartj/ehl412; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Eisenstein EL, 2007, JAMA-J AM MED ASSOC, V297, P159, DOI 10.1001/jama.297.2.joc60179; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kirtane AJ, 2008, J AM COLL CARDIOL, V51, P708, DOI 10.1016/j.jacc.2007.10.035; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuchulakanti PK, 2006, AM J CARDIOL, V98, P187, DOI 10.1016/j.amjcard.2006.01.074; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Lansky A, 2009, AM J CARDIOL, V104, p135D; LEE TH, 2004, NEW ENGL J MED, V4, P350; LEE TH, 2004, NEW ENGL J MED, V350, P1586; Nikolsky E, 2009, AM HEART J, V158, P520, DOI 10.1016/j.ahj.2009.07.025; Pinto DS, 2006, J AM COLL CARDIOL, V48, P32, DOI 10.1016/j.jacc.2006.02.060; Rocic P, 2009, AM J PHYSIOL-HEART C, V297, pH1970, DOI 10.1152/ajpheart.00952.2009; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys Patrick W, 2005, EuroIntervention, V1, P58; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stankovic G, 2006, AM J CARDIOL, V98, P362, DOI 10.1016/j.amjcard.2006.01.104; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528; ten Berg JM, 2001, J AM COLL CARDIOL, V38, P1061, DOI 10.1016/S0735-1097(01)01476-0	28	688	705	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1663	1674		10.1056/NEJMoa0910496	http://dx.doi.org/10.1056/NEJMoa0910496			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445180				2022-12-28	WOS:000277311200004
J	Tseng, HF; Slezak, JM; Quinn, VP; Sy, LS; Van Den Eeden, SK; Jacobsen, SJ				Tseng, Hung Fu; Slezak, Jeffrey M.; Quinn, Virginia P.; Sy, Lina S.; Van Den Eeden, Stephen K.; Jacobsen, Steven J.			Pneumococcal Vaccination and Risk of Acute Myocardial Infarction and Stroke in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; INFLUENZA VACCINATION; PREVENTION; HEALTH	Context Multiple studies have shown that preventing influenza by vaccination reduces the risk of vascular events. However, the effect of pneumococcal polysaccharide vaccine on vascular events remains controversial. Objective To examine the association between pneumococcal vaccination and risk of acute myocardial infarction (MI) and stroke among men. Design, Setting, and Participants A prospective cohort study of Kaiser Permanente Northern and Southern California health plans with 84 170 participants aged 45 to 69 years from the California Men's Health Study who were recruited between January 2002 and December 2003, and followed up until December 31, 2007. The cohort was similar to the population of health plan members and men who responded to a general health survey in California on important demographic and clinical characteristics. Demographic and detailed lifestyle characteristics were collected from surveys. Vaccination records were obtained from the Kaiser Immunization Tracking System. Main Outcome Measure Incidence of acute MI and stroke during the follow-up period in men who had no history of such conditions. Results During follow-up, there were 1211 first MIs in 112 837 vaccinated personyears (10.73 per 1000 person-years) compared with 1494 first MI events in 246 170 unvaccinated person-years (6.07 per 1000 person-years). For stroke, there were 651 events in 122 821 vaccinated person-years (5.30 per 1000 person-years) compared with 483 events in 254 541 unvaccinated person-years (1.90 per 1000 person-years). With propensity score adjustment, we found no evidence for an association between pneumococcal vaccination and reduced risk of acute MI (adjusted hazard ratio [HR], 1.09; 95% confidence interval [CI], 0.98-1.21) or stroke (adjusted HR, 1.14; 95% CI, 1.00-1.31). An inverse association was also not found in men of different age and risk groups. The results appeared to be consistent, because using more specific International Classification of Diseases, Ninth Revision codes for the outcome definition did not change the estimations. Conclusion Among a cohort of men aged 45 years or older, receipt of pneumococcal vaccine was not associated with subsequent reduced risk of acute MI and stroke. JAMA. 2010;303(17):1699-1706 www.jama.com	[Tseng, Hung Fu; Slezak, Jeffrey M.; Quinn, Virginia P.; Sy, Lina S.; Jacobsen, Steven J.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Van Den Eeden, Stephen K.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	Kaiser Permanente; Kaiser Permanente	Tseng, HF (corresponding author), Kaiser Permanente, So Calif Permanente Med Grp, Dept Res & Evaluat, 100 S Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	hung-fu.x.tseng@kp.org	Sy, Lina/AFM-9458-2022	Sy, Lina/0000-0003-2762-9266; Jacobsen, Steven/0000-0002-8174-8533	California Cancer Research Program; Kaiser Permanente	California Cancer Research Program; Kaiser Permanente	This study was funded by California Cancer Research Program and Kaiser Permanente.	[Anonymous], 1997, MMWR Recomm Rep, V46, P1; Chao C, 2008, CANCER EPIDEM BIOMAR, V17, P2692, DOI 10.1158/1055-9965.EPI-08-0410; Davis MM, 2006, J AM COLL CARDIOL, V48, P1498, DOI 10.1016/j.jacc.2006.09.004; Enger SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-172; Grau AJ, 2005, STROKE, V36, P1501, DOI 10.1161/01.STR.0000170674.45136.80; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Lamontagne F, 2008, CAN MED ASSOC J, V179, P773, DOI 10.1503/cmaj.070221; Madjid M, 2005, EXPERT OPIN BIOL TH, V5, P91, DOI 10.1517/14712598.5.1.91; Madjid M, 2008, CAN MED ASSOC J, V179, P749, DOI 10.1503/cmaj.081302; Meyers David G., 2004, HeartDrug, V4, P96, DOI 10.1159/000077705; Meyers David G, 2003, Curr Atheroscler Rep, V5, P146, DOI 10.1007/s11883-003-0087-x; Moberley SA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub2; Rosa EM, 2009, CAN MED ASSOC J, V180, P319, DOI 10.1503/cmaj.1080119; Skowronski DM, 2009, CAN MED ASSOC J, V180, P319, DOI 10.1503/cmaj.1080120; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747	15	53	55	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1699	1706		10.1001/jama.2010.529	http://dx.doi.org/10.1001/jama.2010.529			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442385	Bronze			2022-12-28	WOS:000277276600022
J	Baron, RJ				Baron, Richard J.			What's Keeping Us So Busy in Primary Care? A Snapshot from One Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TIME		Greenhouse Internists, Philadelphia, PA 19119 USA		Baron, RJ (corresponding author), Greenhouse Internists, Philadelphia, PA 19119 USA.							American College of Physicians, 2006, IMP COLL PRIM CAR ME; Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Baron RJ, 2005, ANN INTERN MED, V143, P222, DOI 10.7326/0003-4819-143-3-200508020-00008; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Farber J, 2007, ANN INTERN MED, V147, P693, DOI 10.7326/0003-4819-147-10-200711200-00005; FREUDENHEIM M, 2008, NY TIMES        0721, P1; Gottschalk A, 2005, ANN FAM MED, V3, P488, DOI 10.1370/afm.404; Hauer KE, 2008, JAMA-J AM MED ASSOC, V300, P1154, DOI 10.1001/jama.300.10.1154; *NAT COMM QUAL ASS, PHYS PRACT CONN PAT; TERRY K, 2007, MED EC          1207	10	98	100	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 29	2010	362	17					1632	1636		10.1056/NEJMon0910793	http://dx.doi.org/10.1056/NEJMon0910793			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	589AX	20427812				2022-12-28	WOS:000277117400015
J	Asamoah, AK; Sharfstein, JM				Asamoah, Afia K.; Sharfstein, Joshua M.			Transparency at the Food and Drug Administration.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asamoah, Afia K.] US FDA, Transparency Initiat, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Asamoah, AK (corresponding author), US FDA, Transparency Initiat, Silver Spring, MD USA.								0	32	33	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2341	2343		10.1056/NEJMp1005202	http://dx.doi.org/10.1056/NEJMp1005202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20484392				2022-12-28	WOS:000279043800001
J	Richter, HE; Albo, ME; Zyczynski, HM; Kenton, K; Norton, PA; Sirls, LT; Kraus, SR; Chai, TC; Lemack, GE; Dandreo, KJ; Varner, RE; Menefee, S; Ghetti, C; Brubaker, L; Nygaard, I; Khandwala, S; Rozanski, TA; Johnson, H; Schaffer, J; Stoddard, AM; Holley, RL; Nager, CW; Moalli, P; Mueller, E; Arisco, AM; Corton, M; Tennstedt, S; Chang, TD; Gormley, EA; Litman, HJ				Richter, Holly E.; Albo, Michael E.; Zyczynski, Halina M.; Kenton, Kimberly; Norton, Peggy A.; Sirls, Larry T.; Kraus, Stephen R.; Chai, Toby C.; Lemack, Gary E.; Dandreo, Kimberly J.; Varner, R. Edward; Menefee, Shawn; Ghetti, Chiara; Brubaker, Linda; Nygaard, Ingrid; Khandwala, Salil; Rozanski, Thomas A.; Johnson, Harry; Schaffer, Joseph; Stoddard, Anne M.; Holley, Robert L.; Nager, Charles W.; Moalli, Pamela; Mueller, Elizabeth; Arisco, Amy M.; Corton, Marlene; Tennstedt, Sharon; Chang, T. Debuene; Gormley, E. Ann; Litman, Heather J.		Urinary Incontinence Treatment Net	Retropubic versus Transobturator Midurethral Slings for Stress Incontinence	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIALS; FREE VAGINAL TAPE; URINARY-INCONTINENCE; WOMEN; COMPLICATIONS; METAANALYSIS; COLPOSUSPENSION; DEFINITION; TREAT	BACKGROUND Midurethral slings are increasingly used for the treatment of stress incontinence, but there are limited data comparing types of slings and associated complications. METHODS We performed a multicenter, randomized equivalence trial comparing outcomes with retropubic and transobturator midurethral slings in women with stress incontinence. The primary outcome was treatment success at 12 months according to both objective criteria (a negative stress test, a negative pad test, and no retreatment) and subjective criteria (self-reported absence of symptoms, no leakage episodes recorded, and no retreatment). The predetermined equivalence margin was +/- 12 percentage points. RESULTS A total of 597 women were randomly assigned to a study group; 565 (94.6%) completed the 12-month assessment. The rates of objectively assessed treatment success were 80.8% in the retropubic-sling group and 77.7% in the transobturator-sling group (3.0 percentage-point difference; 95% confidence interval [CI], -3.6 to 9.6). The rates of subjectively assessed success were 62.2% and 55.8%, respectively (6.4 percentage-point difference; 95% CI, -1.6 to 14.3). The rates of voiding dysfunction requiring surgery were 2.7% in those who received retropubic slings and 0% in those who received transobturator slings (P = 0.004), and the respective rates of neurologic symptoms were 4.0% and 9.4% (P = 0.01). There were no significant differences between groups in postoperative urge incontinence, satisfaction with the results of the procedure, or quality of life. CONCLUSIONS The 12-month rates of objectively assessed success of treatment for stress incontinence with the retropubic and transobturator approaches met the prespecified criteria for equivalence; the rates of subjectively assessed success were similar between groups but did not meet the criteria for equivalence. Differences in the complications associated with the two procedures should be discussed with patients who are considering surgical treatment for incontinence. (ClinicalTrials.gov number, NCT00325039.)	[Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35233 USA; [Albo, Michael E.; Nager, Charles W.] Univ Calif San Diego, San Diego, CA 92103 USA; [Menefee, Shawn] Kaiser Permanente Calif, San Diego, CA USA; [Zyczynski, Halina M.; Ghetti, Chiara; Moalli, Pamela] Univ Pittsburgh, Magee Womens Hosp, Pittsburgh, PA 15213 USA; [Norton, Peggy A.; Nygaard, Ingrid] Univ Utah, Salt Lake City, UT USA; [Kenton, Kimberly; Brubaker, Linda; Mueller, Elizabeth] Loyola Univ, Maywood, IL 60153 USA; [Sirls, Larry T.] William Beaumont Hosp, Royal Oak, MI 48072 USA; [Kraus, Stephen R.; Rozanski, Thomas A.; Arisco, Amy M.] Univ Texas San Antonio, San Antonio, TX USA; [Chai, Toby C.; Johnson, Harry] Univ Maryland, Baltimore, MD 21201 USA; [Lemack, Gary E.; Schaffer, Joseph; Corton, Marlene] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Dandreo, Kimberly J.; Stoddard, Anne M.; Tennstedt, Sharon; Litman, Heather J.] New England Res Inst, Watertown, MA 02172 USA; [Khandwala, Salil] Oakwood Hosp, Dearborn, MI USA; [Chang, T. Debuene] NIH, Bethesda, MD 20892 USA; [Gormley, E. Ann] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego; Kaiser Permanente; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Loyola University Chicago; Beaumont Health; University of Texas System; University of Texas at San Antonio (UTSA); University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Southwestern Medical Center Dallas; HealthCore, Inc; Beaumont Health; National Institutes of Health (NIH) - USA; Dartmouth College	Richter, HE (corresponding author), Univ Alabama Birmingham, Dept Obstet & Gynecol, 1700 6th Ave S,Suite 10382, Birmingham, AL 35233 USA.	hrichter@uabmc.edu	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Moxey-Mims, Marva/0000-0001-8542-9313; Richter, Holly E/0000-0001-7741-5771; Chai, Toby/0000-0002-1119-546X; Wadie, Bassem/0000-0002-6977-6849	National Institute of Diabetes and Digestive and Kidney Diseases [U01 DK58225, U01 DK58229, U01 DK58234, U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60393, U01 DK60395, U01 DK60397, U01 DK60401]; National Institute of Child Health and Human Development; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060393, U01DK060397, U01DK060401, U01DK060380, U01DK060379, U01DK058231, U01DK060395, U01DK058225, U01DK058234, U01DK058229] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by cooperative agreements (U01 DK58225, U01 DK58229, U01 DK58234, U01 DK58231, U01 DK60379, U01 DK60380, U01 DK60393, U01 DK60395, U01 DK60397, and U01 DK60401) from the National Institute of Diabetes and Digestive and Kidney Diseases and by the National Institute of Child Health and Human Development.	Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4; Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; Barber MD, 2008, OBSTET GYNECOL, V111, P611, DOI 10.1097/AOG.0b013e318162f22e; Barber MD, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.050; Brittain E, 2005, STAT MED, V24, P1, DOI 10.1002/sim.1934; Costantini E, 2009, UROL INT, V83, P392, DOI 10.1159/000251177; Daneshgari F, 2008, J UROLOGY, V180, P1890, DOI 10.1016/j.juro.2008.07.029; Delorme E, 2001, PROG UROL, V11, P1306; Deng DY, 2007, NEUROUROL URODYNAM, V26, P46, DOI 10.1002/nau.20357; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Hampel C, 1997, UROLOGY, V50, P4, DOI 10.1016/S0090-4295(97)00578-5; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; Latthe PM, 2007, BJOG-INT J OBSTET GY, V114, P522, DOI 10.1111/j.1471-0528.2007.01268.x; LATTHE PM, 2007, BJOG, V114, P1311; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Novara G, 2008, EUR UROL, V53, P288, DOI 10.1016/j.eururo.2007.10.073; Novara G, 2007, EUR UROL, V52, P663, DOI 10.1016/j.eururo.2007.06.018; Ogah J, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006375.PUB2; Oliphant SS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.007; Rechberger T, 2009, EUR UROL, V56, P24, DOI 10.1016/j.eururo.2009.02.038; Schabenberger O.., 2005, INTRO GLIMMIX PROCED; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Stav K, 2010, INT UROGYNECOL J, V21, P149, DOI 10.1007/s00192-009-1020-9; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; Thom DH, 2005, J UROLOGY, V173, P1295, DOI 10.1097/01.ju.0000155679.77895.cb; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Urinary Incontinence Treatment Network (UITN), 2008, J APPL RES CLIN EXP, V8; Ward KL, 2004, AM J OBSTET GYNECOL, V190, P324, DOI 10.1016/j.ajog.2003.07.029; Whiteside JL, 2004, INT UROGYNECOL J, V15, P223, DOI 10.1007/s00192-004-1143-y	30	471	486	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2066	2076		10.1056/NEJMoa0912658	http://dx.doi.org/10.1056/NEJMoa0912658			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20479459	Bronze, Green Accepted			2022-12-28	WOS:000278242200006
J	Skinner, JL				Skinner, James L.			Following the Motions of Water Molecules in Aqueous Solutions	SCIENCE			English	Editorial Material							DYNAMICS; REORIENTATION; SPECTROSCOPY		[Skinner, James L.] Univ Wisconsin, Inst Theoret Chem, Madison, WI 53706 USA; [Skinner, James L.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Skinner, JL (corresponding author), Univ Wisconsin, Inst Theoret Chem, Madison, WI 53706 USA.	skinner@chem.wisc.edu						Asbury JB, 2004, J PHYS CHEM A, V108, P1107, DOI 10.1021/jp036266k; Bakker HJ, 2008, CHEM REV, V108, P1456, DOI 10.1021/cr0206622; Bakker HJ, 2010, CHEM REV, V110, P1498, DOI 10.1021/cr9001879; Ball P, 2008, NATURE, V452, P291, DOI 10.1038/452291a; Fayer MD, 2009, ACCOUNTS CHEM RES, V42, P1210, DOI 10.1021/ar900043h; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Ji MB, 2010, SCIENCE, V328, P1003, DOI 10.1126/science.1187707; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Laage D, 2007, P NATL ACAD SCI USA, V104, P11167, DOI 10.1073/pnas.0701699104; Lin YS, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3242083; Moilanen DE, 2008, P NATL ACAD SCI USA, V105, P5295, DOI 10.1073/pnas.0801554105; Skinner JL, 2009, ADV CHEM PHYS, V142, P59, DOI 10.1002/9780470475935.ch2; Tielrooij KJ, 2010, SCIENCE, V328, P1006, DOI 10.1126/science.1183512	13	44	45	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					985	986		10.1126/science.1190093	http://dx.doi.org/10.1126/science.1190093			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489012				2022-12-28	WOS:000277877100027
J	Akhaddar, A; Boucetta, M				Akhaddar, Ali; Boucetta, Mohamed			Dislocation of the Cervical Spine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Akhaddar, Ali; Boucetta, Mohamed] Mohammed V Mil Teaching Hosp, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Akhaddar, A (corresponding author), Mohammed V Mil Teaching Hosp, Rabat, Morocco.	akhaddar@hotmail.fr	Akhaddar, Ali/B-1107-2011; Akhaddar, Ali/Q-9152-2019	Akhaddar, Ali/0000-0001-5743-2777; 					0	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1920	1920		10.1056/NEJMicm0908013	http://dx.doi.org/10.1056/NEJMicm0908013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484398				2022-12-28	WOS:000277815600011
J	Wu, XW; Nguyen, BC; Dziunycz, P; Chang, S; Brooks, Y; Lefort, K; Hofbauer, GFL; Dotto, GP				Wu, Xunwei; Nguyen, Bach-Cuc; Dziunycz, Piotr; Chang, Sungeun; Brooks, Yang; Lefort, Karine; Hofbauer, Guenther F. L.; Dotto, G. Paolo			Opposing roles for calcineurin and ATF3 in squamous skin cancer	NATURE			English	Article							TRANSFORMED PHENOTYPE; CELLULAR SENESCENCE; TUMOR SUPPRESSION; C-MYC; CELLS; GROWTH; P63; TRANSCRIPTION; INHIBITOR; NFAT	Calcineurin inhibitors such as cyclosporin A (CsA) are the mainstay of immunosuppressive treatment for organ transplant recipients. Squamous cell carcinoma (SCC) of the skin is a major complication of treatment with these drugs, with a 65 to 100-fold higher risk than in the normal population(1). By contrast, the incidence of basal cell carcinoma (BCC), the other major keratinocyte-derived tumour of the skin, of melanoma and of internal malignancies increases to a significantly lesser extent(1). Here we report that genetic and pharmacological suppression of calcineurin/nuclear factor of activated T cells (NFAT) function promotes tumour formation in mouse skin and in xenografts, in immune compromised mice, of H-ras(V12) (also known as Hras1)-expressing primary human keratinocytes or keratinocyte-derived SCC cells. Calcineurin/NFAT inhibition counteracts p53 (also known as TRP53)-dependent cancer cell senescence, thereby increasing tumorigenic potential. ATF3, a member of the 'enlarged' AP-1 family, is selectively induced by calcineurin/NFAT inhibition, both under experimental conditions and in clinically occurring tumours, and increased ATF3 expression accounts for suppression of p53-dependent senescence and enhanced tumorigenic potential. Thus, intact calcineurin/NFAT signalling is critically required for p53 and senescence-associated mechanisms that protect against skin squamous cancer development.	[Wu, Xunwei; Nguyen, Bach-Cuc; Chang, Sungeun; Brooks, Yang; Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Dziunycz, Piotr; Hofbauer, Guenther F. L.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Lefort, Karine; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Harvard University; Massachusetts General Hospital; University of Zurich; University Zurich Hospital; University of Lausanne	Dotto, GP (corresponding author), Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA.	gian-paolo.dotto@unil.ch	chang, sungeun/AAH-1247-2020; Wu, Xunwei/J-9014-2018; Hofbauer, Gunther/B-2671-2010	Wu, Xunwei/0000-0002-0822-1700; Hofbauer, Gunther/0000-0003-0542-7989	NIH [AR054856, AR39190]; Swiss National Foundation [311003A-122281/1]; Oncosuisse [OCS-02361-02-2009]; European Union [LSHB-CT-2005-019067]; Korean Government Foundation [KRF-2007-013-E00044]; Olga-Mayenfisch-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR059471, R01AR054856, R01AR039190] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Oncosuisse; European Union(European Commission); Korean Government Foundation; Olga-Mayenfisch-Stiftung; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank P. Khavari, S. Kitajima, N. Clipstone and G. Crabtree for gift of retroviruses, W. Austen for human skin material, C. Brisken and C. Missero for careful reading of the manuscript, and E. Castillo for sequencing of the ras and p53 genes. This work was supported by grants from NIH (AR054856 and AR39190), the Swiss National Foundation (311003A-122281/1), Oncosuisse (OCS-02361-02-2009), the European Union (Epistem, Sixth Framework Program, LSHB-CT-2005-019067) and, in part, by a grant to S. C. by the Korean Government Foundation (KRF-2007-013-E00044) and to G. F. L. H. by the Olga-Mayenfisch-Stiftung.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; BURNS JE, 1993, BRIT J CANCER, V67, P1274, DOI 10.1038/bjc.1993.238; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; DOTTO GP, 1989, J CELL BIOL, V109, P3115, DOI 10.1083/jcb.109.6.3115; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Krizhanovsky V, 2008, COLD SH Q B, V73, P513, DOI 10.1101/sqb.2008.73.048; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li A, 2004, METH MOL B, V289, P87; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Wang AJ, 2007, MOL CARCINOGEN, V46, P476, DOI 10.1002/mc.20298; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	37	212	214	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					368	U130		10.1038/nature08996	http://dx.doi.org/10.1038/nature08996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485437	Green Accepted			2022-12-28	WOS:000277829200045
J	Druss, BG; Bornemann, TH				Druss, Benjamin G.; Bornemann, Thomas H.			Improving Health and Health Care for Persons With Serious Mental Illness The Window for US Federal Policy Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; DISEASE		[Druss, Benjamin G.] Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30033 USA; [Bornemann, Thomas H.] Carter Ctr Mental Hlth Program, Atlanta, GA USA	Emory University; Rollins School Public Health	Druss, BG (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd, Atlanta, GA 30033 USA.	bdruss@emory.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH075867] Funding Source: NIH RePORTER; NIMH NIH HHS [5K24MH075867] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Felker B, 1996, PSYCHIAT SERV, V47, P1356; Kingdon JohnW., 2003, AGENDAS ALTERNATIVES; Malzberg B, 1932, J AM STAT ASSOC, V27, P160, DOI 10.2307/2277862; Newcomer JW, 2007, JAMA-J AM MED ASSOC, V298, P1794, DOI 10.1001/jama.298.15.1794; Parks J., 2006, MORBIDITY MORTALITY; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Schroeder SA, 2007, NEW ENGL J MED, V357, P1221, DOI 10.1056/NEJMsa073350; *SUBST AB MENT HLT, SAMHSA 10 10 WELLN C; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	10	66	67	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1972	1973		10.1001/jama.2010.615	http://dx.doi.org/10.1001/jama.2010.615			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483975				2022-12-28	WOS:000277764500025
J	Hedayati, SS; Minhajuddin, AT; Afshar, M; Toto, RD; Trivedi, MH; Rush, AJ				Hedayati, S. Susan; Minhajuddin, Abu T.; Afshar, Masoud; Toto, Robert D.; Trivedi, Madhukar H.; Rush, A. John			Association Between Major Depressive Episodes in Patients With Chronic Kidney Disease and Initiation of Dialysis, Hospitalization, or Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEUROPSYCHIATRIC INTERVIEW MINI; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL FACTORS; UNITED-STATES; MORTALITY; SURVIVAL; SYMPTOMS	Context Patients with chronic kidney disease (CKD) experience increased rates of hospitalization and death. Depressive disorders are associated with morbidity and mortality. Whether depression contributes to poor outcomes in patients with CKD not receiving dialysis is unknown. Objective To determine whether the presence of a current major depressive episode (MDE) is associated with poorer outcomes in patients with CKD. Design, Setting, and Patients Prospective cohort study of 267 consecutively recruited outpatients with CKD (stages 2-5 and who were not receiving dialysis) at a VA medical center between May 2005 and November 2006 and followed up for 1 year. An MDE was diagnosed by blinded personnel using the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria. Main Outcome Measures The primary outcome was event-free survival defined as the composite of death, dialysis initiation, or hospitalization. Secondary outcomes included each of these events assessed separately. Results Among 267 patients, 56 had a current MDE (21%) and 211 did not (79%). There were 127 composite events, 116 hospitalizations, 38 dialysis initiations, and 18 deaths. Events occurred more often in patients with an MDE compared with those without an MDE (61% vs 44%, respectively, P=.03). Four patients with missing dates of hospitalization were excluded from survival analyses. The mean (SD) time to the composite event was 206.5 (19.8) days (95% CI, 167.7-245.3 days) for those with an MDE compared with 273.3 (8.5) days (95% CI, 256.6-290.0 days) for those without an MDE (P=.003). The adjusted hazard ratio (HR) for the composite event for patients with an MDE was 1.86 (95% CI, 1.23-2.84). An MDE at baseline independently predicted progression to dialysis (HR, 3.51; 95% CI, 1.77-6.97) and hospitalization (HR, 1.90; 95% CI, 1.23-2.95). Conclusion The presence of an MDE was associated with an increased risk of poor outcomes in CKD patients who were not receiving dialysis, independent of comorbidities and kidney disease severity. JAMA. 2010; 303(19): 1946-1953	[Hedayati, S. Susan] VA N Texas Hlth Care Syst, Nephrol Sect, Div Nephrol, Dept Med, Dallas, TX 75216 USA; [Minhajuddin, Abu T.] Univ Texas SW Med Ctr Dallas, Div Biostat, Dept Clin Sci, Dallas, TX 75390 USA; [Hedayati, S. Susan; Afshar, Masoud; Toto, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA; [Trivedi, Madhukar H.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Rush, A. John] Duke NUS, Div Clin Sci, Singapore, Singapore	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Hedayati, SS (corresponding author), VA N Texas Hlth Care Syst, Nephrol Sect, Div Nephrol, Dept Med, MC 111G1,4500 S Lancaster Rd, Dallas, TX 75216 USA.	susan.hedayati@utsouthwestern.edu	Trivedi, Madhukar/A-9029-2013	Trivedi, Madhukar/0000-0002-2983-1110; Rush, Augustus/0000-0003-2004-2382; Hedayati, S Susan/0000-0001-8850-4729	Advanced Neuromodulation Systems; AstraZeneca; Best Practice Project Management; Bristol-Myers Squibb/Otsuka; Cyberonics Inc; Forest Pharmaceuticals; Gerson Lehrman Group; GlaxoSmithKline; Jazz Pharmaceuticals; Magellan Health Services; Merck Company; Neuronetics; Novartis Pharmaceuticals; Ono Pharmaceuticals; Organon; Otsuka Pharmaceuticals; Pamlab; Pfizer; Transcept Pharmaceuticals; Urban Institute; Wyeth Ayerst; Forest Laboratories; National Institute of Mental Health; Stanley Medical Research Institute; Veterans Integrated Systems Network 17; VA North Texas Health Care System Research Corporation; National Institutes of Health [2K24DK002818-0]; Rosewood Corporation Chair in Biomedical Science;  [P30DK079328]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079328, K24DK002818] Funding Source: NIH RePORTER	Advanced Neuromodulation Systems; AstraZeneca(AstraZeneca); Best Practice Project Management; Bristol-Myers Squibb/Otsuka(Otsuka PharmaceuticalBristol-Myers Squibb); Cyberonics Inc; Forest Pharmaceuticals; Gerson Lehrman Group; GlaxoSmithKline(GlaxoSmithKline); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Magellan Health Services; Merck Company(Merck & Company); Neuronetics; Novartis Pharmaceuticals(Novartis); Ono Pharmaceuticals; Organon; Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Pamlab; Pfizer(Pfizer); Transcept Pharmaceuticals; Urban Institute; Wyeth Ayerst; Forest Laboratories; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stanley Medical Research Institute; Veterans Integrated Systems Network 17; VA North Texas Health Care System Research Corporation(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosewood Corporation Chair in Biomedical Science; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial Disclosure: Dr Rush reported receiving consulting fees from Advanced Neuromodulation Systems, AstraZeneca, Best Practice Project Management, Bristol-Myers Squibb/Otsuka, Cyberonics, Forest Pharmaceuticals, Gerson Lehrman Group, GlaxoSmithKline, Jazz Pharmaceuticals, Magellan Health Services, Merck & Company, Neuronetics, Novartis Pharmaceuticals, Ono Pharmaceuticals, Organon, Otsuka Pharmaceuticals, Pamlab, Pfizer, Transcept Pharmaceuticals, Urban Institute, and Wyeth Ayerst; speaking fees from Cyberonics Inc, Forest Laboratories, GlaxoSmithKline, and Otsuka; royalties from Guilford Publications and Healthcare Technology Systems; and research support from the National Institute of Mental Health and the Stanley Medical Research Institute. He also reported owning shares of stock in Pfizer.; Funding/Support: This work was supported by grants from the Veterans Integrated Systems Network 17 and the VA North Texas Health Care System Research Corporation, which were used for the design and conduct of the study and collection, management, and analysis of data; and grant P30DK079328 to the University of Texas Southwestern Medical Center O'Brien Kidney Research Core Center (pilot and feasibility awarded to Susan Hedayati, MD), which was used for the analysis and interpretation of data and preparation of the manuscript. This work also was supported by National Institutes of Health grant 2K24DK002818-0 (awarded to Robert Toto, MD), which was used for the preparation and review of the manuscript. Support for Dr Rush was provided by the Rosewood Corporation Chair in Biomedical Science.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Ariyo AA, 2000, CIRCULATION, V102, P1773; Barefoot John C, 2003, J Cardiopulm Rehabil, V23, P404, DOI 10.1097/00008483-200311000-00002; Bonnet F, 2005, ATHEROSCLEROSIS, V178, P339, DOI 10.1016/j.atherosclerosis.2004.08.035; Boulware LE, 2006, CLIN J AM SOC NEPHRO, V1, P496, DOI 10.2215/CJN.00030505; BURTON HJ, 1986, PSYCHOSOM MED, V48, P261, DOI 10.1097/00006842-198603000-00011; CHRISTENSEN AJ, 1994, HEALTH PSYCHOL, V13, P521, DOI 10.1037/0278-6133.13.6.521; DEVINS GM, 1990, J NERV MENT DIS, V178, P127, DOI 10.1097/00005053-199002000-00008; Drayer RA, 2006, GEN HOSP PSYCHIAT, V28, P306, DOI 10.1016/j.genhosppsych.2006.03.008; Einwohner R, 2004, PERITON DIALYSIS INT, V24, P256; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Empana JP, 2005, CIRCULATION, V111, P2299, DOI 10.1161/01.CIR.0000164203.54111.AE; EVERETT KD, 1995, BEHAV MED, V21, P25, DOI 10.1080/08964289.1995.9933739; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Friend R, 1997, ADV PERIT D, V13, P155; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Hedayati SS, 2008, KIDNEY INT, V74, P930, DOI 10.1038/ki.2008.311; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P741, DOI 10.1053/j.ajkd.2009.05.003; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P433, DOI 10.1053/j.ajkd.2009.03.016; Hedayati SS, 2009, AM J KIDNEY DIS, V54, P424, DOI 10.1053/j.ajkd.2009.03.017; Hedayati SS, 2006, KIDNEY INT, V69, P1662, DOI 10.1038/sj.ki.5000308; Hedayati SS, 2005, AM J KIDNEY DIS, V46, P642, DOI 10.1053/j.ajkd.2005.07.002; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Kimmel PL, 2000, KIDNEY INT, V57, P2093, DOI 10.1046/j.1523-1755.2000.00059.x; Kimmel PL, 2005, SEMIN DIALYSIS, V18, P91, DOI 10.1111/j.1525-139X.2005.18209.x; Kimmel PL, 1998, KIDNEY INT, V54, P245, DOI 10.1046/j.1523-1755.1998.00989.x; Koo JR, 2003, AM J KIDNEY DIS, V41, P1037, DOI 10.1016/S0272-6386(03)00201-4; Larkin M, 2002, LANCET, V359, P1836, DOI 10.1016/S0140-6736(02)08731-7; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes AA, 2002, KIDNEY INT, V62, P199, DOI 10.1046/j.1523-1755.2002.00411.x; National Kidney Foundation,, FACTS CHRON KIDN DIS; Owen WF, 2003, J AM SOC NEPHROL, V14, pS76, DOI 10.1097/01.ASN.0000070145.00225.EC; *REN PHYS ASS, 2002, CLIN PRACT GUID, V3, P4; Safdar Nilofer, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P293; Sensky T, 1996, PSYCHOTHER PSYCHOSOM, V65, P36, DOI 10.1159/000289029; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Serebruany VL, 2003, BLOOD COAGUL FIBRIN, V14, P563, DOI 10.1097/00001721-200309000-00008; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; SHULMAN R, 1989, PSYCHOL MED, V19, P945, DOI 10.1017/S0033291700005663; Soucie JM, 1996, J AM SOC NEPHROL, V7, P2169; Troidle L, 2003, AM J KIDNEY DIS, V42, P350, DOI 10.1016/S0272-6386(03)00661-9; *US REN DAT SYST, 2009, USRDS 2009 ANN REP A; WAI L, 1981, LANCET, V2, P1155; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818; Zimmermann PR, 2006, INT J PSYCHIAT MED, V36, P457, DOI 10.2190/H8L6-0016-U636-8512; [No title captured]	51	150	156	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1946	1953		10.1001/jama.2010.619	http://dx.doi.org/10.1001/jama.2010.619			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483971	Green Accepted, Bronze			2022-12-28	WOS:000277764500021
J	Rennie, J; Burman-Roy, S; Murphy, S				Rennie, Janet; Burman-Roy, Shona; Murphy, Stephen			Neonatal jaundice: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERBILIRUBINEMIA; UK		[Rennie, Janet] Univ Coll London NHS Fdn Trust London, Elizabeth Garrett Anderson Inst Womens Hlth, London NW1 2BU, England; [Burman-Roy, Shona; Murphy, Stephen] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England		Rennie, J (corresponding author), Univ Coll London NHS Fdn Trust London, Elizabeth Garrett Anderson Inst Womens Hlth, London NW1 2BU, England.	janet.rennie@uclh.nhs.uk		Cullen, Katherine/0000-0002-3704-4598	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Women's and Children's Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Bhutani VK, 2009, J PERINATOL, V29, pS20, DOI 10.1038/jp.2008.212; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Maisels MJ, 2000, MG CLIN PED, P139; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I HLTH, V37; National Institute for Health and Clinical Excellence, 2010, CLIN GUID NAT I HLTH, V98; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Rennie JM, 2009, ARCH DIS CHILD-FETAL, V94, pF323, DOI 10.1136/adc.2008.147686	9	73	77	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 19	2010	340								c2409	10.1136/bmj.c2409	http://dx.doi.org/10.1136/bmj.c2409			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LU	20484363				2022-12-28	WOS:000278061800004
J	van Rhee, F				van Rhee, Frits			Light-chain MGUS: implications for clinical practice	LANCET			English	Editorial Material							UNDETERMINED SIGNIFICANCE MGUS; PRECEDES MULTIPLE-MYELOMA; MONOCLONAL GAMMOPATHY; RISK; PROGRESSION		Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	van Rhee, F (corresponding author), Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA.	vanrheefrits@uams.edu						Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; KYLE RA, 1982, NEW ENGL J MED, V306, P564, DOI 10.1056/NEJM198203113061002; Kyle RA, 2007, BRIT J HAEMATOL, V139, P730, DOI 10.1111/j.1365-2141.2007.06873.x; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Spisek R, 2007, J EXP MED, V204, P831, DOI 10.1084/jem.20062387; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008	10	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 15	2010	375	9727					1670	1671		10.1016/S0140-6736(10)60707-6	http://dx.doi.org/10.1016/S0140-6736(10)60707-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472153				2022-12-28	WOS:000277890200006
J	Garcia-Berro, E; Torres, S; Althaus, LG; Renedo, I; Loren-Aguilar, P; Corsico, AH; Rohrmann, RD; Salaris, M; Isern, J				Garcia-Berro, Enrique; Torres, Santiago; Althaus, Leandro G.; Renedo, Isabel; Loren-Aguilar, Pablo; Corsico, Alejandro H.; Rohrmann, Rene D.; Salaris, Maurizio; Isern, Jordi			A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes	NATURE			English	Article							MONTE-CARLO SIMULATIONS; FINAL MASS RELATIONSHIP; STELLAR EVOLUTION; NGC-6791; NE-22; POPULATION; SEQUENCE; CRYSTALLIZATION; INTERIORS; MIXTURES	NGC 6791 is a well studied open cluster(1) that it is so close to us that can be imaged down to very faint luminosities(2). The main-sequence turn-off age (similar to 8 Gyr) and the age derived from the termination of the white dwarf cooling sequence (similar to 6 Gyr) are very different. One possible explanation is that as white dwarfs cool, one of the ashes of helium burning, (22)Ne, sinks in the deep interior of these stars(3-5). At lower temperatures, white dwarfs are expected to crystallize and phase separation of the main constituents of the core of a typical white dwarf ((12)C and (16)O) is expected to occur(6,7). This sequence of events is expected to introduce long delays in the cooling times(8,9), but has not hitherto been proven. Here we report that, as theoretically anticipated(5,6), physical separation processes occur in the cores of white dwarfs, resolving the age discrepancy for NGC 6791.	[Garcia-Berro, Enrique; Torres, Santiago; Althaus, Leandro G.; Renedo, Isabel; Loren-Aguilar, Pablo] Univ Politecn Cataluna, Dept Fis Aplicada, Castelldefels 08860, Spain; [Garcia-Berro, Enrique; Torres, Santiago; Renedo, Isabel; Loren-Aguilar, Pablo; Isern, Jordi] Inst Estudis Espacials Catalunya, Barcelona 08034, Spain; [Althaus, Leandro G.; Corsico, Alejandro H.] Univ Nacl La Plata, Fac Ciencias Astron & Geofis, RA-1900 La Plata, Argentina; [Althaus, Leandro G.; Corsico, Alejandro H.] Consejo Nacl Invest Cient & Tecn, Inst Astrofis La Plata CCT La Plata, RA-1900 La Plata, Argentina; [Rohrmann, Rene D.] Consejo Nacl Invest Cient & Tecn, Inst Ciencias Astron Tierra & Espacio, RA-5400 San Juan, Argentina; [Salaris, Maurizio] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Isern, Jordi] Fac Ciencies, CSIC, Inst Ciencies Espai, Bellaterra 08193, Spain	Universitat Politecnica de Catalunya; Institut d'Estudis Espacials de Catalunya (IEEC); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Liverpool John Moores University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC)	Garcia-Berro, E (corresponding author), Univ Politecn Cataluna, Dept Fis Aplicada, C Esteve Terrades 5, Castelldefels 08860, Spain.	garcia@fa.upc.edu	Isern, Jordi/B-1844-2015; Garcia-Berro, Enrique/C-8034-2014; Torres, Santiago/K-6827-2014	Isern, Jordi/0000-0002-0819-9574; Althaus, L./0000-0003-2771-7805; Torres, Santiago/0000-0001-5777-5251	MCINN; AGENCIA; Generalitat de Catalunya; STFC; CONICET; AGAUR of the Generalitat de Catalunya; STFC [PP/E001149/1, ST/H002391/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E001149/1, ST/H002391/1] Funding Source: researchfish	MCINN(European Commission); AGENCIA; Generalitat de Catalunya(Generalitat de Catalunya); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); AGAUR of the Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This research was partially supported by MCINN, AGENCIA, the Generalitat de Catalunya, STFC and CONICET. L. G. A. also acknowledges a PIV grant from the AGAUR of the Generalitat de Catalunya. We are indebted to L. Bedin and co-authors for providing the observational colour-magnitude diagram of Fig. 1.	Althaus LG, 2009, ASTROPHYS J, V704, P1605, DOI 10.1088/0004-637X/704/2/1605; Bedin LR, 2008, ASTROPHYS J LETT, V679, pL29, DOI 10.1086/589151; Bedin LR, 2005, ASTROPHYS J, V624, pL45, DOI 10.1086/430310; Bedin LR, 2008, ASTROPHYS J, V678, P1279, DOI 10.1086/529370; Bildsten L, 2001, ASTROPHYS J, V549, pL219, DOI 10.1086/319169; BRAVO E, 1992, ASTRON ASTROPHYS, V257, P534; Catalan S, 2008, MON NOT R ASTRON SOC, V387, P1693, DOI 10.1111/j.1365-2966.2008.13356.x; Deloye CJ, 2002, ASTROPHYS J, V580, P1077, DOI 10.1086/343800; Ferrario L, 2005, MON NOT R ASTRON SOC, V361, P1131, DOI 10.1111/j.1365-2966.2005.09244.x; Garcia-Berro E, 2008, ASTROPHYS J, V677, P473, DOI 10.1086/527536; Garcia-Berro E, 2004, ASTRON ASTROPHYS, V418, P53, DOI 10.1051/0004-6361:20034541; Garcia-Berro E, 1999, MON NOT R ASTRON SOC, V302, P173, DOI 10.1046/j.1365-8711.1999.02115.x; GARCIABERRO E, 1988, NATURE, V333, P642, DOI 10.1038/333642a0; GARCIABERRO E, 1988, ASTRON ASTROPHYS, V193, P141; Gratton R, 2006, ASTROPHYS J, V642, P462, DOI 10.1086/500729; Grundahl F, 2008, ASTRON ASTROPHYS, V492, P171, DOI 10.1051/0004-6361:200810749; Isern J, 1997, ASTROPHYS J, V485, P308, DOI 10.1086/304425; Isern J, 2000, ASTROPHYS J, V528, P397, DOI 10.1086/308153; Kalirai JS, 2007, ASTROPHYS J, V671, P748, DOI 10.1086/521922; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; SEGRETAIN L, 1993, ASTRON ASTROPHYS, V271, pL13; Segretain L, 1996, ASTRON ASTROPHYS, V310, P485; Torres S, 2002, MON NOT R ASTRON SOC, V336, P971, DOI 10.1046/j.1365-8711.2002.05830.x; Weiss A, 2009, ASTRON ASTROPHYS, V508, P1343, DOI 10.1051/0004-6361/200912043	25	177	177	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					194	196		10.1038/nature09045	http://dx.doi.org/10.1038/nature09045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463732	Green Submitted, Green Published			2022-12-28	WOS:000277558500029
J	Kirkwood, BR; Hurt, L; Amenga-Etego, S; Tawiah, C; Zandoh, C; Danso, S; Hurt, C; Edmond, K; Hill, Z; ten Asbroek, G; Fenty, J; Owusu-Agyei, S; Campbell, O; Arthur, P				Kirkwood, Betty R.; Hurt, Lisa; Amenga-Etego, Seeba; Tawiah, Charlotte; Zandoh, Charles; Danso, Samuel; Hurt, Chris; Edmond, Karen; Hill, Zelee; ten Asbroek, Guus; Fenty, Justin; Owusu-Agyei, Seth; Campbell, Oona; Arthur, Paul		ObaapaVitA Trial Team	Effect of vitamin A supplementation in women of reproductive age on maternal survival in Ghana (ObaapaVitA): a cluster-randomised, placebo-controlled trial	LANCET			English	Article							BETA-CAROTENE; CHILD UNDERNUTRITION; INFANT-MORTALITY; PREGNANCY	Background A previous trial in Nepal showed that supplementation with vitamin A or its precursor (betacarotene) in women of reproductive age reduced pregnancy-related mortality by 44% (95% CI 16-63). We assessed the effect of vitamin A supplementation in women in Ghana. Methods ObaapaVitA was a cluster-randomised, double-blind, placebo-controlled trial undertaken in seven districts in Brong Ahafo Region in Ghana. The trial area was divided into 1086 small geographical clusters of compounds with fieldwork areas consisting of four contiguous clusters. All women of reproductive age (15-45 years) who gave informed consent and who planned to remain in the area for at least 3 months were recruited. Participants were randomly assigned by cluster of residence to receive a vitamin A supplement (25 000 IU retinol equivalents) or placebo capsule orally once every week. Randomisation was blocked and based on an independent, computer-generated list of numbers, with two clusters in each fieldwork area allocated to vitamin A supplementation and two to placebo. Capsules were distributed during home visits undertaken every 4 weeks, when data were gathered on pregnancies, births, and deaths. Primary outcomes were pregnancy-related mortality and all-cause female mortality. Cause of death was established by verbal post mortems. Analysis was by intention to treat (ITT) with random-effects regression to account for the cluster-randomised design. Adverse events were synonymous with the trial outcomes. This trial is registered with ClinicalTrials.gov, number NCT00211341. Findings 544 clusters (104 484 women) were randomly assigned to vitamin A supplementation and 542 clusters (103 297 women) were assigned to placebo. The main reason for participant drop out was migration out of the study area. In the ITT analysis, there were 39 601 pregnancies and 138 pregnancy-related deaths in the vitamin A supplementation group (348 deaths per 100 000 pregnancies) compared with 39 234 pregnancies and 148 pregnancy-related deaths in the placebo group (377 per 100 000 pregnancies); adjusted odds ratio 0.92, 95% CI 0.73-1.17; p=0.51. 1326 women died in 292 560 woman-years in the vitamin A supplementation group (453 deaths per 100 000 years) compared with 1298 deaths in 289 310 woman-years in the placebo group (449 per 100 000 years); adjusted rate ratio 1.01, 0.93-1.09; p=0.85. Interpretation The body of evidence, although limited, does not support inclusion of vitamin A supplementation for women in either safe motherhood or child survival strategies.	[Kirkwood, Betty R.; Hurt, Lisa; Edmond, Karen; ten Asbroek, Guus; Fenty, Justin; Owusu-Agyei, Seth; Campbell, Oona; Arthur, Paul] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Amenga-Etego, Seeba; Tawiah, Charlotte; Zandoh, Charles; Danso, Samuel; Owusu-Agyei, Seth; Arthur, Paul] Minist Hlth, Kintampo Hlth Res Ctr, Kintampo, Ghana; [Hurt, Lisa] Cardiff Univ, Wales Canc Trials Unit, Cardiff, Wales; [Hill, Zelee] UCL, Inst Child Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre; Cardiff University; University of London; University College London	Kirkwood, BR (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Nutr & Publ Hlth Intervent Res, Keppel St, London WC1E 7HT, England.	betty.kirkwood@lshtm.ac.uk	Hurt, Lisa/GZG-4796-2022	Kirkwood, Betty/0000-0001-5274-6072; Hurt, Chris/0000-0003-1206-8355; Owusu-Agyei, Seth/0000-0002-0807-1781; Hurt, Lisa/0000-0002-2741-5383; Campbell, Oona/0000-0002-9311-0115; Iqbal Avan, Bilal/0000-0003-4531-4508	UK Department for International Development (DFID); USAID	UK Department for International Development (DFID); USAID(United States Agency for International Development (USAID))	This report is an output from a project funded by the UK Department for International Development (DFID) for the benefit of developing countries; the views expressed are not necessarily those of DFID. The trial also received some contribution from USAID. Vitamin A palmitate for the capsules was kindly donated by Roche. We acknowledge the support of the chiefs, elders, and opinion leaders in the trial area, and the substantial contribution of all women who participated in the trial. We thank the administrative support provided by Angela Vega throughout the trial; all staff at Kintampo Health Research Centre involved in the trial, especially site leaders, coordinators, supervisors, fieldworkers, data managers, data supervisors, data entry clerks, and administrative support staff; and the trial steering committee and data monitoring and ethics committee for their continuing support and guidance.	BEATON GH, 1993, 13 ACC SCN, P1; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Caulfield LE, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P551; Christian P, 2000, AM J EPIDEMIOL, V152, P542, DOI 10.1093/aje/152.6.542; CHRISTIAN P, 2007, EFFECTS MATERNAL VIT; DAULAIRE NMP, 1992, BMJ-BRIT MED J, V304, P207, DOI 10.1136/bmj.304.6821.207; HERRERA MG, 1992, LANCET, V340, P267, DOI 10.1016/0140-6736(92)92357-L; Hill Z, 2008, J MED ETHICS, V34, P48, DOI 10.1136/jme.2006.019059; Hill Z, 2007, PUBLIC HEALTH NUTR, V10, P827, DOI 10.1017/S1368980007382554; *IVACG, 1998, STAT SAF DOS VIT A P; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Katz J, 2000, AM J CLIN NUTR, V71, P1570; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; MUHILAL, 1988, AM J CLIN NUTR, V48, P1271, DOI 10.1093/ajcn/48.5.1271; RAHMATHULLAH L, 1990, NEW ENGL J MED, V323, P929, DOI 10.1056/NEJM199010043231401; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; SOMMER A, 1986, LANCET, V1, P1169; Starrs AM, 2007, LANCET, V370, P1285, DOI 10.1016/S0140-6736(07)61549-9; VIJAYARAGHAVAN K, 1990, LANCET, V336, P1342, DOI 10.1016/0140-6736(90)92895-O; West K. P. Jr., 2003, Food and Nutrition Bulletin, V24, pS78; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; WHO, 1998, SAF VIT A DOS PREGN; *WHO, 1992, INT STAT CLASS DIS R, P1238	28	83	84	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1640	1649		10.1016/S0140-6736(10)60311-X	http://dx.doi.org/10.1016/S0140-6736(10)60311-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20435345				2022-12-28	WOS:000277734700030
J	Kartal, B; Kuenen, JG; van Loosdrecht, MCM				Kartal, B.; Kuenen, J. G.; van Loosdrecht, M. C. M.			Sewage Treatment with Anammox	SCIENCE			English	Editorial Material							AMMONIUM OXIDATION; WASTE-WATER; REACTOR; BACTERIA; REMOVAL; SYSTEM		[Kartal, B.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Kuenen, J. G.; van Loosdrecht, M. C. M.] Delft Univ Technol, NL-2628 BC Delft, Netherlands	Radboud University Nijmegen; Delft University of Technology	Kartal, B (corresponding author), Radboud Univ Nijmegen, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	j.g.kuenen@tudelft.nl	van Loosdrecht, Mark C.M./B-2738-2009; Kartal, Boran/D-2488-2014; van Loosdrecht, Mark/AAA-9997-2019; Kartal, Boran/ABD-5400-2021	van Loosdrecht, Mark C.M./0000-0003-0658-4775; Kartal, Boran/0000-0003-4199-952X				Abma WR, 2010, WATER SCI TECHNOL, V61, P1715, DOI 10.2166/wst.2010.977; Arrigo KR, 2005, NATURE, V438, P122, DOI 10.1038/nature04265; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; de Kreuk MK, 2005, WATER RES, V39, P4476, DOI 10.1016/j.watres.2005.08.031; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Jetten MSM, 1997, WATER SCI TECHNOL, V35, P171, DOI 10.2166/wst.1997.0341; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; LETTINGA G, 1991, WATER SCI TECHNOL, V24, P87, DOI 10.2166/wst.1991.0220; LETTINGA G, 1980, BIOTECHNOL BIOENG, V22, P699, DOI 10.1002/bit.260220402; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1111/j.1574-6941.1995.tb00281.x; Siegrist H, 2008, WATER SCI TECHNOL, V57, P383, DOI 10.2166/wst.2008.048; Third KA, 2001, SYST APPL MICROBIOL, V24, P588, DOI 10.1078/0723-2020-00077; van der Star WRL, 2007, WATER RES, V41, P4149, DOI 10.1016/j.watres.2007.03.044; Wett B, 2007, WATER SCI TECHNOL, V56, P81, DOI 10.2166/wst.2007.611	14	799	933	50	1010	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					702	703		10.1126/science.1185941	http://dx.doi.org/10.1126/science.1185941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448175				2022-12-28	WOS:000277357100027
J	Zindl, CL; Chaplin, DD				Zindl, Carlene L.; Chaplin, David D.			Tumor Immune Evasion	SCIENCE			English	Editorial Material							T-CELL		[Zindl, Carlene L.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Chaplin, David D.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zindl, CL (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	dchaplin@uab.edu		Chaplin, David/0000-0002-1354-3069; Zindl, Carlene/0000-0003-4841-3552	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NIAMS NIH HHS [P30 AR050948-07, P30 AR050948] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Kim D, 2000, J EXP MED, V192, P1467, DOI 10.1084/jem.192.10.1467; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Shevach EM, 2004, NAT MED, V10, P900, DOI 10.1038/nm0904-900; Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Zindl CL, 2009, IMMUNITY, V30, P408, DOI 10.1016/j.immuni.2009.01.010	13	44	45	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 7	2010	328	5979					697	698		10.1126/science.1190310	http://dx.doi.org/10.1126/science.1190310			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448171	Green Accepted			2022-12-28	WOS:000277357100023
J	Brownstein, JS; Freifeld, CC; Chan, EH; Keller, M; Sonricker, AL; Mekaru, SR; Buckeridge, DL				Brownstein, John S.; Freifeld, Clark C.; Chan, Emily H.; Keller, Mikaela; Sonricker, Amy L.; Mekaru, Sumiko R.; Buckeridge, David L.			Information Technology and Global Surveillance of Cases of 2009 H1N1 Influenza.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH		[Brownstein, John S.; Keller, Mikaela] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Pediat, Boston, MA 02215 USA; [Brownstein, John S.; Freifeld, Clark C.; Chan, Emily H.; Keller, Mikaela; Sonricker, Amy L.; Mekaru, Sumiko R.] Harvard Massachusetts Inst Technol, Div Hlth Sci & Technol, Computat Epidemiol Grp, Childrens Hosp Informat Program, Boston, MA USA; [Mekaru, Sumiko R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Freifeld, Clark C.] MIT, Media Lab, Cambridge, MA 02139 USA; [Brownstein, John S.; Buckeridge, David L.] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Buckeridge, David L.] Direct Sante Publ Montreal, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Boston University; Massachusetts Institute of Technology (MIT); McGill University	Brownstein, JS (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Pediat, 1 Autumn St,Rm 451, Boston, MA 02215 USA.	john_brownstein@harvard.edu	Tao, Youyou/D-2367-2014; Brownstein, John S/A-1438-2011	Mekaru, Sumiko/0000-0002-9782-3833	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [G08LM009776] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NIAID NIH HHS [R21 AI073591-02, R21 AI073591] Funding Source: Medline; NLM NIH HHS [G08LM009776-01A2, G08 LM009776-01A2, G08 LM009776] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CIHR(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Diamond CC, 2009, HEALTH AFFAIR, V28, P454, DOI 10.1377/hlthaff.28.2.454; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Hartley Dm, 2010, Emerg Health Threats J, V3, pe3, DOI 10.3134/ehtj.10.003; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mandl KD, 2008, NEW ENGL J MED, V358, P1732, DOI 10.1056/NEJMsb0800220; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102	10	72	74	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1731	1735		10.1056/NEJMsr1002707	http://dx.doi.org/10.1056/NEJMsr1002707			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591OQ	20445186	Green Accepted			2022-12-28	WOS:000277311200013
J	Paoletti, X; Oba, K; Burzykowski, T; Michiels, S; Ohashi, Y; Pignon, JP; Rougier, P; Sakamoto, J; Sargent, D; Sasako, M; Van Cutsem, E; Buyse, M				Paoletti, Xavier; Oba, Koji; Burzykowski, Tomasz; Michiels, Stefan; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Van Cutsem, Eric; Buyse, Marc		GASTRIC Grp	Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHASE-III TRIAL; CURATIVE RESECTION; RANDOMIZED-TRIAL; FOLLOW-UP; UPDATED METAANALYSIS; CLINICAL-TRIAL; ONCOLOGY-GROUP; PLUS TEGAFUR; NO TREATMENT; MITOMYCIN-C	Context Despite potentially curative resection of stomach cancer, 50% to 90% of patients die of disease relapse. Numerous randomized clinical trials (RCTs) have compared surgery alone with adjuvant chemotherapy, but definitive evidence is lacking. Objectives To perform an individual patient-level meta-analysis of all RCTs to quantify the potential benefit of chemotherapy after complete resection over surgery alone in terms of overall survival and disease-free survival, and to further study the role of regimens, including monochemotherapy; combined chemotherapy with fluorouracil derivatives, mitomycin C, and other therapies but no anthracyclines; combined chemotherapy with fluorouracil derivatives, mitomycin C, and anthracyclines; and other treatments. Data Sources Data from all RCTs comparing adjuvant chemotherapy with surgery alone in patients with resectable gastric cancer. We searched MEDLINE (up to 2009), the Cochrane Central Register of Controlled Trials, the National Institutes of Health trial registry, and published proceedings from major oncologic and gastrointestinal cancer meetings. Study Selection All RCTs closed to patient recruitment before 2004 were eligible. Trials testing radiotherapy; neoadjuvant, perioperative, or intraperitoneal chemotherapy; or immunotherapy were excluded. Thirty-one eligible trials (6390 patients) were identified. Data Extraction As of 2010, individual patient data were available from 17 trials (3838 patients representing 60% of the targeted data) with a median follow-up exceeding 7 years. Results There were 1000 deaths among 1924 patients assigned to chemotherapy groups and 1067 deaths among 1857 patients assigned to surgery-only groups. Adjuvant chemotherapy was associated with a statistically significant benefit in terms of overall survival (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.76-0.90; P < .001) and disease-free survival (HR, 0.82; 95% CI, 0.75-0.90; P < .001). There was no significant heterogeneity for overall survival across RCTs (P=.52) or the 4 regimen groups (P=.13). Five-year overall survival increased from 49.6% to 55.3% with chemotherapy. Conclusion Among the RCTs included, postoperative adjuvant chemotherapy based on fluorouracil regimens was associated with reduced risk of death in gastric cancer compared with surgery alone. JAMA. 2010; 303(17):1729-1737 www.jama.com	[Paoletti, Xavier] Natl Canc Inst, Direct Rech, F-92510 Boulogne, France; [Oba, Koji] Kyoto Univ, EBM Res Ctr, Kyoto, Japan; [Burzykowski, Tomasz] Hasselt Univ, Diepenbeek, Belgium; [Michiels, Stefan; Pignon, Jean-Pierre] Inst Gustave Roussy, Villejuif, France; [Ohashi, Yasuo] Univ Tokyo, Tokyo, Japan; [Rougier, Philippe] Univ Hosp Ambroise Pare, AP HP, Boulogne, France; [Sakamoto, Junichi] Nagoya Univ, Aichi, Japan; [Sargent, Daniel] Mayo Clin, Rochester, MN USA; [Sasako, Mitsuru] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Van Cutsem, Eric] Univ Hosp Gasthuisberf, Digest Oncol Unit, Leuven, Belgium; [Buyse, Marc] Int Inst Drug Dev, Louvain, Belgium	Institut National du Cancer (INCA) France; Kyoto University; Hasselt University; UNICANCER; Gustave Roussy; University of Tokyo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Nagoya University; Mayo Clinic; Hyogo College of Medicine; International Drug Development Institute	Paoletti, X (corresponding author), Natl Canc Inst, Direct Rech, 52 Ave Morizet, F-92510 Boulogne, France.	xpaoletti@institutcancer.fr	Oba, Koji/A-6956-2012; Michiels, Stefan/L-1516-2013; Di Bartolomeo, Maria/D-1655-2017; OBA, Koji/I-3980-2019; Burzykowski, Tomasz/T-2222-2018; Van+Cutsem, Eric/ABE-1762-2021; Buyse, Marc/J-4658-2013	Michiels, Stefan/0000-0002-6963-2968; Di Bartolomeo, Maria/0000-0002-7954-6609; OBA, Koji/0000-0001-5468-8988; Burzykowski, Tomasz/0000-0003-3378-975X; Pozzo, Carmelo/0000-0003-4004-9098; Coombes, Raoul Charles/0000-0002-4811-1100; Sargent, Daniel/0000-0002-2684-4741; Buyse, Marc/0000-0002-4559-0994; PIGNON, Jean-Pierre/0000-0003-2047-1582	Japan Clinical Research Support Unit (J-CRSU); Epidemiological and Clinical Research Information Network (ECRIN); Institut National du Cancer (INCa), France	Japan Clinical Research Support Unit (J-CRSU); Epidemiological and Clinical Research Information Network (ECRIN)(NPO Epidemiological and Clinical Research Information Network (ECRIN)); Institut National du Cancer (INCa), France(Institut National du Cancer (INCA) France)	This project was partially funded by the Japan Clinical Research Support Unit (J-CRSU), the Epidemiological and Clinical Research Information Network (ECRIN), and the Institut National du Cancer (INCa), France.	Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; ALLUM WH, 1989, LANCET, V1, P571; Bajetta E, 2002, ANN ONCOL, V13, P299, DOI 10.1093/annonc/mdf040; Boige V, 2007, J CLIN ONCOL, V25; BONFANTI G, 1988, BRIT J SURG, V75, P1100; Bouche O, 2005, ANN ONCOL, V16, P1488, DOI 10.1093/annonc/mdi270; CARRATO A, 1995, P AN M AM SOC CLIN, V14, P468; Chipponi J, 2004, AM J SURG, V187, P440, DOI 10.1016/j.amjsurg.2003.12.014; CHOU FF, 1994, J SURG ONCOL, V57, P239, DOI 10.1002/jso.2930570407; Cirera L, 1999, J CLIN ONCOL, V17, P3810, DOI 10.1200/JCO.1999.17.12.3810; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; COOMBES RC, 1990, J CLIN ONCOL, V8, P1362, DOI 10.1200/JCO.1990.8.8.1362; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; D'Ugo D, 2009, LANCET ONCOL, V10, P191, DOI 10.1016/S1470-2045(09)70021-X; De Vita F, 2007, ANN ONCOL, V18, P1354, DOI 10.1093/annonc/mdm128; Di Costanzo F, 2008, JNCI-J NATL CANCER I, V100, P388, DOI 10.1093/jnci/djn054; DOUGLASS HO, 1982, CANCER-AM CANCER SOC, V49, P1116; *EARL BREAST CANC, 1992, LANCET, V339, P1; ENGSTROM PF, 1985, CANCER-AM CANCER SOC, V55, P1868, DOI 10.1002/1097-0142(19850501)55:9<1868::AID-CNCR2820550904>3.0.CO;2-B; Fujii M, 1994, Gan To Kagaku Ryoho, V21, P1199; Gebski V, 2007, LANCET ONCOL, V8, P226, DOI 10.1016/S1470-2045(07)70039-6; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GRAU JJ, 1993, EUR J CANCER, V29A, P340, DOI 10.1016/0959-8049(93)90381-O; HALLISSEY MT, 1994, LANCET, V343, P1309, DOI 10.1016/S0140-6736(94)92464-3; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HUGUIER M, 1980, AM J SURG, V139, P197, DOI 10.1016/0002-9610(80)90253-6; Jakesz R, 1988, Recent Results Cancer Res, V110, P44; Janunger KG, 2002, EUR J SURG, V168, P597, DOI 10.1080/11024150201680005; KROOK JE, 1991, CANCER, V67, P2454, DOI 10.1002/1097-0142(19910515)67:10<2454::AID-CNCR2820671010>3.0.CO;2-2; LISE M, 1995, J CLIN ONCOL, V13, P2757, DOI 10.1200/JCO.1995.13.11.2757; Liu TS, 2008, EJSO-EUR J SURG ONC, V34, P1208, DOI 10.1016/j.ejso.2008.02.002; MACDONALD JS, 1995, ANN SURG ONCOL, V2, P488, DOI 10.1007/BF02307081; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Mari E, 2000, ANN ONCOL, V11, P837, DOI 10.1023/A:1008377101672; Nakajima T, 2007, BRIT J SURG, V94, P1468, DOI 10.1002/bjs.5996; NAKAJIMA T, 1984, J CLIN ONCOL, V2, P1366, DOI 10.1200/JCO.1984.2.12.1366; Nakajima T, 1999, LANCET, V354, P273, DOI 10.1016/S0140-6736(99)01048-X; Nashimoto A, 2003, J CLIN ONCOL, V21, P2282, DOI 10.1200/JCO.2003.06.103; Neri B, 1996, BRIT J CANCER, V73, P549, DOI 10.1038/bjc.1996.95; Nitti D, 2006, ANN ONCOL, V17, P262, DOI 10.1093/annonc/mdj077; Oba K, 2006, J CHEMOTHERAPY, V18, P311, DOI 10.1179/joc.2006.18.3.311; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pignon JP, 2001, LANCET ONCOL, V2, P475, DOI 10.1016/S1470-2045(01)00453-3; Popiela Tadeusz, 2004, Gastric Cancer, V7, P240, DOI 10.1007/s10120-004-0299-y; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; SCHLAG P, 1982, RECENT RES CANCER, V80, P277; Stewart B.W., 2003, WORLD CANC REPORT; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Tsavaris N, 1996, CHEMOTHERAPY, V42, P220, DOI 10.1159/000239446; Zhao SL, 2008, CANCER INVEST, V26, P317, DOI 10.1080/07357900701834686	53	603	628	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1729	1737		10.1001/jama.2010.534	http://dx.doi.org/10.1001/jama.2010.534			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442389				2022-12-28	WOS:000277276600026
J	Gilbert, C; Schaack, S; Pace, JK; Brindley, PJ; Feschotte, C				Gilbert, Clement; Schaack, Sarah; Pace, John K., II; Brindley, Paul J.; Feschotte, Cedric			A role for host-parasite interactions in the horizontal transfer of transposons across phyla	NATURE			English	Article							GENE-TRANSFER; DNA TRANSPOSON; TRYPANOSOMA-RANGELI; LYMNAEA-STAGNALIS; DIVERGENCE TIMES; PHYLOGENY; MITOCHONDRIAL; RODENTS; MODEL; PHYLOGEOGRAPHY	Horizontal transfer (HT), or the passage of genetic material between non-mating species, is increasingly recognized as an important force in the evolution of eukaryotic genomes(1,2). Transposons, with their inherent ability to mobilize and amplify within genomes, may be especially prone to HT3-7. However, the means by which transposons can spread across widely diverged species remain elusive. Here we present evidence that host-parasite interactions have promoted the HT of four transposon families between invertebrates and vertebrates. We found that Rhodnius prolixus, a triatomine bug feeding on the blood of various tetrapods and vector of Chagas' disease in humans, carries in its genome four distinct transposon families that also invaded the genomes of a diverse, but overlapping, set of tetrapods. The bug transposons are similar to 98% identical and cluster phylogenetically with those of the opossum and squirrel monkey, two of its preferred mammalian hosts in South America. We also identified one of these transposon families in the pond snail Lymnaea stagnalis, a cosmopolitan vector of trematodes infecting diverse vertebrates, whose ancestral sequence is nearly identical and clusters with those found in Old World mammals. Together these data provide evidence for a previously hypothesized role of host-parasite interactions in facilitating HT among animals(3,7). Furthermore, the large amount of DNA generated by the amplification of the horizontally transferred transposons supports the idea that the exchange of genetic material between hosts and parasites influences their genomic evolution.	[Gilbert, Clement; Schaack, Sarah; Pace, John K., II; Feschotte, Cedric] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Brindley, Paul J.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA	University of Texas System; University of Texas Arlington; George Washington University	Feschotte, C (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	cedric@uta.edu	Feschotte, Cedric/C-4048-2011; Gilbert, Clément/A-7538-2015	Gilbert, Clément/0000-0002-2131-7467; Brindley, Paul J./0000-0003-1765-0002	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Betran, J. Demuth, T. Fondon, B. Koskella, J. Meik, E. Pritham, Q. Wang and members of the Feschotte laboratory for comments and suggestions during the preparation of the manuscript; M. Batzer, E. Dotson, S. Goodman, A. Prelat, T. Robinson, A. Ropiquet and the Grosell and Sanchez laboratories for the gifts of tissue samples used in this study; and J. Spieth and The Genome Center at Washington University School of Medicine in St Louis for permission to use the R. prolixus assembly before publication. C. F. is funded by the National Institutes of Health and S.S. by the National Science Foundation.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Da Silva FM, 2007, MOL ECOL, V16, P3361, DOI 10.1111/j.1365-294X.2007.03371.x; da Silva FM, 2009, ACTA TROP, V109, P199, DOI 10.1016/j.actatropica.2008.11.005; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; De Giorgi C, 2002, MOL BIOCHEM PARASIT, V124, P91, DOI 10.1016/S0166-6851(02)00161-5; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FRASER MJ, 1983, J VIROL, V47, P287, DOI 10.1128/JVI.47.2.287-300.1983; FRIESEN PD, 1990, MOL CELL BIOL, V10, P3067, DOI 10.1128/MCB.10.6.3067; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gebo DL, 2000, NATURE, V404, P276, DOI 10.1038/35005066; GENTLES AJ, 2005, REPBASE REPORT, V5, P10; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T., 2004, BIOEDIT VERSION 5 0; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Hecht MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009181; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOUCK MA, 1991, SCIENCE, V253, P1125, DOI 10.1126/science.1653453; Huigens ME, 2000, NATURE, V405, P178, DOI 10.1038/35012066; Jehle JA, 1998, J MOL EVOL, V46, P215, DOI 10.1007/PL00006296; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Loy C, 2001, PARASITOL RES, V87, P878, DOI 10.1007/s004360100462; MARSHALL LG, 1979, SCIENCE, V204, P272, DOI 10.1126/science.204.4390.272; Morgan JAT, 2001, PARASITOLOGY, V123, pS211; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Novick P, 2010, GENE, V449, P85, DOI 10.1016/j.gene.2009.08.017; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Piskurek O, 2007, P NATL ACAD SCI USA, V104, P12046, DOI 10.1073/pnas.0700531104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Ray DA, 2008, GENOME RES, V18, P717, DOI 10.1101/gr.071886.107; Ray DA, 2007, MOL BIOL EVOL, V24, P632, DOI 10.1093/molbev/msl192; Remigio EA, 2002, PARASITOL RES, V88, P687, DOI 10.1007/s00436-002-0658-8; Robertson Hugh M., 2002, P1093; Rogan MT, 2007, J HELMINTHOL, V81, P57, DOI 10.1017/S0022149X07214105; Rossie JB, 2006, P NATL ACAD SCI USA, V103, P4381, DOI 10.1073/pnas.0509424103; Roughgarden J., 1995, ANOLIS LIZARDS CARIB; Smit A, 1996, REPEATMASKER OPEN 30; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Steiner C, 2005, MOL PHYLOGENET EVOL, V35, P363, DOI 10.1016/j.ympev.2004.12.013; Steinke D, 2006, J MOL EVOL, V62, P772, DOI 10.1007/s00239-005-0170-8; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wiegmann BM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-34; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V3rd; Yamanoue Y, 2006, GENES GENET SYST, V81, P29, DOI 10.1266/ggs.81.29; Yoder AD, 1996, P NATL ACAD SCI USA, V93, P5122, DOI 10.1073/pnas.93.10.5122; Yoshiyama M, 2001, MOL BIOL EVOL, V18, P1952, DOI 10.1093/oxfordjournals.molbev.a003735; Zbikowska E, 2006, PARASITOL RES, V99, P434, DOI 10.1007/s00436-006-0178-z	62	173	185	2	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1347	U4		10.1038/nature08939	http://dx.doi.org/10.1038/nature08939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428170	Green Accepted			2022-12-28	WOS:000277149000046
J	Lee, JH; Durand, R; Gradinaru, V; Zhang, F; Goshen, I; Kim, DS; Fenno, LE; Ramakrishnan, C; Deisseroth, K				Lee, Jin Hyung; Durand, Remy; Gradinaru, Viviana; Zhang, Feng; Goshen, Inbal; Kim, Dae-Shik; Fenno, Lief E.; Ramakrishnan, Charu; Deisseroth, Karl			Global and local fMRI signals driven by neurons defined optogenetically by type and wiring	NATURE			English	Article							OPTICAL TECHNOLOGIES; NEURAL CIRCUITRY; CORTEX; INTERROGATION; PROJECTIONS; SYSTEMS; BOLD; RAT	Despite a rapidly-growing scientific and clinical brain imaging literature based on functional magnetic resonance imaging (fMRI) using blood oxygenation level-dependent (BOLD)(1) signals, it remains controversial whether BOLD signals in a particular region can be caused by activation of local excitatory neurons(2). This difficult question is central to the interpretation and utility of BOLD, with major significance for fMRI studies in basic research and clinical applications(3). Using a novel integrated technology unifying optogenetic(4-13) control of inputs with high-field fMRI signal readouts, we show here that specific stimulation of local CaMKII alpha-expressing excitatory neurons, either in the neocortex or thalamus, elicits positive BOLD signals at the stimulus location with classical kinetics. We also show that optogenetic fMRI (ofMRI) allows visualization of the causal effects of specific cell types defined not only by genetic identity and cell body location, but also by axonal projection target. Finally, we show that ofMRI within the living and intact mammalian brain reveals BOLD signals in downstream targets distant from the stimulus, indicating that this approach can be used to map the global effects of controlling a local cell population. In this respect, unlike both conventional fMRI studies based on correlations 14 and fMRI with electrical stimulation that will also directly drive afferent and nearby axons, this ofMRI approach provides causal information about the global circuits recruited by defined local neuronal activity patterns. Together these findings provide an empirical foundation for the widely-used fMRI BOLD signal, and the features of ofMRI define a potent tool that may be suitable for functional circuit analysis as well as global phenotyping of dysfunctional circuitry.	[Lee, Jin Hyung] Univ Calif Los Angeles, Dept Elect Engn Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Lee, Jin Hyung; Durand, Remy; Gradinaru, Viviana; Zhang, Feng; Goshen, Inbal; Fenno, Lief E.; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kim, Dae-Shik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea; [Kim, Dae-Shik] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; Stanford University; Korea Advanced Institute of Science & Technology (KAIST); Boston University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Lee, JH (corresponding author), Univ Calif Los Angeles, Dept Elect Engn Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	ljinhy@gmail.com; deissero@stanford.edu	Bullmore, Ed/C-1706-2012; Fenno, Lief/AAK-2924-2020; Fenno, Lief/AAF-9638-2019; Goshen, Inbal/GQI-2230-2022; Macrae, Rhiannon/AAX-1536-2020; Kim, Dae-Shik/C-2071-2011	Bullmore, Ed/0000-0002-8955-8283; Goshen, Inbal/0000-0001-7578-2615; Ramakrishnan, Charu/0000-0002-3474-6332	NIH [(K99/R00) 1K99EB008738]; NSF; SGF; SIGF; Deisseroth laboratory; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; Coulter Foundation; CIRM; NIMH; NIDA; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R00EB008738, K99EB008738] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); SGF; SIGF; Deisseroth laboratory; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; Coulter Foundation; CIRM(California Institute for Regenerative Medicine); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	J.H.L. is supported by NIH pathway to independence grant (K99/R00) 1K99EB008738. R. D. is supported by an NSF Graduate Research Fellowship. V. G. is supported by SGF and SIGF (Stanford Graduate Fellowships). We acknowledge G. H. Glover, J. M. Pauly and D. G. Nishimura for generous support and advice, and C. Pacharinsak for assistance with rat intubation. We would also like to thank the entire Deisseroth laboratory for discussions and support, and Lee laboratory students, V. Karasev, Z. Fang and C. Jones for help with histological quantification and fMRI data analysis. K. D. is supported by the Keck, Snyder, Woo, Yu, McKnight, and Coulter Foundations, as well as by CIRM, NIMH, NIDA and the NIH Director's Pioneer Award.	Alloway KD, 2008, J COMP NEUROL, V510, P100, DOI 10.1002/cne.21782; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Cohen JD, 2002, NEURON, V36, P193, DOI 10.1016/S0896-6273(02)00973-X; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Donahue MJ, 2006, MAGN RESON MED, V56, P1261, DOI 10.1002/mrm.21072; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; GLOVER GH, 1995, MAGNET RESON MED, V33, P624, DOI 10.1002/mrm.1910330507; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Kuramoto E, 2009, CEREB CORTEX, V19, P2065, DOI 10.1093/cercor/bhn231; Lauritzen M, 2005, NAT REV NEUROSCI, V6, P77, DOI 10.1038/nrn1589; Lee JH, 2003, MAGN RESON MED, V50, P1276, DOI 10.1002/mrm.10644; Lee JH, 2008, MAGN RESON MED, V59, P1099, DOI 10.1002/mrm.21576; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005; Nir Y, 2008, NAT NEUROSCI, V11, P523, DOI 10.1038/nn0508-523; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2010, NAT PROTOC, V5, P439, DOI 10.1038/nprot.2009.226; Zhang Guang Lan, 2006, Immunome Res, V2, P3, DOI 10.1186/1745-7580-2-3	30	430	444	5	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					788	792		10.1038/nature09108	http://dx.doi.org/10.1038/nature09108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20473285	Green Accepted			2022-12-28	WOS:000278551800047
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Tuberculosis-time to accelerate progress	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England		Das, P (corresponding author), The Lancet, London NW1 7BY, England.							Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; WALLIS RS, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60359-5; *WHO, 2009, GLOB TUB CONTR SHORT	8	24	27	2	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1755	1757		10.1016/S0140-6736(10)60600-9	http://dx.doi.org/10.1016/S0140-6736(10)60600-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488528				2022-12-28	WOS:000278216500004
J	Parens, E; Johnston, J; Carlson, GA				Parens, Erik; Johnston, Josephine; Carlson, Gabrielle A.			Pediatric Mental Health Care Dysfunction Disorder?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHILDREN; TRENDS; YOUNG		[Parens, Erik; Johnston, Josephine] Hastings Ctr, Garrison, NY USA; [Carlson, Gabrielle A.] SUNY Stony Brook, Sch Med, Div Child & Adolescent Psychiat, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Parens, E (corresponding author), Hastings Ctr, Garrison, NY USA.			Johnston, Josephine/0000-0002-7411-6992				Barbaresi WJ, 2003, ARCH PEDIAT ADOL MED, V157, P121, DOI 10.1001/archpedi.157.2.121; Carlson GA, 2009, J CHILD ADOL PSYCHOP, V19, P281, DOI 10.1089/cap.2008.0108; Insel TR, 2009, J CLIN INVEST, V119, P700, DOI 10.1172/JCI38832; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Olfson M, 2010, J AM ACAD CHILD PSY, V49, P13, DOI 10.1016/j.jaac.2009.09.003	5	30	30	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1853	1855		10.1056/NEJMp1003175	http://dx.doi.org/10.1056/NEJMp1003175			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598EI	20484395				2022-12-28	WOS:000277815600001
J	Insel, TR; Wang, PS				Insel, Thomas R.; Wang, Philip S.			Rethinking Mental Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FEAR		[Insel, Thomas R.] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Insel, TR (corresponding author), NIMH, NIH, 6001 Execut Blvd,Room 8235, Bethesda, MD 20892 USA.	tinsel@mail.nih.gov						Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Delgado MR, 2008, NEURON, V59, P829, DOI 10.1016/j.neuron.2008.06.029; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Insel TR, 2009, BIOL PSYCHIAT, V66, P988, DOI 10.1016/j.biopsych.2009.10.008; Insel TR, 2009, J CLIN INVEST, V119, P700, DOI 10.1172/JCI38832; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	10	116	125	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1970	1971		10.1001/jama.2010.555	http://dx.doi.org/10.1001/jama.2010.555			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483974				2022-12-28	WOS:000277764500024
J	Allen, C; Pepper, J				Allen, Camilla; Pepper, John			A Patient's Journey External aortic support for people with Marfan's syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pepper, John] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6NP, England	Imperial College London; Royal Brompton Hospital		allen@vilberie.wanadoo.co.uk							0	5	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2010	340								c1692	10.1136/bmj.c1692	http://dx.doi.org/10.1136/bmj.c1692			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LR	20483926				2022-12-28	WOS:000278061500002
J	Parker, BD; Schurgers, LJ; Brandenburg, VM; Christenson, RH; Vermeer, C; Ketteler, M; Shlipak, MG; Whooley, MA; Ix, JH				Parker, Benjamin D.; Schurgers, Leon J.; Brandenburg, Vincent M.; Christenson, Robert H.; Vermeer, Cees; Ketteler, Markus; Shlipak, Michael G.; Whooley, Mary A.; Ix, Joachim H.			The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study	ANNALS OF INTERNAL MEDICINE			English	Article							FETUIN-A LEVELS; SERUM PHOSPHORUS; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; GLYCOPROTEIN/FETUIN-A; PHOSPHATE LEVELS; CALCIFICATION; RISK; CALCIUM; DIALYSIS	Background: Fibroblast growth factor 23 (FGF23), uncarboxylated matrix Gla protein (ucMGP), and fetuin-A are regulators of mineral metabolism and inhibitors of vascular calcification. Whether circulating levels of each are associated with cardiovascular disease (CVD) events or mortality in populations without end-stage renal disease is unknown. Objective: To evaluate the associations of FGF23, ucMGP, and fetuin-A with mortality and CVD events. Design: Observational study. Setting: 12 outpatient clinics in the San Francisco Bay area. Patients: 833 outpatients with stable coronary artery disease (CAD), recruited from 11 September 2000 to 20 December 2002. Measurements: Fibroblast growth factor 23, ucMGP, and fetuin-A concentrations were measured at baseline. Participants were followed until 1 December 2008 for mortality and CVD events. Results: During a median follow-up of 6.0 years, 220 participants died and 182 had CVD events. Compared with participants with FGF-23 levels in the lowest tertile, those in the highest tertile had 2-fold greater risk for mortality (hazard ratio [HR], 2.15 [95% CI, 1.43 to 3.24]) and CVD events (HR, 1.83 [CI, 1.15 to 2.91]) after adjustment for traditional CVD risk factors, C-reactive protein levels, and kidney function. The highest ucMGP tertile was associated with lower mortality risk (HR, 0.48 [CI, 0.31 to 0.75]) and showed a nonsignificant trend toward lower CVD event risk by tertile analysis (HR, 0.65 [CI, 0.40 to 1.05])-an association that was significant when modeled continuously (P = 0.029). No significant association of fetuin-A with mortality (HR, 0.84 [CI, 0.55 to 1.27]) or CVD events (HR, 0.99 [CI, 0.64 to 1.55]) was observed. Limitation: Participants had prevalent CAD. Conclusion: In outpatients with stable CAD, higher FGF23 and lower ucMGP levels are independently associated with mortality and CVD events.	[Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 3350 La Jolla Village Dr,Mail Code 111-H, San Diego, CA 92161 USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Maastricht Univ, Cardiovasc Res Inst, Maastricht, Netherlands; VitaK, Maastricht, Netherlands; Rhein Westfal TH Aachen, Univ Hosp, Aachen, Germany; Klinikum Coburg, Coburg, Germany; Univ Maryland, Baltimore, MD 21201 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Maastricht University; Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; Klinikum Coburg; University System of Maryland; University of Maryland Baltimore	Ix, JH (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 3350 La Jolla Village Dr,Mail Code 111-H, San Diego, CA 92161 USA.	joeix@ucsd.edu	Schurgers, Leon/AAT-7100-2021	Schurgers, Leon/0000-0001-7867-6957; Vermeer, Cees/0000-0002-2300-8561	National Heart, Lung, and Blood Institute (NHLBI) [T32 HL007261, R01HL096851, R01 HL079235]; American Heart Association; Department of Veterans Epidemiology Merit Review Program; Department of Veterans Affairs Health Services Research and Development service; American Federation for Aging Research; Robert Wood Johnson Foundation; Ischemia Research and Education Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235, R01HL096851, T32HL007261] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Department of Veterans Epidemiology Merit Review Program(US Department of Veterans Affairs); Department of Veterans Affairs Health Services Research and Development service(US Department of Veterans Affairs); American Federation for Aging Research; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Ischemia Research and Education Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By a Hypertension Training Grant (T32 HL007261) through the National Heart, Lung, and Blood Institute (NHLBI) (Dr. Parker), an American Heart Association Fellow-to-Faculty transition grant, and the NHLBI (grant R01HL096851, Dr. Ix). The Heart and Soul Study was supported by the Department of Veterans Epidemiology Merit Review Program; the Department of Veterans Affairs Health Services Research and Development service; the NHLBI (grant R01 HL079235); the American Federation for Aging Research (Paul Beeson Scholars Program); the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); and the Ischemia Research and Education Foundation. Dr. Ix had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Chonchol M, 2009, AM J MED, V122, P380, DOI 10.1016/j.amjmed.2008.09.039; Cranenburg ECM, 2008, J VASC RES, V45, P427, DOI 10.1159/000124863; Cranenburg ECM, 2009, THROMB HAEMOSTASIS, V101, P359, DOI 10.1160/TH08-04-0241; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hennige AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001765; Hermans MMH, 2007, KIDNEY INT, V72, P202, DOI 10.1038/sj.ki.5002178; Hermans MMH, 2007, BLOOD PURIFICAT, V25, P395, DOI 10.1159/000108629; Ix J, 2007, KIDNEY INT, V72, P1394, DOI 10.1038/sj.ki.5002549; Ix JH, 2008, JAMA-J AM MED ASSOC, V300, P182, DOI 10.1001/jama.300.2.182; Ix JH, 2007, CIRCULATION, V115, P2533, DOI 10.1161/CIRCULATIONAHA.106.682450; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim P, 2007, CLIN CHEM, V53, P1835, DOI 10.1373/clinchem.2006.084947; Liu SG, 2007, J AM SOC NEPHROL, V18, P1637, DOI 10.1681/ASN.2007010068; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751; PARKER BD, 2010, ATHEROSCLER IN PRESS; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Schurgers LJ, 2005, CLIN CHIM ACTA, V351, P131, DOI 10.1016/j.cccn.2004.08.003; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Takeshita K, 2004, CIRCULATION, V109, P1776, DOI 10.1161/01.CIR.0000124224.48962.32; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Vittinghoff E, 2003, ANN INTERN MED, V138, P81, DOI 10.7326/0003-4819-138-2-200301210-00007; Wang AYM, 2005, NEPHROL DIAL TRANSPL, V20, P1676, DOI 10.1093/ndt/gfh891; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669	56	353	364	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					640	+		10.7326/0003-4819-152-10-201005180-00004	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20479029	Green Accepted			2022-12-28	WOS:000277855500003
J	Costello, A; Osrin, D				Costello, Anthony; Osrin, David			Vitamin A supplementation and maternal mortality	LANCET			English	Editorial Material							CLUSTER-RANDOMIZED-TRIAL; BETA-CAROTENE; DOUBLE-BLIND; PREGNANCY; NEPAL		[Costello, Anthony; Osrin, David] UCL, UCL Inst Global Hlth, London WC1N 1EH, England	University of London; University College London	Costello, A (corresponding author), UCL, UCL Inst Global Hlth, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk		Osrin, David/0000-0001-9691-9684	Wellcome Trust [081052, 085417] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AWASTHI S, 6 MONTHLY VITAMIN A; Benn CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1101; CHRISTIAN PWK, 2007, EFFECTS MATERNAL VIT, P129; de Pee S, 2002, J NUTR, V132, p2895S, DOI 10.1093/jn/132.9.2895S; Gogia S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b919; Kirkwood BR, 2010, LANCET, V375, P1640, DOI 10.1016/S0140-6736(10)60311-X; *MIN ENV FOR GOV I, 2009, IND STAT ENV REP; Prentice AM, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c977; Ronsmans C, 1999, BRIT MED J, V319, P1202; Sachdev HPS, 1999, BRIT MED J, V319, P1202; Shankar AH, 2008, LANCET, V371, P215, DOI 10.1016/S0140-6736(08)60133-6; SOMMER A, 1986, LANCET, V1, P1169; Vijayaraghavan K, 1999, BRIT MED J, V319, P1201, DOI 10.1136/bmj.319.7218.1201a; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; West KP, 1999, BMJ-BRIT MED J, V318, P570, DOI 10.1136/bmj.318.7183.570; [No title captured]	16	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 15	2010	375	9727					1675	1677		10.1016/S0140-6736(10)60443-6	http://dx.doi.org/10.1016/S0140-6736(10)60443-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	599DK	20435344	Green Accepted			2022-12-28	WOS:000277890200009
J	Lloyd, A; White, P; Wessely, S; Sharpe, M; Buchwald, D				Lloyd, Andrew; White, Peter; Wessely, Simon; Sharpe, Michael; Buchwald, Dedra			Comment on "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome"	SCIENCE			English	Editorial Material							VIRUS-RELATED VIRUS; PROSTATE-CANCER	Lombardi et al. (Reports, 23 October 2009, p. 585) reported a significant association between the human retrovirus XMRV and chronic fatigue syndrome (CFS). However, the cases with CFS and the control subjects in their study are poorly described and unlikely to be representative. Independent replication is a critical first step before accepting the validity of this finding.	[Lloyd, Andrew] Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [White, Peter] Queen Mary Univ London, Barts & London Sch Med, Wolfson Inst Prevent Med, London, England; [Wessely, Simon] Kings Coll London, Inst Psychiat, Dept Psychol Med, London, England; [Sharpe, Michael] Univ Edinburgh, Sch Mol & Clin Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Buchwald, Dedra] Univ Washington, Ctr Clin & Epidemiol Res, Seattle, WA 98101 USA	University of New South Wales Sydney; University of London; Queen Mary University London; University of London; King's College London; University of Edinburgh; University of Washington; University of Washington Seattle	Lloyd, A (corresponding author), Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia.	a.lloyd@unsw.edu.au	Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/AFJ-8960-2022; Wessely, Simon C/A-8713-2008; Lloyd, Andrew/E-7334-2017	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; White, Peter/0000-0002-8193-5355; sharpe, michael/0000-0002-6474-9980; Wessely, Simon Charles/0000-0002-6743-9929				DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; GOW JW, 1992, J CLIN PATHOL, V45, P1058, DOI 10.1136/jcp.45.12.1058; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; HENEINE W, 1994, CLIN INFECT DIS, V18, pS121, DOI 10.1093/clinids/18.Supplement_1.S121; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; HONDA M, 1993, MICROBIOL IMMUNOL, V37, P779, DOI 10.1111/j.1348-0421.1993.tb01705.x; KHAN AS, 1993, ANN INTERN MED, V118, P241, DOI 10.7326/0003-4819-118-4-199302150-00001; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018	12	10	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980								10.1126/science.1183706	http://dx.doi.org/10.1126/science.1183706			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466905				2022-12-28	WOS:000277618800018
J	Stroud, DA; Meisinger, C; Pfanner, N; Wiedemann, N				Stroud, David A.; Meisinger, Chris; Pfanner, Nikolaus; Wiedemann, Nils			Assembling the Outer Membrane	SCIENCE			English	Editorial Material							BETA-BARREL PROTEINS; ESCHERICHIA-COLI; MITOCHONDRIA; BIOGENESIS; INSERTION		[Stroud, David A.] Univ Freiburg, Fac Biol, Trinatl Grad Kolleg 1478, Inst Biochem & Mol Biol,ZBMZ, D-79104 Freiburg, Germany; Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Stroud, DA (corresponding author), Univ Freiburg, Fac Biol, Trinatl Grad Kolleg 1478, Inst Biochem & Mol Biol,ZBMZ, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Stroud, David A/B-4929-2016; Pfanner, Nikolaus/AAV-7878-2021; Meisinger, Chris/J-1110-2014; Stroud, David Arthur/HGB-4331-2022	Stroud, David A/0000-0002-2048-3383; Meisinger, Chris/0000-0002-8326-3548; Stroud, David Arthur/0000-0002-2048-3383; Wiedemann, Nils/0000-0001-8305-6728				Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; WIDEMAN JG, 2010, MOL BIOL CELL, DOI DOI 10.1091/MBCE09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283	15	8	8	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					831	832		10.1126/science.1190507	http://dx.doi.org/10.1126/science.1190507			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466908				2022-12-28	WOS:000277618800024
J	Tcherkezian, J; Brittis, PA; Thomas, F; Roux, PP; Flanagan, JG				Tcherkezian, Joseph; Brittis, Perry A.; Thomas, Franziska; Roux, Philippe P.; Flanagan, John G.			Transmembrane Receptor DCC Associates with Protein Synthesis Machinery and Regulates Translation	CELL			English	Article							MESSENGER-RNA LOCALIZATION; PEPTIDYL-TRANSFER-RNA; COLORECTAL-CANCER; GROWTH CONES; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; NETRIN RECEPTOR; GUIDANCE; ACTIN; RIBOSOME	Extracellular signals regulate protein translation in many cell functions. A key advantage of control at the translational level is the opportunity to regulate protein synthesis within specific cellular subregions. However, little is known about mechanisms that may link extracellular cues to translation with spatial precision. Here, we show that a transmembrane receptor, DCC, forms a binding complex containing multiple translation components, including eukaryotic initiation factors, ribosomal large and small subunits, and monosomes. In neuronal axons and dendrites DCC colocalizes in particles with translation machinery, and newly synthesized protein. The extracellular ligand netrin promoted DCC-mediated translation and disassociation of translation components. The functional and physical association of a cell surface receptor with the translation machinery leads to a generalizable model for localization and extracellular regulation of protein synthesis, based on a transmembrane translation regulation complex.	[Tcherkezian, Joseph; Brittis, Perry A.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Thomas, Franziska] Dana Farber Canc Inst, Boston, MA 02115 USA; [Roux, Philippe P.] Univ Montreal, Fac Med, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada; [Roux, Philippe P.] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3T 1J4, Canada	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Universite de Montreal; Universite de Montreal	Brittis, PA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	perry_brittis@hms.harvard.edu; flanagan@hms.harvard.edu	Roux, Philippe P./J-3996-2012; Flanagan, John/AAM-2995-2020	Roux, Philippe P./0000-0002-5962-0250; 	NIH; NCIC; HHMI; CIHR; Canada Research Chair; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI(Howard Hughes Medical Institute); CIHR(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marc Kirschner, Dietmar Schmucker, Melissa Hancock, Marc Tessier-Lavigne, Nancy Kadersha, Steven Gygi, Ross Tomaino, Tom Walz, Maria Ericsson, Natalie Farny, Pam Silver, Joachim Hauber, Taka-Aki Sato, Nathalie Lamarche-Vane, John Blenis, Davie Van Vactor, Judy Glaven, Yao Chen, Dan Nowakowski, Miriam Osterfield, and Nicolas Preitner, for help, reagents, advice, and comments on the manuscript. This work was supported by grants from the NIH (J.G.F.) and NCIC (P.P.R.), an HHMI fellowship (P.A.B.), a CIHR fellowship (J.T.), and a Canada Research Chair and HFSP Career Development Award (P.P.R.).	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Beatty KE, 2008, BIOORG MED CHEM LETT, V18, P5995, DOI 10.1016/j.bmcl.2008.08.046; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Drees F, 2008, CURR OPIN NEUROBIOL, V18, P53, DOI 10.1016/j.conb.2008.05.007; FABIJANSKI S, 1981, MOL GEN GENET, V184, P551, DOI 10.1007/BF00352539; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Finger JH, 2002, J NEUROSCI, V22, P10346; FLANAGAN J, 1978, NATURE, V273, P278, DOI 10.1038/273278a0; Garbe DS, 2004, CRIT REV BIOCHEM MOL, V39, P319, DOI 10.1080/10409230490906797; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; HESKETH JE, 1991, BIOCHEM J, V277, P1; Kebache S, 2002, P NATL ACAD SCI USA, V99, P5406, DOI 10.1073/pnas.082483399; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Koenig E, 1996, J NEUROSCI, V16, P1400; Kruger M, 2001, MOL CELL BIOL, V21, P8357, DOI 10.1128/MCB.21.24.8357-8364.2001; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Parent AT, 2005, J NEUROSCI, V25, P1540, DOI 10.1523/JNEUROSCI.3850-04.2005; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; RAMAIAH KVA, 1992, P NATL ACAD SCI USA, V89, P12063, DOI 10.1073/pnas.89.24.12063; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; Rodriguez AJ, 2008, CURR OPIN CELL BIOL, V20, P144, DOI 10.1016/j.ceb.2008.02.004; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Takahashi Y, 2005, J BIOCHEM, V138, P41, DOI 10.1093/jb/mvi096; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	51	181	182	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					632	644		10.1016/j.cell.2010.04.008	http://dx.doi.org/10.1016/j.cell.2010.04.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20434207	Green Accepted, Bronze			2022-12-28	WOS:000277623600016
J	Wildfeuer, C				Wildfeuer, Christoph			Managing Multistate Quantum Entanglement	SCIENCE			English	Editorial Material									Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Wildfeuer, C (corresponding author), Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA.	wildfeuer@phys.lsu.edu						Afek I, 2010, SCIENCE, V328, P879, DOI 10.1126/science.1188172; Boto AN, 2000, PHYS REV LETT, V85, P2733, DOI 10.1103/PhysRevLett.85.2733; CAVES CM, 1981, PHYS REV D, V23, P1693, DOI 10.1103/PhysRevD.23.1693; Dowling JP, 2008, CONTEMP PHYS, V49, P125, DOI 10.1080/00107510802091298; Hofmann HF, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.031806; Kimble HJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.022002; Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032; Lu YJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.023601; SANDERS BC, 1989, PHYS REV A, V40, P2417, DOI 10.1103/PhysRevA.40.2417	9	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					835	836		10.1126/science.1190491	http://dx.doi.org/10.1126/science.1190491			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466911				2022-12-28	WOS:000277618800027
J	Kesselheim, AS; Studdert, DM; Mello, MM				Kesselheim, Aaron S.; Studdert, David M.; Mello, Michelle M.			Whistle-Blowers' Experiences in Fraud Litigation against Pharmaceutical Companies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ABUSE		[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Studdert, David M.] Univ Melbourne, Sch Law, Melbourne, Vic, Australia; [Studdert, David M.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Melbourne; University of Melbourne	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017; Studdert, David/AAF-3116-2021	Kesselheim, Aaron/0000-0002-8867-2666; Studdert, David/0000-0003-0585-5537; Mello, Michelle/0000-0003-2877-4270	Agency for Healthcare Research and Quality [K08HS18465-01]; Australian Research Council; Greenwall Faculty Scholars Program in Bioethics; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Australian Research Council(Australian Research Council); Greenwall Faculty Scholars Program in Bioethics; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a career development award (K08HS18465-01) from the Agency for Healthcare Research and Quality (to Dr. Kesselheim), a Federation Fellowship from the Australian Research Council (to Dr. Studdert), and funding from the Greenwall Faculty Scholars Program in Bioethics (to Dr. Mello). The study was approved by ethics review boards at Brigham and Women's Hospital and the Harvard School of Public Health.	Alford C. F, 2002, WHISTLEBLOWERS BROKE; Becker D, 2005, J HEALTH ECON, V24, P189, DOI 10.1016/j.jhealeco.2004.07.002; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; BRENNER M., 1996, VANITY FAIR      MAY, P170; Charles Sara, 2005, Bull Am Coll Surg, V90, P17; *DEP JUST CIV DIV, 2007, FRAUS STAT OV OCT 1; Devine T., 1997, WHISTLEBLOWERS SURVI; *GEN ACC OFF, 1992, PUBL GEN ACC OFF; GLAZER M, 1983, HASTINGS CENT REP, V13, P33, DOI 10.2307/3560742; Glazer MP, 1989, WHISTLEBLOWERS EXPOS; Harris G., 2009, NY TIMES         SEP, pB4; Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; Kesselheim AS, 2008, ANN INTERN MED, V149, P342, DOI 10.7326/0003-4819-149-5-200809020-00009; Lenzer J, 2005, PLOS MED, V2, P583, DOI 10.1371/journal.pmed.0020209; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; Meyer J. A, 2006, FIGHTING MEDICARE FR; Rost P., 2006, WHISTLEBLOWER CONFES; SANDBURG B, 2009, PINK SHEET, P21; Sparrow M., 2000, LICENSE STEAL FRAUD; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; WILLMS DG, 1990, MED ANTHROPOL Q, V4, P391, DOI 10.1525/maq.1990.4.4.02a00020; 2009, HOSP REV        1012	22	53	53	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1832	1839		10.1056/NEJMsr0912039	http://dx.doi.org/10.1056/NEJMsr0912039			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463344				2022-12-28	WOS:000277555500014
J	Wijeysundera, HC; Machado, M; Farahati, F; Wang, XS; Witteman, W; van der Velde, G; Tu, JV; Lee, DS; Goodman, SG; Petrella, R; O'Flaherty, M; Krahn, M; Capewell, S				Wijeysundera, Harindra C.; Machado, Marcio; Farahati, Farah; Wang, Xuesong; Witteman, William; van der Velde, Gabrielle; Tu, Jack V.; Lee, Douglas S.; Goodman, Shaun G.; Petrella, Robert; O'Flaherty, Martin; Krahn, Murray; Capewell, Simon			Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MYOCARDIAL-INFARCTION; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; DECREASE; DECLINE; METAANALYSIS; DEATHS; RATES; AGE	Context Coronary heart disease (CHD) mortality has declined substantially in Canada since 1994. Objective To determine what proportion of this decline was associated with temporal trends in CHD risk factors and advancements in medical treatments. Design, Setting, and Patients Prospective analytic study of the Ontario, Canada, population aged 25 to 84 years between 1994 and 2005, using an updated version of the validated IMPACT model, which integrates data on population size, CHD mortality, risk factors, and treatment uptake changes. Relative risks and regression coefficients from the published literature quantified the relationship between CHD mortality and (1) evidence-based therapies in 8 distinct CHD subpopulations (acute myocardial infarction [AMI], acute coronary syndromes, secondary prevention post-AMI, chronic coronary artery disease, heart failure in the hospital vs in the community, and primary prevention for hyperlipidemia or hypertension) and (2) population trends in 6 risk factors (smoking, diabetes mellitus, systolic blood pressure, plasma cholesterol level, exercise, and obesity). Main Outcome Measures The number of deaths prevented or delayed in 2005; secondary outcome measures were improvements in medical treatments and trends in risk factors. Results Between 1994 and 2005, the age-adjusted CHD mortality rate in Ontario decreased by 35% from 191 to 125 deaths per 100 000 inhabitants, translating to an estimated 7585 fewer CHD deaths in 2005. Improvements in medical and surgical treatments were associated with 43% (range, 11% to 124%) of the total mortality decrease, most notably in AMI (8%; range, -5% to 40%), chronic stable coronary artery disease (17%; range, 7% to 35%), and heart failure occurring while in the community (10%; range, 6% to 31%). Trends in risk factors accounted for 3660 fewer CHD deaths prevented or delayed (48% of total; range, 28% to 64%), specifically, reductions in total cholesterol (23%; range, 10% to 33%) and systolic blood pressure (20%; range, 13% to 26%). Increasing diabetes prevalence and body mass index had an inverse relationship associated with higher CHD mortality of 6% (range, 4% to 8%) and 2% (range, 1% to 4%), respectively. Conclusion Between 1994 and 2005, there was a decrease in CHD mortality rates in Ontario that was associated primarily with trends in risk factors and improvements in medical treatments, each explaining about half of the decrease. JAMA. 2010;303(18):1841-1847 www.jama.com	[Wijeysundera, Harindra C.; Tu, Jack V.] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON M4N 3M5, Canada; [Wijeysundera, Harindra C.; Machado, Marcio; Farahati, Farah; Witteman, William; van der Velde, Gabrielle; Krahn, Murray] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Wijeysundera, Harindra C.; Lee, Douglas S.; Goodman, Shaun G.; Krahn, Murray] Univ Toronto, Dept Med, Toronto, ON, Canada; [Krahn, Murray] Univ Toronto, Fac Pharm, Toronto, ON, Canada; [Wang, Xuesong; Tu, Jack V.; Lee, Douglas S.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [van der Velde, Gabrielle] Inst Work & Hlth, Toronto, ON, Canada; [Lee, Douglas S.; Krahn, Murray] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Goodman, Shaun G.] Toronto Gen Hosp, Univ Hlth Network, Toronto, ON, Canada; [Goodman, Shaun G.] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada; [Petrella, Robert] Univ Western Ontario, Dept Family Med, London, ON, Canada; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Institute for Work & Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario); University of Liverpool	Wijeysundera, HC (corresponding author), 2075 Bayview Ave,Ste A209D, Toronto, ON M4N 3M5, Canada.	wijeysundera@gmail.com	Petrella, Robert J/G-6557-2018; Wijeysundera, Harindra/AAA-6058-2020	Krahn, Murray/0000-0001-5836-397X; Lee, Douglas/0000-0001-7078-745X; O'Flaherty, Martin/0000-0001-8944-4131; Wijeysundera, Harindra/0000-0001-8464-1080; Tu, Jack/0000-0003-0111-722X	Canadian Institute of Health Research [MOP 82747]; Canadian Institute of Health Research Team; Ministry of Health and Long-Term Care of Ontario; Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario; UK Medical Research Council; Medical Research Council [G0900847] Funding Source: researchfish; MRC [G0900847] Funding Source: UKRI	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research Team(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-Term Care of Ontario(Ministry of Health and Long-Term Care, Ontario); Tier 1 Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The analysis of this study was funded in part by operating grant MOP 82747 from the Canadian Institute of Health Research and a Canadian Institute of Health Research Team grant in cardiovascular outcomes research. The Toronto Health Economics and Technology Assessment Collaborative and the Institute for Clinical Evaluative Sciences are funded in part by the Ministry of Health and Long-Term Care of Ontario. Dr Wijeysundera is supported by a research fellowship award from the Canadian Institute of Health Research. Dr van der Velde is supported by a postdoctoral fellowship and a Bisby award provided by the Canadian Institute of Health Research. Dr Tu is supported by a Tier 1 Canada Research Chair in Health Services Research and a career investigator award from the Heart and Stroke Foundation of Ontario. Dr Lee is supported by a Clinician Scientist Award from Canadian Institute of Health Research. Dr O'Flaherty was partly funded by the UK Medical Research Council. Dr Krahn holds the F. Norman Hughes Chair in Pharmacoeconomics at the Faculty of Pharmacy, University of Toronto.	Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; Capewell S, 2008, HEART, V94, P1105, DOI 10.1136/hrt.2008.149930; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; Nichol G, 1999, ACAD EMERG MED, V6, P95, DOI 10.1111/j.1553-2712.1999.tb01044.x; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; *POL RES DIV STRAT, EC BURD ILLN CAN 199; Rodriguez T, 2006, HEART, V92, P453, DOI 10.1136/hrt.2004.059295; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; World Health Organization, GLOB BURD COR HEART; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	17	204	213	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1841	1847		10.1001/jama.2010.580	http://dx.doi.org/10.1001/jama.2010.580			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460623	Bronze			2022-12-28	WOS:000277513900025
J	Sarwar, N; Sandhu, MS; Ricketts, SL; Butterworth, AS; Di Angelantonio, E; Boelcholdt, SM; Ouwehand, W; Watkins, H; Samani, NJ; Saleheen, D; Lawlor, D; Reilly, MP; Hingorani, AD; Talmud, PJ; Danesh, J; Braund, PS; Hall, AS; Thompson, J; Marz, W; Sivapalaratnam, S; Soranzo, N; Trip, M; Casas, JP; Ebrahim, S; Arsenault, BJ; Boekholdt, SM; Khaw, KT; Wareham, NJ; Grallert, H; Illig, T; Humphries, SE; Rader, DJ; He, J; Clarke, R; Hamsten, R; Hopewell, JC; Frossard, P; Deloukas, P; Ye, S; Simpson, JA; Onat, A; Komurcu-Bayrak, E; Martinelli, N; Olivieri, O; Girelli, D; Kivimaki, M; Kumari, M; Aouizerat, BE; Baum, L; Campos, H; Chaaba, R; Chen, BS; Cho, EY; Evans, D; Hill, J; Hsu, LA; Hubacek, JA; Lai, CQ; Lee, JH; Klos, K; Liu, H; Masana, L; Melegh, B; Nabika, T; Ribalta, J; Ruiz-Narvaez, E; Thomas, GN; Tomlinson, B; Szalai, C; Vaverkova, H; Yamada, Y; Yang, Y; Tipping, RW; Ford, CE; Pressel, SL; Ballantyne, C; Brautbar, A; Knuiman, M; Winchup, PH; Wannamethee, SG; Morris, RW; Kiechl, S; Willeit, J; Santer, P; Mayr, A; Wald, N; Yarnell, JWG; Gallacher, J; Casiglia, E; Tikhonoff, V; Cushman, M; Psaty, BM; Tracy, RP; Tybjaerg-Hansen, A; Nordestgaard, BG; Benn, M; Frikke-Schmidt, R; Giampaoli, S; Palmieri, L; Panico, S; Vanuzzo, D; Pilotto, L; de la Camara, AG; Gomez-Gerique, JA; Simons, L; McCallum, J; Friedlander, Y; Fowkes, FGR; Lee, AJ; Taylor, J; Guralnik, JM; Phillips, CL; Wallace, WR; Blazer, DG; Brenner, H; Raum, E; Muller, H; Rothenbacher, D; Jansson, JH; Wennberg, P; Nissinen, A; Donfrancesco, C; Salomaa, V; Harald, K; Pencina, MJ; Vartiainen, E; D'Agostino, RB; Vasan, RS; Bladbjerg, EM; Jorgensen, T; Moller, L; Jespersen, J; Dankner, R; Chetrit, A; Lubin, F; Bjorkelund, C; Lissner, L; Bengtsson, C; Cremer, P; Nagel, D; Rodriguez, B; Dekker, JM; Nijpels, G; Stehouwer, CDA; Sato, S; Iso, H; Kitamura, A; Noda, H; Salonen, JT; Nyssonen, K; Tuimainen, TP; Voutilainen, S; Meade, TW; Cooper, JA; Kuller, LH; Grandits, G; Gillum, R; Mussolino, M; Rimm, E; Hankinson, S; Manson, JAE; Pai, JK; Bauer, KA; Naito, Y; Amouyel, P; Arveiler, D; Evans, A; Ferrieres, J; Schulte, H; Assmann, G; Packard, CJ; Sattar, N; Westendorp, RG; Buckley, BM; Cantin, B; Lamarche, B; Despres, JP; Dagenais, GR; Barrett-Connor, E; Wingard, DL; Bettencourt, R; Gudnason, V; Aspelund, T; Sigurdsson, G; Thorsson, B; Trevisan, M; Tunstall-Pedoe, H; Tavendale, R; Lowe, GDO; Woodward, M; Howard, BV; Zhang, Y; Best, L; Umans, J; Ben-Shlomo, Y; Davey-Smith, G; Njolstad, I; Mathiesen, EB; Lochen, ML; Wilsgaard, T; Ingelsson, E; Lind, I; Giedraitis, V; Michaelsson, K; Brunner, E; Shipley, M; Ridker, P; Buring, J; Shepherd, J; Cobbe, SM; Ford, I; Robertson, M; Ibanez, AM; Feskens, EJM; Kromhout, D; Walker, M; Watson, S; Collins, R; Kaptoge, S; Perry, PL; Sarwar, N; Thompson, A; Thompson, SG; White, IR; Wood, AM				Sarwar, Nadeem; Sandhu, Manjinder S.; Ricketts, Sally L.; Butterworth, Adam S.; Di Angelantonio, Emanuele; Boelcholdt, S. Matthijs; Ouwehand, Willem; Watkins, Hugh; Samani, Nilesh J.; Saleheen, Danish; Lawlor, Debbie; Reilly, Muredach P.; Hingorani, Aroon D.; Talmud, Philippa J.; Danesh, John; Braund, P. S.; Hall, A. S.; Thompson, J.; Marz, W.; Sivapalaratnam, S.; Soranzo, N.; Trip, M.; Casas, J. P.; Ebrahim, S.; Arsenault, B. J.; Boekholdt, S. M.; Khaw, K. T.; Wareham, N. J.; Grallert, H.; Illig, T.; Humphries, S. E.; Rader, D. J.; He, J.; Clarke, R.; Hamsten, R.; Hopewell, J. C.; Frossard, P.; Deloukas, P.; Ye, S.; Simpson, J. A.; Onat, A.; Komurcu-Bayrak, E.; Martinelli, N.; Olivieri, O.; Girelli, D.; Kivimaki, M.; Kumari, M.; Aouizerat, B. E.; Baum, L.; Campos, H.; Chaaba, R.; Chen, B. S.; Cho, E. Y.; Evans, D.; Hill, J.; Hsu, L. A.; Hubacek, J. A.; Lai, C. Q.; Lee, J. H.; Klos, K.; Liu, H.; Masana, L.; Melegh, B.; Nabika, T.; Ribalta, J.; Ruiz-Narvaez, E.; Thomas, G. N.; Tomlinson, B.; Szalai, C.; Vaverkova, H.; Yamada, Y.; Yang, Y.; Tipping, R. W.; Ford, C. E.; Pressel, S. L.; Ballantyne, C.; Brautbar, A.; Knuiman, M.; Winchup, P. H.; Wannamethee, S. G.; Morris, R. W.; Kiechl, S.; Willeit, J.; Santer, P.; Mayr, A.; Wald, N.; Yarnell, J. W. G.; Gallacher, J.; Casiglia, E.; Tikhonoff, V.; Cushman, M.; Psaty, B. M.; Tracy, R. P.; Tybjaerg-Hansen, A.; Nordestgaard, B. G.; Benn, M.; Frikke-Schmidt, R.; Giampaoli, S.; Palmieri, L.; Panico, S.; Vanuzzo, D.; Pilotto, L.; Gomez de la Camara, A.; Gomez-Gerique, J. A.; Simons, L.; McCallum, J.; Friedlander, Y.; Fowkes, F. G. R.; Lee, A. J.; Taylor, J.; Guralnik, J. M.; Phillips, C. L.; Wallace, W. R.; Blazer, D. G.; Brenner, H.; Raum, E.; Mueller, H.; Rothenbacher, D.; Jansson, J. H.; Wennberg, P.; Nissinen, A.; Donfrancesco, C.; Salomaa, V.; Harald, K.; Pencina, M. J.; Vartiainen, E.; D'Agostino, R. B.; Vasan, R. S.; Bladbjerg, E. M.; Jorgensen, T.; Moller, L.; Jespersen, J.; Dankner, R.; Chetrit, A.; Lubin, F.; Bjoerkelund, C.; Lissner, L.; Bengtsson, C.; Cremer, P.; Nagel, D.; Rodriguez, B.; Dekker, J. M.; Nijpels, G.; Stehouwer, C. D. A.; Sato, S.; Iso, H.; Kitamura, A.; Noda, H.; Salonen, J. T.; Nyssoenen, K.; Tuimainen, T. -P.; Voutilainen, S.; Meade, T. W.; Cooper, J. A.; Kuller, L. H.; Grandits, G.; Gillum, R.; Mussolino, M.; Rimm, E.; Hankinson, S.; Manson, J. A. E.; Pai, J. K.; Bauer, K. A.; Naito, Y.; Amouyel, P.; Arveiler, D.; Evans, A.; Ferrieres, J.; Schulte, H.; Assmann, G.; Packard, C. J.; Sattar, N.; Westendorp, R. G.; Buckley, B. M.; Cantin, B.; Lamarche, B.; Despres, J. -P.; Dagenais, G. R.; Barrett-Connor, E.; Wingard, D. L.; Bettencourt, R.; Gudnason, V.; Aspelund, T.; Sigurdsson, G.; Thorsson, B.; Trevisan, M.; Tunstall-Pedoe, H.; Tavendale, R.; Lowe, G. D. O.; Woodward, M.; Howard, B. V.; Zhang, Y.; Best, L.; Umans, J.; Ben-Shlomo, Y.; Davey-Smith, G.; Njolstad, I.; Mathiesen, E. B.; Lochen, M. L.; Wilsgaard, T.; Ingelsson, E.; Lind, I.; Giedraitis, V.; Michaeelsson, K.; Brunner, E.; Shipley, M.; Ridker, P.; Buring, J.; Shepherd, J.; Cobbe, S. M.; Ford, I.; Robertson, M.; Marin Ibanez, A.; Feskens, E. J. M.; Kromhout, D.; Walker, M.; Watson, S.; Collins, R.; Kaptoge, S.; Perry, P. L.; Sarwar, N.; Thompson, A.; Thompson, S. G.; White, I. R.; Wood, A. M.		Triglyceride Coronary Dis Genetics	Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies	LANCET			English	Article							APOLIPOPROTEIN-A-V; HEART-DISEASE; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RICH LIPOPROTEINS; RISK; ASSOCIATION; RECEPTOR; SNP; MEN	Background Whether triglyceride-mediated pathways are causally relevant to coronary heart disease is uncertain. We studied a genetic variant that regulates triglyceride concentration to help judge likelihood of causality. Methods We assessed the -1131T>C (rs662799) promoter polymorphism of the apolipoprotein A5 (APOA5) gene in relation to triglyceride concentration, several other risk factors, and risk of coronary heart disease. We compared disease risk for genetically-raised triglyceride concentration (20 842 patients with coronary heart disease, 35 206 controls) with that recorded for equivalent differences in circulating triglyceride concentration in prospective studies (302 430 participants with no history of cardiovascular disease; 12 785 incident cases of coronary heart disease during 2.79 million person-years at risk). We analysed -1131T>C in 1795 people without a history of cardiovascular disease who had information about lipoprotein concentration and diameter obtained by nuclear magnetic resonance spectroscopy. Findings The minor allele frequency of -1131T>C was 8% (95% CI 7-9). -1131T>C was not significantly associated with several non-lipid risk factors or LDL cholesterol, and it was modestly associated with lower HDL cholesterol (mean difference per C allele 3.5% [95% CI 2.6-4.6]; 0.053 mmol/L [0.039-0.068]), lower apolipoprotein AI (1.3% [0.3-2.3]; 0.023 g/L [0.005-0.041]), and higher apolipoprotein B (3.2% [1.3-5.1]; 0.027 g/L [0.011-0.043]). By contrast, for every C allele inherited, mean triglyceride concentration was 16.0% (95% CI 12.9-18.7), or 0.25 mmol/L (0.20-0.29), higher (p=4.4x10(-24)). The odds ratio for coronary heart disease was 1.18 (95% CI 1.11-1.26; p=2.6x10(-7)) per C allele, which was concordant with the hazard ratio of 1.10 (95% CI 1.08-1.12) per 16% higher triglyceride concentration recorded in prospective studies. -1131T>C was significantly associated with higher VLDL particle concentration (mean difference per C allele 12.2 nmol/L [95% CI 7.7-16.7]; p=9.3x10(-8)) and smaller HDL particle size (0.14 nm [0.08-0.20]; p=7.0x10(-5)), factors that could mediate the effects of triglyceride. Interpretation These data are consistent with a causal association between triglyceride-mediated pathways and coronary heart disease.	[Sarwar, Nadeem] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England; [Boelcholdt, S. Matthijs] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Watkins, Hugh] Univ Oxford, Oxford, England; [Samani, Nilesh J.] Univ Leicester, Leicester, Leics, England; [Lawlor, Debbie] Univ Bristol, Bristol, Avon, England; [Reilly, Muredach P.] Univ Penn, Philadelphia, PA 19104 USA; [Hingorani, Aroon D.; Talmud, Philippa J.] UCL, London, England	University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Leicester; University of Bristol; University of Pennsylvania; University of London; University College London	Sarwar, N (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Worts Causeway, Cambridge CB1 8RN, England.	nadeem.sarwar@phpc.cam.ac.uk	Feskens, Edith JM/A-3757-2012; Dankner, Rachel/Q-5245-2019; Aspelund, Thor/C-5983-2008; Knuiman, Matthew W/I-5549-2013; Girelli, Domenico/B-1183-2008; Benn, Marianne/O-4164-2019; Thomas, G. Neil/A-1879-2013; Ye, Shu/C-4067-2009; Aspelund, Thor/F-4826-2011; de la Camara, Agustin Gomez/S-7123-2018; Watson, Stephen P/Q-6292-2016; Gudnason, Vilmundur/K-6885-2015; Brunner, Eric/H-2114-2011; DiAngelantonio, Emanuele/ABE-6852-2020; Ford, Ian/ABE-6145-2020; Tomlinson, Brian/AAD-9404-2019; Hall, Alistair/K-1953-2019; Njolstad, Inger/X-3784-2019; Boekholdt, Matthijs S.M./G-7562-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; MASANA, LUIS/M-7002-2019; Deloukas, Panos/B-2922-2013; Tikhonoff, Valerie/AAC-3728-2019; Blazer, Dan G/D-6675-2012; Olivieri, Oliviero/A-9126-2008; Kivimaki, Mika/B-3607-2012; Grallert, Harald/B-3424-2013; Lamarche, Benoit/ABA-4785-2021; Stehouwer, Coen/AAB-3435-2021; Tomlinson, Brian/P-5365-2015; Ballantyne, Christie/A-6599-2008; Kromhout, Daan/A-8566-2014; Aspelund, Thor/K-7022-2019; Gudnason, Vilmundur/AAE-7126-2019; He, Jing/E-5316-2012; Komurcu Bayrak, Evrim/B-2271-2014; PALMIERI, LUIGI/O-1845-2017; Feskens, Edith/ABI-1446-2020; Ramachandran, Vasan/Y-2527-2019; Brenner, Hermann/ABE-6383-2020; Hubacek, Jaroslav Alois/AAN-6134-2021; Ribalta, Josep/AAD-4859-2020; Ye, Shu/R-6384-2017; Davey Smith, George/A-7407-2013; Khaw, Kay-Tee/AAZ-3209-2021; Lennon, Lucy/ABB-9433-2020; Woodward, Mark/L-6817-2017; Michaelsson, Karl/AAM-9094-2021; donfrancesco, chiara/K-1460-2016; Ferrieres, Jean/S-7993-2016	Dankner, Rachel/0000-0001-6454-6000; Aspelund, Thor/0000-0002-7998-5433; Girelli, Domenico/0000-0001-9684-1899; Benn, Marianne/0000-0002-1701-595X; Thomas, G. Neil/0000-0002-2777-1847; Watson, Stephen P/0000-0002-7846-7423; Gudnason, Vilmundur/0000-0001-5696-0084; Brunner, Eric/0000-0002-0595-4474; Tomlinson, Brian/0000-0001-6717-5444; MASANA, LUIS/0000-0002-0789-4954; Deloukas, Panos/0000-0001-9251-070X; Tikhonoff, Valerie/0000-0001-7846-0101; Olivieri, Oliviero/0000-0001-8209-9056; Kivimaki, Mika/0000-0002-4699-5627; Lamarche, Benoit/0000-0002-4443-5378; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Komurcu Bayrak, Evrim/0000-0003-1271-1208; PALMIERI, LUIGI/0000-0002-4298-2642; Feskens, Edith/0000-0001-5819-2488; Ramachandran, Vasan/0000-0001-7357-5970; Brenner, Hermann/0000-0002-6129-1572; Hubacek, Jaroslav Alois/0000-0001-6537-1353; Ribalta, Josep/0000-0002-8879-4719; Ye, Shu/0000-0002-4126-4278; Davey Smith, George/0000-0002-1407-8314; Lennon, Lucy/0000-0002-1738-1351; Morris, Richard/0000-0001-7240-4563; Lawlor, Debbie A/0000-0002-6793-2262; Humphries, Stephen E/0000-0002-8221-6547; Lai, Chao-Qiang/0000-0003-1107-8375; Boekholdt, Matthijs/0000-0002-0861-0765; Butterworth, Adam/0000-0002-6915-9015; Ricketts, Sally/0000-0002-5644-7958; Kumari, Meena/0000-0001-9716-1035; s, hema/0000-0002-3440-9475; Nordestgaard, Borge/0000-0002-1954-7220; Michaelsson, Karl/0000-0003-2815-1217; Ballantyne, Christie/0000-0002-6432-1730; Whincup, Peter/0000-0002-5589-4107; Hopewell, Jemma/0000-0002-3870-8018; Jespersen, Jorgen/0000-0002-3059-2356; Ouwehand, Willem/0000-0002-7744-1790; Amouyel, Philippe/0000-0001-9088-234X; Gomez de la Camara, Agustin/0000-0001-6827-6319; Lochen, Maja-Lisa/0000-0002-8532-6573; Hingorani, Aroon/0000-0001-8365-0081; Di Angelantonio, Emanuele/0000-0001-8776-6719; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Bladbjerg, Else Marie/0000-0003-0912-2437; donfrancesco, chiara/0000-0002-8040-5571; Hsu, Lung-An/0000-0002-0012-2804; Reilly, Muredach/0000-0002-3035-9386; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hall, Alistair/0000-0003-0306-7887; Stehouwer, Coen/0000-0001-8752-3223; Woodward, Mark/0000-0001-9800-5296; Cushman, Mary/0000-0002-7871-6143; Watkins, Hugh/0000-0002-5287-9016; Talmud, Philippa/0000-0002-5560-1933; Ferrieres, Jean/0000-0001-6144-1297; Rothenbacher, Dietrich/0000-0002-3563-2791; Jorgensen, Torben/0000-0001-9453-2830; Ruiz-Narvaez, Edward/0000-0002-0339-5824	British Heart Foundation; UK Medical Research Council; Novartis; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [MC_U137686857, G0701863, MC_U105260792, G0801566, G0501792] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/08/008/25291, RG/08/013/25942] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [MC_U105260792, G0801566, G0401527, G0600705, MC_U137686857, G0501792, G0701863] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The coordinating centre was supported by the British Heart Foundation, the UK Medical Research Council, and Novartis. A variety of sources have supported investigators, recruitment, follow-up, and laboratory measurements in the studies contributing to this report. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://www.phpc.cam.ac.uk/ceu/. S Shah assisted with provision of tabular data.	Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Barter P, 2008, AM J CARDIOL, V102, P1040, DOI 10.1016/j.amjcard.2008.05.056; Brunzell JD, 2007, NEW ENGL J MED, V357, P1009, DOI 10.1056/NEJMcp070061; Cardona F, 2009, ATHEROSCLEROSIS, V206, P148, DOI 10.1016/j.atherosclerosis.2009.02.024; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; *EM RISK FACT COLL, INT J EPIDE IN PRESS; Gaddi A, 2007, VASC HEALTH RISK MAN, V3, P877; Garg A, 2007, J CLIN ENDOCR METAB, V92, P1581, DOI 10.1210/jc.2007-0275; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Hegele RA, 2007, ARTERIOSCL THROM VAS, V27, P1224, DOI 10.1161/ATVBAHA.107.144980; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hubacek JA, 2009, PHARMACOGENOMICS, V10, P945, DOI 10.2217/PGS.09.17; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Joy TR, 2008, NAT CLIN PRACT CARD, V5, P506, DOI 10.1038/ncpcardio1251; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Matsuda D, 2007, CURR OPIN INVEST DR, V8, P836; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.M411412200; Nilsson SK, 2008, J BIOL CHEM, V283, P25920, DOI 10.1074/jbc.M802721200; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Palmen J, 2008, BBA-MOL BASIS DIS, V1782, P447, DOI 10.1016/j.bbadis.2008.03.003; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Preiss D, 2009, CLIN ENDOCRINOL, V70, P815, DOI 10.1111/j.1365-2265.2008.03490.x; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SMITH GD, 2008, ANN MED, V12, P524; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wong K, 2007, CURR OPIN LIPIDOL, V18, P319, DOI 10.1097/MOL.0b013e328133856c; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530	36	517	524	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1634	1639						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452521	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000277734700029
J	McPherson, R				McPherson, Ruth			Chromosome 9p21 and Coronary Artery Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK		Univ Ottawa, Inst Heart, Atherogenom Lab, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	McPherson, R (corresponding author), Univ Ottawa, Inst Heart, Atherogenom Lab, Ottawa, ON, Canada.							Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801	5	55	54	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1736	1737		10.1056/NEJMcibr1002359	http://dx.doi.org/10.1056/NEJMcibr1002359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445187				2022-12-28	WOS:000277311200014
J	Perfettini, H; Avouac, JP; Tavera, H; Kositsky, A; Nocquet, JM; Bondoux, F; Chlieh, M; Sladen, A; Audin, L; Farber, DL; Soler, P				Perfettini, Hugo; Avouac, Jean-Philippe; Tavera, Hernando; Kositsky, Andrew; Nocquet, Jean-Mathieu; Bondoux, Francis; Chlieh, Mohamed; Sladen, Anthony; Audin, Laurence; Farber, Daniel L.; Soler, Pierre			Seismic and aseismic slip on the Central Peru megathrust	NATURE			English	Article							STRAIN ACCUMULATION; EARTHQUAKE; DEFORMATION; LOCKING	Slip on a subduction megathrust can be seismic or aseismic, with the two modes of slip complementing each other in time and space to accommodate the long-term plate motions. Although slip is almost purely aseismic at depths greater than about 40 km, heterogeneous surface strain(1-8) suggests that both modes of slip occur at shallower depths, with aseismic slip resulting from steady or transient creep in the interseismic and postseismic periods(9-11). Thus, active faults seem to comprise areas that slip mostly during earthquakes, and areas that mostly slip aseismically. The size, location and frequency of earthquakes that a megathrust can generate thus depend on where and when aseismic creep is taking place, and what fraction of the long-term slip rate it accounts for. Here we address this issue by focusing on the central Peru megathrust. We show that the Pisco earthquake, with moment magnitude M-w = 8.0, ruptured two asperities within a patch that had remained locked in the interseismic period, and triggered aseismic frictional afterslip on two adjacent patches. The most prominent patch of afterslip coincides with the subducting Nazca ridge, an area also characterized by low interseismic coupling, which seems to have repeatedly acted as a barrier to seismic rupture propagation in the past. The seismogenic portion of the megathrust thus appears to be composed of interfingering rate-weakening and rate-strengthening patches. The rate-strengthening patches contribute to a high proportion of aseismic slip, and determine the extent and frequency of large interplate earthquakes. Aseismic slip accounts for as much as 50-70% of the slip budget on the seismogenic portion of the megathrust in central Peru, and the return period of earthquakes with M-w = 8.0 in the Pisco area is estimated to be 250 years.	[Perfettini, Hugo; Bondoux, Francis; Chlieh, Mohamed; Audin, Laurence; Soler, Pierre] Inst Rech Dev, F-13572 Marseille 02, France; [Perfettini, Hugo; Tavera, Hernando; Bondoux, Francis; Audin, Laurence] Inst Geofis Peru, Lima, Peru; [Avouac, Jean-Philippe; Kositsky, Andrew; Sladen, Anthony] CALTECH, Div Geol & Planetary Sci, Tecton Observ, Pasadena, CA 91125 USA; [Nocquet, Jean-Mathieu; Chlieh, Mohamed] GeoAzur, F-06560 Valbonne, France; [Farber, Daniel L.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Perfettini, Hugo; Bondoux, Francis] Univ Grenoble 1, CNRS, Observ Sci, Lab Geophys Interne & Tectonophys,LCPC,IRD, F-38041 Grenoble 9, France; [Perfettini, Hugo; Audin, Laurence] Univ Toulouse 3, CNRS, Observ Midi Pyrenees, Lab Mecanismes Transfert Geol,IRD, F-31400 Toulouse, France; [Farber, Daniel L.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Kositsky, Andrew] Ashima Res, Pasadena, CA 91106 USA	Institut de Recherche pour le Developpement (IRD); California Institute of Technology; UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of California System; University of California Santa Cruz; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Gustave-Eiffel; Laboratoire Central des Ponts et Chaussees (LCPC); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Perfettini, H (corresponding author), Inst Rech Dev, 44 Blvd Dunkerque, F-13572 Marseille 02, France.	hugo.perfettini@ird.fr	Farber, Daniel L/F-9237-2011; Sladen, Anthony/A-2532-2017; CHLIEH, Mohamed/GLR-8359-2022; Avouac, Jean-Philippe/B-5699-2015; Laurence, Audin/D-7727-2013; Tavera, Hernando/I-5487-2013	Sladen, Anthony/0000-0003-4126-0020; Avouac, Jean-Philippe/0000-0002-3060-8442; Laurence, Audin/0000-0002-4510-479X; Nocquet, Jean-Mathieu/0000-0002-3436-9354; Chlieh, Mohamed/0000-0003-2252-2187	Institute de Recherche pour le Developpement; Gordon and Betty Moore Foundation; National Science Foundation [EAR-0838495]	Institute de Recherche pour le Developpement; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF))	We thank J. Freymueller and R. Burgmann for reviews that have helped improve this manuscript. We are grateful to A. Copley for help in editing the manuscript. This study has benefited from support from the Institute de Recherche pour le Developpement, the Gordon and Betty Moore Foundation through the Tectonics Observatory, and the National Science Foundation through grant EAR-0838495.	Baba T, 2006, EARTH PLANET SC LETT, V241, P281, DOI 10.1016/j.epsl.2005.10.019; Benioff H., 1951, B SEISMOL SOC AM, V41, P31, DOI [10.1785/BSSA0410010031, DOI 10.1785/BSSA0410010031]; Bevis M, 2001, GEOCHEM GEOPHY GEOSY, V2; Bilek SL, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003039; Burgmann R, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003648; Chlieh M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004981; DORBATH L, 1990, B SEISMOL SOC AM, V80, P551; Freed AM, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003894; Freymueller JT, 1999, GEOPHYS RES LETT, V26, P3233, DOI 10.1029/1999GL008356; Gagnon K, 2005, NATURE, V434, P205, DOI 10.1038/nature03412; Hearn EH, 2002, B SEISMOL SOC AM, V92, P172, DOI 10.1785/0120000832; Hirose H, 1999, GEOPHYS RES LETT, V26, P3237, DOI 10.1029/1999GL010999; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Igarashi T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001920; Johnson KM, 2006, B SEISMOL SOC AM, V96, pS321, DOI 10.1785/0120050808; Kositsky AP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006535; LANGER CJ, 1995, B SEISMOL SOC AM, V85, P665; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Mazzotti S, 2000, J GEOPHYS RES-SOL EA, V105, P13159, DOI 10.1029/2000JB900060; Miyata N, 2004, BIOMATERIALS, V25, P1, DOI 10.1016/S0142-9612(03)00463-0; Moreno MS, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002198; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Perfettini H, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003522; Perfettini H, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002488; Pritchard ME, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004294; Savage JC, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005723; SAVAGE JC, 1983, J GEOPHYS RES, V88, P4984, DOI 10.1029/JB088iB06p04984; Sladen A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006429; Suwa Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003203	29	194	199	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					78	81		10.1038/nature09062	http://dx.doi.org/10.1038/nature09062			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445628				2022-12-28	WOS:000277311900034
J	Poteryaev, D; Datta, S; Ackema, K; Zerial, M; Spang, A				Poteryaev, Dmitry; Datta, Sunando; Ackema, Karin; Zerial, Marino; Spang, Anne			Identification of the Switch in Early-to-Late Endosome Transition	CELL			English	Article							CAENORHABDITIS-ELEGANS; YEAST; PROTEINS; COMPLEX; RABEX-5; SPECIFICITY; ENDOCYTOSIS; MATURATION; CASCADE; VPS21	Sequential transport from early to late endosomes requires the coordinated activities of the small GTPases Rab5 and Rab7. The transition between early and late endosomes could be mediated either through transport carriers or by Rab conversion, a process in which the loss of Rab5 from an endosome occurs concomitantly to the acquisition of Rab7. We demonstrate that Rab conversion is the mechanism by which proteins pass from early to late endosomes in Caenorhabditis elegans coelomocytes. Moreover, we identified SAND-1/Mon1 as the critical switch for Rab conversion in metazoa. SAND-1 serves a dual role in this process. First, it interrupts the positive feedback loop of RAB-5 activation by displacing RABX-5 from endosomal membranes; second, it times the recruitment of RAB-7, probably through interaction with the HOPS complex to the same membranes. SAND-1/Mon1 thus acts as a switch by controlling the localization of RAB-5 and RAB-7 GEFs.	[Poteryaev, Dmitry; Ackema, Karin; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Datta, Sunando; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Basel; Max Planck Society	Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203; Poteryaev, Dmitry/0000-0003-2695-8869	University Basel; Swiss National Science Foundation; Max Planck Society	University Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank H. Fares, N. Andrews, and J. Hegemann for reagents and I.G. Macara and M. Labouesse for critical reading of the manuscript. L. Bermudo and I. G. Macara are acknowledged for fruitful discussions, and B. Grant is thanked for providing information about the RABX-5 ORF. This work was supported by the University Basel, the Swiss National Science Foundation (A.S.), and the Max Planck Society (M.Z.).	Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; BRENNER S, 1974, GENETICS, V77, P71; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Golemis E A, 1997, Methods Mol Biol, V63, P197; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606; Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Seachrist JL, 2000, J BIOL CHEM, V275, P27221; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200; Xiao QF, 2009, ELECTRON J LINEAR AL, V18, P21; Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	32	449	469	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					497	508		10.1016/j.cell.2010.03.011	http://dx.doi.org/10.1016/j.cell.2010.03.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434987	Bronze			2022-12-28	WOS:000277180800020
J	Putterman, L				Putterman, Louis			Cooperation and Punishment	SCIENCE			English	Editorial Material									Brown Univ, Dept Econ, Providence, RI 02912 USA	Brown University	Putterman, L (corresponding author), Brown Univ, Dept Econ, Providence, RI 02912 USA.	louis_putterman@brown.edu						Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Cinyabuguma M, 2006, EXP ECON, V9, P265, DOI 10.1007/s10683-006-9127-z; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Janssen MA, 2010, SCIENCE, V328, P613, DOI 10.1126/science.1183532; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229	6	6	6	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					578	579		10.1126/science.1189969	http://dx.doi.org/10.1126/science.1189969			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589OJ	20431003				2022-12-28	WOS:000277159800028
J	Sauter, D; Specht, A; Kirchhoff, F				Sauter, Daniel; Specht, Anke; Kirchhoff, Frank			Tetherin: Holding On and Letting Go	CELL			English	Article							PLASMACYTOID DENDRITIC CELLS; INHIBITS HIV-1; INTERFERON-PRODUCTION; VPU PROTEIN; VIRUS; RELEASE; RESTRICTION; NEF; SURFACE; SIV		[Sauter, Daniel; Specht, Anke; Kirchhoff, Frank] Univ Clin Ulm, Inst Mol Virol, D-89081 Ulm, Germany	Ulm University	Kirchhoff, F (corresponding author), Univ Clin Ulm, Inst Mol Virol, Meyerhofstr 1, D-89081 Ulm, Germany.	frank.kirchhoff@uni-ulm.de	Kirchhoff, Frank/O-8367-2018	Kirchhoff, Frank/0000-0002-7052-2360	Deutsche Forschungsgemeinschaft; National Institutes of Health	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Beatrice H. Hahn and Guido Silvestri for helpful comments. The authors are supported by Deutsche Forschungsgemeinschaft and the National Institutes of Health.	Alexander L, 1999, J VIROL, V73, P5814, DOI 10.1128/JVI.73.7.5814-5825.1999; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gummuluru S, 2000, J VIROL, V74, P10882, DOI 10.1128/JVI.74.23.10882-10891.2000; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Haupt S, 2008, J VIROL, V82, P8900, DOI 10.1128/JVI.00196-08; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; HINZ A, 2010, CELL HOST MICROBE, DOI DOI 10.1016/J.CHOM2010.03.005; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; JIA B, 2009, PLOS PATHOG, V5, P429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; Kirchhoff F, 2009, NAT REV MICROBIOL, V7, P467, DOI 10.1038/nrmicro2111; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Mansouri M, 2009, J VIROL, V83, P9672, DOI 10.1128/JVI.00597-09; Mauclere P, 1997, AIDS, V11, P445, DOI 10.1097/00002030-199704000-00007; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Pais-Correia AM, 2010, NAT MED, V16, P83, DOI 10.1038/nm.2065; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schindler M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-1; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Heuverswyn Fran, 2007, Curr Infect Dis Rep, V9, P338, DOI 10.1007/s11908-007-0052-x; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Vendrame D, 2009, J VIROL, V83, P10527, DOI 10.1128/JVI.01235-09; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	56	68	70	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					392	398		10.1016/j.cell.2010.04.022	http://dx.doi.org/10.1016/j.cell.2010.04.022			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434978	Bronze			2022-12-28	WOS:000277180800008
J	Campins, H; Hargrove, K; Pinilla-Alonso, N; Howell, ES; Kelley, MS; Licandro, J; Mothe-Diniz, T; Fernandez, Y; Ziffer, J				Campins, Humberto; Hargrove, Kelsey; Pinilla-Alonso, Noemi; Howell, Ellen S.; Kelley, Michael S.; Licandro, Javier; Mothe-Diniz, T.; Fernandez, Y.; Ziffer, Julie			Water ice and organics on the surface of the asteroid 24 Themis	NATURE			English	Article								It has been suggested(1-3) that Earth's current supply of water was delivered by asteroids, some time after the collision that produced the Moon (which would have vaporized any of the pre-existing water). So far, no measurements of water ice on asteroids(4,5) have been made, but its presence has been inferred from the comet-like activity of several small asteroids, including two members of the Themis dynamical family(6). Here we report infrared spectra of the asteroid 24 Themis which show that ice and organic compounds are not only present on its surface but also prevalent. Infrared spectral differences between it and other asteroids make 24 Themis unique so far, and our identification of ice and organics agrees with independent results(7) that rule out other compounds as possible sources of the observed spectral structure. The widespread presence of surface ice on 24 Themis is somewhat unexpected because of the relatively short lifetime of exposed ice at this distance (similar to 3.2 AU) from the Sun. Nevertheless, there are several plausible sources, such as a subsurface reservoir that brings water to the surface through 'impact gardening' and/or sublimation.	[Campins, Humberto; Hargrove, Kelsey; Fernandez, Y.] Univ Cent Florida, Orlando, FL 32816 USA; [Pinilla-Alonso, Noemi] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Howell, Ellen S.] NAIC Arecibo Observ, Arecibo, PR 00612 USA; [Kelley, Michael S.] Univ Maryland, College Pk, MD 20742 USA; [Licandro, Javier] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Spain; [Mothe-Diniz, T.] Univ Fed Rio de Janeiro, BR-20080090 Rio De Janeiro, RJ, Brazil; [Licandro, Javier] Univ La Laguna, Dept Astrophys, E-38205 San Cristobal la Laguna, Spain; [Ziffer, Julie] Univ So Maine, Dept Phys, Portland, ME 04104 USA	State University System of Florida; University of Central Florida; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Maryland; University of Maryland College Park; Instituto de Astrofisica de Canarias; Universidade Federal do Rio de Janeiro; Universidad de la Laguna; University of Maine System; University of Southern Maine	Campins, H (corresponding author), Univ Cent Florida, POB 162385, Orlando, FL 32816 USA.	campins@physics.ucf.edu	Licandro, Javier/L-7667-2014; Mothe-Diniz, Thais/B-8987-2011; Pinilla-Alonso, Noemi/K-4361-2017	Licandro, Javier/0000-0002-9214-337X; Pinilla-Alonso, Noemi/0000-0002-2770-7896; Fernandez, Yanga/0000-0003-1156-9721; Mothe-Diniz, Thais/0000-0002-2707-5534; Kelley, Michael/0000-0002-6702-7676	NASA; US National Science Foundation; Spanish 'Ministerio de Ciencia e Innovacion'; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	NASA(National Aeronautics & Space Administration (NASA)); US National Science Foundation(National Science Foundation (NSF)); Spanish 'Ministerio de Ciencia e Innovacion'(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	H. C. and K. H. are visiting astronomers at the Infrared Telescope Facility (IRTF), which is operated by the University of Hawaii under cooperative agreement no. NCC 5-538 with NASA. All the observations used in this publication were obtained at the IRTF. H. C. acknowledges support from NASA's Planetary Astronomy programme and from the US National Science Foundation. H. C. was a visiting Fulbright Scholar at the "Instituto de Astrofisica de Canarias'' in Tenerife, Spain, and a visiting astronomer at Observatoire de la Cote d'Azur, Nice, France. J.L. acknowledges support from the Spanish 'Ministerio de Ciencia e Innovacion'. T.M.-D. was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. We benefited from discussions with D. Cruikshank, M. Delbo, P. Michel, A. Morbidelli and T. Roush.	Baldridge AM, 2009, REMOTE SENS ENVIRON, V113, P711, DOI 10.1016/j.rse.2008.11.007; Blanco C, 1998, ASTRON ASTROPHYS SUP, V131, P385, DOI 10.1051/aas:1998277; CLARK RN, 2007, DIGITAL DATA SER US, V231; DRAKE MJ, 2006, ASTEROIDS COMETS MET, P381; HEIKEN GH, 1991, LUNAR SOURCEBOOK USE, P736; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; LEBOFSKY LA, 1975, ICARUS, V25, P205, DOI 10.1016/0019-1035(75)90020-2; LICANDRO J, 2007, B AM ASTRON SOC, V39, P470; McKinnon W. B., 2008, SOLAR SYSTEM NEPTUNE, P213; Milliken RE, 2009, NAT GEOSCI, V2, P258, DOI 10.1038/NGEO478; Mottl MJ, 2007, CHEM ERDE-GEOCHEM, V67, P253, DOI 10.1016/j.chemer.2007.09.002; Nesvorny D, 2008, ASTROPHYS J LETT, V679, pL143, DOI 10.1086/588841; Pieters C., 2004, I SC, V35, P1720; Pinilla-Alonso N, 2009, ASTRON ASTROPHYS, V496, P547, DOI 10.1051/0004-6361/200809733; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; RIVKIN AS, 2008, ASTEROIDS COMETS MET; Schorghofer N, 2008, ASTROPHYS J, V682, P697, DOI 10.1086/588633; Sunshine JM, 2006, SCIENCE, V311, P1453, DOI 10.1126/science.1123632; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938	21	248	249	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1320	1321		10.1038/nature09029	http://dx.doi.org/10.1038/nature09029			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428164				2022-12-28	WOS:000277149000039
J	Rivkin, AS; Emery, JP				Rivkin, Andrew S.; Emery, Joshua P.			Detection of ice and organics on an asteroidal surface	NATURE			English	Article							OPTICAL-CONSTANTS; SPECTROSCOPY; SPECTROGRAPH; TELESCOPE; MODEL; BELT; SPEX	Recent observations, including the discovery(1) in typical asteroidal orbits of objects with cometary characteristics (main-belt comets, or MBCs), have blurred the line between comets and asteroids, although so far neither ice nor organic material has been detected on the surface of an asteroid or directly proven to be an asteroidal constituent. Here we report the spectroscopic detection of water ice and organic material on the asteroid 24 Themis, a detection that has been independently confirmed(2). 24 Themis belongs to the same dynamical family as three of the five known MBCs, and the presence of ice on 24 Themis is strong evidence that it also is present in the MBCs. We conclude that water ice is more common on asteroids than was previously thought and may be widespread in asteroidal interiors at much smaller heliocentric distances than was previously expected.	[Rivkin, Andrew S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Emery, Joshua P.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Tennessee System; University of Tennessee Knoxville	Rivkin, AS (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	andy.rivkin@jhuapl.edu	Rivkin, Andrew S/B-7744-2016	Rivkin, Andrew S/0000-0002-9939-9976	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by the NASA Planetary Astronomy programme. A.S.R. is a visiting astronomer at the IRTF, which is operated by the University of Hawaii under cooperative agreement no. NNX-08AE38A with NASA, Science Mission Directorate, Planetary Astronomy programme. All the observations used in this publication were obtained at the IRTF. We would like to thank the telescope operators of the IRTF for their efforts.	Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; COLANGELI L, 1992, ASTROPHYS J, V396, P369, DOI 10.1086/171723; Cushing MC, 2004, PUBL ASTRON SOC PAC, V116, P362, DOI 10.1086/382907; DORSCHNER J, 1995, ASTRON ASTROPHYS, V300, P503; Emery JP, 2006, ICARUS, V182, P496, DOI 10.1016/j.icarus.2006.01.011; Hsieh HH, 2006, SCIENCE, V312, P561, DOI 10.1126/science.1125150; JONES TD, 1988, THESIS U ARIZONA; KHARE BN, 1993, ICARUS, V103, P290, DOI 10.1006/icar.1993.1071; LEBOFSKY LA, 1986, ICARUS, V68, P239, DOI 10.1016/0019-1035(86)90021-7; Mastrapa RM, 2009, ASTROPHYS J, V701, P1347, DOI 10.1088/0004-637X/701/2/1347; Moroz LV, 1998, ICARUS, V134, P253, DOI 10.1006/icar.1998.5955; Rayner JT, 2003, PUBL ASTRON SOC PAC, V115, P362, DOI 10.1086/367745; Schorghofer N, 2008, ASTROPHYS J, V682, P697, DOI 10.1086/588633; Shkuratov Y, 1999, ICARUS, V137, P235, DOI 10.1006/icar.1998.6035	14	238	240	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1322	1323		10.1038/nature09028	http://dx.doi.org/10.1038/nature09028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428165				2022-12-28	WOS:000277149000040
J	Ahmad, T				Ahmad, Tariq			Nana's Words	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tahmad1@partners.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1577	1578		10.1001/jama.2010.480	http://dx.doi.org/10.1001/jama.2010.480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424238				2022-12-28	WOS:000277085200001
J	Calsbeek, R; Cox, RM				Calsbeek, Ryan; Cox, Robert M.			Experimentally assessing the relative importance of predation and competition as agents of selection	NATURE			English	Article							LIZARD ANOLIS-CAROLINENSIS; NATURAL-POPULATIONS; SEXUAL-DIMORPHISM; ADAPTIVE RADIATION; ISLAND LIZARDS; HABITAT USE; PERFORMANCE; MORPHOLOGY; EVOLUTION; BEHAVIOR	Field experiments that measure natural selection in response to manipulations of the selective regime are extremely rare(1), even in systems where the ecological basis of adaptation has been studied extensively. The adaptive radiation of Caribbean Anolis lizards has been studied for decades(2-5), leading to precise predictions about the influence of alternative agents of selection in the wild. Here we present experimental evidence for the relative importance of two putative agents of selection in shaping the adaptive landscape for a classic island radiation. We manipulated whole-island populations of the brown anole lizard, Anolis sagrei, to measure the relative importance of predation versus competition as agents of natural selection. We excluded or included bird and snake predators across six islands that ranged from low to high population densities of lizards, then measured subsequent differences in behaviour and natural selection in each population. Predators altered the lizards' perching behaviour and increased mortality, but predation treatments did not alter selection on phenotypic traits. By contrast, experimentally increasing population density dramatically increased the strength of viability selection favouring large body size, long relative limb length and high running stamina. Our results from A. sagrei are consistent with the hypothesis(6) that intraspecific competition is more important than predation in shaping the selective landscape for traits central to the adaptive radiation of Anolis ecomorphs.	[Calsbeek, Ryan; Cox, Robert M.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Calsbeek, R (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	ryan.calsbeek@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	National Science Foundation; Dartmouth College	National Science Foundation(National Science Foundation (NSF)); Dartmouth College	We thank T. B. Smith for suggestions about experimental design, and B. Calsbeek and A. Gasc for help with predator manipulations. M. C. Duryea, S. Kuchta, M. Logan, M. Najarro and D. Urbach helped to clarify the manuscript. This research was conducted under permits from The Bahamas Ministry of Agriculture and approval from the Dartmouth College Institutional Animal Care and Use Committee. An award from the National Science Foundation to R. Calsbeek, and funding from Dartmouth College, provided financial support.	Anderson D. R., 2008, MODEL BASED INFERENC; Andrews R.M., 1979, BREVIORA, V454, P1; Butler MA, 2007, NATURE, V447, P202, DOI 10.1038/nature05774; Calsbeek R, 2008, EVOLUTION, V62, P478, DOI 10.1111/j.1558-5646.2007.00282.x; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Calsbeek R, 2007, EVOLUTION, V61, P1052, DOI 10.1111/j.1558-5646.2007.00093.x; Calsbeek R, 2009, J ANIM ECOL, V78, P617, DOI 10.1111/j.1365-2656.2009.01527.x; COX RM, EVOLUTION IN PRESS; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 2005, BIOL J LINN SOC, V85, P223, DOI 10.1111/j.1095-8312.2005.00487.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Langerhans RB, 2006, EVOLUTION, V60, P362; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2004, NATURE, V432, P505, DOI 10.1038/nature03039; Losos JB, 2009, ORGANISM ENVIRON, V10, P1; Losos JB, 2006, SCIENCE, V314, P1111, DOI 10.1126/science.1133584; MAC ARTHUR ROBERT H., 1967; Perry G, 2004, ANIM BEHAV, V67, P37, DOI 10.1016/j.anbehav.2003.02.003; RAND A. STANLEY, 1967, PROC U S NAT MUS, V122, P1; Reznick DN, 2005, INTEGR COMP BIOL, V45, P456, DOI 10.1093/icb/45.3.456; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SCHOENER TW, 1967, SCIENCE, V155, P474, DOI 10.1126/science.155.3761.474; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; SCHOENER TW, 1979, ECOLOGY, V60, P1110, DOI 10.2307/1936958; STAMPS JA, 1994, ANIM BEHAV, V47, P1375, DOI 10.1006/anbe.1994.1185; Williams E.E., 1983, P326	30	104	108	4	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 3	2010	465	7298					613	616		10.1038/nature09020	http://dx.doi.org/10.1038/nature09020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20453837				2022-12-28	WOS:000278249000041
J	Ghebreyesus, TA; Kazatchkine, M; Sidibe, M; Nakatani, H				Ghebreyesus, Tedros Adhanom; Kazatchkine, Michel; Sidibe, Michel; Nakatani, Hiroki			Tuberculosis and HIV: time for an intensified response	LANCET			English	Editorial Material									[Ghebreyesus, Tedros Adhanom] Minist Hlth, Addis Ababa, Ethiopia; [Kazatchkine, Michel] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Sidibe, Michel] Joint UN Programme HIV AIDS, Geneva, Switzerland; [Nakatani, Hiroki] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Ghebreyesus, TA (corresponding author), Minist Hlth, Addis Ababa, Ethiopia.	moh.vmo@ethionet.et						Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; *GLOB FUND FIGHT A, 2008, BUILD SUST RESP HALV; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; UNAIDS, 2009, JOINT ACT RES UNAIDS; *WHO, JOINT TB HIV INT; *WHO, 2009, GLOB TUB CONTR SHORT	7	11	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1757	1758		10.1016/S0140-6736(10)60595-8	http://dx.doi.org/10.1016/S0140-6736(10)60595-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488527				2022-12-28	WOS:000278216500005
J	Lewis, G				Lewis, Glyn			Mental health of UK Afghan and Iraq veterans	LANCET			English	Editorial Material							CARE		Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England	University of Bristol	Lewis, G (corresponding author), Univ Bristol, Dept Community Based Med, Bristol BS6 6JL, Avon, England.	Glyn.Lewis@bristol.ac.uk	Lewis, Glyn/E-9944-2012	Lewis, Glyn/0000-0001-5205-8245				Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Dandeker C, 2010, ARMED FORCES SOC, V36, P264, DOI 10.1177/0095327X09344068; Fear NT, 2010, PREV MED, V50, P282, DOI 10.1016/j.ypmed.2010.03.006; Fear NT, 2010, LANCET, V375, P1783, DOI 10.1016/S0140-6736(10)60672-1; Greenberg, 2009, ADV PSYCHIAT TREATME, V15, P100, DOI [10.1192/apt.bp.107.004713, DOI 10.1192/APT.BP.107.004713]; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hotopf M, 2006, LANCET, V367, P1731, DOI 10.1016/S0140-6736(06)68662-5; Leon DA, 2006, LANCET, V367, P52, DOI 10.1016/S0140-6736(06)67924-5; Prior L, 2003, SOC SCI MED, V56, P2191, DOI 10.1016/S0277-9536(02)00235-6; *U LEIC DEP HLTH S, 2009, AD PSYCH MORB ENGL 2; 2009, DEFENCE NEWS    1125	11	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1758	1760		10.1016/S0140-6736(10)60716-7	http://dx.doi.org/10.1016/S0140-6736(10)60716-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20471077				2022-12-28	WOS:000278216500006
J	Yu, YTN; Yuan, X; Velicer, GJ				Yu, Yuen-Tsu N.; Yuan, Xi; Velicer, Gregory J.			Adaptive Evolution of an sRNA That Controls Myxococcus Development	SCIENCE			English	Article									[Yu, Yuen-Tsu N.; Yuan, Xi; Velicer, Gregory J.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Velicer, GJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	gvelicer@indiana.edu			NIH [GM079690]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Sogaard-Andersen and H.-C. T. Tsui for helpful discussion and C. Fuqua for manuscript suggestions. This work was supported by NIH grant GM079690 to G.J.V.	Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Harris BZ, 1998, GENE DEV, V12, P1022, DOI 10.1101/gad.12.7.1022; Shimkets L.J., 2006, PROKARYOTES, P31, DOI [10.1007/0-387-30747-8_3, DOI 10.1007/0-387-30747-8_3]; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347	5	31	32	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					993	993		10.1126/science.1187200	http://dx.doi.org/10.1126/science.1187200			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489016	Green Accepted			2022-12-28	WOS:000277877100031
J	De Bruin, JL; Baas, AF; Buth, J; Prinssen, M; Verhoeven, ELG; Cuypers, PWM; van Sambeek, MRHM; Balm, R; Grobbee, DE; Blankensteijn, JD				De Bruin, Jorg L.; Baas, Annette F.; Buth, Jaap; Prinssen, Monique; Verhoeven, Eric L. G.; Cuypers, Philippe W. M.; van Sambeek, Marc R. H. M.; Balm, Ron; Grobbee, Diederick E.; Blankensteijn, Jan D.		DREAM Study Grp	Long-Term Outcome of Open or Endovascular Repair of Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL	BACKGROUND For patients with large abdominal aortic aneurysms, randomized trials have shown an initial overall survival benefit for elective endovascular repair over conventional open repair. This survival difference, however, was no longer significant in the second year after the procedure. Information regarding the comparative outcome more than 2 years after surgery is important for clinical decision making. METHODS We conducted a long-term, multicenter, randomized, controlled trial comparing open repair with endovascular repair in 351 patients with an abdominal aortic aneurysm of at least 5 cm in diameter who were considered suitable candidates for both techniques. The primary outcomes were rates of death from any cause and reintervention. Survival was calculated with the use of Kaplan-Meier methods on an intention-to-treat basis. RESULTS We randomly assigned 178 patients to undergo open repair and 173 to undergo endovascular repair. Six years after randomization, the cumulative survival rates were 69.9% for open repair and 68.9% for endovascular repair (difference, 1.0 percentage point; 95% confidence interval [CI], -8.8 to 10.8; P=0.97). The cumulative rates of freedom from secondary interventions were 81.9% for open repair and 70.4% for endovascular repair (difference, 11.5 percentage points; 95% CI, 2.0 to 21.0; P=0.03). CONCLUSIONS Six years after randomization, endovascular and open repair of abdominal aortic aneurysm resulted in similar rates of survival. The rate of secondary interventions was significantly higher for endovascular repair. (ClinicalTrials.gov number, NCT00421330.)	[De Bruin, Jorg L.; Blankensteijn, Jan D.] Vrije Univ Amsterdam Med Ctr, Dept Surg, NL-1007 MB Amsterdam, Netherlands; [Baas, Annette F.; Prinssen, Monique; Grobbee, Diederick E.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Buth, Jaap; Cuypers, Philippe W. M.; van Sambeek, Marc R. H. M.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Verhoeven, Eric L. G.] Univ Groningen, Univ Med Ctr Groingen, Dept Surg, Groningen, Netherlands; [van Sambeek, Marc R. H. M.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Balm, Ron] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Catharina Hospital; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Blankensteijn, JD (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Surg, POB 7057, NL-1007 MB Amsterdam, Netherlands.	j.blankensteijn@vumc.nl	Blankensteijn, Jan D/Q-9291-2016; van Sambeek, marc/CAF-1289-2022; Grobbee, Diederick/C-7651-2014	Blankensteijn, Jan D/0000-0002-2062-8749; Grobbee, Diederick/0000-0003-4472-4468; de Mol, Bastian/0000-0001-6888-9430	Netherlands National Health Insurance Council; Medtronic; Eurostar; William Cook Europe; W. L. Gore; Medtronic and Cardialysis	Netherlands National Health Insurance Council; Medtronic(Medtronic); Eurostar; William Cook Europe; W. L. Gore; Medtronic and Cardialysis	Supported by the Netherlands National Health Insurance Council.; Dr. Buth reports receiving reimbursement for travel and accommodation expenses from Medtronic and Eurostar and payments for manuscript preparation from William Cook Europe, W. L. Gore, and Medtronic; Dr. Verhoeven, receiving payment for expert testimony, development of educational presentations, consulting and lecture fees, grant support, and travel and accommodation expenses from William Cook Europe and W. L. Gore and royalties from William Cook Europe; Dr. Cuypers, receiving lecture fees from Medtronic; Dr. van Sambeek, receiving consulting fees from Medtronic and Cardialysis, research support from Medtronic, lecture fees from W. L. Gore, and travel grants from Medtronic and W. L. Gore; Dr. Balm, receiving consulting fees from Medtronic; and Dr. Blankensteijn, receiving consulting fees from Cordis and W. L. Gore. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Becquemin JP, 2009, J VASC SURG, V50, P222, DOI 10.1016/j.jvs.2009.04.074; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Brewster DC, 2006, ANN SURG, V244, P426, DOI 10.1097/01.sla.0000234893.88045.dc; Cao P, 2004, J VASC SURG, V40, P841, DOI 10.1016/j.jvs.2004.08.040; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Cronenwett JL, 2005, LANCET, V365, P2156, DOI 10.1016/S0140-6736(05)66629-9; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Lederle FA, 2005, NEW ENGL J MED, V352, P2443, DOI 10.1056/NEJMe058126; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Leurs LJ, 2007, ARCH SURG-CHICAGO, V142, P33, DOI 10.1001/archsurg.142.1.33; Peterson BG, 2007, J VASC SURG, V45, P885, DOI 10.1016/j.jvs.2007.01.044; Prinssen M, 2002, J CARDIOVASC SURG, V43, P379; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348	15	727	743	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1881	1889		10.1056/NEJMoa0909499	http://dx.doi.org/10.1056/NEJMoa0909499			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20484396	Green Published			2022-12-28	WOS:000277815600006
J	Sud, S; Sud, M; Friedrich, JO; Meade, MO; Ferguson, ND; Wunsch, H; Adhikari, NKJ				Sud, Sachin; Sud, Maneesh; Friedrich, Jan O.; Meade, Maureen O.; Ferguson, Niall D.; Wunsch, Hannah; Adhikari, Neill K. J.			High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							END-EXPIRATORY PRESSURE; CRITICALLY-ILL PATIENTS; CONVENTIONAL MECHANICAL VENTILATION; OPTIMAL PHYSIOLOGICAL APPROACH; 2009 INFLUENZA A(H1N1); TIDAL VOLUME; PROTECTIVE-VENTILATION; RECRUITMENT MANEUVERS; ADULTS; STRATEGY	Objective To determine clinical and physiological effects of high frequency oscillation compared with conventional ventilation in patients with acute lung injury/acute respiratory distress syndrome (ARDS). Design Systematic review and meta-analysis. Data sources Electronic databases to March 2010, conference proceedings, bibliographies, and primary investigators. Study selection Randomised controlled trials of high frequency oscillation compared with conventional ventilation in adults or children with acute lung injury/ARDS. Data selection Three authors independently extracted data on clinical, physiological, and safety outcomes according to a predefined protocol. We contacted investigators of all included studies to clarify methods and obtain additional data. Analyses used random effects models. Results Eight randomised controlled trials (n=419 patients) were included; almost all patients had ARDS. Methodological quality was good. The ratio of partial pressure of oxygen to inspired fraction of oxygen at 24, 48, and 72 hours was 16-24% higher in patients receiving high frequency oscillation. There were no significant differences in oxygenation index because mean airway pressure rose by 22-33% in patients receiving high frequency oscillation (P=0.01). In patients randomised to high frequency oscillation, mortality was significantly reduced (risk ratio 0.77, 95% confidence interval 0.61 to 0.98, P=0.03; six trials, 365 patients, 160 deaths), and treatment failure (refractory hypoxaemia, hypercapnoea, hypotension, or barotrauma) resulting in discontinuation of assigned therapy was less likely (0.67, 0.46 to 0.99, P=0.04; five trials, 337 patients, 73 events). Other risks were similar. There was substantial heterogeneity between trials for physiological (I-2=21-95%) but not clinical (I-2=0%) outcomes. Pooled results were based on few events for most clinical outcomes. Conclusion High frequency oscillation might improve survival and is unlikely to cause harm. As ongoing large multicentre trials will not be completed for several years, these data help clinicians who currently use or are considering this technique for patients with ARDS.	[Friedrich, Jan O.] Univ Toronto, Interdepartmental Div Crit Care, Toronto, ON M5B 1W8, Canada; [Sud, Sachin] Univ Toronto, Toronto Gen Hosp, Interdepartmental Div Crit Care, Crit Care Med Program, Toronto, ON M5G 2N2, Canada; [Sud, Maneesh] Univ Manitoba, Fac Med Brodie Ctr 260, Undergrad Med Off, Winnipeg, MB R3E 3P5, Canada; [Friedrich, Jan O.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Crit Care Dept, Toronto, ON M5B 1W8, Canada; [Friedrich, Jan O.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Med, Toronto, ON M5B 1W8, Canada; [Friedrich, Jan O.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Meade, Maureen O.] McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Meade, Maureen O.] McMaster Univ, Med Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Ferguson, Niall D.] Univ Toronto, Interdepartmental Div Crit Care, Toronto, ON M5G 1X5, Canada; [Ferguson, Niall D.] Univ Hlth Network, Div Respirol, Dept Med, Toronto, ON M5G 1X5, Canada; [Ferguson, Niall D.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Wunsch, Hannah] Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA; [Adhikari, Neill K. J.] Univ Toronto, Interdepartmental Div Crit Care, Toronto, ON M4N 3M5, Canada; [Adhikari, Neill K. J.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Manitoba; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; McMaster University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Columbia University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Friedrich, JO (corresponding author), Univ Toronto, Interdepartmental Div Crit Care, 30 Bond St,4-015 Bond Wing, Toronto, ON M5B 1W8, Canada.	j.friedrich@utoronto.ca	Ferguson, Niall/D-7619-2019	Ferguson, Niall/0000-0002-6213-5264; Friedrich, Jan/0000-0001-7248-2350	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The study received no specific funding. JOF is supported by a Clinician-Scientist award from the Canadian Institutes of Health Research (CIHR). NDF is supported by a CIHR New Investigator Award. CIHR had no involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure. pdf ( available on request from the corresponding author) and declare that all authors had: ( 1) No financial support for the submitted work from anyone other than their employer; (2) No financial relationships with commercial entities that might have an interest in the submitted work; ( 3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; ( 4) The following non-financial interests relevant to the submitted work: MOM and NDF are primary investigators and JOF and NKJA are co-investigators for the ongoing Canadian Institutes of Health Research (CIHR) funded OSCILLATE study. CareFusion (formerly SensorMedics) is providing study oscillators to some of the hospitals involved in the OSCILLATE study for the duration of the study.	*AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55; Albuali WH, 2007, PEDIATR CRIT CARE ME, V8, P324, DOI 10.1097/01.PCC.0000269390.48450.AF; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; *ANZICS H1N1 ECMO, 2009, JAMA-J AM MED ASSOC, V302, P1888; ARNOLD JH, 1994, CRIT CARE MED, V22, P1530, DOI 10.1097/00003246-199422100-00006; Artigas A, 1998, AM J RESP CRIT CARE, V157, P1332, DOI 10.1164/ajrccm.157.4.ats2-98; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bein T, 2007, ANAESTHESIST, V56, P226, DOI 10.1007/s00101-007-1134-8; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bernard GR, 2008, NEW ENGL J MED, V359, P2166, DOI 10.1056/NEJMe0806637; Bollen CW, 2005, CRIT CARE, V9, pR430, DOI 10.1186/cc3737; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; Cartotto R, 2004, BURNS, V30, P453, DOI 10.1016/j.burns.2004.01.015; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; Chan Kenneth P W, 2005, Crit Care Med, V33, pS170, DOI 10.1097/01.CCM.0000155915.97462.80; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Demory D, 2007, CRIT CARE MED, V35, P106, DOI 10.1097/01.CCM.0000251128.60336.FE; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Ferguson ND, 2005, CRIT CARE MED, V33, P479, DOI 10.1097/01.CCM.0000155785.23200.9E; Ferguson ND, 2008, J APPL PHYSIOL, V104, P1230, DOI 10.1152/japplphysiol.01226.2007; Fessler HE, 2007, CRIT CARE MED, V35, P1649, DOI 10.1097/01.CCM.0000269026.40739.2E; Finkielman JD, 2006, BMC EMERG MED, V6, DOI 10.1186/1471-227X-6-2; Fort P, 1997, CRIT CARE MED, V25, P937, DOI 10.1097/00003246-199706000-00008; Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Hager DN, 2007, CRIT CARE MED, V35, P1522, DOI 10.1097/01.CCM.0000266586.04676.55; Hanson James H, 2006, Respir Care Clin N Am, V12, P349; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kacmarek RM, 2008, J APPL PHYSIOL, V104, P1232, DOI 10.1152/japplphysiol.01226.2007a; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Leonet S, 2002, INTENS CARE MED, V28, P576, DOI 10.1007/s00134-002-1274-x; Macaskill P, 2001, STAT MED, V20, P641, DOI 10.1002/sim.698; Meade MO, 2009, AM J RESP CRIT CARE, V179; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Meade MO, 1997, ANN INTERN MED, V127, P531, DOI 10.7326/0003-4819-127-7-199710010-00005; Mehta S, 2004, CHEST, V126, P518, DOI 10.1378/chest.126.2.518; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Mentzelopoulos SD, 2007, INTENS CARE MED, V33, pS142; Mentzelopoulos SD, 2007, CRIT CARE MED, V35, P1500, DOI 10.1097/01.CCM.0000265738.80832.BE; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Miller MP, 2008, CHEST, V134, P969, DOI 10.1378/chest.08-0743; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Muellenbach RM, 2007, INTENS CARE MED, V33, P1423, DOI 10.1007/s00134-007-0708-x; MUSCEDERE JG, 1994, AM J RESP CRIT CARE, V149, P1327, DOI 10.1164/ajrccm.149.5.8173774; Papazian L, 2005, CRIT CARE MED, V33, P2162, DOI 10.1097/01.CCM.0000181298.05474.2B; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Rimensberger PC, 2003, CRIT CARE, V7, P342, DOI 10.1186/cc2327; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Samransamruajkit R, 2005, ASIAN PAC J ALLERGY, V23, P181; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sedeek KA, 2003, ANESTHESIOLOGY, V99, P1102, DOI 10.1097/00000542-200311000-00016; Shah SB, 2004, INTENS CARE MED, V30, pS84; Slutsky AS, 2009, JAMA-J AM MED ASSOC, V302, P2030, DOI 10.1001/jama.2009.1653; Slutsky AS, 2002, NEW ENGL J MED, V347, P630, DOI 10.1056/NEJMp020082; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; Sud S, 2008, CRIT CARE MED, V36, P2711, DOI 10.1097/CCM.0b013e3181846fc0; Sud S, 2007, CRIT CARE MED, V35, pA225; Sud S, 2010, INTENS CARE MED, V36, P585, DOI 10.1007/s00134-009-1748-1; Taccone P, 2009, JAMA-J AM MED ASSOC, V302, P1977, DOI 10.1001/jama.2009.1614; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wunsch H, 2004, COCHRANE DB SYST REV	73	158	177	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2010	340								c2327	10.1136/bmj.c2327	http://dx.doi.org/10.1136/bmj.c2327			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LR	20483951	hybrid			2022-12-28	WOS:000278061500006
J	Del Romero, J; Castilla, J; Hernando, V; Rodriguez, C; Garcia, S				Del Romero, Jorge; Castilla, Jesus; Hernando, Victoria; Rodriguez, Carmen; Garcia, Soledad			Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VIRAL LOAD; SEXUAL TRANSMISSION; COITAL ACT; THERAPY; INFECTION; VIREMIA; PROBABILITY; PLASMA; RAKAI; RISK	Objective To estimate the risk and probability of heterosexual transmission of HIV-1 from infected people taking combined antiretroviral treatment. Design Cross sectional and prospective cohort studies. Setting HIV clinic in Madrid, Spain. Participants Stable heterosexual couples with one partner with HIV-1 infection (index partner) and the other reporting this sexual relationship as the only risk exposure. Main outcome measures HIV seroprevalence in non-index partners at enrolment and seroconversions in follow-up according to antiretroviral treatment taken by the index partner. Results In 476 couples in which the index partner was not taking antiretroviral treatment, HIV seroprevalence at enrolment in non-index partners was 9.2% (n=44), whereas in 149 couples in which the index partner was taking combined antiretroviral therapy no partner was infected (P<0.001). During follow-up, the 341 serodiscordant couples in which the index partner was not taking antiretroviral treatment had about 11 000 acts of intercourse without condoms, 50 natural pregnancies, and five HIV seroconversions (0.0004 per unprotected intercourse; 95% confidence interval 0.0001 to 0.0010); 294 of these couples always used condoms, accounting for about 42 000 acts of intercourse, 136 risk exposures from condom failure, and one HIV seroconversion. The relative risk associated with condom use was 0.07 (0.01 to 0.58). In 144 couples the index partner was taking combined antiretroviral treatment; they accounted for over 7000 unprotected acts of intercourse and 47 natural pregnancies but no HIV seroconversion (0 to 0.0005 per unprotected intercourse). Conclusions The heterosexual infectivity of HIV-1 in individuals taking effective antiretroviral treatment is low. Avoidance of unprotected intercourse and receipt of antiretroviral treatment by the infected partner in accordance with protocols are complementary measures to prevent HIV transmission.	[Del Romero, Jorge; Rodriguez, Carmen; Garcia, Soledad] Ctr Sanitario Sandoval, Comunidad De Madrid, Spain; [Castilla, Jesus] CIBER Epidemiol & Salud Publ, Inst Salud Publ Navarra, Pamplona, Spain; [Hernando, Victoria] CIBER Epidemiol & Salud Publ, Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Del Romero, J (corresponding author), Ctr Sanitario Sandoval, Comunidad De Madrid, Spain.	jorgedelromero@gmail.com	Castilla, Jesus/B-9048-2008; Hernando, Victoria/E-1740-2015	Castilla, Jesus/0000-0002-6396-7265; Hernando, Victoria/0000-0003-2762-4924	FIPSE [24324/02]; Instituto de Salud Carlos III	FIPSE; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Funding: This study was supported by a grant from FIPSE (foundation formed by the Spanish Ministry of Health and Consumer Affairs, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme, and Roche; No 24324/02) and by the Spanish Network for Research on AIDS (RIS), which is funded by the Instituto de Salud Carlos III. The authors affirm the independence of the researchers from the funders.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Carpenter CCJ, 1998, JAMA-J AM MED ASSOC, V280, P78, DOI 10.1001/jama.280.1.78; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; De Cock KM, 2009, LANCET, V373, P7, DOI 10.1016/S0140-6736(08)61732-8; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Di Mascio M, 2003, J VIROL, V77, P12165, DOI 10.1128/JVI.77.22.12165-12172.2003; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Sadiq ST, 2002, AIDS, V16, P219, DOI 10.1097/00002030-200201250-00011; SARACCO A, 1993, J ACQ IMMUN DEF SYND, V6, P497; Shiboski SC, 1998, J ACQ IMMUN DEF SYND, V19, P527, DOI 10.1097/00042560-199812150-00013; Sturmer M, 2008, ANTIVIR THER, V13, P729; van Sighem A, 2008, JAIDS-J ACQ IMM DEF, V48, P104, DOI 10.1097/QAI.0b013e31816a1d4f; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	30	127	128	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2010	340								c2205	10.1136/bmj.c2205	http://dx.doi.org/10.1136/bmj.c2205			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HS	20472675	Green Published, hybrid			2022-12-28	WOS:000277826600002
J	Gu, HZ; Chao, J; Xiao, SJ; Seeman, NC				Gu, Hongzhou; Chao, Jie; Xiao, Shou-Jun; Seeman, Nadrian C.			A proximity-based programmable DNA nanoscale assembly line	NATURE			English	Article							NANOTECHNOLOGY; CHEMISTRY; SUBSTRATE; COHESION; MACHINE; DEVICE; MOTOR; TILES; WILL	Our ability to synthesize nanometre-scale chemical species, such as nanoparticles with desired shapes and compositions, offers the exciting prospect of generating new functional materials and devices by combining them in a controlled fashion into larger structures. Self-assembly can achieve this task efficiently, but may be subject to thermodynamic and kinetic limitations: reactants, intermediates and products may collide with each other throughout the assembly time course to produce non-target species instead of target species. An alternative approach to nanoscale assembly uses information-containing molecules such as DNA(1) to control interactions and thereby minimize unwanted cross-talk between different components. In principle, this method should allow the stepwise and programmed construction of target products by linking individually selected nanoscale components-much as an automobile is built on an assembly line. Here we demonstrate that a nanoscale assembly line can be realized by the judicious combination of three known DNA-based modules: a DNA origami(2) tile that provides a framework and track for the assembly process, cassettes containing three independently controlled two-state DNA machines that serve as programmable cargo-donating devices(3,4) and are attached(4,5) in series to the tile, and a DNA walker that can move on the track from device to device and collect cargo. As the walker traverses the pathway prescribed by the origami tile track, it sequentially encounters the three DNA devices, each of which can be independently switched between an 'ON' state, allowing its cargo to be transferred to the walker, and an 'OFF' state, in which no transfer occurs. We use three different types of gold nanoparticle species as cargo and show that the experimental system does indeed allow the controlled fabrication of the eight different products that can be obtained with three two-state devices.	[Gu, Hongzhou; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Chao, Jie; Xiao, Shou-Jun] Nanjing Univ, State Key Lab Coordinat Chem, Sch Chem & Chem Engn, Nanjing Natl Lab Microstruct, Nanjing 210093, Peoples R China	New York University; Nanjing University	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	ned.seeman@nyu.edu	Chao, Jie/G-3157-2017; Xiao, Shou-Jun/K-7718-2012; Gu, Hongzhou/H-5308-2011	Chao, Jie/0000-0003-1030-9944; Gu, Hongzhou/0000-0001-5058-4815	US National Institute of General Medical Sciences [GM-29544]; US National Science Foundation [CTS-0608889, CCF-0726378]; US Army Research Office [48681-EL, W911NF-07-1-0439]; US Office of Naval Research [N000140910181, N000140911118]; W. M. Keck Foundation; National Basic Research Program of China [2007CB925101]; National Natural Science Foundation of China [20721002]; New York University; Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US National Science Foundation(National Science Foundation (NSF)); US Army Research Office; US Office of Naval Research(Office of Naval Research); W. M. Keck Foundation(W.M. Keck Foundation); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New York University; Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Canary, H. Yan, C. Mao and R. Sha for comments on this manuscript. This research has been supported by the following grants: GM-29544 from the US National Institute of General Medical Sciences, CTS-0608889 and CCF-0726378 from the US National Science Foundation, 48681-EL and W911NF-07-1-0439 from the US Army Research Office, N000140910181 and N000140911118 from the US Office of Naval Research and a grant from the W. M. Keck Foundation (to N.C.S.); and 2007CB925101 from the National Basic Research Program of China and 20721002 from the National Natural Science Foundation of China (to S.-J.X.). H. G. thanks New York University for a Dissertation Fellowship and J. C. thanks the Chinese Scholarship Council for a research fellowship.	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Bath J, 2009, SMALL, V5, P1513, DOI 10.1002/smll.200900078; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Constantinou PE, 2006, ORG BIOMOL CHEM, V4, P3414, DOI 10.1039/b605212f; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Ding BQ, 2004, J AM CHEM SOC, V126, P10230, DOI 10.1021/ja047486u; Drexler KE, 2001, SCI AM, V285, P74, DOI 10.1038/scientificamerican0901-74; Gartner ZJ, 2002, J AM CHEM SOC, V124, P10304, DOI 10.1021/ja027307d; Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/NNANO.2009.5, 10.1038/nnano.2009.5]; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Liu D, 2004, J AM CHEM SOC, V126, P2324, DOI 10.1021/ja031754r; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Sherman WB, 2004, NANO LETT, V4, P1203, DOI 10.1021/nl049527q; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Smalley RE, 2001, SCI AM, V285, P76, DOI 10.1038/scientificamerican0901-76; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	21	584	601	12	548	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					202	U86		10.1038/nature09026	http://dx.doi.org/10.1038/nature09026			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463734	Green Accepted			2022-12-28	WOS:000277558500031
J	Hoffman, J; Earle, S				Hoffman, Jascha; Earle, Sylvia			Q&A: Sylvia Earle on protecting our seas	NATURE			English	Editorial Material												jascha@jaschahoffman.com							0	1	1	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					165	165		10.1038/465165a	http://dx.doi.org/10.1038/465165a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	594SS	20463723	Bronze			2022-12-28	WOS:000277558500019
J	Ashley, EA; Butte, AJ; Wheeler, MT; Chen, R; Klein, TE; Dewey, FE; Dudley, JT; Ormond, KE; Pavlovic, A; Morgan, AA; Pushkarev, D; Neff, NF; Hudgins, L; Gong, L; Hodges, LM; Berlin, DS; Thorn, CF; Sangkuhl, K; Hebert, JM; Woon, M; Sagreiya, H; Whaley, R; Knowles, JW; Chou, MF; Thakuria, JV; Rosenbaum, AM; Zaranek, AW; Church, GM; Greely, HT; Quake, SR; Altman, RB				Ashley, Euan A.; Butte, Atul J.; Wheeler, Matthew T.; Chen, Rong; Klein, Teri E.; Dewey, Frederick E.; Dudley, Joel T.; Ormond, Kelly E.; Pavlovic, Aleksandra; Morgan, Alexander A.; Pushkarev, Dmitry; Neff, Norma F.; Hudgins, Louanne; Gong, Li; Hodges, Laura M.; Berlin, Dorit S.; Thorn, Caroline F.; Sangkuhl, Katrin; Hebert, Joan M.; Woon, Mark; Sagreiya, Hersh; Whaley, Ryan; Knowles, Joshua W.; Chou, Michael F.; Thakuria, Joseph V.; Rosenbaum, Abraham M.; Zaranek, Alexander Wait; Church, George M.; Greely, Henry T.; Quake, Stephen R.; Altman, Russ B.			Clinical assessment incorporating a personal genome	LANCET			English	Article							HYPERTROPHIC CARDIOMYOPATHY; GENE; POLYMORPHISMS; MUTATIONS; ASSOCIATION; VARIANTS; DATABASE; GENOTYPE; APOLIPOPROTEIN(A); IDENTIFICATION	Background The cost of genomic information has fallen steeply, but the clinical translation of genetic risk estimates remains unclear. We aimed to undertake an integrated analysis of a complete human genome in a clinical context. Methods We assessed a patient with a family history of vascular disease and early sudden death. Clinical assessment included analysis of this patient's full genome sequence, risk prediction for coronary artery disease, screening for causes of sudden cardiac death, and genetic counselling. Genetic analysis included the development of novel methods for the integration of whole genome and clinical risk. Disease and risk analysis focused on prediction of genetic risk of variants associated with mendelian disease, recognised drug responses, and pathogenicity for novel variants. We queried disease-specific mutation databases and pharmacogenomics databases to identify genes and mutations with known associations with disease and drug response. We estimated post-test probabilities of disease by applying likelihood ratios derived from integration of multiple common variants to age-appropriate and sex-appropriate pretest probabilities. We also accounted for gene-environment interactions and conditionally dependent risks. Findings Analysis of 2.6 million single nucleotide polymorphisms and 752 copy number variations showed increased genetic risk for myocardial infarction, type 2 diabetes, and some cancers. We discovered rare variants in three genes that are clinically associated with sudden cardiac death-TMEM43, DSP, and MYBPC3. A variant in LPA was consistent with a family history of coronary artery disease. The patient had a heterozygous null mutation in CYP2C19 suggesting probable clopidogrel resistance, several variants associated with a positive response to lipid-lowering therapy, and variants in CYP4F2 and VKORC1 that suggest he might have a low initial dosing requirement for warfarin. Many variants of uncertain importance were reported. Interpretation Although challenges remain, our results suggest that whole-genome sequencing can yield useful and clinically relevant information for individual patients.	[Ashley, Euan A.; Wheeler, Matthew T.; Dewey, Frederick E.; Pavlovic, Aleksandra; Knowles, Joshua W.] Stanford Univ, Sch Med, Div Cardiovasc Med, Ctr Inherited Cardiovasc Dis, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.; Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Hudgins, Louanne] Stanford Univ, Sch Med, Div Med Genet, Stanford, CA 94305 USA; [Butte, Atul J.; Chen, Rong; Dudley, Joel T.; Morgan, Alexander A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Pushkarev, Dmitry; Neff, Norma F.; Quake, Stephen R.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Klein, Teri E.; Ormond, Kelly E.; Gong, Li; Hodges, Laura M.; Berlin, Dorit S.; Thorn, Caroline F.; Sangkuhl, Katrin; Hebert, Joan M.; Woon, Mark; Sagreiya, Hersh; Whaley, Ryan; Altman, Russ B.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Greely, Henry T.] Stanford Univ, Sch Law, Ctr Law & Biosci, Stanford, CA 94305 USA; [Thakuria, Joseph V.] Massachusetts Gen Hosp, Div Clin & Biochem Genet, Boston, MA 02114 USA; [Chou, Michael F.; Thakuria, Joseph V.; Rosenbaum, Abraham M.; Zaranek, Alexander Wait; Church, George M.] Harvard Univ, Dept Genet, Boston, MA 02115 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University	Ashley, EA (corresponding author), Falk Cardiovasc Res Bldg,300 Pasteur Dr, Stanford, CA 94305 USA.	euan@stanford.edu	Ormond, Kelly E/I-5676-2019; Sagreiya, Hersh/Z-1641-2019; Dudley, Joel T/E-9283-2010	Ormond, Kelly E/0000-0002-1033-0818; Thorn, Caroline/0000-0001-5789-5747; church, george/0000-0001-6232-9969; Klein, Teri/0000-0001-5527-6475; Whaley, Ryan/0000-0002-8810-3893; Zaranek, Alexander (Sasha) Wait/0000-0002-0415-9655; Wheeler, Matthew/0000-0001-8721-3022	National Institute of General Medical Sciences; National Heart, Lung And Blood Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; National Library of Medicine, Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL083914, F32HL097462, T32HL094274] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719, U01GM061374, R24GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006511] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung And Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Library of Medicine, Lucile Packard Foundation for Children's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Hewlett Packard Foundation; Breetwor Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding National Institute of General Medical Sciences; National Heart, Lung And Blood Institute; National Human Genome Research Institute; Howard Hughes Medical Institute; National Library of Medicine, Lucile Packard Foundation for Children's Health; Hewlett Packard Foundation; Breetwor Family Foundation.	Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caldwell MD, 2008, BLOOD, V111, P4106, DOI 10.1182/blood-2007-11-122010; CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chasman DI, 2009, ATHEROSCLEROSIS, V203, P371, DOI 10.1016/j.atherosclerosis.2008.07.019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Couvert P, 2008, PHARMACOGENOMICS, V9, P1217, DOI 10.2217/14622416.9.9.1217; CUPPENS H, 1990, HUM GENET, V85, P402, DOI 10.1007/BF02428277; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hymes J, 2001, HUM MUTAT, V18, P375, DOI 10.1002/humu.1208; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Jegga AG, 2007, NUCLEIC ACIDS RES, V35, pD700, DOI 10.1093/nar/gkl826; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; Kamstrup PR, 2008, J CLIN ENDOCR METAB, V93, P3769, DOI 10.1210/jc.2008-0830; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kaye DM, 2003, PHARMACOGENETICS, V13, P379, DOI 10.1097/00008571-200307000-00002; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kivisto KT, 2007, PHARM RES-DORDR, V24, P239, DOI 10.1007/s11095-006-9159-2; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Maron BJ, 2001, J AM COLL CARDIOL, V38, P315, DOI 10.1016/S0735-1097(01)01386-9; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Merner ND, 2008, AM J HUM GENET, V82, P809, DOI 10.1016/j.ajhg.2008.01.010; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Morner S, 2003, J MOL CELL CARDIOL, V35, P841, DOI 10.1016/S0022-2828(03)00146-9; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Pacanowski MA, 2008, CLIN PHARMACOL THER, V84, P715, DOI 10.1038/clpt.2008.139; Perez-Andreu V, 2009, BLOOD, V113, P4977, DOI 10.1182/blood-2008-09-176222; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rau T, 2009, CLIN PHARMACOL THER, V85, P269, DOI 10.1038/clpt.2008.218; Rossi A, 2001, HUM MUTAT, V17, P159, DOI 10.1002/humu.1; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tanaka M, 2004, ANN NY ACAD SCI, V1011, P7, DOI 10.1196/annals.1293.002; Tomatsu S, 2003, P NATL ACAD SCI USA, V100, P15788, DOI 10.1073/pnas.2237037100; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang Z, 2006, CIRC RES, V99, P646, DOI 10.1161/01.RES.0000241482.19382.c6; Yuan HY, 2005, HUM MOL GENET, V14, P1745, DOI 10.1093/hmg/ddi180	54	490	508	1	204	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1525	1535		10.1016/S0140-6736(10)60452-7	http://dx.doi.org/10.1016/S0140-6736(10)60452-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435227	Green Accepted			2022-12-28	WOS:000277655100025
J	Chapple, A; Ziebland, S				Chapple, A.; Ziebland, S.			Viewing the body after bereavement due to a traumatic death: qualitative study in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT; DISASTER	Objective Whether bereaved relatives should be encouraged to view the body after a traumatic death is uncertain. This analysis of narrative interviews interprets people's accounts of why and how they decided whether to view the body and their emotional reactions to this, immediately and at a later stage. Design In depth interviews with qualitative analysis. Participants A maximum variation sample of 80 people bereaved because of suicide or other traumatic death. Setting Most people were interviewed in their homes. Results For those who had the option, decisions about seeing the body varied. Some wanted someone else to identify the body, because they feared how it might look or preferred to remember their relative as they had been in life. Those who had wanted to see the body gave various reasons beyond the need to check identity. Some felt they ought to see the body. Others felt that the body had not lost its social identity, so wanted to make sure the loved one was "being cared for" or to say goodbye. Some people wanted to touch the body, in privacy, but the coroner sometimes allowed this only after the postmortem examination, which made relatives feel that the body had become police property. Seeing the body brought home the reality of death; it could be shocking or distressing, but, in this sample, few who did so said they regretted it. Conclusions Even after a traumatic death, relatives should have the opportunity to view the body, and time to decide which family member, if any, should identify remains. Officials should prepare relatives for what they might see, and explain any legal reasons why the body cannot be touched. Guidelines for professional practice must be sensitive to the needs and preferences of people bereaved by traumatic death. The way that relatives refer to the body can be a strong indication for professionals about whether the person who died retains a social identity for the bereaved.	[Chapple, A.; Ziebland, S.] Univ Oxford, Dept Primary Hlth Care, Headington OX3 7LF, England	University of Oxford	Chapple, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Headington OX3 7LF, England.	Alison.chapple@dphpc.ox.ac.uk		Ziebland, Sue/0000-0002-6496-4859	The Department of Health	The Department of Health	The Department of Health funded the work. The views expressed do not necessarily reflect those of the funder.	[Anonymous], 1991, GRIEF COUNSELING GRI; AWOONORRENNER S, 1992, BRIT MED J, V304, P1566, DOI 10.1136/bmj.304.6841.1566-a; Baglow J. S., 2007, MORTALITY, V12, P223; Blumer H., 1969, SYMB INTERACT; Bogard W., 2008, MORTALITY, V13, P187; COOKE MW, 1992, BRIT MED J, V304, P1207, DOI 10.1136/bmj.304.6836.1207; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dix P, 1998, LANCET, V352, P1061, DOI 10.1016/S0140-6736(98)06491-5; Douglas M., 2003, PURITY DANGER ANAL C, DOI 10.4324/9780203361832; Foltyn J.L., 2008, MORTALITY, V13, P99, DOI [DOI 10.1080/13576270801954351, 10.1080/13576270801954351]; Glaser B.G., 1965, AWARENESS DYING; Green J., 2004, QUALITATIVE METHODS; Hallam E., 1999, BODY DEATH SOCIAL ID; Hallam E., 2001, DEATH MEMORY MAT CUL; Herxheimer A, 2004, NARRATIVE RES HLTH I, P115; Hodgkinson P., 1995, BEREAVEMENT CARE, V14, P2, DOI DOI 10.1080/02682629508657347; HODGKINSON PE, 1993, MED SCI LAW, V33, P197, DOI 10.1177/002580249303300303; Howarth G., 2007, DEATH DYING SOCIOLOG; HOWARTH G, 2000, MORTALITY, V2, P127; MACHIN L, 1982, COMMUNITY CARE, V20, P14; Mowll J, 2007, BEREAVE CARE, V26, P3, DOI 10.1080/02682620708657676; PAUL R, 2001, COMPLICATED GRIEVING; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; SILVERMAN D, 1994, INTERPRETING QUALITA; Silverman P.R., 1996, CONTINUING BONDS NEW; SINGH B, 1981, J NERV MENT DIS, V169, P203, DOI 10.1097/00005053-198104000-00001; Stroebe M., 1996, CONTINUING BONDS NEW, P31; Turner B. S, 2008, BODY SOC; TYE C, 1993, J ADV NURS, V18, P948, DOI 10.1046/j.1365-2648.1993.18060948.x; Valentine C, 2008, BEREAVEMENT NARRATIV; Walter T., 1996, MORTALITY, V1, P7, DOI [10.1080/713685822, DOI 10.1080/713685822]	31	43	43	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2010	340								c2032	10.1136/bmj.c2032	http://dx.doi.org/10.1136/bmj.c2032			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591PP	20435644	Green Published, hybrid			2022-12-28	WOS:000277314400001
J	Fukatsu, T				Fukatsu, Takema			EVOLUTION A Fungal Past to Insect Color	SCIENCE			English	Editorial Material							ENDOSYMBIONT; SYMBIONT		Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Fukatsu, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.	t-fukatsu@aist.go.jp						Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; DEGNAN PH, 2009, ENV MICROBIOL; FUKATSU T, 1994, ZOOL SCI, V11, P613; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Libbrecht R, 2007, J INSECT BEHAV, V20, P25, DOI 10.1007/s10905-006-9055-y; Losey JE, 1997, NATURE, V388, P269, DOI 10.1038/40849; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ruxton GD, 2005, AVOIDING ATTACK EVOL; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Woolfit M, 2009, MOL BIOL EVOL, V26, P367, DOI 10.1093/molbev/msn253	16	10	12	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					574	575		10.1126/science.1190417	http://dx.doi.org/10.1126/science.1190417			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431000				2022-12-28	WOS:000277159800025
J	Qi, SQ; Pang, YX; Hu, Q; Liu, Q; Li, H; Zhou, YL; He, TX; Liang, QL; Liu, YX; Yuan, XQ; Luo, GA; Li, HL; Wang, JW; Yan, N; Shi, YG				Qi, Shiqian; Pang, Yuxuan; Hu, Qi; Liu, Qun; Li, Hua; Zhou, Yulian; He, Tianxi; Liang, Qionglin; Liu, Yexing; Yuan, Xiaoqiu; Luo, Guoan; Li, Huilin; Wang, Jiawei; Yan, Nieng; Shi, Yigong			Crystal Structure of the Caenorhabditis elegans Apoptosome Reveals an Octameric Assembly of CED-4	CELL			English	Article							PROGRAMMED CELL-DEATH; NB-ARC DOMAIN; DISEASE RESISTANCE; CYTOCHROME-C; MEDIATED OLIGOMERIZATION; 3-DIMENSIONAL STRUCTURE; CED-4-CED-9 COMPLEX; NUCLEOTIDE EXCHANGE; DROSOPHILA HOMOLOG; CASPASE ACTIVATION	The CED-4 homo-oligomer or apoptosome is required for initiation of programmed cell death in Caenorhabditis elegans by facilitating autocatalytic activation of the CED-3 caspase zymogen. How the CED-4 apoptosome assembles and activates CED-3 remains enigmatic. Here we report the crystal structure of the complete CED-4 apoptosome and show that it consists of eight CED-4 molecules, organized as a tetramer of an asymmetric dimer via a previously unreported interface among AAA(+) ATPases. These eight CED-4 molecules form a funnel-shaped structure. The mature CED-3 protease is monomeric in solution and forms an active holoenzyme with the CED-4 apoptosome, within which the protease activity of CED-3 is markedly stimulated. Unexpectedly, the octameric CED-4 apoptosome appears to bind only two, not eight, molecules of mature CED-3. The structure of the CED-4 apoptosome reveals shared principles for the NB-ARC family of AAA(+) ATPases and suggests a mechanism for the activation of CED-3.	[Pang, Yuxuan; Hu, Qi; Yuan, Xiaoqiu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane, Beijing 100084, Peoples R China; [Pang, Yuxuan; Hu, Qi; Yuan, Xiaoqiu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Qi, Shiqian; Zhou, Yulian; Liu, Yexing; Shi, Yigong] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Liu, Qun] Brookhaven Natl Lab, New York Struct Biol Ctr, Upton, NY 11973 USA; [Li, Hua; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [He, Tianxi; Liang, Qionglin; Luo, Guoan] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Tsinghua University	Yan, N (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; shi-lab@tsinghua.edu.cn	Liang, Qionglin/A-2407-2011; Liu, Qun/A-8757-2011; Qi, Shiqian/P-9177-2014; Wang, Jiawei/D-1144-2010; Li, Hua/N-6658-2017	Liang, Qionglin/0000-0002-6750-038X; Liu, Qun/0000-0002-1179-290X; Wang, Jiawei/0000-0001-9893-8539; Li, Hua/0000-0002-8786-4295; Qi, Shiqian/0000-0002-7589-8877; Li, Huilin/0000-0001-8085-8928; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801, 2009CB918802]; National Natural Science Foundation of China [30888001]; Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074985] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology; Yuyuan Foundation; Li's Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) and N. Shimizu, S. Baba, and T. Kumasaka at the Spring-8 beamline BL41XU for assistance. This work was supported by funds from the Ministry of Science and Technology (grant # 2009CB918801 and 2009CB918802), Tsinghua University 985 Phase II funds, Project 30888001 supported by National Natural Science Foundation of China, and Beijing Municipal Commissions of Education and Science and Technology. N.Y. acknowledges support from the Yuyuan Foundation and Li's Foundation.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chao Y, 2005, PLOS BIOL, V3, P1079, DOI 10.1371/journal.pbio.0030183; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; del Peso L, 1998, J BIOL CHEM, V273, P33495, DOI 10.1074/jbc.273.50.33495; DeLano W.L, PYMOL MOL GRAPHICS S; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Donepudi M, 2003, MOL CELL, V11, P543, DOI 10.1016/S1097-2765(03)00059-5; Horvitz HR, 2003, CHEMBIOCHEM, V4, P697, DOI 10.1002/cbic.200300614; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; James C, 1997, CURR BIOL, V7, P246, DOI 10.1016/S0960-9822(06)00120-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Moffett P, 2002, EMBO J, V21, P4511, DOI 10.1093/emboj/cdf453; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Neuwald AF, 1999, GENOME RES, V9, P27; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Seshagiri S, 1997, CURR BIOL, V7, P455, DOI 10.1016/S0960-9822(06)00216-8; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Spector MS, 1997, NATURE, V385, P653, DOI 10.1038/385653a0; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wu DY, 1997, SCIENCE, V275, P1126, DOI 10.1126/science.275.5303.1126; Yan N, 2006, J BIOL CHEM, V281, P8667, DOI 10.1074/jbc.M513232200; Yan N, 2006, CELL CYCLE, V5, P31, DOI 10.4161/cc.5.1.2263; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yan NG, 2004, MOL CELL, V15, P999, DOI 10.1016/j.molcel.2004.08.022; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	68	121	130	2	175	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					446	457		10.1016/j.cell.2010.03.017	http://dx.doi.org/10.1016/j.cell.2010.03.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434985	Bronze			2022-12-28	WOS:000277180800016
J	Screen, JA; Simmonds, I				Screen, James A.; Simmonds, Ian			The central role of diminishing sea ice in recent Arctic temperature amplification	NATURE			English	Article							POLAR AMPLIFICATION; VERTICAL STRUCTURE	The rise in Arctic near-surface air temperatures has been almost twice as large as the global average in recent decades(1-3)-a feature known as 'Arctic amplification'. Increased concentrations of atmospheric greenhouse gases have driven Arctic and global average warming(1,4); however, the underlying causes of Arctic amplification remain uncertain. The roles of reductions in snow and sea ice cover(5-7) and changes in atmospheric and oceanic circulation(8-10), cloud cover and water vapour(11,12) are still matters of debate. A better understanding of the processes responsible for the recent amplified warming is essential for assessing the likelihood, and impacts, of future rapid Arctic warming and sea ice loss(13,14). Here we show that the Arctic warming is strongest at the surface during most of the year and is primarily consistent with reductions in sea ice cover. Changes in cloud cover, in contrast, have not contributed strongly to recent warming. Increases in atmospheric water vapour content, partly in response to reduced sea ice cover, may have enhanced warming in the lower part of the atmosphere during summer and early autumn. We conclude that diminishing sea ice has had a leading role in recent Arctic temperature amplification. The findings reinforce suggestions that strong positive ice-temperature feedbacks have emerged in the Arctic(15), increasing the chances of further rapid warming and sea ice loss, and will probably affect polar ecosystems, ice-sheet mass balance and human activities in the Arctic(2).	[Screen, James A.; Simmonds, Ian] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia	University of Melbourne	Screen, JA (corresponding author), Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia.	screenj@unimelb.edu.au	Screen, James/D-7588-2013	Simmonds, Ian/0000-0002-4479-3255; Screen, James/0000-0003-1728-783X	Australian Research Council	Australian Research Council(Australian Research Council)	We thank N. Gillett and R. Graversen for comments on the manuscript. The ERA-Interim data were obtained from the European Centre for Medium-Range Weather Forecasts data server. Parts of this research were supported by funding from the Australian Research Council.	Bitz CM, 2008, NATURE, V455, pE3, DOI 10.1038/nature07258; Boe J, 2009, J CLIMATE, V22, P4682, DOI 10.1175/2009JCLI2885.1; Boe JL, 2009, NAT GEOSCI, V2, P341, DOI 10.1038/NGEO467; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Dee DP, 2009, Q J ROY METEOR SOC, V135, P1830, DOI 10.1002/qj.493; Deser C, 2010, J CLIMATE, V23, P333, DOI 10.1175/2009JCLI3053.1; Francis JA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045011; Gillett NP, 2008, NAT GEOSCI, V1, P750, DOI 10.1038/ngeo338; Grant AN, 2008, NATURE, V455, pE2, DOI 10.1038/nature07257; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Graversen RG, 2009, CLIM DYNAM, V33, P629, DOI 10.1007/s00382-009-0535-6; Higgins ME, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011884; Holland MM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028024; Holland MM, 2003, CLIM DYNAM, V21, P221, DOI 10.1007/s00382-003-0332-6; Intrieri JM, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000439; Kwok R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039035; Lindsay RW, 2009, J CLIMATE, V22, P165, DOI 10.1175/2008JCLI2521.1; Lu JH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040133; Schweiger AJ, 2008, J CLIMATE, V21, P4799, DOI 10.1175/200SJCLI2156.1; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Serreze MC, 2007, SCIENCE, V315, P1533, DOI 10.1126/science.1139426; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Simmonds I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039810; Smedsrud LH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034813; Solomon S., 2007, PHYS SCI BASIS WORKI; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Symon C., 2004, ARCTIC CLIMATE IMPAC; Thorne PW, 2008, NATURE, V455, pE1, DOI 10.1038/nature07256; Winton M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025244	30	1368	1467	29	605	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1334	1337		10.1038/nature09051	http://dx.doi.org/10.1038/nature09051			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428168	Green Submitted			2022-12-28	WOS:000277149000043
J	Gratwohl, A; Baldomero, H; Aljurf, M; Pasquini, MC; Bouzas, LF; Yoshimi, A; Szer, J; Lipton, J; Schwendener, A; Gratwohl, M; Frauendorfer, K; Niederwieser, D; Horowitz, M; Kodera, Y				Gratwohl, Alois; Baldomero, Helen; Aljurf, Mahmoud; Pasquini, Marcelo C.; Bouzas, Luis Fernando; Yoshimi, Ayami; Szer, Jeff; Lipton, Jeff; Schwendener, Alvin; Gratwohl, Michael; Frauendorfer, Karl; Niederwieser, Dietger; Horowitz, Mary; Kodera, Yoshihisa		Worldwide Network Blood & Marrow T	Hematopoietic Stem Cell Transplantation A Global Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYELOID-LEUKEMIA; INTERNATIONAL-BLOOD; THERAPY; EUROPE; DISEASES; DONOR; IMPACT; ADULTS; SCT	Context Hematopoietic stem cell transplantation (HSCT) requires significant infrastructure. Little is known about HSCT use and the factors associated with it on a global level. Objectives To determine current use of HSCT to assess differences in its application and to explore associations of macroeconomic factors with transplant rates on a global level. Design, Setting, and Patients Retrospective survey study of patients receiving allogeneic and autologous HSCTs for 2006 collected by 1327 centers in 71 participating countries of the Worldwide Network for Blood and Marrow Transplantation. The regional areas used herein are (1) the Americas (the corresponding World Health Organization regions are North and South America); (2) Asia (Southeast Asia and the Western Pacific Region, which includes Australia and New Zealand); (3) Europe (includes Turkey and Israel); and (4) the Eastern Mediterranean and Africa. Main Outcome Measures Transplant rates (number of HSCTs per 10 million inhabitants) by indication, donor type, and country; description of main differences in HSCT use; and macroeconomic factors of reporting countries associated with HSCT rates. Results There were 50 417 first HSCTs; 21 516 allogeneic (43%) and 28 901 autologous (57%). The median HSCT rates varied between regions and countries from 48.5 (range, 2.5-505.4) in the Americas, 184 (range, 0.6-488.5) in Asia, 268.9 (range, 5.7-792.1) in Europe, and 47.7 (range, 2.8-95.3) in the Eastern Mediterranean and Africa. No HSCTs were performed in countries with less than 300 000 inhabitants, smaller than 960 km(2), or having less than US $680 gross national income per capita. Use of allogeneic or autologous HSCT, unrelated or family donors for allogeneic HSCT, and proportions of disease indications varied significantly between countries and regions. In linear regression analyses, government health care expenditures (r(2)=77.33), HSCT team density (indicates the number of transplant teams per 1 million inhabitants; r(2)=76.28), human development index (r(2)=74.36), and gross national income per capita (r(2)=74.04) showed the highest associations with HSCT rates. Conclusion Hematopoietic stem cell transplantation is used for a broad spectrum of indications worldwide, but most frequently in countries with higher gross national incomes, higher governmental health care expenditures, and higher team densities. JAMA. 2010; 303(16): 1617-1624	[Gratwohl, Alois; Baldomero, Helen] Univ Basel Hosp, Dept Hematol, European Grp Blood & Marrow Transplantat, Transplant Act Survey Off, CH-4031 Basel, Switzerland; [Aljurf, Mahmoud] King Faisal Specialist Hosp & Res Ctr, Eastern Mediterranean Blood & Marrow Transplant G, Riyadh 11211, Saudi Arabia; [Pasquini, Marcelo C.; Horowitz, Mary] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA; [Bouzas, Luis Fernando] Inst Nacl Canc, Soc Brasileira Transplante Medula Ossea, Rio De Janeiro, Brazil; [Yoshimi, Ayami] Nagoya Univ, Sch Med, Asian Pacific Blood & Marrow Transplant Grp, Ctr Data, Nagoya, Aichi 466, Japan; [Szer, Jeff] Royal Melbourne Hosp, Australian Bone Marrow Transplant Recipient Regis, Parkville, Vic 3050, Australia; [Lipton, Jeff] Princess Margaret Hosp, Canadian Blood & Marrow Transplant Grp, Toronto, ON M4X 1K9, Canada; [Schwendener, Alvin; Gratwohl, Michael; Frauendorfer, Karl] Univ St Gallen, Inst Operat Res & Computat Finance, St Gallen, Switzerland; [Niederwieser, Dietger] Univ Hosp, Dept Hematol Oncol, Leipzig, Germany; [Kodera, Yoshihisa] Aichi Med Univ, Sch Med, Aichi, Japan	University of Basel; King Faisal Specialist Hospital & Research Center; Center for International Blood & Marrow Transplant Research; Medical College of Wisconsin; National Cancer Institute (Inca); Nagoya University; Royal Melbourne Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of St Gallen; Leipzig University; Aichi Medical University	Gratwohl, A (corresponding author), Univ Basel Hosp, Dept Hematol, European Grp Blood & Marrow Transplantat, Transplant Act Survey Off, CH-4031 Basel, Switzerland.	hematology@uhbs.ch	horowitz, Mary/ABH-2173-2021	Szer, Jeff/0000-0001-6783-2301	European Leukaemia Net [LSH-2002-2.2.0-3]; Swiss National Research Foundation [3200B0-118176]; Swiss Cancer League; Regional Cancer League; Horton Foundation; National Cancer Institute [U24-CA76518]; National Heart, Lung, and Blood Institute [5U01HL069294]; National Institute of Allergy and Infectious Diseases; Health Resources and Services Administration [HHSH234200637015C]; Office of Naval Research [N00014-06-1-0704, N00014-08-1-0058]; AABB; Aetna; American Society for Blood and Marrow Transplantation; Amgen Inc; NATIONAL CANCER INSTITUTE [U24CA076518] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069294] Funding Source: NIH RePORTER	European Leukaemia Net; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Regional Cancer League; Horton Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Office of Naval Research(Office of Naval Research); AABB; Aetna; American Society for Blood and Marrow Transplantation; Amgen Inc(Amgen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This work was supported in part by grant LSH-2002-2.2.0-3 from the European Leukaemia Net, by grant 3200B0-118176 from the Swiss National Research Foundation, the Swiss Cancer League, the Regional Cancer League, and the Horton Foundation. The Center for International Blood and Marrow Transplantation is supported by public health service grant/cooperative agreement U24-CA76518 from the National Cancer Institute, the National Heart, Lung, and Blood Institute, and the National Institute of Allergy and Infectious Diseases; by grant/cooperative agreement 5U01HL069294 from the National Heart, Lung, and Blood Institute and the National Cancer Institute; by contract HHSH234200637015C with the Health Resources and Services Administration; by grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and by grants from AABB, Aetna, the American Society for Blood and Marrow Transplantation, Amgen Inc, an anonymous donation to the Medical College of Wisconsin, Astellas Pharma US Inc, Baxter International Inc, Bayer HealthCare Pharmaceuticals, Be the Match Foundation, Biogen IDEC, BioMarin Pharmaceutical Inc, Biovitrum AB, Blood Center of Wisconsin, Blue Cross and Blue Shield Association, Bone Marrow Foundation, Canadian Blood and Marrow Transplant Group, CaridianBCT, Celgene Corporation, CellGenix GmbH, Centers for Disease Control and Prevention, Children's Leukemia Research Association, ClinImmune Labs, CTI Clinical Trial and Consulting Services, Cubist Pharmaceuticals, Cylex Inc, CytoTherm, DOR BioPharma Inc, Dynal Biotech (an Invitrogen company), Eisai Inc, Enzon Pharmaceuticals Inc, the European Group for Blood and Marrow Transplantation, Gamida Cell Ltd, GE Healthcare, Genentech Inc, Genzyme Corporation, Histogenetics Inc, HKS Medical Information Systems, Hospira Inc, Infectious Diseases Society of America, Kiadis Pharma, Kirin Brewery Co Ltd, the Leukemia & Lymphoma Society, Merck & Company, the Medical College of Wisconsin, MGI Pharma Inc, Michigan Community Blood Centers, Millennium Pharmaceuticals Inc, Miller Pharmacal Group, Milliman USA Inc, Miltenyi Biotec Inc, National Marrow Donor Program, Nature Publishing Group, New York Blood Center, Novartis Oncology, Oncology Nursing Society, Osiris Therapeutics Inc, Otsuka America Pharmaceutical Inc, Pall Life Sciences, Pfizer Inc, Saladax Biomedical Inc, Schering Corporation, Society for Healthcare Epidemiology of America, StemCyte Inc, StemSoft Software Inc, Sysmex America Inc, Teva Pharmaceutical Industries, THERAKOS Inc, Thermogenesis Corporation, Vidacare Corporation, Vion Pharmaceuticals Inc, ViraCor Laboratories, ViroPharma Inc, and Wellpoint Inc. The European Group for Blood and Marrow Transplantation is supported by grants from the corporate members Amgen Europe, ViroPharma Europe, Gilead Sciences UK, Miltenyl Biotec GmbH, Schering-Plough, Celegene International SARL, Genzyme, Fresenius Biotech GmbH, Therakos, Bristol-Myers Squibb, Cephalon, F. Hoffmann-La Roche Ltd, Pierre Fabre Medicament, Alexion Europe, Pfizer, Merck Sharp and Dohme, Chugai Sanofi-Aventis, and Novartis.	Aljurf MD, 2009, BONE MARROW TRANSPL, V43, P1, DOI 10.1038/bmt.2008.389; Appelbaum FR, 2007, NEW ENGL J MED, V357, P1472, DOI 10.1056/NEJMp078166; Appelbaum FR, 2008, BEST PRACT RES CL HA, V21, P667, DOI 10.1016/j.beha.2008.06.005; Aubrey P, 2008, TRANSPL P, V40, P1008, DOI 10.1016/j.transproceed.2008.03.059; Barclay E, 2009, LANCET, V373, P883, DOI 10.1016/S0140-6736(09)60529-8; Beeres SLMA, 2008, HEART, V94, P1214, DOI 10.1136/hrt.2008.149476; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Cornelissen JJ, 2007, BLOOD, V109, P3658, DOI 10.1182/blood-2006-06-025627; Daikeler T, 2009, BONE MARROW TRANSPL, V44, P27, DOI 10.1038/bmt.2008.424; Einstein O, 2008, ARCH NEUROL-CHICAGO, V65, P452, DOI 10.1001/archneur.65.4.452; Gajewski JL, 2007, LEUKEMIA, V21, P387, DOI 10.1038/sj.leu.2404534; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Gratwohl A, 2007, LEUKEMIA, V21, P383, DOI 10.1038/sj.leu.2404509; Gratwohl A, 2002, BRIT J HAEMATOL, V117, P451, DOI 10.1046/j.1365-2141.2002.03440.x; GRATWOHL A, 1991, BONE MARROW TRANSPL, V8, P197; Gratwohl A, 2007, HAEMATOLOGICA, V92, P1679, DOI 10.3324/haematol.11260; Gratwohl A, 2009, CANCER-AM CANCER SOC, V115, P4715, DOI 10.1002/cncr.24531; Hegenbart U, 2006, J CLIN ONCOL, V24, P444, DOI 10.1200/JCO.2005.03.1765; Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24; Horowitz MM, 2008, BONE MARROW TRANSPL, V42, pS1, DOI 10.1038/bmt.2008.101; HOROWITZ MM, 2009, HEMATOPOIETIC CELL T, P9; Kodera Y, 2008, BONE MARROW TRANSPL, V42, pS6, DOI 10.1038/bmt.2008.103; Ljungman P, 2006, BONE MARROW TRANSPL, V37, P439, DOI 10.1038/sj.bmt.1705265; Nivison-Smith I, 2007, BIOL BLOOD MARROW TR, V13, P905, DOI 10.1016/j.bbmt.2007.04.003; Novotny NM, 2008, J AM COLL SURGEONS, V207, P423, DOI 10.1016/j.jamcollsurg.2008.04.013; Saito AM, 2008, BIOL BLOOD MARROW TR, V14, P197, DOI 10.1016/j.bbmt.2007.10.010; Sorror M, 2008, CANCER-AM CANCER SOC, V112, P1992, DOI 10.1002/cncr.23375; Swanson RC, 2009, LANCET, V374, P433, DOI 10.1016/S0140-6736(09)61212-5; Tan SS, 2007, EUR J CANCER, V43, P2359, DOI 10.1016/j.ejca.2007.08.020	30	421	436	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1617	1624		10.1001/jama.2010.491	http://dx.doi.org/10.1001/jama.2010.491			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424252	Green Accepted, Bronze			2022-12-28	WOS:000277085200025
J	Flothmann, S; von Kistowski, K; Dolan, E; Lee, E; Meere, F; Album, G				Flothmann, Stefan; von Kistowski, Kristin; Dolan, Emily; Lee, Elsa; Meere, Frank; Album, Gunnar			Closing Loopholes: Getting Illegal Fishing Under Control	SCIENCE			English	Editorial Material							GLOBAL FISHERIES; WORLD FISHERIES; IMPACTS; TRENDS		[Flothmann, Stefan; von Kistowski, Kristin; Lee, Elsa; Meere, Frank] Int Ocean Governance, Pew Environm Grp, Pew Charitable Trusts, Washington, DC 20004 USA; [Dolan, Emily] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium; [Album, Gunnar] Trygg Mat Fdn, Barents Sea Offi, N-8285 Leines, Norway	Ghent University	von Kistowski, K (corresponding author), Int Ocean Governance, Pew Environm Grp, Pew Charitable Trusts, Washington, DC 20004 USA.	kristin@kistowski.de						Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2006, CLOS NET STOPP ILL F; Barnes CT, 2004, FISH PIRACY COMBATIN; CULLISSUZUKI S, MAR POLICY; Delgado CL, 2003, OUTLOOK FISH 2020 M; FAO, 2007, MODEL SCHEME PORT ST; FAO, 2009, STAT WORLD FISH AQ 2; *FAO, 1993, AGR PROM COMPL INT C; FAO, 2009, AGR PORT STAT MEAS P; Gianni Matthew, 2005, CHANGING NATURE HIGH; Gupta A, 2008, GLOBAL ENVIRON POLIT, V8, P1, DOI 10.1162/glep.2008.8.2.1; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Langley Paul, 2001, GLOBAL SOC, V15, P73, DOI DOI 10.1080/13600820123590; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Pauly D, 2005, PHILOS T R SOC B, V360, P5, DOI 10.1098/rstb.2004.1574; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x	22	43	44	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1235	1236		10.1126/science.1190245	http://dx.doi.org/10.1126/science.1190245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	605AC	20488991				2022-12-28	WOS:000278318600018
J	Ercan-Sencicek, AG; Stillman, AA; Ghosh, AK; Bilguvar, K; O'Roak, BJ; Mason, CE; Abbott, T; Gupta, A; King, RA; Pauls, DL; Tischfield, JA; Heiman, GA; Singer, HS; Gilbert, DL; Hoekstra, PJ; Morgan, TM; Loring, E; Yasuno, K; Fernandez, T; Sanders, S; Louvi, A; Cho, JH; Mane, S; Colangelo, CM; Biederer, T; Lifton, RP; Gunel, M; State, MW				Ercan-Sencicek, A. Gulhan; Stillman, Althea A.; Ghosh, Ananda K.; Bilguvar, Kaya; O'Roak, Brian J.; Mason, Christopher E.; Abbott, Thomas; Gupta, Abha; King, Robert A.; Pauls, David L.; Tischfield, Jay A.; Heiman, Gary A.; Singer, Harvey S.; Gilbert, Donald L.; Hoekstra, Pieter J.; Morgan, Thomas M.; Loring, Erin; Yasuno, Katsuhito; Fernandez, Thomas; Sanders, Stephan; Louvi, Angeliki; Cho, Judy H.; Mane, Shrikant; Colangelo, Christopher M.; Biederer, Thomas; Lifton, Richard P.; Gunel, Murat; State, Matthew W.			L-Histidine Decarboxylase and Tourette's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HISTAMINE; MICE; SCHIZOPHRENIA; COGNITION; EFFICACY; GENOME	Tourette's syndrome is a common developmental neuropsychiatric disorder characterized by chronic motor and vocal tics. Despite a strong genetic contribution, inheritance is complex, and risk alleles have proven difficult to identify. Here, we describe an analysis of linkage in a two-generation pedigree leading to the identification of a rare functional mutation in the HDC gene encoding l-histidine decarboxylase, the rate-limiting enzyme in histamine biosynthesis. Our findings, together with previously published data from model systems, point to a role for histaminergic neurotransmission in the mechanism and modulation of Tourette's syndrome and tics.	[State, Matthew W.] Yale Univ, Sch Med, Program Neurogenet, Dept Child Psychiat, New Haven, CT 06520 USA; [Ghosh, Ananda K.; Mason, Christopher E.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [O'Roak, Brian J.] Univ Washington, Seattle, WA 98195 USA; [Pauls, David L.] Harvard Univ, Boston, MA 02115 USA; [Tischfield, Jay A.; Heiman, Gary A.] New Jersey Ctr Tourette Syndrome & Associated Dis, Somerville, NJ USA; [Tischfield, Jay A.; Heiman, Gary A.] Rutgers State Univ, Piscataway, NJ USA; [Singer, Harvey S.] Johns Hopkins Univ, Baltimore, MD USA; [Gilbert, Donald L.] Univ Cincinnati, Sch Med, Cincinnati, OH USA; [Gilbert, Donald L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Hoekstra, Pieter J.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Morgan, Thomas M.] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Yale University; Cornell University; University of Washington; University of Washington Seattle; Harvard University; Rutgers State University New Brunswick; Johns Hopkins University; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Groningen; Vanderbilt University	State, MW (corresponding author), Yale Univ, Sch Med, Program Neurogenet, Dept Child Psychiat, 230 S Frontage Rd, New Haven, CT 06520 USA.	matthew.state@yale.edu	Morgan, Tom/C-3478-2012; Mason, Christopher/HCH-3977-2022; State, Matthew/W-2256-2019; Hoekstra, Pieter/O-4396-2014; Sanders, Stephan/S-8645-2019; Sandor, Paul/I-7211-2016; Heiman, Gary A/K-2366-2018; Sander-Effron, Samuel/AAX-2231-2020; Fernandez, Thomas V/D-4295-2009; Yasuno, Katsuhito/E-1960-2012; Gilbert, Donald L./D-6443-2016; Resource Center, NINDS Human Genetics/AGF-2474-2022; Biederer, Thomas/AAZ-6133-2021	Sandor, Paul/0000-0003-2397-0758; Heiman, Gary A/0000-0001-5859-0259; Fernandez, Thomas V/0000-0003-0830-022X; Yasuno, Katsuhito/0000-0002-3606-532X; Gilbert, Donald L./0000-0002-9245-6878; Biederer, Thomas/0000-0003-0912-1514; Sanders, Stephan/0000-0001-9112-5148; State, Matthew/0000-0003-1624-8302; Colangelo, Christopher/0000-0002-0438-1395; Tischfield, Jay/0000-0003-3217-8287; O'Roak, Brian/0000-0002-4141-0095	National Institute of Neurological Disorders and Stroke, grants [R01 NS43520, NS016648, NS040024]; National Institutes of Health [U24 NS051869-02S1, UL1 RR024139, NCRR UL1 RR024139]; National Institute of Mental Health [U24 MH068457]; Lawrence Family; Overlook International Foundation; Shepherd Fund; New Jersey Center for Tourette Syndrome and Associated Disorders [08-1827-FS-N-0]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026707, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, R01NS040024, R01NS016648, U01NS040024, R01NS043520] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lawrence Family; Overlook International Foundation; Shepherd Fund; New Jersey Center for Tourette Syndrome and Associated Disorders; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants (R01 NS43520, to Drs. State and Louvi; and NS016648 and NS040024, to Dr. Pauls) from the National Institute of Neurological Disorders and Stroke, grants (Neuroscience Micro-array Consortium U24 NS051869-02S1 and UL1 RR024139, to Dr. Mane; and NCRR UL1 RR024139, to Mr. Abbott and Dr. Colangelo) from the National Institutes of Health, and a grant (U24 MH068457, to Drs. Tischfield and Heiman) from the National Institute of Mental Health; additional funding from the Lawrence Family (to Dr. State), the Overlook International Foundation (to Dr. State), and the Shepherd Fund (to Dr. State); and a grant (08-1827-FS-N-0) from the New Jersey Center for Tourette Syndrome and Associated Disorders (through the New Jersey Department of Health and Senior Services).	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Acevedoa SF, 2006, BEHAV BRAIN RES, V168, P92, DOI 10.1016/j.bbr.2005.10.016; Dere E, 2004, EUR J NEUROSCI, V20, P1051, DOI 10.1111/j.1460-9568.2004.03546.x; Fleming JV, 2003, J BIOL CHEM, V278, P686, DOI 10.1074/jbc.M210718200; Fox GB, 2005, INFLAMM RES, V54, pS23, DOI 10.1007/s00011-004-0410-1; Fox GB, 2005, J PHARMACOL EXP THER, V313, P176, DOI 10.1124/jpet.104.078402; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffries KJ, 2002, NEUROPSYCHOPHARMACOL, V27, P92, DOI 10.1016/S0893-133X(01)00428-6; KATAYAMA KYK, 2008, MOL PSYCHIATR, V15, P177; Kubota Y, 2002, J NEUROCHEM, V83, P837, DOI 10.1046/j.1471-4159.2002.01189.x; Leckman JF, 2006, J CHILD NEUROL, V21, P642, DOI 10.1177/08830738060210081001; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Ligneau X, 2007, BIOCHEM PHARMACOL, V73, P1215, DOI 10.1016/j.bcp.2007.01.023; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Ohtsu H, 2003, BIOCHEM BIOPH RES CO, V305, P443, DOI 10.1016/S0006-291X(03)00696-X; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saka E, 2003, BRAIN DEV-JPN, V25, pS15, DOI 10.1016/S0387-7604(03)90002-7; TSIRKA S, 1992, J BIOL CHEM, V267, P23057	20	217	220	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2010	362	20					1901	1908		10.1056/NEJMoa0907006	http://dx.doi.org/10.1056/NEJMoa0907006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598EI	20445167	Green Accepted			2022-12-28	WOS:000277815600008
J	Kupfer, DJ; Regier, DA				Kupfer, David J.; Regier, Darrel A.			Why All of Medicine Should Care About DSM-5	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kupfer, David J.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, Pittsburgh, PA 15213 USA; [Regier, Darrel A.] Amer Psychiat Assoc, Amer Psychiat Inst Res & Educ, Arlington, VA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC	Kupfer, DJ (corresponding author), Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Med Ctr, 3811 OHara St,Room 210, Pittsburgh, PA 15213 USA.	kupferdj@upmc.edu	Regier, Darrel A./HHT-1027-2022					Andrews G, 2009, PSYCHOL MED, V39, P1993, DOI 10.1017/S0033291709990250; Andrews G, 2009, STRESS INDUCED FEAR; [Anonymous], 1996, GLOBAL BURDEN DIS CO; HELZER J, 2007, DIMENSIONAL APPROACH; HOLLANDER E, OBSESSIVE C IN PRESS; Hyman SE, 2007, NAT REV NEUROSCI, V8, P725, DOI 10.1038/nrn2218; Kupfer David J., 2002, RES AGENDA DSM V; Narrow W. E., 2007, AGE GENDER CONSIDERA; Regier DA, 2009, AM J PSYCHIAT, V166, P645, DOI 10.1176/appi.ajp.2009.09020279; Weissman MM, 2010, PSYCHIAT SERV, V61, P151, DOI 10.1176/ps.2010.61.2.151	10	16	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1974	1975		10.1001/jama.2010.646	http://dx.doi.org/10.1001/jama.2010.646			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483976				2022-12-28	WOS:000277764500026
J	Ito, K; Elkin, EB; Girotra, M; Morris, MJ				Ito, Kouta; Elkin, Elena B.; Girotra, Monica; Morris, Michael J.			Cost-Effectiveness of Fracture Prevention in Men Who Receive Androgen Deprivation Therapy for Localized Prostate Cancer	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	45th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)	MAY 29-JUN 02, 2009	Orlando, FL	Amer Soc Clin Oncol			BONE-MINERAL DENSITY; CLINICAL-PRACTICE GUIDELINE; RANDOMIZED CONTROLLED-TRIAL; ZOLEDRONIC ACID; HIP FRACTURE; VERTEBRAL FRACTURES; HORMONE AGONISTS; AMERICAN-COLLEGE; UNITED-STATES; OSTEOPOROSIS	Background: Androgen deprivation therapy (ADT) increases the risk for fractures in patients with prostate cancer. Objective: To assess the cost-effectiveness of measuring bone mineral density (BMD) before initiating ADT followed by alendronate therapy in men with localized prostate cancer. Design: Markov state-transition model simulating the progression of prostate cancer and the incidence of hip fracture. Data Sources: Published literature. Target Population: A hypothetical cohort of men aged 70 years with locally advanced or high-risk localized prostate cancer starting a 2-year course of ADT after radiation therapy. Time Horizon: Lifetime. Perspective: Societal. Intervention: No BMD test or alendronate therapy, a BMD test followed by selective alendronate therapy for patients with osteoporosis, or universal alendronate therapy without a BMD test. Outcome Measures: Incremental cost-effectiveness ratio (ICER), measured by cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: The ICERs for the strategy of a BMD test and selective alendronate therapy for patients with osteoporosis and universal alendronate therapy without a BMD test were $66 800 per QALY gained and $178 700 per QALY gained, respectively. Results of Sensitivity Analyses: The ICER for universal alendronate therapy without a BMD test decreased to $100 000 per QALY gained, assuming older age, a history of fractures, lower mean BMD before ADT, or a lower cost of alendronate. Limitations: No evidence shows that alendronate reduces actual fracture rates in patients with prostate cancer who receive ADT. The model predicted fracture rates by using data on the surrogate BMD end point. Conclusion: In patients starting adjuvant ADT for locally advanced or high-risk localized prostate cancer, a BMD test followed by selective alendronate for those with osteoporosis is a cost-effective use of resources. Routine use of alendronate without a BMD test is justifiable in patients at higher risk for hip fractures.	[Ito, Kouta; Elkin, Elena B.; Girotra, Monica; Morris, Michael J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Ito, K (corresponding author), 1275 York Ave, New York, NY 10065 USA.	itok1@mskcc.org		Morris, Michael J./0000-0002-9454-0096	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alibhai SMH, 2006, UROLOGY, V68, P126, DOI 10.1016/j.urology.2006.01.054; Allain TJ, 2006, GERONTOLOGY, V52, P107, DOI 10.1159/000090956; American Urological Association, 2007, GUID MAN CLIN LOC PR; Arias E, 2007, NATL VITAL STAT REPO, V56; Berruti A, 2002, J UROLOGY, V167, P2361, DOI 10.1016/S0022-5347(05)64985-3; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cadarette SM, 2009, OSTEOPOROSIS INT, V20, P1735, DOI 10.1007/s00198-009-0871-8; *CTR MED MED SERV, PHYS SCHED SEARCH 20; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Daniell HW, 2000, J UROLOGY, V163, P181, DOI 10.1016/S0022-5347(05)68000-7; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; DeLaet CEDH, 1997, BRIT MED J, V315, P221, DOI 10.1136/bmj.315.7102.221; DESHARNAIS CL, 2001, SUPPORT CARE CANCER, V9, P545; Diamond TH, 2004, CANCER-AM CANCER SOC, V100, P892, DOI 10.1002/cncr.20056; Eastham JA, 2007, J UROLOGY, V177, P17, DOI 10.1016/j.juro.2006.08.089; Edwards BJ, 2008, LANCET ONCOL, V9, P1166, DOI 10.1016/S1470-2045(08)70305-X; *END SOC, 2009, POS STAT MED COV DXA; Gabriel SE, 2002, OSTEOPOROSIS INT, V13, P323, DOI 10.1007/s001980200033; Gold MR, 1996, COST EFFECTIVENESS H; Greenspan SL, 2008, J CLIN ONCOL, V26, P4426, DOI 10.1200/JCO.2007.15.1233; Greenspan SL, 2008, J CLIN ENDOCR METAB, V93, P2, DOI 10.1210/jc.2007-1402; Greenspan SL, 2007, ANN INTERN MED, V146, P416, DOI 10.7326/0003-4819-146-6-200703200-00006; Hannan MT, 2000, J BONE MINER RES, V15, P710, DOI 10.1359/jbmr.2000.15.4.710; Horwitz EM, 2008, J CLIN ONCOL, V26, P2497, DOI 10.1200/JCO.2007.14.9021; Hummel S, 2003, Health Technol Assess, V7, pix; Hummel S, 2003, HEALTH TECHNOL ASSES, V7, pix; Israeli RS, 2007, CLIN GENITOURIN CANC, V5, P271, DOI 10.3816/CGC.2007.n.003; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Kanis JA, 2002, J BONE MINER RES, V17, pS146; Kattan MW, 1997, J GEN INTERN MED, V12, P299, DOI 10.1046/j.1525-1497.1997.012005299.x; Kiratli BJ, 2001, UROLOGY, V57, P127, DOI 10.1016/S0090-4295(00)00895-5; Kothawala P, 2007, MAYO CLIN PROC, V82, P1493, DOI 10.4065/82.12.1493; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; Maillefert JF, 1999, J UROLOGY, V161, P1219, DOI 10.1016/S0022-5347(01)61639-2; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Michaelson MD, 2007, J CLIN ONCOL, V25, P1038, DOI 10.1200/JCO.2006.07.3361; Miksad RA, 2007, J CLIN ONCOL, V25; National Osteoporosis Foundation, 2013, CLIN GUID PREV TREAT; NCCN, 2010, NCCN CLIN PRACT GUID; *NY STAT DEP HLTH, PRESCR DRUG PRIC NEW; Orwoll E, 2000, NEW ENGL J MED, V343, P604, DOI 10.1056/NEJM200008313430902; Polascik TJ, 2008, PROSTATE CANCER P D, V11, P13, DOI 10.1038/sj.pcan.4501019; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Ringe JD, 2006, RHEUMATOL INT, V26, P427, DOI 10.1007/s00296-005-0004-4; Ross JR, 2003, BMJ-BRIT MED J, V327, P469, DOI 10.1136/bmj.327.7413.469; Ryan CW, 2006, J UROLOGY, V176, P972, DOI 10.1016/j.juro.2006.04.078; Saad F, 2008, J CLIN ONCOL, V26, P5465, DOI 10.1200/JCO.2008.18.4184; Scher HI, 2000, UROLOGY, V55, P323, DOI 10.1016/S0090-4295(99)00471-9; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Simonelli C, 2002, MAYO CLIN PROC, V77, P334, DOI 10.4065/77.4.334; Smith MR, 2008, J UROLOGY, V179, P152, DOI 10.1016/j.juro.2007.08.137; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; Smith MR, 2006, J UROLOGY, V175, P136, DOI 10.1016/S0022-5347(05)00033-9; Smith MR, 2005, J CLIN ONCOL, V23, P7897, DOI 10.1200/JCO.2004.00.6908; Smith MR, 2005, J CLIN ONCOL, V23, P2918, DOI 10.1200/JCO.2005.01.529; Smith MR, 2003, J UROLOGY, V169, P2008, DOI 10.1097/01.ju.0000063820.94994.95; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Tanvetyanon T, 2005, CANCER-AM CANCER SOC, V103, P237, DOI 10.1002/cncr.20766; Tosteson ANA, 2008, OSTEOPOROSIS INT, V19, P437, DOI 10.1007/s00198-007-0550-6; TOSTESON ANA, 1990, ANN INTERN MED, V113, P594, DOI 10.7326/0003-4819-113-8-594; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; *US DEP LAB, US CONS PRIC IND MED; US Office of Technology Assessment, 1995, EFF COSTS OST SCREEN, VII; Wilcox A, 2006, ANN PHARMACOTHER, V40, P2107, DOI 10.1345/aph.1H209; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Winstead NS, 2007, ALIMENT PHARM THERAP, V26, P1371, DOI 10.1111/j.1365-2036.2007.03516.x; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yee EFT, 2007, J GEN INTERN MED, V22, P1305, DOI 10.1007/s11606-007-0291-4; [No title captured]	75	39	41	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					621	+		10.7326/0003-4819-152-10-201005180-00002	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	598RJ	20479027	Green Accepted			2022-12-28	WOS:000277855500001
J	Weustink, AC; Mollet, NR; Neefjes, LA; Meijboom, WB; Galema, TW; van Mieghem, CA; Kyrzopoulous, S; Eu, RN; Nieman, K; Cademartiri, F; van Geuns, RJ; Boersma, E; Krestin, GP; de Feyter, PJ				Weustink, Annick C.; Mollet, Nico R.; Neefjes, Lisan A.; Meijboom, W. Bob; Galema, Tjebbe W.; van Mieghem, Carlos A.; Kyrzopoulous, Stamatis; Eu, Rick Neoh; Nieman, Koen; Cademartiri, Filippo; van Geuns, Robert-Jan; Boersma, Eric; Krestin, Gabriel P.; de Feyter, Pim J.			Diagnostic Accuracy and Clinical Utility of Noninvasive Testing for Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE			English	Article							COMPUTED TOMOGRAPHIC ANGIOGRAPHY; OPTIMAL MEDICAL THERAPY; STABLE ANGINA-PECTORIS; ASSOCIATION TASK-FORCE; 2002 GUIDELINE UPDATE; PROGNOSTIC VALUE; AMERICAN-COLLEGE; HEART-RATE; MANAGEMENT; PERFUSION	Background: Computed tomography coronary angiography (CTCA) has become a popular noninvasive test for diagnosing coronary artery disease. Objective: To compare the accuracy and clinical utility of stress testing and CTCA for identifying patients who require invasive coronary angiography (ICA). Design: Observational study. Setting: University medical center in Rotterdam, the Netherlands. Patients: 517 patients referred by their treating physicians for evaluation of chest symptoms by using stress testing or ICA. Intervention: Stress testing and CTCA in all patients. Measurements: Diagnostic accuracy of stress testing and CTCA compared with ICA; pretest probabilities of disease by Duke clinical score; and clinical utility of noninvasive testing, defined as a pretest or posttest probability that suggests how to proceed with testing (no further testing if <= 5%, proceed with ICA if between 5% and 90%, and refer directly for ICA if >= 90%). Results: Stress testing was not as accurate as CTCA; CTCA sensitivity approached 100%. In patients with a low (<20%) pretest probability of disease, negative stress test or CTCA results suggested no need for ICA. In patients with an intermediate (20% to 80%) pretest probability, a positive CTCA result suggested need to proceed with ICA (posttest probability, 93% [95% CI, 92% to 93%]) and a negative result suggested no need for further testing (posttest probability, 1% [CI, 1% to 1%]). Physicians could proceed directly with ICA in patients with a high (>80%) pretest probability (91% [CI, 90% to 92%]). Limitations: Referral and verification bias might have influenced findings. Stress testing provides functional information that may add value to that from anatomical (CTCA or ICA) imaging. Conclusion: Computed tomography coronary angiography seems most valuable in patients with intermediate pretest probability of disease, because the test can distinguish which of these patients need invasive angiography. These findings need to be confirmed before CTCA can be routinely recommended for these patients.	[de Feyter, Pim J.] Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Feyter, PJ (corresponding author), Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr, Box 2040, NL-3000 CA Rotterdam, Netherlands.	p.j.defeyter@erasmusmc.nl	Cademartiri, Filippo/H-7336-2015; van Geuns, Robert/AAR-6386-2021; van Geuns, Robert-Jan M/N-7976-2017	Cademartiri, Filippo/0000-0002-0579-3279; van Geuns, Robert-Jan M/0000-0003-2943-5932				Abdulla J, 2007, EUR HEART J, V28, P3042, DOI 10.1093/eurheartj/ehm466; Austen W G, 1975, Circulation, V51, P5; Berman DS, 2007, J NUCL CARDIOL, V14, P521, DOI 10.1016/j.nuclcard.2007.05.008; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Dewey M, 2007, EUR HEART J, V28, P2485, DOI 10.1093/eurheartj/ehl148; Elhendy A, 1998, J NUCL MED, V39, P1662; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fox K, 2006, REV ESP CARDIOL, V59, P919, DOI 10.1157/13092800; Gibbons RJ, 2002, CIRCULATION, V106, P1883, DOI 10.1161/01.CIR.0000034670.06526.15; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gilard M, 2007, ARCH INTERN MED, V167, P1686, DOI 10.1001/archinte.167.15.1686; Lima RSL, 2003, J AM COLL CARDIOL, V42, P64, DOI 10.1016/S0735-1097(03)00562-X; Meijboom WB, 2007, J AM COLL CARDIOL, V50, P1469, DOI 10.1016/j.jacc.2007.07.007; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Min James K, 2009, Curr Cardiol Rep, V11, P47; Mollet NR, 2005, CIRCULATION, V112, P2318, DOI 10.1161/CIRCULATIONAHA.105.533471; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Pundziute G, 2007, J AM COLL CARDIOL, V49, P62, DOI 10.1016/j.jacc.2006.07.070; REIBER JHC, 1985, CIRCULATION, V71, P280, DOI 10.1161/01.CIR.71.2.280; Rispler S, 2007, J AM COLL CARDIOL, V49, P1059, DOI 10.1016/j.jacc.2006.10.069; Ropers U, 2007, J AM COLL CARDIOL, V50, P2393, DOI 10.1016/j.jacc.2007.09.017; Sampson UK, 2007, J AM COLL CARDIOL, V49, P1052, DOI 10.1016/j.jacc.2006.12.015; Schinkel AFL, 2002, RADIOLOGY, V225, P701, DOI 10.1148/radiol.2253020053; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Stein PD, 2008, AM J MED, V121, P715, DOI 10.1016/j.amjmed.2008.02.039; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Vanhoenacker PK, 2007, RADIOLOGY, V244, P419, DOI 10.1148/radiol.2442061218; Weustink AC, 2008, RADIOLOGY, V248, P792, DOI 10.1148/radiol.2483072098; Weustink AC, 2007, J AM COLL CARDIOL, V50, P786, DOI 10.1016/j.jacc.2007.04.068	36	58	59	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					630	+		10.7326/0003-4819-152-10-201005180-00003	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00003			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20479028				2022-12-28	WOS:000277855500002
J	Bloom, AJ; Burger, M; Rubio-Asensio, JS; Cousins, AB				Bloom, Arnold J.; Burger, Martin; Rubio-Asensio, Jose Salvador; Cousins, Asaph B.			Carbon Dioxide Enrichment Inhibits Nitrate Assimilation in Wheat and Arabidopsis	SCIENCE			English	Article							ELEVATED CO2; NITROGEN; RESPONSES; REDOX; PHOTOSYNTHESIS; CHLOROPLAST; METABOLISM; GRASSLAND; GROWTH; LEAVES	The concentration of carbon dioxide in Earth's atmosphere may double by the end of the 21st century. The response of higher plants to a carbon dioxide doubling often includes a decline in their nitrogen status, but the reasons for this decline have been uncertain. We used five independent methods with wheat and Arabidopsis to show that atmospheric carbon dioxide enrichment inhibited the assimilation of nitrate into organic nitrogen compounds. This inhibition may be largely responsible for carbon dioxide acclimation, the decrease in photosynthesis and growth of plants conducting C-3 carbon fixation after long exposures (days to years) to carbon dioxide enrichment. These results suggest that the relative availability of soil ammonium and nitrate to most plants will become increasingly important in determining their productivity as well as their quality as food.	[Bloom, Arnold J.; Burger, Martin; Rubio-Asensio, Jose Salvador; Cousins, Asaph B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Bloom, AJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	ajbloom@ucdavis.edu	Rubio Asensio, Jose Salvador/E-3361-2010	Rubio Asensio, Jose Salvador/0000-0002-2813-601X	NSF [IBN-03-43127, IOS-08-18435]; National Research Initiative Competitive, U.S. Department of Agriculture National Institute of Food and Agriculture [2008-35100-04459]; Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain; Direct For Biological Sciences [0818435] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); National Research Initiative Competitive, U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank C. van Kessel, L. Jackson, and E. Carlisle for their review of the manuscript. This research was supported by NSF grants IBN-03-43127 and IOS-08-18435, by the National Research Initiative Competitive grant number 2008-35100-04459 from the U.S. Department of Agriculture National Institute of Food and Agriculture, and by a postdoctoral fellowship from Agencia Regional de Ciencia y Tecnologia, Region de Murcia, Spain to J.S.R.A. A.J.B. is a paid consultant to the Monsanto Corporation.	[Anonymous], 2005, MINERAL NUTR PLANTS; Backhausen JE, 2000, PHOTOSYNTH RES, V64, P1, DOI 10.1023/A:1026523809147; Backhausen JE, 1998, PLANTA, V207, P105, DOI 10.1007/s004250050461; BLOOM AJ, 1989, PLANT PHYSIOL, V91, P352, DOI 10.1104/pp.91.1.352; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Cen YP, 2001, PLANT PHYSIOL, V126, P1555, DOI 10.1104/pp.126.4.1555; Cousins AB, 2003, PLANT CELL ENVIRON, V26, P1525, DOI 10.1046/j.1365-3040.2003.01075.x; CRAWFORD NM, 2002, ARABIDOPSIS BOOK; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Ellsworth DS, 2004, GLOBAL CHANGE BIOL, V10, P2121, DOI 10.1111/j.1365-2486.2004.00867.x; Erickson JE, 2007, GLOBAL CHANGE BIOL, V13, P202, DOI 10.1111/j.1365-2486.2006.01285.x; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Hogy P, 2009, PLANT BIOLOGY, V11, P60, DOI 10.1111/j.1438-8677.2009.00230.x; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Igamberdiev AU, 2001, PHYSIOL PLANTARUM, V111, P427, DOI 10.1034/j.1399-3054.2001.1110402.x; Kimball BA, 2001, NEW PHYTOL, V150, P295, DOI 10.1046/j.1469-8137.2001.00107.x; Knaff D.B., 1996, OXYGENIC PHOTOSYNTHE, V4, P333; Li PH, 2006, PLANT MOL BIOL, V62, P593, DOI 10.1007/s11103-006-9041-y; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Mariscal V, 2006, PROTIST, V157, P421, DOI 10.1016/j.protis.2006.06.003; Myers J., 1949, PHOTOSYNTHESIS PLANT, P349; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Quesada A, 2000, TRENDS PLANT SCI, V5, P463, DOI 10.1016/S1360-1385(00)01770-2; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; RATHNAM CKM, 1976, PLANT PHYSIOL, V57, P881, DOI 10.1104/pp.57.6.881; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Robinson J. M., 1987, MODELS PLANT PHYSL B, P25; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; SCHULZE ED, 1984, PLANT PHYSIOL, V76, P827, DOI 10.1104/pp.76.3.827; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Tcherkez G, 2006, FUNCT PLANT BIOL, V33, P531, DOI 10.1071/FP05284; von Caemmerer S., 2000, BIOCH MODELS LEAF PH	33	383	405	11	337	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					899	903		10.1126/science.1186440	http://dx.doi.org/10.1126/science.1186440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466933				2022-12-28	WOS:000277618800051
J	Hailey, DW; Rambold, AS; Satpute-Krishnan, P; Mitra, K; Sougrat, R; Kim, PK; Lippincott-Schwartz, J				Hailey, Dale W.; Rambold, Angelika S.; Satpute-Krishnan, Prasanna; Mitra, Kasturi; Sougrat, Rachid; Kim, Peter K.; Lippincott-Schwartz, Jennifer			Mitochondria Supply Membranes for Autophagosome Biogenesis during Starvation	CELL			English	Article							ENDOPLASMIC-RETICULUM; PROTEIN; TRANSPORT; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPIDS; CYTOCHROME-B5; INTERACTS; MACHINERY; BECLIN-1	Starvation-induced autophagosomes engulf cytosol and/or organelles and deliver them to lysosomes for degradation, thereby resupplying depleted nutrients. Despite advances in understanding the molecular basis of this process, the membrane origin of autophagosomes remains unclear. Here, we demonstrate that, in starved cells, the outer membrane of mitochondria participates in autophagosome biogenesis. The early autophagosomal marker, Atg5, transiently localizes to punctae on mitochondria, followed by the late autophagosomal marker, LC3. The tail-anchor of an outer mitochondrial membrane protein also labels autophagosomes and is sufficient to deliver another outer mitochondrial membrane protein, Fis1, to autophagosomes. The fluorescent lipid NBD-PS (converted to NBD-phos-photidylethanolamine in mitochondria) transfers from mitochondria to autophagosomes. Photo-bleaching reveals membranes of mitochondria and autophagosomes are transiently shared. Disruption of mitochondria/ER connections by mitofusin2 depletion dramatically impairs starvation-induced autophagy. Mitochondria thus play a central role in starvation-induced autophagy, contributing membrane to autophagosomes.	[Hailey, Dale W.; Rambold, Angelika S.; Satpute-Krishnan, Prasanna; Mitra, Kasturi; Sougrat, Rachid; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD 20892 USA; [Kim, Peter K.] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Lippincott-Schwartz, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, 18 Lib Dr, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov	Satpute-Krishnan, Prasanna/ABE-5421-2020	Sougrat, Rachid/0000-0001-6476-1886	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA HD001609-16] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Achleitner G, 1999, EUR J BIOCHEM, V264, P545, DOI 10.1046/j.1432-1327.1999.00658.x; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Bozidis P, 2008, J VIROL, V82, P2715, DOI 10.1128/JVI.02456-07; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Fengsrud M, 2000, EUR J CELL BIOL, V79, P871, DOI 10.1078/0171-9335-00125; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Hailey DW, 2009, METHOD ENZYMOL, V452, P25, DOI 10.1016/S0076-6879(08)03603-3; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Juhasz G, 2006, PLOS BIOL, V4, P161, DOI 10.1371/journal.pbio.0040036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KOBAYASHI T, 1991, J CELL BIOL, V113, P235, DOI 10.1083/jcb.113.2.235; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; LEDERER F, 1983, EUR J BIOCHEM, V132, P95, DOI 10.1111/j.1432-1033.1983.tb07330.x; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Overbye A, 2007, AUTOPHAGY, V3, P300, DOI 10.4161/auto.3910; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Reggiori F, 2009, DEV CELL, V17, P747, DOI 10.1016/j.devcel.2009.12.004; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schmidt K, 2004, CURR BIOL, V14, P1002, DOI 10.1016/j.cub.2004.05.044; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Sneve ML, 2005, AUTOPHAGY, V1, P157, DOI 10.4161/auto.1.3.2037; Tadini-Buoninsegni F, 2008, MOL PHARMACOL, V73, P1134, DOI 10.1124/mol.107.043745; TAKAGAKI Y, 1983, J BIOL CHEM, V258, P9128; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; THOMAS PD, 1989, BIOCHIM BIOPHYS ACTA, V978, P85, DOI 10.1016/0005-2736(89)90502-6; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	57	982	1017	6	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					656	667		10.1016/j.cell.2010.04.009	http://dx.doi.org/10.1016/j.cell.2010.04.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478256	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000277623600018
J	Mucha, PJ; Richardson, T; Macon, K; Porter, MA; Onnela, JP				Mucha, Peter J.; Richardson, Thomas; Macon, Kevin; Porter, Mason A.; Onnela, Jukka-Pekka			Community Structure in Time-Dependent, Multiscale, and Multiplex Networks	SCIENCE			English	Article								Network science is an interdisciplinary endeavor, with methods and applications drawn from across the natural, social, and information sciences. A prominent problem in network science is the algorithmic detection of tightly connected groups of nodes known as communities. We developed a generalized framework of network quality functions that allowed us to study the community structure of arbitrary multislice networks, which are combinations of individual networks coupled through links that connect each node in one network slice to itself in other slices. This framework allows studies of community structure in a general setting encompassing networks that evolve over time, have multiple types of links (multiplexity), and have multiple scales.	[Mucha, Peter J.; Richardson, Thomas; Macon, Kevin] Univ N Carolina, Dept Math, Carolina Ctr Interdisciplinary Appl Math, Chapel Hill, NC 27599 USA; [Mucha, Peter J.] Univ N Carolina, Inst Adv Mat Nanosci & Technol, Chapel Hill, NC 27599 USA; [Richardson, Thomas] N Carolina State Univ, Raleigh, NC 27695 USA; [Porter, Mason A.] Univ Oxford, Math Inst, Oxford Ctr Ind & Appl Math, Oxford OX1 3LB, England; [Porter, Mason A.] Univ Oxford, CABDyN Complex Ctr, Oxford OX1 1HP, England; [Onnela, Jukka-Pekka] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Onnela, Jukka-Pekka] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; University of Oxford; University of Oxford; Harvard University; Harvard Medical School; Harvard University	Mucha, PJ (corresponding author), Univ N Carolina, Dept Math, Carolina Ctr Interdisciplinary Appl Math, Chapel Hill, NC 27599 USA.	mucha@unc.edu		Macon, Kevin/0000-0003-3589-2179; Richardson, Thomas/0000-0001-7767-452X	NSF [DMS-0645369]; James S. McDonnell Foundation [220020177]; Fulbright Program	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Fulbright Program	We thank N. A. Christakis, L. Meneades, and K. Lewis for access to and helping with the "Tastes, Ties, and Time" data; S. Reid and A. L. Traud for help developing code; and A. Clauset, J.-C. Delvenne, S. Fortunato, M. Gould, and V. Traag for discussions. Congressional roll call data are from http://voteview.com (26). Supported by NSF grant DMS-0645369 (P.J.M.), James S. McDonnell Foundation grant 220020177 (M. A. P.), and the Fulbright Program (J.-P.O.).	[Anonymous], P 13 C KNOWL DISC DA, DOI DOI 10.1145/1281192.1281266; Arenas A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/176; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Berger-Wolf TY, 2006, P 12 ACM SIGKDD INT, P523, DOI [10.1145/1150402.1150462, DOI 10.1145/1150402.1150462]; Fenn DJ, 2009, CHAOS, V19, DOI 10.1063/1.3184538; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016114; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Hopcroft J, 2004, P NATL ACAD SCI USA, V101, P5249, DOI 10.1073/pnas.0307750100; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Richardson T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036111; SELEE TM, 2007, CSRI SUMM P 2007, P87; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	22	1214	1263	15	346	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					876	878		10.1126/science.1184819	http://dx.doi.org/10.1126/science.1184819			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466926	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000277618800043
J	Logan, PA; Coupland, CAC; Gladman, JRF; Sahota, O; Stoner-Hobbs, V; Robertson, K; Tomlinson, V; Ward, M; Sach, T; Avery, AJ				Logan, Philippa A.; Coupland, C. A. C.; Gladman, J. R. F.; Sahota, O.; Stoner-Hobbs, V.; Robertson, K.; Tomlinson, V.; Ward, M.; Sach, T.; Avery, A. J.			Community falls prevention for people who call an emergency ambulance after a fall: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OLDER-PEOPLE; CARE; PROGRAM; RISK	Objective To evaluate whether a service to prevent falls in the community would help reduce the rate of falls in older people who call an emergency ambulance when they fall but are not taken to hospital. Design Randomised controlled trial. Setting Community covered by four primary care trusts, England. Participants 204 adults aged more than 60 living at home or in residential care who had fallen and called an emergency ambulance but were not taken to hospital. Interventions Referral to community fall prevention services or standard medical and social care. Main outcome measures The primary outcome was the rate of falls over 12 months, ascertained from monthly diaries. Secondary outcomes were scores on the Barthel index, Nottingham extended activities of daily living scale, and falls efficacy scale at baseline and by postal questionnaire at 12 months. Analysis was by intention to treat. Results 102 people were allocated to each group. 99 (97%) participants in the intervention group received the intervention. Falls diaries were analysed for 88.6 person years in the intervention group and 84.5 person years in the control group. The incidence rates of falls per year were 3.46 in the intervention group and 7.68 in the control group (incidence rate ratio 0.45, 95% confidence interval 0.35 to 0.58, P<0.001). The intervention group achieved higher scores on the Barthel index and Nottingham extended activities of daily living and lower scores on the falls efficacy scale (all P<0.05) at the 12 month follow-up. The number of times an emergency ambulance was called because of a fall was significantly different during follow-up (incidence rate ratio 0.60, 95% confidence interval 0.40 to 0.92, P=0.018). Conclusion A service to prevent falls in the community reduced the fall rate and improved clinical outcome in the high risk group of older people who call an emergency ambulance after a fall but are not taken to hospital.	[Logan, Philippa A.] Univ Nottingham, Queens Med Ctr, Div Rehabil & Ageing, Sch Community Hlth Sci, Nottingham NG7 2UH, England; [Sahota, O.] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Stoner-Hobbs, V.; Tomlinson, V.] E Midlands Ambulance Serv Headquarters, Nottingham, England; [Robertson, K.] Lings Bar Hosp, Nottinghamshire Community Hlth, Nottingham, England; [Ward, M.] Nottingham City Primary Care Trust, Nottingham, England; [Sach, T.] Univ E Anglia, Sch Med Hlth Policy & Practice, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England	University of Nottingham; University of Nottingham; University of East Anglia	Logan, PA (corresponding author), Univ Nottingham, Queens Med Ctr, Div Rehabil & Ageing, Sch Community Hlth Sci, Nottingham NG7 2UH, England.	Pip.logan@nottingham.ac.uk	Gladman, John/M-7429-2015	Gladman, John/0000-0002-8506-7786; Sach, Tracey/0000-0002-8098-9220; Coupland, Carol/0000-0002-2327-3306; Sahota, Opinder/0000-0003-0055-7637; Avery, Anthony/0000-0001-7591-4438; Logan, Philippa/0000-0002-6657-2381	UK NHS National Institute of Health Research	UK NHS National Institute of Health Research	Funding: This study was funded by a postdoctoral training scholarship awarded to PAL from the UK NHS National Institute of Health Research. The funding source provided an external peer review of the study protocol but did not have any role in the data collection, analysis, report writing, or decision to publish this paper.	Clemson L, 2004, J AM GERIATR SOC, V52, P1487, DOI 10.1111/j.1532-5415.2004.52411.x; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Collin C, 1988, Int Disabil Stud, V10, P61; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P613, DOI 10.1111/j.1532-5415.1988.tb06155.x; Department of Health, 2005, TAK HEALTHC PAT TRAN; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; GLADMAN JRF, 1993, AGE AGEING, V22, P419, DOI 10.1093/ageing/22.6.419; Guidelines commissioned by the National Institute for Clinical Excellence (NICE), 2004, FALLS ASS PREV FALLS; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Marks PJ, 2002, EMERG MED J, V19, P449, DOI 10.1136/emj.19.5.449; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; Snijder MB, 2006, J CLIN ENDOCR METAB, V91, P2980, DOI 10.1210/jc.2006-0510; Snooks HA, 2006, QUAL SAF HEALTH CARE, V15, P390, DOI 10.1136/qshc.2006.018697; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Weatherall M, 2004, INTERN MED J, V34, P102, DOI 10.1111/j.1444-0903.2004.t01-15-.x; Weiss Steven J, 2003, Prehosp Emerg Care, V7, P79, DOI 10.1080/10903120390937148	19	64	64	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 11	2010	340								c2102	10.1136/bmj.c2102	http://dx.doi.org/10.1136/bmj.c2102			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	598HO	20460331	hybrid, Green Published			2022-12-28	WOS:000277826200005
J	Ransohoff, DF				Ransohoff, David F.			Can endoscopy protect against colorectal cancer? An RCT	LANCET			English	Editorial Material							COLONOSCOPY; SIGMOIDOSCOPY		[Ransohoff, David F.] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA; [Ransohoff, David F.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ransohoff, DF (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA.	ransohof@med.unc.edu						ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Pignone M, 2002, ANN INTERN MED, V137, P96, DOI 10.7326/0003-4819-137-2-200207160-00007; Pignone M, 2005, EC MODELS COLORECTAL; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Ransohoff DF, 2005, GASTROENTEROLOGY, V129, P1815, DOI 10.1053/j.gastro.2005.10.032; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	11	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1582	1584		10.1016/S0140-6736(10)60626-5	http://dx.doi.org/10.1016/S0140-6736(10)60626-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20430430				2022-12-28	WOS:000277734700005
J	Koh, HK				Koh, Howard K.			A 2020 Vision for Healthy People.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Dept Hlth & Human Serv, Washington, DC USA		Koh, HK (corresponding author), Dept Hlth & Human Serv, Washington, DC USA.							Department of Health Human Services Washington DC. Healthy People 2010 (Group) and United States Government Printing Office., 2000, HLTH PEOPL 2010; Fielding J, 2009, AM J PREV MED, V37, P255, DOI 10.1016/j.amepre.2009.04.029; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; *I MED, 2007, END TOB PROBL BLUEPR; Sondik EJ, 2010, ANNU REV PUBL HEALTH, V31, P271, DOI 10.1146/annurev.publhealth.012809.103613	5	145	146	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1653	1656		10.1056/NEJMp1001601	http://dx.doi.org/10.1056/NEJMp1001601			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591OQ	20445177				2022-12-28	WOS:000277311200001
J	Lv, S; Dudek, DM; Cao, Y; Balamurali, MM; Gosline, J; Li, HB				Lv, Shanshan; Dudek, Daniel M.; Cao, Yi; Balamurali, M. M.; Gosline, John; Li, Hongbin			Designed biomaterials to mimic the mechanical properties of muscles	NATURE			English	Article							CARDIAC-MUSCLE; PROTEIN TITIN; ELASTIN; RESILIN; CONNECTIN/TITIN; MYOFIBRILS; MOLECULES; FILAMENTS; DOMAINS; TENSION	The passive elasticity of muscle is largely governed by the I-band part of the giantmuscle protein titin(1-4), a complex molecular spring composed of a series of individually folded immunoglobulin-like domains as well as largely unstructured unique sequences(5). These mechanical elements have distinct mechanical properties, and when combined, they provide the desired passive elastic properties of muscle(6-11), which are a unique combination of strength, extensibility and resilience. Single-molecule atomic force microscopy (AFM) studies demonstrated that the macroscopic behaviour of titin in intact myofibrils can be reconstituted by combining the mechanical properties of these mechanical elements measured at the single-molecule level(8). Here we report artificial elastomeric proteins that mimic the molecular architecture of titin through the combination of well-characterized protein domains GB1(12) and resilin(13). We show that these artificial elastomeric proteins can be photochemically crosslinked and cast into solid biomaterials. These biomaterials behave as rubber-like materials showing high resilience at low strain and as shock-absorber-like materials at high strain by effectively dissipating energy. These properties are comparable to the passive elastic properties of muscles within the physiological range of sarcomere length(14) and so these materials represent a new muscle-mimetic biomaterial. The mechanical properties of these biomaterials can be fine-tuned by adjusting the composition of the elastomeric proteins, providing the opportunity to develop biomaterials that are mimetic of different types of muscles. We anticipate that these biomaterials will find applications in tissue engineering(15) as scaffold and matrix for artificial muscles.	[Lv, Shanshan; Cao, Yi; Balamurali, M. M.; Li, Hongbin] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Dudek, Daniel M.; Gosline, John] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Li, HB (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	gosline@zoology.ubc.ca; hongbin@chem.ubc.ca	Yi, Cao/A-4200-2011; MM, Balamurali/ABG-9767-2020; Li, Hongbin/G-2949-2012	Yi, Cao/0000-0003-1493-7868; Li, Hongbin/0000-0001-7813-1332; Lv, Shanshan/0000-0002-6068-3048; MM, Balamurali/0000-0001-7948-9950	Canadian Institutes of Health Research; Canada Research Chairs program; Canada Foundation for Innovation; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank M. Lillie and R. Shadwick for discussions. This work is supported by the Canadian Institutes of Health Research, the Canada Research Chairs program, the Canada Foundation for Innovation, the Michael Smith Foundation for Health Research, and the Natural Sciences and Engineering Research Council of Canada. H. L. is a Michael Smith Foundation for Health Research Career Investigator.	Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bochicchio B, 2005, MACROMOL BIOSCI, V5, P502, DOI 10.1002/mabi.200500007; Cao Y, 2007, NAT MATER, V6, P109, DOI 10.1038/nmat1825; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; DUDEK DM, 2009, ANN M SOC INT COMP B, pE50; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; Higuchi H, 1996, ADV BIOPHYS, V33, P159; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; LILLIE MA, 1994, CONNECT TISSUE RES, V31, P23, DOI 10.3109/03008209409005632; LINKE WA, 1994, BIOPHYS J, V67, P782, DOI 10.1016/S0006-3495(94)80538-7; Linke WA, 1999, J CELL BIOL, V146, P631, DOI 10.1083/jcb.146.3.631; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Nagapudi K, 2005, MACROMOLECULES, V38, P345, DOI 10.1021/ma0491199; Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wang K, 1996, ADV BIOPHYS, V33, P123; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914	33	398	403	11	470	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					69	73		10.1038/nature09024	http://dx.doi.org/10.1038/nature09024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445626				2022-12-28	WOS:000277311900032
J	Halpin, LJL; Anderson, CL; Corriette, N				Halpin, Laura J. L.; Anderson, Claire L.; Corriette, Nicole			10-Minute Consultation Stridor in children	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Halpin, Laura J. L.] Medway Maritime Hosp, Gillingham ME7 5NY, England; [Anderson, Claire L.] Royal Brompton Hosp, London SW3 6NP, England	Medway Maritime Hospital; Royal Brompton Hospital	Halpin, LJL (corresponding author), Medway Maritime Hosp, Gillingham ME7 5NY, England.	laurajhalpin@doctors.org.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2010	340								c2193	10.1136/bmj.c2193	http://dx.doi.org/10.1136/bmj.c2193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XB	20442228				2022-12-28	WOS:000277572400005
J	Kimura, K; Sakai-Kimura, M; Takahashi, R; Watanabe, A; Mukai, M; Noma, S; Fukuda, K				Kimura, Kensuke; Sakai-Kimura, Miho; Takahashi, Ryuichi; Watanabe, Atsushi; Mukai, Makio; Noma, Shigetaka; Fukuda, Keiichi			Too friable to treat?	LANCET			English	Editorial Material							SYNDROME TYPE-IV; VASCULAR TYPE		[Kimura, Kensuke] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Shinjuku Ku, Tokyo 1608582, Japan; [Mukai, Makio] Keio Univ Hosp, Div Diagnost Pathol, Shinjuku Ku, Tokyo, Japan; [Sakai-Kimura, Miho] Kitasato Univ, Sch Med, Dept Rheumatol & Infect Dis, Kanagawa, Japan; [Takahashi, Ryuichi] Saiseikai Utsunomiya Hosp, Dept Cardiovasc Surg, Utsunomiya, Tochigi, Japan; [Noma, Shigetaka] Saiseikai Utsunomiya Hosp, Dept Cardiol, Utsunomiya, Tochigi, Japan; [Watanabe, Atsushi] Nippon Med Coll Hosp, Div Clin Genet, Bunkyo Ku, Tokyo, Japan	Keio University; Keio University; Kitasato University; Nippon Medical School	Kimura, K (corresponding author), Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kimuken@cpnet.med.keio.ac.jp	WATANABE, Atsushi/F-5687-2019; Fukuda, Keiichi/L-3777-2013	WATANABE, Atsushi/0000-0001-9143-3079				FANN JI, 1993, ANN VASC SURG, V7, P530; Lauwers G, 1997, ANN VASC SURG, V11, P178, DOI 10.1007/s100169900031; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Watanabe A, 2007, CIRC J, V71, P261, DOI 10.1253/circj.71.261	4	4	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1578	1578		10.1016/S0140-6736(10)60238-3	http://dx.doi.org/10.1016/S0140-6736(10)60238-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435230				2022-12-28	WOS:000277655100031
J	Holm, MS; Saravanamurugan, S; Taarning, E				Holm, Martin Spangsberg; Saravanamurugan, Shunmugavel; Taarning, Esben			Conversion of Sugars to Lactic Acid Derivatives Using Heterogeneous Zeotype Catalysts	SCIENCE			English	Article							COMMODITY CHEMICALS; CARBONYL-COMPOUNDS; D-FRUCTOSE; ZEOLITE; BIOMASS; DEHYDRATION; EXTRACTION; REDUCTION; GLUCOSE; PHASE	Presently, very few compounds of commercial interest are directly accessible from carbohydrates by using nonfermentive approaches. We describe here a catalytic process for the direct formation of methyl lactate from common sugars. Lewis acidic zeotypes, such as Sn-Beta, catalyze the conversion of mono-and disaccharides that are dissolved in methanol to methyl lactate at 160 C. With sucrose as the substrate, methyl lactate yield reaches 68%, and the heterogeneous catalyst can be easily recovered by filtration and reused multiple times after calcination without any substantial change in the product selectivity.	[Holm, Martin Spangsberg; Saravanamurugan, Shunmugavel; Taarning, Esben] Tech Univ Denmark, Ctr Sustainable & Green Chem, Dept Chem, DK-2800 Kongens Lyngby, Denmark; [Holm, Martin Spangsberg; Saravanamurugan, Shunmugavel] Tech Univ Denmark, Ctr Catalysis & Sustainable Chem, Dept Chem, DK-2800 Kongens Lyngby, Denmark; [Holm, Martin Spangsberg; Taarning, Esben] Haldor Topsoe Res Labs, DK-2800 Kongens Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark; Haldor Topsoe	Taarning, E (corresponding author), Tech Univ Denmark, Ctr Sustainable & Green Chem, Dept Chem, Anker Engelundsvej 1, DK-2800 Kongens Lyngby, Denmark.	esta@topsoe.dk	Shunmugavel, Saravanamurugan/I-3771-2017	Shunmugavel, Saravanamurugan/0000-0002-3980-5020; shunmugavel, saravanamurugan/0000-0002-8428-1895; Taarning, Esben/0000-0001-8193-0303	Danish Ministry of Science, Technology and Innovation; Danish National Research Foundation	Danish Ministry of Science, Technology and Innovation; Danish National Research Foundation(Danmarks Grundforskningsfond)	The Catalysis for Sustainable Energy initiative is funded by the Danish Ministry of Science, Technology and Innovation. The Center for Sustainable and Green Chemistry is sponsored by the Danish National Research Foundation. Haldor Topsoe A/S holds patent application EP 090137829 related to the work described in this report. The authors thank C. Hviid Christensen (Haldor Topsoe A/S) for helpful advice.	Aida TM, 2007, J SUPERCRIT FLUID, V42, P110, DOI 10.1016/j.supflu.2006.12.017; Bicker M, 2003, GREEN CHEM, V5, P280, DOI 10.1039/b211468b; Boronat M, 2006, CHEM-EUR J, V12, P7067, DOI 10.1002/chem.200600478; BRAUN G, 1935, Patent No. 2024565; Christensen CH, 2008, CHEMSUSCHEM, V1, P283, DOI 10.1002/cssc.200700168; Corma A, 2002, J AM CHEM SOC, V124, P3194, DOI 10.1021/ja012297m; Corma A, 2007, CHEM REV, V107, P2411, DOI 10.1021/cr050989d; Danner H, 1999, CHEM SOC REV, V28, P395, DOI 10.1039/a806968i; Datta R, 2006, J CHEM TECHNOL BIOT, V81, P1119, DOI 10.1002/jctb.1486; Fan YX, 2009, CATAL REV, V51, P293, DOI 10.1080/01614940903048513; Hayashi Y, 2005, CHEM COMMUN, P2716, DOI 10.1039/b501964h; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; JOW J, 1987, BIOMASS, V14, P185, DOI 10.1016/0144-4565(87)90046-1; Lunt J, 1998, POLYM DEGRAD STABIL, V59, P145, DOI 10.1016/S0141-3910(97)00148-1; MONTGOMERY R, 1953, IND ENG CHEM, V45, P1144; Renz M, 2002, CHEM-EUR J, V8, P4708, DOI 10.1002/1521-3765(20021018)8:20<4708::AID-CHEM4708>3.0.CO;2-U; RIVALIER P, 1995, CATAL TODAY, V24, P165, DOI 10.1016/0920-5861(95)00026-C; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Sasaki M, 2002, GREEN CHEM, V4, P285, DOI 10.1039/b203968k; Serrano-Ruiz JC, 2009, CHEMSUSCHEM, V2, P581, DOI 10.1002/cssc.200900004; Taarning E, 2009, CHEMSUSCHEM, V2, P625, DOI 10.1002/cssc.200900099; Thomas JM, 2005, ANGEW CHEM INT EDIT, V44, P6456, DOI 10.1002/anie.200462473; van der Waal JC, 1997, TOP CATAL, V4, P261, DOI 10.1023/A:1019160827175; Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5; Wasewar KL, 2004, IND ENG CHEM RES, V43, P5969, DOI 10.1021/ie049963n; West RM, 2010, J CATAL, V269, P122, DOI 10.1016/j.jcat.2009.10.023; Yang BY, 1996, CARBOHYD RES, V280, P47, DOI 10.1016/0008-6215(95)00233-2; Zhao HB, 2007, SCIENCE, V316, P1597, DOI 10.1126/science.1141199	29	691	732	22	624	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					602	605		10.1126/science.1183990	http://dx.doi.org/10.1126/science.1183990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431010				2022-12-28	WOS:000277159800037
J	Kreiss, Y; Merin, O; Peleg, K; Levy, G; Vinker, S; Sagi, R; Abargel, A; Bartal, C; Lin, G; Bar, A; Bar-On, E; Schwaber, MJ; Ash, N				Kreiss, Yitshak; Merin, Ofer; Peleg, Kobi; Levy, Gad; Vinker, Shlomo; Sagi, Ram; Abargel, Avi; Bartal, Carmi; Lin, Guy; Bar, Ariel; Bar-On, Elhanan; Schwaber, Mitchell J.; Ash, Nachman			Early Disaster Response in Haiti: The Israeli Field Hospital Experience	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							EARTHQUAKE	The earthquake that struck Haiti in January 2010 caused an estimated 230 000 deaths and injured approximately 250 000 people. The Israel Defense Forces Medical Corps Field Hospital was fully operational on site only 89 hours after the earthquake struck and was capable of providing sophisticated medical care. During the 10 days the hospital was operational, its staff treated 1111 patients, hospitalized 737 patients, and performed 244 operations on 203 patients. The field hospital also served as a referral center for medical teams from other countries that were deployed in the surrounding areas. The key factor that enabled rapid response during the early phase of the disaster from a distance of 6000 miles was a well-prepared and trained medical unit maintained on continuous alert. The prompt deployment of advanced-capability field hospitals is essential in disaster relief, especially in countries with minimal medical infrastructure. The changing medical requirements of people in an earthquake zone dictate that field hospitals be designed to operate with maximum flexibility and versatility regarding triage, staff positioning, treatment priorities, and hospitalization policies. Early coordination with local administrative bodies is indispensable.	Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel; Israel Natl Ctr Trauma & Emergency Med Res, Gertner Inst Epidemiol & Hlth Policy Reasearch, Tel Hashomer, Israel; Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Assaf Harofeh Med Ctr, Sch Publ Hlth, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Israel Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel; Soroka Univ Med Ctr, Beer Sheva, Israel; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; Western Galilee Hosp, Nahariyya, Israel; Schneider Childrens Med Ctr, Petah Tiqwa, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Chaim Sheba Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Western Galilee Hospital	Kreiss, Y (corresponding author), 182 Kedem St,POB 1773, Shoham, Israel.	ykreiss@gmail.com	Schwaber, Mitchell/AAI-2486-2019; Ash, Nachman/ABC-2961-2020	bartal, carmi/0000-0003-0894-5466				Adler J, 2001, Harefuah, V140, P877; ADLER J, 2001, HAREFUAH, V140, P893; Amital Howard, 2003, Prehosp Disaster Med, V18, P301; Aoki Noriaki, 2004, Prehosp Emerg Care, V8, P217, DOI 10.1016/j.prehos.2003.12.019; Bar-Dayan Y, 2000, DISASTERS, V24, P262, DOI 10.1111/1467-7717.00147; Bar-Dayan Y, 2005, PREHOSP DISASTER MED, V20, P103, DOI 10.1017/S1049023X00002272; HEYMAN SN, 1988, PREHOSP DISASTER MED, V13, P21; Medecins Sans Frontieres, 2010, HAIT ON EM NEXT; Merin O, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1001693; NOJI EK, 1990, ANN EMERG MED, V19, P891, DOI 10.1016/S0196-0644(05)81563-X; Schultz CH, 1996, NEW ENGL J MED, V334, P438, DOI 10.1056/NEJM199602153340706; SHENG ZY, 1987, J TRAUMA, V27, P1130; Tanaka K, 1996, Eur J Emerg Med, V3, P263, DOI 10.1097/00063110-199612000-00009; World Medical Association, 2006, STAT MED ETH EV DIS	14	75	77	4	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					45	48		10.7326/0003-4819-153-1-201007060-00253	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00253			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20442270				2022-12-28	WOS:000279487700007
J	Gibson, DG; Glass, JI; Lartigue, C; Noskov, VN; Chuang, RY; Algire, MA; Benders, GA; Montague, MG; Ma, L; Moodie, MM; Merryman, C; Vashee, S; Krishnakumar, R; Assad-Garcia, N; Andrews-Pfannkoch, C; Denisova, EA; Young, L; Qi, ZQ; Segall-Shapiro, TH; Calvey, CH; Parmar, PP; Hutchison, CA; Smith, HO; Venter, JC				Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Benders, Gwynedd A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig			Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome	SCIENCE			English	Article							MYCOPLASMA-GENITALIUM GENOME; MINIMAL GENOME; DNA FRAGMENTS; YEAST; CLONING; GENES	We report the design, synthesis, and assembly of the 1.08-mega-base pair Mycoplasma mycoides JCVI-syn1.0 genome starting from digitized genome sequence information and its transplantation into a M. capricolum recipient cell to create new M. mycoides cells that are controlled only by the synthetic chromosome. The only DNA in the cells is the designed synthetic DNA sequence, including "watermark" sequences and other designed gene deletions and polymorphisms, and mutations acquired during the building process. The new cells have expected phenotypic properties and are capable of continuous self-replication.	[Gibson, Daniel G.; Glass, John I.; Lartigue, Carole; Noskov, Vladimir N.; Chuang, Ray-Yuan; Algire, Mikkel A.; Montague, Michael G.; Ma, Li; Moodie, Monzia M.; Merryman, Chuck; Vashee, Sanjay; Krishnakumar, Radha; Assad-Garcia, Nacyra; Andrews-Pfannkoch, Cynthia; Denisova, Evgeniya A.; Young, Lei; Qi, Zhi-Qing; Segall-Shapiro, Thomas H.; Calvey, Christopher H.; Parmar, Prashanth P.; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA; [Benders, Gwynedd A.; Hutchison, Clyde A., III; Smith, Hamilton O.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA	J. Craig Venter Institute; J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, 9704 Med Ctr Dr, Rockville, MD 20850 USA.	jcventer@jcvi.org	Lartigue, Carole/GQP-4896-2022; lartigue, carole/I-1576-2013; Glass, John/A-6572-2015	Lartigue, Carole/0000-0001-5550-7579; Segall-Shapiro, Thomas/0000-0001-9364-6537; Calvey, Christopher/0000-0002-7330-4983; Glass, John/0000-0002-3784-5301	Synthetic Genomics, Inc.; National Center for Microscopy and Imaging Research at the University of California at San Diego	Synthetic Genomics, Inc.; National Center for Microscopy and Imaging Research at the University of California at San Diego	We thank Synthetic Genomics, Inc. for generous funding of this work. We thank J. B. Hostetler, D. Radune, N. B. Fedorova, M. D. Kim, B. J. Szczypinski, I. K. Singh, J. R. Miller, S. Kaushal, R. M. Friedman, and J. Mulligan for their contributions to this work. Electron micrographs were generously provided by T. Deerinck and M. Ellisman of the National Center for Microscopy and Imaging Research at the University of California at San Diego. J. C. V. is chief executive officer and co-chief scientific officer of SGI. H.O.S. is co-chief scientific officer and on the Board of Directors of SGI. C. A. H. is chairman of the SGI Scientific Advisory Board. All three of these authors and JCVI hold SGI stock. JCVI has filed patent applications on some of the techniques described in this paper.	Benders GA, 2010, NUCLEIC ACIDS RES, V38, P2558, DOI 10.1093/nar/gkq119; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; DEAN WW, 1973, ANAL BIOCHEM, V56, P417, DOI 10.1016/0003-2697(73)90207-8; DEVENISH RJ, 1982, GENE, V18, P277, DOI 10.1016/0378-1119(82)90166-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Garfinkel MS, 2007, BIOSECUR BIOTERROR, V5, P359, DOI 10.1089/bsp.2007.0923; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; ITAYA M, 1995, FEBS LETT, V362, P257, DOI 10.1016/0014-5793(95)00233-Y; Itaya M, 2005, P NATL ACAD SCI USA, V102, P15971, DOI 10.1073/pnas.0503868102; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029; Mizoguchi H, 2007, BIOTECHNOL APPL BIOC, V46, P157, DOI 10.1042/BA200650107; Noskov VN, 2010, NUCLEIC ACIDS RES, V38, P2570, DOI 10.1093/nar/gkq099; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; SMITH HO, 2008, ACCESSING UNCULTIVAT, P320; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187	25	1431	1659	28	862	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					52	56		10.1126/science.1190719	http://dx.doi.org/10.1126/science.1190719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20488990				2022-12-28	WOS:000279402700028
J	Jennings, CC; Hayes, KJ				Jennings, Christopher C.; Hayes, Katherine J.			Health Insurance Reform and the Tensions of Federalism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jennings, Christopher C.; Hayes, Katherine J.] Jennings Policy Strategies, Washington, DC USA; [Hayes, Katherine J.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC USA	George Washington University	Jennings, CC (corresponding author), Jennings Policy Strategies, Washington, DC USA.								0	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2244	2246		10.1056/NEJMp1004761	http://dx.doi.org/10.1056/NEJMp1004761			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20463334				2022-12-28	WOS:000278816300002
J	Kaufmann, SHE; Hussey, G; Lambert, PH				Kaufmann, Stefan H. E.; Hussey, Gregory; Lambert, Paul-Henri			New vaccines for tuberculosis	LANCET			English	Article							HEPARIN-BINDING HEMAGGLUTININ; T-CELL SUBSETS; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; MUTANT STRAIN; BOVIS BCG; VACCINATION; PROTECTION; EFFICACY; MEMORY	New vaccines are urgently needed if we want to reach the goal of substantially reducing the incidence of tuberculosis by 2050. Despite a steady increase in funding over the past decade, there is still a striking financial shortfall for vaccine research and development for tuberculosis. Yet, around ten vaccine candidates have left the laboratory stage and entered clinical trials. These vaccines are either aimed at replacing the present vaccine, BCG, or at enhancing immunity induced by BCG. However, these pre-exposure candidates are designed for prevention of disease and will therefore neither eradicate the pathogen, nor prevent stable infection. Long-term vaccination strategies need to target these more ambitious goals. Even though vaccine development will have a price, the return of investment will greatly exceed original costs.	[Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Hussey, Gregory] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Hussey, Gregory] Univ Cape Town, Sch Child & Adolescent Hlth, ZA-7925 Cape Town, South Africa; [Lambert, Paul-Henri] Ctr Med Univ Geneva, Ctr Vaccinol, Geneva, Switzerland	Max Planck Society; University of Cape Town; University of Cape Town; University of Geneva	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268	EU; Bill & Melinda Gates Foundation [GC6-74, 37772, GC12-82, 37885]; Aeras; European and Developing Countries; Oxford University; National Institutes of Health	EU(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Aeras; European and Developing Countries; Oxford University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M L Grossman and S Sibaei for help in preparing the report. SHEK's laboratory receives financial support for tuberculosis vaccine research and development from EU FP6-TBVAC, FP6-MUVAPRED and FP6-PRIBOMAL, FP7-TBVIR, FP7-NEWTBVAC, and Bill & Melinda Gates Foundation Grand Challenges in Global Health GC6-74 (number 37772), of which he is also principal investigator, and GC12-82 (number 37885). GH's research group (SATVI) is funded by Aeras, the European and Developing Countries Clinical Trials Partnership, Oxford University, National Institutes of Health, and Bill & Melinda Gates Foundation Grand Challenges in Global Health GC6-74 (number 37772) and GC12-82 (number 37885).	Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; AGARWAL N, 2009, CRITICAL ANAL FUNDIN; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; [Anonymous], 2009, NEW PLAGUES PANDEMIC; Azzopardi P, 2009, INT J TUBERC LUNG D, V13, P1331; Bangari DS, 2006, VACCINE, V24, P849, DOI 10.1016/j.vaccine.2005.08.101; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Brennan MJ, 2007, PLOS MED, V4, P1299, DOI 10.1371/journal.pmed.0040252; CALMETTE AGC, 1927, PROPHYLACTIC VACCINA; Cardona PJ, 2006, TUBERCULOSIS, V86, P273, DOI 10.1016/j.tube.2006.01.024; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2006, J IMMUNOL, V177, P6353, DOI 10.4049/jimmunol.177.9.6353; Dlugovitzky D, 2006, RESP MED, V100, P1079, DOI 10.1016/j.rmed.2005.09.026; Dorhoi A, 2009, CURR OPIN IMMUNOL, V21, P367, DOI 10.1016/j.coi.2009.07.004; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Foulds KE, 2006, IMMUNOL REV, V211, P58, DOI 10.1111/j.0105-2896.2006.00400.x; *GAVI ALL, 2009, CONS ADV PROC ADV MA; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Hatherill M, 2009, VACCINE, V27, P4743, DOI 10.1016/j.vaccine.2009.05.021; Hesseling AC, 2007, VACCINE, V25, P6565, DOI 10.1016/j.vaccine.2007.06.045; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; Kaufmann SHE, 2005, TRENDS IMMUNOL, V26, P660, DOI 10.1016/j.it.2005.09.012; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2008, NAT IMMUNOL, V9, P705, DOI 10.1038/ni0708-705; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kaufmann SHE, 2007, NAT MED, V13, P299, DOI 10.1038/nm0307-299; Kaufmann SHE, 2006, NAT REV IMMUNOL, V6, P699, DOI 10.1038/nri1920; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lin MY, 2008, BIOL CHEM, V389, P497, DOI 10.1515/BC.2008.057; Lingnau K, 2007, EXPERT REV VACCINES, V6, P741, DOI 10.1586/14760584.6.5.741; Locht C, 2006, TUBERCULOSIS, V86, P303, DOI 10.1016/j.tube.2006.01.016; Mansoor N, 2009, J INFECT DIS, V199, P982, DOI 10.1086/597304; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Menozzi FD, 1996, J EXP MED, V184, P993, DOI 10.1084/jem.184.3.993; Minnies Deon, 2008, BMC Med Ethics, V9, P15, DOI 10.1186/1472-6939-9-15; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; MORAN M, 2008, NEGLECTED DIS RES DE; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; Parida SK, 2010, DRUG DISCOV TODAY, V15, P148, DOI 10.1016/j.drudis.2009.10.005; Pethe K, 2001, NATURE, V412, P190, DOI 10.1038/35084083; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Rook GAW, 1996, CURR TOP MICROBIOL, V215, P239; ROONEY JF, 1988, J VIROL, V62, P1530, DOI 10.1128/JVI.62.5.1530-1534.1988; Rouanet C, 2009, MICROBES INFECT, V11, P995, DOI 10.1016/j.micinf.2009.07.005; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; Stanford J, 2004, FRONT BIOSCI-LANDMRK, V9, P1701, DOI 10.2741/1292; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; *STOPTB PARTN WORK, TUB VACC CAND 2009; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; *TREATM ACT GROUP, 2009, TUB RES DEV 2009 REP; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vilaplana C, 2010, VACCINE, V28, P1106, DOI 10.1016/j.vaccine.2009.09.134; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; WILSON ME, 1995, CLIN INFECT DIS, V20, P982, DOI 10.1093/clinids/20.4.982; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Winau F, 2005, APOPTOSIS, V10, P707, DOI 10.1007/s10495-005-2940-6; World Medical Association, DECL HELS ETH PRINC; Young D, 2006, CELL, V124, P683, DOI 10.1016/j.cell.2006.02.013	81	228	252	1	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2110	2119		10.1016/S0140-6736(10)60393-5	http://dx.doi.org/10.1016/S0140-6736(10)60393-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20488515				2022-12-28	WOS:000279069300024
J	Sharma, S; Fitzgerald, KA				Sharma, Shruti; Fitzgerald, Katherine A.			Viral Defense: It Takes Two MAVs to Tango	CELL			English	Editorial Material							ANTIVIRAL SIGNALING PROTEIN; HEPATITIS-C-VIRUS; INNATE IMMUNITY; PEROXISOMAL FISSION; MAMMALIAN-CELLS; RIG-I; MITOCHONDRIAL		[Sharma, Shruti; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, 364 Plantat St, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X				Camoes F, 2009, J INHERIT METAB DIS, V32, P163, DOI 10.1007/s10545-008-1018-3; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x	9	10	10	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					570	572		10.1016/j.cell.2010.04.043	http://dx.doi.org/10.1016/j.cell.2010.04.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478250	Bronze			2022-12-28	WOS:000277623600010
J	Peleg, AY; Hooper, DC				Peleg, Anton Y.; Hooper, David C.			CURRENT CONCEPTS Hospital-Acquired Infections Due to Gram-Negative Bacteria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							VENTILATOR-ASSOCIATED PNEUMONIA; CARE-ASSOCIATED INFECTIONS; BLOOD-STREAM INFECTIONS; ANTIBIOTIC-THERAPY; DISEASES-SOCIETY; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; CRITICALLY-ILL; MANAGEMENT		[Peleg, Anton Y.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Peleg, Anton Y.; Hooper, David C.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Peleg, Anton Y.; Hooper, David C.] Harvard Univ, Sch Med, Boston, MA USA; [Peleg, Anton Y.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Peleg, Anton Y.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Florey Institute of Neuroscience & Mental Health; Monash University	Peleg, AY (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St, Boston, MA 02215 USA.	apeleg@bidmc.harvard.edu		Peleg, Anton/0000-0002-2296-2126	Abbott Molecular; Ortho-McNeil-Janssen; Cubist; Johnson Johnson; Mutabilis; Daiichi-Sankyo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057576] Funding Source: NIH RePORTER	Abbott Molecular; Ortho-McNeil-Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Cubist; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Mutabilis; Daiichi-Sankyo(Daiichi Sankyo Company Limited); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Peleg reports receiving consulting fees from Abbott Molecular and Ortho-McNeil-Janssen; and Dr. Hooper, serving on scientific advisory boards for Pfizer and Novexel, receiving consulting fees from Cubist, Johnson & Johnson, and Mutabilis, and receiving lecture fees from Daiichi-Sankyo. No other conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bergen PJ, 2008, J ANTIMICROB CHEMOTH, V61, P636, DOI 10.1093/jac/dkm511; Berton DC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006482.pub2; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Carratala J, 2007, ARCH INTERN MED, V167, P1393, DOI 10.1001/archinte.167.13.1393; Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Chopra I, 2008, LANCET INFECT DIS, V8, P133, DOI 10.1016/S1473-3099(08)70018-5; Duflo F, 2002, ANESTHESIOLOGY, V96, P74, DOI 10.1097/00000542-200201000-00018; Fagon JY, 2000, ANN INTERN MED, V132, P621, DOI 10.7326/0003-4819-132-8-200004180-00004; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Garnacho-Montero J, 2007, CRIT CARE MED, V35, P1888, DOI 10.1097/01.CCM.0000275389.31974.22; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Heyland DK, 2008, CRIT CARE MED, V36, P737, DOI 10.1097/01.CCM.0B013E31816203D6; HIDRON AI, 2009, INFECT CONT HOSP EP, V30, P107; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Jacobsen SM, 2008, CLIN MICROBIOL REV, V21, P26, DOI 10.1128/CMR.00019-07; Jaruratanasirikul S, 2005, ANTIMICROB AGENTS CH, V49, P1337, DOI 10.1128/AAC.49.4.1337-1339.2005; Jarvis WR, 2007, J HOSP INFECT, V65, P3, DOI 10.1016/S0195-6701(07)60005-X; Joffe AR, 2008, J CRIT CARE, V23, P82, DOI 10.1016/j.jcrc.2007.12.006; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kollef KE, 2008, CHEST, V134, P281, DOI 10.1378/chest.08-1116; Kollef MH, 2005, CHEST, V128, P3854, DOI 10.1378/chest.128.6.3854; Kollef MH, 2006, CHEST, V129, P1210, DOI 10.1378/chest.129.5.1210; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Navon-Venezia S, 2009, ANTIMICROB AGENTS CH, V53, P818, DOI 10.1128/AAC.00987-08; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Paterson DL, 2007, CRIT CARE MED, V35, P1789, DOI 10.1097/01.CCM.0000269352.39174.A4; Peleg AY, 2007, J ANTIMICROB CHEMOTH, V59, P128, DOI 10.1093/jac/dkl441; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Shorr AF, 2008, ARCH INTERN MED, V168, P2205, DOI 10.1001/archinte.168.20.2205; Shorr AF, 2008, J CRIT CARE, V23, P64, DOI 10.1016/j.jcrc.2007.11.010; Souli M, 2008, EURO SURVEILL, V13, P19045; Stone PW, 2005, AM J INFECT CONTROL, V33, P542, DOI 10.1016/j.ajic.2005.08.003; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Tam VH, 2005, ANTIMICROB AGENTS CH, V49, P4920, DOI 10.1128/AAC.49.12.4920-4927.2005; Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678; Tenke P, 2008, INT J ANTIMICROB AG, V31, pS68, DOI 10.1016/j.ijantimicag.2007.07.033; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Valencia R, 2009, INFECT CONT HOSP EP, V30, P257, DOI 10.1086/595977; Wallace SJ, 2008, ANTIMICROB AGENTS CH, V52, P1159, DOI 10.1128/AAC.01101-07; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	51	912	974	4	164	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1804	1813		10.1056/NEJMra0904124	http://dx.doi.org/10.1056/NEJMra0904124			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463340	Green Accepted			2022-12-28	WOS:000277555500007
J	Janssen, MA; Holahan, R; Lee, A; Ostrom, E				Janssen, Marco A.; Holahan, Robert; Lee, Allen; Ostrom, Elinor			Lab Experiments for the Study of Social-Ecological Systems	SCIENCE			English	Article							PUBLIC-GOODS; PUNISHMENT; INSTITUTIONS; COOPERATION; COMMUNICATION; CULTURE; COMMONS; GOVERN	Governance of social-ecological systems is a major policy problem of the contemporary era. Field studies of fisheries, forests, and pastoral and water resources have identified many variables that influence the outcomes of governance efforts. We introduce an experimental environment that involves spatial and temporal resource dynamics in order to capture these two critical variables identified in field research. Previous behavioral experiments of commons dilemmas have found that people are willing to engage in costly punishment, frequently generating increases in gross benefits, contrary to game-theoretical predictions based on a static pay-off function. Results in our experimental environment find that costly punishment is again used but lacks a gross positive effect on resource harvesting unless combined with communication. These findings illustrate the importance of careful generalization from the laboratory to the world of policy.	[Janssen, Marco A.; Lee, Allen; Ostrom, Elinor] Arizona State Univ, Tempe, AZ 85287 USA; [Holahan, Robert; Ostrom, Elinor] Indiana Univ, Bloomington, IN 47408 USA	Arizona State University; Arizona State University-Tempe; Indiana University System; Indiana University Bloomington	Janssen, MA (corresponding author), Arizona State Univ, POB 872402, Tempe, AZ 85287 USA.	Marco.Janssen@asu.edu		Lee, Allen/0000-0002-6523-6079	U.S. NSF [BCS 0625354, SES 0748632]	U.S. NSF(National Science Foundation (NSF))	This research was funded by the U.S. NSF (grants BCS 0625354 and SES 0748632). We thank R. Goldstone, R. Tobias, J. Walker, and the Workshop's Experimental Reading Group for helpful comments and the Interdisciplinary Experimental Laboratory at Indiana University for providing use of its facility.	Bochet O, 2006, J ECON BEHAV ORGAN, V60, P11, DOI 10.1016/j.jebo.2003.06.006; Bochet O, 2009, EUR ECON REV, V53, P309, DOI 10.1016/j.euroecorev.2008.09.005; Bornstein G., 1992, SOCIAL DILEMMAS THEO, P247; BREHMER B, 1992, ACTA PSYCHOL, V81, P211, DOI 10.1016/0001-6918(92)90019-A; Buchan NR, 2006, J ECON BEHAV ORGAN, V60, P373, DOI 10.1016/j.jebo.2004.03.017; Casari M, 2009, J ECON BEHAV ORGAN, V71, P273, DOI 10.1016/j.jebo.2009.03.022; CLARK CW, 2006, WORLDWIDE CRISIS FIS; Dasgupta P., 1979, EC THEORY EXHAUSTIBL; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Du┬rner D., 1996, LOGIC FAILURE; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Goldstone RL, 2008, CURR DIR PSYCHOL SCI, V17, P10, DOI 10.1111/j.1467-8721.2008.00539.x; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Messick D. M., 1983, REV PERSONALITY SOCI, V4, P11; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Radovich J., 1981, RESOURCE MANAGEMENT, P107; SCHLAGER E, 1994, LAND ECON, V70, P294, DOI 10.2307/3146531; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; WILSON JA, 1994, MAR POLICY, V18, P291, DOI 10.1016/0308-597X(94)90044-2	29	204	207	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					613	617		10.1126/science.1183532	http://dx.doi.org/10.1126/science.1183532			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589OJ	20431012				2022-12-28	WOS:000277159800041
J	Ferry, G				Ferry, Georgina			The making of an exceptional scientist	NATURE			English	Editorial Material												mgf@georginaferry.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1268	1270		10.1038/4641268a	http://dx.doi.org/10.1038/4641268a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	589LI	20428143				2022-12-28	WOS:000277149000017
J	Karunadasa, HI; Chang, CJ; Long, JR				Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.			A molecular molybdenum-oxo catalyst for generating hydrogen from water	NATURE			English	Article							TRANSITION-METAL-COMPLEXES; ACTIVE-SITE; OXIDATIVE ADDITION; LOW OVERPOTENTIALS; EVOLUTION; CHEMISTRY; ENZYMES; MODELS; H-2	A growing awareness of issues related to anthropogenic climate change and an increase in global energy demand have made the search for viable carbon-neutral sources of renewable energy one of the most important challenges in science today(1). The chemical community is therefore seeking efficient and inexpensive catalysts that can produce large quantities of hydrogen gas from water(1-7). Here we identify a molybdenum-oxo complex that can catalytically generate gaseous hydrogen either from water at neutral pH or from sea water. This work shows that high-valency metal-oxo species can be used to create reduction catalysts that are robust and functional in water, a concept that has broad implications for the design of 'green' and sustainable chemistry cycles.	[Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Karunadasa, Hemamala I.; Chang, Christopher J.; Long, Jeffrey R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Chang, Christopher J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Chang, CJ (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	chrischang@berkeley.edu; jrlong@berkeley.edu	Karunadasa, Hemamala I./ABE-6223-2020		NSF [CHE-0617063]; Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; Tyco Electronics	NSF(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Tyco Electronics	We acknowledge the NSF (grant number CHE-0617063) for research funding in the initial stages of this project. For the later stages, we acknowledge the Helios Solar Energy Research Center, which is supported by the Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract number DE-AC02-05CH11231. C. J. C. is an Investigator with the Howard Hughes Medical Institute. We thank Tyco Electronics for the partial support of H. I. K. We also thank M. Majda for discussions, D. M. Jenkins and P. Dechambenoit for experimental assistance, A. T. Iavarone for obtaining the mass spectra, and J. D. Breen for fabrication of the electrochemical cells.	Appel AM, 2005, J AM CHEM SOC, V127, P12717, DOI 10.1021/ja054034o; Armstrong FA, 2004, CURR OPIN CHEM BIOL, V8, P133, DOI 10.1016/j.cbpa.2004.02.004; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Baffert C, 2007, INORG CHEM, V46, P1817, DOI 10.1021/ic061625m; Bernhardt PV, 1999, INORG CHEM, V38, P5086, DOI 10.1021/ic981425d; Blum O, 2002, J AM CHEM SOC, V124, P11456, DOI 10.1021/ja012611c; COLLIN JP, 1988, INORG CHEM, V27, P1986, DOI 10.1021/ic00284a030; Dance I, 2005, J AM CHEM SOC, V127, P10925, DOI 10.1021/ja0504946; Darensbourg MY, 2003, P NATL ACAD SCI USA, V100, P3683, DOI 10.1073/pnas.0536955100; Du PW, 2008, J AM CHEM SOC, V130, P12576, DOI 10.1021/ja804650g; Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; Felton GAN, 2007, J AM CHEM SOC, V129, P12521, DOI 10.1021/ja073886g; Fihri A, 2008, ANGEW CHEM INT EDIT, V47, P564, DOI 10.1002/anie.200702953; Frey M, 2002, CHEMBIOCHEM, V3, P153, DOI 10.1002/1439-7633(20020301)3:2/3<153::AID-CBIC153>3.0.CO;2-B; Gebbink RJMK, 2002, INORG CHEM, V41, P4633, DOI 10.1021/ic025617r; Gloaguen F, 2009, CHEM SOC REV, V38, P100, DOI 10.1039/b801796b; Goldsmith JI, 2005, J AM CHEM SOC, V127, P7502, DOI 10.1021/ja0427101; Hinnemann B, 2005, J AM CHEM SOC, V127, P5308, DOI 10.1021/ja0504690; Hu XL, 2007, J AM CHEM SOC, V129, P8988, DOI 10.1021/ja067876b; JAKSIC MM, 1966, ELECTROCHEM TECHNOL, V4, P49; Jaramillo TF, 2007, SCIENCE, V317, P100, DOI 10.1126/science.1141483; Kohl SW, 2009, SCIENCE, V324, P74, DOI 10.1126/science.1168600; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Ozerov OV, 2009, CHEM SOC REV, V38, P83, DOI 10.1039/b802420k; Sun LC, 2005, COORDIN CHEM REV, V249, P1653, DOI 10.1016/j.ccr.2005.01.013; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y; Yoon M, 1997, CHEM COMMUN, P639, DOI 10.1039/a700087a	30	560	562	8	330	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1329	1333		10.1038/nature08969	http://dx.doi.org/10.1038/nature08969			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428167				2022-12-28	WOS:000277149000042
J	Carr, DB; Ott, BR				Carr, David B.; Ott, Brian R.			The Older Adult Driver With Cognitive Impairment: "It's a Very Frustrating Life"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MOTOR-VEHICLE CRASHES; QUALITY STANDARDS SUBCOMMITTEE; EARLY ALZHEIMER-DISEASE; DRIVING PERFORMANCE; AMERICAN ASSOCIATION; GERIATRIC PSYCHIATRY; CONSENSUS CONFERENCE; PRACTICE PARAMETER; DEMENTIA; RISK		[Carr, David B.] Washington Univ, Dept Med, St Louis, MO 63017 USA; [Carr, David B.] Washington Univ, Dept Neurol, St Louis, MO 63017 USA; [Carr, David B.] Rehabil Inst St Louis, St Louis, MO USA; [Ott, Brian R.] Brown Univ, Dept Neurol, Warren Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Brown University	Carr, DB (corresponding author), Washington Univ, Dept Med, 4488 Forest Pk Ave, St Louis, MO 63017 USA.	dcarr@im.wustl.edu		Carr, David/0000-0003-2641-3850	Washington University Alzheimer's Disease Research Center [P50AG05681]; Healthy Aging and Senile Dementia [P01AG03991, AG16335]; The SCAN Foundation; NATIONAL INSTITUTE ON AGING [R01AG016335, P01AG003991, P50AG005681] Funding Source: NIH RePORTER	Washington University Alzheimer's Disease Research Center; Healthy Aging and Senile Dementia; The SCAN Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	and serving as a paid speaker for Forrest. Funding/Support: This work was supported in part by the Washington University Alzheimer's Disease Research Center (P50AG05681, J. Morris, principal investigator [PI]), the program project, Healthy Aging and Senile Dementia (P01AG03991, J. Morris, PI), and grant AG16335 (B. Ott, PI) from the NIA. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	*ALZH ASS, 2001, POS STAT DRIV; *AM MED ASS, 2010, AM MED ASS PHYS GUID; *AM MED ASS COD ME, OP 2 24 IMP DRIV THE; [Anonymous], 1997, Am J Psychiatry, V154, P1; Arbesman M, 2007, DRIVING COMMUNITY MO; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bedard M, 1998, ALZ DIS ASSOC DIS, V12, P135; Bedard M, 2008, TRAFFIC INJ PREV, V9, P336, DOI 10.1080/15389580802117184; Berndt A, 2008, AUSTRALAS J AGEING, V27, P157, DOI 10.1111/j.1741-6612.2008.00300.x; Brown LB, 2005, ARCH CLIN NEUROPSYCH, V20, P209, DOI 10.1016/j.acn.2004.06.003; Byszewski AM, 2003, J AM GERIATR SOC, V51, P1484, DOI 10.1046/j.1532-5415.2003.51483.x; Canadian Medical Association, 2006, CMA DRIVERS GUIDE DE; Carr DB, 2000, J AM GERIATR SOC, V48, P18, DOI 10.1111/j.1532-5415.2000.tb03023.x; Charlton JL., 2004, MONASH U ACCIDENT RE, P482; Cox D J, 1998, J Am Board Fam Pract, V11, P264; Croston J, 2009, TOP GERIATR REHABIL, V25, P154; DAIELLO LA, J CLIN PSYC IN PRESS; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; de Simone V, 2007, DEMENT GERIATR COGN, V23, P1, DOI 10.1159/000096317; DOBBS BM, MED CONDITIONS REV L; DOBBS BM, 2002, NHTSA PUBLICATION; DRACHMAN DA, 1993, NEUROLOGY, V43, P2448, DOI 10.1212/WNL.43.12.2448; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; DUBINSKY RM, 1992, J AM GERIATR SOC, V40, P1112, DOI 10.1111/j.1532-5415.1992.tb01799.x; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; FITTEN LJ, 1995, JAMA-J AM MED ASSOC, V273, P1360, DOI 10.1001/jama.273.17.1360; Foley DJ, 2000, J AM GERIATR SOC, V48, P928, DOI 10.1111/j.1532-5415.2000.tb06889.x; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Freeman EE, 2006, AM J PUBLIC HEALTH, V96, P1254, DOI 10.2105/AJPH.2005.069146; Freund B, 2002, J AM GERIATR SOC, V50, P1309, DOI 10.1046/j.1532-5415.2002.50325.x; FRIEDLAND RP, 1988, ANN NEUROL, V24, P782, DOI 10.1002/ana.410240613; Frittelli C, 2009, INT J GERIATR PSYCH, V24, P232, DOI 10.1002/gps.2095; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Johansson K, 1997, ALZ DIS ASSOC DIS, V11, P62, DOI 10.1097/00002093-199706001-00013; Kelly R, 1999, POSTGRAD MED J, V75, P537, DOI 10.1136/pgmj.75.887.537; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Langford J, 2008, ACCIDENT ANAL PREV, V40, P1913, DOI 10.1016/j.aap.2008.08.010; Leproust S, 2008, J GEN INTERN MED, V23, P1796, DOI 10.1007/s11606-008-0777-8; Lesikar Sandra E, 2002, J Am Board Fam Pract, V15, P11; Lincoln NB, 2010, INT J GERIATR PSYCH, V25, P489, DOI 10.1002/gps.2367; LOCOCO K, 2008, MED RELATED IMPAIRED; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Marmeleira JF, 2009, ACCIDENT ANAL PREV, V41, P90, DOI 10.1016/j.aap.2008.09.008; Marottoli RA, 2000, J GERONTOL B-PSYCHOL, V55, pS334, DOI 10.1093/geronb/55.6.S334; Martin AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006222.pub2; McCarthy DP, 2006, TOP GERIATR REHABIL, V22, P139; Meuser TM, 2006, GERONTOLOGIST, V46, P680, DOI 10.1093/geront/46.5.680; Meuser TM, 2009, ACCIDENT ANAL PREV, V41, P246, DOI 10.1016/j.aap.2008.11.003; Mezuk B, 2008, J GERONTOL B-PSYCHOL, V63, pS298, DOI 10.1093/geronb/63.5.S298; Molnar FJ, 2006, J AM GERIATR SOC, V54, P1809, DOI 10.1111/j.1532-5415.2006.00967.x; Nasvadi GC, 2009, GERONTOLOGIST, V49, P474, DOI 10.1093/geront/gnp039; Odenheimer G L, 1993, Clin Geriatr Med, V9, P349; Ott BR, 2000, DEMENT GERIATR COGN, V11, P153, DOI 10.1159/000017229; Ott BR, 2005, J AM GERIATR SOC, V53, P829, DOI 10.1111/j.1532-5415.2005.53265.x; Ott BR, 2008, J GERIATR PSYCH NEUR, V21, P18, DOI 10.1177/0891988707311031; Patterson CJS, 1999, CAN MED ASSOC J, V160, P1738; Perkinson MA, 2005, GERONTOLOGIST, V45, P676, DOI 10.1093/geront/45.5.676; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Rapoport MJ, 2007, CAN MED ASSOC J, V177, P599, DOI 10.1503/cmaj.070342; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Silverstein NM, 2008, GERONTOL GERIATR EDU, V29, P305, DOI 10.1080/02701960802497795; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; Snellgrove C, 2005, COGNITIVE SCREENING; Staplin L, 2003, J SAFETY RES, V34, P389, DOI 10.1016/j.jsr.2003.09.002; Stutts JC, 1998, ACCIDENT ANAL PREV, V30, P337, DOI 10.1016/S0001-4575(97)00108-5; Taylor BD, 2001, ACCIDENT ANAL PREV, V33, P519, DOI 10.1016/S0001-4575(00)00065-8; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; TUOKKO H, 1995, J GERONTOL B-PSYCHOL, V50, pS173, DOI 10.1093/geronb/50B.3.S173; Uc EY, 2008, CURR NEUROL NEUROSCI, V8, P377, DOI 10.1007/s11910-008-0059-1; Uc EY, 2004, NEUROLOGY, V63, P832, DOI 10.1212/01.WNL.0000139301.01177.35; Wadley VG, 2009, J GERIATR PSYCH NEUR, V22, P87, DOI 10.1177/0891988708328215; Wang CC, 2004, J AM GERIATR SOC, V52, P143, DOI 10.1111/j.1532-5415.2004.52025.x; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Zuin D, 2002, EUR J NEUROL, V9, P29, DOI 10.1046/j.1468-1331.2002.00296.x	78	117	118	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1632	1641		10.1001/jama.2010.481	http://dx.doi.org/10.1001/jama.2010.481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	588PQ	20424254	Green Accepted			2022-12-28	WOS:000277085200027
J	Paton, C				Paton, Calum			Personal View We could eschew "UK style" rationing here too	BRITISH MEDICAL JOURNAL			English	Editorial Material									Keele Univ, Keele, Staffs, England	Keele University	Paton, C (corresponding author), Keele Univ, Keele, Staffs, England.	c.paton@keele.ac.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 28	2010	340								c1136	10.1136/bmj.c1136	http://dx.doi.org/10.1136/bmj.c1136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591PN	20427443				2022-12-28	WOS:000277314200001
J	Blumberg, HM; Migliori, GB; Ponomarenko, O; Heldal, E				Blumberg, Henry M.; Migliori, Giovanni B.; Ponomarenko, Oksana; Heldal, Einar			Tuberculosis on the move	LANCET			English	Editorial Material							MIGRANTS; COUNTRIES; EPIDEMIOLOGY; IMPACT		[Blumberg, Henry M.] Emory Univ, Div Infect Dis, Atlanta, GA 30303 USA; [Migliori, Giovanni B.] WHO, Collaborating Ctr TB & Lung Dis, Fdn S Maugeri, Care & Res Inst, Tradate, Italy; [Ponomarenko, Oksana] Partners Hlth, Representat Off Russian Federat, Moscow, Russia; [Heldal, Einar] Norwegian Inst Publ Hlth, Oslo, Norway	Emory University; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; Norwegian Institute of Public Health (NIPH)	Blumberg, HM (corresponding author), Emory Univ, Div Infect Dis, Atlanta, GA 30303 USA.	hblumbe@emory.edu	Migliori, Giovanni Battista/AAB-8589-2020; Blumberg, Henry/W-2156-2019	Migliori, Giovanni Battista/0000-0002-2597-574X; Blumberg, Henry/0000-0002-3110-2443	FIC NIH HHS [D43 TW007124] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; European Centre for Disease Prevention and Control (ECDC), 2009, MIGR HLTH BACKGR NOT; Hargreaves S, 2009, LANCET INFECT DIS, V9, P139, DOI 10.1016/S1473-3099(09)70026-X; Heldal E, 2008, INT J TUBERC LUNG D, V12, P878; International_Union_Against_Tuberculosis_and_Lung_Disease, 2008, REC ENS DIAGN TREATM; Schwartzman K, 2005, NEW ENGL J MED, V353, P1008, DOI 10.1056/NEJMsa043194; Stop TB Partnership, GLOB PLAN STOP TB; *UN DEV PROGR, HUM DEV REP 2009 OV; United Nations High Commission for Refugees, 2009, 2008 GLOB TRENDS REF; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; Zhang LX, 2006, INT J TUBERC LUNG D, V10, P959; 2008, 61 WORLD HLTH ASS HL	14	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2127	2129		10.1016/S0140-6736(10)60574-0	http://dx.doi.org/10.1016/S0140-6736(10)60574-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20488513				2022-12-28	WOS:000279255100007
J	Leoncini, G; Viazzi, F; Pontremoli, R				Leoncini, Giovanna; Viazzi, Francesca; Pontremoli, Roberto			Overall health assessment: a renal perspective	LANCET			English	Editorial Material							CHRONIC KIDNEY-DISEASE; RISK		[Pontremoli, Roberto] Univ Genoa, Dept Cardionephrol, I-16132 Genoa, Italy; Univ Genoa, Dept Internal Med, Azienda Osped Univ San Martino, I-16132 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST	Pontremoli, R (corresponding author), Univ Genoa, Dept Cardionephrol, I-16132 Genoa, Italy.	roberto.pontremoli@unige.it	Viazzi, Francesca/AAB-2479-2019	Pontremoli, Roberto/0000-0003-1238-872X; Viazzi, Francesca/0000-0003-4219-7043				Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Viazzi F, 2005, J AM SOC NEPHROL, V16, pS89, DOI 10.1681/ASN.2004110956; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Yuyun MF, 2004, INT J EPIDEMIOL, V33, P189, DOI 10.1093/ije/dyh008	12	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2053	2054		10.1016/S0140-6736(10)60748-9	http://dx.doi.org/10.1016/S0140-6736(10)60748-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20483450				2022-12-28	WOS:000279069300004
J	Mucke, M; Figueroa, E; Bochmann, J; Hahn, C; Murr, K; Ritter, S; Villas-Boas, CJ; Rempe, G				Muecke, Martin; Figueroa, Eden; Bochmann, Joerg; Hahn, Carolin; Murr, Karim; Ritter, Stephan; Villas-Boas, Celso J.; Rempe, Gerhard			Electromagnetically induced transparency with single atoms in a cavity	NATURE			English	Article							STRONGLY INTERACTING PHOTONS; GENERATION	Optical nonlinearities offer unique possibilities for the control of light with light. A prominent example is electromagnetically induced transparency (EIT), where the transmission of a probe beam through an optically dense medium is manipulated by means of a control beam(1-3). Scaling such experiments into the quantum domain with one (or just a few) particles of light and matter will allow for the implementation of quantum computing protocols with atoms and photons(4-7), or the realization of strongly interacting photon gases exhibiting quantum phase transitions of light(8,9). Reaching these aims is challenging and requires an enhanced matter-light interaction, as provided by cavity quantum electrodynamics(10-12). Here we demonstrate EIT with a single atom quasi-permanently trapped inside a high-finesse optical cavity. The atom acts as a quantum-optical transistor with the ability to coherently control(13) the transmission of light through the cavity. We investigate the scaling of EIT when the atom number is increased one-by-one. The measured spectra are in excellent agreement with a theoretical model. Merging EIT with cavity quantum electrodynamics and single quanta of matter is likely to become the cornerstone for novel applications, such as dynamic control of the photon statistics of propagating light fields(14) or the engineering of Fock state superpositions of flying light pulses(15)	[Muecke, Martin; Figueroa, Eden; Bochmann, Joerg; Hahn, Carolin; Murr, Karim; Ritter, Stephan; Villas-Boas, Celso J.; Rempe, Gerhard] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Villas-Boas, Celso J.] Univ Fed Sao Carlos, Dept Fis, BR-13565905 Sao Paulo, Brazil	Max Planck Society; Universidade Federal de Sao Carlos	Figueroa, E (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	eden.figueroa@mpq.mpg.de	Villas-Boas, Celso J/E-8984-2012; Ritter, Stephan/F-1579-2010; Villas-Boas, Celso/P-2651-2019; quantica, Inct Informacao/H-9493-2013	Villas-Boas, Celso J/0000-0001-5622-786X; Ritter, Stephan/0000-0001-9002-7407; Villas-Boas, Celso/0000-0001-5622-786X; 	Deutsche Forschungsgemeinschaft (Research Unit) [635]; European Union (IST); Alexander von Humboldt Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Brazilian National Institute for Science and Technology of Quantum Information (INCT-IQ)	Deutsche Forschungsgemeinschaft (Research Unit)(German Research Foundation (DFG)); European Union (IST)(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Institute for Science and Technology of Quantum Information (INCT-IQ)	We thank D. L. Moehring, H. P. Specht, C. Nolleke, A. Neuzner and C. Guhl for their contributions during the early stages of the experiment. This work was supported by the Deutsche Forschungsgemeinschaft (Research Unit 635) and the European Union (IST programmes SCALA and AQUTE). E. F. acknowledges support from the Alexander von Humboldt Foundation. C.J.V.-B. acknowledges support from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and the Brazilian National Institute for Science and Technology of Quantum Information (INCT-IQ).	Bermel P, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.043818; Birnbaum KM, 2005, NATURE, V436, P87, DOI 10.1038/nature03804; Boozer AD, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.193601; Cardimona DA, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063817; Figueroa E, 2006, OPT LETT, V31, P2625, DOI 10.1364/OL.31.002625; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Grangier P, 1998, PHYS REV LETT, V81, P2833, DOI 10.1103/PhysRevLett.81.2833; Greentree AD, 2006, NAT PHYS, V2, P856, DOI 10.1038/nphys466; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Hartmann MJ, 2006, NAT PHYS, V2, P849, DOI 10.1038/nphys462; Hernandez G, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053814; Hwang J, 2009, NATURE, V460, P76, DOI 10.1038/nature08134; Imamoglu A, 1998, PHYS REV LETT, V81, P2836, DOI 10.1103/PhysRevLett.81.2836; Imamoglu A, 1997, PHYS REV LETT, V79, P1467, DOI 10.1103/PhysRevLett.79.1467; KAMPSCHULTE T, 2010, OPTICAL CONTROL REFR; Keller M, 2004, NATURE, V431, P1075, DOI 10.1038/nature02961; Khudaverdyan M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123006; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kuhn A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067901; Lukin MD, 2003, REV MOD PHYS, V75, P457, DOI 10.1103/RevModPhys.75.457; Lukin MD, 1998, OPT LETT, V23, P295, DOI 10.1364/OL.23.000295; McKeever J, 2004, SCIENCE, V303, P1992, DOI 10.1126/science.1095232; NIKOGHOSYAN G, 2009, PHOTON NUMBER SELECT; Nussmann S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.173602; Rebic S, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063804; Rebic S, 1999, J OPT B-QUANTUM S O, V1, P490, DOI 10.1088/1464-4266/1/4/322; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Schuster I, 2008, NAT PHYS, V4, P382, DOI 10.1038/nphys940; Werner MJ, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.011801; Wilk T, 2007, SCIENCE, V317, P488, DOI 10.1126/science.1143835; Wu HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.173602; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120	33	227	228	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					755	758		10.1038/nature09093	http://dx.doi.org/10.1038/nature09093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20463661	Green Submitted			2022-12-28	WOS:000278551800039
J	Yu, SY; Colman, SM; Lowell, TV; Milne, GA; Fisher, TG; Breckenridge, A; Boyd, M; Teller, JT				Yu, Shi-Yong; Colman, Steven M.; Lowell, Thomas V.; Milne, Glenn A.; Fisher, Timothy G.; Breckenridge, Andy; Boyd, Matthew; Teller, James T.			Freshwater Outburst from Lake Superior as a Trigger for the Cold Event 9300 Years Ago	SCIENCE			English	Article							COMPUTING 3-DIMENSIONAL DEFORMATIONS; GLACIAL ISOSTATIC-ADJUSTMENT; LAURENTIDE ICE-SHEET; EARLY HOLOCENE; GREAT-LAKES; SPECTRAL FORMALISM; NORTH-ATLANTIC; SURFACE LOADS; RECORD; EARTH	Paleoclimate proxy records reveal a pervasive cooling event with a Northern Hemispheric extent similar to 9300 years ago. Coeval changes in the oceanic circulation of the North Atlantic imply freshwater forcing. However, the source, magnitude, and routing of meltwater have remained unknown. Located in central North America, Lake Superior is a key site for regulating the outflow of glacial meltwater to the oceans. Here, we show evidence for an similar to 45-meter rapid lake-level fall in this basin, centered on 9300 calibrated years before the present, due to the failure of a glacial drift dam on the southeast corner of the lake. We ascribe the widespread climate anomaly similar to 9300 years ago to this freshwater outburst delivered to the North Atlantic Ocean through the Lake Huron-North Bay-Ottawa River-St. Lawrence River valleys.	[Yu, Shi-Yong; Colman, Steven M.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Yu, Shi-Yong] Tulane Univ, Dept Earth & Environm Sci, New Orleans, LA 70118 USA; [Colman, Steven M.] Univ Minnesota, Dept Geol Sci, Duluth, MN 55812 USA; [Lowell, Thomas V.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Milne, Glenn A.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Fisher, Timothy G.] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA; [Breckenridge, Andy] Mercyhurst Coll, Dept Geol, Erie, PA 16546 USA; [Boyd, Matthew] Lakehead Univ, Dept Anthropol, Thunder Bay, ON P7B 5E1, Canada; [Teller, James T.] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of Minnesota System; University of Minnesota Duluth; Tulane University; University of Minnesota System; University of Minnesota Duluth; University System of Ohio; University of Cincinnati; University of Ottawa; University System of Ohio; University of Toledo; Lakehead University; University of Manitoba	Yu, SY (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.	syu2@tulane.edu	Fisher, Timothy G/C-2609-2011; Colman, Steven M/E-4658-2012	Lowell, Thomas/0000-0001-7826-0636	University of Minnesota Duluth; Comer Science and Education Foundation; Canada Research Chairs program; Natural Sciences and Engineering Research Council (NSERC) of Canada	University of Minnesota Duluth(University of Minnesota System); Comer Science and Education Foundation; Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	S.Y.Y. thanks the University of Minnesota Duluth for providing financial support for this work. T. V. L. thanks the Comer Science and Education Foundation for support of this work. G. A. M. acknowledges support from the Canada Research Chairs program and the Natural Sciences and Engineering Research Council (NSERC) of Canada. J.T.T. thanks the NSERC of Canada for support through the Discovery Grants Program. We are indebted to the Sleeping Giant National Park, Ontario, for allowing us access to and coring of the lakes on southern Sibley Peninsula of Ontario. Our gratitude is also extended to A. Noren, A. Myrbo, and K. Brady at the National Lacustrine Core Repository, University of Minnesota Twin Cities, for their kind assistance in core logging, and to two anonymous reviewers for comments.	Alley RB, 1997, GEOLOGY, V25, P483, DOI 10.1130/0091-7613(1997)025<0483:HCIAPW>2.3.CO;2; Barber DC, 1999, NATURE, V400, P344, DOI 10.1038/22504; Boch R, 2009, QUATERNARY SCI REV, V28, P2527, DOI 10.1016/j.quascirev.2009.05.015; Breckenridge A, 2009, QUATERNARY RES, V71, P397, DOI 10.1016/j.yqres.2009.01.003; Cai BG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL030986; Came RE, 2007, GEOLOGY, V35, P315, DOI 10.1130/G23455A.1; Carlson AE, 2008, NAT GEOSCI, V1, P620, DOI 10.1038/ngeo285; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; COLMAN SM, 1994, GEOLOGY, V22, P547, DOI 10.1130/0091-7613(1994)022<0547:TEOMIF>2.3.CO;2; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Farrand W.R., 1985, 30 GEOL ASS CAN, P17; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; Fleitmann D, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001519; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hillaire-Marcel C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030396; Johnston JW, 2004, J GREAT LAKES RES, V30, P1, DOI 10.1016/S0380-1330(04)70374-3; LARSEN CE, 1994, J GREAT LAKES RES, V20, P108, DOI 10.1016/S0380-1330(94)71135-7; LEWIS C F M, 1989, Journal of Paleolimnology, V2, P99; Lewis C.F.M., 2005, GEOG PHYS QUATERN, V59, P187, DOI DOI 10.7202/014754AR; Mainville A, 2005, GEOL SOC AM BULL, V117, P1070, DOI 10.1130/B25392.1; Marshall JD, 2007, GEOLOGY, V35, P639, DOI 10.1130/G23498A.1; McFadden MA, 2004, LIMNOL OCEANOGR, V49, P1570, DOI 10.4319/lo.2004.49.5.1570; MITROVICA JX, 1994, J GEOPHYS RES-SOL EA, V99, P7075, DOI 10.1029/93JB03401; Mitrovica JX, 2001, GEOPHYS J INT, V147, P562, DOI 10.1046/j.1365-246x.2001.01550.x; MITROVICA JX, 1994, J GEOPHYS RES-SOL EA, V99, P7057, DOI 10.1029/93JB03128; Moore TC, 2000, PALEOCEANOGRAPHY, V15, P4, DOI 10.1029/1999PA000437; Oppo DW, 2003, NATURE, V422, P277, DOI 10.1038/422277b; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; Rasmussen SO, 2007, QUATERNARY SCI REV, V26, P1907, DOI 10.1016/j.quascirev.2007.06.015; REA DK, 1994, CAN J EARTH SCI, V31, P1586, DOI 10.1139/e94-141; SAARNISTO M, 1975, CAN J EARTH SCI, V12, P300, DOI 10.1139/e75-026; Tevesz MJS, 1998, J PALEOLIMNOL, V20, P295, DOI 10.1023/A:1007976400698; Thornalley DJR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001772; TUSHINGHAM AM, 1991, J GEOPHYS RES-SOLID, V96, P4497, DOI 10.1029/90JB01583; von Grafenstein U, 1999, SCIENCE, V284, P1654, DOI 10.1126/science.284.5420.1654	37	92	93	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1262	1266		10.1126/science.1187860	http://dx.doi.org/10.1126/science.1187860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20430972				2022-12-28	WOS:000278318600030
J	Guiguemde, WA; Shelat, AA; Bouck, D; Duffy, S; Crowther, GJ; Davis, PH; Smithson, DC; Connelly, M; Clark, J; Zhu, FY; Jimenez-Diaz, MB; Martinez, MS; Wilson, EB; Tripathi, AK; Gut, J; Sharlow, ER; Bathurst, I; El Mazouni, F; Fowble, JW; Forquer, I; McGinley, PL; Castro, S; Angulo-Barturen, I; Ferrer, S; Rosenthal, PJ; DeRisi, JL; Sullivan, DJ; Lazo, JS; Roos, DS; Riscoe, MK; Phillips, MA; Rathod, PK; Van Voorhis, WC; Avery, VM; Guy, RK				Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Duffy, Sandra; Crowther, Gregory J.; Davis, Paul H.; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Jimenez-Diaz, Maria B.; Martinez, Maria S.; Wilson, Emily B.; Tripathi, Abhai K.; Gut, Jiri; Sharlow, Elizabeth R.; Bathurst, Ian; El Mazouni, Farah; Fowble, Joseph W.; Forquer, Isaac; McGinley, Paula L.; Castro, Steve; Angulo-Barturen, Inigo; Ferrer, Santiago; Rosenthal, Philip J.; DeRisi, Joseph L.; Sullivan, David J., Jr.; Lazo, John S.; Roos, David S.; Riscoe, Michael K.; Phillips, Margaret A.; Rathod, Pradipsinh K.; Van Voorhis, Wesley C.; Avery, Vicky M.; Guy, R. Kiplin			Chemical genetics of Plasmodium falciparum	NATURE			English	Article							MALARIA; IDENTIFICATION; DISRUPTION; RESISTANCE; SURVIVAL; GROWTH	Malaria caused by Plasmodium falciparum is a disease that is responsible for 880,000 deaths per year worldwide. Vaccine development has proved difficult and resistance has emerged for most antimalarial drugs. To discover new antimalarial chemotypes, we have used a phenotypic forward chemical genetic approach to assay 309,474 chemicals. Here we disclose structures and biological activity of the entire library-many of which showed potent in vitro activity against drug-resistant P. falciparum strains-and detailed profiling of 172 representative candidates. A reverse chemical genetic study identified 19 new inhibitors of 4 validated drug targets and 15 novel binders among 61 malarial proteins. Phylochemogenetic profiling in several organisms revealed similarities between Toxoplasma gondii and mammalian cell lines and dissimilarities between P. falciparum and related protozoans. One exemplar compound displayed efficacy in a murine model. Our findings provide the scientific community with new starting points for malaria drug discovery.	[Guiguemde, W. Armand; Shelat, Anang A.; Bouck, David; Smithson, David C.; Connelly, Michele; Clark, Julie; Zhu, Fangyi; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Duffy, Sandra; Avery, Vicky M.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Brisbane, Qld 4111, Australia; [Crowther, Gregory J.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Davis, Paul H.; Roos, David S.] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Davis, Paul H.; Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Jimenez-Diaz, Maria B.; Martinez, Maria S.; Angulo-Barturen, Inigo; Ferrer, Santiago] GlaxoSmithKline, Dis Developing World, Tres Cantos 28760, Spain; [Wilson, Emily B.; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tripathi, Abhai K.; Sullivan, David J., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Gut, Jiri; Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA; [Sharlow, Elizabeth R.; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Bathurst, Ian] Med Malaria Venture, CH-1215 Geneva, Switzerland; [El Mazouni, Farah; Phillips, Margaret A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Fowble, Joseph W.; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Forquer, Isaac; Riscoe, Michael K.] Portland VA Med Ctr, Expt Chemotherapy Lab, Portland, OR 97239 USA; [McGinley, Paula L.; Castro, Steve] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	St Jude Children's Research Hospital; Griffith University; University of Washington; University of Washington Seattle; University of Pennsylvania; University of Pennsylvania; GlaxoSmithKline; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Rutgers State University New Brunswick	Guy, RK (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA.	kip.guy@stjude.org	Avery, Vicky M/A-5449-2010; Ferrer-Bazaga, Santiago/AAA-7749-2021; duffy, sandra/AAX-7527-2021; Davis, Paul H/J-6141-2012; Shelat, Anang/J-4995-2013; Guy, Rodney/J-7107-2013; duffy, sandra/B-8479-2017	Avery, Vicky M/0000-0003-4914-2299; Ferrer-Bazaga, Santiago/0000-0002-6672-551X; duffy, sandra/0000-0002-2814-1193; Davis, Paul H/0000-0002-0526-3841; Shelat, Anang/0000-0002-6266-2910; Guy, Rodney/0000-0002-9638-2060; duffy, sandra/0000-0002-2814-1193; Roos, David Siker/0000-0001-6725-4089; Bouck, David/0000-0002-6281-2544; Tripathi, Abhai/0000-0001-9848-0142; Crowther, Gregory/0000-0003-0530-9130	American Lebanese Syrian Associated Charities (ALSAC); St Jude Children's Research Hospital (SJCRH); Medicines for Malaria Venture; National Institute of Allergy and Infectious Diseases [AI772682, AI075517, AI067921, AI080625, AI28724, AI53862, AI35707, AI053680, AI075594, AI082617, AI045774]; National Cancer Institute [CA78039]; Welch Foundation [I-1257]; Doris Duke Charitable Foundation; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA078039] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI082617, R56AI053680, R01AI045774, U01AI053862, R01AI028724, P01AI067921, R37AI028724, R21AI053680, U01AI075517, U01AI075594, R01AI080625, F32AI077268, R01AI053680, P01AI035707] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St Jude Children's Research Hospital (SJCRH); Medicines for Malaria Venture; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the American Lebanese Syrian Associated Charities (ALSAC) and St Jude Children's Research Hospital (SJCRH, R. K. G.), the Medicines for Malaria Venture (W. C. V. V. and V. M. A.), National Institute of Allergy and Infectious Diseases (AI772682 (P. H. D.), AI075517 (R. K. G.), AI067921 (W. C. V. V.) and AI080625 (W. C. V. V.), AI28724 (D. S. R.), AI53862 (J.L.D.), AI35707 (P.J.R.), AI053680 (M. A. P. and P. K. R.), AI075594 (M. A. P., P. K. R. and I. B.), AI082617 (P. K. R.) and AI045774 (D.J.S.)), the National Cancer Institute (CA78039 (J.S.L.)), the Welch Foundation (I-1257 (M. A. P.)), the Doris Duke Charitable Foundation (P.J.R.), and the Ellison Medical Foundation (D. S. R.). We acknowledge A. B. Vaidya for providing the parasite strain D10_yDHOD. We acknowledge M. Sigal for assistance in the early leads project coordination, the SJCRH High Throughput Screening Center, particularly J. Cui; the SJCRH Lead Discovery Informatics Center, and the SJCRH High Throughput Analytical Chemistry Center, particularly C. Nelson and A. Lemoff; at UW, F. Buckner, W. Hol and A. Napuli (AI067921, W. Hol); S. Wei and W. Hao in the UT Southwestern HTS Center; and the Australian Red Cross Blood Service for the provision of O+ erythrocytes to Griffith University.	Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Cibulskis RE, 2007, AM J TROP MED HYG, V77, P133; Crowther GJ, 2009, J BIOMOL SCREEN, V14, P700, DOI 10.1177/1087057109335749; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Gujjar R, 2009, J MED CHEM, V52, P1864, DOI 10.1021/jm801343r; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Krnajski Z, 2002, J BIOL CHEM, V277, P25970, DOI 10.1074/jbc.M203539200; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; McFadden GI, 1999, TRENDS MICROBIOL, V7, P328, DOI 10.1016/S0966-842X(99)01547-4; Munos B, 2006, NAT REV DRUG DISCOV, V5, P723, DOI 10.1038/nrd2131; Patel V, 2008, J BIOL CHEM, V283, P35078, DOI 10.1074/jbc.M804990200; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Reynolds MG, 1998, J BIOL CHEM, V273, P3461, DOI 10.1074/jbc.273.6.3461; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Ritz C, 2005, J STAT SOFTW, V12, P1; Shelat AA, 2007, NAT CHEM BIOL, V3, P442, DOI 10.1038/nchembio0807-442; Shelat AA, 2007, CURR OPIN CHEM BIOL, V11, P244, DOI 10.1016/j.cbpa.2007.05.003; Shenai BR, 2003, ANTIMICROB AGENTS CH, V47, P154, DOI 10.1128/AAC.47.1.154-160.2003; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Sijwali PS, 2006, MOL BIOCHEM PARASIT, V150, P96, DOI 10.1016/j.molbiopara.2006.06.013; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	27	427	435	1	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					311	315		10.1038/nature09099	http://dx.doi.org/10.1038/nature09099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485428	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000277829200032
J	McCracken, CB				McCracken, Clinton B.			Intellectualization of Drug Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												clinton.mccracken1@gmail.com						ANNITTO WJ, 1991, DUAL DIAGNOSIS SUBST, P289; Bryson EO, 2008, ANESTHESIOLOGY, V109, P905, DOI 10.1097/ALN.0b013e3181895bc1; Griffith J, 1999, Nurs Forum, V34, P19, DOI 10.1111/j.1744-6198.1999.tb01167.x; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; WHITE RK, 1998, MD MED J, V37, P183	5	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1894	1895		10.1001/jama.2010.581	http://dx.doi.org/10.1001/jama.2010.581			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483960				2022-12-28	WOS:000277764500001
J	Burr, DB				Burr, David B.			Cortical bone: a target for fracture prevention?	LANCET			English	Editorial Material							PARATHYROID-HORMONE 1-34; MECHANICAL-PROPERTIES; POSTMENOPAUSAL WOMEN; OSTEOPOROSIS; POROSITY; STRENGTH; DENSITY; LY333334; RABBITS; MASS		Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46077 USA	Indiana University System; Indiana University Bloomington	Burr, DB (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46077 USA.	dburr@iupui.edu						Borah B, 2010, J BONE MINER RES, V25, P41, DOI 10.1359/jbmr.090711; Burr David B, 2005, Curr Osteoporos Rep, V3, P19, DOI 10.1007/s11914-005-0023-9; Hirano T, 1999, J BONE MINER RES, V14, P536, DOI 10.1359/jbmr.1999.14.4.536; Hodsman AB, 2000, BONE, V27, P311, DOI 10.1016/S8756-3282(00)00316-1; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8; Mashiba T, 2001, BONE, V28, P538, DOI 10.1016/S8756-3282(01)00433-1; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; RICE JC, 1988, J BIOMECH, V21, P155, DOI 10.1016/0021-9290(88)90008-5; ROCKOFF SD, 1969, CALC TISS RES, V3, P163, DOI 10.1007/BF02058659; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; SCHAFFLER MB, 1988, J BIOMECH, V21, P13, DOI 10.1016/0021-9290(88)90186-8; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	13	40	43	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 15	2010	375	9727					1672	1673		10.1016/S0140-6736(10)60444-8	http://dx.doi.org/10.1016/S0140-6736(10)60444-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472154				2022-12-28	WOS:000277890200007
J	Mason, A; McNeill, E; Wallace, AM; Connell, JM; Donaldson, MDC				Mason, A.; McNeill, E.; Wallace, A. M.; Connell, J. M.; Donaldson, M. D. C.			Lesson of the Week Sexual precocity in a 4 year old boy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TESTOSTERONE GEL; VIRILIZATION; EXPOSURE		[Mason, A.; McNeill, E.; Donaldson, M. D. C.] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Wallace, A. M.] Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland; [Connell, J. M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 4HN, Scotland	University of Glasgow; University of Glasgow; University of Dundee	Donaldson, MDC (corresponding author), Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland.	M.Donaldson@clinmed.gla.ac.uk		s, hema/0000-0002-3440-9475; Mason, Anne/0000-0002-5823-3064; Venkatasubramanian, Siddharth/0000-0002-5860-0768				Basaria S, 2001, J CLIN ENDOCR METAB, V86, P392, DOI 10.1210/jc.86.1.392; Brachet C, 2005, EUR J PEDIATR, V164, P646, DOI 10.1007/s00431-005-1714-z; de Ronde W, 2009, HUM REPROD, V24, P425, DOI 10.1093/humrep/den372; Kunz GJ, 2004, PEDIATRICS, V114, P282, DOI 10.1542/peds.114.1.282; Rolf C, 2002, CLIN ENDOCRINOL, V56, P637, DOI 10.1046/j.1365-2265.2002.01529.x; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Tanner JM., 1983, ASSESSMENT SKELETAL; Voelker R, 2009, JAMA-J AM MED ASSOC, V301, P2428, DOI 10.1001/jama.2009.810; Yu YM, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.2.e23	9	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2010	340								c2319	10.1136/bmj.c2319	http://dx.doi.org/10.1136/bmj.c2319			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598HS	20472676	Green Accepted			2022-12-28	WOS:000277826600013
J	Sanders, KM; Stuart, AL; Williamson, EJ; Simpson, JA; Kotowicz, MA; Young, D; Nicholson, GC				Sanders, Kerrie M.; Stuart, Amanda L.; Williamson, Elizabeth J.; Simpson, Julie A.; Kotowicz, Mark A.; Young, Doris; Nicholson, Geoffrey C.			Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							D SUPPLEMENTATION; DOUBLE-BLIND; CALCIUM SUPPLEMENTATION; ELDERLY-PEOPLE; HIP-FRACTURES; PREVENTION; RISK; POPULATION; BONE; MEN	Context Improving vitamin D status may be an important modifiable risk factor to reduce falls and fractures; however, adherence to daily supplementation is typically poor. Objective To determine whether a single annual dose of 500 000 IU of cholecalciferol administered orally to older women in autumn or winter would improve adherence and reduce the risk of falls and fracture. Design, Setting, and Participants A double-blind, placebo-controlled trial of 2256 community-dwelling women, aged 70 years or older, considered to be at high risk of fracture were recruited from June 2003 to June 2005 and were randomly assigned to receive cholecalciferol or placebo each autumn to winter for 3 to 5 years. The study concluded in 2008. Intervention 500 000 IU of cholecalciferol or placebo. Main Outcome Measures Falls and fractures were ascertained using monthly calendars; details were confirmed by telephone interview. Fractures were radiologically confirmed. In a substudy, 137 randomly selected participants underwent serial blood sampling for 25-hydroxycholecalciferol and parathyroid hormone levels. Results Women in the cholecalciferol (vitamin D) group had 171 fractures vs 135 in the placebo group; 837 women in the vitamin D group fell 2892 times (rate, 83.4 per 100 person-years) while 769 women in the placebo group fell 2512 times (rate, 72.7 per 100 person-years; incidence rate ratio [RR], 1.15; 95% confidence interval [CI], 1.02-1.30; P=.03). The incidence RR for fracture in the vitamin D group was 1.26 (95% CI, 1.00-1.59; P=.047) vs the placebo group (rates per 100 person-years, 4.9 vitamin D vs 3.9 placebo). A temporal pattern was observed in a post hoc analysis of falls. The incidence RR of falling in the vitamin D group vs the placebo group was 1.31 in the first 3 months after dosing and 1.13 during the following 9 months (test for homogeneity; P=.02). In the substudy, the median baseline serum 25-hydroxycholecalciferol was 49 nmol/L. Less than 3% of the substudy participants had 25-hydroxycholecalciferol levels lower than 25 nmol/L. In the vitamin D group, 25-hydroxycholecalciferol levels increased at 1 month after dosing to approximately 120 nmol/L, were approximately 90 nmol/L at 3 months, and remained higher than the placebo group 12 months after dosing. Conclusion Among older community-dwelling women, annual oral administration of high-dose cholecalciferol resulted in an increased risk of falls and fractures.	[Sanders, Kerrie M.; Stuart, Amanda L.; Kotowicz, Mark A.; Nicholson, Geoffrey C.] Univ Melbourne, Dept Clin & Biomed Sci, Geelong, Vic 3220, Australia; [Williamson, Elizabeth J.; Simpson, Julie A.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Carlton, Vic 3053, Australia; [Williamson, Elizabeth J.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Williamson, Elizabeth J.] Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Young, Doris] Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Sanders, KM (corresponding author), Univ Melbourne, Dept Clin & Biomed Sci, POB 281, Geelong, Vic 3220, Australia.	kerrie@barwonhealth.org.au	Nicholson, Geoffrey C/F-1901-2010; Simpson, Julie A/P-7299-2014; Sanders, Kerrie/A-1981-2011; Williamson, Elizabeth/H-3876-2019; Sanders, Kerrie/E-9033-2015; Kotowicz, Mark/AAI-4135-2021	Nicholson, Geoffrey C/0000-0002-0152-1153; Williamson, Elizabeth/0000-0001-6905-876X; Sanders, Kerrie/0000-0002-2718-6592; Simpson, Julie/0000-0002-2660-2013; Kotowicz, Mark/0000-0002-8094-1411	National Health and Medical Research Council [251682]; Australian Government Department of Health and Ageing	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The study was supported by project grant No. 251682 from the National Health and Medical Research Council and by the Australian Government Department of Health and Ageing.	Abrahamsen B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5463; ANGUS RM, 1989, J AM DIET ASSOC, V89, P209; Avenell A, 2009, COCHRANE DB SYST REV, V2; Bacon CJ, 2009, OSTEOPOROSIS INT, V20, P1407, DOI 10.1007/s00198-008-0814-9; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; CHAPUY MC, 1994, BRIT MED J, V308, P1081, DOI 10.1136/bmj.308.6936.1081; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cranney A, 2008, AM J CLIN NUTR, V88, p513S, DOI 10.1093/ajcn/88.2.513S; CUMMING R, 2000, AUSTRALASIAN EPIDEMI, V7, P10; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Heaney RP, 2008, NUTR REV, V66, pS178, DOI 10.1111/j.1753-4887.2008.00102.x; HEIKINHEIMO RJ, 1992, CALCIFIED TISSUE INT, V51, P105, DOI 10.1007/BF00298497; *HLTH CAN, VIT D REC REV STAT; Ilahi M, 2008, AM J CLIN NUTR, V87, P688, DOI 10.1093/ajcn/87.3.688; Izaks GJ, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-26; Jackson C, 2007, QJM-INT J MED, V100, P185, DOI 10.1093/qjmed/hcm005; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Latham NK, 2003, J AM GERIATR SOC, V51, P1219, DOI 10.1046/j.1532-5415.2003.51405.x; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; LAW MR, 1991, BMJ-BRIT MED J, V303, P453, DOI 10.1136/bmj.303.6800.453; LORD S, 2000, AUSTRALASIAN EPIDEMI, P13; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; NIH Office of Dietary Supplements, DIET S FACT SHEET VI; Pasco JA, 2004, J BONE MINER RES, V19, P752, DOI 10.1359/JBMR.040125; Pasco JA, 2001, MED J AUSTRALIA, V175, P401, DOI 10.5694/j.1326-5377.2001.tb143643.x; Pietras SM, 2009, ARCH INTERN MED, V169, P1806, DOI 10.1001/archinternmed.2009.361; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Reid IR, 2008, OSTEOPOROSIS INT, V19, P1119, DOI 10.1007/s00198-008-0563-9; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; Sanders KM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-78; Sanders KM, 1999, OSTEOPOROSIS INT, V10, P240, DOI 10.1007/s001980050222; Smith H, 2007, RHEUMATOLOGY, V46, P1852, DOI 10.1093/rheumatology/kem240; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Wu Fiona, 2003, N Z Med J, V116, pU536	43	913	957	2	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2010	303	18					1815	1822		10.1001/jama.2010.594	http://dx.doi.org/10.1001/jama.2010.594			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594DK	20460620	Bronze			2022-12-28	WOS:000277513900022
J	Novarino, G; Weinert, S; Rickheit, G; Jentsch, TJ				Novarino, Gaia; Weinert, Stefanie; Rickheit, Gesa; Jentsch, Thomas J.			Endosomal Chloride-Proton Exchange Rather Than Chloride Conductance Is Crucial for Renal Endocytosis	SCIENCE			English	Article							DENTS-DISEASE; CLC PROTEINS; IMPAIRS ENDOCYTOSIS; PROXIMAL TUBULE; CHANNEL; MODEL; NEPHROLITHIASIS; ACIDIFICATION; ANTIPORTER; MOUSE	Loss of the endosomal anion transport protein ClC-5 impairs renal endocytosis and underlies human Dent's disease. ClC-5 is thought to promote endocytosis by facilitating endosomal acidification through the neutralization of proton pump currents. However, ClC-5 is a 2 chloride (Cl(-))/proton (H(+)) exchanger rather than a Cl(-) channel. We generated mice that carry the uncoupling E211A (unc) mutation that converts ClC-5 into a pure Cl(-) conductor. Adenosine triphosphate (ATP)-dependent acidification of renal endosomes was reduced in mice in which ClC-5 was knocked out, but normal in Clcn5(unc) mice. However, their proximal tubular endocytosis was also impaired. Thus, endosomal chloride concentration, which is raised by ClC-5 in exchange for protons accumulated by the H(+)-ATPase, may play a role in endocytosis.	[Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Weinert, Stefanie/AAR-1481-2021	Weinert, Stefanie/0000-0003-3036-1440; Jentsch, Thomas/0000-0002-3509-2553	Deutsche Forschungsgemeinschaft [Zd58/1, Je164/6, Je164/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank R. Pareja-Alcaraz and S. Rode for technical assistance and P. Verroust, S. Bachmann, W. Blaner, and C. Wagner for antibodies against cubilin, megalin, retinol binding protein, and AE1, respectively. This work was supported by the Deutsche Forschungsgemeinschaft (grants Zd58/1, Je164/6, and Je164/9).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Christensen EI, 2003, P NATL ACAD SCI USA, V100, P8472, DOI 10.1073/pnas.1432873100; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Reed AAC, 2010, AM J PHYSIOL-RENAL, V298, pF365, DOI 10.1152/ajprenal.00038.2009; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Scheinman SJ, 1998, KIDNEY INT, V53, P3, DOI 10.1046/j.1523-1755.1998.00718.x; Wang SS, 2000, HUM MOL GENET, V9, P2937, DOI 10.1093/hmg/9.20.2937; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	25	116	125	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1398	1401		10.1126/science.1188070	http://dx.doi.org/10.1126/science.1188070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20430975				2022-12-28	WOS:000278598400039
J	Prindle, A; Hasty, J				Prindle, Arthur; Hasty, Jeff			Stochastic Emergence of Groupthink	SCIENCE			English	Editorial Material							QUORUM		[Prindle, Arthur; Hasty, Jeff] Univ Calif San Diego, Dept Biol & Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Prindle, A (corresponding author), Univ Calif San Diego, Dept Biol & Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079333] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079333-04, R01 GM079333] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253	4	10	10	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					987	988		10.1126/science.1190372	http://dx.doi.org/10.1126/science.1190372			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489014	Green Accepted			2022-12-28	WOS:000277877100029
J	Macilwain, C				Macilwain, Colin			Disaster, unmitigated	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					287	287		10.1038/465287a	http://dx.doi.org/10.1038/465287a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485411	Bronze			2022-12-28	WOS:000277829200014
J	Ruddiman, WF				Ruddiman, William F.			A Paleoclimatic Enigma?	SCIENCE			English	Editorial Material							ATMOSPHERIC CARBON-DIOXIDE; CO2		Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	University of Virginia	Ruddiman, WF (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	wfr5c@virginia.edu						BARRON EJ, 1985, GEOPHYS MONOGR AM GE, V32, P504; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; MIKOLAJEWICZ U, 1993, PALEOCEANOGRAPHY, V8, P409, DOI 10.1029/93PA00893; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; RUDDIMAN WF, 1991, SCI AM, V264, P66, DOI 10.1038/scientificamerican0391-66; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; WOLFE JA, 1978, AM SCI, V66, P994; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	14	31	34	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					838	839		10.1126/science.1188292	http://dx.doi.org/10.1126/science.1188292			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466913				2022-12-28	WOS:000277618800029
J	Schonbachler, M; Carlson, RW; Horan, MF; Mock, TD; Hauri, EH				Schoenbaechler, M.; Carlson, R. W.; Horan, M. F.; Mock, T. D.; Hauri, E. H.			Heterogeneous Accretion and the Moderately Volatile Element Budget of Earth	SCIENCE			English	Article							TERRESTRIAL PLANET FORMATION; EARLY CORE FORMATION; HF-W CHRONOMETRY; SOLAR-SYSTEM; MOON; DIFFERENTIATION; ORIGIN; CONSTRAINTS; CHONDRITES; METEORITES	Several models exist to describe the growth and evolution of Earth; however, variables such as the type of precursor materials, extent of mixing, and material loss during accretion are poorly constrained. High-precision palladium-silver isotope data show that Earth's mantle is similar in (107)Ag/(109)Ag to primitive, volatile-rich chondrites, suggesting that Earth accreted a considerable amount of material with high contents of moderately volatile elements. Contradictory evidence from terrestrial chromium and strontium isotope data are reconciled by heterogeneous accretion, which includes a transition from dominantly volatile-depleted to volatile-rich materials with possibly high water contents. The Moon-forming giant impact probably involved the collision with a Mars-like protoplanet that had an oxidized mantle, enriched in moderately volatile elements.	[Schoenbaechler, M.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Schoenbaechler, M.; Carlson, R. W.; Horan, M. F.; Mock, T. D.; Hauri, E. H.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA	University of Manchester; Carnegie Institution for Science	Schonbachler, M (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	maria.schonbachler@manchester.ac.uk	Schönbächler, Maria/AAL-3318-2020	Schönbächler, Maria/0000-0003-4304-214X	NSF [EAR-0229417]; Carnegie Institution of Washington; British Science and Technology Facility Council; STFC [ST/G003068/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G003068/1] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Carnegie Institution of Washington; British Science and Technology Facility Council; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Norman and T. Grove for supplying the samples from Hawaii and Mount Shasta, respectively. This work was supported by NSF grant EAR-0229417 and the Carnegie Institution of Washington. M. S. also acknowledges the British Science and Technology Facility Council.	Allegre C, 2001, EARTH PLANET SC LETT, V185, P49, DOI 10.1016/S0012-821X(00)00359-9; Allegre CJ, 2008, EARTH PLANET SC LETT, V267, P386, DOI 10.1016/j.epsl.2007.11.056; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 1988, EARTH PLANET SC LETT, V90, P119, DOI 10.1016/0012-821X(88)90095-7; Chen JH, 1996, GEOPHYS MONOGR SER, V95, P1; Chou CL, 1978, P LUNAR PLANET SCI, V9, P219; Drake MJ, 2002, NATURE, V416, P39, DOI 10.1038/416039a; Halliday AN, 2009, SCIENCE, V325, P44, DOI 10.1126/science.1172587; Halliday AN, 2004, NATURE, V427, P505, DOI 10.1038/nature02275; Halliday AN, 2001, EARTH PLANET SC LETT, V192, P545, DOI 10.1016/S0012-821X(01)00479-4; Jacobsen SB, 2005, ANNU REV EARTH PL SC, V33, P531, DOI 10.1146/annurev.earth.33.092203.122614; Jacobsen SB, 2008, PHILOS T R SOC A, V366, P4129, DOI 10.1098/rsta.2008.0174; Kleine T, 2002, NATURE, V418, P952, DOI 10.1038/nature00982; Kleine T, 2004, EARTH PLANET SC LETT, V228, P109, DOI 10.1016/j.epsl.2004.09.023; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Moynier F, 2007, ASTROPHYS J LETT, V671, pL181, DOI 10.1086/525527; O'Brien DP, 2006, ICARUS, V184, P39, DOI 10.1016/j.icarus.2006.04.005; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Qin LP, 2010, GEOCHIM COSMOCHIM AC, V74, P1122, DOI 10.1016/j.gca.2009.11.005; Schaefer L, 2010, ICARUS, V205, P483, DOI 10.1016/j.icarus.2009.08.025; Schersten A, 2006, EARTH PLANET SC LETT, V241, P530, DOI 10.1016/j.epsl.2005.11.025; Schmitt AD, 2009, EARTH PLANET SC LETT, V277, P262, DOI 10.1016/j.epsl.2008.10.025; Schonbachler M, 2008, GEOCHIM COSMOCHIM AC, V72, P5330, DOI 10.1016/j.gca.2008.07.032; Schoenberg R, 2002, GEOCHIM COSMOCHIM AC, V66, P3151, DOI 10.1016/S0016-7037(02)00911-0; Shukolyukov A, 2006, EARTH PLANET SC LETT, V250, P200, DOI 10.1016/j.epsl.2006.07.036; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Trinquier A, 2008, GEOCHIM COSMOCHIM AC, V72, P5146, DOI 10.1016/j.gca.2008.03.023; Wanke H., 1984, ARCHAEAN GEOCHEMISTR, P1, DOI [10.1007/978-3-642-70001-9_1, DOI 10.1007/978-3-642-70001-9_1]; Wombacher F, 2003, GEOCHIM COSMOCHIM AC, V67, P4639, DOI 10.1016/S0016-7037(03)00389-2; Wood BJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1415, DOI 10.1016/j.gca.2007.11.036; Yin QZ, 2002, NATURE, V418, P949, DOI 10.1038/nature00995	34	136	139	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					884	887		10.1126/science.1186239	http://dx.doi.org/10.1126/science.1186239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466929				2022-12-28	WOS:000277618800046
J	Scheuermann, JC; Alonso, AGD; Oktaba, K; Ly-Hartig, N; McGinty, RK; Fraterman, S; Wilm, M; Muir, TW; Muller, J				Scheuermann, Johanna C.; Alonso, Andres Gaytan de Ayala; Oktaba, Katarzyna; Ly-Hartig, Nga; McGinty, Robert K.; Fraterman, Sven; Wilm, Matthias; Muir, Tom W.; Mueller, Juerg			Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB	NATURE			English	Article							GROUP PROTEIN COMPLEXES; BITHORAX COMPLEX; DROSOPHILA; GENES; MECHANISMS; CORE; TRIMETHYLATION; UBIQUITINATION; UBIQUITYLATION; HYDROLASES	Polycomb group (PcG) proteins are transcriptional repressors that control processes ranging from the maintenance of cell fate decisions and stem cell pluripotency in animals to the control of flowering time in plants(1-6). In Drosophila, genetic studies identified more than 15 different PcG proteins that are required to repress homeotic (HOX) and other developmental regulator genes in cells where they must stay inactive(1,7,8). Biochemical analyses established that these PcG proteins exist in distinct multiprotein complexes that bind to and modify chromatin of target genes(1-4). Among those, Polycomb repressive complex 1 (PRC1) and the related dRing-associated factors (dRAF) complex contain an E3 ligase activity for monoubiquitination of histone H2A (refs 1-4). Here we show that the uncharacterized Drosophila PcG gene calypso encodes the ubiquitin carboxy-terminal hydrolase BAP1. Biochemically purified Calypso exists in a complex with the PcG protein ASX, and this complex, named Polycomb repressive deubiquitinase (PR-DUB), is bound at PcG target genes in Drosophila. Reconstituted recombinant Drosophila and human PR-DUB complexes remove monoubiquitin from H2A but not from H2B in nucleosomes. Drosophila mutants lacking PR-DUB show a strong increase in the levels of monoubiquitinated H2A. A mutation that disrupts the catalytic activity of Calypso, or absence of the ASX subunit abolishes H2A deubiquitination in vitro and HOX gene repression in vivo. Polycomb gene silencing may thus entail adynamic balance between H2A ubiquitination by PRC1 and dRAF, and H2A deubiquitination by PR-DUB.	[Scheuermann, Johanna C.; Alonso, Andres Gaytan de Ayala; Oktaba, Katarzyna; Ly-Hartig, Nga; Fraterman, Sven; Wilm, Matthias; Mueller, Juerg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [McGinty, Robert K.; Muir, Tom W.] Rockefeller Univ, New York, NY 10065 USA	European Molecular Biology Laboratory (EMBL); Rockefeller University	Muller, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	juerg.mueller@embl.de	Müller, Jürg/ABB-3007-2020; Oktaba, Katarzyna/A-7737-2018; Muir, Tom/AHD-0860-2022; Ferris, Laura/I-7689-2012	Müller, Jürg/0000-0003-2391-4641; Oktaba, Katarzyna/0000-0002-3950-5626; Muir, Tom/0000-0001-9635-0344; Wilm, Matthias/0000-0002-5461-6834	NIH [RC2CA148354]; EMBL; DFG; NATIONAL CANCER INSTITUTE [RC2CA148354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739, R01GM086868] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBL; DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Sixma and G. Buchwald for the gift of proteins, H. W. Brock, R. E. Kingston, B. Korn and B. Turner for plasmids, baculoviruses and antibodies, V. Benes, J. de Graaf, S. Muller and A. Riddell for technical support, and W. Huber and J. Gagneur for discussions. T. W. M. is supported by NIH grant RC2CA148354. J. C. S., A. G. A. A., K.O., N.L.-H. and J. M. are supported by EMBL and by grants from the DFG.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Alonso AGD, 2007, GENETICS, V176, P2099, DOI 10.1534/genetics.107.075739; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fraterman S, 2007, MOL CELL PROTEOMICS, V6, P728, DOI 10.1074/mcp.M600345-MCP200; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Luger K, 1999, METHOD ENZYMOL, V304, P3; Mason DE, 2004, BIOCHEMISTRY-US, V43, P6535, DOI 10.1021/bi049722j; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2	40	546	563	1	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 13	2010	465	7295					243	U138		10.1038/nature08966	http://dx.doi.org/10.1038/nature08966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20436459	Green Accepted, Green Published			2022-12-28	WOS:000277558500041
J	Gray, N; Hecht, SS				Gray, Nigel; Hecht, Stephen S.			Smokeless tobacco-proposals for regulation	LANCET			English	Editorial Material									[Gray, Nigel] Canc Council Victoria, Victoria, Vic 3122, Australia; [Hecht, Stephen S.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA	Cancer Council Victoria; University of Minnesota System; University of Minnesota Twin Cities	Gray, N (corresponding author), Canc Council Victoria, Victoria, Vic 3122, Australia.	gray.nigel@bigpond.com		Hecht, Stephen/0000-0001-7228-1356				Alderman J, 2010, J PUBLIC HEALTH POL, V31, P1, DOI 10.1057/jphp.2009.52; [Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V32, P1; CULLEN JW, 1986, PUBLIC HEALTH REP, V101, P355; IDRIS AM, 1991, CARCINOGENESIS, V12, P1115, DOI 10.1093/carcin/12.6.1115; International Agency for Research on Cancer, 2007, IARC MONOGRAPHS EVAL, V89, P421; McNeill A, 2006, TOB CONTROL, V15, P64, DOI 10.1136/tc.2005.013011; O'Connor RJ, 2008, TOB CONTROL, V17, pI39, DOI 10.1136/tc.2007.023689; Stepanov I, 2008, NICOTINE TOB RES, V10, P1773, DOI 10.1080/14622200802443544; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; US Government, 2009, FAM SMOK PREV TOB CO; *WHO STUD GROUP, 2010, 3 WHO STUD GROUP	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1589	1591		10.1016/S0140-6736(10)60516-8	http://dx.doi.org/10.1016/S0140-6736(10)60516-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452507				2022-12-28	WOS:000277734700009
J	Dacre, J; Raven, P				Dacre, Jane; Raven, Peter			Should undergraduate medical students be regulated? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							DISCIPLINARY ACTION; BOARDS		[Dacre, Jane; Raven, Peter] UCL Med Sch, London, England	University of London; University College London	Dacre, J (corresponding author), UCL Med Sch, London, England.	jdacre@medsch.ucl.ac.uk						*GMC, STUD FITN PRACT; *GMC, QUAL ASS BAS MED ED; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Papadakis MA, 2008, ANN INTERN MED, V148, P869, DOI 10.7326/0003-4819-148-11-200806030-00009; SMITH J, 2005, SHIPMAN INQUIRY 5 RE; *SOL REG AUTH, SOL TRAIN REG	6	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 5	2010	340								c1677	10.1136/bmj.c1677	http://dx.doi.org/10.1136/bmj.c1677			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	594XC	20444832				2022-12-28	WOS:000277572500001
J	Adashi, EY; Geiger, HJ; Fine, MD				Adashi, Eli Y.; Geiger, H. Jack; Fine, Michael D.			Health Care Reform and Primary Care - The Growing Importance of the Community Health Center	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Providence, RI 02912 USA; [Fine, Michael D.] HealthAccessRI, Providence, RI USA; [Geiger, H. Jack] CUNY, Sch Med, New York, NY 10031 USA	Brown University; City University of New York (CUNY) System	Adashi, EY (corresponding author), Brown Univ, Providence, RI 02912 USA.							[Anonymous], 2009, PUBL GOV ACC OFF; Cook NL, 2007, HEALTH AFFAIR, V26, P1459, DOI 10.1377/hlthaff.26.5.1459; Hicks LS, 2006, HEALTH AFFAIR, V25, P1712, DOI 10.1377/hlthaff.25.6.1712; Qualis Health, SAF NET MED HOM IN T; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	5	152	153	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2047	2050		10.1056/NEJMp1003729	http://dx.doi.org/10.1056/NEJMp1003729			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603XU	20427777				2022-12-28	WOS:000278242200002
J	Sawamiphak, S; Seidel, S; Essmann, CL; Wilkinson, GA; Pitulescu, ME; Acker, T; Acker-Palmer, A				Sawamiphak, Suphansa; Seidel, Sascha; Essmann, Clara L.; Wilkinson, George A.; Pitulescu, Mara E.; Acker, Till; Acker-Palmer, Amparo			Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis	NATURE			English	Article							VASCULAR MORPHOGENESIS; RECEPTORS; GUIDANCE; PHOSPHORYLATION; ASTROCYTES; PTP	The formation and guidance of specialized endothelial tip cells is essential for both developmental and pathological angiogenesis(1). Notch-1 signalling regulates the generation of tip cells, which respond to gradients of vascular endothelial growth factor (VEGF-A)(2). The molecular cues and signalling pathways that control the guidance of tip cells are poorly understood. Bidirectional signalling by Eph receptors and ephrin ligands represents one of the most important guidance cues involved in axon path finding(3). Here we show that ephrin-B2 reverse signalling involving PDZ interactions regulates endothelial tip cell guidance to control angiogenic sprouting and branching in physiological and pathological angiogenesis. In vivo, ephrin-B2 PDZ-signalling-deficient mice (ephrin-B2DV) exhibit a reduced number of tip cells with fewer filopodial extensions at the vascular front in the mouse retina. In pathological settings, impaired PDZ signalling decreases tumour vascularization and growth. Mechanistically, we show that ephrin-B2 controls VEGF receptor (VEGFR)-2 internalization and signalling. Importantly, internalization of VEGFR2 is necessary for activation and downstream signalling of the receptor and is required for VEGF-induced tip cell filopodial extension. Together, our results suggest that ephrin-B2 at the tip cell filopodia regulates the proper spatial activation of VEGFR2 endocytosis and signalling to direct filopodial extension. Blocking ephrin-B2 reverse signalling may be an attractive alternative or combinatorial anti-angiogenic therapy strategy to disrupt VEGFR2 function in tumour angiogenesis.	[Sawamiphak, Suphansa; Essmann, Clara L.; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Sawamiphak, Suphansa; Essmann, Clara L.; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany; [Seidel, Sascha; Acker, Till] Univ Giessen, Inst Neuropathol, D-35392 Giessen, Germany; [Wilkinson, George A.] Med Coll Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53226 USA; [Pitulescu, Mara E.] Univ Munster, Fac Med, D-48149 Munster, Germany; [Pitulescu, Mara E.] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Justus Liebig University Giessen; Medical College of Wisconsin; University of Munster; Max Planck Society	Acker-Palmer, A (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Acker-Palmer@bio.uni-frankfurt.de		Acker, Till/0000-0001-6357-7227; Pitulescu, Mara E/0000-0001-5322-8146; Seidel, Sascha/0000-0001-9411-8795	Deutsche Forschungsgemeinschaft [AC110/3-1, 3-2, AC180/3-1, 3-2]; Deutsche Krebshilfe [107231]; Clusters of Excellence 'Macromolecular Complexes (CEF)' at University Frankfurt [EXC 115]; 'Cardio-Pulmonary System (ECCPS)' at the Universities of Giessen and Frankfurt [EXC 147]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Clusters of Excellence 'Macromolecular Complexes (CEF)' at University Frankfurt; 'Cardio-Pulmonary System (ECCPS)' at the Universities of Giessen and Frankfurt	We thank R. Klein for the ephrin-B2<SUP>lox/lox</SUP> mice, A. Filosa, F. Finkelmeier and H. zum Buttel for technical support, A. Filosa and B. Garvalov for comments on the manuscript and R. Adams for scientific input and reading the manuscript. We acknowledge the Max Planck Institute of Neurobiology in Martinsried (Germany) and the Edinger Institute at Frankfurt University (Germany) for support and the use of equipment and animal facilities in the early stages of this project. This work was supported by grants from the Deutsche Forschungsgemeinschaft within the SPP1190 (AC110/3-1, 3-2 to T. A. and AC180/3-1, 3-2 to A.A.-P.), the Deutsche Krebshilfe (107231 to T. A.) and the Clusters of Excellence 'Macromolecular Complexes (CEF)' (EXC 115) at the University Frankfurt and 'Cardio-Pulmonary System (ECCPS)' (EXC 147) at the Universities of Giessen and Frankfurt.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Gariano RF, 2005, NATURE, V438, P960, DOI 10.1038/nature04482; Gariano RF, 1996, INVEST OPHTH VIS SCI, V37, P2367; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Lauterbach J, 2006, J NEUROSCI, V26, P11575, DOI 10.1523/JNEUROSCI.2697-06.2006; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Padera TP, 2008, DEV CELL, V15, P178, DOI 10.1016/j.devcel.2008.07.014; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; WATANABE T, 1988, NATURE, V332, P834, DOI 10.1038/332834a0; Wilkinson GA, 2008, DEV DYNAM, V237, P2220, DOI 10.1002/dvdy.21643; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	32	391	408	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 27	2010	465	7297					487	U115		10.1038/nature08995	http://dx.doi.org/10.1038/nature08995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601FM	20445540				2022-12-28	WOS:000278043700037
J	Migliori, GB; Sotgiu, G				Migliori, Giovanni Battista; Sotgiu, Giovanni			XDR tuberculosis in South Africa: old questions, new answers	LANCET			English	Editorial Material							DRUG-RESISTANT TUBERCULOSIS; TB		[Migliori, Giovanni Battista] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy; [Sotgiu, Giovanni] Univ Sassari, Hyg & Prevent Med Inst, I-07100 Sassari, Italy	Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization; University of Sassari	Migliori, GB (corresponding author), Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, I-21049 Tradate, Italy.	gbmigliori@fsm.it	Sotgiu, Giovanni/N-1032-2017; Migliori, Giovanni Battista/AAB-8589-2020	Sotgiu, Giovanni/0000-0002-1600-4474; Migliori, Giovanni Battista/0000-0002-2597-574X				Bonilla Cesar A, 2008, PLoS One, V3, pe2957, DOI 10.1371/journal.pone.0002957; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Migliori GB, 2007, EUR RESPIR J, V30, P623, DOI 10.1183/09031936.00077307; Migliori GB, 2008, AM J RESP CRIT CARE, V178, P1000, DOI 10.1164/rccm.200809-1380ED; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; SAXE JG, 1868, POEMS JG SAXE; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Tuberculosis Coalition for Technical Assistance, 2009, INT STAND TUB CAR IS; WHO, 2004, INT POL COLL TB HIV; *WHO, 2006, PAT CHART TUB CAR	14	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 22	2010	375	9728					1760	1761		10.1016/S0140-6736(10)60593-4	http://dx.doi.org/10.1016/S0140-6736(10)60593-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488526				2022-12-28	WOS:000278216500007
J	Duan, Z; Andronescu, M; Schutz, K; McIlwain, S; Kim, YJ; Lee, C; Shendure, J; Fields, S; Blau, CA; Noble, WS				Duan, Zhijun; Andronescu, Mirela; Schutz, Kevin; McIlwain, Sean; Kim, Yoo Jung; Lee, Choli; Shendure, Jay; Fields, Stanley; Blau, C. Anthony; Noble, William S.			A three-dimensional model of the yeast genome	NATURE			English	Article							SPATIAL-ORGANIZATION; CHROMATIN; GENES; ARCHITECTURE; PRINCIPLES; DYNAMICS; NUCLEI	Layered on top of information conveyed by DNA sequence and chromatin are higher order structures that encompass portions of chromosomes, entire chromosomes, and even whole genomes(1-3). Interphase chromosomes are not positioned randomly within the nucleus, but instead adopt preferred conformations(4-7). Disparate DNA elements co-localize into functionally defined aggregates or 'factories' for transcription(8) and DNA replication(9). In budding yeast, Drosophila and many other eukaryotes, chromosomes adopt a Rabl configuration, with arms extending from centromeres adjacent to the spindle pole body to telomeres that abut the nuclear envelope(10-12). Nonetheless, the topologies and spatial relationships of chromosomes remain poorly understood. Here we developed a method to globally capture intra-and inter-chromosomal interactions, and applied it to generate a map at kilobase resolution of the haploid genome of Saccharomyces cerevisiae. The map recapitulates known features of genome organization, thereby validating the method, and identifies new features. Extensive regional and higher order folding of individual chromosomes is observed. Chromosome XII exhibits a striking conformation that implicates the nucleolus as a formidable barrier to interaction between DNA sequences at either end. Inter-chromosomal contacts are anchored by centromeres and include interactions among transfer RNA genes, among origins of early DNA replication and among sites where chromosomal breakpoints occur. Finally, we constructed a three-dimensional model of the yeast genome. Our findings provide a glimpse of the interface between the form and function of a eukaryotic genome.	[Duan, Zhijun; Kim, Yoo Jung; Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Duan, Zhijun; Kim, Yoo Jung; Fields, Stanley; Blau, C. Anthony] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Andronescu, Mirela; McIlwain, Sean; Lee, Choli; Shendure, Jay; Fields, Stanley; Blau, C. Anthony; Noble, William S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Schutz, Kevin] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Fields, Stanley] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Blau, CA (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	tblau@u.washington.edu; william-noble@u.washington.edu	Shendure, Jay/AAU-3684-2021	Kim, Yoo Jung/0000-0003-4589-5875; Shendure, Jay/0000-0002-1516-1865	NIH [P01GM081619, P41RR0011823]; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We appreciate the advice and assistance of M. Dorschner, the comments of S. Di Rienzi, B. Brewer and B. Byers, and the assistance of L. Zhang and G. Schroth (Illumina Inc.) in performing sequencing. We thank A. Brown for help with the 3D model. Supported by NIH grants P01GM081619, P41RR0011823, a post-doctoral fellowship (to M. A.) from the Natural Sciences and Engineering Research Council of Canada, and the Howard Hughes Medical Institute.	Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bystricky K, 2005, J CELL BIOL, V168, P375, DOI 10.1083/jcb.200409091; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Di Rienzi SC, 2009, GENOME BIOL EVOL, V1, P350, DOI 10.1093/gbe/evp034; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, J CELL BIOCHEM, V107, P30, DOI 10.1002/jcb.22116; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Jin QW, 1998, J CELL BIOL, V141, P21, DOI 10.1083/jcb.141.1.21; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lorenz A, 2002, J CELL SCI, V115, P3829, DOI 10.1242/jcs.00066; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stone EM, 2000, CURR BIOL, V10, P373, DOI 10.1016/S0960-9822(00)00413-9; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Zhao YF, 2009, J FLUORESC, V19, P179, DOI 10.1007/s10895-008-0401-7; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	30	667	693	3	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					363	367		10.1038/nature08973	http://dx.doi.org/10.1038/nature08973			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20436457	Green Accepted			2022-12-28	WOS:000277829200044
J	Bao, YQ; Ma, XJ; Li, HT; Zhou, M; Hu, C; Wu, HY; Tang, JL; Hou, XH; Xiang, KS; Jia, WP				Bao, Yuqian; Ma, Xiaojing; Li, Huating; Zhou, Mi; Hu, Cheng; Wu, Haiya; Tang, Junling; Hou, Xuhong; Xiang, Kunsan; Jia, Weiping			Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FASTING PLASMA-GLUCOSE; GLYCOHEMOGLOBIN STANDARDIZATION PROGRAM; GLYCEMIA; HBA(1C); TESTS; MELLITUS; HEALTH	Objectives To evaluate haemoglobin A1c (HbA(1c)) in diagnosing diabetes and identify the optimal HbA(1c) threshold to be used in Chinese adults. Design Multistage stratified cross sectional epidemiological survey. Setting Shanghai, China, 2007-8. Participants 4886 Chinese adults over 20 years of age with no history of diabetes. Main outcome measures Performance of HbA(1c) at increasing thresholds for diagnosing diabetes. Results The area under the receiver operating characteristics curve for detecting undiagnosed diabetes was 0.856 (95% confidence interval 0.828 to 0.883) for HbA(1c) alone and 0.920 (0.900 to 0.941) for fasting plasma glucose alone. Very high specificity (96.1%, 95% confidence interval 95.5% to 96.7%) was achieved at an HbA(1c) threshold of 6.3% (2 SD above the normal mean). Moreover, the corresponding sensitivity was 62.8% (57.1% to 68.3%), which was equivalent to that of a fasting plasma glucose threshold of 7.0 mmol/l (57.5%, 51.7% to 63.1%) in detecting undiagnosed diabetes. In participants at high risk of diabetes, the HbA(1c) threshold of 6.3% showed significantly higher sensitivity (66.9%, 61.0% to 72.5%) than both fasting plasma glucose >= 7.0 mmol/l (54.4%, 48.3% to 60.4%) and HbA(1c) >= 6.5% (53.7%, 47.6% to 59.7%) (P<0.01). Conclusions An HbA(1c) threshold of 6.3% was highly specific for detecting undiagnosed diabetes in Chinese adults and had sensitivity similar to that of using a fasting plasma glucose threshold of 7.0 mmol/ l. This optimal HbA(1c) threshold may be suitable as a diagnostic criterion for diabetes in Chinese adults when fasting plasma glucose and oral glucose tolerance tests are not available.	[Bao, Yuqian; Ma, Xiaojing; Li, Huating; Zhou, Mi; Hu, Cheng; Wu, Haiya; Tang, Junling; Hou, Xuhong; Xiang, Kunsan; Jia, Weiping] Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University	Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 6, Shanghai Diabet Inst, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China.	wpjia@sjtu.edu.cn	Jia, Weiping/B-7483-2012; Hu, Cheng/C-3346-2008	Hu, Cheng/0000-0003-4314-2386	Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12006101]; Chinese National 973 Project [2007CB914702]; Shanghai Key Laboratory of Diabetes Mellitus [08DZ2230200]; Major Program of Shanghai Municipality for Basic Research [08dj1400601]; National Key Technology R&D Program of China [2009BAI80B01]	Shanghai United Developing Technology Project of Municipal Hospitals; Chinese National 973 Project(National Basic Research Program of China); Shanghai Key Laboratory of Diabetes Mellitus; Major Program of Shanghai Municipality for Basic Research; National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was funded by Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12006101), Chinese National 973 Project (2007CB914702), Shanghai Key Laboratory of Diabetes Mellitus (08DZ2230200), Major Program of Shanghai Municipality for Basic Research (08dj1400601), and National Key Technology R&D Program of China (2009BAI80B01).	Anand SS, 2003, DIABETES CARE, V26, P290, DOI 10.2337/diacare.26.2.290; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Buell C, 2007, DIABETES CARE, V30, P2233, DOI 10.2337/dc07-0585; Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913; Gavin JR, 1999, DIABETES CARE, V22, pS5; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HARRIS MI, 1993, DIABETES CARE, V16, P642, DOI 10.2337/diacare.16.4.642; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Lacher DA, 2005, CLIN CHEM, V51, P450, DOI 10.1373/clinchem.2004.039354; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Little RR, 2001, CLIN CHEM, V47, P1985; Miedema K, 2004, DIABETOLOGIA, V47, P1143, DOI 10.1007/s00125-004-1453-0; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Olabi B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4354; Perry RC, 2001, DIABETES CARE, V24, P465, DOI 10.2337/diacare.24.3.465; Qiao Q, 2000, DIABETOLOGIA, V43, P1470, DOI 10.1007/s001250051557; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Viberti G, 2006, DIABETIC MED, V23, P1289, DOI 10.1111/j.1464-5491.2006.02022.x; W.H. Organization, 1999, DEFINITION DIAGNOSIS; WHO, 2008, WORLD HLTH REP PRIM; WHO Expert Committee on Diabetes Mellitus, 1980, TECHN REP SER WHO; Wiener K, 1998, DIABETIC MED, V15, P558, DOI 10.1002/(SICI)1096-9136(199807)15:7<558::AID-DIA669>3.3.CO;2-H; Yang Zhao-jun, 2003, Zhonghua Yi Xue Za Zhi, V83, P2128; Zhang YD, 2009, POPUL HEALTH MANAG, V12, P95, DOI 10.1089/pop.2009.12202; Zhou Beifan, 2002, Obes Rev, V3, P147, DOI 10.1046/j.1467-789X.2002.00068.x	35	99	142	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 17	2010	340								c2249	10.1136/bmj.c2249	http://dx.doi.org/10.1136/bmj.c2249			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	601LQ	20478961	Green Published, hybrid			2022-12-28	WOS:000278061400002
J	Dvorin, JD; Martyn, DC; Patel, SD; Grimley, JS; Collins, CR; Hopp, CS; Bright, AT; Westenberger, S; Winzeler, E; Blackman, MJ; Baker, DA; Wandless, TJ; Duraisingh, MT				Dvorin, Jeffrey D.; Martyn, Derek C.; Patel, Saurabh D.; Grimley, Joshua S.; Collins, Christine R.; Hopp, Christine S.; Bright, A. Taylor; Westenberger, Scott; Winzeler, Elizabeth; Blackman, Michael J.; Baker, David A.; Wandless, Thomas J.; Duraisingh, Manoj T.			A Plant-Like Kinase in Plasmodium falciparum Regulates Parasite Egress from Erythrocytes	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; MALARIA PARASITE; HOST-CELLS; TOXOPLASMA-GONDII; CALCIUM; EXPRESSION	Clinical malaria is associated with the proliferation of Plasmodium parasites in human erythrocytes. The coordinated processes of parasite egress from and invasion into erythrocytes are rapid and tightly regulated. We have found that the plant-like calcium-dependent protein kinase PfCDPK5, which is expressed in invasive merozoite forms of Plasmodium falciparum, was critical for egress. Parasites deficient in PfCDPK5 arrested as mature schizonts with intact membranes, despite normal maturation of egress proteases and invasion ligands. Merozoites physically released from stalled schizonts were capable of invading new erythrocytes, separating the pathways of egress and invasion. The arrest was downstream of cyclic guanosine monophosphate-dependent protein kinase (PfPKG) function and independent of protease processing. Thus, PfCDPK5 plays an essential role during the blood stage of malaria replication.	[Dvorin, Jeffrey D.; Patel, Saurabh D.; Duraisingh, Manoj T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Dvorin, Jeffrey D.] Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Patel, Saurabh D.] Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Martyn, Derek C.] Broad Inst, Cambridge, MA 02142 USA; [Grimley, Joshua S.; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Collins, Christine R.; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Hopp, Christine S.; Baker, David A.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bright, A. Taylor; Westenberger, Scott; Winzeler, Elizabeth] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Winzeler, Elizabeth] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; MRC National Institute for Medical Research; University of London; London School of Hygiene & Tropical Medicine; Scripps Research Institute; Novartis	Duraisingh, MT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	mduraisi@hsph.harvard.edu	Winzeler, Elizabeth/AAP-6752-2020	Winzeler, Elizabeth/0000-0002-4049-2113; Hopp, Christine/0000-0002-0528-9531; Dvorin, Jeffrey/0000-0002-5883-7271; Baker, David/0000-0002-5490-8933	Pediatric Scientist Development Program [K12-HD000850]; National Institutes of Health [R01AI057919]; Burroughs Wellcome Fund; MRC UK [U117532063]; Wellcome Trust [086550]; NIH [GM073046]; EU [MALSIG 223044]; MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI087874, R01AI057919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	Pediatric Scientist Development Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Kettleborough, S. Osborne, and colleagues at Medical Research Council (MRC) Technology for provision of compound 1, S. Badrinath, E. Duraisingh, C. Merrick, and B. Coleman for critical reading of the manuscript, and D. Wirth for essential guidance and support. This work was supported by Pediatric Scientist Development Program Fellowship awards K12-HD000850 (J.D.D. and S.D.P.), National Institutes of Health R01 grant R01AI057919 (M.T.D.), a Burroughs Wellcome Fund New Investigator in the Pathogenesis of Infectious Diseases Fellowship (M.T.D.), the MRC UK U117532063 (M.J.B.), a Wellcome Trust Project grant 086550 (C.R.C.), the NIH GM073046 (T.J.W.), and an EU FP7 grant MALSIG 223044 (D.A.B.).	Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Farber PM, 1997, MOL BIOCHEM PARASIT, V87, P211, DOI 10.1016/S0166-6851(97)00052-2; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; ZHAO Y, 1993, J BIOL CHEM, V268, P4347	22	220	230	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 14	2010	328	5980					910	912		10.1126/science.1188191	http://dx.doi.org/10.1126/science.1188191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466936	Green Accepted			2022-12-28	WOS:000277618800054
J	Pastor, F; Kolonias, D; Giangrande, PH; Gilboa, E				Pastor, Fernando; Kolonias, Despina; Giangrande, Paloma H.; Gilboa, Eli			Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay	NATURE			English	Article							COMBINATION IMMUNOTHERAPY; T-CELLS; EXPRESSION; RECOGNITION; REJECTION; APTAMERS	The main reason why tumours are not controlled by the immune system is that, unlike pathogens, they do not express potent tumour rejection antigens (TRAs). Tumour vaccination aims at stimulating a systemic immune response targeted to, mostly weak, antigens expressed in the disseminated tumour lesions. Main challenges in developing effective vaccination protocols are the identification of potent and broadly expressed TRAs1-3 and effective adjuvants to stimulate a robust and durable immune response(4-6). Here we describe an alternative approach in which the expression of new, and thereby potent, antigens are induced in tumour cells by inhibiting nonsense-mediated messenger RNA decay (NMD)(7-10). Small interfering RNA (siRNA)-mediated inhibition of NMD in tumour cells led to the expression of new antigenic determinants and their immune-mediated rejection. In subcutaneous and metastatic tumour models, tumour-targeted delivery of NMD factor-specific siRNAs conjugated to oligonucleotide aptamer ligands led to significant inhibition of tumour growth that was superior to that of vaccination with granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing irradiated tumour cells(11), and could be further enhanced by co-stimulation. Tumour-targeted NMD inhibition forms the basis of a simple, broadly useful, and clinically feasible approach to enhance the antigenicity of disseminated tumours leading to their immune recognition and rejection. The cell-free chemically synthesized oligonucleotide backbone of aptamer-siRNAs reduces the risk of immunogenicity and enhances the feasibility of generating reagents suitable for clinical use.	[Pastor, Fernando; Kolonias, Despina; Gilboa, Eli] Univ Miami, Miller Sch Med Miami, Dodson Interdisciplinary Immunotherapy Inst, Dept Microbiol & Immunol, Miami, FL 33134 USA; [Giangrande, Paloma H.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Giangrande, Paloma H.] Univ Iowa, Dept Radiat Oncol, Mol & Cellular Biol Program, Iowa City, IA 52242 USA	University of Miami; University of Iowa; University of Iowa	Gilboa, E (corresponding author), Univ Miami, Miller Sch Med Miami, Dodson Interdisciplinary Immunotherapy Inst, Dept Microbiol & Immunol, Miami, FL 33134 USA.	egilboa@med.miami.edu	Pastor, Fernando/T-6239-2017	Pastor, Fernando/0000-0003-0432-3133	Dodson foundation; Sylvester Comprehensive Cancer Center (Medical School, University of Miami); NATIONAL CANCER INSTITUTE [R01CA151857, R01CA138503] Funding Source: NIH RePORTER	Dodson foundation; Sylvester Comprehensive Cancer Center (Medical School, University of Miami); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Zhang for assistance in the mouse studies, A.-M. Jegg for technical assistance in characterizing Smg1 siRNAs, J. Rossi for advising in the design of aptamer-siRNA conjugates, and S. Nair and D. Boczkowski for advice in performing T-cell assays. This work was supported by the Dodson foundation and the Sylvester Comprehensive Cancer Center (Medical School, University of Miami).	Aagaard L, 2007, MOL THER, V15, P938, DOI 10.1038/sj.mt.6300118; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Duval A, 2002, CANCER RES, V62, P2447; El-Bchiri J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002583; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gilboa E, 1999, IMMUNITY, V11, P263, DOI 10.1016/S1074-7613(00)80101-6; Gilboa E, 2004, NAT REV CANCER, V4, P401, DOI 10.1038/nrc1359; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Li MJ, 2005, METHOD ENZYMOL, V392, P218, DOI 10.1016/S0076-6879(04)92013-7; Lupold SE, 2002, CANCER RES, V62, P4029; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; McNamara JO, 2008, J CLIN INVEST, V118, P376, DOI 10.1172/JCI33365; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muhlemann O, 2008, BBA-GENE REGUL MECH, V1779, P538, DOI 10.1016/j.bbagrm.2008.06.012; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pardoll DM, 2002, NAT REV IMMUNOL, V2, P227, DOI 10.1038/nri774; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	30	186	204	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					227	U114		10.1038/nature08999	http://dx.doi.org/10.1038/nature08999			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463739	Green Accepted			2022-12-28	WOS:000277558500037
J	Sanyal, AJ; Chalasani, N; Kowdley, KV; McCullough, A; Diehl, AM; Bass, NM; Neuschwander-Tetri, BA; Lavine, JE; Tonascia, J; Unalp, A; Van Natta, M; Clark, J; Brunt, EM; Kleiner, DE; Hoofnagle, JH; Robuck, PR				Sanyal, Arun J.; Chalasani, Naga; Kowdley, Kris V.; McCullough, Arthur; Diehl, Anna Mae; Bass, Nathan M.; Neuschwander-Tetri, Brent A.; Lavine, Joel E.; Tonascia, James; Unalp, Aynur; Van Natta, Mark; Clark, Jeanne; Brunt, Elizabeth M.; Kleiner, David E.; Hoofnagle, Jay H.; Robuck, Patricia R.		NASH CRN	Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FATTY LIVER-DISEASE; FOLLOW-UP; METAANALYSIS; VARIABILITY; STEATOSIS; HISTORY; NAFLD	Background: Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. Methods: We randomly assigned 247 adults with nonalcoholic steatohepatitis and without diabetes to receive pioglitazone at a dose of 30 mg daily (80 subjects), vitamin E at a dose of 800 IU daily (84 subjects), or placebo (83 subjects), for 96 weeks. The primary outcome was an improvement in histologic features of nonalcoholic steatohepatitis, as assessed with the use of a composite of standardized scores for steatosis, lobular inflammation, hepatocellular ballooning, and fibrosis. Given the two planned primary comparisons, P values of less than 0.025 were considered to indicate statistical significance. Results: Vitamin E therapy, as compared with placebo, was associated with a significantly higher rate of improvement in nonalcoholic steatohepatitis (43% vs. 19%, P=0.001), but the difference in the rate of improvement with pioglitazone as compared with placebo was not significant (34% and 19%, respectively; P=0.04). Serum alanine and aspartate aminotransferase levels were reduced with vitamin E and with pioglitazone, as compared with placebo (P<0.001 for both comparisons), and both agents were associated with reductions in hepatic steatosis (P=0.005 for vitamin E and P<0.001 for pioglitazone) and lobular inflammation (P=0.02 for vitamin E and P=0.004 for pioglitazone) but not with improvement in fibrosis scores (P=0.24 for vitamin E and P=0.12 for pioglitazone). Subjects who received pioglitazone gained more weight than did those who received vitamin E or placebo; the rates of other side effects were similar among the three groups. Conclusions: Vitamin E was superior to placebo for the treatment of nonalcoholic steatohepatitis in adults without diabetes. There was no benefit of pioglitazone over placebo for the primary outcome; however, significant benefits of pioglitazone were observed for some of the secondary outcomes. (ClinicalTrials.gov number, NCT0063622.) N Engl J Med 2010;362:1675-85.	[Sanyal, Arun J.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Chalasani, Naga] Indiana Univ, Indianapolis, IN 46204 USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Seattle, WA 98101 USA; [McCullough, Arthur] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Diehl, Anna Mae] Duke Univ, Durham, NC USA; [Bass, Nathan M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Neuschwander-Tetri, Brent A.] St Louis Univ, St Louis, MO 63103 USA; [Brunt, Elizabeth M.] Washington Univ, St Louis, MO 63130 USA; [Lavine, Joel E.] Univ Calif San Diego, San Diego, CA 92103 USA; [Tonascia, James; Unalp, Aynur; Van Natta, Mark; Clark, Jeanne] Johns Hopkins Univ, Baltimore, MD USA; [Kleiner, David E.] NCI, Bethesda, MD 20892 USA; [Hoofnagle, Jay H.; Robuck, Patricia R.] NIDDKD, Bethesda, MD 20892 USA	Virginia Commonwealth University; Indiana University System; Indiana University-Purdue University Indianapolis; Virginia Mason Medical Center; Case Western Reserve University; Duke University; University of California System; University of California San Francisco; Saint Louis University; Washington University (WUSTL); University of California System; University of California San Diego; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Sanyal, AJ (corresponding author), MCV Box 980342, Richmond, VA 23298 USA.	asanyal@mcvh-vcu.edu	Kowdley, Kris/AAF-5202-2019; Kleiner, David E/N-2770-2013; Clark, Jeanne/AGG-8199-2022	Kleiner, David E/0000-0003-3442-4453; Clark, Jeanne/0000-0003-1194-0092	National Institutes of Health (NIH) [U01DK61718, U01DK61728, U01DK61731, U01DK61732, U01DK61734, U01DK61737, U01DK61738, U01DK61730, U01DK61713, UL1RR024989, UL1RR024128, UL1RR000750, UL1RR024131, M01RR000827, UL1RR025014, M01RR600065]; Takeda Pharmaceuticals North America through a Cooperative Research and Development Agreement with the NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014, UL1RR024128, UL1RR024989, M01RR000827, M01RR000750, UL1RR024131, M01RR000065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061732, K24DK002957, U01DK061731, U01DK061730, U01DK061738, U01DK061737, U01DK061728, U01DK061734, U01DK061718, U01DK061713] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Pharmaceuticals North America through a Cooperative Research and Development Agreement with the NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (U01DK61718, U01DK61728, U01DK61731, U01DK61732, U01DK61734, U01DK61737, U01DK61738, U01DK61730, and U01DK61713) from the National Institutes of Health (NIH), by the intramural program of the National Cancer Institute, and by NIH General Clinical Research Center grants or Clinical and Translational Science Awards (UL1RR024989, UL1RR024128, UL1RR000750, UL1RR024131, M01RR000827, UL1RR025014, and M01RR600065). Additional funding was provided by Takeda Pharmaceuticals North America through a Cooperative Research and Development Agreement with the NIH. The vitamin E softgels and matching placebo were provided by Pharmavite through a Clinical Trial Agreement with the NIH.	Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; BACON BR, 1994, GASTROENTEROLOGY, V107, P1103, DOI 10.1016/0016-5085(94)90235-6; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2009, HEPATOLOGY, V49, P809, DOI 10.1002/hep.22724; Caldwell SH, 2001, AM J GASTROENTEROL, V96, P519; Chalasani N, 2008, J HEPATOL, V48, P829, DOI 10.1016/j.jhep.2008.01.016; Chalasani NP, 2009, CONTEMP CLIN TRIALS, V30, P88, DOI 10.1016/j.cct.2008.09.003; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1046/j.1360-0443.1995.901013496.x; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P1645, DOI 10.1001/jama.297.15.1645; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavine JE, 2000, J PEDIATR-US, V136, P734, DOI 10.1016/S0022-3476(00)05040-X; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Mannucci E, 2008, DIABETES OBES METAB, V10, P1221, DOI 10.1111/j.1463-1326.2008.00892.x; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; McClain CJ, 2004, ALCOHOL, V34, P67, DOI 10.1016/j.alcohol.2004.07.007; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V38, P1008, DOI 10.1053/jhep.2003.50420; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2004, CLIN GASTROENTEROL H, V2, P1107, DOI 10.1016/S1542-3565(04)00457-4; SKINNER HA, 1984, ANN INTERN MED, V101, P847, DOI 10.7326/0003-4819-101-6-847; Younossi ZM, 1998, MODERN PATHOL, V11, P560	29	2010	2105	16	171	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1675	1685		10.1056/NEJMoa0907929	http://dx.doi.org/10.1056/NEJMoa0907929			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20427778	Green Accepted, Green Published			2022-12-28	WOS:000277311200005
J	Hernandez, AF; Greiner, MA; Fonarow, GC; Hammill, BG; Heidenreich, PA; Yancy, CW; Peterson, ED; Curtis, LH				Hernandez, Adrian F.; Greiner, Melissa A.; Fonarow, Gregg C.; Hammill, Bradley G.; Heidenreich, Paul A.; Yancy, Clyde W.; Peterson, Eric D.; Curtis, Lesley H.			Relationship Between Early Physician Follow-up and 30-Day Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; TRANSITIONAL CARE; OPTIMIZE-HF; INPATIENT; OPPORTUNITIES; CHALLENGES; OUTPATIENT; PROGRAM	Context Readmission after hospitalization for heart failure is common. Early outpatient follow-up after hospitalization has been proposed as a means of reducing readmission rates. However, there are limited data describing patterns of follow-up after heart failure hospitalization and its association with readmission rates. Objective To examine associations between outpatient follow-up within 7 days after discharge from a heart failure hospitalization and readmission within 30 days. Design, Setting, and Patients Observational analysis of patients 65 years or older with heart failure and discharged to home from hospitals participating in the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure and the Get With the Guidelines-Heart Failure quality improvement program from January 1, 2003, through December 31, 2006. Main Outcome Measure All-cause readmission within 30 days after discharge. Results The study population included 30 136 patients from 225 hospitals. Median length of stay was 4 days (interquartile range, 2-6) and 21.3% of patients were readmitted within 30 days. At the hospital level, the median percentage of patients who had early follow-up after discharge from the index hospitalization was 38.3% (interquartile range, 32.4%-44.5%). Compared with patients whose index admission was in a hospital in the lowest quartile of early follow-up (30-day readmission rate, 23.3%), the rates of 30-day readmission were 20.5% among patients in the second quartile (riskadjusted hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.78-0.93), 20.5% among patients in the third quartile (risk-adjusted HR, 0.87; 95% CI, 0.78-0.96), and 20.9% among patients in the fourth quartile (risk-adjusted HR, 0.91; 95% CI, 0.83-1.00). Conclusions Among patients who are hospitalized for heart failure, substantial variation exists in hospital-level rates of early outpatient follow-up after discharge. Patients who are discharged from hospitals that have higher early follow-up rates have a lower risk of 30-day readmission.	[Hernandez, Adrian F.; Greiner, Melissa A.; Hammill, Bradley G.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27715 USA; [Hernandez, Adrian F.; Peterson, Eric D.; Curtis, Lesley H.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Heidenreich, Paul A.] Palo Alto VA Med Ctr, Palo Alto, CA USA; [Fonarow, Gregg C.] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA; [Yancy, Clyde W.] Baylor Heart & Vasc Inst, Dallas, TX USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Hernandez, AF (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	adrian.hernandez@duke.edu	Peterson, Eric David/ABF-5033-2021; Heidenreich, Paul/AAU-6864-2021; Hernandez, Adrian F/A-7818-2016; Fonarow, Gregg C/D-5988-2014	Heidenreich, Paul/0000-0001-7730-8490; Hernandez, Adrian F/0000-0003-3387-9616; Fonarow, Gregg C/0000-0002-3192-8093	GlaxoSmithKline; Medtronic; American Heart Association Pharmaceutical Round-table Outcomes Center [087512N]; American Heart Association Pharmaceutical Roundtable [0675060N]; Agency for Healthcare Research and Quality [U18HS016964]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); American Heart Association Pharmaceutical Round-table Outcomes Center; American Heart Association Pharmaceutical Roundtable(American Heart Association); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Get With the Guidelines-Heart Failure is a program of the American Heart Association and is supported in part by an unrestricted educational grant from GlaxoSmithKline and Medtronic. OPTIMIZE-HF was supported by GlaxoSmithKline. This study was supported by American Heart Association Pharmaceutical Round-table Outcomes Center grant 087512N. Dr Hernandez was supported by American Heart Association Pharmaceutical Roundtable grant 0675060N. Drs Peterson and Curtis were supported by grant U18HS016964 from the Agency for Healthcare Research and Quality.	Adams KF, 2006, J CARD FAIL, V12, P10, DOI 10.1016/j.cardfail.2005.12.001; *AM COLL CARD I HE, HOSP HOM H2H; *AM HOSP ASS, 2008, AHA ANN SURV DAT 200; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; *CTR MED MED SERV, 2007, CTR MED MED SERV M S; Curtis LH, 2009, CIRC-CARDIOVASC QUAL, V2, P377, DOI 10.1161/CIRCOUTCOMES.108.822692; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Fonarow GC, 2004, AM HEART J, V148, P43, DOI 10.1016/j.ahj.2004.03.004; Hammill BG, 2009, AM HEART J, V157, P995, DOI 10.1016/j.ahj.2009.04.002; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; *JOINT COMM, 2006, JOINT COMM SPEC MAN; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Kuo Y, 2009, NEW ENGL J MED, V360, P1102, DOI 10.1056/NEJMsa0802381; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Romano PS, 2005, NEW ENGL J MED, V353, P302, DOI 10.1056/NEJMe058150; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517	22	722	731	2	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 5	2010	303	17					1716	1722		10.1001/jama.2010.533	http://dx.doi.org/10.1001/jama.2010.533			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591CR	20442387	Bronze			2022-12-28	WOS:000277276600024
J	Rosenson, RS				Rosenson, Robert S.			Lp-PLA(2) and risk of atherosclerotic vascular disease	LANCET			English	Editorial Material							SECRETORY PHOSPHOLIPASE A(2); CARDIOVASCULAR-DISEASE		Mt Sinai Sch Med, New York, NY 10028 USA	Icahn School of Medicine at Mount Sinai	Rosenson, RS (corresponding author), Mt Sinai Sch Med, New York, NY 10028 USA.	robert.rosenson@mssm.edu						DEGRAAF J, 1991, ARTERIOSCLER THROMB, V11, P298, DOI 10.1161/01.ATV.11.2.298; Koenig WG, 2009, CARDIOVASC DRUG THER, V23, P85, DOI 10.1007/s10557-008-6135-6; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Rosenson Robert S, 2009, Curr Cardiol Rep, V11, P445; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Rosenson RS, 2009, CARDIOVASC DRUG THER, V23, P93, DOI 10.1007/s10557-008-6148-1; Shaposhnik Z, 2009, J LIPID RES, V50, P623, DOI 10.1194/jlr.M800361-JLR200; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; 2009, STABILIZATION PLAQUE; 2008, STABILIZATION ATHERO	12	17	17	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1498	1500		10.1016/S0140-6736(10)60488-6	http://dx.doi.org/10.1016/S0140-6736(10)60488-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435213				2022-12-28	WOS:000277655100005
J	Thompson, A; Gao, P; Orfei, L; Watson, S; Di Angelantonio, E; Kaptoge, S; Ballantyne, C; Cannon, CP; Criqui, M; Cushman, M; Hofman, A; Packard, C; Thompson, SG; Collins, R; Danesh, J; Ballantyne, C; Willeit, J; Kiechl, S; Wiedemann, C; Cushman, M; Psaty, B; Furberg, C; Khaw, KT; Sandhu, M; Benjamin, EJ; Vasan, RS; Schnabel, RB; Oldgren, J; Rossi, GP; Cesari, M; Lenzini, L; Zanchetta, M; James, SK; Rimm, E; Hatoum, I; Collins, R; Anderson, JL; May, HT; Home, BD; Carlquist, JF; Muhlestein, JB; Koenig, W; Brenner, H; Rothenbacher, D; Marz, W; Bohm, B; Winkelmann, BR; Winkler, K; Berglund, G; Persson, M; Roger, V; Gerber, Y; Berger, PB; Brilakis, ES; McConnell, JP; Koenig, W; Meisinger, C; Rimm, E; Hatoum, I; Sacco, R; Elkind, M; Talmud, PJ; O'Donoghue, M; Sabatine, MS; Morrow, DA; Packard, C; Caslake, M; Braunwald, E; Cannon, CP; Barrett-Connor, E; Daniels, LB; Laughlin, GA; Hofman, A; Kardys, I; Witteman, JCM; Criqui, M; Corsetti, JP; Rainwater, DL; Moss, AJ; Wassertheil-Smoller, S; Ridker, P; Packard, C; Ballantyne, C; Cannon, CP; Collins, R; Criqui, M; Cushman, M; Danesh, J; Hofman, A; Nelson, JJ; Packard, C; Thompson, SG; Zariffa, N; Zalewski, A; Watson, S; Walker, M				Thompson, Alexander; Gao, Pei; Orfei, Lia; Watson, Sarah; Di Angelantonio, Emanuele; Kaptoge, Stephen; Ballantyne, Christie; Cannon, Christopher P.; Criqui, Michael; Cushman, Mary; Hofman, Albert; Packard, Chris; Thompson, Simon G.; Collins, Rory; Danesh, John; Ballantyne, Christie; Willeit, Johann; Kiechl, Stefan; Wiedemann, Christian; Cushman, Mary; Psaty, Bruce; Furberg, Curt; Khaw, Kay-Tee; Sandhu, Manjinder; Benjamin, Emelia J.; Vasan, Ramachandran S.; Schnabel, Renate B.; Oldgren, Jonas; Rossi, Gian Paolo; Cesari, Maurizio; Lenzini, Livia; Zanchetta, Mario; James, Stefan K.; Rimm, Eric; Hatoum, Ida; Collins, Rory; Anderson, Jeffrey L.; May, Heidi T.; Home, Benjamin D.; Carlquist, John F.; Muhlestein, Joseph B.; Koenig, Wolfgang; Brenner, Herrnann; Rothenbacher, Dietrich; Maerz, Winfried; Boehm, Bernhard; Winkelmann, Bernhard R.; Winkler, Karl; Berglund, Goran; Persson, Margaretha; Roger, Veronique; Gerber, Yariv; Berger, Peter B.; Brilakis, Emmanouil S.; McConnell, Joseph P.; Koenig, Wolfgang; Meisinger, Christa; Rimm, Eric; Hatoum, Ida; Sacco, Ralph; Elkind, Mitchell; Talmud, Philippa J.; O'Donoghue, Michelle; Sabatine, Marc S.; Morrow, David A.; Packard, Chris; Caslake, Muriel; Braunwald, Eugene; Cannon, Christopher P.; Barrett-Connor, Elizabeth; Daniels, Lori B.; Laughlin, Gail A.; Hofman, Albert; Kardys, Isabella; Witteman, Jacqueline C. M.; Criqui, Michael; Corsetti, James P.; Rainwater, David L.; Moss, Arthur J.; Wassertheil-Smoller, Sylvia; Ridker, Paul; Packard, Chris; Ballantyne, Christie; Cannon, Christopher P.; Collins, Rory; Criqui, Michael; Cushman, Mary; Danesh, John; Hofman, Albert; Nelson, Jeanenne J.; Packard, Chris; Thompson, Simon G.; Zariffa, Nevine; Zalewski, Andrew; Watson, Sarah; Walker, Mat		Lp-PLA2 Studies Collaboration	Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies	LANCET			English	Article							ACTIVATING-FACTOR ACETYLHYDROLASE; LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; PLASMA; LYSOPHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS; EXPRESSION; OXIDATION	Background Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), an inflammatory enzyme expressed in atherosclerotic plaques, is a therapeutic target being assessed in trials of vascular disease prevention. We investigated associations of circulating Lp-PLA(2) mass and activity with risk of coronary heart disease, stroke, and mortality under different circumstances. Methods With use of individual records from 79 036 participants in 32 prospective studies (yielding 17 722 incident fatal or non-fatal outcomes during 474 976 person-years at risk), we did a meta-analysis of within-study regressions to calculate risk ratios (RRs) per 1 SD higher value of Lp-PLA(2) or other risk factor. The primary outcome was coronary heart disease. Findings Lp-PLA(2) activity and mass were associated with each other (r=0.51, 95% CI 0.47-0.56) and proatherogenic lipids. We noted roughly log-linear associations of Lp-PLA(2) activity and mass with risk of coronary heart disease and vascular death. RRs, adjusted for conventional risk factors, were: 1.10 (95% CI 1.05-1.16) with Lp-PLA(2) activity and 1.11 (1.07-1-16) with Lp-PLA(2) mass for coronary heart disease; 1.08 (0.97-1.20) and 1.14 (1-02-1.27) for ischaemic stroke; 1.16 (1-09-1.24) and 1.13 (1.05-1.22) for vascular mortality; and 1-10 (1.04-1.17) and 1.10 (1.03-1.18) for non-vascular mortality, respectively. RRs with Lp-PLA(2) did not differ significantly in people with and without initial stable vascular disease, apart from for vascular death with Lp-PLA(2) mass. Adjusted RRs for coronary heart disease were 1-10 (1.02-1.18) with non-HDL cholesterol and 1.10 (1.00-1.21) with systolic blood pressure. Interpretation Lp-PLA(2) activity and mass each show continuous associations with risk of coronary heart disease, similar in magnitude to that with non-HDL cholesterol or systolic blood pressure in this population. Associations of Lp-PLA(2) mass and activity are not exclusive to vascular outcomes, and the vascular associations depend at least partly on lipids.	[Thompson, Alexander] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Coordinating Ctr, Cambridge CB1 8RN, England; [Ballantyne, Christie] Baylor Coll Med, Houston, TX 77030 USA; [Cannon, Christopher P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Criqui, Michael] Univ Calif San Diego, La Jolla, CA 92093 USA; [Cushman, Mary] Univ Vermont, Burlington, VT USA; [Hofman, Albert] Erasmus MC, Rotterdam, Netherlands; [Packard, Chris] Univ Glasgow, Glasgow, Lanark, Scotland; [Thompson, Simon G.] MRC, Biostat Unit, Cambridge CB2 2BW, England; [Collins, Rory] Univ Oxford, Oxford, England; [Hofman, Albert; Kardys, Isabella; Witteman, Jacqueline C. M.] Rotterdam Study, Rotterdam, Netherlands	University of Cambridge; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Diego; University of Vermont; Erasmus University Rotterdam; Erasmus MC; University of Glasgow; MRC Biostatistics Unit; University of Oxford	Thompson, A (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Coordinating Ctr, Cambridge CB1 8RN, England.		Cannon, Christopher P/AAY-7644-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Gao, Pei/AAF-3065-2019; Sacco, Ralph/Y-9278-2019; Ramachandran, Vasan/Y-2527-2019; Gao, Pei/R-4794-2018; Boehm, Bernhard Otto/F-8750-2015; Collins, Rory/ABA-8487-2020; Khaw, Kay-Tee/AAZ-3209-2021; Brilakis, Emmanouil/B-5282-2009; James, Stefan K/J-4554-2014; Meisinger, Christine/B-5358-2014; Roger, Veronique/AAV-5951-2020; Brenner, Hermann/B-4627-2017; Ballantyne, Christie/A-6599-2008; Gerber, Yariv/AAU-8222-2021; Schnabel, Renate B/F-6527-2014; Sabatine, Marc/AAJ-6751-2020; Daniels, Lori/AAR-2641-2021; Watson, Sarah/HGB-2661-2022; Brenner, Hermann/ABE-6383-2020; Schnabel, Renate B/ABE-6668-2021	Cannon, Christopher P/0000-0003-4596-2791; Gao, Pei/0000-0001-8649-1290; Ramachandran, Vasan/0000-0001-7357-5970; Gao, Pei/0000-0001-8649-1290; Brenner, Hermann/0000-0002-6129-1572; Sabatine, Marc/0000-0002-0691-3359; Brenner, Hermann/0000-0002-6129-1572; Schnabel, Renate B/0000-0001-7170-9509; Rothenbacher, Dietrich/0000-0002-3563-2791; Cushman, Mary/0000-0002-7871-6143; Di Angelantonio, Emanuele/0000-0001-8776-6719; Koenig, Wolfgang/0000-0002-2064-9603; Daniels, Lori/0000-0002-4841-9922; Wood, Angela/0000-0002-7937-304X; Lenzini, Livia/0000-0001-6146-3015; Brilakis, Emmanouil/0000-0001-9416-9701; Ballantyne, Christie/0000-0002-6432-1730; ROSSI, GIAN PAOLO/0000-0002-7963-0931	UK Medical Research Council [G0601284]; GlaxoSmithKline; British Heart Foundation [RG/08/014]; British Heart Foundation [RG/08/008/25291, RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0801566, MC_U137686851, G0401527, G0600705, MC_U105260792, MC_U137686853, G0601284] Funding Source: researchfish; MRC [G0601284, MC_U137686853, MC_U105260792, G0600705, G0801566, MC_U137686851] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); GlaxoSmithKline(GlaxoSmithKline); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The independent academic Lp-PLA<INF>2</INF> Studies Collaboration coordinating centre has been supported by specific grants from the UK Medical Research Council (G0601284) and GlaxoSmithKline, and is underpinned by a programme grant from the British Heart Foundation (RG/08/014). Alexander Thompson and Emanuele Di Angelantonio were supported by UK Medical Research Council doctoral training grants. A variety of sources have supported recruitment, follow-up, and laboratory measurements in the 32 studies contributing to the Lp-PLA<INF>2</INF> Studies Collaboration. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://www.phpc.cam.ac.ukiceu/lsc. Pierre Jacob and Clement Pravin provided statistical support. Hannah Sneath, Angela Harper, and Karina Prasad provided administrative support. Mary Cushman provided limited tabular data on Lp-PLA<INF>2</INF> reproducibility on behalf of the Multi-Ethnic Study of Atherosclerosis (MESA) investigators.	Ballantyne C, 2007, EUR J CARDIOV PREV R, V14, P3; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Caslake MJ, 2003, CURR OPIN LIPIDOL, V14, P347, DOI 10.1097/00041433-200308000-00002; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Corson MA, 2009, LANCET, V373, P608, DOI 10.1016/S0140-6736(09)60378-0; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Davidson MH, 2008, AM J CARDIOL, V101, p51F, DOI 10.1016/j.amjcard.2008.04.019; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Garza CA, 2007, MAYO CLIN PROC, V82, P159; Gazi I, 2005, CLIN CHEM, V51, P2264, DOI 10.1373/clinchem.2005.058404; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann MM, 2009, J THROMB HAEMOST, V7, P41, DOI 10.1111/j.1538-7836.2008.03216.x; Hou LP, 2009, HUM GENET, V125, P11, DOI 10.1007/s00439-008-0587-4; Jackson LA, 2000, J INFECT DIS, V181, pS579, DOI 10.1086/315628; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karabina SAP, 1997, EUR J CLIN INVEST, V27, P595, DOI 10.1046/j.1365-2362.1997.1570706.x; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Mannheim D, 2008, STROKE, V39, P1448, DOI 10.1161/STROKEAHA.107.503193; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; Mohler ER, 2008, J AM COLL CARDIOL, V51, P1632, DOI 10.1016/j.jacc.2007.11.079; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Robins SJ, 2008, ARTERIOSCL THROM VAS, V28, P1172, DOI 10.1161/ATVBAHA.107.160739; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wilensky RL, 2008, NAT MED, V14, P1059, DOI 10.1038/nm.1870; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Yamada Y, 2006, THROMB HAEMOSTASIS, V96, P220, DOI 10.1160/TH06-02-0117; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7; STABILIZATION PLAQUE; STABILIZATION ATHERO	37	488	516	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2010	375	9725					1536	1544						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435228	Green Published			2022-12-28	WOS:000277655100026
J	Bardy, GH; Smith, WM; Hood, MA; Crozier, IG; Melton, IC; Jordaens, L; Theuns, D; Park, RE; Wright, DJ; Connelly, DT; Fynn, SP; Murgatroyd, FD; Sperzel, J; Neuzner, J; Spitzer, SG; Ardashev, AV; Oduro, A; Boersma, L; Maass, AH; Van Gelder, IC; Wilde, AA; van Dessel, PF; Knops, RE; Barr, CS; Lupo, P; Cappato, R; Grace, AA				Bardy, Gust H.; Smith, Warren M.; Hood, Margaret A.; Crozier, Ian G.; Melton, Iain C.; Jordaens, Luc; Theuns, Dominic; Park, Robert E.; Wright, David J.; Connelly, Derek T.; Fynn, Simon P.; Murgatroyd, Francis D.; Sperzel, Johannes; Neuzner, Joerg; Spitzer, Stefan G.; Ardashev, Andrey V.; Oduro, Amo; Boersma, Lucas; Maass, Alexander H.; Van Gelder, Isabelle C.; Wilde, Arthur A.; van Dessel, Pascal F.; Knops, Reinoud E.; Barr, Craig S.; Lupo, Pierpaolo; Cappato, Riccardo; Grace, Andrew A.			An Entirely Subcutaneous Implantable Cardioverter-Defibrillator	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL HEART-DISEASE; PERMANENT PACEMAKER; SURGICAL REVISION; LEADS; COMPLICATIONS; FAILURE; FIDELIS; CHILDREN; THERAPY; MALFUNCTIONS	BACKGROUND Implantable cardioverter-defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, we designed and tested an entirely subcutaneous ICD system. METHODS First, we conducted two shortterm clinical trials to identify a suitable device configuration and assess energy requirements. We evaluated four subcutaneous ICD configurations in 78 patients who were candidates for ICD implantation and subsequently tested the best configuration in 49 additional patients to determine the subcutaneous defibrillation thresh old in comparison with that of the standard transvenous ICD. Then we evaluated the long-term use of subcutaneous ICDs in a pilot study, involving 6 patients, which was followed by a trial involving 55 patients. RESULTS The best device configuration consisted of a parasternal electrode and a left lateral thoracic pulse generator. This configuration was as effective as a transvenous ICD for terminating induced ventricular fibrillation, albeit with a significantly higher mean (+/- SD) energy requirement (36.6 +/- 19.8 J vs. 11.1 +/- 8.5 J). Among patients who received a permanent subcutaneous ICD, ventricular fibrillation was successfully detected in 100% of 137 induced episodes. Induced ventricular fibrillation was converted twice in 58 of 59 patients (98%) with the delivery of 65-J shocks in two consecutive tests. Clinically significant adverse events included two pocket infections and four lead revisions. After a mean of 10 +/- 1 months, the device had successfully detected and treated all 12 episodes of spontaneous, sustained ventricular tachyarrhythmia. CONCLUSIONS In small, nonrandomized studies, an entirely subcutaneous ICD consistently detected and converted ventricular fibrillation induced during electrophysiological testing. The device also successfully detected and treated all 12 episodes of spontaneous, sustained ventricular tachyarrhythmia. (ClinicalTrials.gov numbers, NCT00399217 and NCT00853645.)	[Bardy, Gust H.] Seattle Inst Cardiac Res, Bellevue, WA 98004 USA; [Smith, Warren M.; Hood, Margaret A.] Auckland City Hosp, Auckland, New Zealand; [Crozier, Ian G.; Melton, Iain C.; Park, Robert E.] Christchurch Hosp, Christchurch, New Zealand; [Wright, David J.] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England; [Connelly, Derek T.] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland; [Murgatroyd, Francis D.] Kings Coll Hosp London, London, England; [Fynn, Simon P.; Grace, Andrew A.] Papworth Hosp, Dept Cardiol, Cambridge CB3 8RE, England; [Oduro, Amo] Papworth Hosp, Dept Anaesthet & Intens Care, Cambridge CB3 8RE, England; [Barr, Craig S.] Russells Hall Hosp, Dudley, England; [Grace, Andrew A.] Univ Cambridge, Sch Biol Sci, Cambridge, England; [Ardashev, Andrey V.] Burdenko Hosp, Moscow, Russia; [Lupo, Pierpaolo; Cappato, Riccardo] Ist Policlin San Donato, IRCCS, Milan, Italy; [Sperzel, Johannes] Kerckhoff Klin, Bad Nauheim, Germany; [Spitzer, Stefan G.] Tech Univ Dresden, Akad Lehrpraxisklin, Dresden, Germany; [Neuzner, Joerg] Klinikum Kassel, Kassel, Germany; [Jordaens, Luc; Theuns, Dominic] Erasmus MC, Rotterdam, Netherlands; [Boersma, Lucas] St Antonius Hosp, Nieuwegein, Netherlands; [Maass, Alexander H.; Van Gelder, Isabelle C.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Wilde, Arthur A.; van Dessel, Pascal F.; Knops, Reinoud E.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Auckland City Hospital; Christchurch Hospital New Zealand; Liverpool Heart & Chest Hospital; University of Glasgow; King's College Hospital NHS Foundation Trust; King's College Hospital; Papworth Hospital; Papworth Hospital; Russells Hall Hospital; University of Cambridge; IRCCS Policlinico San Donato; Kerckhoff Clinic; Technische Universitat Dresden; Klinikum Kassel; Erasmus University Rotterdam; Erasmus MC; St. Antonius Hospital Utrecht; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam	Bardy, GH (corresponding author), Seattle Inst Cardiac Res, 10115 NE 24th St, Bellevue, WA 98004 USA.	gbardy@sicr.org	Jordaens, Luc/AAI-6541-2020; Maass, Alexander/B-8534-2008; Ардашев, Андрей/AAI-9523-2021; Knops, R/AAX-2027-2021	Jordaens, Luc/0000-0002-1407-7186; Maass, Alexander/0000-0002-7936-360X; Ардашев, Андрей/0000-0003-1908-9802; Boersma, Lucas/0000-0003-4591-4220	Cameron Health	Cameron Health	Supported by Cameron Health.	Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888; Alexander ME, 2004, J CARDIOVASC ELECTR, V15, P72, DOI 10.1046/j.1540-8167.2004.03388.x; Alter P, 2005, PACE, V28, P926, DOI 10.1111/j.1540-8159.2005.00195.x; Armitage P., 2002, STAT METHODS MED RES; Bardy G., 2002, PACING CLIN ELECTROP, V25, P578; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Burke MC, 2005, HEART RHYTHM, V2, P1332, DOI 10.1016/j.hrthm.2005.09.007; Byrd CL, 1999, PACE, V22, P1348, DOI 10.1111/j.1540-8159.1999.tb00628.x; Cannom DS, 2008, PACE, V31, P1233, DOI 10.1111/j.1540-8159.2008.01170.x; Cappato R, 2005, J AM COLL CARDIOL, V45, p106A; Corrado A, 2009, EUROPACE, V11, P276, DOI 10.1093/europace/eun385; Danik SB, 2007, HEART RHYTHM, V4, P439, DOI 10.1016/j.hrthm.2006.12.044; Dorwarth U, 2003, J CARDIOVASC ELECTR, V14, P38, DOI 10.1046/j.1540-8167.2003.02305.x; Duray GZ, 2009, EUROPACE, V11, P297, DOI 10.1093/europace/eun322; Eckstein J, 2008, CIRCULATION, V117, P2727, DOI 10.1161/CIRCULATIONAHA.107.740670; Ellenbogen KA, 2003, J AM COLL CARDIOL, V41, P73, DOI 10.1016/S0735-1097(02)02620-7; Ellenbogen KA, 2008, HEART RHYTHM, V5, P1380, DOI 10.1016/j.hrthm.2008.08.001; EPSTEIN AE, 2009, HEART RHYTHM, V6, pE1; Epstein AE, 2008, J AM COLL CARDIOL, V52, P1122, DOI 10.1016/j.jacc.2008.06.035; Epstein AE, 2009, HEART RHYTHM, V6, P204, DOI 10.1016/j.hrthm.2008.10.030; Farwell D, 2008, HEART RHYTHM, V5, P1375, DOI 10.1016/j.hrthm.2008.06.024; *FOOD DRUG ADM, 2007, STAT MED VOL MARK SU; Friedman RA, 2001, J CARDIOVASC ELECTR, V12, P361, DOI 10.1046/j.1540-8167.2001.00361.x; Gould PA, 2008, HEART RHYTHM, V5, P1675, DOI 10.1016/j.hrthm.2008.09.020; Gradaus R, 2001, J CARDIOVASC ELECTR, V12, P356, DOI 10.1046/j.1540-8167.2001.00356.x; Grimm W, 1999, PACE, V22, P206, DOI 10.1111/j.1540-8159.1999.tb00334.x; Hauser RG, 2005, CIRCULATION, V112, P2040, DOI 10.1161/CIRCULATIONAHA.105.580381; Hauser RG, 2007, HEART RHYTHM, V4, P892, DOI 10.1016/j.hrthm.2007.03.041; Hauser RG, 2008, NEW ENGL J MED, V359, P2517, DOI 10.1056/NEJMp0805359; Jolley M, 2008, HEART RHYTHM, V5, P565, DOI 10.1016/j.hrthm.2008.01.018; Jones DG, 2006, PACE, V29, P852, DOI 10.1111/j.1540-8159.2006.00451.x; Khairy P, 2006, CIRCULATION, V113, P2391, DOI 10.1161/CIRCULATIONAHA.106.622076; Kleemann T, 2007, CIRCULATION, V115, P2474, DOI 10.1161/CIRCULATIONAHA.106.663807; Lelakowski Jacek, 2007, Cardiol J, V14, P155; Lieberman R, 2008, HEART RHYTHM, V5, P28, DOI 10.1016/j.hrthm.2007.08.030; Maisel WH, 2006, JAMA-J AM MED ASSOC, V295, P1901, DOI 10.1001/jama.295.16.1901; Maisel WH, 2008, HEART RHYTHM, V5, P1673, DOI 10.1016/j.hrthm.2008.10.014; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Myerburg RJ, 2008, NEW ENGL J MED, V359, P2245, DOI 10.1056/NEJMra0803409; Rhee EK, 2008, HEART RHYTHM, V5, P573, DOI 10.1016/j.hrthm.2008.02.040; Sacher F, 2006, CIRCULATION, V114, P2317, DOI 10.1161/CIRCULATIONAHA.106.628537; Schoenfed MH, 2008, HEART RHYTHM, V5, P1682, DOI 10.1016/j.hrthm.2008.10.010; Sherrid MV, 2008, PROG CARDIOVASC DIS, V51, P237, DOI 10.1016/j.pcad.2008.10.001; Smith SC, 2008, HEART RHYTHM, V5, P934, DOI 10.1016/j.hrthm.2008.04.015; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Toal SC, 2007, HEART RHYTHM, V4, P381, DOI 10.1016/j.hrthm.2006.08.003; Tung R, 2008, J AM COLL CARDIOL, V52, P1111, DOI 10.1016/j.jacc.2008.05.058; Van Rooden CJ, 2004, J CARDIOVASC ELECTR, V15, P1258, DOI 10.1046/j.1540-8167.2004.04081.x; Wilkoff BL, 2007, HEART RHYTHM, V4, P897, DOI 10.1016/j.hrthm.2007.05.002; Winer BJ., 1970, STAT PRINCIPLES EXPT, V2nd	52	454	468	0	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					36	44		10.1056/NEJMoa0909545	http://dx.doi.org/10.1056/NEJMoa0909545			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20463331	Bronze			2022-12-28	WOS:000279343000006
J	Akugizibwe, P; Ramakant, B				Akugizibwe, Paula; Ramakant, Bobby			Challenges for community role in tuberculosis response	LANCET			English	Editorial Material									[Akugizibwe, Paula] AIDS & Rights Alliance So Africa, Cape Town, South Africa; [Ramakant, Bobby] Stop TB Citizen News Serv, Lucknow, Uttar Pradesh, India		Akugizibwe, P (corresponding author), AIDS & Rights Alliance So Africa, Cape Town, South Africa.	paula@arasa.info						DONNELLY J, 2009, AIRBORNE JOURNEY CHA; Garner P, 2007, B WORLD HEALTH ORGAN, V85, P404, DOI 10.2471/BLT.06.035568; Geffen N, 2008, S AFR J HIV MED, P12; Hadley M, 2000, INT J TUBERC LUNG D, V4, P401; *HEALTHDEV NET, 2009, NEW DELH NEW IN IMPR; *STOP TB DEP, 2003, COMM PART TB CAR PRA; *STOP TB PARTN, 2008, TB HIV COMM MOB TB H; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR; *WORLD CAR COUNC, 2010, PATIENTS CHARTER TUB; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2009, GLOB TUB CONTR EP ST	11	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2059	2061		10.1016/S0140-6736(10)60581-8	http://dx.doi.org/10.1016/S0140-6736(10)60581-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20488520				2022-12-28	WOS:000279069300008
J	Weinert, S; Jabs, S; Supanchart, C; Schweizer, M; Gimber, N; Richter, M; Rademann, J; Stauber, T; Kornak, U; Jentsch, TJ				Weinert, Stefanie; Jabs, Sabrina; Supanchart, Chayarop; Schweizer, Michaela; Gimber, Niclas; Richter, Martin; Rademann, Joerg; Stauber, Tobias; Kornak, Uwe; Jentsch, Thomas J.			Lysosomal Pathology and Osteopetrosis upon Loss of H+-Driven Lysosomal Cl- Accumulation	SCIENCE			English	Article							STORAGE DISEASE; CHLORIDE; ACIDIFICATION; ENDOSOMES; CLC-7; PROTEINS; PATHWAY; MOUSE; LEADS	During lysosomal acidification, proton-pump currents are thought to be shunted by a chloride ion (Cl-) channel, tentatively identified as ClC-7. Surprisingly, recent data suggest that ClC-7 instead mediates Cl-/proton (H+) exchange. We generated mice carrying a point mutation converting ClC-7 into an uncoupled (unc) Cl- conductor. Despite maintaining lysosomal conductance and normal lysosomal pH, these Clcn7(unc/unc) mice showed lysosomal storage disease like mice lacking ClC-7. However, their osteopetrosis was milder, and they lacked a coat color phenotype. Thus, only some roles of ClC-7 Cl-/H+ exchange can be taken over by a Cl- conductance. This conductance was even deleterious in Clcn7(+/unc) mice. Clcn7(-/-) and Clcn7(unc/unc) mice accumulated less Cl- in lysosomes than did wild-type mice. Thus, lowered lysosomal chloride may underlie their common phenotypes.	[Weinert, Stefanie; Jabs, Sabrina; Gimber, Niclas; Rademann, Joerg; Stauber, Tobias; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Weinert, Stefanie; Jabs, Sabrina; Gimber, Niclas; Stauber, Tobias; Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Supanchart, Chayarop; Kornak, Uwe] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Schweizer, Michaela] Univ Hamburg, ZMNH, D-20251 Hamburg, Germany; [Kornak, Uwe] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Jabs, Sabrina; Richter, Martin; Rademann, Joerg] Free Univ Berlin, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; Max Planck Society; Free University of Berlin	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Jabs, Sabrina/F-9026-2019; Stauber, Tobias/E-4005-2010; Weinert, Stefanie/AAR-1481-2021; Rademann, Jörg/F-4893-2017	Jabs, Sabrina/0000-0001-8065-8002; Stauber, Tobias/0000-0003-0727-6109; Rademann, Jörg/0000-0001-6678-3165; Jentsch, Thomas/0000-0002-3509-2553; Gimber, Niclas/0000-0001-9456-3063; Weinert, Stefanie/0000-0003-3036-1440	Deutsche Forschungsgemeinschaft [Je164/7, SFB740 (C5), SFB765(Ra895/6)]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank I. Freyert, A. von Bock, and P. Goritz for technical assistance; M. Falcke for help with modeling; and S. Grinstein for suggesting protonophore pretreatment of lysosomes. Support was provided by the Deutsche Forschungsgemeinschaft [grants Je164/7 and SFB740 (C5)] to T.J.J., SFB765(Ra895/6) to J.R., and the OSTEOPETR E-Rare grant (Bundesministerium fur Bildung und Forschung) to UK	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; FUCHS R, 1989, J BIOL CHEM, V264, P2212; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Gunther W, 2003, PFLUG ARCH EUR J PHY, V445, P456, DOI 10.1007/s00424-002-0950-6; Hara-Chikuma M, 2005, BIOCHEM BIOPH RES CO, V329, P941, DOI 10.1016/j.bbrc.2005.02.060; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; OHKUMA S, 1983, J BIOCHEM, V94, P1935, DOI 10.1093/oxfordjournals.jbchem.a134547; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; VANDYKE RW, 1993, AM J PHYSIOL, V265, pC901, DOI 10.1152/ajpcell.1993.265.4.C901; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880	22	164	167	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1401	1403		10.1126/science.1188072	http://dx.doi.org/10.1126/science.1188072			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20430974				2022-12-28	WOS:000278598400040
J	Khor, CC; Vannberg, FO; Chapman, SJ; Guo, HY; Wong, SH; Walley, AJ; Vukcevic, D; Rautanen, A; Mills, TC; Chang, KC; Kam, KM; Crampin, AC; Ngwira, B; Leung, CC; Tam, CM; Chan, CY; Sung, JJY; Yew, WW; Toh, KY; Tay, SKH; Kwiatkowski, D; Lienhardt, C; Hien, TT; Day, NP; Peshu, N; Marsh, K; Maitland, K; Scott, JA; Williams, TN; Berkley, JA; Floyd, S; Tang, NLS; Fine, PEM; Goh, DLM; Hill, AVS				Khor, Chiea C.; Vannberg, Fredrik O.; Chapman, Stephen J.; Guo, Haiyan; Wong, Sunny H.; Walley, Andrew J.; Vukcevic, Damjan; Rautanen, Anna; Mills, Tara C.; Chang, Kwok-Chiu; Kam, Kai-Man; Crampin, Amelia C.; Ngwira, Bagrey; Leung, Chi-Chiu; Tam, Cheuk-Ming; Chan, Chiu-Yeung; Sung, Joseph J. Y.; Yew, Wing-Wai; Toh, Kai-Yee; Tay, Stacey K. H.; Kwiatkowski, Dominic; Lienhardt, Christian; Hien, Tran-Tinh; Day, Nicholas P.; Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.; Floyd, Sian; Tang, Nelson L. S.; Fine, Paul E. M.; Goh, Denise L. M.; Hill, Adrian V. S.			CISH and Susceptibility to Infectious Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIGNALING PATHWAYS; T-CELLS; INTERLEUKIN-2; TUBERCULOSIS; PROTEIN; RECEPTOR; MALARIA; CHILDREN; STAT5	BACKGROUND The interleukin-2-mediated immune response is critical for host defense against infectious pathogens. Cytokine-inducible SRC homology 2 (SH2) domain protein (CISH), a suppressor of cytokine signaling, controls interleukin-2 signaling. METHODS Using a case-control design, we tested for an association between CISH polymorphisms and susceptibility to major infectious diseases (bacteremia, tuberculosis, and severe malaria) in blood samples from 8402 persons in Gambia, Hong Kong, Kenya, Malawi, and Vietnam. We had previously tested 20 other immune-related genes in one or more of these sample collections. RESULTS We observed associations between variant alleles of multiple CISH polymorphisms and increased susceptibility to each infectious disease in each of the study populations. When all five single-nucleotide polymorphisms (SNPs) (at positions -639, -292, -163, +1320, and +3415 [all relative to CISH]) within the CISH-associated locus were considered together in a multiple-SNP score, we found an association between CISH genetic variants and susceptibility to bacteremia, malaria, and tuberculosis (P = 3.8x10(-11) for all comparisons), with -292 accounting for most of the association signal (P = 4.58x10(-7)). Peripheral-blood mononuclear cells obtained from adult subjects carrying the -292 variant, as compared with wild-type cells, showed a muted response to the stimulation of interleukin-2 production-that is, 25 to 40% less CISH expression. CONCLUSIONS Variants of CISH are associated with susceptibility to diseases caused by diverse infectious pathogens, suggesting that negative regulators of cytokine signaling have a role in immunity against various infectious diseases. The overall risk of one of these infectious diseases was increased by at least 18% among persons carrying the variant CISH alleles.	[Khor, Chiea C.; Vannberg, Fredrik O.; Chapman, Stephen J.; Wong, Sunny H.; Vukcevic, Damjan; Rautanen, Anna; Mills, Tara C.; Kwiatkowski, Dominic; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Khor, Chiea C.; Guo, Haiyan; Toh, Kai-Yee; Goh, Denise L. M.] Agcy Sci Technol & Res, Host Susceptibil Infect Program, Singapore Inst Clin Sci, Singapore, Singapore; [Tay, Stacey K. H.; Goh, Denise L. M.] Natl Univ Hlth Syst, Univ Childrens Med Inst, Dept Paediat, Singapore, Singapore; [Tay, Stacey K. H.; Goh, Denise L. M.] Natl Univ Singapore, Singapore 117548, Singapore; [Walley, Andrew J.] Hammersmith Hosp, Imperial Coll, Sect Genom Med, London, England; [Marsh, Kevin; Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr, Clin Trop Med, London SW7 2AZ, England; [Marsh, Kevin; Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England; [Floyd, Sian; Fine, Paul E. M.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London, England; [Chang, Kwok-Chiu; Leung, Chi-Chiu; Tam, Cheuk-Ming] Chinese Univ Hong Kong, TB & Chest Serv, Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Kam, Kai-Man] Chinese Univ Hong Kong, Publ Hlth Lab, Dept Hlth, Hong Kong, Hong Kong, Peoples R China; [Chan, Chiu-Yeung] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Sung, Joseph J. Y.] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Dept Chem Pathol, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Lab Genet Dis Susceptibil, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Yew, Wing-Wai] Grantham Hosp, Hosp Author, TB & Chest Unit, Hong Kong, Hong Kong, Peoples R China; [Crampin, Amelia C.; Ngwira, Bagrey] Karonga Prevent Study, Chilumba, Malawi; [Lienhardt, Christian] Inst Rech Dev, Dakar, Senegal; [Hien, Tran-Tinh; Day, Nicholas P.] Cho Quan Hosp, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Hien, Tran-Tinh; Day, Nicholas P.] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Kilifi Dist Hosp, Ctr Geog Med Res, Wellcome Trust Programme, Kilifi, Kenya; [Peshu, Nobert; Marsh, Kevin; Maitland, Kathryn; Scott, J. Anthony; Williams, Thomas N.; Berkley, James A.] Kenya Govt Med Res Ctr, Kilifi, Kenya	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; Imperial College London; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Malawi Epidemiology and Intervention Research Unit; Institut de Recherche pour le Developpement (IRD); Kenya Medical Research Institute	Khor, CC (corresponding author), Genome Inst Singapore, Div Infect Dis, 60 Biopolis St, Singapore, Singapore.	khorcc@gis.a-star.edu.sg; adrian.hill@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Chan, Raphael Chiu Yeung/J-9649-2013; Tay, Stacey/E-7029-2015; SUNG, Joseph J Y/R-3203-2018; Tang, Nelson/P-5018-2017	Lienhardt, Christian/0000-0003-0233-893X; Tay, Stacey/0000-0002-3077-4184; Walley, Andrew/0000-0001-7707-7549; Kwiatkowski, Dominic/0000-0002-5023-0176; Vukcevic, Damjan/0000-0001-7780-9586; SUNG, Joseph J Y/0000-0003-3125-5199; Berkley, James/0000-0002-1236-849X; Crampin, Amelia/0000-0002-1513-4330; Maitland, Kathryn/0000-0002-0007-0645; Tang, Nelson/0000-0002-3607-5819; Khor, Chiea Chuen/0000-0002-1128-4729; Toh, Kai Yee/0000-0001-9763-1762; Wong, Sunny/0000-0002-3354-9310	Wellcome Trust; Agency for Science, Technology and Research, Singapore; MRC [G19/9] Funding Source: UKRI; Medical Research Council [G19/9, G0600718B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants (to Drs. Khor, Goh, and Hill) and clinical research fellowships (to Drs. Chapman, Williams, Scott, and Berkley) from the Wellcome Trust and the Agency for Science, Technology and Research, Singapore; and by the Wellcome Trust Kenya Major Overseas Programme.	Aman MJ, 1999, J BIOL CHEM, V274, P30266, DOI 10.1074/jbc.274.42.30266; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Chistiakov DA, 2008, IMMUNOL LETT, V118, P1, DOI 10.1016/j.imlet.2008.03.002; CLAYTON D, 2003, HDB STAT GENETICS, P519; Crampin AC, 2001, T ROY SOC TROP MED H, V95, P481, DOI 10.1016/S0035-9203(01)90009-4; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; FAUCI AS, 1999, 39 INT C ANT AG CHEM; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Jin P, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-26; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Lin Jian-Xin, 1997, Cytokine and Growth Factor Reviews, V8, P313; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; McDermott DF, 2007, CLIN CANCER RES, V13, p716S, DOI 10.1158/1078-0432.CCR-06-1872; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nakajima H, 1997, IMMUNITY, V7, P691, DOI 10.1016/S1074-7613(00)80389-1; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Summerfield JA, 1997, BRIT MED J, V314, P1229, DOI 10.1136/bmj.314.7089.1229; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x	41	91	98	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2092	2101		10.1056/NEJMoa0905606	http://dx.doi.org/10.1056/NEJMoa0905606			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603XU	20484391	Green Accepted			2022-12-28	WOS:000278242200008
J	Schmidt, BH; Burgin, AB; Deweese, JE; Osheroff, N; Berger, JM				Schmidt, Bryan H.; Burgin, Alex B.; Deweese, Joseph E.; Osheroff, Neil; Berger, James M.			A novel and unified two-metal mechanism for DNA cleavage by type II and IA topoisomerases	NATURE			English	Article							SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; ACTIVE-SITE; RELIGATION REACTION; PURIFICATION; SUBSTRATE; DOMAIN; COMPLEXES; CATALYSIS; TRANSPORT	Type II topoisomerases are required for the management of DNA tangles and supercoils(1), and are targets of clinical antibiotics and anticancer agents(2). These enzymes catalyse the ATP-dependent passage of one DNA duplex (the transport or T-segment) through a transient, double-stranded break in another (the gate or G-segment), navigating DNA through the protein using a set of dissociable internal interfaces, or 'gates'(3,4). For more than 20 years, it has been established that a pair of dimer-related tyrosines, together with divalent cations, catalyse G-segment cleavage(5-7). Recent efforts have proposed that strand scission relies on a 'two-metal mechanism'(8-10), a ubiquitous biochemical strategy that supports vital cellular processes ranging from DNA synthesis to RNA self-splicing(11,12). Here we present the structure of the DNA-binding and cleavage core of Saccharomyces cerevisiae topoisomerase II covalently linked to DNA through its active-site tyrosine at 2.5 angstrom resolution, revealing for the first time the organization of a cleavage-competent type II topoisomerase configuration. Unexpectedly, metal-soaking experiments indicate that cleavage is catalysed by a novel variation of the classic two-metal approach. Comparative analyses extend this scheme to explain how distantly-related type IA topoisomerases cleave single-stranded DNA, unifying the cleavage mechanisms for these two essential enzyme families. The structure also highlights a hitherto undiscovered allosteric relay that actuates a molecular 'trapdoor' to prevent subunit dissociation during cleavage. This connection illustrates how an indispensable chromosome-disentangling machine auto-regulates DNA breakage to prevent the aberrant formation of mutagenic and cytotoxic genomic lesions.	[Schmidt, Bryan H.; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Burgin, Alex B.] Emerald BioStruct, Bainbridge Isl, WA 98110 USA; [Deweese, Joseph E.; Osheroff, Neil] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Osheroff, Neil] Vanderbilt Univ, Dept Med Hematol Oncol, Sch Med, Nashville, TN 37232 USA	University of California System; University of California Berkeley; Vanderbilt University; Vanderbilt University	Berger, JM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Thurtle-Schmidt, Bryan/0000-0002-0509-0987; Deweese, Joseph/0000-0001-9683-6723	NIH [GM033944, GM053960, T32CA09592, GM08295, CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373, T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM033944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported the NIH (GM033944 and GM053960 for N.O.; T32CA09592 for J.E.D.; GM08295 for B. H. S. and CA077373 for J.M.B.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BURGIN AB, 1995, NUCLEIC ACIDS RES, V23, P2973, DOI 10.1093/nar/23.15.2973; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Cheng BK, 2009, J MOL BIOL, V385, P558, DOI 10.1016/j.jmb.2008.10.073; DeLano W.L, PYMOL MOL GRAPHICS S; Deweese JE, 2008, BIOCHEMISTRY-US, V47, P4129, DOI 10.1021/bi702194x; Deweese JE, 2009, BIOCHEMISTRY-US, V48, P8940, DOI 10.1021/bi900875c; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; DOMANICO PL, 1991, J INORG BIOCHEM, V42, P87, DOI 10.1016/0162-0134(91)80035-G; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fass D, 1999, NAT STRUCT BIOL, V6, P322; GOTO T, 1984, J BIOL CHEM, V259, P422; GOTO T, 1982, J BIOL CHEM, V257, P5866; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Nowotny M, 2006, EMBO J, V25, P1924, DOI 10.1038/sj.emboj.7601076; Okada Y, 2000, J BIOL CHEM, V275, P24630, DOI 10.1074/jbc.M003243200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Sabbagh G, 2004, NUCLEIC ACIDS RES, V32, P495, DOI 10.1093/nar/gkh189; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Strahs D, 2006, NUCLEIC ACIDS RES, V34, P1785, DOI 10.1093/nar/gkl109; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Wang J, 1996, BIOCHEMISTRY-US, V35, P8110, DOI 10.1021/bi960178r; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; ZECHIEDRICH EL, 1989, BIOCHEMISTRY-US, V28, P6229, DOI 10.1021/bi00441a014	41	117	119	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 3	2010	465	7298					641	U139		10.1038/nature08974	http://dx.doi.org/10.1038/nature08974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	604AF	20485342	Green Accepted			2022-12-28	WOS:000278249000047
J	Marteyn, B; West, NP; Browning, DF; Cole, JA; Shaw, JG; Palm, F; Mounier, J; Prevost, MC; Sansonetti, P; Tang, CM				Marteyn, Benoit; West, Nicholas P.; Browning, Douglas F.; Cole, Jeffery A.; Shaw, Jonathan G.; Palm, Fredrik; Mounier, Joelle; Prevost, Marie-Christine; Sansonetti, Philippe; Tang, Christoph M.			Modulation of Shigella virulence in response to available oxygen in vivo	NATURE			English	Article							III SECRETION MACHINERY; ESCHERICHIA-COLI K-12; CHROMOSOMAL GENES; FLEXNERI; PROTEINS; EXPRESSION; INVASION; CELLS; IPAC; CONSTRUCTION	Bacteria coordinate expression of virulence determinants in response to localized microenvironments in their hosts. Here we show that Shigella flexneri, which causes dysentery, encounters varying oxygen concentrations in the gastrointestinal tract, which govern activity of its type three secretion system (T3SS). The T3SS is essential for cell invasion and virulence(1). In anaerobic environments (for example, the gastrointestinal tract lumen), Shigella is primed for invasion and expresses extended T3SS needles while reducing Ipa (invasion plasmid antigen) effector secretion. This is mediated by FNR (fumarate and nitrate reduction), a regulator of anaerobic metabolism that represses transcription of spa32 and spa33, virulence genes that regulate secretion through the T3SS. We demonstrate there is a zone of relative oxygenation adjacent to the gastrointestinal tract mucosa, caused by diffusion from the capillary network at the tips of villi. This would reverse the anaerobic block of Ipa secretion, allowing T3SS activation at its precise site of action, enhancing invasion and virulence.	[Marteyn, Benoit; West, Nicholas P.; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Browning, Douglas F.; Cole, Jeffery A.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Shaw, Jonathan G.] Univ Sheffield, Sch Med, Div Genom Med, Sheffield S10 2RX, S Yorkshire, England; [Palm, Fredrik] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, S-75123 Uppsala, Sweden; [Mounier, Joelle; Sansonetti, Philippe] Inst Pasteur, INSERM, U786, F-75724 Paris 15, France; [Mounier, Joelle; Sansonetti, Philippe] Inst Pasteur, Unite Pathogenie Microbienne Mol, F-75724 Paris 15, France; [Sansonetti, Philippe] Coll France, F-75231 Paris 05, France	Imperial College London; University of Birmingham; University of Sheffield; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France	Tang, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, Ctr Mol Microbiol & Infect, Flowers Bldg, London SW7 2AZ, England.	psanson@pasteur.fr; c.tang@imperial.ac.uk	Marteyn, Benoit S/M-3763-2017; West, Nicholas P/C-3119-2008	West, Nicholas P/0000-0003-0955-9890; Marteyn, Benoit/0000-0001-5638-702X; Browning, Douglas/0000-0003-4672-3514	Fondation pour la Recherche Medicale; Royal Society; ERC; European Union [QLRT-1999-00938]; Wellcome Trust; Medical Research Council	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Royal Society(Royal Society of London); ERC(European Research Council (ERC)European Commission); European Union(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Fondation pour la Recherche Medicale, the Royal Society, an ERC Advanced Grant (HOMEOEPITH), and the European Union (QLRT-1999-00938). Work in CMT's laboratory is supported by the Wellcome Trust and The Medical Research Council, and PJS is a Howard Hughes Medical Institute scholar. Imaging was performed at the PFID station (Institut Pasteur). We are grateful to J. Green for the anti-FNR pAbs and advice. R. Exley, D. Holden and K. Ray provided suggestions and reviewed the manuscript; we thank M.-A. Nicola for technical help.	Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996; Browning DF, 2002, MOL MICROBIOL, V43, P687, DOI 10.1046/j.1365-2958.2002.02776.x; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; GHISLA S, 1978, P NATL ACAD SCI USA, V75, P5860, DOI 10.1073/pnas.75.12.5860; Hansen MC, 2001, MICROBIOL-SGM, V147, P1383, DOI 10.1099/00221287-147-5-1383; HOITINK CWG, 1990, GENE, V90, P15, DOI 10.1016/0378-1119(90)90434-S; Jaumouille V, 2008, EMBO J, V27, P447, DOI 10.1038/sj.emboj.7601976; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Liss P, 1997, PFLUG ARCH EUR J PHY, V434, P705, DOI 10.1007/s004240050455; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Miller J. H, 1972, EXPT MOL GENETICS; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; PHALIPON A, 1992, INFECT IMMUN, V60, P1919, DOI 10.1128/IAI.60.5.1919-1926.1992; Phalipon A, 2007, IMMUNOL CELL BIOL, V85, P119, DOI 10.1038/sj.icb7100025; PODKOVYROV SM, 1995, GENE, V156, P151, DOI 10.1016/0378-1119(95)00053-9; SANSONETTI PJ, 1983, INFECT IMMUN, V39, P1392, DOI 10.1128/IAI.39.3.1392-1402.1983; SASAKAWA C, 1993, J BACTERIOL, V175, P2334, DOI 10.1128/JB.175.8.2334-2346.1993; Schuch R, 2001, INFECT IMMUN, V69, P2180, DOI 10.1128/IAI.69.4.2180-2189.2001; Takahashi E, 2006, AM J PHYSIOL-CELL PH, V291, pC781, DOI 10.1152/ajpcell.00067.2006; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; TOBE T, 1991, MOL MICROBIOL, V5, P887, DOI 10.1111/j.1365-2958.1991.tb00762.x; TORRES IP, 1994, P NATL ACAD SCI USA, V91, P2081, DOI 10.1073/pnas.91.6.2081; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472	35	232	236	0	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					355	U113		10.1038/nature08970	http://dx.doi.org/10.1038/nature08970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20436458	Green Accepted			2022-12-28	WOS:000277829200042
J	Dixit, E; Boulant, S; Zhang, YJ; Lee, ASY; Odendall, C; Shum, B; Hacohen, N; Chen, ZJ; Whelan, SP; Fransen, M; Nibert, ML; Superti-Furga, G; Kagan, JC				Dixit, Evelyn; Boulant, Steeve; Zhang, Yijing; Lee, Amy S. Y.; Odendall, Charlotte; Shum, Bennett; Hacohen, Nir; Chen, Zhijian J.; Whelan, Sean P.; Fransen, Marc; Nibert, Max L.; Superti-Furga, Giulio; Kagan, Jonathan C.			Peroxisomes Are Signaling Platforms for Antiviral Innate Immunity	CELL			English	Article							RIG-I; MAMMALIAN-CELLS; TRANSCRIPTION FACTORS; MEMBRANE-PROTEINS; GENE-EXPRESSION; POTENTIAL ROLE; RNA VIRUSES; MITOCHONDRIAL; RESPONSES; RECOGNITION	Peroxisomes have long been established to play a central role in regulating various metabolic activities in mammalian cells. These organelles act in concert with mitochondria to control the metabolism of lipids and reactive oxygen species. However, while mitochondria have emerged as an important site of antiviral signal transduction, a role for peroxisomes in immune defense is unknown. Here, we report that the RIG-I-like receptor (RLR) adaptor protein MAVS is located on peroxisomes and mitochondria. We find that peroxisomal and mitochondrial MAVS act sequentially to create an antiviral cellular state. Upon viral infection, peroxisomal MAVS induces the rapid interferon-independent expression of defense factors that provide short-term protection, whereas mitochondrial MAVS activates an interferon-dependent signaling pathway with delayed kinetics, which amplifies and stabilizes the antiviral response. The interferon regulatory factor IRF1 plays a crucial role in regulating MAVS-dependent signaling from peroxisomes. These results establish that peroxisomes are an important site of antiviral signal transduction.	[Boulant, Steeve; Lee, Amy S. Y.; Whelan, Sean P.; Nibert, Max L.; Kagan, Jonathan C.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Dixit, Evelyn; Zhang, Yijing; Odendall, Charlotte; Kagan, Jonathan C.] Childrens Hosp Boston, Div Gastroenterol, Boston, MA 02115 USA; [Dixit, Evelyn; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Lee, Amy S. Y.; Whelan, Sean P.; Nibert, Max L.] Harvard Univ, Div Med Sci, Training Program Virol, Boston, MA 02115 USA; [Shum, Bennett; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Fransen, Marc] Katholieke Univ Leuven, Fac Geneeskunde, Dept Mol Celbiol, LIPIT, B-3000 Leuven, Belgium	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; KU Leuven	Kagan, JC (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu	Fransen, Marc/ADL-0723-2022; Superti-Furga, Giulio/F-4755-2015; Boulant, Steeve/W-3754-2019; Chen, Zhijian/C-6039-2012; Superti-Furga, Giulio/AAE-5681-2019; Fransen, Marc/C-6262-2008	Superti-Furga, Giulio/0000-0002-0570-1768; Boulant, Steeve/0000-0001-8614-4993; Chen, Zhijian/0000-0002-8475-8251; Fransen, Marc/0000-0001-9284-1197; Shum, Bennett/0000-0001-6150-7233; Whelan, Sean/0000-0003-1564-8590; Zhang, Yijing/0000-0001-9568-9389	Children's Hospital; Austrian Science Fund (FWF) [DK CCHD W1205]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G.0754.09]; Bijzonder Onderzoeksfonds of the K.U. Leuven [OT/09/045]; National Institutes of Health [AI059371]; Bill and Melinda Gates Foundation; National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059371, R37AI059371] Funding Source: NIH RePORTER	Children's Hospital(Tehran University of Medical Sciences); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO); Bijzonder Onderzoeksfonds of the K.U. Leuven; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Defense Science and Engineering Graduate Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank B. Boush (FACS), J. Wagner (microscopy), and C. Brees (cell fractionation) for expert help. We would like to thank S. Brubaker, C. Glanemann, L.R. Marek, M. Schneider, and I. Zanoni for helpful discussions. This work has been supported by the following sources: Children's Hospital Boston Career Development Fellowship (J. K.), Austrian Science Fund (FWF; DK CCHD W1205) (E.D.), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G.0754.09) and the Bijzonder Onderzoeksfonds of the K.U. Leuven (OT/09/045) (M.F.), the National Institutes of Health (AI059371 to S.P.W.); the Bill and Melinda Gates Foundation (S.B. and M.L.N., through a Vaccine Discovery Consortium grant to the International AIDS Vaccine Initiative), and the National Defense Science and Engineering Graduate Fellowship (A.S.Y. L.).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Ferran MC, 1997, J VIROL, V71, P371, DOI 10.1128/JVI.71.1.371-377.1997; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fransen M, 2004, J BIOL CHEM, V279, P12615, DOI 10.1074/jbc.M304941200; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Koch A, 2005, MOL BIOL CELL, V16, P5077, DOI 10.1091/mbc.E05-02-0159; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mossman KL, 2001, J VIROL, V75, P750, DOI 10.1128/JVI.75.2.750-758.2001; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Nemoto Y, 1999, EMBO J, V18, P2991, DOI 10.1093/emboj/18.11.2991; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Sacksteder KA, 2000, J CELL BIOL, V148, P931, DOI 10.1083/jcb.148.5.931; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Vastiau IMK, 2006, CELL MOL LIFE SCI, V63, P1686, DOI 10.1007/s00018-006-6110-y; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	45	556	570	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					668	681		10.1016/j.cell.2010.04.018	http://dx.doi.org/10.1016/j.cell.2010.04.018			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20451243	Bronze, Green Accepted			2022-12-28	WOS:000277623600019
J	Jeltsch, A				Jeltsch, Albert			Phylogeny of Methylomes	SCIENCE			English	Editorial Material							DNA METHYLATION; WIDESPREAD; SEQUENCE; MAPS		Jacobs Univ, Sch Sci & Engn, D-28759 Bremen, Germany	Jacobs University	Jeltsch, A (corresponding author), Jacobs Univ, Sch Sci & Engn, D-28759 Bremen, Germany.	a.jeltsch@jacobs-university.de	Jeltsch, Albert/O-7404-2014	Jeltsch, Albert/0000-0001-6113-9290				Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; GOYON C, 1994, J MOL BIOL, V240, P42, DOI 10.1006/jmbi.1994.1416; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jullien PE, 2009, CURR OPIN PLANT BIOL, V12, P637, DOI 10.1016/j.pbi.2009.07.004; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Panning Barbara, 2008, Journal of Biology (London), V7, P301, DOI 10.1186/jbiol95; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	24	50	51	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					837	838		10.1126/science.1190738	http://dx.doi.org/10.1126/science.1190738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466912				2022-12-28	WOS:000277618800028
J	Delage, M; Naouri, M				Delage, Maia; Naouri, Michael			Erythema Gyratum Repens	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Delage, Maia; Naouri, Michael] Univ Tours, Tours, France	Universite de Tours	Delage, M (corresponding author), Univ Tours, Tours, France.	maiadelage@hotmail.com							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1814	1814		10.1056/NEJMicm0906654	http://dx.doi.org/10.1056/NEJMicm0906654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463341				2022-12-28	WOS:000277555500008
J	Phillips, A				Phillips, Alexander			F1 designed to save lives	LANCET			English	Editorial Material									Queen Elizabeth High Sch, Hexham NE46 3JB, England		Phillips, A (corresponding author), Queen Elizabeth High Sch, Hexham NE46 3JB, England.	Alexander_jp@hotmail.co.uk						*BABYPOD 2, ADV HEALTHC TECHN; *SCI MUS, FAST FORW 20 WAYS F1	2	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1509	1509		10.1016/S0140-6736(10)60638-1	http://dx.doi.org/10.1016/S0140-6736(10)60638-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435217				2022-12-28	WOS:000277655100011
J	Banerjee, J; Roy, MM; Bhojani, S; Emcy, N				Banerjee, Jayanta; Roy, Mita M.; Bhojani, Sheetal; Emcy, Naina			10-Minute Consultation "My baby keeps bringing up his feeds!"	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Banerjee, Jayanta; Bhojani, Sheetal; Emcy, Naina] Southend Univ Hosp NHS Fdn Trust, Southend On Sea SS0 0RY, England; [Roy, Mita M.] SW Essex Primary Care Trust, Basildon SS14 3HG, England		Banerjee, J (corresponding author), Southend Univ Hosp NHS Fdn Trust, Southend On Sea SS0 0RY, England.	docjayanta@hotmail.com							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 30	2010	340								c2189	10.1136/bmj.c2189	http://dx.doi.org/10.1136/bmj.c2189			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PP	20435633				2022-12-28	WOS:000277314400002
J	Floer, M; Wang, X; Prabhu, V; Berrozpe, G; Narayan, S; Spagna, D; Alvarez, D; Kendall, J; Krasnitz, A; Stepansky, A; Hicks, J; Bryant, GO; Ptashne, M				Floer, Monique; Wang, Xin; Prabhu, Vidya; Berrozpe, Georgina; Narayan, Santosh; Spagna, Dan; Alvarez, David; Kendall, Jude; Krasnitz, Alexander; Stepansky, Asya; Hicks, James; Bryant, Gene O.; Ptashne, Mark			A RSC/Nucleosome Complex Determines Chromatin Architecture and Facilitates Activator Binding	CELL			English	Article							NUCLEOSOME OCCUPANCY; TRANSCRIPTION FACTOR; RSC; ORGANIZATION; LOCATION; PROMOTER; GENES; REPRESSION; TURNOVER; SEQUENCE	How is chromatin architecture established and what role does it play in transcription? We show that the yeast regulatory locus UASg bears, in addition to binding sites for the activator Gal4, sites bound by the RSC complex. RSC positions a nucleosome, evidently partially unwound, in a structure that facilitates Gal4 binding to its sites. The complex comprises a barrier that imposes characteristic features of chromatin architecture. In the absence of RSC, ordinary nucleosomes encroach over the UASg and compete with Gal4 for binding. Taken with our previous work, the results show that both prior to and following induction, specific DNA-binding proteins are the predominant determinants of chromatin architecture at the GAL1/10 genes. RSC/nucleosome complexes are also found scattered around the yeast genome. Higher eukaryotic RSC lacks the specific DNA-binding determinants found on yeast RSC, and evidently Gal4 works in those organisms despite whatever obstacle broadly positioned nucleosomes present.	[Floer, Monique; Wang, Xin; Prabhu, Vidya; Berrozpe, Georgina; Narayan, Santosh; Spagna, Dan; Alvarez, David; Bryant, Gene O.; Ptashne, Mark] Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; [Kendall, Jude; Krasnitz, Alexander; Stepansky, Asya; Hicks, James] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory	Ptashne, M (corresponding author), Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.	m-ptashne@mskcc.org			NIH [R01GM032308]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francisco Asturias for preparing the space filling model of the RSC/nucleosome complex bound to the UASg together with two Gal4 DNA-binding domain dimers. We would also like to thank Timothy Hughes, Brad Cairns, TomKodadek, Francesc Posas, and David Allis for yeast strains and plasmids, Hiten Madhani for the antibody against H2A.Z, and Alex Gann for helpful comments on the manuscript. This work was supported by a grant (R01GM032308) from the NIH to M.P.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bryan WW, 2003, AMYOTROPH LATERAL SC, V4, P11, DOI 10.1080/14660820310006661; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; CAVALLI G, 1993, EMBO J, V12, P4603, DOI 10.1002/j.1460-2075.1993.tb06149.x; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Du J, 1998, GENETICS, V150, P987; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Korber P, 2004, J BIOL CHEM, V279, P35113, DOI 10.1074/jbc.M405446200; KORNBERG R, 1981, NATURE, V292, P579, DOI 10.1038/292579a0; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Linger J, 2006, EUKARYOT CELL, V5, P1780, DOI 10.1128/EC.00202-06; LOHR D, 1993, P NATL ACAD SCI USA, V90, P10628, DOI 10.1073/pnas.90.22.10628; LOHR D, 1984, NUCLEIC ACIDS RES, V12, P8457, DOI 10.1093/nar/12.22.8457; Lorch Y, 2001, MOL CELL, V7, P89, DOI 10.1016/S1097-2765(01)00157-5; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; RAINBOW M, 1989, BIOCHEMISTRY-US, V28, P7486, DOI 10.1021/bi00444a048; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reagan MS, 1998, MOL GEN GENET, V259, P142, DOI 10.1007/s004380050799; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Terrell AR, 2002, J BIOL CHEM, V277, P31038, DOI 10.1074/jbc.M204662200; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	36	135	135	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					407	418		10.1016/j.cell.2010.03.048	http://dx.doi.org/10.1016/j.cell.2010.03.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434983	Green Accepted, Bronze			2022-12-28	WOS:000277180800013
J	Price, DH				Price, David H.			Regulation of RNA Polymerase II Elongation by c-Myc	CELL			English	Editorial Material							POL-II; DROSOPHILA; ACTIVATION; INITIATION; PROMOTERS; EMBRYO		Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Price, DH (corresponding author), Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA.	david-price@uiowa.edu	Price, David H/F-6173-2010	Price, David/0000-0002-5597-385X	NIAID NIH HHS [R33 AI074392] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI074392] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	8	15	15	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 30	2010	141	3					399	400		10.1016/j.cell.2010.04.016	http://dx.doi.org/10.1016/j.cell.2010.04.016			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434979	Bronze			2022-12-28	WOS:000277180800009
J	Yaron, D; Karabinos, M; Lange, D; Greeno, JG; Leinhardt, G				Yaron, David; Karabinos, Michael; Lange, Donovan; Greeno, James G.; Leinhardt, Gaea			The ChemCollective-Virtual Labs for Introductory Chemistry Courses	SCIENCE			English	Editorial Material							PERFORMANCE		[Yaron, David; Karabinos, Michael; Lange, Donovan; Greeno, James G.; Leinhardt, Gaea] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Yaron, D (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	yaron@cmu.edu		Yaron, David J./0000-0001-8485-8685	Direct For Education and Human Resources [0817493] Funding Source: National Science Foundation	Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))		Bransford JD., 2000, PEOPLE LEARN; Cuadros J, 2007, J CHEM EDUC, V84, P1047; DAVENPORT J, 2008, P 13 ANN C COGN SCI, P1699; Evans KL, 2008, CHEM EDUC RES PRACT, V9, P208, DOI 10.1039/b812409b; Evans KL, 2006, J CHEM EDUC, V83, P655, DOI 10.1021/ed083p655; Koedinger KR, 2007, EDUC PSYCHOL REV, V19, P239, DOI 10.1007/s10648-007-9049-0; LARKIN J, 1980, SCIENCE, V208, P1335, DOI 10.1126/science.208.4450.1335; Nakhleh M. B., 1995, J COLL SCI TEACH, V25, P174; NAKONECHNY J, 2003, P ED MEDIA, P2475	9	55	56	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					584	585		10.1126/science.1182435	http://dx.doi.org/10.1126/science.1182435			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431007				2022-12-28	WOS:000277159800032
J	Matyas, C				Matyas, Csaba			Forecasts needed for retreating forests	NATURE			English	Editorial Material									[Matyas, Csaba] Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, Inst Environm & Earth Sci, H-9401 Sopron, Hungary; [Matyas, Csaba] Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, No Eurasian Earth Sci Partnership Initiat, H-9401 Sopron, Hungary	University of West Hungary; University of West Hungary	Matyas, C (corresponding author), Univ W Hungary, Focus Res Ctr Nonboreal Eastern Europe, Inst Environm & Earth Sci, H-9401 Sopron, Hungary.	cm@emk.nyme.hu							0	82	87	3	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 29	2010	464	7293					1271	1271		10.1038/4641271a	http://dx.doi.org/10.1038/4641271a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428144	Bronze			2022-12-28	WOS:000277149000018
J	Ganin, AY; Takabayashi, Y; Jeglic, P; Arcon, D; Potocnik, A; Baker, PJ; Ohishi, Y; McDonald, MT; Tzirakis, MD; McLennan, A; Darling, GR; Takata, M; Rosseinsky, MJ; Prassides, K				Ganin, Alexey Y.; Takabayashi, Yasuhiro; Jeglic, Peter; Arcon, Denis; Potocnik, Anton; Baker, Peter J.; Ohishi, Yasuo; McDonald, Martin T.; Tzirakis, Manolis D.; McLennan, Alec; Darling, George R.; Takata, Masaki; Rosseinsky, Matthew J.; Prassides, Kosmas			Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition	NATURE			English	Article							DOPED C-60; FULLERIDES; RB3C60	The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units-a two-dimensional square lattice-is available to study the competition between the cooperative electronic states of magnetic order and superconductivity(1). Crystals of the spherical molecular C-60(3-) anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A(3)C(60) (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C-60(3-) (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, T-o ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order(5,6). Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A(3)C(60) fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature T-N = 2.2 K) than in the b.c.c.-based packing (T-N = 46 K). The different lattice packings of C-60(3-) change T-c from 38 K in b.c.c. Cs3C60 to 35 K in f.c.c. Cs3C60 (the highest found in the f.c.c. A(3)C(60) family). The existence of two superconducting packings of the same electronically active unit reveals that T-c scales universally in a structure-independent dome-like relationship with proximity to the Mott metal-insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.	[Ganin, Alexey Y.; McLennan, Alec; Darling, George R.; Rosseinsky, Matthew J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Takabayashi, Yasuhiro; McDonald, Martin T.; Tzirakis, Manolis D.; Prassides, Kosmas] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Jeglic, Peter; Arcon, Denis; Potocnik, Anton] Jozef Stefan Inst, Ljubljana 1000, Slovenia; [Arcon, Denis] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Baker, Peter J.] STFC Rutherford Appleton Lab, ISIS Pulsed Neutron & Muon Source, Didcot OX11 0QX, Oxon, England; [Ohishi, Yasuo; Takata, Masaki] Japan Synchrotron Radiat Res Inst, SPring 8, Hyogo 6795198, Japan; [Takata, Masaki] RIKEN, Ctr SPring 8, Mikazuki, Hyogo 6795148, Japan	University of Liverpool; Durham University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; RIKEN	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	M.J.Rosseinsky@liverpool.ac.uk; K.Prassides@durham.ac.uk	Prassides, Kosmas/GVU-9219-2022; Takabayashi, Yasuhiro/A-5014-2013; Jeglic, Peter/AAB-7347-2022; Prassides, Kosmas/C-9804-2009; Takata, Masaki/M-1525-2014; Tzirakis, Manolis D./N-5429-2014; Baker, Peter J/E-4216-2010; Potocnik, Anton/P-3793-2017	Takabayashi, Yasuhiro/0000-0002-3493-2194; Prassides, Kosmas/0000-0003-4524-3084; Tzirakis, Manolis D./0000-0002-8591-2038; Baker, Peter J/0000-0002-2306-2648; Potocnik, Anton/0000-0002-0352-6388; Jeglic, Peter/0000-0001-8163-9065; Ganin, Alexey/0000-0002-3754-5819; Darling, George/0000-0001-9329-9993	EPSRC [EP/G037132, EP/G037949]; EPSRC [EP/G037949/1, EP/G037132/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G037132/1, EP/G037949/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank EPSRC for support (EP/G037132 and EP/G037949) and STFC for access to the synchrotron X-ray facilities at the ESRF (where we thank A. N. Fitch for assistance on beamline ID31) and Diamond (where we thank C. Tang for assistance on beamline I11) and to the muon facilities at ISIS. We also thank SPring-8 for access to the synchrotron X-ray facilities.	Bendele GM, 1998, EUROPHYS LETT, V41, P553, DOI 10.1209/epl/i1998-00190-3; Capone M, 2002, SCIENCE, V296, P2364, DOI 10.1126/science.1071122; Capone M, 2009, REV MOD PHYS, V81, P943, DOI 10.1103/RevModPhys.81.943; Darling GR, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.136404; Ganin AY, 2008, NAT MATER, V7, P367, DOI 10.1038/nmat2179; Gunnarsson O, 2005, STRUCT BOND, V114, P71, DOI 10.1007/b101017; Gunnarsson O, 1997, REV MOD PHYS, V69, P575, DOI 10.1103/RevModPhys.69.575; Gunnarsson O, 1996, PHYS REV B, V54, P11026, DOI 10.1103/PhysRevB.54.R11026; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; Jeglic P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195424; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P327, DOI 10.1016/0038-1098(94)00786-1; Pennington CH, 1996, REV MOD PHYS, V68, P855, DOI 10.1103/RevModPhys.68.855; Prassides K, 1999, J AM CHEM SOC, V121, P11227, DOI 10.1021/ja992931k; Sato N, 1998, PHYS REV B, V58, P12433, DOI 10.1103/PhysRevB.58.12433; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0; Tanigaki K, 1996, J PHYS I, V6, P2159, DOI 10.1051/jp1:1996212; WALSTEDT RE, 1993, NATURE, V362, P611, DOI 10.1038/362611a0; Wiebe CR, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.134410	20	178	180	4	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					221	U93		10.1038/nature09120	http://dx.doi.org/10.1038/nature09120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20485340				2022-12-28	WOS:000279580800033
J	Li, TC; Kheifets, S; Medellin, D; Raizen, MG				Li, Tongcang; Kheifets, Simon; Medellin, David; Raizen, Mark G.			Measurement of the Instantaneous Velocity of a Brownian Particle	SCIENCE			English	Article							MOTION; MECHANICS; MOVEMENT	Brownian motion of particles affects many branches of science. We report on the Brownian motion of micrometer-sized beads of glass held in air by an optical tweezer, over a wide range of pressures, and we measured the instantaneous velocity of a Brownian particle. Our results provide direct verification of the energy equipartition theorem for a Brownian particle. For short times, the ballistic regime of Brownian motion was observed, in contrast to the usual diffusive regime. We discuss the applications of these methods toward cooling the center-of-mass motion of a bead in vacuum to the quantum ground motional state.	[Raizen, Mark G.] Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA; Univ Texas Austin, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Raizen, MG (corresponding author), Univ Texas Austin, Ctr Nonlinear Dynam, Austin, TX 78712 USA.	raizen@physics.utexas.edu	Kheifets, Simon/M-9776-2016; Medellin, David/H-6557-2017; Li, Tongcang/C-7454-2009	Kheifets, Simon/0000-0001-8196-9208; Medellin, David/0000-0002-9241-8708; Li, Tongcang/0000-0001-8604-6592; Li, Tongcang/0000-0003-3308-8718	Sid W. Richardson Foundation; R. A. Welch Foundation [F-1258]; El Consejo Nacional de Ciencia y Tecnologia (CONACYT) [206429]	Sid W. Richardson Foundation; R. A. Welch Foundation(The Welch Foundation); El Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	M. G. R. acknowledges support from the Sid W. Richardson Foundation and the R. A. Welch Foundation grant number F-1258. D. M. acknowledges support from El Consejo Nacional de Ciencia y Tecnologia (CONACYT) for his graduate fellowship (206429). The authors would also like to thank E.-L. Florin and Z. Yin for helpful discussions and I. Popov for his help with the experiment.	ASHKIN A, 1976, APPL PHYS LETT, V28, P333, DOI 10.1063/1.88748; Blum J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.230601; BURNHAM DR, BROWNIAN DY IN PRESS; Chang DE, 2010, P NATL ACAD SCI USA, V107, P1005, DOI 10.1073/pnas.0912969107; Chavez I, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.3002422; Einstein A, 1907, Z ELKTROCHEM ANGEW P, V13, P41, DOI 10.1002/bbpc.19070130602; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Einstein A., 1926, INVESTIGATIONS THEOR, P63; EXNER FM, 1900, ANN PHYS, V2, P843; FEDELE PD, 1980, PHYS REV LETT, V44, P691, DOI 10.1103/PhysRevLett.44.691; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Hopkins A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.235328; KERKER M, 1974, J CHEM EDUC, V51, P764, DOI 10.1021/ed051p764; Kleckner D, 2006, NATURE, V444, P75, DOI 10.1038/nature05231; KUBO R, 1986, SCIENCE, V233, P330, DOI 10.1126/science.233.4761.330; Langevin P, 1908, CR HEBD ACAD SCI, V146, P530; Libbrecht KG, 2004, PHYS LETT A, V321, P99, DOI 10.1016/j.physleta.2003.12.022; Lukic B, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.160601; Moshfegh A, 2009, COLLOID SURFACE A, V345, P112, DOI 10.1016/j.colsurfa.2009.04.042; Romero-Isart O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033015; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wang GM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050601; WANG MC, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323; ZWANZIG R, 1975, J FLUID MECH, V69, P21, DOI 10.1017/S0022112075001280	24	423	436	36	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1673	1675		10.1126/science.1189403	http://dx.doi.org/10.1126/science.1189403			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20488989				2022-12-28	WOS:000279107400037
J	Atun, R; Weil, DEC; Eang, MT; Mwakyusa, D				Atun, Rifat; Weil, Diana E. C.; Eang, Mao Tan; Mwakyusa, David			Tuberculosis 7 Health-system strengthening and tuberculosis control	LANCET			English	Article							SECTOR REFORM; TB CONTROL; COMMUNICABLE DISEASE; RUSSIAN-FEDERATION; ECONOMIC-IMPACT; PRIVATE MIX; CARE; BURDEN; SERVICES; HIV	Weak health systems are hindering global efforts for tuberculosis care and control, but little evidence is available on effective interventions to address system bottlenecks. This report examines published evidence, programme reviews, and case studies to identify innovations in system design and tuberculosis control to resolve these bottlenecks. We outline system bottlenecks in relation to governance, financing, supply chain management, human resources, health-information systems, and service delivery; and adverse effects from rapid introduction of suboptimum system designs. This report also documents innovative solutions for disease control and system design. Solutions pursued in individual countries are specific to the nature of the tuberculosis epidemic, the underlying national health system, and the contributors engaged: no one size fits all. Findings from countries, including Bangladesh, Cambodia, India, Tanzania, Thailand, and Vietnam, suggest that advances in disease control and system strengthening are complementary. Tuberculosis care and control are essential elements of health systems, and simultaneous efforts to innovate systems and disease response are mutually reinforcing. Highly varied and context-specific responses to tuberculosis show that solutions need to be documented and compared to develop evidence-based policies and practice.	[Atun, Rifat] Global Fund Fight AIDS TB & Malaria, CH-1204 Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Weil, Diana E. C.] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Eang, Mao Tan] Minist Hlth, Natl Ctr TB & Leprosy Control, Phnom Penh, Cambodia; [Mwakyusa, David] Minist Hlth, Dar Es Salaam, Tanzania	Imperial College London; World Health Organization	Atun, R (corresponding author), Global Fund Fight AIDS TB & Malaria, Chemin Blandonnet 8, CH-1204 Geneva, Switzerland.	r.atun@imperial.ac.uk	chiu, takeung/A-2046-2013; Tao, Youyou/D-2367-2014; Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983				Ahmed Jameel, 2009, J Pak Med Assoc, V59, P82; *AMST DECL STOP TB, 2000, MIN C TUB SUST DEV A; [Anonymous], HLTH SYSTEMS CHALLEN; Arbelaez MP, 2004, INT J HEALTH PLAN M, V19, pS25, DOI 10.1002/hpm.775; Atun RA, 2006, HEALTH POLICY PLANN, V21, P353, DOI 10.1093/heapol/czl023; Atun RA, 2005, B WORLD HEALTH ORGAN, V83, P217; Atun RA, 2004, EUR J PUBLIC HEALTH, V14, P267, DOI 10.1093/eurpub/14.3.267; Atun RA, 2008, DO VERTICAL STAND AL; Atun R, 2008, B WORLD HEALTH ORGAN, V86, P147, DOI 10.2471/BLT.06.034991; Atun RA, 2006, HEALTH POLICY, V79, P79, DOI 10.1016/j.healthpol.2005.12.005; Bonilla C, 2007, B WORLD HEALTH ORGAN, V85, P402, DOI 10.2471/BLT.06.036335; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; Brugha R, 2001, BRIT MED J, V323, P152, DOI 10.1136/bmj.323.7305.152; CASSELS A, 1995, WHOSHSNHP954; Chakaya J, 2008, INT J TUBERC LUNG D, V12, P1274; CHAULET P, 1997, INT J TUBERC LUNG D, V1, P3; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cockcroft A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S4; Coker RJ, 2004, LANCET, V363, P1389, DOI 10.1016/S0140-6736(04)16053-4; Collins CD, 2002, HEALTH POLICY, V62, P141, DOI 10.1016/S0168-8510(02)00006-4; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; *DFID, 2009, JOINT MON MISS REV N; Douthwaite M, 2005, HEALTH POLICY PLANN, V20, P117, DOI 10.1093/heapol/czi014; Drobniewski FA, 2004, INT J STD AIDS, V15, P641, DOI 10.1258/0956462041944303; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Edginton ME, 1999, INT J TUBERC LUNG D, V3, P445; Elzinga G, 2004, LANCET, V363, P814, DOI 10.1016/S0140-6736(04)15698-5; Erhola ML, 2009, INT J TUBERC LUNG D, V13, P540; Figueroa-Munoz J., 2005, HUM RESOUR HEALTH, V3, P2, DOI [10.1186/1478-4491-3-2/TABLES/4, DOI 10.1186/1478-4491-3-2/TABLES/4]; Frieden TR, 2003, TUBERCULOSIS, V83, P82, DOI 10.1016/S1472-9792(02)00060-4; *G8 COMM OK, 2000, KYUSH OK SUMM OK JAP; Gidado M, 2009, ANN AFR MED, V8, P25, DOI 10.4103/1596-3519.55760; *GLOB FUND FLIGHT, TECHN REV PAN SECR F; *GLOB FUND FLIGHT, TECHN REV PAN SECR R; *GLOB FUND FLIGHT, GLOB FUND 2010 INN I; GODINHO J, 2005, ECSHDECCU8 WORLD BAN; Hanson C, 2000, INT J TUBERC LUNG D, V4, P627; Hill PS, 2007, B WORLD HEALTH ORGAN, V85, P631, DOI 10.2471/BLT.06.036822; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Khaleghian P, 2004, SOC SCI MED, V59, P163, DOI 10.1016/j.socscimed.2003.10.013; *KNCV, 2007, JUN 2006 REV VIETN N; Kritski AL, 2000, INT J TUBERC LUNG D, V4, P622; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Kumaresan JA, 2000, INT J TUBERC LUNG D, V4, P615; Lagrada Leizel P, 2008, Kekkaku, V83, P765; Leimane V, 2006, Euro Surveill, V11, P29, DOI 10.2807/esm.11.03.00610-en; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Marica C, 2009, EUR RESPIR J, V33, P168, DOI 10.1183/09031936.00104308; Marquez P, 2008, HLTH SYSTEMS CHALLEN; MERRICK T, 1999, DELIVERING REPROD HL; Miller B, 2000, INT J TUBERC LUNG D, V4, P593; Miti S, 2003, INT J TUBERC LUNG D, V7, pS92; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Newell JN, 2005, HEALTH POLICY, V73, P212, DOI 10.1016/j.healthpol.2004.11.014; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; Raviglione MC, 2001, ANN NY ACAD SCI, V953, P88, DOI 10.1111/j.1749-6632.2001.tb11364.x; de Figueiredo TMRM, 2009, REV SAUDE PUBL, V43, P825, DOI 10.1590/S0034-89102009005000054; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sinanovic Edina, 2006, Cost Eff Resour Alloc, V4, P11, DOI 10.1186/1478-7547-4-11; Sleigh AC, 2007, LANCET, V369, P626, DOI 10.1016/S0140-6736(07)60292-X; Soltan V, 2008, B WORLD HEALTH ORGAN, V86, P71, DOI 10.2471/BLT.06.038265; *STOP TB PARTN, 2006, WHOHTMSTB200635; Stop TB Partnership, GLOB DRUG FAC; Tang SL, 2000, INT J HEALTH PLAN M, V15, P189; *THAI MIN HLTH WHO, 2008, M JUL 16 27 2007 NEW; Travis P, 2006, B WORLD HEALTH ORGAN, V84, P427, DOI 10.2471/BLT.06.032755; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR IS; UPLEKAR M, 2009, TUBERCULOSIS ESSENTI; Uplekar M, 2007, B WORLD HEALTH ORGAN, V85, P413, DOI 10.2471/BLT.07.041756; Van Rie A, 2006, LANCET, V368, P1554, DOI 10.1016/S0140-6736(06)69575-5; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Weil DEC, 2000, INT J TUBERC LUNG D, V4, P597; *WHO, 2001, 1 5 BILL NEED MEET T; *WHO, 2009, HUM RES HLTH ACT FRA; *WHO, 1974, WHO TECHN REP SER, V552, P1; *WHO, 2000, 53 WORLD HLTH ASS MA; *WHO, 2004, INT POL COLL TB HIV; WHO, 2009, WHOHTMTB2009411; *WHO, HUM RES DEV VIS GOAL; WHO, 2007, EV BUS STRENGTH HLTH; *WHO, 2006, WHOHTM2006368; *WHO, 2003, WHOCDS2003318; Wilkinson D, 1999, INT J TUBERC LUNG D, V3, P938; World Health Organization, 2008, WHOHTMTB2008400; World Health Organization, 1994, WHOTB94177; World Health Organization, WORLD HLTH REP 2000; World Health Organization, 2019, WHO GLOB TASK FORC T; World Health Organization, 1994, WHOTB94179; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization (WHO), 2009, WHOHTMTB2009426; Wyss K, 2001, TROP MED INT HEALTH, V6, P60, DOI 10.1046/j.1365-3156.2001.00677.x; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015	99	87	89	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2169	2178		10.1016/S0140-6736(10)60493-X	http://dx.doi.org/10.1016/S0140-6736(10)60493-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20488514				2022-12-28	WOS:000279255100028
J	Povolotskaya, IS; Kondrashov, FA				Povolotskaya, Inna S.; Kondrashov, Fyodor A.			Sequence space and the ongoing expansion of the protein universe	NATURE			English	Article							AMINO-ACID GAIN; COMMON ANCESTOR; MAXIMUM-LIKELIHOOD; GENOME EVOLUTION; SELECTION; PERSPECTIVE; PROKARYOTES; TOLERANCE; EPISTASIS; ALIGNMENT	The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions(1-4). However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: similar to 98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, similar to 3.5 x 10(9) yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.	[Povolotskaya, Inna S.; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, Calle Dr Aiguader 88,Barcelona Biomed Res Pk Bldg, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Povolotskaya, Inna/0000-0001-6621-232X				Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Camps M, 2007, CRIT REV BIOCHEM MOL, V42, P313, DOI 10.1080/10409230701597642; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P14132, DOI 10.1073/pnas.202497999; Doolittle WF, 2000, CURR OPIN STRUC BIOL, V10, P355, DOI 10.1016/S0959-440X(00)00096-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GOLDING B, 1990, J MOL EVOL, V31, P511, DOI 10.1007/BF02102078; Goldstein RA, 2006, MOL BIOL EVOL, V23, P1444, DOI 10.1093/molbev/msl010; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Guzzo L, 2008, NATURE, V451, P541, DOI 10.1038/nature06555; Heger A, 2000, PROG BIOPHYS MOL BIO, V73, P321, DOI 10.1016/S0079-6107(00)00013-4; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huang WZ, 1996, J MOL BIOL, V258, P688, DOI 10.1006/jmbi.1996.0279; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kondrashov AS, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-5; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Taylor SV, 2001, P NATL ACAD SCI USA, V98, P10596, DOI 10.1073/pnas.191159298; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	36	141	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					922	U7		10.1038/nature09105	http://dx.doi.org/10.1038/nature09105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20485343				2022-12-28	WOS:000278804500037
J	Matsushita, K; van der Velde, M; Astor, BC; Woodward, M; Levey, AS; de Jong, PE; Coresh, J; Gansevoort, RT				Matsushita, Kunihiro; van der Velde, Marije; Astor, Brad C.; Woodward, Mark; Levey, Andrew S.; de Jong, Paul E.; Coresh, Josef; Gansevoort, Ron T.		Chronic Kidney Dis Prognosis Cons	Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis	LANCET			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTOR; CYSTATIN-C; SERUM CREATININE; POOLED ANALYSIS; RENAL-DISEASE; OLDER; PREVALENCE; EQUATION; EVENTS	Background Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associations of eGFR and albuminuria with mortality. Methods In this collaborative meta-analysis of general population cohorts, we pooled standardised data for all-cause and cardiovascular mortality from studies containing at least 1000 participants and baseline information about eGFR and urine albumin concentrations. Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality associated with eGFR and albuminuria, adjusted for potential confounders. Findings The analysis included 105 872 participants (730 577 person-years) from 14 studies with urine albumin-to-creatinine ratio (ACR) measurements and 1128 310 participants (4 732110 person-years) from seven studies with urine protein dipstick measurements. In studies with ACR measurements, risk of mortality was unrelated to eGFR between 75 mL/min/1.73 m(2) and 105 mL/min/1.73 m(2) and increased at lower eGFRs. Compared with eGFR 95 mL/min/1.73 m(2), adjusted HRs for all-cause mortality were 1.18 (95% CI 1.05-1.32) for eGFR 60 mL/min/1.73 m(2), 1.57 (1.39-1.78) for 45 mL/min/1.73 m(2), and 3.14 (2.39-4.13) for 15 mL/min/1. 73 m(2). ACR was associated with risk of mortality linearly on the log-log scale without threshold effects. Compared with ACR 0.6 mg/mmol, adjusted HRs for all-cause mortality were 1.20 (1.15-1.26) for ACR 1.1 mg/mmol, 1.63 (1.50-1.77) for 3.4 mg/mmol, and 2.22 (1.97-2.51) for 33.9 mg/mmol. eGFR and ACR were multiplicatively associated with risk of mortality without evidence of interaction. Similar findings were recorded for cardiovascular mortality and in studies with dipstick measurements. Interpretation eGFR less than 60 mi./min/1.73 m(2) and ACR 1.1 mg/mmol (10 mg/g) or more are independent predictors of mortality risk in the general population. This study provides quantitative data for use of both kidney measures for risk assessment and definition and staging of chronic kidney disease.	[Matsushita, Kunihiro; Astor, Brad C.; Coresh, Josef] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA; [van der Velde, Marije; de Jong, Paul E.; Gansevoort, Ron T.] Univ Groningen, Dept Nephrol, Univ Med Ctr Groningen, Groningen, Netherlands; [Woodward, Mark] Univ Sydney, George Inst, Sydney, NSW 2006, Australia; [Levey, Andrew S.] Tufts Med Ctr, Div Nephrol, Boston, MA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Groningen; University of Sydney; Tufts Medical Center	Coresh, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument,Suite 2-630, Baltimore, MD 21287 USA.	coresh@jhu.edu	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Hemmelgarn, Brenda R./I-6894-2012; Matsushita, Kunihiro/AAJ-5817-2020; Ärnlöv, Johan/AAF-2746-2019; Woodward, Mark/D-8492-2015; Kikuya, Masahiro/X-5662-2018; Woodward, Mark/L-6817-2017; Matsushita, Kunihiro/B-1021-2018; Metoki, Hirohito/B-3376-2009; Cirillo, Massimo/G-5480-2018	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Matsushita, Kunihiro/0000-0002-7179-718X; Ärnlöv, Johan/0000-0002-6933-4637; Kikuya, Masahiro/0000-0002-3080-6107; Matsushita, Kunihiro/0000-0002-7179-718X; Metoki, Hirohito/0000-0002-1894-3328; Koenig, Wolfgang/0000-0002-2064-9603; Rothenbacher, Dietrich/0000-0002-3563-2791; Klein, Ronald/0000-0002-4428-6237; Woodward, Mark/0000-0001-9800-5296; Nitsch, Dorothea/0000-0001-5767-248X; Howard, George/0000-0002-3068-5720; Cirillo, Massimo/0000-0002-6409-3504; Polkinghorne, Kevan/0000-0002-9851-002X; Cushman, Mary/0000-0002-7871-6143	Improving Global Outcomes (KDIGO); US National Kidney Foundation; Dutch Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC095169, N01HC045133, N01HC075150, N01HC085086, N01HC085079, N01HC095159, N01HC025195, N01HC035129] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL068140, R01HL043232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073217, K23DK067303, R01DK031801, U01DK035073, K23DK002904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007181, R01AG023629, R01AG020098, R01AG028507, R01AG015928, R01AG027058] Funding Source: NIH RePORTER	Improving Global Outcomes (KDIGO); US National Kidney Foundation; Dutch Kidney Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding Kidney Disease: Improving Global Outcomes (KDIGO), US National Kidney Foundation, and Dutch Kidney Foundation.	Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033; Bauer C, 2008, J AM SOC NEPHROL, V19, P844, DOI 10.1681/ASN.2008010110; Bui AL, 2009, AM J KIDNEY DIS, V53, P389, DOI 10.1053/j.ajkd.2008.06.025; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Crowe E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1530; de Jong PE, 2008, CLIN J AM SOC NEPHRO, V3, P616, DOI 10.2215/CJN.04381007; Eckardt KU, 2009, AM J KIDNEY DIS, V53, P915, DOI 10.1053/j.ajkd.2009.04.001; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gansevoort RT, 2009, J AM SOC NEPHROL, V20, P465, DOI 10.1681/ASN.2008111212; Genuth S, 2003, DIABETES CARE, V26, P3160; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ingelsson E, 2007, EUR HEART J, V28, P1739, DOI 10.1093/eurheartj/ehm130; Jafar TH, 2009, NEPHROL DIAL TRANSPL, V24, P2111, DOI 10.1093/ndt/gfp042; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; KRUMHOLZ HM, 1994, JAMA-J AM MED ASSOC, V272, P1335, DOI 10.1001/jama.272.17.1335; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Nakayama M, 2007, NEPHROL DIAL TRANSPL, V22, P1910, DOI 10.1093/ndt/gfm051; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Parikh NI, 2008, AM J CARDIOL, V102, P47, DOI 10.1016/j.amjcard.2008.02.095; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Reese PP, 2009, J AM SOC NEPHROL, V20, P2088, DOI 10.1681/ASN.2009080832; ROBERT DT, 2004, J CLIN HYPERTENS, V6, P2; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2009, AM J NEPHROL, V30, P171, DOI 10.1159/000212381; Soveri I, 2009, J INTERN MED, V266, P406, DOI 10.1111/j.1365-2796.2009.02122.x; Stevens LA, 2008, AM J KIDNEY DIS, V51, P395, DOI 10.1053/j.ajkd.2007.11.018; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Zhang LX, 2007, NEPHROL DIAL TRANSPL, V22, P1093, DOI 10.1093/ndt/gfl763; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	50	2676	2755	7	168	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2073	2081		10.1016/S0140-6736(10)60674-5	http://dx.doi.org/10.1016/S0140-6736(10)60674-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20483451	Green Published, Green Accepted			2022-12-28	WOS:000279069300019
J	Gruber, J				Gruber, Jonathan			The Cost Implications of Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gruber, J (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							de Water Paul Van, 2010, HLTH REFORM WILL RED; Elmendorf Doug W., 2010, COMMUNICATION   0318; *HJ KAIS FAM FDN, 2009, EMPL HLTH BEN 2009 A	3	27	28	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 3	2010	362	22					2050	2051		10.1056/NEJMp1005117	http://dx.doi.org/10.1056/NEJMp1005117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603XU	20463330				2022-12-28	WOS:000278242200003
J	Gandhi, NR; Nunn, P; Dheda, K; Schaaf, HS; Zignol, M; van Soolingen, D; Jensen, P; Bayona, J				Gandhi, Neel R.; Nunn, Paul; Dheda, Keertan; Schaaf, H. Simon; Zignol, Matteo; van Soolingen, Dick; Jensen, Paul; Bayona, Jaime			Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis	LANCET			English	Article							HIV-INFECTED PATIENTS; NEW-YORK-CITY; COMMUNITY-BASED THERAPY; MYCOBACTERIUM-TUBERCULOSIS; XDR-TB; PULMONARY TUBERCULOSIS; NOSOCOMIAL TRANSMISSION; TREATMENT OUTCOMES; CLINICAL-FEATURES; WESTERN-CAPE	Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis during the past decade threatens to undermine these advances. However, countries are responding far too slowly. Of the estimated 440000 cases of MDR tuberculosis that occurred in 2008, only 7% were identified and reported to WHO. Of these cases, only a fifth were treated according to WHO standards. Although treatment of MDR and XDR tuberculosis is possible with currently available diagnostic techniques and drugs, the treatment course is substantially more costly and laborious than for drug-susceptible tuberculosis, with higher rates of treatment failure and mortality. Nonetheless, a few countries provide examples of how existing technologies can be used to reverse the epidemic of MDR tuberculosis within a decade. Major improvements in laboratory capacity, infection control, performance of tuberculosis control programmes, and treatment regimens for both drug-susceptible and drug-resistant disease will be needed, together with a massive scale-up in diagnosis and treatment of MDR and XDR tuberculosis to prevent drug-resistant strains from becoming the dominant form of tuberculosis. New diagnostic tests and drugs are likely to become available during the next few years and should accelerate control of MDR and XDR tuberculosis. Equally important, especially in the highest-burden countries of India, China, and Russia, will be a commitment to tuberculosis control including improvements in national policies and health systems that remove financial barriers to treatment, encourage rational drug use, and create the infrastructure necessary to manage MDR tuberculosis on a national scale.	[Gandhi, Neel R.] Albert Einstein Coll Med, Dept Med, New York, NY 10467 USA; [Gandhi, Neel R.] Montefiore Med Ctr, Div Gen Internal Med, New York, NY 10467 USA; [Gandhi, Neel R.] Tugela Ferry Care & Res Collaborat TF CARES, Tugela Ferry, South Africa; [Nunn, Paul; Zignol, Matteo] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; [Dheda, Keertan] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Dept Infect, London, England; [Schaaf, H. Simon] Univ Stellenbosch, Dept Pediat & Child Hlth, Cape Town, South Africa; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm, TB Reference Lab, NL-3720 BA Bilthoven, Netherlands; [Jensen, Paul] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Bayona, Jaime] Socios Salud & Partners Hlth, Lima, Peru	Yeshiva University; Montefiore Medical Center; World Health Organization; University of Cape Town; University of Cape Town; University of London; University College London; Stellenbosch University; Netherlands National Institute for Public Health & the Environment; Centers for Disease Control & Prevention - USA	Gandhi, NR (corresponding author), Albert Einstein Coll Med, Dept Med, 111 E 210 St, New York, NY 10467 USA.	neelgandhi@alumni.williams.edu		Schaaf, Hendrik Simon/0000-0001-5755-4133	Doris Duke Charitable Foundation; South African Research Chair Initiative; MRC; European Union; EDCTP; South African Medical Research Council; National Research Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); South African Research Chair Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); EDCTP; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation	NRG is the recipient of the Doris Duke Charitable Foundation Clinical Scientist Development Award. KD is supported by a South African Research Chair Initiative award, a MRC Career Development Fellowship, the European Union (FW7-TBsusgent), and the EDCTP (TESA and TB-NEAT). HSS is supported by the South African Medical Research Council and National Research Foundation for MDR TB studies.	ALLAN WGL, 1977, AM REV RESPIR DIS, V115, P727; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; [Anonymous], 2008, GUID PROGR MAN DRUG; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; BATEMAN C, 2007, S AFR MED J, V97, P1028; BATEMAN C, 2007, S AFR MED J, V97, P1030; Bateman Chris, 2007, S Afr Med J, V97, P1030; Bayona J, 2003, INT J TUBERC LUNG D, V7, pS501; Ben Amor Y, 2008, EMERG INFECT DIS, V14, P1345, DOI 10.3201/eid1409.061524; Bernardo J, 2009, AM J RESP CRIT CARE, V180, P288, DOI 10.1164/rccm.200906-0863ED; Blomberg B, 2001, B WORLD HEALTH ORGAN, V79, P61; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Borgdorff MW, 2009, LANCET, V373, P1822, DOI 10.1016/S0140-6736(09)60557-2; Burman WJ, 1997, CHEST, V112, P57, DOI 10.1378/chest.112.1.57; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Caminero JA, 2006, INT J TUBERC LUNG D, V10, P829; Cato A, 1998, CLIN PHARMACOL THER, V63, P414, DOI 10.1016/S0009-9236(98)90036-4; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; *CDCP, 1991, JAMA-J AM MED ASSOC, V266, P1483; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; CHIRENDA J, 2009, INT J TUBERC LUNG S1, V13, pS3; Churchyard GJ, 2009, CLIN CHEST MED, V30, P769, DOI 10.1016/j.ccm.2009.08.009; Cohen T, 2008, AM J RESP CRIT CARE, V177, P1302, DOI 10.1164/rccm.200801-175PP; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; Cox HS, 2007, CLIN INFECT DIS, V44, P1421, DOI 10.1086/517536; DAVID HL, 1970, APPL MICROBIOL, V20, P810, DOI 10.1128/AEM.20.5.810-814.1970; Devasia RA, 2009, AM J RESP CRIT CARE, V180, P365, DOI 10.1164/rccm.200901-0146OC; Devaux I, 2009, EMERG INFECT DIS, V15, P1052, DOI 10.3201/eid1507.080994; DHEDA K, LANCET IN PRESS; DHEDA K, 2009, TUBERCULOSIS COMPREH, P746; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Dubrovina I, 2008, INT J TUBERC LUNG D, V12, P756; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; Dye C, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000346; EAST AFRICAN /BRITISH MEDICAL RESEARCH COUNCILS, 1973, Lancet, P1331; Eker B, 2008, EMERG INFECT DIS, V14, P1700, DOI 10.3201/eid1411.080729; ESCOMBE A, 2007, PLOS MED, V4, pE63; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Espinal M, 2009, INT J TUBERC LUNG D, V13, P1; Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca; FLOYD K, 2006, TB COMPREHENSIVE INT, P649; Forsythe CT, 2007, CAN J EMERG MED, V9, P459; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gagneux S, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02685.x; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; Grandjean L, 2008, CURR OPIN INFECT DIS, V21, P454, DOI 10.1097/QCO.0b013e32830ce783; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kobaidze K, 2009, INTERDISCIP PERSPECT, V2009; Laserson KF, 2001, INT J TUBERC LUNG D, V5, P448; Laszlo A, 2002, INT J TUBERC LUNG D, V6, P748; Legrand J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002100; Lienhardt C, 2010, CURR OPIN PULM MED, V16, P186, DOI 10.1097/MCP.0b013e328337580c; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2000, INT J TUBERC LUNG D, V4, P1052; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Migliori GB, 2009, EUR RESPIR J, V34, P387, DOI 10.1183/09031936.00009509; Migliori GB, 2007, EUROSURVEILLANCE, V12, P5, DOI DOI 10.2807/ESW.12.20.03194-EN; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Mitnick CD, 2007, PLOS MED, V4, P1730, DOI 10.1371/journal.pmed.0040292; Mlambo CK, 2008, INT J TUBERC LUNG D, V12, P99; MOLL A, 2009, 40 UN WORLD C LUNG H; MPHAHLELE M, 2009, 40 UN WORLD C LUNG H; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Nkengasong JN, 2009, AM J CLIN PATHOL, V131, P852, DOI 10.1309/AJCPC51BLOBBPAKC; Nunes EA, 2005, INT J TUBERC LUNG D, V9, P494; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; ODONNELL MR, 2009, 5 INT AIDS SOC C HIV; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Perez-Guzman C, 2002, INT J TUBERC LUNG D, V6, P1102; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Post FA, 2004, J INFECT DIS, V190, P99, DOI 10.1086/421501; Raviglione M, 2008, HARRISONS PRINCIPLES, P1006; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; RILEY RL, 1989, AM REV RESPIR DIS, V139, P1286, DOI 10.1164/ajrccm/139.5.1286; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Sahai J, 1997, ANN INTERN MED, V127, P289, DOI 10.7326/0003-4819-127-4-199708150-00006; Scano F, 2008, INT J TUBERC LUNG D, V12, P1370; Schaaf HS, 2009, CLIN CHEST MED, V30, P667, DOI 10.1016/j.ccm.2009.08.019; Schaaf HS, 2009, PEDIATR INFECT DIS J, V28, P748, DOI 10.1097/INF.0b013e31819bc491; Schaaf HS, 2002, PEDIATRICS, V109, P765, DOI 10.1542/peds.109.5.765; Schaaf HS, 2003, ARCH DIS CHILD, V88, P1106, DOI 10.1136/adc.88.12.1106; Schluger NW, 1996, PEDIATR PULM, V21, P138, DOI 10.1002/(SICI)1099-0496(199602)21:2<138::AID-PPUL9>3.0.CO;2-N; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; SHAH N, 2009, 40 UN WORLD C LUNG H; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shingadia D, 2003, LANCET INFECT DIS, V3, P624, DOI 10.1016/S1473-3099(03)00771-0; Shiraishi Y, 2009, J THORAC CARDIOV SUR, V138, P1180, DOI 10.1016/j.jtcvs.2009.07.018; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Soeters M, 2005, SAMJ S AFR MED J, V95, P602; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Story A, 2007, THORAX, V62, P667, DOI 10.1136/thx.2006.065409; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Supply P, 2003, MOL MICROBIOL, V47, P529, DOI 10.1046/j.1365-2958.2003.03315.x; THOMAS T, INT J TUBER IN PRESS; Toungoussova OS, 2004, FEMS IMMUNOL MED MIC, V42, P281, DOI 10.1016/j.femsim.2004.05.012; Tsiouris Simon J, 2007, MedGenMed, V9, P62, DOI 10.1186/1758-2652-9-3-62; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Upshur R, 2009, B WORLD HEALTH ORGAN, V87, P481, DOI 10.2471/BLT.08.051698; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Victor TC, 2007, INT J TUBERC LUNG D, V11, P195; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Weiner M, 2005, CLIN INFECT DIS, V41, P1343, DOI 10.1086/496980; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2010, MULT EXT DRUG RES TU; *WHO, 2009, 62 WORLD HLTH ASS PR; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO, 2007, GLOB MDR TB XFR TB R; WHO, 2009, WHOHTMTB2009422; *WHO, 2009, COUNTR HAD REP LEAST; *WHO, 2008, WHOHTMTB2008394; *WHO STOP TB PARTN, 2006, WHOHTMSTB200635 STOP; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; Zhao M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004370; Zumla A, 2009, CLIN CHEST MED, V30, pXIII, DOI 10.1016/j.ccm.2009.08.020	151	756	791	4	237	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1830	1843		10.1016/S0140-6736(10)60410-2	http://dx.doi.org/10.1016/S0140-6736(10)60410-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	603NY	20488523				2022-12-28	WOS:000278216500034
J	Buffett, BA				Buffett, Bruce A.			The Enigmatic Inner Core	SCIENCE			English	Editorial Material							ANISOTROPY; TIMES; TOP		Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Buffett, BA (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	bbuffett@berkeley.edu						Buffett BA, 2009, GEOPHYS J INT, V179, P711, DOI 10.1111/j.1365-246X.2009.04311.x; Cao A, 2004, EARTH PLANET SC LETT, V228, P243, DOI 10.1016/j.epsl.2004.09.032; Deuss A, 2010, SCIENCE, V328, P1018, DOI 10.1126/science.1188596; Ishii M, 2002, P NATL ACAD SCI USA, V99, P14026, DOI 10.1073/pnas.172508499; Labrosse S, 2001, EARTH PLANET SC LETT, V190, P111, DOI 10.1016/S0012-821X(01)00387-9; Monnereau M, 2010, SCIENCE, V328, P1014, DOI 10.1126/science.1186212; MORELLI A, 1986, GEOPHYS RES LETT, V13, P1545, DOI 10.1029/GL013i013p01545; Niu FL, 2001, NATURE, V410, P1081, DOI 10.1038/35074073; Sun XL, 2008, PHYS EARTH PLANET IN, V167, P53, DOI 10.1016/j.pepi.2008.02.011; Tanaka S, 1997, J GEOPHYS RES-SOL EA, V102, P2925, DOI 10.1029/96JB03187; Wheeler J, 2009, GEOPHYS J INT, V178, P1723, DOI 10.1111/j.1365-246X.2009.04241.x; WOODHOUSE JH, 1986, GEOPHYS RES LETT, V13, P1549, DOI 10.1029/GL013i013p01549	12	2	2	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					982	983		10.1126/science.1190506	http://dx.doi.org/10.1126/science.1190506			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489010				2022-12-28	WOS:000277877100025
J	Lyman, JM; Good, SA; Gouretski, VV; Ishii, M; Johnson, GC; Palmer, MD; Smith, DM; Willis, JK				Lyman, John M.; Good, Simon A.; Gouretski, Viktor V.; Ishii, Masayoshi; Johnson, Gregory C.; Palmer, Matthew D.; Smith, Doug M.; Willis, Josh K.			Robust warming of the global upper ocean	NATURE			English	Article							SEA-LEVEL RISE; HEAT-CONTENT; TEMPERATURE; REEVALUATION; VARIABILITY; PROFILES; QUALITY; ARGO; XBT	A large (similar to 10(23) J) multi-decadal globally averaged warming signal in the upper 300 m of the world's oceans was reported roughly a decade ago(1) and is attributed to warming associated with anthropogenic greenhouse gases(2,3). The majority of the Earth's total energy uptake during recent decades has occurred in the upper ocean(3), but the underlying uncertainties in ocean warming are unclear, limiting our ability to assess closure of sea-level budgets(4-7), the global radiation imbalance(8) and climate models(5). For example, several teams have recently produced different multi-year estimates of the annually averaged global integral of upper-ocean heat content anomalies (hereafter OHCA curves) or, equivalently, the thermosteric sea-level rise(5,9-16). Patterns of inter-annual variability, in particular, differ among methods. Here we examine several sources of uncertainty that contribute to differences among OHCA curves from 1993 to 2008, focusing on the difficulties of correcting biases in expendable bathythermograph (XBT) data. XBT data constitute the majority of the in situ measurements of upper-ocean heat content from 1967 to 2002, and we find that the uncertainty due to choice of XBT bias correction dominates among-method variability in OHCA curves during our 1993-2008 study period. Accounting for multiple sources of uncertainty, a composite of several OHCA curves using different XBT bias corrections still yields a statistically significant linear warming trend for 1993-2008 of 0.64 W m(-2) (calculated for the Earth's entire surface area), with a 90-per-cent confidence interval of 0.53-0.75 W m(-2).	[Lyman, John M.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Lyman, John M.; Johnson, Gregory C.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; [Good, Simon A.; Palmer, Matthew D.; Smith, Doug M.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England; [Gouretski, Viktor V.] Univ Hamburg, D-20144 Hamburg, Germany; [Ishii, Masayoshi] Meteorol Res Inst, Climate Res Dept, Tsukuba, Ibaraki 3050052, Japan; [Ishii, Masayoshi] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Willis, Josh K.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; Met Office - UK; Hadley Centre; University of Hamburg; Meteorological Research Institute - Japan; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Lyman, JM (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	john.lyman@noaa.gov	Smith, Doug/ABD-5204-2021; Willis, Josh/AGY-7817-2022; Johnson, Gregory C/I-6559-2012	Johnson, Gregory C/0000-0002-8023-4020; Palmer, Matthew/0000-0001-7422-198X; Lyman, John/0000-0002-7200-4663	US National Oceanic and Atmospheric Administration (NOAA) Climate Program Office; NOAA; DECC/Defra [GA01101]	US National Oceanic and Atmospheric Administration (NOAA) Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); DECC/Defra(Department for Environment, Food & Rural Affairs (DEFRA))	J.M.L. and G.C.J. were funded by the US National Oceanic and Atmospheric Administration (NOAA) Climate Program Office and NOAA Research. S. A. G., M. D. P. and D. M. S. were supported by the Joint DECC and Defra Integrated Climate Programme DECC/Defra (GA01101). C. Domingues, S. Levitus, T. Boyer, M. Ferrante and D. Trossman provided comments. C. Domingues, S. Levitus, and T. Boyer also provided corrected XBT profiles. This is Pacific Marine Environment Laboratory contribution number 3476 and Joint Institute for Marine and Atmospheric Research contribution number 09-372.	AchutaRao KM, 2007, P NATL ACAD SCI USA, V104, P10768, DOI 10.1073/pnas.0611375104; Barnett TP, 2005, SCIENCE, V309, P284, DOI 10.1126/science.1112418; BOYER TP, 2006, WORLD OCEAN DATABASE, pCH1; Cazenave A, 2009, GLOBAL PLANET CHANGE, V65, P83, DOI 10.1016/j.gloplacha.2008.10.004; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gouretski V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027834; Gouretski V, 2010, DEEP-SEA RES PT I, V57, P812, DOI 10.1016/j.dsr.2010.03.011; Ingleby B, 2007, J MARINE SYST, V65, P158, DOI 10.1016/j.jmarsys.2005.11.019; Ishii M, 2009, J OCEANOGR, V65, P287, DOI 10.1007/s10872-009-0027-7; Johnson GC, 2008, J CLIMATE, V21, P5351, DOI 10.1175/2008JCLI2384.1; Johnson GC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026769; Johnson GC, 2007, J CLIMATE, V20, P5365, DOI 10.1175/2007JCLI1879.1; Knight J., 2009, B AM METEOROL SOC, V90, pS56; Leuliette EW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036010; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Lyman JM, 2008, J CLIMATE, V21, P5629, DOI 10.1175/2008JCLI2259.1; Murphy DM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012105; Palmer M., 2010, P OCEANOBS 09 SUST O, V2; Palmer MD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031712; Reseghetti F, 2007, OCEAN SCI, V3, P59, DOI 10.5194/os-3-59-2007; Roemmich D, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.65; Smith DM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2005JC003172; TRENBERTH KE, 2010, P OCEANOBS 09 SUST O, V1; Trenberth KE, 2009, CURR OPIN ENV SUST, V1, P19, DOI 10.1016/j.cosust.2009.06.001; Wijffels SE, 2008, J CLIMATE, V21, P5657, DOI 10.1175/2008JCLI2290.1; Willis JK, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002260; Willis JK, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004517	30	256	268	1	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 20	2010	465	7296					334	337		10.1038/nature09043	http://dx.doi.org/10.1038/nature09043			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485432				2022-12-28	WOS:000277829200037
J	Rajaratnam, JK; Marcus, JR; Levin-Rector, A; Chalupka, AN; Wang, HD; Dwyer, L; Costa, M; Lopez, AD; Murray, CJL				Rajaratnam, Julie Knoll; Marcus, Jake R.; Levin-Rector, Alison; Chalupka, Andrew N.; Wang, Haidong; Dwyer, Laura; Costa, Megan; Lopez, Alan D.; Murray, Christopher J. L.			Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis	LANCET			English	Article							ADULT MORTALITY; HEALTH; POPULATION; COUNTRIES; NUMBER; DEATH; BIAS	Background Adult deaths are a crucial priority for global health. Causes of adult death are important components of Millennium Development Goals 5 and 6. However, adult mortality has received little policy attention, resources, or monitoring efforts. This study aimed to estimate worldwide mortality in men and women aged 15-59 years. Methods We compiled a database of 3889 measurements of adult mortality for 187 countries from 1970 to 2010 using vital registration data and census and survey data for deaths in the household corrected for completeness, and sibling history data from surveys corrected for survival bias. We used Gaussian process regression to generate yearly estimates of the probability of death between the ages of 15 years and 60 years (45q15) for men and women for every country with uncertainty intervals that indicate sampling and non-sampling error. We showed that these analytical methods have good predictive validity for countries with missing data. Findings Adult mortality varied substantially across countries and over time. In 2010, the countries with the lowest risk of mortality for men and women are Iceland and Cyprus, respectively. In Iceland, male 45q15 is 65 (uncertainty interval 61-69) per 1000; in Cyprus, female 45q15 is 38 (36-41) per 1000. Highest risk of mortality in 2010 is seen in Swaziland for men (45q15 of 765 [692-845] per 1000) and Zambia for women (606 [518-708] per 1000). Between 1970 and 2010, substantial increases in adult mortality occurred in sub-Saharan Africa because of the HIV epidemic and in countries in or related to the former Soviet Union. Other regional trends were also seen, such as stagnation in the decline of adult mortality for large countries in southeast Asia and a striking decline in female mortality in south Asia. Interpretation The prevention of premature adult death is just as important for global health policy as the improvement of child survival. Routine monitoring of adult mortality should be given much greater emphasis.	[Rajaratnam, Julie Knoll; Marcus, Jake R.; Levin-Rector, Alison; Wang, Haidong; Dwyer, Laura; Costa, Megan; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Chalupka, Andrew N.] Harvard Univ, Sch Med, Boston, MA USA; [Lopez, Alan D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@u.washington.edu	Levin-Rector, Alison/AAA-6756-2020; Lopez, Alan D/F-1487-2010; Lopez, Alan/AAA-2734-2022	Lopez, Alan D/0000-0001-5818-6512; Costa, Megan/0000-0002-0256-477X; Dwyer-Lindgren, Laura/0000-0002-3872-6451	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by funding from the Bill & Melinda Gates Foundation. We thank the many individuals around the world who have helped us collate data from various sources. We also thank David Phillips and Summer Ohno for their assistance with the production of this report.	AHMAD OB, 2008, B WORLD HEALTH ORGAN, V78, P1175; [Anonymous], WORLD POP PROSP 2008; *BANGL BUR STAT, 2006, REP SAMPL VIT REG SY; *BANGL BUR STAT, 1994, REP SAMPL VIT REG BA; Bangladesh Bureau of Statistics, 2007, REP SAMPL VIT REG SY; Bangladesh Bureau of Statistics, 2008, REP SAMPL VIT REG SY; Beegle K, 2005, ECON DEV CULT CHANGE, V53, P655, DOI 10.1086/427410; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; *CDC, CDC REPR HLTH SURV; *CENTR OFF STAT IN, 2005, IR MULT IND RAP ASS; *CENTR STAT OFF RE, 2009, BOTSW DEM SURV; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; *CHIN NAT DAT CTR, 2010, CHIN FERT SURV; COALE AJ, 1991, POPUL DEV REV, V17, P517, DOI 10.2307/1971953; *CTR RES EP DIS, 2009, DEATHS DUE NAT DIS 1; *DEP POP LAB STAT, 2007, INV VIET NAM POP CHA; Dorrington R. E., 2001, IMPACT HIV AIDS ADUL; *EG MIN HLTH PAN A, 1993, EG MAT CHILD HLTH SU; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Feachem RGA, 1992, HLTH ADULTS DEV WORL; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; FRENK J, 1995, HEALTH POLICY, V32, P257, DOI 10.1016/0168-8510(95)00739-F; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; *HARV U I HLTH MET, 2009, GLOB BURD DIS STUD O; HILL K, 1989, POPUL DEV REV, V15, P657, DOI 10.2307/1972594; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Human Security Report Project, 2009, HUM SEC REP 2009 SHR; *IND NETW, 2009, HLTH DEM SURV DYST; *IND NETW, 2004, INDEPTH MOD LIF TABL; Kambou G, 1993, Rev Econ Dev, V1, P37; Klasen S, 2002, POPUL DEV REV, V28, P285, DOI 10.1111/j.1728-4457.2002.00285.x; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; *LEB MIN PUBL HLTH, 2006, LEB FAM HLTH SURV; *LEB MIN PUBL HLTH, 1998, LEB MAT CHILD HLTH S; LESSLER JT, 1985, MILBANK FUND Q, V63, P565, DOI 10.2307/3349848; *LIB AR JAM MIN HL, 1996, AR LIB MAT CHILD HLT; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; *MACR INT, 2009, MEASURE DHS DEM HLTH; Marshall SJ, 2004, B WORLD HEALTH ORGAN, V82, P556; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; *MAUR NAT STAT OFF, 1992, MAUR MAT CHILD HLTH; *MIN EC PLAN, 2009, WORLD FERT SURV CAM; *MIN HLTH FAM WELF, 2004, DISTR LEV HOUS FAC S, V2; *MIN HLTH FAM WELF, 2010, DISTR LEV HOUS FAC S, V3; *MOPH DEP HLTH EP, 1994, 1992 ANN REP CHIN DI; *MOR MIN HLTH PAN, 2000, MOR MAT CHILD HLTH S; Mufunda J, 2006, ETHNIC DIS, V16, P521; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; MURRAY CJL, 1992, HLTH ADULTS DEV WORL, P23; *NAT STAT OFF MONG, 1999, MONG STAT YB NSO MON; *NIPORT, 2001, BANGL MAT HLTH SERV; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; *OFF REG GEN CONS, 2009, SAMPL REG SYST STAT; *ORG EC COOP DEV, 2010, OECD EC SURV; PHILLIPS M, 1993, AM J PUBLIC HEALTH, V83, P1527, DOI 10.2105/AJPH.83.11.1527; Preston SH, 2007, INT J EPIDEMIOL, V36, P484, DOI 10.1093/ije/dym075; *RAND LAB POP, 2009, IND FAM LIF SURV IFL; *RAND LAB POP, NAT SOC SURV SUSENAS; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143; SEN A, 1990, NEW YORK REV BOOKS, V37, P61; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; *SUD MIN PUBL HLTH, 1995, SUD MAT CHILD HLTH S; *SYR AR REP CENTR, 1992, SYR MAT CHILD HLTH S; TIMAEUS IM, 1991, POPUL INDEX, V57, P552, DOI 10.2307/3644262; *TUN MIN PUBL HLTH, 1996, TUN MAT CHILD HLTH S; Udjo EO, 2006, CURR HIV RES, V4, P469, DOI 10.2174/157016206778560054; *UN STAT DIV, 2007, DEM YB UN STAT DIV; *UNAIDS, 2006, AIDS EP UPD; *UNICEF, 2010, STAT WORLDS CHILDR 2; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; *UPPS CONFL DAT PR, 2009, UCDP NONST CONFL DAT; *UPPS CONFL DAT PR, 2009, UCDP PRIO ARM CONFL; *UPPS CONFL DAT PR, 2009, UCDP NONST ACT DAT V; W.H. Organization, 2009, WORLD HLTH STAT 2009; WALTISPERGER D, 1998, MORTALITY ANTANANARI; *WHO, 2008, IR FAM HLTH SURV REP; *WHO, MORT POP DAT; World Health Organization, 2008, GLOB BURD DIS 2004 U; XU J, 2009, NAT VITAL STAT REP, V58; Yamano T, 2004, WORLD DEV, V32, P91, DOI 10.1016/j.worlddev.2003.07.004; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	88	124	126	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2010	375	9727					1704	1720		10.1016/S0140-6736(10)60517-X	http://dx.doi.org/10.1016/S0140-6736(10)60517-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	599DK	20434763				2022-12-28	WOS:000277890200032
J	Askarieh, G; Hedhammar, M; Nordling, K; Saenz, A; Casals, C; Rising, A; Johansson, J; Knight, SD				Askarieh, Glareh; Hedhammar, My; Nordling, Kerstin; Saenz, Alejandra; Casals, Cristina; Rising, Anna; Johansson, Jan; Knight, Stefan D.			Self-assembly of spider silk proteins is controlled by a pH-sensitive relay	NATURE			English	Article							DRAGLINE; FIBROIN; DOMAIN; PHENIX	Nature's high-performance polymer, spider silk, consists of specific proteins, spidroins, with repetitive segments flanked by conserved non-repetitive domains(1,2). Spidroins are stored as a highly concentrated fluid dope. On silk formation, intermolecular interactions between repeat regions are established that provide strength and elasticity(3,4). How spiders manage to avoid premature spidroin aggregation before self-assembly is not yet established. A pH drop to 6.3 along the spider's spinning apparatus, altered salt composition and shear forces are believed to trigger the conversion to solid silk, but no molecular details are known. Miniature spidroins consisting of a few repetitive spidroin segments capped by the carboxy-terminal domain form metre-long silk-like fibres irrespective of pH(5). We discovered that incorporation of the amino-terminal domain of major ampullate spidroin 1 from the dragline of the nursery web spider Euprosthenops australis (NT) into mini-spidroins enables immediate, charge-dependent self-assembly at pH values around 6.3, but delays aggregation above pH7. The X-ray structure of NT, determined to 1.7 angstrom resolution, shows a homodimer of dipolar, antiparallel five-helix bundle subunits that lack homologues. The overall dimeric structure and observed charge distribution of NT is expected to be conserved through spider evolution and in all types of spidroins. Our results indicate a relay-like mechanism through which the N-terminal domain regulates spidroin assembly by inhibiting precocious aggregation during storage, and accelerating and directing self-assembly as the pH is lowered along the spider's silk extrusion duct.	[Askarieh, Glareh; Knight, Stefan D.] SLU, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden; [Askarieh, Glareh] Univ Oslo, Dept Chem, N-0315 Oslo, Norway; [Hedhammar, My; Nordling, Kerstin; Rising, Anna; Johansson, Jan] SLU, Biomed Ctr, Dept Anat Physiol & Biochem, SE-75123 Uppsala, Sweden; [Saenz, Alejandra; Casals, Cristina] Univ Complutense Madrid, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Saenz, Alejandra; Casals, Cristina] Univ Complutense Madrid, CIBER Enfermedades Resp, E-28040 Madrid, Spain	Swedish University of Agricultural Sciences; University of Oslo; Swedish University of Agricultural Sciences; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Complutense University of Madrid	Knight, SD (corresponding author), SLU, Biomed Ctr, Uppsala BioCtr, Dept Mol Biol, SE-75124 Uppsala, Sweden.	jan.johansson@afb.slu.se; stefan.knight@molbio.slu.se	Saenz, Alejandra/G-7275-2015; Casals, Cristina/H-4658-2015; Rising, Anna/ABE-8822-2020; Knight, Stefan/D-4315-2015	Saenz, Alejandra/0000-0001-8439-2985; Casals, Cristina/0000-0003-2696-0918; Rising, Anna/0000-0002-1872-1207; Johansson, Jan/0000-0002-8719-4703; Knight, Stefan/0000-0002-7180-8758	Swedish Research Council; FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas)	This work was supported by grants (to J.J., M. H. and S. D. K.) from the Swedish Research Council and FORMAS. We thank E. Andersson, K. Tars and D. Ericsson for collecting the high resolution wild-type X-ray diffraction data set, H. Bramfeldt and C. Aulin for help with collecting scanning electron microscopy images, L. Serpell, I. Andersson, A. Zavialov and T. Hard for comments on the manuscript, and a number of other colleagues for discussions. We thank the ESRF (Grenoble, France) beamline staff for help during data collection.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CANDELAS GC, 1981, J EXP ZOOL, V216, P1, DOI 10.1002/jez.1402160102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; LESLIE AGW, 1992, JOINT CCP4 ESF EACBM; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pace CN, 2009, J BIOL CHEM, V284, P13285, DOI 10.1074/jbc.R800080200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Weeks CM, 2003, METHOD ENZYMOL, V374, P37, DOI 10.1016/S0076-6879(03)74003-8; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	27	312	330	13	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					236	U125		10.1038/nature08962	http://dx.doi.org/10.1038/nature08962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463740				2022-12-28	WOS:000277558500039
J	De Maeseneer, J; van Weel, C; Roberts, R				De Maeseneer, Jan; van Weel, Chris; Roberts, Richard			Family medicine's commitment to the MDGs	LANCET			English	Editorial Material							PRIMARY-CARE; HEALTH		[De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, Primafamed Ctr, B-9000 Ghent, Belgium; [van Weel, Chris] Radboud Univ Nijmegen Med Ctr, Dept Primary & Community Care, Nijmegen, Netherlands; [Roberts, Richard] Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, Madison, WI USA	Ghent University; Radboud University Nijmegen; University of Wisconsin System; University of Wisconsin Madison	De Maeseneer, J (corresponding author), Univ Ghent, Dept Family Med & Primary Hlth Care, Primafamed Ctr, B-9000 Ghent, Belgium.	Jan.demaeseneer@ugent.be	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				BOELEN C, 2002, IMPROVING HLTH SYSTE; De Maeseneer J, 2008, BRIT MED J, V336, P518, DOI 10.1136/bmj.39496.444271.80; De Maeseneer J, 2010, BRIT J GEN PRACT, V60, P286, DOI 10.3399/bjgp10X483977; DEMAESENEER J, 2009, AFR J PRIM HLTH CARE, V1; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; *NETW UN HLTH, ADV QUAL PARTN HLTH; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; *UN, 2009, MILL DEV GOALS 2009; *WHO, 2009, PRIM HLTH CAR IND HL; WHO, 2008, PHARMAFORUM 0121; 2008, 15BY2015 QUALITY HLT	12	4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 8	2010	375	9726					1588	1589		10.1016/S0140-6736(10)60658-7	http://dx.doi.org/10.1016/S0140-6736(10)60658-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	597CX	20452506				2022-12-28	WOS:000277734700008
J	Nebesio, TD; Eugster, EA				Nebesio, Todd D.; Eugster, Erica A.			Delayed Graves' Ophthalmopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nebesio, Todd D.; Eugster, Erica A.] Indiana Univ Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Nebesio, TD (corresponding author), Indiana Univ Sch Med, Indianapolis, IN USA.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					E60	E60		10.1056/NEJMicm0809071	http://dx.doi.org/10.1056/NEJMicm0809071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591OQ	20445176				2022-12-28	WOS:000277311200010
J	Simberkoff, MS; Arbeit, RD; Johnson, GR; Oxman, MN; Boardman, KD; Williams, HM; Levin, MJ; Schmader, KE; Gelb, LD; Keay, S; Neuzil, K; Greenberg, RN; Griffin, MR; Davis, LE; Morrison, VA; Annunziato, PW				Simberkoff, Michael S.; Arbeit, Robert D.; Johnson, Gary R.; Oxman, Michael N.; Boardman, Kathy D.; Williams, Heather M.; Levin, Myron J.; Schmader, Kenneth E.; Gelb, Lawrence D.; Keay, Susan; Neuzil, Kathleen; Greenberg, Richard N.; Griffin, Marie R.; Davis, Larry E.; Morrison, Vicki A.; Annunziato, Paula W.		Shingles Prevention Study Grp	Safety of Herpes Zoster Vaccine in the Shingles Prevention Study A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							SMALLPOX VACCINATION; INTUSSUSCEPTION; EVENTS; HEALTH	Background: The herpes zoster vaccine is effective in preventing herpes zoster and postherpetic neuralgia in immunocompetent older adults. However, its safety has not been described in depth. Objective: To describe local adverse effects and short-and long-term safety profiles of herpes zoster vaccine in immunocompetent older adults. Design: Randomized, placebo-controlled trial with enrollment from November 1998 to September 2001 and follow-up through April 2004 (mean, 3.4 years). A Veterans Affairs Coordinating Center generated the permutated block randomization scheme, which was stratified by site and age. Participants and follow-up study personnel were blinded to treatment assignments. (ClinicalTrials.gov registration number: NCT00007501) Setting: 22 U.S. academic centers. Participants: 38 546 immunocompetent adults 60 years or older, including 6616 who participated in an adverse events substudy. Intervention: Single dose of herpes zoster vaccine or placebo. Measurements: Serious adverse events and rashes in all participants and inoculation-site events in substudy participants during the first 42 days after inoculation. Thereafter, vaccination-related serious adverse events and deaths were monitored in all participants, and hospitalizations were monitored in substudy participants. Results: After inoculation, 255 (1.4%) vaccine recipients and 254 (1.4%) placebo recipients reported serious adverse events. Local inoculation-site side effects were reported by 1604 (48%) vaccine recipients and 539 (16%) placebo recipients in the substudy. A total of 977 (56.6%) of the vaccine recipients reporting local side effects were aged 60 to 69 years, and 627 (39.2%) were older than 70 years. After inoculation, herpes zoster occurred in 7 vaccine recipients versus 24 placebo recipients. Long-term follow-up (mean, 3.39 years) showed that rates of hospitalization or death did not differ between vaccine and placebo recipients. Limitations: Participants in the substudy were not randomly selected. Confirmation of reported serious adverse events with medical record data was not always obtained. Conclusion: Herpes zoster vaccine is well tolerated in older, immunocompetent adults.	[Simberkoff, Michael S.] Vet Affairs New York Harbor Healthcare Syst, New York, NY 10010 USA; NYU, Sch Med, New York, NY USA; Tufts Univ, Sch Med, Boston, MA 02111 USA; Vet Affairs Cooperat Studies Program Coordinating, West Haven, CT USA; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA; New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM USA; NCI, NIH, Bethesda, MD 20892 USA; Univ Colorado Denver, Aurora, CO USA; Durham Vet Affairs Med Ctr, GRECC, Durham, NC USA; St Louis Vet Affairs Med Ctr, St Louis, MO USA; Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; Univ Maryland, Sch Med, Baltimore, MD 21201 USA; Univ Washington, Sch Med, Seattle, WA USA; Lexington Vet Affairs Med Ctr, Lexington, KY USA; Vet Affairs Tennessee Valley Healthcare Syst, GRECC, Nashville, TN USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Merck & Co Inc, Whitehouse Stn, NJ USA	New York University; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Merck & Company	Simberkoff, MS (corresponding author), Vet Affairs New York Harbor Healthcare Syst, 423 E 23rd St, New York, NY 10010 USA.	Mike.SimberkoffMD@va.gov	OXMAN, MICHAEL NEIL/AGB-4695-2022; Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431	Department of Veterans Affairs, Office of Research and Development; Merck; James R. and Jesse V. Scott Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	Department of Veterans Affairs, Office of Research and Development(US Department of Veterans Affairs); Merck(Merck & Company); James R. and Jesse V. Scott Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Cooperative Studies Program of the Department of Veterans Affairs, Office of Research and Development; Merck; and the James R. and Jesse V. Scott Fund for Shingles Research.	ARVIN AM, 1992, J INFECT DIS, V166, pS35, DOI 10.1093/infdis/166.Supplement_1.S35; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P201; Chidiac C, 2001, CLIN INFECT DIS, V33, P62, DOI 10.1086/320884; *COSTART, 1995, FDACDER9524 COSTART; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; *ICH, CLIN SAF DAT MAN GUI; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kung H. C., 2008, DEATHS FINAL DATA 20; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Macaladad N, 2007, VACCINE, V25, P2139, DOI 10.1016/j.vaccine.2006.11.011; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Murphy BR, 2003, J INFECT DIS, V187, P1301, DOI 10.1086/367895; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Oxman MN, 2008, J INFECT DIS, V197, pS228, DOI 10.1086/522159; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Schmader KE, 2007, CLIN J PAIN, V23, P490, DOI 10.1097/AJP.0b013e318065b6c9; Sniadack MM, 2008, CLIN INFECT DIS, V46, pS251, DOI 10.1086/524741; Swerdlow DL, 2008, CLIN INFECT DIS, V46, pS234, DOI 10.1086/524745; van Seventer R, 2006, AGE AGEING, V35, P132, DOI 10.1093/ageing/afj048	21	82	84	1	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					545	+		10.7326/0003-4819-152-9-201005040-00004	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439572				2022-12-28	WOS:000277604000001
J	Gostin, L				Gostin, Lawrence			The unconscionable health gap: a global plan for justice	LANCET			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, L (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				[Anonymous], 2008, FIN REP COMM SOC DET; Committee on Economic Social and Cultural Rights, 2000, ADOPTED 22 SESSION C; Gostin LO, 2008, GEORGETOWN LAW J, V96, P331; Ooms G, 2008, PUBLIC HEALTH ETH-UK, V1, P154, DOI 10.1093/phe/phn018; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; *WHO, 2010, ESS MED; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096; World Health Assembly, 2009, RED HLTH IN ACT SOC	8	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1504	1505		10.1016/S0140-6736(10)60065-7	http://dx.doi.org/10.1016/S0140-6736(10)60065-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	596AH	20435214	Green Submitted			2022-12-28	WOS:000277655100008
J	Wallis, RS; Pai, M; Menzies, D; Doherty, TM; Walzl, G; Perkins, MD; Zumla, A				Wallis, Robert S.; Pai, Madhukar; Menzies, Dick; Doherty, T. Mark; Walzl, Gerhard; Perkins, Mark D.; Zumla, Alimuddin			Tuberculosis 4 Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice	LANCET			English	Article							INTERFERON-GAMMA RESPONSES; T-CELL RESPONSES; HEALTH-CARE WORKERS; INTRACELLULAR MYCOBACTERIUM-TUBERCULOSIS; COMMERCIAL URINARY LIPOARABINOMANNAN; MULTIDRUG-RESISTANT TUBERCULOSIS; ACTIVE PULMONARY TUBERCULOSIS; POTENTIAL SURROGATE MARKER; HIGH HIV PREVALENCE; C-REACTIVE PROTEIN	Human infection with Mycobacterium tuberculosis can progress to active disease, be contained as latent infection, or be eradicated by the host response. Tuberculosis diagnostics classify a patient into one of these categories. These are not fixed distinct states, but rather are continua along which patients can move, and are affected by HIV infection, immunosuppressive therapies, antituberculosis treatments, and other poorly understood factors. Tuberculosis biomarkers host or pathogen-specific provide prognostic information, either for individual patients or study cohorts, about these outcomes. Tuberculosis case detection remains difficult, partly because of inaccurate diagnostic methods. Investments have yielded some progress in development of new diagnostics, although the existing pipeline is limited for tests for sputum-smear-negative cases, childhood tuberculosis, and accurate prediction of reactivation of latent tuberculosis. Despite new, sensitive, automated molecular platforms for detection of tuberculosis and drug resistance, a simple, inexpensive point-of-care test is still not available. The effect of any new tests will depend on the method and extent of their introduction, the strength of the laboratories, and the degree to which access to appropriate therapy follows access to diagnosis. Translation of scientific progress in biomarkers and diagnostics into clinical and public health programmes is possible with political commitment, increased funding, and engagement of all stakeholders.	[Zumla, Alimuddin] UCL, Sch Med, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth,Dept Infect, London W1T 4JF, England; [Wallis, Robert S.] Pfizer, New London, CT USA; [Pai, Madhukar; Menzies, Dick] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Pai, Madhukar; Menzies, Dick] Montreal Chest Inst, Montreal, PQ, Canada; [Doherty, T. Mark] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [Walzl, Gerhard] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Perkins, Mark D.] Fdn Innovat New Diagnost, Geneva, Switzerland	University of London; University College London; UCL Medical School; Pfizer; McGill University; McGill University; Statens Serum Institut; Stellenbosch University; Foundation For Innovative New Diagnostics	Zumla, A (corresponding author), UCL, Sch Med, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth,Dept Infect, 46 Cleveland St, London W1T 4JF, England.	mark.perkins@finddiagnostics.org; a.zumla@ucl.ac.uk	Trajman, Anete/C-7679-2016; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021; ZUMLA, Alimuddin/ABA-8208-2020; Wallis, Robert S/A-8018-2009; Walzl, Gerhard/N-6371-2016	Trajman, Anete/0000-0002-4000-4984; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; ZUMLA, Alimuddin/0000-0002-5111-5735; Wallis, Robert S/0000-0001-6152-5183; Walzl, Gerhard/0000-0003-2487-125X	GlaxoSmithKline, Bill & Melinda Gates Foundation; Aeras Foundation; TB Alliance; EDCTP; EU-FP7; Drug development; EuropeAID-ADAT; UK Medical Research Council; UK NIHR CBRC; Research Council of Norway; Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases; Danish Agency for Science, Technology and Innovation; Canadian Institutes of Health Research (CIHR); European Commission; Fonds de la Recherche en Sante du Quebec (FRSQ)	GlaxoSmithKline, Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationGlaxoSmithKline); Aeras Foundation; TB Alliance; EDCTP; EU-FP7(European Commission); Drug development; EuropeAID-ADAT; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR CBRC; Research Council of Norway(Research Council of Norway); Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases; Danish Agency for Science, Technology and Innovation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	RSW is employed by Pfizer, USA. AZ is principal investigator of the EuropeAID Active Detection of Active Tuberculosis (ADAT) and European Union Framework 7 Trans-renal DNA (EU-FW7-TrDNA) projects, which are assessing new tuberculosis diagnostics, and serves on the Stop TB Research Movement Task Force. MDP is the Chief Scientific Officer of Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland, a non-profit agency that works with several industry partners in developing and evaluating new diagnostics for neglected infectious diseases. MP serves as an external consultant for FIND; serves as a co-chair of the Stop TB Partnership's New Diagnostics Working Group; and serves as chair of the Task Force of the Stop TB Research Movement. GW receives support from GlaxoSmithKline, Bill & Melinda Gates Foundation, Aeras Foundation, TB Alliance, and EDCTP. TMD receives support from EDCTP and EU-FP7 None of the funding agencies had any role in the development or submission of this report. DM declares that he has no conflicts of interest.; AZ receives support from the EU-FP7, EDCTP, Global Alliance for TB Drug development, EuropeAID-ADAT, UK Medical Research Council, and the UK NIHR CBRC. TMD receives support from the EU-FP7; EDCTP; Research Council of Norway; Netherlands-African partnership for capacity development and clinical interventions against poverty-related diseases; and the Danish Agency for Science, Technology and Innovation. MP is a recipient of a New Investigator Award from the Canadian Institutes of Health Research (CIHR), and receives support from EDCTP and European Commission (TBSusgent, EU-FP7). DM is recipient of a career award from the Fonds de la Recherche en Sante du Quebec (FRSQ). None of the funding agencies had any role in the development or submission of this report.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Aceti A, 1999, THORAX, V54, P145, DOI 10.1136/thx.54.2.145; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Azzurri A, 2006, INT J IMMUNOPATH PH, V19, P199; BAJAJ G, 1989, Indian Pediatrics, V26, P1010; Bakir M, 2008, ANN INTERN MED, V149, P777, DOI 10.7326/0003-4819-149-11-200812020-00248; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Baylan O, 2006, JPN J INFECT DIS, V59, P164; BAYNES R, 1986, SCAND J CLIN LAB INV, V46, P695, DOI 10.3109/00365518609083733; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Brahmbhatt S, 2006, CLIN EXP IMMUNOL, V146, P243, DOI 10.1111/j.1365-2249.2006.03211.x; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Cannas A, 2008, INT J TUBERC LUNG D, V12, P146; CANNAS A, 2008, 7 INT C PATH MYC INF; Carrara S, 2004, CLIN INFECT DIS, V38, P754, DOI 10.1086/381754; Chaisson RE, 2009, INT J TUBERC LUNG D, V13, P558; Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; CHENG SH, 1988, CLIN EXP IMMUNOL, V74, P20; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; Choudhry V, 2002, EUR J CLIN MICROBIOL, V21, P1, DOI 10.1007/s10096-001-0651-7; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Daley P, 2009, INT J TUBERC LUNG D, V13, P989; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Davies GR, 2006, ANTIMICROB AGENTS CH, V50, P3154, DOI 10.1128/AAC.00774-05; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; del Corral H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008257; Demir T, 2002, INT J TUBERC LUNG D, V6, P155; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Desjardin LE, 1999, AM J RESP CRIT CARE, V160, P203, DOI 10.1164/ajrccm.160.1.9811006; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dowdy DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004057; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; EDWARDS LB, 1973, AM REV RESPIR DIS, V108, P1334; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; FUCHS D, 1984, LUNG, V162, P337, DOI 10.1007/BF02715666; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Geldmacher C, 2008, J INFECT DIS, V198, P1590, DOI 10.1086/593017; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Green C, 2009, LANCET INFECT DIS, V9, P505, DOI 10.1016/S1473-3099(09)70149-5; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hawkridge A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2052; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Herrmann JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004130; Higuchi K, 2008, TUBERCULOSIS, V88, P244, DOI 10.1016/j.tube.2007.11.009; Higuchi K, 2008, RESPIROLOGY, V13, P468, DOI 10.1111/j.1440-1843.2008.01244.x; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Hosp M, 1997, LUNG, V175, P265, DOI 10.1007/PL00007573; Immanuel C, 2001, INT J TUBERC LUNG D, V5, P185; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jafari C, 2009, AM J RESP CRIT CARE, V180, P666, DOI 10.1164/rccm.200904-0557OC; Janulionis E, 2004, ANTIMICROB AGENTS CH, V48, P3133, DOI 10.1128/AAC.48.8.3133-3135.2004; Kafwabulula M, 2002, INT J TUBERC LUNG D, V6, P732; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Kampmann B, 2006, AIDS, V20, P1011, DOI 10.1097/01.aids.0000222073.45372.ce; Kandemir O, 2003, ARCH MED RES, V34, P311, DOI 10.1016/S0188-4409(03)00050-X; Kashino SS, 2008, CLIN EXP IMMUNOL, V153, P56, DOI 10.1111/j.1365-2249.2008.03672.x; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kik SV, 2010, EUR RESPIR J, V35, P1346, DOI 10.1183/09031936.00098509; Kim K, 2009, CLIN LAB MED, V29, P47, DOI 10.1016/j.cll.2009.02.001; Kobashi Y, 2009, J INFECTION, V58, P197, DOI 10.1016/j.jinf.2008.08.009; KUMAR V, 2009, ICAAC, V49, pF1; LAI CKW, 1993, CLIN EXP IMMUNOL, V94, P522; Lalvani A, 2001, LANCET, V357, P2017, DOI 10.1016/S0140-6736(00)05115-1; Lathia CD, 2009, CLIN PHARMACOL THER, V86, P32, DOI 10.1038/clpt.2009.69; Lawn SD, 2001, T ROY SOC TROP MED H, V95, P41, DOI 10.1016/S0035-9203(01)90328-1; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lee Jin Hwa, 2003, Korean J Intern Med, V18, P138; Li L, 2010, J CLIN MICROBIOL, V48, P46, DOI 10.1128/JCM.01526-09; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Makae H, 2003, RESPIROLOGY, V8, P326, DOI 10.1046/j.1440-1843.2003.00471.x; Marais BJ, 2007, PAEDIATR RESPIR REV, V8, P124, DOI 10.1016/j.prrv.2007.04.002; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; *MED SANS FRONT, 2009, PAR M TB POINT OF CA; Minion J, 2009, EXPERT REV MED DEVIC, V6, P341, DOI [10.1586/erd.09.26, 10.1586/ERD.09.26]; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Mutetwa R, 2009, INT J TUBERC LUNG D, V13, P1253; Napolitano DR, 2008, CLIN VACCINE IMMUNOL, V15, P638, DOI 10.1128/CVI.00010-08; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nyamande K, 2006, INT J TUBERC LUNG D, V10, P510; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Ozdemir D, 2006, MED SCI MONITOR, V12, pCR521; Pai M, 2009, 2 GLOB S IGRAS DUBR; Pai M, 2008, SEMIN RESP CRIT CARE, V29, P560, DOI 10.1055/s-0028-1085707; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Pai M, 2009, EXPERT REV MOL DIAGN, V9, P637, DOI [10.1586/erm.09.48, 10.1586/ERM.09.48]; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Perkins MD, 2006, NAT BIOTECHNOL, V24, P919, DOI 10.1038/nbt0806-919; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; Petrucci R, 2008, PEDIATR INFECT DIS J, V27, P1073, DOI 10.1097/INF.0b013e31817d05a3; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Plit ML, 1998, INT J TUBERC LUNG D, V2, P590; Polzin A, 2003, EUR RESPIR J, V21, P939, DOI 10.1183/09031936.03.00055103; Prat C, 2006, J INFECTION, V52, P169, DOI 10.1016/j.jinf.2005.05.019; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007760; Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018; Reid A, 2006, LANCET INFECT DIS, V6, P483, DOI 10.1016/S1473-3099(06)70549-7; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Rosas-Taraco AG, 2009, ARCH MED RES, V40, P128, DOI 10.1016/j.arcmed.2008.11.003; Ruhwald Morten, 2009, BMC Res Notes, V2, P19, DOI 10.1186/1756-0500-2-19; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Saliu OY, 2006, J INFECT DIS, V194, P486, DOI 10.1086/505430; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sauzullo I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005187; Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schunemann Holger J, 2008, Evid Based Med, V13, P162, DOI 10.1136/ebm.13.6.162-a; SCOTT GM, 1990, J INFECTION, V21, P61, DOI 10.1016/0163-4453(90)90669-Y; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Siawaya JFD, 2008, CLIN VACCINE IMMUNOL, V15, P1165, DOI 10.1128/CVI.00084-08; Siawaya JFD, 2008, J INFECTION, V56, P340, DOI 10.1016/j.jinf.2008.02.007; Silva VMC, 2008, MICROBIOL IMMUNOL, V52, P544, DOI 10.1111/j.1348-0421.2008.00072.x; Singh KK, 2003, J INFECT DIS, V188, P371, DOI 10.1086/376532; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sohn H, 2009, EXPERT REV ANTI-INFE, V7, P723, DOI [10.1586/eri.09.52, 10.1586/ERI.09.52]; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; *STOP TB PARTN, 2008, TB RES MOV; [Stop TB Partnership World Health Organization], 2006, GLOB PLAN STOP TB 20; [STOP TB Partnership's New Diagnostics Working Group World Health Organization], 2009, PATHW BETT DIAGN TUB; Syhre M, 2008, TUBERCULOSIS, V88, P317, DOI 10.1016/j.tube.2008.01.002; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tena GN, 2003, J INFECT DIS, V187, P1544, DOI 10.1086/374799; Tessema TA, 2002, SCAND J INFECT DIS, V34, P167, DOI 10.1080/00365540110077254; Thomas MM, 2008, INT J TUBERC LUNG D, V12, P651; Torrea G, 2005, J MED MICROBIOL, V54, P39, DOI 10.1099/jmm.0.45688-0; *TREATM ACT GROUP, 2009, TUB RES DEV 2009 REP; Turgut T, 2006, TOHOKU J EXP MED, V209, P321, DOI 10.1620/tjem.209.321; *US FDA, 2004, INN STAGN CHALL OPP; Usdin M, 2006, NATURE, V441, P283, DOI 10.1038/441283a; Veenstra H, 2007, CLIN IMMUNOL, V124, P336, DOI 10.1016/j.clim.2007.05.014; Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT; Wagner JA, 2002, DIS MARKERS, V18, P41, DOI 10.1155/2002/929274; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Wallis RS, 2009, CLIN INFECT DIS, V48, P1429, DOI 10.1086/598504; Wallis RS, 2009, TUBERCULOSIS, V89, P221, DOI 10.1016/j.tube.2009.02.001; Wallis RS, 1998, J INFECT DIS, V178, P1115, DOI 10.1086/515701; Wallis RS, 1996, TUBERCLE LUNG DIS, V77, P516, DOI 10.1016/S0962-8479(96)90049-0; Wallis RS, 2003, J INFECT DIS, V187, P270, DOI 10.1086/346053; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Wallis RS, 2001, ANTIMICROB AGENTS CH, V45, P1302, DOI 10.1128/AAC.45.4.1302-1304.2001; Wallis RS, 2000, AM J RESP CRIT CARE, V161, P1076, DOI 10.1164/ajrccm.161.4.9903087; Walzl G, 2008, J INFECTION, V57, P103, DOI 10.1016/j.jinf.2008.06.007; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Weldingh K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001978; Wenner M, 2009, NAT MED, V15, P978, DOI 10.1038/nm0909-978b; Whittaker E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003901; *WHO, 2008, RED NUMB SMEARS DIAG; WHO, 2009, GLOB TUB CONTR 2009; [WHO Specal Programme for Researchand Training in Tropical Diseases (TDR) and Foundation for Innovative New Diagnostics (FIND)], 2006, SPEC PROGR RES TRAIN; WHO, 2008, RAP TESTS DRUG RES T; *WHO, 2008, DEF NEW SPUT SMEAR P; *WHO, 2007, US LIQ MED CULT DST; WHO, 2009, 9 M STRAT TECHN ADV; *WHO STOP TB PARTN, 2008, NEW LAB DIAGN TOOLS; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; World Health Organization, 2008, POL STAT MOL LIN PRO; World Health Organization (WHO), 2008, MOV RES FIND NEW WHO; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	211	333	353	1	87	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY-JUN	2010	375	9729					1920	1937		10.1016/S0140-6736(10)60359-5	http://dx.doi.org/10.1016/S0140-6736(10)60359-5			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609BC	20488517				2022-12-28	WOS:000278628800033
J	McGrew, WC				McGrew, William C.			Chimpanzee Technology	SCIENCE			English	Editorial Material							SAVANNA CHIMPANZEES; TOOLS		Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England	University of Cambridge	McGrew, WC (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England.	wcm21@cam.ac.uk						Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; Fowler A, 2007, INT J PRIMATOL, V28, P997, DOI 10.1007/s10764-007-9166-0; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Koops K, 2010, PRIMATES, V51, P175, DOI 10.1007/s10329-009-0178-6; Matsuzawa T, 2009, ANIM COGN, V12, pS1, DOI 10.1007/s10071-009-0277-1; McGrew William, 2004, CULTURED CHIMPANZEE; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; PETERSON D, 2006, J GOODALL WOMAN REDE, P212; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Sanz CM, 2007, J HUM EVOL, V52, P420, DOI 10.1016/j.jhevol.2006.11.001; Sousa C, 2009, ANIM COGN, V12, pS115, DOI 10.1007/s10071-009-0278-0; Stewart FA, 2007, AM J PRIMATOL, V69, P930, DOI 10.1002/ajp.20432; Watts DP, 2008, INT J PRIMATOL, V29, P83, DOI 10.1007/s10764-007-9227-4	18	65	67	4	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					579	580		10.1126/science.1187921	http://dx.doi.org/10.1126/science.1187921			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431004				2022-12-28	WOS:000277159800029
J	Daigaku, Y; Davies, AA; Ulrich, HD				Daigaku, Yasukazu; Davies, Adelina A.; Ulrich, Helle D.			Ubiquitin-dependent DNA damage bypass is separable from genome replication	NATURE			English	Article							CELL NUCLEAR ANTIGEN; SACCHAROMYCES-CEREVISIAE; POSTREPLICATION REPAIR; TRANSLESION SYNTHESIS; ULTRAVIOLET-LIGHT; POLYMERASE-ETA; BUDDING YEAST; ERROR-FREE; POL-ETA; S-PHASE	Post-replication repair (PRR) is a pathway that allows cells to bypass or overcome lesions during DNA replication(1). In eukaryotes, damage bypass is activated by ubiquitylation of the replication clamp PCNA through components of the RAD6 pathway(2). Whereas monoubiquitylation of PCNA allows mutagenic translesion synthesis by damage-tolerant DNA polymerases(3-5), polyubiquitylation is required for an error-free pathway that probably involves a template switch to the undamaged sister chromatid(6). Both the timing of PRR events during the cell cycle and their location relative to replication forks, as well as the factors required downstream of PCNA ubiquitylation, have remained poorly characterized. Here we demonstrate that the RAD6 pathway normally operates during S phase. However, using an inducible system of DNA damage bypass in budding yeast (Saccharomyces cerevisiae), we show that the process is separable in time and space from genome replication, thus allowing direct visualization and quantification of productive PRR tracts. We found that both during and after S phase ultraviolet-radiation-induced lesions are bypassed predominantly via translesion synthesis, whereas the error-free pathway functions as a backup system. Our approach has revealed the distribution of PRR tracts in a synchronized cell population. It will allow an in-depth mechanistic analysis of how cells manage the processing of lesions to their genomes during and after replication.	[Daigaku, Yasukazu; Davies, Adelina A.; Ulrich, Helle D.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Ulrich, HD (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223; Daigaku, Yasukazu/0000-0002-8404-7492	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank O. Aparicio for plasmid p306-BrdU-Inc and the laboratory of V. Costanzo for advice on DNA fibre analysis. This work was funded by Cancer Research UK.	Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bresson A, 2002, EMBO J, V21, P3881, DOI 10.1093/emboj/cdf363; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; DICAPRIO L, 1981, MUTAT RES, V82, P69, DOI 10.1016/0027-5107(81)90139-1; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; LEHMANN AR, 1972, J MOL BIOL, V66, P319, DOI 10.1016/0022-2836(72)90418-4; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lopes M, 2006, MOL CELL, V21, P15, DOI 10.1016/j.molcel.2005.11.015; MacAlpine D, 2005, CHROMOSOME RES, V13, P309, DOI 10.1007/s10577-005-1508-1; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parker JL, 2007, NUCLEIC ACIDS RES, V35, P881, DOI 10.1093/nar/gkl1102; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; RESNICK MA, 1972, J BACTERIOL, V109, P979, DOI 10.1128/JB.109.3.979-986.1972; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; UNRAU P, 1973, BIOCHIM BIOPHYS ACTA, V312, P626, DOI 10.1016/0005-2787(73)90065-8; Viggiani CJ, 2006, YEAST, V23, P1045, DOI 10.1002/yea.1406; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2006, P NATL ACAD SCI USA, V103, P8971, DOI 10.1073/pnas.0510167103; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	30	198	200	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					951	U13		10.1038/nature09097	http://dx.doi.org/10.1038/nature09097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20453836	Green Accepted			2022-12-28	WOS:000278804500043
J	Cotter, L; Ozcelik, M; Jacob, C; Pereira, JA; Locher, V; Baumann, R; Relvas, JB; Suter, U; Tricaud, N				Cotter, Laurent; Ozcelik, Murat; Jacob, Claire; Pereira, Jorge A.; Locher, Veronica; Baumann, Reto; Relvas, Joao B.; Suter, Ueli; Tricaud, Nicolas			Dlg1-PTEN Interaction Regulates Myelin Thickness to Prevent Damaging Peripheral Nerve Overmyelination	SCIENCE			English	Article							NEUREGULIN-1; POLARITY; PHOSPHORYLATION; BINDING; SHEATH; PTEN	The thickness of the myelin sheath that insulates axons is fitted for optimal nerve conduction velocity. Here, we show that, in Schwann cells, mammalian disks large homolog 1 (Dlg1) interacts with PTEN (phosphatase and tensin homolog deleted on chromosome 10) to inhibit axonal stimulation of myelination. This mechanism limits myelin sheath thickness and prevents overmyelination in mouse sciatic nerves. Removing this brake results also in myelin outfoldings and demyelination, characteristics of some peripheral neuropathies. Indeed, the Dlg1 brake is no longer functional in a mouse model of Charcot-Marie-Tooth disease. Therefore, negative regulation of myelination appears to be essential for optimization of nerve conduction velocity and myelin maintenance.	[Cotter, Laurent; Ozcelik, Murat; Jacob, Claire; Pereira, Jorge A.; Locher, Veronica; Baumann, Reto; Relvas, Joao B.; Suter, Ueli; Tricaud, Nicolas] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Relvas, Joao B.] Univ Porto, IBMC, P-4150180 Oporto, Portugal	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade do Porto	Tricaud, N (corresponding author), ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland.	nicolas.tricaud@cell.biol.ethz.ch	Suter, Ueli/A-1624-2010; Relvas, Joao B/A-1142-2008; Jacob, Claire/C-1485-2012	Relvas, Joao B/0000-0001-7636-0924; Jacob, Claire/0000-0001-9567-3950; Tricaud, Nicolas/0000-0002-1620-4046	Swiss National Science Foundation; National Centre of Competence in Research; ETH Zurich (ETHIIRA)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research; ETH Zurich (ETHIIRA)(ETH Zurich)	We thank J. Salzer for his help with cocultures, N. Mantei, C. Perrin-Tricaud for critically reading the manuscript, and the Light Microscopy Center and Electron Microscopy Center at ETH facilities of the ETHZ for technical help. Supported by the Swiss National Science Foundation (N. T. and U. S.), the National Centre of Competence in Research "Neural Plasticity and Repair," and ETH Zurich (ETHIIRA).	Adey NB, 2000, CANCER RES, V60, P35; Bolis A, 2005, J NEUROSCI, V25, P8567, DOI 10.1523/JNEUROSCI.2493-05.2005; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Bonneick S, 2005, HUM MOL GENET, V14, P3685, DOI 10.1093/hmg/ddi400; Chan JR, 2006, SCIENCE, V314, P832, DOI 10.1126/science.1134069; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Contreras-Paredes A, 2009, VIROLOGY, V383, P78, DOI 10.1016/j.virol.2008.09.040; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Ogata T, 2006, MOL NEUROBIOL, V33, P51, DOI 10.1385/MN:33:1:051; Ozcelik M, 2010, J NEUROSCI, V30, P4120, DOI 10.1523/JNEUROSCI.5185-09.2010; Pegtel DM, 2007, CURR BIOL, V17, P1623, DOI 10.1016/j.cub.2007.08.035; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; STAHL N, 1990, MOL BRAIN RES, V8, P209, DOI 10.1016/0169-328X(90)90018-9; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; Yamanaka T, 2008, FRONT BIOSCI-LANDMRK, V13, P6693, DOI 10.2741/3182	24	137	139	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1415	1418		10.1126/science.1187735	http://dx.doi.org/10.1126/science.1187735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20448149				2022-12-28	WOS:000278598400044
J	Lonnroth, K; Castro, KG; Chakaya, JM; Chauhan, LS; Floyd, K; Glaziou, P; Raviglione, MC				Loennroth, Knut; Castro, Kenneth G.; Chakaya, Jeremiah Muhwa; Chauhan, Lakhbir Singh; Floyd, Katherine; Glaziou, Philippe; Raviglione, Mario C.			Tuberculosis control and elimination 2010-50: cure, care, and social development	LANCET			English	Article							PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; DIABETES-MELLITUS; PUBLIC-HEALTH; GLOBAL HEALTH; ALCOHOL-USE; RISK-FACTOR; LOW-INCOME; TRENDS; IMPACT	Rapid expansion of the standardised approach to tuberculosis diagnosis and treatment that is recommended by WHO allowed more than 36 million people to be cured between 1995 and 2008, averting up to 6 million deaths. Yet tuberculosis remains a severe global public health threat. There are more than 9 million new cases every year worldwide, and the incidence rate is falling at less than 1% per year. Although the overall target related to the Millennium Development Goals of halting and beginning to reverse the epidemic might have already been reached in 2004, the more important long-term elimination target set for 2050 will not be met with present strategies and instruments. Several key challenges persist. Many vulnerable people do not have access to affordable services of sufficient quality. Technologies for diagnosis, treatment, and prevention are old and inadequate. Multidrug-resistant tuberculosis is a serious threat in many settings. HIV/AIDS continues to fuel the tuberculosis epidemic, especially in Africa. Furthermore, other risk factors and underlying social determinants help to maintain tuberculosis in the community. Acceleration of the decline towards elimination of this disease will need invigorated actions in four broad areas: continued scale-up of early diagnosis and proper treatment for all forms of tuberculosis in line with the Stop TB Strategy; development and enforcement of bold health-system policies; establishment of links with the broader development agenda; and promotion and intensification of research towards innovations.	[Loennroth, Knut; Floyd, Katherine; Glaziou, Philippe; Raviglione, Mario C.] WHO, Stop TB Dept, CH-1211 Geneva 27, GE, Switzerland; [Castro, Kenneth G.] Ctr Dis Control & Prevent, Div TB Eliminat Natl Ctr HIV Viral Hepatitis STD, Atlanta, GA USA; [Chakaya, Jeremiah Muhwa] Natl Leprosy & TB Programme, Nairobi, Kenya; [Chakaya, Jeremiah Muhwa] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Chauhan, Lakhbir Singh] Minist Hlth & Family Welf, New Delhi, India	World Health Organization; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute	Lonnroth, K (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva 27, GE, Switzerland.	lonnrothk@who.int	Lönnroth, Knut/L-2339-2014; Castro, Kenneth G/P-1882-2018; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Castro, Kenneth G/0000-0001-7964-6354; Lonnroth, Knut/0000-0001-6944-0256; RAVIGLIONE, Mario/0000-0002-9331-2067; Muhwa, Chakaya Jeremiah/0000-0002-3229-2429; Glaziou, Philippe/0000-0002-0649-1272				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; ALUOCH JA, 1984, AM REV RESPIR DIS, V129, P915; [Anonymous], 1999, EPIDEMIOLOGIC BASIS; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; BLAS E, 2010, PRIORITY PUBLIC HLTH; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Boggio Andrea, 2008, Health Hum Rights, V10, P121; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Camacho M, 2007, INT J TUBERC LUNG D, V11, P1246; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chaisson RE, 2009, INT J TUBERC LUNG D, V13, P558; Chen XY, 2004, LANCET, V364, P417; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Commission on Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; de Vries G, 2007, AM J RESP CRIT CARE, V176, P201, DOI 10.1164/rccm.200612-1877OC; DEMARCO JR, 2007, CONTROL TUBERCULOSIS; DIWAN V, 1998, 19983 NORD SCH PUBL; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Dye C, 2007, INT J TUBERC LUNG D, V11, P1225; Dye C, 2006, INT J TUBERC LUNG D, V10, P460; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2000, INT J TUBERC LUNG D, V4, pS146; DYE C, 2004, BMJ-BRIT MED J, V330, P195; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; *GLOB FUND, 2009, GLOB FUND 2009 INN I; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Gonzalez E, 2007, INT J TUBERC LUNG D, V11, P405; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; HANSON C, 2006, TB COMPREHENSIVE INT, P1097; Harries A, 2004, TOMANS TUBERCULOSIS; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Harries AD, 2009, T ROY SOC TROP MED H, V103, P1, DOI 10.1016/j.trstmh.2008.08.008; Hassmiller K, 2007, IMPACT SMOKING POPUL; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Hirao S, 2007, TROP MED INT HEALTH, V12, P1459, DOI 10.1111/j.1365-3156.2007.01952.x; HOLT DF, 2008, LANCET, V372, P164; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; *IDF, 2010, INT DIAB FED DIAB AT; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jaramillo E, 2001, HEALTH POLICY PLANN, V16, P68, DOI 10.1093/heapol/16.1.68; Jaramillo E, 1999, SOC SCI MED, V49, P393, DOI 10.1016/S0277-9536(99)00114-8; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; John TJ, 2009, TROP MED INT HEALTH, V14, P1428, DOI 10.1111/j.1365-3156.2009.02392.x; Kjellstrom T., 2007, OUR CITIES OUR HLTH; Kobaidze Ketevan, 2009, Interdiscip Perspect Infect Dis, V2009, P513609, DOI 10.1155/2009/513609; Lagomarsino G., 2009, PUBLIC STEWARDSHIP P; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Laxminarayan R, 2009, HEALTH AFFAIR, V28, pW730, DOI 10.1377/hlthaff.28.4.w730; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; LONNROTH K, 2009, TUBERCULOSIS ESSENTI; LONNROTH K, 2006, TB COMPREHENSIVE INT; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maher D, 2007, B WORLD HEALTH ORGAN, V85, P341, DOI 10.2471/BLT.06.037820; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Miller TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005080; *MIN HLTH, 2002, NAT TB PREV SURV 200; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray CJL, 2004, BMJ-BRIT MED J, V329, P1096, DOI 10.1136/bmj.329.7474.1096; Nganda B, 2003, INT J TUBERC LUNG D, V7, pS14; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pai M, 2008, PLOS MED, V5, P1043, DOI 10.1371/journal.pmed.0050156; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Sanchez-Perez HJ, 2002, ANN EPIDEMIOL, V12, P166, DOI 10.1016/S1047-2797(01)00308-8; Shilova MV, 2001, PHILOS T R SOC B, V356, P1069, DOI 10.1098/rstb.2001.0895; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; *STOP TB PARTN, 2006, WHOHTMST13200635 STO; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; STYBLO K, 1991, TUBERCULOSIS CAN BE; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; Subramani R, 2007, INT J EPIDEMIOL, V36, P387, DOI 10.1093/ije/dyl216; *TB ALL, 2007, PATHW PAT CHART DYN; *TDR, 2006, TDR REP SER, V3; *TEATM ACT GROUP, 2009, 2009 REP TUB RES FUN; Thomas Aleyamma, 2008, Indian J Tuberc, V55, P77; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNAIDS, 2008, UNAIDS0825EJC1510E; United Nations High Commissioner for Refugees, 2017, DESP JOURN REF MIGR; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; van der Werf MJ, 2007, B WORLD HEALTH ORGAN, V85, P370, DOI 10.2471/BLT.06.039941; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; VOLMINK J, 2006, COCHRANE DB SYST REV, V2; Vree M, 2007, EMERG INFECT DIS, V13, P796, DOI 10.3201/eid1305.060904; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; W.H. Organization, 2009, WORLD HLTH STAT 2009; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; WATT C, 2009, TUBERCULOSIS; WHO, 2008, GLOBAL TUBERCULOSIS; *WHO, 2007, WHOHTMTB2007379; WHO, 2004, GLOB STAT REP ALC 20; *WHO, 2008, TOB ATL; WHO, 2009, TREATM TUB GUID; *WHO, 2006, WHOHTMTB2006373; *WHO, 1974, WHO TECHN SER, V552; *WHO, 2009, WH0HTMTB2009426; *WHO, 2008, WHOTB2007390; *WHO, 2008, REV CAS DEF SPUT SME; World Health Organization, 1998, WHOTB98250; World Health Organization, 2005, WHOHTMTB2005352; World Health Organization, 2008, WHOHTMTB2008400; World Health Organization, 2006, WHO HOUS EN DAT; World Health Organization, 2008, WHOHTMTB2008401; World Health Organization, 2008, WHOHTMTB2008404; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Xu L, 2008, T ROY SOC TROP MED H, V102, P797, DOI 10.1016/j.trstmh.2008.04.027; ZUÑIGA G. MANUEL, 2002, Rev. chil. enferm. respir., V18, P55	138	533	554	3	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2010	375	9728					1814	1829		10.1016/S0140-6736(10)60483-7	http://dx.doi.org/10.1016/S0140-6736(10)60483-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	603NY	20488524				2022-12-28	WOS:000278216500033
J	Jadamec, MA; Billen, MI				Jadamec, Margarete A.; Billen, Magali I.			Reconciling surface plate motions with rapid three-dimensional mantle flow around a slab edge	NATURE			English	Article							TRENCH-PARALLEL FLOW; SEISMIC ANISOTROPY; CIRCULATION; CONSTRAINTS; RHEOLOGY; INSIGHTS; STRENGTH; BENEATH; FAULTS; FIELD	The direction of tectonic plate motion at the Earth's surface and the flow field of the mantle inferred from seismic anisotropy are well correlated globally, suggesting large-scale coupling between the mantle and the surface plates(1,2). The fit is typically poor at subduction zones, however, where regional observations of seismic anisotropy suggest that the direction of mantle flow is not parallel to(3-7) and may be several times faster than(6) plate motions. Here we present three-dimensional numerical models of buoyancy-driven deformation with realistic slab geometry for the Alaska subduction-transform system and use them to determine the origin of this regional decoupling of flow. We find that near a subduction zone edge, mantle flow velocities can have magnitudes of more than ten times the surface plate motions, whereas surface plate velocities are consistent with plate motions(8) and the complex mantle flow field is consistent with observations from seismic anisotropy(5). The seismic anisotropy observations constrain the shape of the eastern slab edge and require non-Newtonian mantle rheology. The incorporation of the non-Newtonian viscosity(9,10) results in mantle viscosities of 10(17) to 10(18) Pa s in regions of high strain rate (10(-12) s(-1)), and this low viscosity enables the mantle flow field to decouple partially from the motion of the surface plates. These results imply local rapid transport of geochemical signatures through subduction zones and that the internal deformation of slabs decreases the slab-pull force available to drive subducting plates.	[Jadamec, Margarete A.; Billen, Magali I.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA	University of California System; University of California Davis	Jadamec, MA (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic 3800, Australia.	majadamec@ucdavis.edu	Billen, Magali/E-7381-2013	Billen, Magali/0000-0002-7316-1791	US National Science Foundation [EAR-0537995]; Texas Advanced Computing Center [TG-EAR080015N]	US National Science Foundation(National Science Foundation (NSF)); Texas Advanced Computing Center	This work was supported by US National Science Foundation grant EAR-0537995. High-resolution models were run on the TeraGrid cluster Lonestar at the Texas Advanced Computing Center, through grant TG-EAR080015N. We thank Computational Infrastructure for Geodynamics for the CitcomCU source code and C. Conrad and M. Behn for the source code used to calculate the ISAs. 3D data were visualized at the W. M. Keck Center for Active Visualization in the Earth Sciences at the University of California, Davis. We thank D. Christensen and G. Abers (shear-wave splitting data) and N. Ruppert (earthquake hypocentral data). We thank D. Turcotte, L. Kellogg, O. Kreylos, D. Eberhart-Phillips, S. M. Roeske, J. Dewey, T. Taylor, L. Moresi and G. Hirth for comments and discussions.	Becker TW, 2003, GEOPHYS J INT, V155, P696, DOI 10.1046/j.1365-246X.2003.02085.x; Billen MI, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001597; Christensen DH, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006712; Conder JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015390; Conrad CP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004608; Conrad CP, 2002, SCIENCE, V298, P207, DOI 10.1126/science.1074161; DeMets C, 1999, GEOPHYS RES LETT, V26, P1921, DOI 10.1029/1999GL900405; Funiciello F, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003792; GARFUNKEL Z, 1986, J GEOPHYS RES-SOLID, V91, P7205, DOI 10.1029/JB091iB07p07205; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; Hoernle K, 2008, NATURE, V451, P1094, DOI 10.1038/nature06550; Jadamec M. A., 2009, THESIS U CALIFORNIA; Kaminski E, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000222; Karato S, 2008, ANNU REV EARTH PL SC, V36, P59, DOI 10.1146/annurev.earth.36.031207.124120; Kneller EA, 2007, NATURE, V450, P1222, DOI 10.1038/nature06429; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Lallemand S, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000917; Lassak TM, 2006, EARTH PLANET SC LETT, V243, P632, DOI 10.1016/j.epsl.2006.01.022; Long MD, 2008, SCIENCE, V319, P315, DOI 10.1126/science.1150809; Moresi L, 1996, EARTH PLANET SC LETT, V138, P15, DOI 10.1016/0012-821X(95)00221-W; Moresi L, 1996, PHYS EARTH PLANET IN, V97, P83, DOI 10.1016/0031-9201(96)03163-9; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Muller RD, 1997, J GEOPHYS RES-SOL EA, V102, P3211, DOI 10.1029/96JB01781; Peyton V, 2001, GEOPHYS RES LETT, V28, P379, DOI 10.1029/2000GL012200; Piromallo C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025390; Preece SJ, 2004, TECTONOPHYSICS, V392, P165, DOI 10.1016/j.tecto.2004.04.011; RUSSO RM, 1994, SCIENCE, V263, P1105, DOI 10.1126/science.263.5150.1105; Savage MK, 1999, REV GEOPHYS, V37, P65, DOI 10.1029/98RG02075; Schellart WP, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB002970; Smith GP, 2001, SCIENCE, V292, P713, DOI 10.1126/science.1058763; Stegman DR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001056; TURCOTTE DL, 2002, GEODYNAMICS, P153; Turner S, 2003, REV MINERAL GEOCHEM, V52, P255, DOI 10.2113/0520255; Zandt G, 2008, GEOLOGY, V36, P295, DOI 10.1130/G24611A.1; Zhong SJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003972; Zhong SJ, 1998, J GEOPHYS RES-SOL EA, V103, P15255, DOI 10.1029/98JB00605; Zhong SJ, 1996, NATURE, V383, P245, DOI 10.1038/383245a0	37	177	178	4	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 20	2010	465	7296					338	U89		10.1038/nature09053	http://dx.doi.org/10.1038/nature09053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598IO	20485433				2022-12-28	WOS:000277829200038
J	Bombardier, CH; Fann, JR; Temkin, NR; Esselman, PC; Barber, J; Dikmen, SS				Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Barber, Jason; Dikmen, Sureyya S.			Rates of Major Depressive Disorder and Clinical Outcomes Following Traumatic Brain Injury	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHEDULED TELEPHONE INTERVENTION; COMORBIDITY SURVEY REPLICATION; PSYCHIATRIC-DISORDERS; PRIMARY-CARE; MENTAL-DISORDERS; SELF-REPORT; 1ST YEAR; SEVERITY; ALCOHOL; REHABILITATION	Context Uncertainties exist about the rates, predictors, and outcomes of major depressive disorder (MDD) among individuals with traumatic brain injury (TBI). Objective To describe MDD-related rates, predictors, outcomes, and treatment during the first year after TBI. Design Cohort from June 2001 through March 2005 followed up by structured telephone interviews at months 1 through 6, 8, 10, and 12 (data collection ending February 2006). Setting Harborview Medical Center, a level I trauma center in Seattle, Washington. Participants Five hundred fifty-nine consecutively hospitalized adults with complicated mild to severe TBI. Main Outcome Measures The Patient Health Questionnaire (PHQ) depression and anxiety modules were administered at each assessment and the European Quality of Life measure was given at 12 months. Results Two hundred ninety-seven of 559 patients (53.1%) met criteria for MDD at least once in the follow-up period. Point prevalences ranged between 31% at 1 month and 21% at 6 months. In a multivariate model, risk of MDD after TBI was associated with MDD at the time of injury (risk ratio [RR], 1.62; 95% confidence interval [CI], 1.37-1.91), history of MDD prior to injury (but not at the time of injury) (RR, 1.54; 95% CI, 1.31-1.82), age (RR, 0.61; 95% CI, 0.44-0.83 for >60 years vs 18-29 years), and lifetime alcohol dependence (RR, 1.34; 95% CI, 1.14-1.57). Those with MDD were more likely to report comorbid anxiety disorders after TBI than those without MDD (60% vs 7%; RR, 8.77; 95% CI, 5.56-13.83). Only 44% of those with MDD received antidepressants or counseling. After adjusting for predictors of MDD, persons with MDD reported lower quality of life at 1 year compared with the nondepressed group. Conclusions Among a cohort of patients hospitalized for TBI, 53.1% met criteria for MDD during the first year after TBI. Major depressive disorder was associated with history of MDD and was an independent predictor of poorer health-related quality of life. JAMA. 2010; 303(19): 1938-1945	[Bombardier, Charles H.; Fann, Jesse R.; Temkin, Nancy R.; Esselman, Peter C.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA; [Fann, Jesse R.; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Temkin, Nancy R.; Barber, Jason; Dikmen, Sureyya S.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98104 USA; [Fann, Jesse R.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Temkin, Nancy R.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bombardier, CH (corresponding author), Univ Washington, Sch Med, Dept Rehabil Med, Box 359612,325 Ninth Ave, Seattle, WA 98104 USA.	chb@uw.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283	National Center for Medical Rehabilitation Research; National Institute of Child Health and Human Development; National Institutes of Health [R01 HD39415]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039415] Funding Source: NIH RePORTER	National Center for Medical Rehabilitation Research; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding/Support: This work was supported by the National Center for Medical Rehabilitation Research, the National Institute of Child Health and Human Development, and National Institutes of Health grant R01 HD39415 to Drs Bombardier and Fann (co-principal investigators). Pfizer supplied masked sertraline and placebo for the controlled trial.	Agency for Healthcare Research and Quality, CALC US POP BAS EQ 5; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Dobrez D, 2010, ARCH PHYS MED REHAB, V91, P184, DOI 10.1016/j.apmr.2009.10.020; Donker T, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1134; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2002, J NEUROL NEUROSUR PS, V72, P615, DOI 10.1136/jnnp.72.5.615; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; First M. B., 2001, USERS GUIDE STRUCTUR; GENTILELLO LM, 1995, JAMA-J AM MED ASSOC, V274, P1043, DOI 10.1001/jama.274.13.1043; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gorlyn M, 2008, J NEURAL TRANSM, V115, P1213, DOI 10.1007/s00702-008-0084-x; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huddleston Mary, 2004, J Healthc Qual, V26, P12; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Rush AJ, 2009, CNS DRUGS, V23, P627, DOI 10.2165/00023210-200923080-00001; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P395, DOI 10.1001/archpsyc.58.4.395; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	49	432	438	1	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2010	303	19					1938	1945		10.1001/jama.2010.599	http://dx.doi.org/10.1001/jama.2010.599			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597NJ	20483970	Green Accepted			2022-12-28	WOS:000277764500020
J	Hopkins, TG; Salem, V; El-Gayar, H; Palazzo, FF; Meeran, K; Tan, T				Hopkins, Tom Glass; Salem, Victoria; El-Gayar, Heba; Palazzo, Fausto F.; Meeran, Karim; Tan, Tricia			Familial adenomatous polyposis and hypertension	LANCET			English	Editorial Material									[Hopkins, Tom Glass; Salem, Victoria; El-Gayar, Heba; Meeran, Karim; Tan, Tricia] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Endocrine Unit, London W12 0HS, England; [Palazzo, Fausto F.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Endocrine Surg, London W12 0HS, England	Imperial College London; Imperial College London	Hopkins, TG (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Endocrine Unit, Du Cane Rd, London W12 0HS, England.	tomg.hopkins@gmail.com	Tan, Tricia/ABD-5502-2020; Tan, Tricia M.M./C-7140-2011	Tan, Tricia M.M./0000-0001-5873-3432; Salem, Victoria/0000-0001-6463-7471	Medical Research Council [G0701371] Funding Source: Medline; MRC [G0701371] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bhandaru M, 2009, AM J PHYSIOL-REG I, V297, pR571, DOI 10.1152/ajpregu.00070.2009; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Groen EJ, 2008, ANN SURG ONCOL, V15, P2439, DOI 10.1245/s10434-008-9981-3; Marchesa P, 1997, DIS COLON RECTUM, V40, P1023, DOI 10.1007/BF02050923; Will OCC, 2009, DIS COLON RECTUM, V52, P1637, DOI 10.1007/DCR.0b013e3181a876d6	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 15	2010	375	9727					1752	1752		10.1016/S0140-6736(10)60405-9	http://dx.doi.org/10.1016/S0140-6736(10)60405-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	599DK	20472175	Green Submitted			2022-12-28	WOS:000277890200037
J	Willenbring, JK; von Blanckenburg, F				Willenbring, Jane K.; von Blanckenburg, Friedhelm			Long-term stability of global erosion rates and weathering during late-Cenozoic cooling	NATURE			English	Article							CLIMATE-CHANGE; ACCUMULATION RATES; BERYLLIUM; SEDIMENT; WATER	Over geologic timescales, CO2 is emitted from the Earth's interior and is removed from the atmosphere by silicate rock weathering and organic carbon burial. This balance is thought to have stabilized greenhouse conditions within a range that ensured habitable conditions(1). Changes in this balance have been attributed to changes in topographic relief, where varying rates of continental rock weathering and erosion(1,2) are superimposed on fluctuations in organic carbon burial(3). Geological strata provide an indirect yet imperfectly preserved record of this change through changing rates of sedimentation(1,2,4). Widespread observations of a recent (0-5-Myr) fourfold increase in global sedimentation rates require a global mechanism to explain them(4-6). Accelerated uplift and global cooling have been given as possible causes(2,4,6,7), but because of the links between rates of erosion and the correlated rate of weathering(8,9), an increase in the drawdown of CO2 that is predicted to follow may be the cause of global climate change instead(2). However, globally, rates of uplift cannot increase everywhere in the way that apparent sedimentation rates do(4,10). Moreover, proxy records of past atmospheric CO2 provide no evidence for this large reduction in recent CO2 concentrations(11,12). Here we question whether this increase in global weathering and erosion actually occurred and whether the apparent increase in the sedimentation rate is due to observational biases in the sedimentary record(13). As evidence, we recast the ocean dissolved Be-10/Be-9 isotope system as a weathering proxy spanning the past similar to 12 Myr (ref. 14). This proxy indicates stable weathering fluxes during the late-Cenozoic era. The sum of these observations shows neither clear evidence for increased erosion nor clear evidence for a pulse in weathered material to the ocean. We conclude that processes different from an increase in denudation caused Cenozoic global cooling, and that global cooling had no profound effect on spatially and temporally averaged weathering rates.	[Willenbring, Jane K.; von Blanckenburg, Friedhelm] Deutsch GeoForschungsZentrum, Sect Earth Surface Geochem 3 4, D-14473 Potsdam, Germany	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	von Blanckenburg, F (corresponding author), Deutsch GeoForschungsZentrum, Sect Earth Surface Geochem 3 4, D-14473 Potsdam, Germany.	jane.willenbring@sas.upenn.edu; fvb@gfz-potsdam.de	von Blanckenburg, Friedhelm/K-4711-2013; Willenbring, Jane/ABG-1300-2020; Willenbring, Jane/B-6431-2011	von Blanckenburg, Friedhelm/0000-0002-2964-717X; Willenbring, Jane/0000-0003-2722-9537	Alexander von Humboldt Postdoctoral Fellowship	Alexander von Humboldt Postdoctoral Fellowship(Alexander von Humboldt Foundation)	J.K.W. gratefully acknowledges an Alexander von Humboldt Postdoctoral Fellowship.	BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BROWN ET, 1992, EARTH PLANET SC LETT, V114, P101, DOI 10.1016/0012-821X(92)90154-N; Derry LA, 1996, PALEOCEANOGRAPHY, V11, P267, DOI 10.1029/95PA03839; Frank M, 2009, GEOCHIM COSMOCHIM AC, V73, P6114, DOI 10.1016/j.gca.2009.07.010; Gabet EJ, 2009, GEOLOGY, V37, P151, DOI 10.1130/G25270A.1; Galy V, 2007, NATURE, V450, P407, DOI 10.1038/nature06273; GILLULY J, 1949, GEOL SOC AM BULL, V60, P561, DOI 10.1130/0016-7606(1949)60[561:DOMBIG]2.0.CO;2; HAY WW, 1988, J GEOPHYS RES-SOLID, V93, P14933, DOI 10.1029/JB093iB12p14933; IGEL H, 1999, GEOCHEM GEOPHY GEOSY, V1, P1; Kleman J, 1999, NATURE, V402, P63, DOI 10.1038/47005; Kuhlemann J, 2002, INT J EARTH SCI, V91, P818, DOI 10.1007/s00531-002-0266-y; Marshall SJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015192; Metivier F, 1999, GEOPHYS J INT, V137, P280, DOI 10.1046/j.1365-246X.1999.00802.x; Molnar P, 2004, ANNU REV EARTH PL SC, V32, P67, DOI 10.1146/annurev.earth.32.091003.143456; MOLNAR P, 1990, NATURE, V346, P29, DOI 10.1038/346029a0; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Pagani M, 2009, NATURE, V460, P85, DOI 10.1038/nature08133; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Riebe CS, 2004, EARTH PLANET SC LETT, V224, P547, DOI 10.1016/j.epsl.2004.05.019; RONOV AB, 1994, AM J SCI, V294, P777, DOI 10.2475/ajs.294.7.777; Roy M, 2004, EARTH PLANET SC LETT, V227, P281, DOI 10.1016/j.epsl.2004.09.001; Royer D.L., 2004, GSA TODAY, V14, P4, DOI DOI 10.1130/1052-5173(2004)014; Sadler P. M., 1999, GEORESEARCH FORUM, V5, P15; von Blanckenburg F, 1996, EARTH PLANET SC LETT, V141, P213, DOI 10.1016/0012-821X(96)00059-3; von Blanckenburg F, 1999, EARTH PLANET SC LETT, V167, P175, DOI 10.1016/S0012-821X(99)00028-X; West AJ, 2005, EARTH PLANET SC LETT, V235, P211, DOI 10.1016/j.epsl.2005.03.020; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1; Wilkinson BH, 2009, GEOL SOC AM BULL, V121, P760, DOI 10.1130/B26457.1; Wittmann H, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000729; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	30	271	284	12	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 13	2010	465	7295					211	214		10.1038/nature09044	http://dx.doi.org/10.1038/nature09044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	594SS	20463736				2022-12-28	WOS:000277558500033
J	Pare, G; Anand, SS				Pare, Guillaume; Anand, Sonia S.			Mendelian randomisation, triglycerides, and CHD	LANCET			English	Editorial Material							GENETIC EPIDEMIOLOGY; RISK; APOLIPOPROTEINS; DISEASE; LIPIDS		[Anand, Sonia S.] McMaster Univ, Dept Clin Epidemiol, Populat Genom Program, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Pathol, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Anand, SS (corresponding author), McMaster Univ, Dept Clin Epidemiol, Populat Genom Program, Hamilton, ON L8N 3Z5, Canada.	anands@mcmaster.ca	Pare, Guillaume/T-9631-2018	Pare, Guillaume/0000-0002-6795-4760				Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Lai CQ, 2004, J LIPID RES, V45, P2096, DOI 10.1194/jlr.M400192-JLR200; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070	12	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2010	375	9726					1584	1586		10.1016/S0140-6736(10)60659-9	http://dx.doi.org/10.1016/S0140-6736(10)60659-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	597CX	20452504				2022-12-28	WOS:000277734700006
J	Burbano, HA; Hodges, E; Green, RE; Briggs, AW; Krause, J; Meyer, M; Good, JM; Maricic, T; Johnson, PLF; Xuan, ZY; Rooks, M; Bhattacharjee, A; Brizuela, L; Albert, FW; de la Rasilla, M; Fortea, J; Rosas, A; Lachmann, M; Hannon, GJ; Paabo, S				Burbano, Hernan A.; Hodges, Emily; Green, Richard E.; Briggs, Adrian W.; Krause, Johannes; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Johnson, Philip L. F.; Xuan, Zhenyu; Rooks, Michelle; Bhattacharjee, Arindam; Brizuela, Leonardo; Albert, Frank W.; de la Rasilla, Marco; Fortea, Javier; Rosas, Antonio; Lachmann, Michael; Hannon, Gregory J.; Paeaebo, Svante			Targeted Investigation of the Neandertal Genome by Array-Based Sequence Capture	SCIENCE			English	Article							SELECTION; FOXP2; EVOLUTION; SPEECH; HUMANS	It is now possible to perform whole-genome shotgun sequencing as well as capture of specific genomic regions for extinct organisms. However, targeted resequencing of large parts of nuclear genomes has yet to be demonstrated for ancient DNA. Here we show that hybridization capture on microarrays can successfully recover more than a megabase of target regions from Neandertal DNA even in the presence of similar to 99.8% microbial DNA. Using this approach, we have sequenced similar to 14,000 protein-coding positions inferred to have changed on the human lineage since the last common ancestor shared with chimpanzees. By generating the sequence of one Neandertal and 50 present-day humans at these positions, we have identified 88 amino acid substitutions that have become fixed in humans since our divergence from the Neandertals.	[Burbano, Hernan A.; Green, Richard E.; Briggs, Adrian W.; Krause, Johannes; Meyer, Matthias; Good, Jeffrey M.; Maricic, Tomislav; Albert, Frank W.; Lachmann, Michael; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Hodges, Emily; Xuan, Zhenyu; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Rooks, Michelle; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Good, Jeffrey M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Johnson, Philip L. F.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Bhattacharjee, Arindam; Brizuela, Leonardo] Agilent Technol, Life Sci Grp, Santa Clara, CA 95051 USA; [de la Rasilla, Marco; Fortea, Javier] Univ Oviedo, Dept Hist, Area Prehist, Oviedo, Spain; [Rosas, Antonio] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain	Max Planck Society; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Montana System; University of Montana; Emory University; Agilent Technologies; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Burbano, HA (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.		Krause, Johannes/E-6640-2015; Rosas, Antonio/D-9742-2016; Burbano, Hernán/F-2952-2010; Krause, Johannes/AFP-2642-2022; Hannon, Gregory/AAB-3568-2019	Krause, Johannes/0000-0001-5475-4690; Rosas, Antonio/0000-0002-5829-9952; Krause, Johannes/0000-0001-9144-3920; Albert, Frank/0000-0002-1380-8063; Green, Richard/0000-0003-0516-5827; Hodges, Emily/0000-0001-6513-610X; Xuan, Zhenyu/0000-0001-9344-8493; Burbano, Hernan A./0000-0003-3433-719X; de la RASILLA, Marco/0000-0002-5505-0625	NSF [OISE-0754461]; NIH; Max Planck Society; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. S. Burbano, C. de Filippo, J. Kelso, and D. Reich for helpful comments; M. Kircher, K. Pruefer, and U. Stenzel for technical support; C. D. Bustamante and K. E. Lohmueller for access to human resequencing databases; D. L. Goode and A. Sidow for providing conservation scores; J. M. Akey for providing coordinates of genome-wide scans for selection; I. Gut for human genotyping; E. Leproust and M. Srinivasan for providing early access to the 1 Million feature Agilent microarrays; and the Genome Center at Washington University for pre-publication use of the orangutan genome assembly (http://genome.wustl.edu/genomes/view/pongo_abelii/). The government of the Principado de Asturias funded excavations at the Sidron site. J. M. G. was supported by an NSF international postdoctoral fellowship (OISE-0754461) and E. H. by a postdoctoral training grant from the NIH and by a gift from the Stanley Foundation. G. J. H. is an investigator of the Howard Hughes Medical Institute, which together with the Presidential Innovation Fund of the Max Planck Society provided generous financial support. DNA sequences are deposited in the European Bioinformatics Institute short read archive, with accession number ERP000125. The array capture technologies used in this study are the subject of pending patent filings U. S. 60/478, 382 (filed 2003) and U. S. 61/205, 834 (filed 2009), on which G. J. H. and E. H. are listed as inventors.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Cann HM, 2002, SCIENCE, V296, P261; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de Torres T, 2010, ARCHAEOMETRY, V52, P680, DOI 10.1111/j.1475-4754.2009.00491.x; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Wu HH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-192	24	197	211	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 7	2010	328	5979					723	725		10.1126/science.1188046	http://dx.doi.org/10.1126/science.1188046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	592DZ	20448179	Green Accepted			2022-12-28	WOS:000277357100031
J	Bergeal, N; Schackert, F; Metcalfe, M; Vijay, R; Manucharyan, VE; Frunzio, L; Prober, DE; Schoelkopf, RJ; Girvin, SM; Devoret, MH				Bergeal, N.; Schackert, F.; Metcalfe, M.; Vijay, R.; Manucharyan, V. E.; Frunzio, L.; Prober, D. E.; Schoelkopf, R. J.; Girvin, S. M.; Devoret, M. H.			Phase-preserving amplification near the quantum limit with a Josephson ring modulator	NATURE			English	Article							PARAMETRIC-AMPLIFIER; LINEAR-AMPLIFIERS; SHOT-NOISE; FLUCTUATIONS	Recent progress in solid-state quantum information processing(1) has stimulated the search for amplifiers and frequency converters with quantum-limited performance in the microwave range. Depending on the gain applied to the quadratures of a single spatial and temporal mode of the electromagnetic field, linear amplifiers can be classified into two categories ( phase sensitive and phase preserving) with fundamentally different noise properties(2). Phase-sensitive amplifiers use squeezing to reduce the quantum noise, but are useful only in cases in which a reference phase is attached to the signal, such as in homodyne detection. A phase-preserving amplifier would be preferable in many applications, but such devices have not been available until now. Here we experimentally realize a proposal(3) for an intrinsically phase-preserving, superconducting parametric amplifier of non-degenerate type. It is based on a Josephson ring modulator, which consists of four Josephson junctions in a Wheatstone bridge configuration. The device symmetry greatly enhances the purity of the amplification process and simplifies both its operation and its analysis. The measured characteristics of the amplifier in terms of gain and bandwidth are in good agreement with analytical predictions. Using a newly developed noise source, we show that the upper bound on the total system noise of our device under real operating conditions is three times the quantum limit. We foresee applications in the area of quantum analog signal processing, such as quantum non-demolition single-shot readout of qubits(4), quantum feedback(5) and the production of entangled microwave signal pairs(6).	[Bergeal, N.; Schackert, F.; Metcalfe, M.; Vijay, R.; Manucharyan, V. E.; Frunzio, L.; Prober, D. E.; Schoelkopf, R. J.; Girvin, S. M.; Devoret, M. H.] Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA; [Bergeal, N.] ESPCI ParisTech, CNRS, LPEM UPR5, F-75005 Paris, France; [Metcalfe, M.] Univ Maryland, Joint Quantum Inst, College Pk, MD 20742 USA; [Vijay, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	Yale University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University System of Maryland; University of Maryland College Park; University of California System; University of California Berkeley	Bergeal, N (corresponding author), Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA.	nicolas.bergeal@espci.fr; michel.devoret@yale.edu	Schoelkopf, Robert J/J-8178-2012; Frunzio, Luigi/O-1573-2019	Frunzio, Luigi/0000-0002-0272-5481	US National Security Agency through the US Army Research Office [W911NF-05-01-0365]; W. M. Keck Foundation; US National Science Foundation [DMR-032-5580]; College de France; French Agence Nationale de la Recherche	US National Security Agency through the US Army Research Office; W. M. Keck Foundation(W.M. Keck Foundation); US National Science Foundation(National Science Foundation (NSF)); College de France; French Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank B. Abdo for his reading of the manuscript. This work was supported by the US National Security Agency through the US Army Research Office grant W911NF-05-01-0365, the W. M. Keck Foundation, and the US National Science Foundation through grant DMR-032-5580. M. H. D. acknowledges partial support from the College de France and from the French Agence Nationale de la Recherche.	Ahn C, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042301; Andre MO, 1999, APPL PHYS LETT, V75, P698, DOI 10.1063/1.124486; Bergeal N, 2010, NAT PHYS, V6, P296, DOI 10.1038/NPHYS1516; Boulant N, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014525; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Castellanos-Beltrana MA, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773988; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; CLERK AA, 2008, REV MOD PHY IN PRESS; GORDON JP, 1963, PHYS REV, V129, P481, DOI 10.1103/PhysRev.129.481; HAUS HA, 1962, PHYS REV, V128, P2407, DOI 10.1103/PhysRev.128.2407; Kinion D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2902173; LOUISELL WH, 1961, PHYS REV, V124, P1646, DOI 10.1103/PhysRev.124.1646; Lupascu A, 2007, NAT PHYS, V3, P119, DOI 10.1038/nphys509; Mallet F, 2009, NAT PHYS, V5, P791, DOI 10.1038/NPHYS1400; Manucharyan VE, 2009, SCIENCE, V326, P113, DOI 10.1126/science.1175552; Marquardt F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205416; Metcalfe M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174516; MOVSHOVICH R, 1990, PHYS REV LETT, V65, P1419, DOI 10.1103/PhysRevLett.65.1419; NAGAEV KE, 1995, PHYS REV B, V52, P4740, DOI 10.1103/PhysRevB.52.4740; Pothier H, 1997, PHYS REV LETT, V79, P3490, DOI 10.1103/PhysRevLett.79.3490; Prober DE, 2007, IEEE T APPL SUPERCON, V17, P241, DOI 10.1109/TASC.2007.897397; Santavicca DF, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3336008; Spietz L, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970967; Steinbach AH, 1996, PHYS REV LETT, V76, P3806, DOI 10.1103/PhysRevLett.76.3806; Vijay R, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3224703; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Yamamoto T, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2964182; YURKE B, 1988, PHYS REV LETT, V60, P764, DOI 10.1103/PhysRevLett.60.764; YURKE B, 1989, PHYS REV A, V39, P2519, DOI 10.1103/PhysRevA.39.2519	30	312	328	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 6	2010	465	7294					64	U70		10.1038/nature09035	http://dx.doi.org/10.1038/nature09035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	591OW	20445625	Green Submitted			2022-12-28	WOS:000277311900031
J	Sarewitz, D				Sarewitz, Daniel			Brick by brick	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	2	2	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 6	2010	465	7294					29	29		10.1038/465029a	http://dx.doi.org/10.1038/465029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	591OW	20445605	Bronze			2022-12-28	WOS:000277311900012
J	Healey, F; Sanders, DS; Lamont, T; Scarpello, J; Agbabiaka, T				Healey, Frances; Sanders, David S.; Lamont, Tara; Scarpello, John; Agbabiaka, Taofikat			SAFETY ALERTS Early detection of complications after gastrostomy: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Healey, Frances; Lamont, Tara; Scarpello, John; Agbabiaka, Taofikat] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Sanders, David S.] Univ Sheffield, Sheffield, S Yorkshire, England; [Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	Healey, F (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	frances.healey@npsa.nhs.uk	Agbabiaka, Taofikat B/V-1348-2017	Agbabiaka, Taofikat B/0000-0003-0211-7555				Johnston SD, 2008, GASTROINTEST ENDOSC, V68, P223, DOI 10.1016/j.gie.2007.10.019; *NAT PAT SAF AG, 2010, NPSA2010RRR010; Sanders DS, 2004, CLIN MED, V4, P235, DOI 10.7861/clinmedicine.4-3-235; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; The Royal College of Physicians, 2010, OR FEED DIFF DIL GUI	5	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2010	340								c2160	10.1136/bmj.c2160	http://dx.doi.org/10.1136/bmj.c2160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594XB	20442227				2022-12-28	WOS:000277572400003
J	Weng, CL; Zhao, YT; Liu, QH; Fu, CJ; Sun, F; Ma, YL; Chen, YW; He, QY				Weng, Cui-Lian; Zhao, Yun-Tao; Liu, Qing-Hua; Fu, Chang-Jun; Sun, Feng; Ma, Yan-Liang; Chen, Yan-Wen; He, Quan-Ying			Meta-analysis: Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema	ANNALS OF INTERNAL MEDICINE			English	Review							POSITIVE AIRWAY PRESSURE; EMERGENCY-DEPARTMENT PATIENTS; RANDOMIZED CONTROLLED-TRIAL; SUPPORT VENTILATION; MYOCARDIAL-INFARCTION; FACE MASK; OXYGEN-THERAPY; BILEVEL; FAILURE; MORTALITY	Background: Noninvasive ventilation (NIV) is commonly used to treat patients with acute cardiogenic pulmonary edema (ACPE), but the findings of a recent large clinical trial suggest that NIV may be less effective for ACPE than previously thought. Purpose: To provide an estimate of the effect of NIV on clinical outcomes in patients with ACPE that incorporates recent trial evidence and explore ways to interpret that evidence in the context of preceding evidence that favors NIV. Data Sources: PubMed and EMBASE from 1966 to December 2009, Cochrane Central Register of Controlled Trials and conference proceedings through December 2009, and reference lists, without language restriction. Study Selection: Randomized trials that compared continuous positive airway pressure and bilevel ventilation with standard therapy or each other. Data Extraction: Two independent reviewers extracted data. Outcomes examined were mortality, intubation rate, and incidence of new myocardial infarction (MI). Data Synthesis: Compared with standard therapy, continuous positive airway pressure reduced mortality (relative risk [RR], 0.64 [95% CI, 0.44 to 0.92]) and need for intubation (RR, 0.44 [CI, 0.32 to 0.60]) but not incidence of new MI (RR, 1.07 [CI, 0.84 to 1.37]). The effect was more prominent in trials in which myocardial ischemia or infarction caused ACPE in higher proportions of patients (RR, 0.92 [CI, 0.76 to 1.10] when 10% of patients had ischemia or MI vs. 0.43 [CI, 0.17 to 1.07] when 50% had ischemia or MI). Bilevel ventilation reduced the need for intubation (RR, 0.54 [CI, 0.33 to 0.86]) but did not reduce mortality or new MI. No differences were detected between continuous positive airway pressure and bilevel ventilation on any clinical outcomes for which they were directly compared. Limitations: The quality of the evidence base was limited. Definitions, cause, and severity of ACPE differed among the trials, as did patient characteristics and clinical settings. Conclusion: Although a recent large trial contradicts results from previous studies, the evidence in aggregate still supports the use of NIV for patients with ACPE. Continuous positive airway pressure reduces mortality more in patients with ACPE secondary to acute myocardial ischemia or infarction.	[Weng, Cui-Lian] Capital Med Univ, Beijing Chaoyang Hosp Affiliate, Peking Univ, Peking Univ Peoples Hosp, Beijing 100044, Peoples R China; Tsinghua Univ, Beijing 100084, Peoples R China; Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China	Capital Medical University; Peking University; Tsinghua University; Xiamen University	Zhao, YT (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp Affiliate, Peking Univ, Peking Univ Peoples Hosp, 11 Xizhimen S St, Beijing 100044, Peoples R China.		Sun, Feng/AGF-7912-2022; Sun, Feng/E-8859-2010	Sun, Feng/0000-0003-4334-6805; Sun, Feng/0000-0001-9212-0496				Bellone A, 2005, INTENS CARE MED, V31, P807, DOI 10.1007/s00134-005-2649-6; Bellone A, 2004, CRIT CARE MED, V32, P1860, DOI 10.1097/01.CCM.0000139694.47326.B6; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; Bhogal SK, 2005, J CLIN EPIDEMIOL, V58, P668, DOI 10.1016/j.jclinepi.2005.01.002; BOLLAERT PE, 2002, AM J RESP CRIT CARE, V165, pA387; Collins SP, 2006, ANN EMERG MED, V48, P260, DOI 10.1016/j.annemergmed.2006.01.038; Crane SD, 2004, EMERG MED J, V21, P155, DOI 10.1136/emj.2003.005413; Cross AM, 2003, EMERG MED J, V20, P531, DOI 10.1136/emj.20.6.531; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; DUCROS C, 2007, CONTINUOUS POSITIVE; Felker GM, 2003, AM HEART J, V145, pS18, DOI 10.1067/mhj.2003.150; FERRARI G, 2009, J EMERG MED; FERRARI G, 2006, J EMERGENCY MED, V30, P246; Ferrari G, 2007, CHEST, V132, P1804, DOI 10.1378/chest.07-1058; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; GHANEM MK, 2009, NONINVASIVE MECH VEN; Gray AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13330; Gray A, 2008, NEW ENGL J MED, V359, P142, DOI 10.1056/NEJMoa0707992; [赫朝霞 Hao Chaoxia], 2002, [江西医学院学报, Acta Academiae Medicinae Jiangxi], V42, P48; Ho KM, 2006, CRIT CARE, V10, DOI 10.1186/cc4861; Kelly CA, 2002, EUR HEART J, V23, P1379, DOI 10.1053/euhj.2001.3156; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; Levitt MA, 2001, J EMERG MED, V21, P363, DOI 10.1016/S0736-4679(01)00385-7; LIESCHING TN, 2003, AM J RESP CRIT CARE, V167, pA864; LIN M, 1995, CHEST, V107, P1379, DOI 10.1378/chest.107.5.1379; MARTINBERMUDEZ R, 2002, INTENS CARE MED, V28, pA255; Masip J, 2005, JAMA-J AM MED ASSOC, V294, P3124, DOI 10.1001/jama.294.24.3124; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Masip J, 2008, NEW ENGL J MED, V359, P2068; Mehta S, 1997, CRIT CARE MED, V25, P620, DOI 10.1097/00003246-199704000-00011; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moritz F, 2007, ANN EMERG MED, V50, P666, DOI 10.1016/j.annemergmed.2007.06.488; Nava S, 2003, AM J RESP CRIT CARE, V168, P1432, DOI 10.1164/rccm.200211-1270OC; Park M, 2004, CRIT CARE MED, V32, P2407, DOI 10.1097/01.CCM.0000147770.20400.10; Park M, 2001, Arq Bras Cardiol, V76, P221; Peter JV, 2006, LANCET, V367, P1155, DOI 10.1016/S0140-6736(06)68506-1; Plaisance P, 2007, EUR HEART J, V28, P2895, DOI 10.1093/eurheartj/ehm502; Poppas A, 2002, AM J RESP CRIT CARE, V165, P4, DOI 10.1164/ajrccm.165.1.2102075; Potts JM, 2009, POL ARCH MED WEWN, V119, P349, DOI 10.20452/pamw.705; RASANEN J, 1985, AM J CARDIOL, V55, P296, DOI 10.1016/0002-9149(85)90364-9; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; STEVENSON R, 1993, BMJ-BRIT MED J, V307, P349, DOI 10.1136/bmj.307.6900.349; Takeda S, 1997, ANESTH ANALG, V84, P1091, DOI 10.1097/00000539-199705000-00025; Takeda S, 1998, JPN CIRC J, V62, P553, DOI 10.1253/jcj.62.553; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; THYS FC, 2006, HERMES STUDY STUDY F; Vital FMR, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005351.pub2; Weitz G, 2007, EUR J EMERG MED, V14, P276, DOI 10.1097/MEJ.0b013e32826fb377; Winck JC, 2006, CRIT CARE, V10, DOI 10.1186/cc4905	49	133	149	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					590	+		10.7326/0003-4819-152-9-201005040-00009	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00009			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439577				2022-12-28	WOS:000277604000006
J	Vendrell, JF; Hoa, D; Gahide, G				Vendrell, Jean-Francois; Hoa, Denis; Gahide, Gerald			Mature teratoma arising from the sella	LANCET			English	Editorial Material									[Vendrell, Jean-Francois] Gui de Chauliac Univ Hosp Ctr, Dept Neuroradiol, F-34295 Montpellier, France; [Hoa, Denis] Lapeyronie Univ Hosp Ctr, Dept Radiol, Montpellier, France; [Gahide, Gerald] Arnaud de Villneuve Univ Hosp Ctr, Dept Cardiovasc Thorac Radiol, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Vendrell, JF (corresponding author), Gui de Chauliac Univ Hosp Ctr, Dept Neuroradiol, 80 Ave Augustin Fliche, F-34295 Montpellier, France.	jfvendrell@yahoo.fr		Vendrell, Jean-Francois/0000-0003-0351-2696					0	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1556	1556		10.1016/S0140-6736(09)60300-7	http://dx.doi.org/10.1016/S0140-6736(09)60300-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435229				2022-12-28	WOS:000277655100028
J	Edwards, EJ; Osborne, CP; Stromberg, CAE; Smith, SA; Bond, WJ; Christin, PA; Cousins, AB; Duvall, MR; Fox, DL; Freckleton, RP; Ghannoum, O; Hartwell, J; Huang, YS; Janis, CM; Keeley, JE; Kellogg, EA; Knapp, AK; Leakey, ADB; Nelson, DM; Saarela, JM; Sage, RF; Sala, OE; Salamin, N; Still, CJ; Tipple, B				Edwards, Erika J.; Osborne, Colin P.; Stroemberg, Caroline A. E.; Smith, Stephen A.; Bond, William J.; Christin, Pascal-Antoine; Cousins, Asaph B.; Duvall, Melvin R.; Fox, David L.; Freckleton, Robert P.; Ghannoum, Oula; Hartwell, James; Huang, Yongsong; Janis, Christine M.; Keeley, Jon E.; Kellogg, Elizabeth A.; Knapp, Alan K.; Leakey, Andrew D. B.; Nelson, David M.; Saarela, Jeffery M.; Sage, Rowan F.; Sala, Osvaldo E.; Salamin, Nicolas; Still, Christopher J.; Tipple, Brett		C4 Grasses Consortium	The Origins of C-4 Grasslands: Integrating Evolutionary and Ecosystem Science	SCIENCE			English	Review							MIOCENE EXPANSION; ISOTOPIC EVIDENCE; ATMOSPHERIC CO2; CLIMATE; GRASSES; PHOTOSYNTHESIS; VEGETATION; MONSOONS; HISTORY; DECLINE	The evolution of grasses using C-4 photosynthesis and their sudden rise to ecological dominance 3 to 8 million years ago is among the most dramatic examples of biome assembly in the geological record. A growing body of work suggests that the patterns and drivers of C-4 grassland expansion were considerably more complex than originally assumed. Previous research has benefited substantially from dialog between geologists and ecologists, but current research must now integrate fully with phylogenetics. A synthesis of grass evolutionary biology with grassland ecosystem science will further our knowledge of the evolution of traits that promote dominance in grassland systems and will provide a new context in which to evaluate the relative importance of C-4 photosynthesis in transforming ecosystems across large regions of Earth.	[Edwards, Erika J.; Janis, Christine M.; Sala, Osvaldo E.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Osborne, Colin P.; Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Stroemberg, Caroline A. E.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Stroemberg, Caroline A. E.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Smith, Stephen A.] Natl Evolutionary Synth Ctr, Durham, NC 27705 USA; [Bond, William J.] Univ Cape Town, Dept Bot, Cape Town, South Africa; [Christin, Pascal-Antoine; Salamin, Nicolas] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Cousins, Asaph B.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Duvall, Melvin R.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Fox, David L.] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Ghannoum, Oula] Univ Western Sydney, Dept Plants Soil & Environm, S Penrith Distribut Ctr, New South Wales, Australia; [Hartwell, James] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Huang, Yongsong] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Keeley, Jon E.] Western Ecol Res Ctr, Sequoia Kings Canyon Field Stat, Three Rivers, CA 93271 USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA 90024 USA; [Kellogg, Elizabeth A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Knapp, Alan K.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Leakey, Andrew D. B.] Univ Illinois, Inst Genom Biol, Dept Plant Biol, Urbana, IL 61801 USA; [Nelson, David M.] Univ Maryland, Ctr Environm Sci Appalachian Lab, Frostburg, MD 21532 USA; [Saarela, Jeffery M.] Canadian Museum Nat, Res Div, Ottawa, ON, Canada; [Sage, Rowan F.] Univ Toronto, Dept Ecol & Evolut Biol, Toronto, ON, Canada; [Salamin, Nicolas] Swiss Inst Bioinformat, Quartier Sorge, Lausanne, Switzerland; [Still, Christopher J.] Univ Calif, Dept Geography, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA; [Tipple, Brett] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Brown University; University of Sheffield; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The National Evolutionary Synthesis Center; University of Cape Town; University of Lausanne; Washington State University; Northern Illinois University; University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Liverpool; Brown University; University of California System; University of California Los Angeles; University of Missouri System; University of Missouri Saint Louis; Colorado State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; Swiss Institute of Bioinformatics; University of California System; University of California Santa Barbara; Utah System of Higher Education; University of Utah	Edwards, EJ (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	erika_edwards@brown.edu; c.p.osborne@sheffield.ac.uk; caestrom@u.washington.edu	Kellogg, Elizabeth/M-2845-2013; Nelson, David M/D-5596-2009; edwards, erika/D-8027-2012; Nelson, David/AAP-9412-2020; Bond, William/AAY-7631-2020; Knapp, Alan K/A-2931-2008; Leakey, Andrew DB/Q-9889-2016; Hartwell, James/M-7249-2014; Smith, Stephen/AAE-8623-2019; Janis, Christine/GPT-3398-2022; Freckleton, Rob P/B-6455-2013; Smith, Stephen/B-3451-2010; Hartwell, James/P-4410-2019; Christin, Pascal-Antoine/A-6634-2013	Kellogg, Elizabeth/0000-0003-1671-7447; Nelson, David M/0000-0003-2755-5535; Nelson, David/0000-0003-2755-5535; Leakey, Andrew DB/0000-0001-6251-024X; Hartwell, James/0000-0001-5000-223X; Smith, Stephen/0000-0003-2035-9531; Hartwell, James/0000-0001-5000-223X; Christin, Pascal-Antoine/0000-0001-6292-8734; Saarela, Jeffery/0000-0003-1790-4332; Freckleton, Robert/0000-0002-8338-864X; Ghannoum, Oula/0000-0002-1341-0741; Stromberg, Caroline A. E./0000-0003-0612-0305; Bond, William/0000-0002-3441-2084; Fox, David L/0000-0002-2291-6146; Still, Christopher/0000-0002-8295-4494; Salamin, Nicolas/0000-0002-3963-4954	NSF National Evolutionary Synthesis Center (NESCent); Royal Society; Biotechnology and Biological Sciences Research Council [BB/F009313/1] Funding Source: researchfish; BBSRC [BB/F009313/1] Funding Source: UKRI	NSF National Evolutionary Synthesis Center (NESCent); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the NSF National Evolutionary Synthesis Center (NESCent) for funding the catalysis meeting "Toward a new synthesis of the evolutionary history and ecology of C<INF>4</INF> grasses," which inspired this paper. We thank B. Passey (Johns Hopkins Univ.) for many stimulating discussions; D. Beerling and M. Donoghue for their critical comments on the manuscript; and V. Visser, M. Lomas, and I. Woodward for their help with Fig. 1. Funding was provided by The Royal Society (University Research Fellowship to C.P.O.).	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Behrensmeyer AK, 2007, GEOL SOC AM BULL, V119, P1486, DOI 10.1130/B26064.1; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Christin PA, 2008, CURR BIOL, V18, P37, DOI 10.1016/j.cub.2007.11.058; Coupland R. T., 1993, NATURAL GRASSLANDS B, V8B; COUPLAND RT, 1992, NATURAL GRASSLANDS A, V8; Cousins AB, 2008, J EXP BOT, V59, P1695, DOI 10.1093/jxb/ern001; Craine JM., 2009, RESOURCE STRATEGIES; Dettman DL, 2001, GEOLOGY, V29, P31, DOI 10.1130/0091-7613(2001)029<0031:SSIEFA>2.0.CO;2; Edwards EJ, 2007, TRENDS ECOL EVOL, V22, P243, DOI 10.1016/j.tree.2007.02.002; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; EHLERINGER JR, 1978, OECOLOGIA, V31, P255, DOI 10.1007/BF00346246; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Fox DL, 2003, GEOLOGY, V31, P809, DOI 10.1130/G19580.1; GUTIERRE.M, 1974, PLANTA, V119, P279, DOI 10.1007/BF00388331; Heckathorn SA, 1999, C4 PLANT BIOL, P285; Huang YS, 2007, GEOLOGY, V35, P531, DOI 10.1130/G23666A.1; Ibrahim DG, 2008, PLANT CELL ENVIRON, V31, P1038, DOI 10.1111/j.1365-3040.2008.01815.x; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; Keeley JE, 2003, INT J PLANT SCI, V164, pS55, DOI 10.1086/374192; Kellogg EA, 1999, ANN BOT-LONDON, V84, P279, DOI 10.1006/anbo.1999.0899; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kuypers MMM, 1999, NATURE, V399, P342, DOI 10.1038/20659; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; Monson R.K., 1999, C4 PLANT BIOL, P215, DOI DOI 10.1016/B978-012614440-6/50008-2; Osborne CP, 2008, J ECOL, V96, P35, DOI 10.1111/j.1365-2745.2007.01323.x; Osborne CP, 2006, PHILOS T R SOC B, V361, P173, DOI 10.1098/rstb.2005.1737; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Passey BH, 2009, EARTH PLANET SC LETT, V277, P443, DOI 10.1016/j.epsl.2008.11.008; Prasad V, 2005, SCIENCE, V310, P1177, DOI 10.1126/science.1118806; Retallack GJ, 2001, J GEOL, V109, P407, DOI 10.1086/320791; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; Taub DR, 2000, AM J BOT, V87, P1211, DOI 10.2307/2656659; TEERI JA, 1976, OECOLOGIA, V23, P1, DOI 10.1007/BF00351210; Tipple BJ, 2007, ANNU REV EARTH PL SC, V35, P435, DOI 10.1146/annurev.earth.35.031306.140150; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x	46	691	718	8	413	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2010	328	5978					587	591		10.1126/science.1177216	http://dx.doi.org/10.1126/science.1177216			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20431008				2022-12-28	WOS:000277159800033
J	Schlissel, MS				Schlissel, Mark S.			Epigenetics Drives RAGs to Recombination Riches	CELL			English	Editorial Material							LYSINE-4; CELL		Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Schlissel, MS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mss@berkeley.edu						Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P1209, DOI 10.1073/pnas.0237043100; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Schlissel MS, 2006, GENE DEV, V20, P1539, DOI 10.1101/gad.1446506; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011	9	4	4	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					400	402		10.1016/j.cell.2010.04.014	http://dx.doi.org/10.1016/j.cell.2010.04.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434980	Bronze			2022-12-28	WOS:000277180800010
J	Xu, X; Zheng, XT; You, HL				Xu, Xing; Zheng, Xiaoting; You, Hailu			Exceptional dinosaur fossils show ontogenetic development of early feathers	NATURE			English	Article							EVOLUTIONARY ORIGIN; CHINA; DIVERSIFICATION; MORPHOGENESIS; THEROPOD; BIRDS	Recent discoveries of feathered dinosaur specimens have greatly improved our understanding of the origin and early evolution of feathers, but little information is available on the ontogenetic development of early feathers(1-7). Here we describe an early-juvenile specimen and a late-juvenile specimen, both referable to the oviraptorosaur Similicaudipteryx(8), recovered from the Lower Cretaceous Yixian Formation of western Liaoning, China(9). The two specimens have strikingly different remiges and rectrices, suggesting that a radical morphological change occurred during feather development, as is the case for modern feathers(10). However, both the remiges and the rectrices are proximally ribbon-like in the younger specimen but fully pennaceous in the older specimen, a pattern not known in any modern bird(10). In combination with the wide distribution of proximally ribbon-like pennaceous feathers and elongate broad filamentous feathers among extinct theropods, this find suggests that early feathers were developmentally more diverse than modern ones and that some developmental features, and the resultant morphotypes, have been lost in feather evolution.	[Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Zheng, Xiaoting] Shandong Tianyu Museum Nat, Pingyi 273300, Shandong, Peoples R China; [You, Hailu] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Geological Sciences	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com; ty4291666@163.com		You, Hai-Lu/0000-0003-2203-6461	Chinese Academy of Sciences; National Natural Science Foundation of China; Special Funds For Major State Basic Research Projects of China	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds For Major State Basic Research Projects of China	The authors thank P.-J. Chen, L.-H. Hou and Z.-M. Dong for coordinating the project, M. Kundrat and F. C. Zhang for discussions, and M. Kundrat and C. Sullivan for commenting on and editing the manuscript. This work was supported by grants from the Chinese Academy of Sciences, the National Natural Science Foundation of China and Special Funds For Major State Basic Research Projects of China, presented to X.X.	BRUSH AH, 1972, BIOCHEM GENET, V7, P87, DOI 10.1007/BF00487012; Chiappe LM, 1999, B AM MUS NAT HIST, P3; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Harris MP, 2002, J EXP ZOOL, V294, P160, DOI 10.1002/jez.10157; He Tao, 2008, Vertebrata Palasiatica, V46, P178; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lingham-Soliar T, 2010, J ORNITHOL, V151, P193, DOI 10.1007/s10336-009-0446-7; Lucas A. M., 1972, AVIAN ANATOMY INTEGU, P197; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Osmolska H, 2004, DINOSAURIA, 2ND EDITION, P165; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2005, J EXP ZOOL PART B, V304B, P570, DOI 10.1002/jez.b.21073; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Raff R. A., 1996, SHAPE LIFE GENES DEV; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Widelitz RB, 2003, J EXP ZOOL PART B, V298B, P109, DOI 10.1002/jez.b.00029; Witmer LM, 2009, NATURE, V458, P293, DOI 10.1038/458293a; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; ZHENG XT, 2009, ORIGIN BIRDS, P1; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	29	99	111	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1338	1341		10.1038/nature08965	http://dx.doi.org/10.1038/nature08965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20428169				2022-12-28	WOS:000277149000044
J							Drug Therapeutics Bulletin	From Drug and Therapeutics Bulletin Management of medication overuse headache	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OPEN-LABEL TRIAL; CHRONIC MIGRAINE; DOUBLE-BLIND; WITHDRAWAL THERAPY; CLINICAL-FEATURES; PREDICTORS; CRITERIA; RELAPSE; RATES; DETOXIFICATION		[Drug Therapeutics Bulletin] Drug & Therapeut Bulletin Editorial Off, London WC1H 9JR, England									Atasoy HT, 2005, EUR J PAIN, V9, P285, DOI 10.1016/j.ejpain.2004.07.006; Bahra A, 2003, HEADACHE, V43, P179, DOI 10.1046/j.1526-4610.2003.03041.x; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Boe MG, 2009, EUR J NEUROL, V16, P705, DOI 10.1111/j.1468-1331.2009.02571.x; Boe MG, 2007, NEUROLOGY, V69, P26, DOI 10.1212/01.wnl.0000263652.46222.e8; *CLIN KNOWL SUMM, 2009, HEAD MED OV; D'Amico D, 2008, NEUROL SCI, V29, pS158, DOI 10.1007/s10072-008-0912-7; Descombes S, 2001, HEADACHE, V41, P178, DOI 10.1046/j.1526-4610.2001.111006178.x; Diener H C, 2001, Curr Pain Headache Rep, V5, P545, DOI 10.1007/s11916-001-0061-7; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Diener HC, 2004, LANCET NEUROL, V3, P475, DOI 10.1016/S1474-4422(04)00824-5; Grande RB, 2009, J NEUROL NEUROSUR PS, V80, P784, DOI 10.1136/jnnp.2008.168864; Hagen K, 2009, CEPHALALGIA, V29, P221, DOI 10.1111/j.1468-2982.2008.01711.x; *JOINT FORM COMM, 2009, BRIT NAT FORM; Katsarava Z, 2005, CEPHALALGIA, V25, P12, DOI 10.1111/j.1468-2982.2004.00789.x; Katsarava Z, 2003, NEUROLOGY, V60, P1682, DOI 10.1212/01.WNL.0000063322.14078.90; Katsarava Z, 2001, NEUROLOGY, V57, P1694, DOI 10.1212/WNL.57.9.1694; Katsarava Z, 2009, CURR NEUROL NEUROSCI, V9, P115, DOI 10.1007/s11910-009-0019-4; Krymchantowski AV, 2003, CEPHALALGIA, V23, P982, DOI 10.1046/j.1468-2982.2003.00648.x; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; MATHEW NT, 1987, HEADACHE, V27, P130, DOI 10.1111/j.1526-4610.1987.hed2703130.x; MATHEW NT, 1990, HEADACHE, V30, P634, DOI 10.1111/j.1526-4610.1990.hed3010634.x; Mei D, 2006, CLIN NEUROPHARMACOL, V29, P269, DOI 10.1097/01.WNF.000022888.49044.99; Meskunas CA, 2006, HEADACHE, V46, P766, DOI 10.1111/j.1526-4610.2006.00442.x; Olesen J, 2006, CEPHALALGIA, V26, P742, DOI 10.1111/j.1468-2982.2006.01172.x; Paemeleire K, 2006, NEUROLOGY, V67, P109, DOI 10.1212/01.wnl.0000223332.35936.6e; Pageler L, 2008, CEPHALALGIA, V28, P152, DOI 10.1111/j.1468-2982.2007.01488.x; Rapoport AM, 2008, CNS DRUGS, V22, P995, DOI 10.2165/0023210-200822120-00003; Rossi P, 2008, CEPHALALGIA, V28, P1196, DOI 10.1111/j.1468-2982.2008.01659.x; Rossi P, 2006, CEPHALALGIA, V26, P1097, DOI 10.1111/j.1468-2982.2006.01175.x; *SCOTT INT GUID NE, 2008, 107 DIAGN MAN HEAD A; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; SILVERMAN K, 1992, NEW ENGL J MED, V327, P1109, DOI 10.1056/NEJM199210153271601; Steiner T, 2007, GUIDELINES ALL HEALT; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Suhr B, 1999, CEPHALALGIA, V19, P44, DOI 10.1046/j.1468-2982.1999.1901044.x; Watson DPB, 2008, BRIT J GEN PRACT, V58, P77, DOI 10.3399/bjgp08X264009; Wilkinson SM, 2001, HEADACHE, V41, P303, DOI 10.1046/j.1526-4610.2001.111006303.x; Zeeberg P, 2006, CEPHALALGIA, V26, P1192, DOI 10.1111/j.1468-2982.2006.01190.x; Zeeberg P, 2006, NEUROLOGY, V66, P1894, DOI 10.1212/01.wnl.0000217914.30994.bd	41	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2010	340								c1305	10.1136/bmj.c1305	http://dx.doi.org/10.1136/bmj.c1305			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PN	20427444				2022-12-28	WOS:000277314200002
J	Polonsky, TS; McClelland, RL; Jorgensen, NW; Bild, DE; Burke, GL; Guerci, AD; Greenland, P				Polonsky, Tamar S.; McClelland, Robyn L.; Jorgensen, Neal W.; Bild, Diane E.; Burke, Gregory L.; Guerci, Alan D.; Greenland, Philip			Coronary Artery Calcium Score and Risk Classification for Coronary Heart Disease Prediction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INCIDENT CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS; CALCIFICATION; IMPROVE	Context The coronary artery calcium score (CACS) has been shown to predict future coronary heart disease (CHD) events. However, the extent to which adding CACS to traditional CHD risk factors improves classification of risk is unclear. Objective To determine whether adding CACS to a prediction model based on traditional risk factors improves classification of risk. Design, Setting, and Participants CACS was measured by computed tomography in 6814 participants from the Multi-Ethnic Study of Atherosclerosis (MESA), a population-based cohort without known cardiovascular disease. Recruitment spanned July 2000 to September 2002; follow-up extended through May 2008. Participants with diabetes were excluded from the primary analysis. Five-year risk estimates for incident CHD were categorized as 0% to less than 3%, 3% to less than 10%, and 10% or more using Cox proportional hazards models. Model 1 used age, sex, tobacco use, systolic blood pressure, antihypertensive medication use, total and high-density lipoprotein cholesterol, and race/ethnicity. Model 2 used these risk factors plus CACS. We calculated the net reclassification improvement and compared the distribution of risk using model 2 vs model 1. Main Outcome Measures Incident CHD events. Results During a median of 5.8 years of follow-up among a final cohort of 5878, 209 CHD events occurred, of which 122 were myocardial infarction, death from CHD, or resuscitated cardiac arrest. Model 2 resulted in significant improvements in risk prediction compared with model 1 (net reclassification improvement=0.25; 95% confidence interval, 0.16-0.34; P<.001). In model 1, 69% of the cohort was classified in the highest or lowest risk categories compared with 77% in model 2. An additional 23% of those who experienced events were reclassified as high risk, and an additional 13% without events were reclassified as low risk using model 2. Conclusion In this multi-ethnic cohort, addition of CACS to a prediction model based on traditional risk factors significantly improved the classification of risk and placed more individuals in the most extreme risk categories. JAMA. 2010; 303(16): 1610-1616	[Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [McClelland, Robyn L.; Jorgensen, Neal W.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Bild, Diane E.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Burke, Gregory L.] Wake Forest Univ, Div Publ Hlth Sci, Sch Med, Winston Salem, NC 27109 USA; [Guerci, Alan D.] St Francis Hosp, Ctr Heart, Roslyn, NY USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Wake Forest University	Greenland, P (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 750 N Lake Shore Dr,11th Floor, Chicago, IL 60611 USA.		Greenland, Philip/ABD-5528-2021		Pfizer; National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-95159, N01-HC-95169, 5T32HL069771]; National Center for Research Resources [1UL1RR025741]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095167, N01HC095165, N01HC095166, N01HC095160, N01HC095159, N01HC095168, N01HC095169, N01HC095162, N01HC095163, N01HC095161, N01HC095164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095169, R43HL095169, T32HL069771] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial Disclosures: Dr Guerci reports that he has received grant suppot from Pfizer. Dr Greenland reports that he has served as a consultant to Pfizer and GE/Toshiba. No other disclosures were reported.; Funding/Support: MESA was supported by contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute (NHLBI). Dr Polonsky is supported by an NHLBI training grant in cardiovascular epidemiology and prevention (grant 5T32HL069771). Dr Greenland is supported by a grant from the National Center for Research Resources (grant number 1UL1RR025741).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Diamond GA, 2007, AM J CARDIOL, V99, P1013, DOI 10.1016/j.amjcard.2006.10.070; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; May S, 1998, LIFETIME DATA ANAL, V4, P109, DOI 10.1023/A:1009612305785; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	24	773	800	0	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1610	1616		10.1001/jama.2010.461	http://dx.doi.org/10.1001/jama.2010.461			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424251	Green Accepted, Bronze			2022-12-28	WOS:000277085200024
J	Angers, RC; Kang, HE; Napier, D; Browning, S; Seward, T; Mathiason, C; Balachandran, A; McKenzie, D; Castilla, J; Soto, C; Jewell, J; Graham, C; Hoover, EA; Telling, GC				Angers, Rachel C.; Kang, Hae-Eun; Napier, Dana; Browning, Shawn; Seward, Tanya; Mathiason, Candace; Balachandran, Aru; McKenzie, Debbie; Castilla, Joaquin; Soto, Claudio; Jewell, Jean; Graham, Catherine; Hoover, Edward A.; Telling, Glenn C.			Prion Strain Mutation Determined by Prion Protein Conformational Compatibility and Primary Structure	SCIENCE			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; TRANSGENIC MICE; VARIANT CJD; SCRAPIE; ELK; DEER; TRANSMISSION; PRP; ADAPTATION	Prions are infectious proteins composed of the abnormal disease-causing isoform PrP(Sc), which induces conformational conversion of the host-encoded normal cellular prion protein PrP(C) to additional PrP(Sc). The mechanism underlying prion strain mutation in the absence of nucleic acids remains unresolved. Additionally, the frequency of strains causing chronic wasting disease (CWD), a burgeoning prion epidemic of cervids, is unknown. Using susceptible transgenic mice, we identified two prevalent CWD strains with divergent biological properties but composed of PrP(Sc) with indistinguishable biochemical characteristics. Although CWD transmissions indicated stable, independent strain propagation by elk PrP(C), strain coexistence in the brains of deer and transgenic mice demonstrated unstable strain propagation by deer PrP(C). The primary structures of deer and elk prion proteins differ at residue 226, which, in concert with PrP(Sc) conformational compatibility, determines prion strain mutation in these cervids.	[Angers, Rachel C.; Browning, Shawn; Telling, Glenn C.] Univ Kentucky, Med Ctr, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA; [Kang, Hae-Eun; Napier, Dana; Seward, Tanya; Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Telling, Glenn C.] Univ Kentucky, Dept Neurol, Med Ctr, Lexington, KY 40536 USA; [Mathiason, Candace; Hoover, Edward A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Balachandran, Aru] Canadian Food Inspect Agcy, Ottawa, ON K2H 8P9, Canada; [McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada; [Castilla, Joaquin] Basque Fdn Sci, CIC bioGUNE & IKERBasque, Derio 48992, Bizkaia, Spain; [Castilla, Joaquin] Basque Fdn Sci, CIC bioGUNE & IKERBasque, Bilbao 48011, Bizkaia, Spain; [Soto, Claudio] Univ Texas Med Sch Houston, Houston, TX 77030 USA; [Jewell, Jean] Univ Wyoming, Dept Vet Sci, Laramie, WY 82070 USA; [Graham, Catherine] Canadian Food Inspect Agcy, Lethbridge, AB T1J 3Z4, Canada	University of Kentucky; University of Kentucky; University of Kentucky; Colorado State University; Canadian Food Inspection Agency; University of Alberta; Basque Foundation for Science; CIC bioGUNE; Basque Foundation for Science; University of Texas System; University of Texas Health Science Center Houston; University of Wyoming; Canadian Food Inspection Agency	Telling, GC (corresponding author), Univ Kentucky, Med Ctr, Dept Microbiol Mol Genet & Immunol, Lexington, KY 40536 USA.	gtell2@uky.edu	Mathiason, Candace K/E-7843-2017; Castilla, Joaquín/J-8414-2019; Telling, Glenn C/G-1217-2019; Castilla, Joaquin/E-6952-2012; Mathiason, Candace/H-9769-2017; Castilla, Joaquin/D-5261-2011; McKenzie, Debbie/G-4459-2015	Mathiason, Candace K/0000-0002-5920-4556; Castilla, Joaquín/0000-0002-2216-1361; Telling, Glenn C/0000-0002-6294-1805; Mathiason, Candace/0000-0002-5920-4556; Castilla, Joaquin/0000-0002-2216-1361; McKenzie, Debbie/0000-0002-9291-6977	National Institute of Neurological Disorders and Stroke [2RO1 NS040334-04]; National Institute of Allergy and Infectious Diseases [N01-AI-25491, 1P01AI077774-01]; U.S. Department of Defense [V180003]; National Institute on Drug Abuse [T32 DA022738, T32 AI49795]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025491, T32AI049795, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040334, R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022738] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Defense(United States Department of Defense); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Prionics for mAb 6H4, V. Saylor for technical help, A. Aguzzi for mAb POM2, P. Nelson for neuropathological expertise, R. Kryscio and J. Marcum for biostatistical advice, and C. Ryou for reading the manuscript. C. S. is currently Founder and Chief Scientific Officer of Amprion Inc., a privately held company focusing on exploiting PMCA for sensitive detection of prions and early disease diagnosis. These studies were supported by grant 2RO1 NS040334-04 from the National Institute of Neurological Disorders and Stroke, grants N01-AI-25491 and 1P01AI077774-01 from the National Institute of Allergy and Infectious Diseases, and grant V180003 from the U.S. Department of Defense. R. C. A. and S. B. were supported by T32 DA022738 and T32 AI49795 Training Programs from the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Diseases, respectively.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; BRUCE ME, 1982, ACTA NEUROPATHOL, V58, P133, DOI 10.1007/BF00691654; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Bruce ME, 1979, SLOW TRANSMISSIBLE D, V2, P71; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DICKINSON AG, 1971, MOL GEN GENET, V112, P73, DOI 10.1007/BF00266934; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Green KM, 2008, J GEN VIROL, V89, P598, DOI 10.1099/vir.0.83168-0; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	30	162	163	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 28	2010	328	5982					1154	1158		10.1126/science.1187107	http://dx.doi.org/10.1126/science.1187107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601YR	20466881	Green Accepted			2022-12-28	WOS:000278104700043
J	Lengner, CJ; Gimelbrant, AA; Erwin, JA; Cheng, AW; Guenther, MG; Welstead, GG; Alagappan, R; Frampton, GM; Xu, P; Muffat, J; Santagata, S; Powers, D; Barrett, CB; Young, RA; Lee, JT; Jaenisch, R; Mitalipova, M				Lengner, Christopher J.; Gimelbrant, Alexander A.; Erwin, Jennifer A.; Cheng, Albert Wu; Guenther, Matthew G.; Welstead, G. Grant; Alagappan, Raaji; Frampton, Garrett M.; Xu, Ping; Muffat, Julien; Santagata, Sandro; Powers, Doug; Barrett, C. Brent; Young, Richard A.; Lee, Jeannie T.; Jaenisch, Rudolf; Mitalipova, Maisam			Derivation of Pre-X Inactivation Human Embryonic Stem Cells under Physiological Oxygen Concentrations	CELL			English	Article							EARLY MOUSE EMBRYOS; CHROMOSOME INACTIVATION; IN-VITRO; HUMAN BLASTOCYSTS; HISTONE H3; XIST RNA; SELF-RENEWAL; LINES; DIFFERENTIATION; METHYLATION	The presence of two active X chromosomes (XaXa) is a hallmark of the ground state of pluripotency specific to murine embryonic stem cells (ESCs). Human ESCs (hESCs) invariably exhibit signs of X chromosome inactivation (XCI) and are considered developmentally more advanced than their murine counterparts. We describe the establishment of XaXa hESCs derived under physiological oxygen concentrations. Using these cell lines, we demonstrate that (1) differentiation of hESCs induces random XCI in a manner similar to murine ESCs, (2) chronic exposure to atmospheric oxygen is sufficient to induce irreversible XCI with minor changes of the transcriptome, (3) the Xa exhibits heavy methylation of the XIST promoter region, and (4) XCI is associated with demethylation and transcriptional activation of XIST along with H3K27-me3 deposition across the Xi. These findings indicate that the human blastocyst contains pre-X-inactivation cells and that this state is preserved in vitro through culture under physiological oxygen.	[Lengner, Christopher J.; Cheng, Albert Wu; Guenther, Matthew G.; Welstead, G. Grant; Alagappan, Raaji; Frampton, Garrett M.; Xu, Ping; Muffat, Julien; Santagata, Sandro; Young, Richard A.; Jaenisch, Rudolf; Mitalipova, Maisam] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Frampton, Garrett M.; Young, Richard A.; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert Wu] MIT, Dept Computat & Syst Biol, Cambridge, MA 02139 USA; [Gimelbrant, Alexander A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gimelbrant, Alexander A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Erwin, Jennifer A.; Lee, Jeannie T.] Howard Hughes Med Inst, Ann Arbor, MI 48108 USA; [Powers, Doug] Incept Biosyst, Ann Arbor, MI 48108 USA; [Barrett, C. Brent] Waltham Ctr, Boston IVF, Waltham, MA 02451 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu; mitalipo@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Santagata, Sandro/0000-0002-7528-9668; Muffat, Julien/0000-0003-1889-7023; Gimelbrant, Alexander/0000-0001-6986-0285; Erwin, Jennifer/0000-0002-6784-9290; Cheng, Albert/0000-0003-2653-5743; Frampton, Garrett/0000-0002-2361-2750; Lengner, Christopher/0000-0002-0574-5189	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BATT PA, 1991, REPROD FERT DEVELOP, V3, P601, DOI 10.1071/RD9910601; Bernardi ML, 1996, J REPROD FERTIL, V106, P161, DOI 10.1530/jrf.0.1060161; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Chen HF, 2009, HUM REPROD, V24, P71, DOI 10.1093/humrep/den345; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Forsyth NR, 2008, REGEN MED, V3, P817, DOI 10.2217/17460751.3.6.817; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; HARLOW GM, 1979, AUST J BIOL SCI, V32, P363; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Karja NWK, 2004, THERIOGENOLOGY, V62, P1585, DOI 10.1016/j.theriogenology.2004.03.012; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Kitagawa Y, 2004, THERIOGENOLOGY, V62, P1186, DOI 10.1016/j.theriogenology.2004.01.011; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nesterova TB, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-2; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Prasad SM, 2009, CELL PROLIFERAT, V42, P63, DOI 10.1111/j.1365-2184.2008.00571.x; QUINN P, 1978, J EXP ZOOL, V206, P73, DOI 10.1002/jez.1402060108; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; THOMPSON JGE, 1990, J REPROD FERTIL, V89, P573, DOI 10.1530/jrf.0.0890573; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Wang FN, 2006, CLONING STEM CELLS, V8, P108, DOI 10.1089/clo.2006.8.108; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	54	271	285	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 28	2010	141	5					872	883		10.1016/j.cell.2010.04.010	http://dx.doi.org/10.1016/j.cell.2010.04.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	602IO	20471072	Bronze, Green Published			2022-12-28	WOS:000278132900021
J	Collier, RJ				Collier, R. John			Salmonella's Safety Catch	SCIENCE			English	Editorial Material									Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	john_collier@hms.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022021] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI022021] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Rappl C, 2003, FEMS MICROBIOL LETT, V226, P363, DOI 10.1016/S0378-1097(03)00638-4; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000	6	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 21	2010	328	5981					981	982		10.1126/science.1190758	http://dx.doi.org/10.1126/science.1190758			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	598YW	20489009				2022-12-28	WOS:000277877100024
J	Kappe, SHI; Vaughan, AM; Boddey, JA; Cowman, AF				Kappe, Stefan H. I.; Vaughan, Ashley M.; Boddey, Justin A.; Cowman, Alan F.			That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda	SCIENCE			English	Review							RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; HOST ERYTHROCYTE; PARASITE; VACCINE; TRANSMISSION; RESISTANCE; INFECTION; PROTEINS; EXPORT	The global research community must take up the challenge to work toward the eradication of malaria. In the past, malaria research has focused on drugs and vaccines that target the blood stage of infection, and mainly on the most deadly species, Plasmodium falciparum, all of which is justified by the need to prevent and treat the disease. This work remains critically important today. However, an increased research focus is now being placed on potential interventions that aim to kill the parasite stages transmitted to and by the mosquito vector because they may represent more vulnerable targets to stop the spread of malaria. Here, we highlight some of the research into malaria parasite biology that has the potential to provide new intervention targets for antimalarial drugs and vaccines.	[Kappe, Stefan H. I.; Vaughan, Ashley M.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Boddey, Justin A.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; Walter & Eliza Hall Institute	Kappe, SHI (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	stefan.kappe@seattlebiomed.org	Cowman, Alan F/C-7642-2013	Cowman, Alan F/0000-0001-5145-9004; Boddey, Justin/0000-0001-7322-2040	Foundation for the National Institutes of Health; NIH [R01 AI053709, RO1 A144008]; National Health and Medical Research Council (NHMRC) of Australia; Australia fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053709] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We apologize to many in the field whose work we could not cite because of space constraints. S. H. I. K. is supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiaitve and NIH grant R01 AI053709. A. F. C. is supported by the National Health and Medical Research Council (NHMRC) of Australia, NIH grant RO1 A144008, and an Australia fellowship and is an International Scholar of the Howard Hughes Medical Institute. J.A.B. is supported by a Peter Doherty Postdoctoral Fellowship from NHMRC.	ALY AS, CELL MICROBIOL, DOI DOI 10.1111/J.1462-5822.2010.01440.X; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Bruder JT, 2010, HUM VACCINES, V6, P54, DOI 10.4161/hv.6.1.10463; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Fidock DA, 2008, TRENDS PARASITOL, V24, P537, DOI 10.1016/j.pt.2008.09.005; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Nirmalan N, 2002, MOL MICROBIOL, V46, P179, DOI 10.1046/j.1365-2958.2002.03148.x; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; Pombo DJ, 2002, LANCET, V360, P610, DOI 10.1016/S0140-6736(02)09784-2; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Sutherland CJ, 2009, MOL BIOCHEM PARASIT, V166, P93, DOI 10.1016/j.molbiopara.2009.03.007; Tarun AS, 2008, P NATL ACAD SCI USA, V105, P305, DOI 10.1073/pnas.0710780104; Ting LM, 2008, NAT MED, V14, P954, DOI 10.1038/nm.1867; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; VanBuskirk KM, 2009, P NATL ACAD SCI USA, V106, P13004, DOI 10.1073/pnas.0906387106; Vaughan AM, 2008, CELL HOST MICROBE, V4, P209, DOI 10.1016/j.chom.2008.08.010; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Wang RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001318; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Yuthavong Y, 2006, FUTURE MICROBIOL, V1, P113, DOI 10.2217/17460913.1.1.113; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	39	171	178	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					862	866		10.1126/science.1184785	http://dx.doi.org/10.1126/science.1184785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466924				2022-12-28	WOS:000277618800040
J	Krol, J; Busskamp, V; Markiewicz, I; Stadler, MB; Ribi, S; Richter, J; Duebel, J; Bicker, S; Fehling, HJ; Schubeler, D; Oertner, TG; Schratt, G; Bibel, M; Roska, B; Filipowicz, W				Krol, Jacek; Busskamp, Volker; Markiewicz, Ilona; Stadler, Michael B.; Ribi, Sebastian; Richter, Jens; Duebel, Jens; Bicker, Silvia; Fehling, Hans Joerg; Schuebeler, Dirk; Oertner, Thomas G.; Schratt, Gerhard; Bibel, Miriam; Roska, Botond; Filipowicz, Witold			Characterizing Light-Regulated Retinal MicroRNAs Reveals Rapid Turnover as a Common Property of Neuronal MicroRNAs	CELL			English	Article							GLUTAMATE TRANSPORTERS; EXPRESSION; MECHANISMS; CELLS; IDENTIFICATION; PLASTICITY; TARGET; ACID; RNAS	Adaptation to different levels of illumination is central to the function of the retina. Here, we demonstrate that levels of the miR-183/96/182 cluster, miR-204, and miR-211 are regulated by different light levels in the mouse retina. Concentrations of these microRNAs were downregulated during dark adaptation and upregulated in light-adapted retinas, with rapid decay and increased transcription being responsible for the respective changes. We identified the voltage-dependent glutamate transporter Slc1a1 as one of the miR-183/96/182 targets in photoreceptor cells. We found that microRNAs in retinal neurons decay much faster than microRNAs in nonneuronal cells. The high turnover is also characteristic of microRNAs in hippocampal and cortical neurons, and neurons differentiated from ES cells in vitro. Blocking activity reduced turnover of microRNAs in neuronal cells while stimulation with glutamate accelerated it. Our results demonstrate that microRNA metabolism in neurons is higher than in most other cells types and linked to neuronal activity.	[Krol, Jacek; Busskamp, Volker; Markiewicz, Ilona; Stadler, Michael B.; Ribi, Sebastian; Duebel, Jens; Schuebeler, Dirk; Oertner, Thomas G.; Roska, Botond; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; [Richter, Jens; Bibel, Miriam] Novartis Inst Biomed Res, Neurodegenerat Dept, CH-4002 Basel, Switzerland; [Bicker, Silvia; Schratt, Gerhard] Univ Klinikum Heidelberg, Inst Neuroanat, Heidelberg, Germany; [Bicker, Silvia; Schratt, Gerhard] Heidelberg Univ, Interdisziplinares Zentrum Neurowissensch, Heidelberg, Germany; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany	Friedrich Miescher Institute for Biomedical Research; Novartis; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	botond.roska@fmi.ch; witold.filipowicz@fmi.ch	Oertner, Thomas/F-2214-2010; Roska, Botond/AAD-7268-2021; Busskamp, Volker/E-6339-2015; Ribi, Sebastian/J-4927-2014	Oertner, Thomas/0000-0002-2312-7528; Busskamp, Volker/0000-0001-7517-8944; Ribi, Sebastian/0000-0003-0242-1362; Duebel, Jens/0000-0002-9906-5597	EC FP6 Program; EMBO; National Centers of Competence in Research, Frontiers in Genetics; Novartis Research Foundation	EC FP6 Program; EMBO(European Molecular Biology Organization (EMBO)); National Centers of Competence in Research, Frontiers in Genetics; Novartis Research Foundation	We thank K. J. Sweadner and N. Sonenberg for antibodies; B. Gross Scherf, S. Djaffer, D. Gerosa Erni, and T. Wust for excellent technical help; E. Oakeley for array analysis; and E. Cabuy, H. Kohler, and K. Jacobeit for help with LCM, FASC, and sequencing. We also thank members of W. F. and B. R. groups for valuable discussions. The work done in the laboratory of W. F. is supported by the EC FP6 Program "Sirocco.'' J. K. is the recipient of an EMBO Fellowship. V. B. and B. R. are supported by a fellowship and grant, respectively, from National Centers of Competence in Research, Frontiers in Genetics. The Friedrich Miescher Institute is supported by the Novartis Research Foundation.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; Ding XC, 2009, TRENDS BIOTECHNOL, V27, P27, DOI 10.1016/j.tibtech.2008.09.006; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Kugler P, 2003, HISTOCHEM CELL BIOL, V120, P199, DOI 10.1007/s00418-003-0555-y; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ryan D, 2006, MOL VIS, V12, P1175; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weiler R, 1998, P NATL ACAD SCI USA, V95, P7139, DOI 10.1073/pnas.95.12.7139; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200	41	357	369	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					618	631		10.1016/j.cell.2010.03.039	http://dx.doi.org/10.1016/j.cell.2010.03.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478254	Bronze			2022-12-28	WOS:000277623600015
J	Le Trong, I; Aprikian, P; Kidd, BA; Forero-Shelton, M; Tchesnokova, V; Rajagopal, P; Rodriguez, V; Interlandi, G; Klevit, R; Vogel, V; Stenkamp, RE; Sokurenko, EV; Thomas, WE				Le Trong, Isolde; Aprikian, Pavel; Kidd, Brian A.; Forero-Shelton, Manu; Tchesnokova, Veronika; Rajagopal, Ponni; Rodriguez, Victoria; Interlandi, Gianluca; Klevit, Rachel; Vogel, Viola; Stenkamp, Ronald E.; Sokurenko, Evgeni V.; Thomas, Wendy E.			Structural Basis for Mechanical Force Regulation of the Adhesin FimH via Finger Trap-like beta Sheet Twisting	CELL			English	Article							ESCHERICHIA-COLI; CATCH BONDS; MOLECULAR REPLACEMENT; BACTERIAL ADHESION; CRYSTAL-STRUCTURE; CELL-ADHESION; COMPLEX; BINDING; ALLOSTERY; SELECTIN	The Escherichia coli fimbrial adhesive protein, FimH, mediates shear-dependent binding to mannosylated surfaces via force-enhanced allosteric catch bonds, but the underlying structural mechanism was previously unknown. Here we present the crystal structure of FimH incorporated into the multiprotein fimbrial tip, where the anchoring ( pilin) domain of FimH interacts with the mannose-binding ( lectin) domain and causes a twist in the beta sandwich fold of the latter. This loosens the mannose-binding pocket on the opposite end of the lectin domain, resulting in an inactive low-affinity state of the adhesin. The autoinhibition effect of the pilin domain is removed by application of tensile force across the bond, which separates the domains and causes the lectin domain to untwist and clamp tightly around the ligand like a finger-trap toy. Thus, b sandwich domains, which are common in multidomain proteins exposed to tensile force in vivo, can undergo drastic allosteric changes and be subjected to mechanical regulation.	[Le Trong, Isolde; Stenkamp, Ronald E.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Aprikian, Pavel; Tchesnokova, Veronika; Sokurenko, Evgeni V.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Kidd, Brian A.; Rodriguez, Victoria; Interlandi, Gianluca; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Rajagopal, Ponni; Klevit, Rachel; Stenkamp, Ronald E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Stenkamp, Ronald E.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; [Forero-Shelton, Manu] Univ Los Andes, Dept Phys, Bogota, Colombia; [Forero-Shelton, Manu; Vogel, Viola] ETH, Lab Biol Oriented Mat, Dept Mat, Zurich, Switzerland	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidad de los Andes (Colombia); Swiss Federal Institutes of Technology Domain; ETH Zurich	Stenkamp, RE (corresponding author), Univ Washington, Dept Biol Struct, Box 357420, Seattle, WA 98195 USA.	stenkamp@u.washington.edu; evs@u.washington.edu; wendyt@u.washington.edu	Klevit, Rachel/AAI-7038-2021; Vogel, Viola/O-8025-2015	Klevit, Rachel/0000-0002-3476-969X; Vogel, Viola/0000-0003-2898-7671; Forero-Shelton, Manu/0000-0002-7989-0311; Kidd, Brian/0000-0003-2110-1145	NIH [1RO1 AI50940, 5R01 AI045820, 5T32 GM008268]; AHA [0820107Z]; Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045820, R01AI050940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank NIH (1RO1 AI50940, 5R01 AI045820, and 5T32 GM008268) and the AHA Postdoctoral Fellowship # 0820107Z for funding this work. We thank Eric Larson for helpful discussions and the Advanced Light Source for beamtime. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, the U. S. Department of Energy, under Contract No. DE-AC02-05CH11231.	Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gossert AD, 2008, J MOL BIOL, V375, P752, DOI 10.1016/j.jmb.2007.10.059; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Puorger C, 2008, STRUCTURE, V16, P631, DOI 10.1016/j.str.2008.01.013; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; Sokurenko EV, 2004, MOL BIOL EVOL, V21, P1373, DOI 10.1093/molbev/msh136; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Tchesnokova V, 2008, J BIOL CHEM, V283, P7823, DOI 10.1074/jbc.M707804200; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Waldron TT, 2009, P NATL ACAD SCI USA, V106, P85, DOI 10.1073/pnas.0810620105; Wellens A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002040; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	51	197	200	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 14	2010	141	4					645	655		10.1016/j.cell.2010.03.038	http://dx.doi.org/10.1016/j.cell.2010.03.038			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478255	Bronze, Green Accepted			2022-12-28	WOS:000277623600017
J	Lorincz, A; Nusser, Z				Lorincz, Andrea; Nusser, Zoltan			Molecular Identity of Dendritic Voltage-Gated Sodium Channels	SCIENCE			English	Article							ACTIVITY-DEPENDENT ATTENUATION; ACTION-POTENTIAL INITIATION; NA+ CHANNELS; ION CHANNELS; CELL-TYPE; HIPPOCAMPAL; SUBUNITS; LOCALIZATION; RECEPTORS; DENSITY	Active invasion of the dendritic tree by action potentials (APs) generated in the axon is essential for associative synaptic plasticity and neuronal ensemble formation. In cortical pyramidal cells (PCs), this AP back-propagation is supported by dendritic voltage-gated Na+ (Nav) channels, whose molecular identity is unknown. Using a highly sensitive electron microscopic immunogold technique, we revealed the presence of the Nav1.6 subunit in hippocampal CA1 PC proximal and distal dendrites. Here, the subunit density is lower by a factor of 35 to 80 than that found in axon initial segments. A gradual decrease in Nav1.6 density along the proximodistal axis of the dendritic tree was also detected without any labeling in dendritic spines. Our results reveal the characteristic subcellular distribution of the Nav1.6 subunit, identifying this molecule as a key substrate enabling dendritic excitability.	[Lorincz, Andrea; Nusser, Zoltan] Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Lorincz, A (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Cellular Neurophysiol, H-1083 Budapest, Hungary.	lorincz@koki.hu; nusser@koki.hu	Nusser, Zoltan/K-8587-2014	Nusser, Zoltan/0000-0001-7004-4111	Hungarian Academy of Sciences; European Young Investigator Award; Wellcome Trust	Hungarian Academy of Sciences(Hungarian Academy of Sciences); European Young Investigator Award; Wellcome Trust(Wellcome TrustEuropean Commission)	A.L. is the recipient of a Janos Bolyai Scholarship of the Hungarian Academy of Sciences. Z.N. is the recipient of a European Young Investigator Award (www.esf.org/euryi) and Wellcome Trust Project and Equipment grants. We thank D. Ronaszeki and E. Dobai for their excellent technical help, W. Sieghart and J.-M. Fritschy for antibodies to the GABA<INF>A</INF> receptors, and M. Eyre and M. Farrant for their comments on the manuscript.	BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Boiko T, 2003, J NEUROSCI, V23, P2306; Colbert CM, 1998, J NEUROPHYSIOL, V79, P491, DOI 10.1152/jn.1998.79.1.491; Colbert CM, 1997, J NEUROSCI, V17, P6512; Fritschy JM, 1998, J COMP NEUROL, V390, P194; FUJIMOTO K, 1995, J CELL SCI, V108, P3443; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2002, J PHYSIOL-LONDON, V541, P665, DOI 10.1113/jphysiol.2002.020503; Gong B, 1999, J COMP NEUROL, V412, P342; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; Kamondi A, 1998, J NEUROSCI, V18, P3919; Kole MHP, 2008, NAT NEUROSCI, V11, P1253, DOI 10.1038/nn.2203; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005	32	195	197	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2010	328	5980					906	909		10.1126/science.1187958	http://dx.doi.org/10.1126/science.1187958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	595NT	20466935	Green Accepted			2022-12-28	WOS:000277618800053
J	Martin, KC				Martin, Kelsey C.			Anchoring Local Translation in neurons	CELL			English	Editorial Material							PROTEIN-SYNTHESIS; PLASTICITY		[Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, BSRB 390B,615 Charles E Young Dr S, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH077022] Funding Source: Medline; NINDS NIH HHS [R01 NS045324] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; YOON BC, 2009, CELL DIFFER, V48, P269	6	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 14	2010	141	4					566	568		10.1016/j.cell.2010.04.031	http://dx.doi.org/10.1016/j.cell.2010.04.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	595PH	20478248	Green Accepted, Bronze			2022-12-28	WOS:000277623600008
J	Kaminski, MF; Regula, J; Kraszewska, E; Polkowski, M; Wojciechowska, U; Didkowska, J; Zwierko, M; Rupinski, M; Nowacki, MP; Butruk, E				Kaminski, Michal F.; Regula, Jaroslaw; Kraszewska, Ewa; Polkowski, Marcin; Wojciechowska, Urszula; Didkowska, Joanna; Zwierko, Maria; Rupinski, Maciej; Nowacki, Marek P.; Butruk, Eugeniusz			Quality Indicators for Colonoscopy and the Risk of Interval Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOCIETY TASK-FORCE; COLORECTAL-CANCER; ADENOMA; SURVEILLANCE; PREVENTION; GUIDELINES; FAILURE	BACKGROUND Although rates of detection of adenomatous lesions (tumors or polyps) and cecal intubation are recommended for use as quality indicators for screening colonoscopy, these measurements have not been validated, and their importance remains uncertain. METHODS We used a multivariate Cox proportional-hazards regression model to evaluate the influence of quality indicators for colonoscopy on the risk of interval cancer. Data were collected from 186 endoscopists who were involved in a colonoscopy-based colorectal-cancer screening program involving 45,026 subjects. Interval cancer was defined as colorectal adenocarcinoma that was diagnosed between the time of screening colonoscopy and the scheduled time of surveillance colonoscopy. We derived data on quality indicators for colonoscopy from the screening program's database and data on interval cancers from cancer registries. The primary aim of the study was to assess the association between quality indicators for colonoscopy and the risk of interval cancer. RESULTS A total of 42 interval colorectal cancers were identified during a period of 188,788 person-years. The endoscopist's rate of detection of adenomas was significantly associated with the risk of interval colorectal cancer (P = 0.008), whereas the rate of cecal intubation was not significantly associated with this risk (P = 0.50). The hazard ratios for adenoma detection rates of less than 11.0%, 11.0 to 14.9%, and 15.0 to 19.9%, as compared with a rate of 20.0% or higher, were 10.94 (95% confidence interval [CI], 1.37 to 87.01), 10.75 (95% CI, 1.36 to 85.06), and 12.50 (95% CI, 1.51 to 103.43), respectively (P = 0.02 for all comparisons). CONCLUSIONS The adenoma detection rate is an independent predictor of the risk of interval colorectal cancer after screening colonoscopy.	[Regula, Jaroslaw] Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, Inst Oncol, Warsaw, Poland; [Wojciechowska, Urszula; Didkowska, Joanna] Maria Sklodowska Curie Mem Canc Ctr, Natl Canc Registry Poland, Warsaw, Poland; [Zwierko, Maria] Maria Sklodowska Curie Mem Canc Ctr, Masovian Canc Registry, Warsaw, Poland; [Nowacki, Marek P.] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland; [Regula, Jaroslaw; Kraszewska, Ewa; Polkowski, Marcin; Rupinski, Maciej; Butruk, Eugeniusz] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Regula, J (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol, Inst Oncol, Roentgen St 5, Warsaw, Poland.	jregula@coi.waw.pl	Didkowska, Joanna Aleksandra/ABG-8672-2020; Kaminski, Michal F./AFN-3411-2022; Polkowski, Marcin/K-8897-2012	Didkowska, Joanna Aleksandra/0000-0001-9160-9118; Polkowski, Marcin/0000-0003-4934-9759; Regula, Jaroslaw/0000-0001-7071-3151; Kaminski, Michal/0000-0002-9714-6457; Zwierko, Maria/0000-0001-7294-4164; Rupinski, Maciej/0000-0002-1041-1159	Polish Ministry of Health; Polish Foundation of Gastroenterology	Polish Ministry of Health; Polish Foundation of Gastroenterology	Supported by the Polish Ministry of Health and the Polish Foundation of Gastroenterology.	AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Aronchick CA, 1999, AM J GASTROENTEROL, V94, P2667; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Day N, 1995, J Med Screen, V2, P180; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Doria-Rose VP, 2004, GASTROENTEROLOGY, V127, P714, DOI 10.1053/j.gastro.2004.06.048; Farrar WD, 2006, CLIN GASTROENTEROL H, V4, P1259, DOI 10.1016/j.cgh.2006.07.012; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; Haseman JH, 1997, GASTROINTEST ENDOSC, V45, P451, DOI 10.1016/S0016-5107(97)70172-X; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Percy C, 2000, INT CLASSIFICATION D; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2008, CLIN GASTROENTEROL H, V6, P506, DOI 10.1016/j.cgh.2008.02.025; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Sawhney MS, 2006, GASTROENTEROLOGY, V131, P1700, DOI 10.1053/j.gastro.2006.10.022; Sawhney MS, 2008, GASTROENTEROLOGY, V135, P1892, DOI 10.1053/j.gastro.2008.08.024; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wojciechowska U, 2006, CANC POLAND 2004	33	1310	1353	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2010	362	19					1795	1803		10.1056/NEJMoa0907667	http://dx.doi.org/10.1056/NEJMoa0907667			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	594RQ	20463339				2022-12-28	WOS:000277555500006
J	Tucker, JD; Chen, XS; Peeling, RW				Tucker, Joseph D.; Chen, Xiang-Sheng; Peeling, Rosanna W.			Syphilis and Social Upheaval in China.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tucker, Joseph D.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Tucker, Joseph D.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Chen, Xiang-Sheng] Chinese Acad Med Sci, Dept Epidemiol, Natl Ctr STD Control, Nanjing, Peoples R China; [Chen, Xiang-Sheng] Peking Union Med Coll, Inst Dermatol, Nanjing, Peoples R China; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England	Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; University of London; London School of Hygiene & Tropical Medicine	Tucker, JD (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.			Tucker, Joseph/0000-0003-2804-1181				Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Cohen MS, 1996, J INFECT DIS, V174, pS223, DOI 10.1093/infdis/174.Supplement_2.S223; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; TUCKER JD, B WHO IN PRESS; Tucker J, 2010, SOC SCI MED, V70, P121, DOI 10.1016/j.socscimed.2009.10.010	5	122	138	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2010	362	18					1658	1661		10.1056/NEJMp0911149	http://dx.doi.org/10.1056/NEJMp0911149			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	591OQ	20445179	Bronze, Green Published			2022-12-28	WOS:000277311200003
J	Labonte, R; Marriott, A				Labonte, Ronald; Marriott, Anna			IHP plus : little progress in accountability or just little progress?	LANCET			English	Editorial Material									[Labonte, Ronald] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [Labonte, Ronald] Univ Ottawa, Dept Community Med & Epidemiol, Ottawa, ON K1N 6N5, Canada; [Marriott, Anna] Dev Finance & Publ Serv Team, Oxford, England	University of Ottawa; University of Ottawa	Labonte, R (corresponding author), Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	rlabonte@uottawa.ca	Labonte, Ronald/G-4229-2011					High-Level Forum on Aid Effectiveness, 2008, ACCR AG ACT; *IHP, WELC INT HLTH PARTN; *INT HLTH PARTN, 2007, GLOB COMP ACH MILL D; Kar D., 2010, ILLICIT FINANCIAL FL; Organisation for Economic Co-operation and Development, 2005, OWN HARM AL RES MUT; 2010, DAC MEMBERS COMMITME	6	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 1	2010	375	9725					1505	1507		10.1016/S0140-6736(10)60625-3	http://dx.doi.org/10.1016/S0140-6736(10)60625-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	596AH	20435215				2022-12-28	WOS:000277655100009
J	Teng, XC; Hardwick, JM				Teng, Xinchen; Hardwick, J. Marie			The Apoptosome at High Resolution	CELL			English	Editorial Material							PROVIDES INSIGHTS; CELL-DEATH; CASPASE-9; PLATFORM		[Teng, Xinchen; Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Teng, Xinchen; Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Hardwick, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mhardwic@jhsph.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037402] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077875, R01 GM077875-04] Funding Source: Medline; NINDS NIH HHS [R01 NS037402] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Danot O, 2009, STRUCTURE, V17, P172, DOI 10.1016/j.str.2009.01.001; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Yu XC, 2005, STRUCTURE, V13, P1725, DOI 10.1016/j.str.2005.09.006	9	7	7	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 30	2010	141	3					402	404		10.1016/j.cell.2010.04.015	http://dx.doi.org/10.1016/j.cell.2010.04.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	589UX	20434981	Green Accepted, Bronze			2022-12-28	WOS:000277180800011
J	Wallis, A; Saunders, T				Wallis, Adam; Saunders, Tim			Rational Imaging Imaging transient ischaemic attack with diffusion weighted magnetic resonance imaging	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STROKE; RISK; SCORES		[Wallis, Adam] Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Infirm, Bristol BS2 8HW, Avon, England; [Saunders, Tim] Great Western Hosp NHS Fdn Trust, Great Western Hosp, Swindon SN3 6BB, Wilts, England	Bristol Royal Infirmary; University of Bristol	Wallis, A (corresponding author), Univ Hosp Bristol NHS Fdn Trust, Bristol Royal Infirm, Bristol BS2 8HW, Avon, England.	aw7823@hotmail.com						Asimos AW, 2009, STROKE, V40, P3252, DOI 10.1161/STROKEAHA.109.555425; Boulanger JM, 2007, STROKE, V38, P2367, DOI 10.1161/STROKEAHA.106.475541; Calvet D, 2009, STROKE, V40, P187, DOI 10.1161/STROKEAHA.108.515817; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Crisostomo RA, 2003, STROKE, V34, P932, DOI 10.1161/01.STR.0000061496.00669.5E; Department of Health, 2007, NAT STROK STRAT; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Gonzalez RG, 1999, RADIOLOGY, V210, P155, DOI 10.1148/radiology.210.1.r99ja02155; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Josephson SA, 2008, STROKE, V39, P3096, DOI 10.1161/STROKEAHA.108.514562; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; National Collaborating Centre for Chronic Conditions (UK), 2008, STROK NAT CLIN GUID; Purroy F, 2009, STROKE, V40, P2229, DOI 10.1161/STROKEAHA.108.537969; von Kummer R, 1999, STROKE, V30, P250	15	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2010	340								c2215	10.1136/bmj.c2215	http://dx.doi.org/10.1136/bmj.c2215			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	591PP	20435634				2022-12-28	WOS:000277314400003
J	Eby, DW; Molnar, LJ				Eby, David W.; Molnar, Lisa J.			Driving Fitness and Cognitive Impairment Issues for Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Eby, David W.; Molnar, Lisa J.] Univ Michigan, Transportat Res Inst, Michigan Ctr Advancing Safe Transportat Lifespan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eby, DW (corresponding author), Univ Michigan, Transportat Res Inst, Michigan Ctr Advancing Safe Transportat Lifespan, 2901 Baxter Rd, Ann Arbor, MI 48109 USA.	eby@umich.edu		Eby, David W./0000-0001-8650-0628				*ADED, 2009, BEST PRACT DEL DRIV; Carr D. B., 2010, PHYS GUIDE ASSESSING, V2nd; Dickerson AE, 2007, GERONTOLOGIST, V47, P578, DOI 10.1093/geront/47.5.578; Eby D., 2009, MAINTAINING SAFE MOB; Eby D.W., 2009, MCASTL200903; Langford J, 2006, IATSS RES, V30, P97, DOI 10.1016/S0386-1112(14)60174-6; LOCOCO KH, 809874 DOT HS NAT HI; MAROTTOLI RA, 2008, P N AM LIC POL WORKS; MOLNAR LJ, 2008, CONS BAS REC N AM LI; VANDERBUR M, COMMUNITY MOBILITY D	10	30	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2010	303	16					1642	1643		10.1001/jama.2010.495	http://dx.doi.org/10.1001/jama.2010.495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588PQ	20424255				2022-12-28	WOS:000277085200028
J	Fancher, TL; Henderson, MC; Harris, T; Pitman, D				Fancher, Tonya L.; Henderson, Mark C.; Harris, Tracie; Pitman, Dorothy			Teaching Health Centers and the Primary Care Workforce Crisis for the Underserved	ANNALS OF INTERNAL MEDICINE			English	Letter									[Fancher, Tonya L.; Henderson, Mark C.; Harris, Tracie] Univ Calif Davis, Davis, CA 95616 USA; [Pitman, Dorothy] Sacramento Primary Care Ctr, Sacramento, CA 95820 USA	University of California System; University of California Davis	Fancher, TL (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.			Kravitz, Richard/0000-0001-5575-529X	NIMH NIH HHS [K24 MH072756] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Holmboe ES, 2006, J CONTIN EDUC HEALTH, V26, P109, DOI 10.1002/chp.59; JOLLY P, 2009, ACAD INTERNAL MED IN, V7, P8; Phillips RL, 2009, SPECIALTY GEOGRAPHIC; Rieselbach RE, 2010, ANN INTERN MED, V152, P118, DOI 10.7326/0003-4819-152-2-201001190-00186	4	5	5	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 4	2010	152	9					615	616		10.7326/0003-4819-152-9-201005040-00017	http://dx.doi.org/10.7326/0003-4819-152-9-201005040-00017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	595IN	20439582				2022-12-28	WOS:000277604000012
